0001104659-26-047667.txt : 20260423 0001104659-26-047667.hdr.sgml : 20260423 20260423155932 ACCESSION NUMBER: 0001104659-26-047667 CONFORMED SUBMISSION TYPE: 485BPOS PUBLIC DOCUMENT COUNT: 29 FILED AS OF DATE: 20260423 DATE AS OF CHANGE: 20260423 EFFECTIVENESS DATE: 20260501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT CENTRAL INDEX KEY: 0000948923 ORGANIZATION NAME: EIN: 630169720 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 485BPOS SEC ACT: 1940 Act SEC FILE NUMBER: 811-07337 FILM NUMBER: 26888418 BUSINESS ADDRESS: STREET 1: 2801 STREET 2: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223 BUSINESS PHONE: 2058683586 MAIL ADDRESS: STREET 1: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT CENTRAL INDEX KEY: 0000948923 ORGANIZATION NAME: EIN: 630169720 STATE OF INCORPORATION: TN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 485BPOS SEC ACT: 1933 Act SEC FILE NUMBER: 333-267465 FILM NUMBER: 26888417 BUSINESS ADDRESS: STREET 1: 2801 STREET 2: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223 BUSINESS PHONE: 2058683586 MAIL ADDRESS: STREET 1: 2801 HIGHWAY 280 SOUTH CITY: BIRMINGHAM STATE: AL ZIP: 35223

0000948923 S000010421 PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT

C000239749 Protective Investors Benefit Advisory VUL

485BPOS 1 tm262570d1_485bpos.htm 485BPOS

As Filed with the Securities and Exchange Commission on April 23, 2026

Registration File No. 333-267465
811-07337

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM N-6

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ☒

Pre-Effective Amendment No. ☐

Post-Effective Amendment No. 11 ☒

and

REGISTRATION STATEMENT UNDER THE INVESTMENT COMPANY ACT OF 1940 ☒

Amendment No. 129 ☒

(Check appropriate box or boxes)

Protective Variable Life Separate Account

(Exact name of registrant)

Protective Life Insurance Company

(Name of depositor)

2801 Highway 280 South

Birmingham, Alabama 35223

(Address of depositor’s principal executive offices)

(800) 265-1545

Depositor’s Telephone Number, including Area Code

BRANDON CAGE, Esq.

2801 Highway 280 South

Birmingham, Alabama 35223

(Name and address of agent for service)

Copy to:

STEPHEN E. ROTH, Esquire

THOMAS E. BISSET, Esquire

Eversheds Sutherland (US) LLP

700 Sixth Street, N.W., Suite 700

Washington, DC 20001-3980

It is proposed that this filing will become effective (check appropriate box):

☐ immediately upon filing pursuant to paragraph (b) of Rule 485

☒ on May 1, 2026 pursuant to paragraph (b) of Rule 485

☐ 60 days after filing pursuant to paragraph (a)(1) of Rule 485

☐ on pursuant to paragraph (a)(1) of Rule 485

Title of Securities Being Registered: Interests in Individual
Flexible Premium Variable and Fixed Life Insurance Policies

TABLE OF CONTENTS

PROSPECTUS

May 1, 2026

Protective Investors Benefit Advisory VUL
An Individual Flexible Premium Variable and Fixed Life Insurance Policy

Issued by
Protective Variable Life Separate Account
and
Protective Life Insurance Company
2801 Highway 280 South
Birmingham, Alabama 35223
Telephone: (800) 265‑1545

This Prospectus describes an individual flexible premium variable and fixed life insurance policy (the “Policy”) issued by Protective Life Insurance Company (“Protective Life,” the “Company”, “we”, “our” and “us”) with variable investment options offered under the Company’s Protective Variable Life Separate Account (the “Variable Account”). Variable and fixed life insurance policies are complex investment vehicles and you should speak with a financial professional about Policy features, benefits, risks, and fees and whether the Policy is appropriate for you based on your financial situation and objectives.

This Policy is only available through Financial Intermediaries that may charge an Advisory Fee for their services. The fee that your Financial Intermediary charges you for the management of the Policy Value (“Advisory Fee”) is covered in a separate agreement between you and the Financial Intermediary, and is in addition to the fees and expenses for the Policy that are described in this Prospectus (although some Financial Intermediaries may choose not to charge you an Advisory Fee). If you elect to pay the Advisory Fee from the Policy Value, then these payments will reduce the Policy Value and may reduce the death benefit and other guaranteed benefits, and may be subject to federal and state income taxes, including a 10% additional tax if you are younger than age 59½ and the Policy is a modified endowment contract (“MEC”).

Certain Policy features and/or certain Investment Options offered under the Policy may not be available through all Financial Intermediaries. For further details, please work with your Financial Intermediary to help you choose features and Investment Options for your investment goals and risk tolerance.

If you are a new investor, you may cancel your Policy within 10 days of receiving it without paying fees or penalties. In some states, this Cancellation Period may be longer. Upon cancellation, we will refund the greater of the full amount you paid with your application or the Policy Value. You should review the Prospectus, or consult with your investment professional, for additional information about the specific cancellation terms that apply.

Protective Investors Benefit Advisory VUL provides life insurance coverage, plus the opportunity to earn a return in (i) our guaranteed interest option, and/or (ii) one or more variable investment options set forth in “Fund Appendix: Funds Available Under The Policy” to the Prospectus.

This Prospectus sets forth a description of all material features of the Policy and the Variable Account that you should know before investing. This Prospectus also describes all material state variations to the Policy. Information about certain investment products, including variable life insurance, has been prepared by the SEC staff and is available at Investor.gov.

The Company is not a Financial Intermediary. We are not registered as an investment adviser with the SEC or any state securities regulatory authority. We are not acting in any fiduciary capacity with respect to your Policy. The information in this Prospectus does not constitute personalized investment advice or financial planning advice.

The SEC has not approved or disapproved these securities or passed upon the adequacy of this Prospectus. Any representation to the contrary is a criminal offense.

PRO.PIBAVUL.0526

TABLE OF CONTENTS

	SPECIAL TERMS			3
	IMPORTANT INFORMATION YOU SHOULD CONSIDER ABOUT THE POLICY			6
	FEES AND EXPENSES			6
	RISKS			7
	RESTRICTIONS			7
	TAXES			8
	CONFLICTS OF INTEREST			8
	OVERVIEW OF THE PROTECTIVE INVESTORS BENEFIT ADVISORY VUL POLICY			8
	FEE TABLE			11
	ANNUAL FUND EXPENSES			17
	PRINCIPAL RISKS OF INVESTING IN THE POLICY			17
	THE COMPANY AND THE FIXED ACCOUNT			19
	THE VARIABLE ACCOUNT AND THE FUNDS			20
	CHARGES AND DEDUCTIONS			24
	ADVISORY FEES PAID FROM YOUR POLICY VALUE			28
	THE POLICY			29
	PREMIUMS			30
	CALCULATION OF POLICY VALUE			32

	STANDARD DEATH BENEFITS			33
	OTHER BENEFITS AVAILABLE UNDER THE POLICY			38
	SUPPLEMENTAL RIDERS AND ENDORSEMENTS			43
	TRANSFERS			49
	SURRENDERS AND WITHDRAWALS			51
	LOANS			47
	SUSPENSION OR DELAYS IN PAYMENTS			51
	LAPSE AND REINSTATEMENT			52
	TAX CONSIDERATIONS			53
	EXCHANGE PRIVILEGE			58
	USE OF THE POLICY			60
	STATE VARIATIONS			60
	SALE OF THE POLICIES			60
	LEGAL PROCEEDINGS			61
	FINANCIAL STATEMENTS			61
	APPENDIX: FUNDS AVAILABLE UNDER THE POLICY			62
	APPENDIX: RETURN OF PURCHASE PAYMENT DEATH BENEFIT CALCULATION EXAMPLES			65
	APPENDIX: RIGHT TO CANCEL			67
	APPENDIX: FINANCIAL INTERMEDIARY VARIATIONS			68

TABLE OF CONTENTS

SPECIAL TERMS

“We”, “us”, “our”, “Protective Life”, and “Company” Refer to Protective Life Insurance Company. “You”, “your” and “Owner” refer to the person(s) who have been issued a Policy.

Advisory Fee Advisory Fees are fees paid to your Financial Intermediary for providing investment advice regarding your Policy and for managing your Policy Value. Advisory Fees may be paid directly by you or, subject to certain restrictions, may be paid out of your Policy Value.

Attained Age The Insured’s age as of the nearest birthday on the Policy Effective Date, plus the number of complete Policy Years since the Policy Effective Date.

Beneficiary The person, persons or entity whom the Owner designates to receive the proceeds of the Policy upon the death of the Insured. The Owner may designate a primary Beneficiary or Beneficiaries, as well as a contingent Beneficiary or Beneficiaries to receive the proceeds if there is no primary Beneficiary(ies) living at the time of the Insured’s death. A Beneficiary may also be designated as irrevocable which may limit the Owner’s ability to alter that designation or make future Policy changes.

Cash Value Cash Value is the same as Policy Value.

Code (the “Code”) The Internal Revenue Code of 1986, as amended (the “Code”).

Death Benefit The amount of insurance provided under the Policy used to determine the Death Benefit Proceeds.

Death Benefit Option One of two options that an Owner may select for the computation of Death Benefit Proceeds, Total Face Amount (Option A, Level), or Total Face Amount Plus Policy Value (Option B, Increasing).

Death Benefit Proceeds The amount payable to the Beneficiary if the Insured dies while the Policy is in force. It is equal to the Death Benefit plus any Death Benefit under any rider or endorsement to the Policy less (1) any Policy Debt (2) any liens and (3) less any unpaid Monthly Deductions if the Insured dies during a grace period.

Due Proof of Death Receipt at our Home Office of a certified death certificate or judicial order from a court of competent jurisdiction or similar tribunal.

Evidence of Insurability Information about an Insured which is used to approve or reinstate this Policy or any additional benefit.

Face Amount A dollar amount selected by the Owner and shown in the Policy on the Policy Specifications Page or Supplemental Policy Specifications Page. The minimum Face Amount permitted under the Policy is $100,000.

Financial Intermediary A bank, or an investment adviser registered as such with the SEC or state securities regulatory authorities.

Fixed Account Part of Protective Life’s General Account to or from which Policy Value may be transferred and into which Net Premiums may be allocated under a Policy.

Fixed Account Value The Policy Value in the Fixed Account.

Fund A separate investment portfolio of an open-end management investment company or unit investment trust in which a Sub-Account invests. Also referred to as an “Investment Option”.

General Account All of the Company’s assets other than those allocated to the Variable Account or any other separate account. The Company has complete ownership and control of the assets in the General Account.

Good Order A Request or transaction generally is considered in “Good Order” if we receive it at our Home Office within the time limits, if any, we prescribe for a particular transaction or instruction, it includes all information necessary for us to execute the requested instruction or transaction, and is signed by the individual or individuals authorized to provide the instruction or engage in the transaction. A Request or transaction may be rejected or delayed if not in Good Order. Good Order generally means the actual receipt by us of the instructions relating to the requested transaction in writing (or, when permitted, by telephone or Internet as described above) along with all forms, information and supporting legal documentation we require to affect the instruction or transaction. This information and documentation generally includes, to the extent applicable: the completed application or instruction form; Evidence of Insurability; your Policy number; the transaction amount (in dollars or percentage terms); the names and allocations to and/or from the Funds affected by the requested transaction; the signatures of the Policy Owner (exactly as indicated on the Policy), if necessary; Social Security Number or Tax I.D.; and any other information or supporting documentation that

TABLE OF CONTENTS

we may require, including any consents. With respect to premium payments, Good Order also generally includes receipt by us of sufficient funds to affect the purchase. We may, in our sole discretion, determine whether any particular transaction Request is in Good Order, and we reserve the right to change or waive any Good Order requirement at any time. If you have questions, you should contact us or your financial professional before submitting the form or Request.

Home Office 2801 Highway 280 South, Birmingham, Alabama 35223. The mailing address for the Home Office is P.O. Box 292 Birmingham, AL 35201-0292. The Home Office is referred to as the “Administrative Office” in the Policy.

Initial Face Amount The Face Amount on the Policy Effective Date.

Insured The person whose life is covered by the Policy.

Issue Age The Insured’s age as of the nearest birthday on the Policy Effective Date.

Lapse Termination of the Policy at the expiration of the grace period while the Insured is still living.

Loan Account An account within Protective Life’s General Account to which Fixed Account Value and/or Variable Account Value plus interest credited on the portion of the Policy Value being used as collateral for the outstanding Policy loans is transferred as collateral for Policy loans.

Loan Account Value The Policy Value in the Loan Account.

Minimum Monthly Guarantee Amount For Policies issued on Insured’s Issue Age through 80, the minimum amount of premium payments (net of any Policy Debt or withdrawals) that must be paid each month in order for the Policy’s lapse protection to remain in effect.

Monthly Anniversary Day The same day in each month as the Policy Effective Date.

Monthly Deduction The fees and charges deducted monthly from the Fixed Account Value and/or Variable Account Value as described on the Policy Specifications Page of the Policy Schedule.

Net Amount at Risk The Net Amount at Risk as of any Monthly Anniversary Day is equal to: (a) the Death Benefit discounted at one plus the monthly guaranteed interest rate (the minimum interest rate that may be credited to Fixed Account Value) minus the Policy Value (prior to deducting the Cost of Insurance), if the Death Benefit Option is Death Benefit Option A (Level Death Benefit); or, (b) the Death Benefit minus the Policy Value (prior to deducting the Cost of Insurance) discounted at one plus the monthly guaranteed interest rate, if the Death Benefit Option is Death Benefit Option B (Increasing Death Benefit).

Net Premium A premium payment minus the applicable premium expense charges.

Owner The person, or persons, or entity entitled to all rights in this Policy while the Insured is living including designation as a Beneficiary. These rights are subject to any assignment and to the rights of any irrevocable Beneficiary. The Owner may name a contingent Owner who will own this Policy if the Owner dies while this Policy is in force. If the Owner dies before the Insured, any contingent Owner named in the application, or subsequent endorsement, will become the new Owner. If no contingent Owner is named, the Owner’s estate becomes the new Owner. The Owner may change the Owner (including a contingent Owner) by Written Notice.

Policy Anniversary The same day and month in each Policy Year as the Policy Effective Date.

Policy Debt The sum of all outstanding Policy loans plus accrued interest.

Policy Effective Date The date shown in the Policy as of which coverage under the Policy begins.

Policy Month The Policy Month begins on a Monthly Anniversary Day and ends on the day prior to the next Monthly Anniversary Day.

Policy Value The sum of the Variable Account Value, the Fixed Account Value, and the Loan Account Value.

Policy Year Each period of twelve months commencing with the Policy Effective Date and each Policy Anniversary thereafter.

Request Any written, telephoned, electronic or computerized instruction in a form satisfactory to the Company and received at the Home or Administrative Office from the Owner or an assignee of record, as specified in a form acceptable to the Company and which may be required in writing, or the Beneficiary (as applicable) as required by any provision of the Policy or as required by the Company. In addition, subject to the Company’s administrative requirements as they

TABLE OF CONTENTS

may exist from time to time and to any requirements that may be imposed by the Funds or other investments, the Company reserves the right to require advance Written Notice from the Owner.

Settlement Option The proceeds of the policy are distributed over a period rather than paying them in a lump sum. If a Settlement Option is not selected, the Beneficiary may select a Settlement Option from among those available at that time, or may take the amount due immediately in a lump sum.

Sub-Account A separate division of the Variable Account established to invest in a particular Fund.

Sub-Account Value The sum of the values of the Sub-Accounts credited to the Owner as Policy Value.

Surrender Value The Cash Value minus any outstanding Policy Debt and any liens for payments made under an accelerated death benefit rider or endorsement plus accrued interest.

Valuation Day Each day the New York Stock Exchange and the Home Office are open for business except for a day that a Sub-Account’s corresponding Fund does not value its shares.

Valuation Period The period commencing with the close of regular trading on the New York Stock Exchange on any Valuation Date and ending at the close of regular trading on the New York Stock Exchange on the next succeeding Valuation Date.

Variable Account Protective Variable Life Separate Account, a separate investment account of Protective Life to and from which Policy Value may be transferred and into which Net Premiums may be allocated.

Variable Account Value The sum of all Sub-Account Values.

Written Notice A notice or Request submitted in writing in a form satisfactory to Protective Life and received at the Home Office via U.S. postal service or nationally recognized overnight delivery service.

TABLE OF CONTENTS

IMPORTANT INFORMATION YOU SHOULD CONSIDER ABOUT THE POLICY

	FEES AND EXPENSES
	Charges for Early Withdrawals			If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25. The withdrawal charge applies for as long as you own the Policy. For additional information about charges for early withdrawals, see “CHARGES AND DEDUCTIONS” in the Prospectus.
	Transaction Charges			In addition to withdrawal charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy and charges for transfers between investment options, requesting Policy illustrations, and exercising the Overloan Protection Endorsement. For additional information about transaction charges, see “CHARGES AND DEDUCTIONS” in the Prospectus.
	Ongoing Fees and Expenses (annual charges)			In addition to the withdrawal charge and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, administration, mortality and expense risk, loans including fees and expenses covering the cost of insurance (“COI”) under the Policy and the cost of optional Policy Loans benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy. Fees and expenses under the Policy do not reflect any Advisory Fees paid from your Policy Value or your other assets to the Financial Intermediary. You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:

	Annual Fee			Minimum			Maximum
	Fund Options (Fund fees and expenses) (1)			0.03%			1.24%

(1)

As a percentage of Fund assets.

For additional information about ongoing fees and expenses, see “CHARGES AND DEDUCTIONS” in the Prospectus.

	RISKS
	Risk of Loss			You can lose money by investing in this Policy, including loss of principal. For additional information about the risk of loss, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” in the Prospectus.
	Not a Short-Term Investment			The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered. Withdrawals are not available in the first Policy Year. If you elect to pay Advisory Fees from your Policy Value, such payments will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits. For additional information about the investment profile of the Policy, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “CHARGES AND DEDUCTIONS,” “USE OF THE POLICY,” “TAX CONSIDERATIONS--Taxation of Insurance Policies” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.

TABLE OF CONTENTS

	RISKS
	Risks Associated with Investment Options			An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision. For additional information about the risks associated with Investment Options, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “THE COMPANY AND THE FIXED ACCOUNT,” “THE VARIABLE ACCOUNT AND THE FUNDS” and “FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY” in the Prospectus.
	Insurance Company Risks			An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-888-353-2654. For additional information about Company risks, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” and “THE COMPANY AND THE FIXED ACCOUNT” in the Prospectus.
	Policy Lapse			Your Policy could terminate if the value of your Policy becomes too low to support the Policy’s monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed. For additional information about Policy Lapse, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “PREMIUMS,” “LOANS,” and “LAPSE AND REINSTATEMENT” in the Prospectus.

	RESTRICTIONS
	Investments			While you may transfer amounts in the Sub-Accounts (which invest in shares of a corresponding Fund) and the Fixed Account, certain restrictions and transfer fees apply with regard to the number and amount of such transfers. Transfers are also subject to the excessive trading and market timing policies described in the Prospectus. We reserve the right to remove or substitute Funds as investment options. For additional information about Investment Options, see “TRANSFERS” and “ADDITION, DELETION, OR SUBSTITUTION OF INVESTMENTS” in the Prospectus.
	Optional Benefits			Optional benefits, including Policy Loans, are subject to additional charges. Some optional benefits are available only at the time your Policy is issued and may not be available for all Owners or Insureds. The maximum loan amount we allow at any time may not exceed 99% of the Policy’s Cash Value reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received. If You elect to pay Advisory Fees from your Policy Value, these payments may reduce the death benefit and other guaranteed benefits. For additional information about the optional benefits, see “OTHER BENEFITS AVAILABLE UNDER THE POLICY,” “SUPPLEMENTAL RIDERS AND ENDORSEMENTS,” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Payment of Advisory Fees” in the Prospectus.

TABLE OF CONTENTS

	TAXES
	Tax Implications			You should consult with a tax professional to determine the tax implications regarding the purchase, ownership, and use of a Policy. Withdrawals and surrenders may be subject to income tax and will be taxed at ordinary tax rates. In addition, withdrawals and surrenders may be subject to an additional tax depending on the circumstances. If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC. For additional information about tax implications, see “TAX CONSIDERATIONS” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.

	CONFLICTS OF INTEREST
	Investment Professional Compensation			Some investment professionals have and may receive compensation for selling the Policy to investors which may include revenue sharing, marketing allowances and other compensation. These investment professionals may have a financial incentive to offer or recommend the Policy over another investment. For additional information about compensation, see “SALE OF THE POLICIES” in the Prospectus.
	Exchanges			Some investment professionals may have a financial incentive to offer an investor a new policy in place of the one he or she already owns. You should only exchange your policy if you determine, after comparing the features, fees, and risks of both policies, that it is preferable for you to purchase the new policy rather than continue to own the existing policy. For additional information about exchanges, see “EXCHANGE PRIVILEGE” and “TAX CONSIDERATIONS--Section 1035 Exchanges” in the Prospectus.

OVERVIEW OF THE PROTECTIVE INVESTORS BENEFIT ADVISORY VUL POLICY

Q: What is the Policy, and what is it designed to do?

A: The Policy is an individual flexible premium variable and fixed life insurance policy the primary purpose of which is to provide a Death Benefit which is paid upon the death of the Insured person. The Owner of the Policy is the person, persons, or entity entitled to all rights in this Policy while the Insured (the person whose life is covered by the Policy) is living, including designation of a Beneficiary.

Your Policy is a “flexible premium” policy because you have considerable flexibility in determining when and how much premium you want to pay. Your Policy is “variable” because the Death Benefit and Policy Value vary according to the investment performance of the Sub-Accounts to which you have allocated your premiums and Policy Value. The Policy provides you with an opportunity to take advantage of any increase in your Policy Value but you also bear the risk of any decrease.

Because the Policy is designed to provide benefits on a long-term basis and is not intended for short-term investing, the Policy may not be appropriate for those who have a short-term investment horizon.

If you elect to pay Advisory Fees from your Policy Value, then those payments will reduce the Policy Value and may reduce the death benefits and other guaranteed benefits. If certain requirements are not satisfied, the Advisory Fee payments may be subject to federal and state income taxes, including a 10% additional tax if you are younger than age 59½ and the Policy is a MEC.

Q: What are the Premiums for this Policy?

A: The Policy is designed to be flexible to meet your specific life insurance needs. You have the flexibility to choose the investment options and premiums you pay.

Premium is an amount you pay to the Company to establish and maintain life insurance coverage. The minimum initial premium will vary based on various factors, including the age of the Insured and the Death Benefit Option you select. Thereafter, you have the flexibility to choose the amount and timing of premium payments, within certain limits. Before your premiums are allocated to a Sub-Account, we deduct a premium expense charge.

TABLE OF CONTENTS

You may establish a planned periodic premium. You are not required to pay the planned periodic premium and we will not terminate your Policy merely because you did not. However, payment of insufficient premiums may result in a Lapse of the Policy. Your Policy could Lapse if the value of your Policy becomes too low to support the Policy’s monthly charges.

You may allocate premium to your choice of numerous different investment options available in the Sub-Accounts, as well as a Fixed Account, within your Policy. The Sub-Accounts are separate divisions of the Variable Account (Protective Variable Life Separate Account) that invest in a particular Fund (an underlying mutual fund).

ADDITIONAL INFORMATION ABOUT EACH FUND IS PROVIDED IN AN APPENDIX TO THIS PROSPECTUS. See FUND APPENDIX – Funds Available Under the Policy.

The Fixed Account is part of the Company’s General Account, which holds all of the Company’s assets other than those held in the Variable Account or other separate accounts.

Q: What are the primary features and options that this Policy offers?

Choice of Death Benefit Options. When you apply for the Policy, you must select one of two available Death Benefit Options used to determine the amount payable on the death of the Insured. Each Death Benefit Option is the greater of an amount noted below and the minimum death benefit on the date of death:

Option A (Level): The Face Amount on the Insured’s date of death.

Option B (Increasing): The current Face Amount plus the Policy Value on the Insured’s date of death.

The minimum death benefit is determined by one of two federal tax compliance tests. You choose the test when you apply for the Policy. You cannot change your choice of test after the Policy is issued.

Transfers. At any time after the Cancellation Period (period during which the Owner may return the Policy for a refund), you may transfer Policy Value among the Sub-Accounts and the Fixed Account, subject to restrictions on the amount and frequency of transfers. The Company also may restrict or refuse to honor frequent transfers, including “market timing” transfers.

Withdrawals. You may request a partial withdrawal of your Policy at any time after the first Policy Year. The amount of any partial withdrawal must be at least $500. We will charge an administrative fee not greater than $25 per withdrawal on partial withdrawals. Withdrawals may have tax consequences.

Surrender Benefit. The Owner may surrender this Policy for the surrender benefit. The surrender benefit is the Surrender Value on the date of surrender. The Surrender Value is the Cash Value minus Policy Debt and any liens for payments made under an accelerated death benefit rider or endorsement, plus accrued interest. All coverage will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of surrender of the Policy. Surrenders may have tax consequences.

Loans. While the Policy is in force, the Owner may obtain a loan on the security of the Policy. Policy loan amounts will be withdrawn first on a pro rata basis from the Sub-Accounts and/or Fixed Account unless the Owner specifies otherwise.

Loans may be treated as taxable income if your Policy is a “modified endowment contract” (“MEC”) for federal income tax purposes. See “Tax Considerations”.

Additional Benefits. The following additional benefits are available:

•

Terminal Illness Accelerated Death Benefit Endorsement: This endorsement provides for an accelerated Death Benefit payment to the Owner if the Insured has a qualifying terminal illness and all the terms and conditions of the endorsement are met.

•

ExtendCare Chronic Illness Accelerated Death Benefit Rider: This rider provides one or more accelerated Death Benefit payments to the Owner if the Insured has a qualifying chronic illness that is expected to last 90

TABLE OF CONTENTS

days or more and all of the terms and conditions of the rider are met. There is an additional monthly charge for this optional benefit rider. Not available in CA.

•

Overloan Protection Endorsement: This endorsement provides that your Policy will not Lapse and the Death Benefit will be at least $10,000 as long as all of the terms and conditions of this endorsement are met. There is an additional charge for this optional benefit at the time it is exercised.

•

Income Provider Option Pre-Determined Death Benefit Payout Endorsement: This endorsement converts the payment of Death Benefit Proceeds from a single lump sum to a series of payments pursuant to a specified payment schedule that describes the amount, frequency, and duration of payment of the Death Benefit Proceeds.

•

Accidental Death Benefit Rider: This rider provides an additional death benefit payable if the Insured’s death results from certain accidental causes. There is an additional monthly charge for this optional benefit rider.

•

Children’s Term Insurance Rider: This rider provides a death benefit payable on the death of a covered child. There is an additional monthly charge for this optional benefit rider.

•

Lapse Protection Endorsement: This endorsement guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule as long as all of the terms and conditions of this endorsement are met.

•

Protected Insurability Benefit Rider: This rider provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. There is an additional monthly charge for this optional benefit rider.

•

Waiver of Specified Premium Rider: This rider provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured if the Insured is disabled for at least 6 consecutive months and all the terms and conditions of the rider are met. There is an additional monthly charge for this optional benefit rider.

•

Dollar-Cost Averaging: This program allows for the systematic and automatic transfer, on a monthly or quarterly basis, of specified dollar amounts from a Sub-Account or the Fixed Account to one or more other specified Sub- Accounts.

•

Portfolio Rebalancing: This program allows for the automatic transfer, on a quarterly, semi-annual or annual basis, of Variable Account Value among specified Sub-Accounts to maintain a particular percentage allocation of Variable Account Value.

See “OTHER BENEFITS AVAILABLE UNDER THE POLICY” and “SUPPLEMENTAL RIDERS AND ENDORSEMENTS” in the Prospectus for details on obtaining optional benefits.

TABLE OF CONTENTS

FEE TABLE

The following tables describe the fees and expenses that you will pay when buying, owning, and surrendering or making withdrawals from the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay. Please refer to your Policy specifications page for information about the specific fees you will pay each year based on the options you have elected. On and after the Policy Anniversary when the Insured is age 121, we do not deduct any fees and charges other than the interest charged on loans (if a loan is outstanding).

The first table describes the fees and expenses that you will pay at the time that you pay premiums, allow the Policy to Lapse, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals. These fees and expenses do not reflect any Advisory Fees paid to Financial Intermediaries from Policy Value or other assets of the Owner for the provision of investment advice. If such fees were reflected, costs would be higher.

Transaction Fees
Charge	When Charge is Deducted	Amount Deducted — Maximum Guaranteed Charge	Amount Deducted — Current Charge
Premium Expense Charge (for Policies with an application signed on or after October 13, 2025):	Upon receipt of each premium payment	5%	2%
Premium Expense Charge (for Policies with an application signed before October 13, 2025):	Upon receipt of each premium payment	3.5%	2%
Transfer Fee: (1)	Upon each transfer in excess of 12 in a Policy Year	$25 per transfer	$0 per transfer
Withdrawal Charge:	At the time of each withdrawal of Policy Value	The lesser of 2.0% of the amount withdrawn or $25	The lesser of 2.0% of the amount withdrawn or $25
Overloan Protection Endorsement	When the Benefit is Exercised	5% of Policy Value	5% of Policy Value
Policy Illustration Fee (2)	Upon each illustration request in excess of 1 in a Policy Year	$50 per illustration requested	$0 per illustration requested

(1)

Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.

(2)

Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.

TABLE OF CONTENTS

The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds’ fees and expenses.These fees and expenses do not reflect any Advisory Fees paid to Financial Intermediaries from Policy Value or other assets of the Owner for the provision of investment advice.

Periodic Charges Other Than Fund Operating Expenses
Charge	When Charge is Deducted	Amount Deducted — Maximum Guaranteed Charge	Amount Deducted — Current Charge
Base Contract Charge:
Cost of Insurance (for Policies with an application signed on or after October 13, 2025): (1) (2)
Minimum and Maximum Charge	On the Policy Effective Date and each Monthly Anniversary Day	$0.01-$83.33 per $1,000 of Net Amount at Risk (2)	$0.01-$70.46 per $1,000 of Net Amount at Risk (2)
Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.	On the Policy Effective Date and each Monthly Anniversary Day	$0.18 per $1,000 of Net Amount at Risk	$0.04 per $1000 of Net Amount at Risk
Cost of Insurance (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025): (1) (2)
Minimum and Maximum Charge	On the Policy Effective Date and each Monthly Anniversary Day	$0.01-$83.33 per $1,000 of Net Amount at Risk (2)	$0.01-$59.39 per $1,000 of Net Amount at Risk (2)
Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.	On the Policy Effective Date and each Monthly Anniversary Day	$0.18 per $1,000 of Net Amount at Risk	$0.04 per $1000 of Net Amount at Risk
Cost of Insurance (for Policies with an application signed before February 1, 2024): (1) (2)
Minimum and Maximum Charge	On the Policy Effective Date and each Monthly Anniversary Day	$0.01 – $83.33 per $1,000 of Net Amount at Risk (2)	$0.01 – $81.67 per $1,000 of Net Amount at Risk (2)
Charge for a 49 year old male in the nontobacco class during the first Policy Year.	On the Policy Effective Date and each Monthly Anniversary Day	$0.18 per $1,000 of Net Amount at Risk	$0.07 per $1,000 of Net Amount at Risk

(1)

Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.

(2)

See definition of Net Amount at Risk in the Special Terms.

TABLE OF CONTENTS

Periodic Charges Other Than Fund Operating Expenses
Charge	When Charge is Deducted	Amount Deducted — Maximum Guaranteed Charge	Amount Deducted — Current Charge
Mortality and Expense Risk Charge:	On the Policy Effective Date and each Monthly Anniversary Day	0.050% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount	0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.
Standard Administrative Fee (for Policies with an application signed on or after October 13, 2025):	On the Policy Effective Date and each Monthly Anniversary Day	$9.00	$9.00
Standard Administrative Fee (for Policies with an application signed before October 13, 2025):	On the Policy Effective Date and each Monthly Anniversary Day	$8.00	$8.00
Administrative Charge (for Policies with an application signed on or after October 13, 2025): (3)
Minimum and Maximum Charge	On the Policy Effective Date and each Monthly Anniversary Day	$0.10 – $3.75 per $1,000 of Initial Face Amount	$0.10 – $3.41 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.04-$1.36 per $1,000 of Initial Face Amount thereafter
Charge for a 49 year old male in the nontobacco rate classwith a Face Amount of $100,000.	On the Policy Effective Date and each Monthly Anniversary Day	$0.89 per $1,000 of Initial Face Amount	$0.81 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.33 per $1,000 of Initial Face Amount thereafter
Administrative Charge (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025): (3)
Minimum and Maximum Charge	On the Policy Effective Date and each Monthly Anniversary Day	$0.09 – $3.66 per $1,000 of Initial Face Amount	$0.09 – $3.66 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter
Charge for a 49 year old male in the nontobacco rate class with a Face Amount of $100,000.	On the Policy Effective Date and each Monthly Anniversary Day	$0.45 per $1,000 of Initial Face Amount	$0.45 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter.

(3)

We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

TABLE OF CONTENTS

Periodic Charges Other Than Fund Operating Expenses
Charge	When Charge is Deducted	Amount Deducted — Maximum Guaranteed Charge	Amount Deducted — Current Charge
Administrative Charge (for Policies with an application signed before February 1, 2024): (3)
Minimum and Maximum Charge	On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years	$0.09 – $3.66 per $1,000 of Initial Face Amount	$0.09 – $3.66 per $1,000 of Initial Face Amount
Charge for a 49 year old male in the nontobacco rate class	On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years	$0.31 per $1,000 of Initial Face Amount	$0.31 per $1,000 of Initial Face Amount
Administrative Charge For Face Amount Increases (for Policies with an application signed on or after October 13, 2025): (4)
Minimum and Maximum Charge	On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days	$0.75 – $4.95 per $1,000 of any increase in Face Amount	$0.75 – $4.95 per $1,000 of any increase in Face Amount
Charge for a 49 year old male in the nontobacco rate class	On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days	$3.30 per $1,000 of any increase in Face Amount	$3.30 per $1,000 of any increase in Face Amount
Administrative Charge For Face Amount Increases (for Policies with an application signed before October 13, 2025): (4)
Minimum and Maximum Charge	On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days	$0.39 – $1.74 per $1,000 of any increase in Face Amount	$0.39 – $1.74 per $1,000 of any increase in Face Amount
Charge for a 49 year old male in the nontobacco rate class	On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days	$1.09 per $1,000 of any increase in Face Amount	$1.09 per $1,000 of any increase in Face Amount

(3)

(4)

The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

TABLE OF CONTENTS

Periodic Charges Other Than Fund Operating Expenses
Charge	When Charge is Deducted	Amount Deducted — Maximum Guaranteed Charge	Amount Deducted — Current Charge
Optional Benefit Charges:
Net Cost of Loans (for Policies with an application signed on or after October 13, 2025) (5)	On each Policy Anniversary, as applicable (6)	2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carryover loans.	2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter
Net Cost of Loans (for Policies with an application signed before October 13, 2025) (5)	On each Policy Anniversary, as applicable (6)	4.00% (annually) in Policy Years 1 through 10; 2.25% in Policy Years 11 and thereafter for both standard and carryover loans.	2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter
Children’s Term Life Insurance Rider	On the Effective Date and each Monthly Anniversary Day	$0.45 per $1,000 of rider coverage amount	$0.45 per $1,000 of rider coverage amount
Accidental Death Benefit Rider (7)
Minimum and Maximum Charge	On the Effective Date and each Monthly Anniversary Day	$0.08 – $0.14 per $1,000 of rider coverage amount	$0.08 – $0.14 per $1,000 of rider coverage amount
Charge for a 34 year old	On the Effective Date and each Monthly Anniversary Day	$0.08 per $1,000 of rider coverage amount	$0.08 per $1,000 of rider coverage amount
Waiver of Specified Premium Rider (8)
Minimum and Maximum Charge	On the Effective Date and each Monthly Anniversary Day	$1.86 – $19.19 per $100 of rider coverage amount	$1.86 – $19.19 per $100 of rider coverage amount
Charge for a 39 year old male in the nontobacco class	On the Effective Date and each Monthly Anniversary Day	$4.42 per $100 of rider coverage amount	$4.42 per $100 of rider coverage amount

(5)

The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).

(6)

As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.

(7)

The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

(8)

The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

TABLE OF CONTENTS

Periodic Charges Other Than Fund Operating Expenses
Charge	When Charge is Deducted	Amount Deducted — Maximum Guaranteed Charge	Amount Deducted — Current Charge
ExtendCare Rider (for Policies with an application signed on or after October 13, 2025) (9)
Minimum and Maximum Charge	On the Effective Date and each Monthly Anniversary Day	$0.01 – $18.96 per $1,000 of Net Amount at Risk	$0.01 – $16.62 per $1,000 of Net Amount at Risk
Charge for a 57 year old female in the nontobacco rate class with a Face Amount of $250,000 and monthly benefit of $10,800	On the Effective Date and each Monthly Anniversary Day	$0.01 per $1,000 of Net Amount at Risk	$0.01 per $1,000 of Net Amount at Risk
ExtendCare Rider (for Policies with an application signed before October 13, 2025) (9)
Minimum and Maximum Charge	On the Effective Date and each Monthly Anniversary Day	$0.01 – $29.77 per $1,000 of Net Amount at Risk	$0.01 – $17.90 per $1,000 of Net Amount at Risk
Charge for a 57 year old female in the nontobacco rate class in the First Policy Year with a Face Amount of $250,000 and monthly benefit of $10,800	On the Effective Date and each Monthly Anniversary Day	$0.01 per $1,000 of Net Amount at Risk	$0.01 per $1,000 of Net Amount at Risk
Protected Insurability Benefit Rider (10)
Minimum and Maximum Charge	On the Effective Date and each Monthly Anniversary Day	$0.03 – $0.13 per $1,000 of rider coverage amount	$0.03 – $0.13 per $1,000 of rider coverage amount
Charge for a child less than 6 months old	On the Effective Date and each Monthly Anniversary Day	$0.03 per $1,000 of rider coverage amount	$0.03 per $1,000 of rider coverage amount

(9)

The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. Not available in CA.

(10)

The charge for the Protected Insurability Rider varies based on the Insured’s Issue Age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

TABLE OF CONTENTS

ANNUAL FUND EXPENSES

The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund’s fees and expenses is contained in the prospectus for each Fund.A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See “APPENDIX - FUNDS AVAILABLE UNDER THE POLICY”.

Annual Fund Expenses

Minimum

Maximum

Total Annual Fund Expenses

0.03%

–

1.24% (1)

(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)

(1)

The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.

PRINCIPAL RISKS OF INVESTING IN THE POLICY

Investment Risk

If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. You could lose everything you invest. If you allocate Policy Value to the Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See “The Variable Account and The Funds.”

Risk of Lapse

There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement of the Policy will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See “Lapse and Reinstatement--Lapse” and “Lapse Protection.”

Withdrawal and Surrender Risks

The Surrender Value of the Policy is generally the Cash Value less any Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. The Policy is not suitable as a short-term investment.

Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.

A surrender or withdrawal may have tax consequences. See “TAX CONSIDERATIONS.”

TABLE OF CONTENTS

Advisory Fee Risk

Advisory Fees paid from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits. If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC. See “TAX CONSIDERATIONS--Advisory Fees” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Maximum Permitted Advisory Fee Paid from Policy Value.”

Tax Risks

Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy’s Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.

Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 59½ at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.

If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.

See “Tax Considerations.” You should consult a qualified tax adviser for assistance in all Policy related tax matters.

Loan Risks

A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.

Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See “Policy Loans” and “Tax Considerations — Tax Treatment of Loans.” Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.

If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.

Specialized Uses of the Policy

Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See “Tax Considerations — Other Considerations.”

Fund Risks

A comprehensive discussion of the risks of each Fund may be found in each Fund’s prospectus. Please refer to the Funds’ prospectuses for more information.

TABLE OF CONTENTS

Business Disruption and Cyber Security Risks

We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure (e.g., hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds’ ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.

We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.

THE COMPANY AND THE FIXED ACCOUNT

Protective Life Insurance Company

The Policies are issued by Protective Life. Protective Life is a Nebraska corporation that was founded in 1907. Following its receipt of an Order Approving Redomestication on December 20, 2024, Protective Life redomesticated from Tennessee to Nebraska, and became an insurance company domiciled in the State of Nebraska as of December 31, 2024. Protective Life’s address is P.O. Box 10648, Birmingham, Alabama 35202-0648. Protective Life markets individual life insurance, credit life and disability insurance, guaranteed investment contracts, guaranteed funding agreements, fixed and variable annuities and extended service contracts. Protective Life is currently licensed to transact life insurance business in 49 states and the District of Columbia. Protective Life is the principal operating subsidiary of Protective Life Corporation (“PLC”), a U.S. insurance holding company and a wholly-owned subsidiary of Daiichi Life Group, Inc. (“Daiichi”) (formerly Dai-ichi Life Holdings, Inc.). Daiichi’s stock is traded on the Tokyo Stock Exchange. For more information about us, go to www.protective.com.

The Fixed Account

The Fixed Account consists of assets owned by Protective Life with respect to the Policies, other than those in the Variable Account. Subject to applicable law, Protective Life has sole discretion over the investment of the assets of the Fixed Account. The Loan Account is part of the Fixed Account. Guarantees of Net Premiums allocated to the Fixed Account, and interest credited thereto, are backed by Protective Life. The Fixed Account Value is calculated daily.

You generally may allocate some or all of your Net Premium and may transfer some or all of your Policy Value to the Fixed Account. However, there are limitations on transfers involving the Fixed Account. Due to these limitations, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. You should carefully consider whether the Fixed Account meets your investment needs. See “Transfers of Policy Value.”

Because of exemptive and exclusionary provisions, interests in the Fixed Account have not been registered under the Securities Act of 1933 nor has the Fixed Account been registered as an investment company under the Investment Company Act of 1940. Accordingly, neither the Fixed Account nor any interests therein are subject to the provisions of

TABLE OF CONTENTS

these Acts. The disclosure regarding the Fixed Account may, however, be subject to certain generally applicable provisions of the federal securities laws relating to the accuracy and completeness of statements made in prospectuses.

Interest Credited on Fixed Account Value. The interest rate credited to Net Premiums allocated to or amounts transferred to the Fixed Account will be the annual effective interest rate in effect on the date that the Net Premium(s) is received by Protective Life or the date that the transfer is made. Protective Life, in its sole discretion, may declare a new current interest rate from time to time. Protective Life will credit annual effective interest rates of not less than 1.00%. For purposes of crediting interest, amounts deducted, transferred or withdrawn from the Fixed Account are accounted for on a “first-in-first-out” (FIFO) basis.

For Policies with an application signed before October 13, 2025, Protective Life guarantees that the interest credited during the first Policy Year to the initial Net Premiums allocated to the Fixed Account will not be less than the initial annual effective interest rate shown in the Policy. The interest rate is guaranteed to apply to such amounts for a twelve month period which begins on the date that the Net Premium(s) is allocated or the date that the transfer is made. After an interest rate guarantee expires as to a Net Premium or amount transferred, (i.e., 12 months after the Net Premium or transfer is placed in the Fixed Account) Protective Life will credit interest on the Fixed Account Value attributable to such Net Premium or transferred amount at the current interest rate in effect. New current interest rates are effective for such Fixed Account Value for 12 months from the time that they are first applied.

Payments from the Fixed Account. Payments from the Fixed Account for a withdrawal, surrender or loan request may be deferred for up to six months from the date Protective Life receives the Written Notice in Good Order. If a payment from the Fixed Account is deferred for 30 days or more, it will bear interest at a rate of 3% per year (or an alternative rate if required by applicable state insurance law), compounded annually while payment is deferred.

Our General Account

The Fixed Account is part of our General Account. Unlike premiums and Policy Value allocated to the Variable Account, we assume the risk of investment gain or loss on amounts held in the Fixed Account.

The assets of our General Account support our insurance and annuity obligations and are subject to our general liabilities from business operations and to claims by our creditors. Because amounts allocated to the Fixed Account, plus any guarantees under the Policy that exceed your Policy Value (such as those that may be associated with the Death Benefit), are paid from our General Account, any amounts that we may pay under the Policy in excess of Variable Account Value are subject to our financial strength and claims-paying ability. It is important to note that there is no guarantee that we will always be able to meet our claims-paying obligations, and that there are risks to purchasing any insurance product.

We encourage both existing and prospective Policy Owners to read and understand our financial statements. We prepare our financial statements on a statutory basis, as required by state regulators. Our audited financial statements are incorporated by reference in the Statement of Additional Information (which is available at no charge by calling us at 1-800-456-6330 or writing us at the address shown on the cover page of this Prospectus). In addition, the Statement of Additional Information is available on the SEC’s website at http://www.sec.gov.

You also will find on our website information on ratings assigned to us by one or more independent rating organizations. These ratings are opinions of our financial capacity to meet the obligations of our insurance and annuity contracts based on our financial strength and/or claims-paying ability.

THE VARIABLE ACCOUNT AND THE FUNDS

Protective Variable Life Separate Account

Protective Variable Life Separate Account is a separate investment account of Protective Life established under Tennessee law by the board of directors of Protective Life on February 22, 1995. On December 31, 2024, Protective Life changed to a Nebraska corporation and, accordingly, the Variable Account currently operates under the laws and regulations of Nebraska. The Variable Account is registered with the SEC as a unit investment trust under the 1940 Act and is a “separate account” within the meaning of the federal securities laws.

Protective Life owns the assets of the Variable Account. These assets are held separate from other assets and are not part of Protective Life’s General Account. You assume all of the investment risk for premiums and Policy Value allocated to the Sub-Accounts. Your Policy Value in the Sub-Accounts is part of the assets of the Variable Account. Assets of the Variable Account equal to the reserves or other contract liabilities of the Variable Account will not be charged with liabilities that arise from any other business that Protective Life conducts. Protective Life may transfer to its General Account any assets of the Variable Account which exceed the reserves and other contract liabilities of the Variable Account (which are always at least equal to the aggregate Variable Account Values under the Policies).

TABLE OF CONTENTS

Protective Life may accumulate in the Variable Account the charge for mortality and expense risks and investment results applicable to those assets that are in excess of the reserves and other contract liabilities related to the Policies. Protective Life is obligated to pay all benefits provided under the Policies.

The Variable Account is divided into Sub-Accounts. The income, gains or losses, whether or not realized, from the assets of each Sub-Account are credited to or charged against that Sub-Account without regard to any other income, gains or losses of Protective Life. Each Sub-Account invests exclusively in shares of a corresponding Fund. Therefore, the investment experience of your Policy depends on the experience of the Sub-Accounts you select. In the future, the Variable Account may include other Sub-Accounts that are not available under the Policies and are not otherwise discussed in this Prospectus.

The Funds

Information regarding each Fund is included in an Appendix to this Prospectus. (See Fund Appendix - Funds Available Under the Policy). The Appendix includes the following information about each fund:

•

Fund Name;

•

Type of Fund;

•

Investment adviser and any sub-advisor;

•

Current expenses; and

•

Performance.

There is no assurance that the stated objectives and policies of any of the Funds will be achieved. Each Fund also has a prospectus that contains more detailed information about the Fund. You may obtain a prospectus or a Statement of Additional Information for any of the Funds by contacting Protective Life or by asking your financial professional. You should read the Funds’ prospectuses carefully before making any decision concerning the allocation of Net Premiums or transfers among the Sub-Accounts.

Selection of Funds

We select the Funds offered through the Policies based on several criteria, including the following:

•

asset class coverage;

•

the strength of the investment adviser’s (or sub-adviser’s) reputation and tenure;

•

brand recognition;

•

performance;

•

the capability and qualification of each investment firm; and

•

whether our distributors are likely to recommend the Funds to Policy Owners.

Another factor we consider during the selection process is whether the Fund, its adviser, its sub-adviser, or an affiliate will make payments to us or our affiliates. For a discussion of these arrangements, see “Certain Payments We Receive With Regard to the Funds.” We also consider whether the Fund, its adviser, sub-adviser, or distributor (or an affiliate) can provide marketing and distribution support for sale of the Policies. We review each Fund periodically after it is selected. Upon review, we may remove a Fund or restrict allocation of additional Purchase Payments and/or transfers of Policy Value to a Fund if we determine the Fund no longer meets one or more of the criteria and/or if the Fund has not attracted significant Policy Owner assets. We do not recommend or endorse any particular Fund, and we do not provide investment advice.

Asset Allocation Model Portfolios. Four asset allocation models (“Model Portfolios”) are available at no additional charge as Investment Options under your Policy.

Each Model Portfolio invests different percentages of Policy Value in some or all of the Sub-Accounts under your Policy, and these Model Portfolios range from conservative to aggressive. The Model Portfolios are intended to provide a diversified investment portfolio by combining different asset classes to help you reach your investment goal. Also, while diversification may help reduce overall risk, it does not eliminate the risk of losses and it does not protect against losses in a declining market. There can be no assurance that any of the Model Portfolios will achieve their investment objectives.

TABLE OF CONTENTS

Pursuant to an agreement with Protective, Milliman Financial Risk Management LLC (“Milliman”), a diversified financial services firm and registered investment adviser under the Investment Advisers Act of 1940, as amended, Milliman provides consulting services to Protective Life regarding the composition and review of the Model Portfolios and is compensated by Protective for doing so. There is no investment advisory relationship between Milliman and Owners with respect to the Model Portfolios. In the future, Protective Life may modify or discontinue its arrangement with Milliman, in which case Protective may contract with another firm to provide similar asset allocation models, provide its own asset allocation models, or cease offering asset allocation models. Protective does not provide investment advisory services in making the Model Portfolios or any other service or feature available under the Policy.

The selection of Investment Options in the Model Portfolios involves balancing a number of factors including, but not limited to, the investment objectives, policies and expenses of the Fund in each Model Portfolio, the overall historical performance and volatility of the Funds, marketability of individual Funds and Fund families, marketing support provided to Protective Life and the broker-dealers who sell the Policies and administrative services and marketing support payments made by the Fund’s manager to Protective Life or Investment Distributors, Inc. (“IDI”). Unlike 12b-1 fees, these payments are not paid out of Fund assets.

The available Model Portfolios may change from time to time. In addition, the target asset allocations of these Model Portfolios may vary from time to time in response to market conditions and changes in the portfolio holdings of the Funds in the underlying Sub-Accounts. We will provide written notice if the composition of a model portfolio changes, if there is a material change in our arrangement with Milliman, or if we cease offering asset allocation models altogether. We will not change your existing Policy Value or premium allocation or percentages in response to these changes, however, if you desire to change your Policy Value or premium allocation or percentages to reflect a revised or different Model Portfolio, you must submit new allocation instructions to us in writing to the Home Office.

The following is a brief description of the four Model Portfolios currently available. They are more fully described in a separate brochure. Your Financial Intermediary can provide additional information about the Model Portfolios and help you select which Model Portfolio, if any, may be suitable for you. Please talk to him or her if you have additional questions about these Model Portfolios.

•

Conservative Growth portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 50% in equity and 50% in fixed income investments. The largest of the asset class target allocations are in fixed income, large cap blend and global equity.

•

Moderate Growth portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 65% in equity and 35% in fixed income investments. The largest asset class target allocations are in fixed income, global equity and large cap blend.

•

Growth and Income portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 75% in equity and 25% in fixed income investments. The largest asset class target allocations are in fixed income, large cap blend and global equity.

•

Aggressive Growth portfolio is composed of underlying Sub-Accounts representing a target allocation of approximately 90% in equity and 10% in fixed income investments. The largest asset class target allocations are in large cap blend, global equity, large cap growth, large cap value and small cap growth.

Other Information About the Funds

Shares of these Funds are offered only to: (1) the Variable Account, (2) other separate accounts of Protective Life supporting variable annuity contracts or variable life insurance policies, (3) separate accounts of other life insurance companies supporting variable annuity contracts or variable life insurance policies, and (4) certain qualified retirement plans. Such shares are not offered directly to investors but are available only through the purchase of such variable annuity contracts or variable life insurance policies or through such qualified retirement plans. See the prospectus for each Fund for details about that Fund.

Certain Funds may have investment objectives and policies similar to other mutual funds (sometimes having similar names) that are managed by the same investment adviser or manager. The investment results of the Funds, however, may be more or less favorable than the results of such other mutual funds. Protective Life does not guarantee or make any representation that the investment results of any Fund is, or will be, comparable to any other mutual fund, even one with the same investment adviser or manager.

Certain Payments We Receive With Regard to the Funds from Advisers and/or Distributors

We (and our affiliates) may receive payments from the Funds’ advisers, sub-advisers, distributors, or affiliates thereof. These payments are negotiated and thus differ by Fund (sometimes substantially), and the amounts we (or our affiliates)

TABLE OF CONTENTS

receive may be significant. These payments are made for various purposes, including payment for services provided and expenses incurred by us (and our affiliates) in promoting, marketing, distributing, and administering the Policies; and, in our role as intermediary to the Funds. We (and our affiliates) may profit from these payments. Unlike 12b-1 fees, these payments are not paid out of Fund assets.

We (or our affiliates) also receive payments from the investment advisers, sub-advisers, or distributors (or affiliates thereof) of the Funds. Unlike 12b-1 fees, these payments are not paid out of Fund assets. These payments may be derived, in whole or in part, from the investment advisory fees deducted from Fund assets. Owners, through their indirect investment in the Funds, bear the costs of these investment advisory fees. See the Funds’ prospectuses for more information. The amount of the payments we receive is based on a percentage of the average daily net assets of the particular Fund attributable to the Policies and to certain other variable insurance policies issued or administered by us (or our affiliate). The payments we receive from the investment advisers, sub-advisers or distributors of the Funds currently range from 0.00% to 0.50% of Fund assets attributable to our variable insurance policies. The amount of the payments may be significant.

Other Payments A Fund’s adviser, sub-adviser, or distributor or its affiliates may provide us (or our affiliates) and/ or broker-dealers that sell the Policies (“selling firms”) with marketing support, may pay us (or our affiliates) and/or selling firms amounts to participate in national and regional sales conferences and meetings with the sales desks, and may occasionally provide us (or our affiliates) and/or selling firms with items of relatively small value, such as promotional gifts, meals, tickets, or other similar items in the normal course of business.

For details about the compensation payments we make in connection with the sale of the Policies, see “Sale of the Policies.”

Addition, Deletion, or Substitution of Investments

Protective Life may make additions to, deletions from, or substitutions for the shares that are held in or purchased by the Variable Account. If the shares of a Fund are no longer available for investment or further investment in any Fund should become inappropriate in view of the purposes of the Variable Account, Protective Life may redeem the shares of that Fund and substitute shares of another Fund. Substituted Funds may have higher fees and expenses or may be available only to certain classes of purchasers. Protective Life will not substitute any shares without notice and any necessary approval of the SEC and state insurance authorities.

Protective Life also reserves the right to establish additional Sub-Accounts of the Variable Account, which would each invest in shares corresponding to a new Fund. Subject to applicable law and any required SEC approval, Protective Life may establish new Sub-Accounts or eliminate one or more Sub-Accounts if marketing needs, tax considerations or investment conditions warrant. Any new Sub-Accounts may be made available to existing Owner(s) or may be closed to certain classes of purchasers. Protective Life may prohibit the allocation of Net Premium and transfer of Policy Value to a Sub-Account.

If any of these substitutions or changes are made, Protective Life may by appropriate endorsement change the Policy to reflect the substitution or other change. If Protective Life deems it to be in the best interest of Owner(s), the Variable Account may be operated as a management investment company under the 1940 Act, it may be deregistered under that Act if registration is no longer required, or it may be combined with other Protective Life separate accounts, or its assets may be transferred to other Protective Life separate accounts, subject to any required Owner and/or regulatory approval. Protective Life may make any changes to the Variable Account required by the 1940 Act or other applicable law or regulation.

Voting Fund Shares

Protective Life is the legal owner of Fund shares held by the Sub-Accounts and has the right to vote on all matters submitted to shareholders of the Funds. However, in accordance with applicable law, Protective Life will vote shares held in the Sub-Accounts at meetings of shareholders of the Funds in accordance with instructions received from Owners with Policy Value in the Sub-Accounts. Should Protective Life determine that it is permitted to vote such shares in its own right, it may elect to do so.

Protective Life will send or make available to Owners voting instruction forms and other voting materials (such as Fund proxy statements, reports and other proxy materials) prior to shareholders meetings. The number of votes as to which an Owner may give instructions is calculated separately for each Sub-Account and may include fractional votes.

An Owner holds a voting interest in each Sub-Account to which Variable Account Value is allocated under his or her Policy. Owners only have voting interests while the Insured is alive. The number of votes for which an Owner may give instructions is based on the Owner’s percentage interest of a Sub-Account determined as of the date established by the Fund for determining shareholders eligible to vote at the meeting of that Fund.

TABLE OF CONTENTS

It is important that each Owner provide voting instructions to Protective Life because shares as to which no timely instructions are received and shares held directly by Protective Life are voted by Protective Life in proportion to the voting instructions that are received with respect to all Policies participating in a Sub-Account. As a result, a small number of Owners may control the outcome of a vote. Voting instructions to abstain on any item are applied to reduce the votes eligible to be cast on that item.

Protective Life may, if required by state insurance officials, disregard Owner voting instructions if such instructions would require shares to be voted so as to cause a change in sub-classification or investment objectives of one or more of the Funds, or to approve or disapprove the investment management agreement or an investment advisory agreement. In addition, Protective Life may under certain circumstances disregard voting instructions that would require changes in the investment management agreement, investment manager, an investment advisory agreement or an investment adviser of one or more of the Funds, provided that Protective Life reasonably disapproves of such changes in accordance with applicable regulations under the 1940 Act. If Protective Life ever disregards voting instructions, Owners will be advised of that action and of the reasons for such action in the next semiannual report.

CHARGES AND DEDUCTIONS

This section describes the charges and deductions we make under the Policy to compensate us for the services and benefits we provide, costs and expenses we incur, and risks we assume. We may profit from the charges deducted, and we may use any such profits for any purpose, including payment of distribution expenses. On and after the Policy Anniversary when the Insured is age 121, we do not make any charges and deductions under the Policy, other than the interest charged on loans (if a loan is outstanding).

Premium Expense Charge

We deduct a premium expense charge from each premium you pay. The premium expense charge compensates us for certain sales and premium tax expenses associated with the Policies and the Variable Account. The premium expense charge is equal to 2% of each premium payment you make.

Monthly Deduction

Each month we will deduct an amount from your Policy Value to pay for the benefits provided by your Policy. This amount is called the Monthly Deduction and equals the sum of:

•

the cost of insurance charges;

•

the monthly administration fees and charges;

•

the mortality and expense risk charge; and

•

any charges for supplemental riders.

If you do not select the Sub-Account(s) from which the Monthly Deduction is deducted, the Monthly Deduction, except for the mortality and expense risk charge, will be deducted from the Sub-Accounts and the Fixed Account pro-rata on the basis of the unloaned Policy Value. The mortality and expense risk charge will be deducted from the Sub-Accounts.

The Owner may select the Sub-Accounts from which you want us to deduct the Monthly Deduction, other than the mortality and expense risk charge. However, if as of the date the Monthly Deduction is to be deducted, the value in any of the selected Sub-Accounts is less than the charge to be deducted from that Sub-Account, Protective Life will instead deduct the Monthly Deduction on a pro-rata basis from each Sub-Account and the Fixed Account under the Policy based on the unloaned Policy Value attributable to each Sub-Account and the Fixed Account. Protective Life deducts the mortality and expense risk charge prior to the deduction of the other charges that comprise the Monthly Deduction.

Cost of Insurance Charge. This charge compensates Protective Life for the expense of underwriting the Death Benefit. The charge depends on a number of variables and therefore will vary from Policy to Policy and from Monthly Anniversary Day to Monthly Anniversary Day.

The cost of insurance is equal to:

•

the cost of insurance rate, multiplied by

•

the Net Amount at Risk under the Policy for that Monthly Anniversary Day.

The Net Amount at Risk is equal to:

•

the Death Benefit discounted at one plus the monthly guaranteed interest rate minus the Policy Value (prior to deducting the Cost of Insurance), if the Death Benefit Option is Death Benefit Option A (Level Death Benefit); or

TABLE OF CONTENTS

•

the Death Benefit minus the Policy Value (prior to deducting the Cost of Insurance), discounted at one plus the monthly guaranteed interest rate, if the Death Benefit Option is Death Benefit Option B (increasing Death Benefit).

Anything that decreases Policy Value, such as negative investment experience, withdrawals, or the payment of Advisory Fees from Policy Value, will increase the Net Amount at Risk and result in higher cost of insurance charges. The Net Amount at Risk is affected by investment performance, loans, payments of premiums, Policy fees and charges, the Death Benefit Option chosen, withdrawals, the payment of Advisory Fees from Policy Value, and increases or decreases in Face Amount.

The cost of insurance charge for each increment of Face Amount is calculated separately to the extent a different cost of insurance rate applies. Because the Net Amount at Risk for Death Benefit Option A is equal to the Death Benefit less Policy Value, the entire Policy Value is applied first to offset the Death Benefit derived from the Initial Face Amount. Only if the Policy Value exceeds the Initial Face Amount is the excess applied to offset the portion of the Death Benefit derived from increases in Face Amount in the order of the increases. If there is a decrease in Face Amount after an increase, the decrease is applied first to decrease any prior increases in Face Amount, starting with the most recent increase.

Cost of Insurance Rates. The cost of insurance rate for a Policy is based on and varies with the Issue Age, sex and rate class of the Insured, Face Amount (for Policies with an application signed on or after February 1, 2024), and on the number of years that a Policy has been in force. Protective Life places Insureds in the following rate classes, based on underwriting: Juvenile (ages 0-17), Preferred (ages 18-80) or Nontobacco (ages 18-80), or Select Preferred (ages 18-75), or Tobacco (ages 18-80), and substandard rate classes, which involve a higher mortality risk than these classes. Protective Life guarantees that the cost of insurance rates used to calculate the monthly cost of insurance charge will not exceed the maximum cost of insurance rates set forth in the Policies. The guaranteed rates for standard classes are based on the 2017 Commissioners’ Standard Ordinary Mortality Tables, Male or Female, Smoker or Nonsmoker Mortality Rates, and composite for Juvenile (ages 0-17) (“2017 CSO Tables”). The guaranteed rates for substandard classes are based on multiples of, or additions to, the 2017 CSO Tables.

Protective Life’s current cost of insurance rates may be less than the guaranteed rates that are set forth in the Policy. Current cost of insurance rates will be determined based on Protective Life’s expectations as to future mortality, investment earnings, expenses, taxes, and persistency experience. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience.

Cost of insurance rates (whether guaranteed or current) for an Insured in a non-tobacco standard class are generally lower than guaranteed rates for an Insured of the same age and sex in a tobacco standard class. Cost of insurance rates (whether guaranteed or current) for an Insured in a non-tobacco or tobacco standard class are generally lower than guaranteed rates for an Insured of the same age and sex and smoking status in a substandard class.

Protective Life will also determine a separate cost of insurance rate for each increment of Face Amount above the Initial Face Amount based on the Policy duration and the Issue Age, sex and rate class of the Insured at the time of the request for an increase. The following rules will apply for purposes of determining the Net Amount at Risk for each rate class.

Protective Life places the Insured in a rate class when the Policy is issued, based on Protective Life’s underwriting of the application. This original rate class applies to the Initial Face Amount. When an increase in Face Amount is requested, Protective Life conducts underwriting before approving the increase (except as noted below) to determine whether a different rate class will apply to the increase. If the rate class for the increase has lower cost of insurance rates than the original rate class (or the rate class of a previous increase), the rate class for the increase also will be applied to the Initial Face Amount and any previous increases in Face Amount beginning as of the effective date of the current increase. If the rate class for the increase has a higher cost of insurance rate than the original rate class (or the rate class of a previous increase), the rate class for the increase will apply only to the increase in Face Amount.

Protective Life does not conduct underwriting for an increase in Face Amount if the increase is requested as part of an exercise of any available guaranteed option to increase the Face Amount without underwriting. See “Supplemental Riders and Endorsements.”

In the case of a term conversion, the rate class that applies is the same rate class that applied to the term contract, where applicable. In the case of a guaranteed option, the Insured’s rate class for an increase will be the class in effect when the guaranteed option rider was issued.

Legal Considerations Relating to Sex — Distinct Premium Payments and Benefits. Mortality tables for the Policies generally distinguish between males and females. Thus, premiums and benefits under Policies covering males and females of the same age will generally differ.

Protective Life does, however, also offer Policies based on unisex mortality tables on Policies issued in Montana. Employers and employee organizations considering purchase of a Policy should consult with their legal advisors to

TABLE OF CONTENTS

determine whether purchase of a Policy based on sex-distinct actuarial tables is consistent with Title VII of the Civil Rights Act of 1964 or other applicable law. Upon request, Protective Life may offer Policies with unisex mortality tables to such prospective purchasers.

Monthly Administration Fees (for Policies with an application signed on or after October 13, 2025). We deduct a monthly administrative charge from your Policy Value to compensate us for issue and administrative costs. The monthly administrative charge is $9 per month. We also deduct a monthly administrative charge for the Initial Face Amount which is equal to a fee per $1,000 of Initial Face Amount per month while the Policy is in effect on a guaranteed basis. The administrative charge will apply for all Policy Years and will be higher in the first two Policy Years. The actual fee varies depending on the Insured’s Issue Age, sex and rate classification, and Face Amount. We guarantee that the current monthly administrative charge per $1,000 of Initial Face Amount will not exceed the maximum monthly administrative charge per $1,000 of Initial Face Amount set forth in your Policy. Representative guaranteed administrative charges per $1,000 of Initial Face Amount for an Insured male non-tobacco at each specified Issue Age, and a Face Amount of $100,000 are set forth below:

For Policies with an application signed on or after October 13, 2025:

Issue Age		Administrative Charge Per $1,000 of Initial Face Amount
	35		$	2.50
	40			2.70
	45			3.00
	50			3.40
	55			3.80
	60			4.50
	65			4.95
	70			4.95
	75			4.95

Monthly Administration Fees (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025). We deduct a monthly administrative charge from your Policy Value to compensate us for issue and administrative costs. The monthly administrative charge is $8 per month. We also deduct a monthly administrative charge for the Initial Face Amount which is equal to a fee per $1,000 of Initial Face Amount per month while the Policy is in effect on a guaranteed basis (only imposed for the first 10 Policy Years on a current basis). The actual fee varies depending on the Insured’s Issue Age, sex and rate classification and Face Amount (for Policies with an application signed on or after February 1, 2024). We guarantee that the current monthly administrative charge per $1,000 of Initial Face Amount will not exceed the maximum monthly administrative charge per $1,000 of Initial Face Amount set forth in your Policy. Representative guaranteed administrative charges per $1,000 of Initial Face Amount for an Insured male non-tobacco at each specified Issue Age, and a Face Amount of $100,000 are set forth below:

For Policies with an application signed on or after February 1, 2024, but before October 13, 2025:

Issue Age		Administrative Charge Per $1,000 of Initial Face Amount
	35		$	0.34
	40			0.39
	45			0.45
	50			0.45
	55			0.56
	60			0.70
	65			0.88
	70			1.17
	75			1.56

TABLE OF CONTENTS

For Policies with an application signed before February 1, 2024:

Issue Age		Administrative Charge Per $1,000 of Initial Face Amount
	35		$	0.17
	40			0.22
	45			0.27
	50			0.32
	55			0.41
	60			0.49
	65			0.61
	70			0.78
	75			1.00

For the first twelve months following an increase in Face Amount, the monthly administrative fee will also include an administrative charge for the increase, based on the amount of the increase. The monthly administrative charge for an increase is equal to a fee per $1,000 of increase in Face Amount, which varies depending on Issue Age, sex, and rate classification of the Insured and is set forth in your Policy. Representative administrative charges per $1,000 of increase for an Insured male non-tobacco at each specified Issue Age are set forth below:

Issue Age		Administrative Charge per $1,000 Increase
	35		$	0.71
	40			0.81
	45			0.95
	50			1.13
	55			1.37
	60			1.71
	65			1.73
	70			1.72
	75			1.71

Supplemental Rider Charges. We deduct a monthly charge from your Policy Value to cover administrative expenses for any riders as part of the Monthly Deduction. See “Fee Table -- Periodic Charges Other Than Annual Fund Expenses.”

Mortality and Expense Risk Charge. We deduct a mortality and expense risk charge each month from your Policy Value. This charge compensates Protective Life for the mortality risk it assumes under the Policies. The mortality risk is that the Insureds will live for a shorter time than we project. The expense risk Protective Life assumes is that the expenses that we incur in issuing and administering the Policies and the Variable Account will exceed the amounts realized from the administrative charges assessed against the Policies.

We deduct a monthly charge from assets in the Sub-Accounts attributable to the Policies. This charge does not apply to Fixed Account assets attributable to the Policies. The maximum monthly mortality and expense risk charge to be deducted is generally equal to 0.050% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount. Protective Life reserves the right to charge less than the maximum charge.

The current monthly mortality and expense risk charge is 0.017% multiplied by the Variable Account Value for the first 10 Policy Years, which is equivalent to an annual rate of 0.204% of such amount. After the tenth Policy Year, the current monthly mortality and expense risk charge is 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096%.

Transfer Fee

We allow you to make 12 free transfers of Policy Value each Policy Year. However, Protective Life may charge a $25 transfer fee on any additional transfers in a Policy Year to cover administrative expenses. We will give written notice at least thirty (30) days before we impose a transfer fee or limit the number of transfers. If the fee is imposed, it will be deducted from the amount requested to be transferred. If an amount is being transferred from more than one Sub-Account or the Fixed Account, the transfer fee will be deducted proportionately from the amount being transferred from each. Currently, Protective Life does not charge a transfer fee.

TABLE OF CONTENTS

Withdrawal Charges

Protective Life will deduct an administrative charge upon a withdrawal. This charge is the lesser of 2% of the amount withdrawn or $25. This charge will be deducted from the Policy Value in addition to the amount requested to be withdrawn. See “Withdrawal Privilege” for rules for allocating the deduction.

Net Cost of Loans

The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (1.00% guaranteed for Policies with applications signed before October 13, 2025, and 3.00% guaranteed for Policies with applications signed on or after October 13, 2025).

Fund Expenses

The value of the net assets of each Sub-Account reflects the investment management fees and other expenses incurred by the corresponding Fund in which the Sub-Account invests. For further information, consult the Funds’ prospectuses.

Other Information

We sell the Policies through financial advisers associated with Financial Intermediaries. These financial advisers are also appointed and licensed as insurance agents of Protective Life. We intend to recover marketing, administrative and other expenses and costs of Policy benefits through the fees and charges imposed under the Policies. See “SALE OF THE POLICIES” for more information about these expenses.

Corporate Purchasers or Eligible Groups

The Policy is available for individuals and for corporations and other institutions. For corporate or other group or sponsored arrangements, fee-only arrangements or clients of registered investment advisers purchasing one or more Policies, Protective Life may reduce the amount of the premium expense fee, monthly administration charge, or other charges where the expenses associated with the sale of the Policy or Policies or the underwriting or other administrative costs associated with the Policy or Policies are reduced. Sales, underwriting or other administrative expenses may be reduced for reasons such as expected economies resulting from a corporate purchase, a group or sponsored arrangement or arrangements, fee-only arrangements or clients of registered investment advisers.

ADVISORY FEES PAID FROM YOUR POLICY VALUE

Payment of Advisory Fees

You purchased this Policy through a Financial Intermediary that manages your Policy Value for a fee (“Advisory Fee”). The Advisory Fee for this service is covered in a separate agreement between you and the Financial Intermediary and is in addition to the fees and expenses described in this Prospectus. Subject to certain restrictions, you may elect to have the Advisory Fee paid out of your Policy Value. In order to do so, you will need to fill out an instruction form authorizing these payments (an “Advisory Fee Authorization”). We will deduct the Advisory Fee per your instructions as set forth on the Advisory Fee Authorization on a quarterly or annual basis. The Advisory Fee will be assessed as a percentage of the Policy Value.

Generally, we will not treat the Advisory Fee paid from your Policy Value as a taxable withdrawal if certain conditions are met. In that regard, Protective Life obtained a private letter ruling (PLR) from the Internal Revenue Service regarding the tax treatment of Advisory Fee payments. However, PLRs generally can be relied upon only by the taxpayers who obtained them. For example, you cannot rely on the PLR issued to Protective Life. In any event, Protective Life will follow the conclusions reached in the PLR it received for purposes of Protective Life’s federal income tax reporting and withholding obligations with respect to this Policy, provided that the requirements of that PLR are met. The requirements of the PLR include the following:

•

You and your Financial Intermediary must provide a written Advisory Fee Authorization form (which we will provide to you) that sets forth the amount of the Advisory Fees and the frequency with which the Advisory Fees should be deducted from your Policy Value and paid to your Financial Intermediary.

•

The Advisory Fee may not exceed an amount equal to an annual rate of 1.5% of the Policy Value and the Advisory Fee may be used to compensate your adviser only for investment advice provided to you with respect to the Policy and not for any other services.

TABLE OF CONTENTS

•

During any period for which the Advisory Fee Authorization is in effect, the Advisory Fees that are subject to such authorization must be paid solely out of the Policy Value and you, as the Owner, may not pay such Advisory Fees directly to the Financial Intermediary.

•

The Advisory Fee Authorization must be irrevocable with respect to Advisory Fees paid and to Advisory Fees accrued but not yet paid.

Because the only IRS guidance addressing the treatment of Advisory Fees paid from your Policy are PLRs rather than more precedential guidance, the federal income tax treatment of Advisory Fees paid from your Policy Value remains somewhat uncertain. Regardless of how Protective Life treats the payment of such Advisory Fees for tax reporting and withholding purposes, federal and/or state taxing authorities could determine that the Advisory Fees should be treated as taxable withdrawals from your Policy, in which case the amount of the Advisory Fees deducted from your Policy Value could be included in your gross income for state and federal income tax purposes and a 10% additional tax could apply if the Advisory Fees were withdrawn from your Policy Value before you attained age 59½ and the Policy is a MEC. You should consult a tax adviser regarding the tax treatment of Advisory Fee payments from your Policy Value and consider whether paying such Advisory Fees from another source might be more appropriate for you. (See “FEDERAL TAX MATTERS” and “TAX CONSIDERATIONS--Advisory Fees.”)

Advisory Fees will reduce your Policy Value and the death benefit under the Policy may also be reduced, perhaps significantly.

Maximum Permitted Advisory Fee Paid from Policy Value

If you elect to have the Advisory Fee paid out of your Policy Value, we will deduct the amount of the Advisory Fee pro-rata from the Investment Options (i.e., in the same proportion that each Investment Option has to Policy Value).

If you elect to have the Advisory Fee paid out of your Policy Value, the Advisory Fee will be calculated as a percentage of Policy Value and may be deducted on a quarterly or annual basis. Both the Advisory Fee rate and frequency of deduction are based upon the agreement between you and your Financial Intermediary. However, the annual rate cannot exceed 1.5%. The Advisory Fee will be calculated based upon the Policy Value as of the last day of the end of the previous period. If the Advisory Fee is deducted on a period shorter than annually, the annual rate will be applied to the Policy Value and prorated for the number of days in the period. The Advisory Fee may be charged in advance or arrears.

Once you submit the Advisory Fee Authorization to us to pay your Advisory Fee from your Policy Value, we will continue to make such payments unless you or your Financial Intermediary instruct us to terminate such payment. Owners or their Financial Intermediaries may instruct us to terminate this Advisory Fee Authorization by Written Notice at any time. The Advisory Fee Authorization may also be terminated by telephone, facsimile, automated telephone system or via the Internet at www.protective.com (“non-written instructions”). For non-written instructions regarding termination of your Advisory Fee Authorization we receive via telephone, facsimile or the internet, we may require a form of personal identification prior to acting on instructions and we will record any telephone voice instructions. If we follow these procedures, we will not be liable for any losses due to unauthorized or fraudulent instructions. We reserve the right to limit or eliminate any of these non-written communication methods for any Policy or class of Policies at any time for any reason. For any changes to the Advisory Fee, you must submit a new Advisory Fee Authorization.

We will verify that the amount of the Advisory Fee deducted from your Policy is the amount called for in your Advisory Fee Authorization. We will send you a confirmation of the amount deducted, and you should review to verify that the Advisory Fee amount is accurate.

Please note that we have not made any independent assessment of the qualifications of your Financial Intermediary or its financial advisers to provide investment advisory services, nor do we endorse any Financial Intermediaries or their financial advisers or make any representations as to those qualifications.

THE POLICY

Purchasing a Policy

For insurance coverage to take effect under a Policy, you must submit a completed application and at least the minimum initial premium payment through a licensed representative of Protective Life who is also a registered representative of a broker-dealer having a distribution agreement with Investment Distributors, Inc. Protective Life requires satisfactory evidence of the insurability, which may include a medical examination of the Insured. Generally, Protective Life will issue a Policy covering an Insured up to age 80 if evidence of insurability satisfies Protective Life’s underwriting rules. Minimum age requirements may apply. Acceptance of an application depends on Protective Life’s underwriting rules, and Protective Life may reject an application for any reason. With your consent, a Policy may be issued on a basis other than that applied for (e.g., on a higher premium class basis due to increased risk factors). A

TABLE OF CONTENTS

Policy is issued after Protective Life approves the application. Payment of Premium is not a requirement to issue a Policy but your insurance will not take effect until you pay your minimum initial premium. Premium may be collected at the time of Policy delivery.

Insurance coverage under a Policy begins on the Policy Effective Date. Temporary life insurance coverage also may be provided under the terms of a temporary insurance agreement. Under such agreements, the total amount of insurance which may become effective prior to the Policy Effective Date may not exceed $1,000,000 (including the amount of any life insurance and accidental death benefits then in force or applied for with the Company), may be dependent on satisfactory underwriting and other conditions and may not be in effect for more than 60 days. In addition, such agreement may not be issued on proposed Insureds under 15 days of age.

In order to obtain a more favorable Issue Age, Protective Life may permit the Owner to “backdate” a Policy by electing a Policy Effective Date up to six months prior to the date of the original application, subject to state requirements (3 months in Ohio, not allowed in Montana). Charges for the Monthly Deduction for the backdated period are deducted as of the Policy Effective Date and the calculation of the Policy’s lapse protection will include the Minimum Monthly Premiums for the backdated period.

The Owner of the Policy may exercise all rights provided under the Policy. The Insured is the Owner, unless a different person or entity is named as Owner in the application. By Written Notice received by Protective Life at the Home Office while the Insured is living, the Owner may name a contingent Owner or a new Owner. If there are joint Owners, all Owners must authorize the exercise of any right under the Policy. Unless the Owner provides otherwise, in the event of one joint Owner’s death, ownership passes to any surviving joint Owner(s). Unless a contingent Owner has been named, ownership of the Policy passes to the estate of the last surviving Owner upon his or her death. A change in Owner may have tax consequences. See “Tax Considerations — Other Considerations” in the Prospectus.

Fees, charges and benefits available under the Policy may vary depending on the state in which the Policy is issued.

Cancellation Privilege

You may cancel your Policy for a refund during the Cancellation Period by returning it to Protective Life’s Home Office or to the sales representative who sold it along with a written cancellation request. The Cancellation Period is determined by the law of the state in which the application is signed and is shown in your Policy. In most states it expires at the latest of

10 days after you receive your Policy, or

45 days after you sign your application.

Within seven calendar days after receiving the returned Policy, Protective Life will refund either:

the premiums paid (if required by law), or

the total Policy Value plus any charges that were deducted less any outstanding loan and accrued loan interest. This amount may be more or less than the aggregate premiums paid.

In states requiring the return of premiums paid, Protective Life will refund the greater of 1 and 2 above.

Changes in the Policy or Benefits

At any time Protective Life may make such changes in the Policy as are necessary to assure compliance with any applicable laws or with regulations or rulings issued by a government agency. This includes, but is not limited to, changes necessary to comply at all times with the definition of life insurance prescribed by the Internal Revenue Code of 1986, as amended (“Internal Revenue Code” or “Code”). Any such changes will apply uniformly to all affected Policies and Owners will receive notification of such changes.

PREMIUMS

Minimum Initial Premium. The minimum initial premium required depends on a number of factors, including the age, sex and rate class of the proposed Insured, the Initial Face Amount requested by the applicant, any supplemental riders requested by the applicant and the planned periodic premiums that the applicant selects. Consult your Financial Intermediary for information about the initial premium required for the coverage you desire.

Planned Periodic Premiums. In the application the Owner selects a plan for paying level premiums at specified intervals (i.e., quarterly, semi-annually or annually). At the Owner’s election, we will also arrange for payment of planned periodic premiums on a monthly basis (on any day except the 29th, 30th, or 31st of a month) under a pre-authorized payment arrangement. You are not required to pay premiums in accordance with these plans. You can pay more or less

TABLE OF CONTENTS

than planned or skip a planned periodic premium entirely. See “Lapse and Reinstatement.” Subject to the limits described below, you can change the amount and frequency of planned periodic premiums at any time by Written Notice to Protective Life at the Home Office. Additional premiums may be required to maintain the Policy, depending on a number of factors including past premiums paid, investment experience and loans and/or withdrawals on the Policy.

Unless you have arranged to pay planned periodic premiums by pre-authorized payment arrangement or have otherwise requested, you will be sent reminder notices for planned periodic premiums.

Unscheduled Premiums. Subject to the limitations described below, additional unscheduled premiums may be paid in any amount and at any time. By Written Notice to Protective Life at the Home Office, the Owner may specify that all unscheduled premiums are to be applied as repayments of Policy Debt, if any.

Premium Limitations. Premiums are accepted until Attained Age of 121. Premiums may be paid by any method acceptable to Protective Life. If by check, the check must be from an Owner (or the Owner’s designee other than a sales representative), payable to Protective Life, and be dated prior to its receipt at the Home Office.

Additional limitations apply to premiums. Premium payments must be at least $150 ($50 if paid monthly by a pre-authorized payment arrangement) and must be remitted to the Home Office. Protective Life also reserves the right to limit the amount and frequency of any premium payment. In addition, at any point in time aggregate premiums paid under a Policy may not exceed limitations for life insurance policies as set forth in the Internal Revenue Code. See “Tax Considerations” in the Prospectus and the discussion of Guideline Premium Limitation and Cash Value Accumulation Test under “Calculation of Death Benefit Proceeds.” Protective Life will immediately refund any portion of any premium payment, with interest thereon, that is determined to be in excess of the limits established by law to qualify a Policy as a contract for life insurance. Protective Life will also monitor Policies and will attempt to notify the Owner on a timely basis if his or her Policy is in jeopardy of becoming a modified endowment contract under the Internal Revenue Code, if applicable. See “Tax Considerations” in the Prospectus.

Premium Payments Upon Increase in Face Amount. Depending on the Policy Value at the time of an increase in the Face Amount and the amount of the increase requested, an additional premium payment may be necessary to keep the Policy in force or a change in the amount of planned periodic premiums may be advisable. You will be notified if a premium payment is necessary or a change is appropriate.

Net Premium Allocations

You must indicate in the application how Net Premiums are to be allocated to the Sub-Accounts and/or to the Fixed Account. These allocation instructions apply to both initial and subsequent Net Premiums. You may change the allocation instructions in effect at any time until Attained Age of 121 by Written Notice to Protective Life at the Home Office or by telephone, facsimile, automated telephone system, or via the Internet at www.protective.com. Whole percentages must be used. The sum of the allocations to the Sub-Accounts and the Fixed Account must be equal to 100% of any Net Premiums. Protective Life reserves the right to establish (i) a limitation on the number of Sub-Accounts to which Net Premiums may be allocated and/or (ii) a minimum allocation requirement for the Sub-Accounts and the Fixed Account.

For Policies issued in states where, upon cancellation during the Cancellation Period, Protective Life returns at least your premiums, Protective Life reserves the right to allocate your initial Net Premium (and any subsequent Net Premiums paid during the Cancellation Period) to the Invesco V.I. U.S. Government Money Portfolio Sub-Account or the Fixed Account until the expiration of the number of days in the Cancellation Period plus 6 days starting from the date that the Policy is mailed from the Home Office. Thereafter, the Policy Value in the Invesco V.I. U.S. Government Money Portfolio Sub-Account or the Fixed Account and all Net Premiums will be allocated according to your allocation instructions then in effect.

If Protective Life receives a premium payment at the Home Office before 3:00 P.M. Central Time, Protective Life will process the payment as of the Valuation Day it is received. Protective Life processes premium payments received at the Home Office at or after 3:00 P.M. Central Time as of the next Valuation Day. However, premium will not be accepted in connection with an increase in Face Amount until underwriting has been completed. When approved, Net Premium received will be allocated in accordance to your allocation instructions then in effect.

Unless designated by the Owner as a loan repayment, premiums received from Owners (other than planned periodic premiums) are treated as unscheduled premiums.

Protective Life reserves the right to limit the amount and frequency of planned periodic premiums and additional unscheduled premiums (each an “additional premium”) under the Policy or the amount and frequency of Net Premiums that may be allocated to the Fixed Account at any time. Protective Life also reserves the right to refuse to accept such additional premium under the Policy or allocate additional Net Premium to the Fixed Account at any time without prior notice. In all cases, Protective Life will accept additional premium necessary to prevent the Policy from lapsing.

TABLE OF CONTENTS

Protective Life will attempt to notify the Owner that a premium payment may result in a Policy becoming a Modified Endowment Contract (“MEC”), and will accept the premium payment unless otherwise instructed by the Owner. If a premium payment would cause the Policy to no longer qualify as life insurance under the Internal Revenue Code, the Company will refuse to accept the premium payment.

If mandated by law, we may reject a premium payment. We may also provide information about you and your account to a government regulator.

CALCULATION OF POLICY VALUE

Variable Account Value

The Variable Account Value reflects the investment experience of the Sub-Accounts to which it is allocated, any premiums allocated to the Sub-Accounts, transfers in or out of the Sub-Accounts (including loans), any withdrawals of Variable Account Value, the payment of Advisory Fees from Variable Account Value, and Monthly Deductions. There is no guaranteed minimum Variable Account Value. A Policy’s Variable Account Value therefore depends upon a number of factors. The Variable Account Value for a Policy at any time is the sum of the Sub-Account Values for the Policy on the Valuation Day most recently completed.

Determination of Units

For each Sub-Account, the Net Premium(s) or unloaned Policy Value transferred are converted into units. The number of units credited is determined by dividing the dollar amount directed to each Sub-Account by the value of the unit for that Sub-Account for the Valuation Day on which the Net Premium(s) or transferred amount is invested in the Sub-Account. Therefore, Net Premiums allocated to or amounts transferred to a Sub-Account under a Policy increase the number of units of that Sub-Account credited to the Policy.

Determination of Unit Value

The unit value at the end of every Valuation Day is the unit value at the end of the previous Valuation Day times the net investment factor, as described below. The Sub-Account Value for a Policy is determined on any day by multiplying the number of units attributable to the Policy in that Sub-Account by the unit value for that Sub-Account on that day.

Net Investment Factor

The net investment factor is an index applied to measure the investment performance of a Sub-Account from one Valuation Period to the next. Each Sub-Account has a net investment factor for each Valuation Period which may be greater or less than one. Therefore, the value of a unit may increase or decrease. The net investment factor for any Sub-Account for any Valuation Period is determined by dividing (1) by (2), where:

is the result of:

the net asset value per share of the Fund held in the Sub-Account, determined at the end of the current Valuation Period; plus

the per share amount of any dividend or capital gain distributions made by the Fund to the Sub-Account, if the “ex-dividend” date occurs during the current Valuation Period; plus or minus

a per share charge or credit for any taxes reserved for, which is determined by Protective Life to have resulted from the operations of the Sub-Account.

is the net asset value per share of the Fund held in the Sub-Account, determined at the end of the last prior Valuation Period.

Fixed Account Value

The Fixed Account Value under a Policy at any time is equal to: (1) the Net Premium(s) allocated to the Fixed Account, plus (2) amounts transferred to the Fixed Account, plus (3) interest credited to the Fixed Account, less (4) transfers from the Fixed Account (including any transfer fees deducted), less (5) withdrawals from the Fixed Account (including any withdrawal charges deducted, less (6) loan balances, less (7) Monthly Deductions, and less (8) any Advisory Fees paid from Fixed Account Value. See “The Fixed Account,” for a discussion of how interest is credited to the Fixed Account.

Policy Value Credit

The Policy is eligible for a Policy Value Credit if the Policy is maintained beyond 6 Policy Years. The Policy Value Credit ends immediately upon termination of the Policy. If your Policy is in default or has lapsed, we will not credit your Policy with the Policy Value Credit.

TABLE OF CONTENTS

The Policy Value Credit is not guaranteed. We would pay the Policy Value Credit if the expense, mortality, investment, and persistency experience for all Policies issued under this Prospectus is at least as favorable as the Company assumed when the Policies were issued. The Company assesses the expense, mortality, investment, and persistency experience for the Policies issued under this Prospectus periodically, but no more frequently than annually. The Policy Value Credit actually paid will be determined and applied on a uniform and nondiscriminatory basis. The Policy Value Credit, if any, the Company would pay on a monthly basis will be equal to 0.021% (0.252% annualized) of unloaned Policy Value up to the attained age 100 of the Insured. After age 100, the Policy Value Credit will be 0%. Any Policy Value Credit we pay will not be subject to recapture for any reason. The Policy Value Credit is considered investment experience, not premium and is therefore not subject to the premium expense charge.

The Company may modify or discontinue offering the Policy Value Credit on a prospective basis for new policies issued at any time.

If the conditions for providing the Policy Value Credit have been met, the Policy Value Credit, will be calculated and applied as follows:

•

On each Monthly Anniversary Day, beginning with the first Monthly Anniversary Day in Policy Year 7, the Company will credit additional Policy Value to your Policy.

•

The Policy Value Credit is equal to the Policy Value Credit percentage multiplied by the unloaned Policy Value on the Monthly Anniversary Day plus any Net Premium received on that day and after the processing of any loan, withdrawal, transfer, or surrender requests on that day.

•

The Policy Value Credit is calculated before the Company processes any monthly deductions.

When made, the Company allocates credits to Policy Value among the various Sub-Accounts and the Fixed Account in accordance with the Owner’s current allocation instructions for premiums.

For example, assume your Policy is eligible for a Policy Value Credit and the Policy Value on the Monthly Anniversary Day is $50,000 with a loan balance of $10,000. No premiums have been paid on this day, nor has there been a loan, transfer or surrender request on this day. The Policy Value Credit would be calculated as follows:

•

Unloaned Policy Value = $50,000 – $10,000 = $40,000

•

Policy Value Credit Percentage = 0.021%

•

Policy Value Credit = $40,000 × 0.021% = $8.40

Assume your current allocation instructions for premiums are as follows: 50% to the Fund A Sub-Account; 30% to the Fund B Sub-Account; 20% to the Fixed Account. The Policy Value Credit would be allocated to the following Funds as follows:

•

$8.40 x 50% = $4.20 allocated to the Fund A Sub-Account

•

$8.40 x 30% = $2.52 allocated to the Fund B Sub-Account

•

$8.40 x 20% = $1.68 allocated to the Fixed Account

STANDARD DEATH BENEFITS

Payment of Advisory Fees from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits under your Policy. Work with your Financial Intermediary when selecting your Death Benefit Option and the potential impact of Advisory Fee payments on the death benefit.

As long as the Policy remains in force, Protective Life will pay the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner’s estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option. Payment of the Death Benefit Proceeds may have tax consequences. See “Tax Considerations — Tax Treatment of Life Insurance Death Benefit Proceeds” in the Prospectus.

Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.

If an Owner has elected the Income Provider Option Pre-Determined Death Benefit Payout Endorsement, we will pay the Death Benefit Proceeds pursuant to a payment schedule established according to the terms of the endorsement. See “Supplemental Riders and Endorsements” in the Prospectus.

TABLE OF CONTENTS

Limits on Policy Rights

Incontestability. Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider, after the Policy or rider has been in force during the Insured’s lifetime for two years from the Policy Effective Date or the effective date of the rider. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the evidence of insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.

Suicide Exclusion. If the Insured dies by suicide, while sane or insane, within two years after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Insured dies by suicide within two years after an increase in Face Amount, the Death Benefit with respect to the increase will be limited to the sum of the monthly cost of insurance charges made for that increase.

Misstatement of Age or Sex. If the Insured’s age or sex has been misstated in the application for the Policy or in any application for supplemental riders, the Death Benefit under the Policy or such supplemental riders is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders, at the correct age and sex.

Calculation of Death Benefit Proceeds

The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured’s death, plus benefits under any supplemental riders or endorsements, minus (1) any Policy Debt on that date, (2) any liens for payments made under an accelerated death benefit rider or endorsement including accrued interest, and (3) any past due Monthly Deductions if the Insured died during the grace period.

The calculation of the Death Benefit depends on the Death Benefit option and the federal tax compliance test that you select. You must select the Death Benefit option and the tax compliance test before your Policy is issued. Once the Policy is issued, you may not change the tax compliance test.

Federal Tax Compliance Tests. Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies one of two federal tax compliance tests: (1) the Guideline Premium Limitation/Cash Value Corridor Test, and (2) the Cash Value Accumulation Test.

The Guideline Premium Limitation/Cash Value Corridor Test (“GPT”) has two components, a premium limit component and a corridor component. The premium limit restricts the amount of premium payments that can be paid into the Policy. The corridor requires that the Death Benefit be at least a certain percentage (varying each year by Attained Age of the Insured) of the Policy Value. The Cash Value Accumulation Test (“CVAT”) does not have a premium limit, but does have a requirement that the Death Benefit be at least a certain percentage (varying based on the Attained Age, duration at death, sex and rate class of the Insured) of the Policy Value.

In applying for the Policy, you may select either federal tax compliance test. The Death Benefit will vary depending on which test is selected. There are a number of considerations involved in deciding which test to use.

For example, if your goal is to maximize your Cash Value in early Policy Years relative to the Policy’s Death Benefit and other benefits, you may want to consider selecting the CVAT because it generally permits more premiums to be paid in early Policy years. The CVAT may require the Policy to have a higher Death Benefit relative to the Policy’s Cash Value in later Policy Years, however, which could increase the mortality charges that will apply in those later years.

Alternatively, if your goal is to maximize your Cash Value in later Policy Years relative to the Policy’s Death Benefit and other benefits, you may want to consider selecting the GPT and paying premiums up to the maximum permitted by the GPT. Funding a Policy in this manner may allow for lower mortality charges in later Policy Years in comparison with the mortality charges that would apply under a Policy tested under the CVAT.

Which federal tax compliance test is better for you will depend on not only your goals, but on a number of other considerations. These other considerations include, but are not limited to, the characteristics of the Insured, the amount and timing of premiums that will be paid, and the earnings under the Policy.

The Death Benefit Option you choose will also affect the amount of your Death Benefit. If the GPT applies to the Policy, under Death Benefit Option A, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the Policy Value multiplied by the applicable specified percentage is greater than the Face Amount under the Policy. Under Death Benefit Option B, your Death Benefit will always vary with Policy Value.

Similarly, if the CVAT applies to the Policy, under Death Benefit Option A, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the minimum death benefit is greater

TABLE OF CONTENTS

than the Face Amount under the Policy. Under Death Benefit Option B, your Death Benefit will always vary with the Policy Value. See “Death Benefit Options” for detailed information about each Death Benefit Option.

You should consult your Financial Intermediary for more information about which federal tax compliance test and death benefit option you should choose in light of your specific goals and circumstances.

The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary, or Beneficiaries, in a lump sum, unless a Settlement Option has been selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured’s death and are moved to the general account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.

Death Benefit Options

Payments of Advisory Fees from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits under your Policy. Work with your Financial Intermediary when selecting your Death Benefit Option and the potential impact of Advisory Fee payments on the death benefit.

Death Benefit Options Under Policies Complying with the Guideline Premium Limitation/Cash Value Corridor Test. If the Policy is not issued under the Cash Value Accumulation Test, it will satisfy the Guideline Premium Limitation/Cash Value Corridor Test of federal tax law and the Death Benefit is determined as follows:

•

Under Death Benefit Option A, the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured’s death, or (2) a specified percentage of the Policy Value on the date of the Insured’s death as indicated on a table set forth in Appendix A to the Prospectus.

•

Under Death Benefit Option B, the Death Benefit is the greater of: (1) the Face Amount under the Policy plus the Policy Value on the date of the Insured’s death, or (2) a specified percentage of the Policy Value on the date of the Insured’s death as indicated on a table set forth in Appendix A to the Prospectus.

The specified percentage under both options is 250% when the Insured has reached an Attained Age of 40 or less by date of death and decreases each year thereafter to 100% when the Insured has reached an Attained Age of 95 or greater at death. A table showing these percentages for Attained Ages 0 to 95 and examples of Death Benefit calculations for both Death Benefit Options are found in Appendix A to the Prospectus.

Under Death Benefit Option A, the Death Benefit remains level at the Face Amount unless the Policy Value multiplied by the specified percentage of Policy Value exceeds that Face Amount, in which event the Death Benefit varies as the Policy Value varies. Owners who are satisfied with the amount of their insurance coverage under the Policy and who prefer to have favorable investment performance and additional premiums reflected in higher Policy Value, rather than increased Death Benefits, generally should select Option A. Under Death Benefit Option B, the Death Benefit always varies as the Policy Value varies (although it is never less than the Face Amount). Owners who prefer to have favorable investment performance and additional premiums reflected in increased Death Benefits generally should select Option B.

Death Benefit Options Under Policies Complying with the Cash Value Accumulation Test. If the Policy is issued under the Cash Value Accumulation Test, the Death Benefit is determined as follows:

•

Under Death Benefit Option A, the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured’s death, or (2) the minimum death benefit described below.

•

Under Death Benefit Option B, the Death Benefit is the greater of: (1) the Face Amount under the Policy plus the Policy Value on the date of the Insured’s death, or (2) the minimum death benefit described below.

The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.

For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating

TABLE OF CONTENTS

the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured attains age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.

Owners who are satisfied with the amount of their insurance coverage under the Policy and who prefer to have favorable investment performance and additional premiums reflected in higher Policy Value, rather than increased Death Benefits, generally should select Option A. Under Death Benefit Option B, the Death Benefit always varies as the Policy Value varies (although it is never less than the Face Amount). Owners who prefer to have favorable investment performance and additional premiums reflected in increased Death Benefits generally should select Option B.

Examples of Death Benefit calculations for both Death Benefit Options under the Cash Value Accumulation Test are found in Appendix A to the Prospectus.

Changing Death Benefit Options

The Owner must indicate a Death Benefit Option in the application for the Policy. On or after the first Policy Anniversary, the Owner may change the Death Benefit Option on the Policy subject to the following rules. The request must be received in writing in Good Order at the Home Office. After any change, the Face Amount must be at least $100,000. The effective date of the change will be the Monthly Anniversary Day that coincides with or next follows the day that Protective Life approves the request. Protective Life may require satisfactory evidence of insurability. All changes must be approved by Protective Life at the Home Office before they will be effective. Protective Life reserves the right to decline to change the Death Benefit Option if the change would cause the Policy to fail to qualify as a life insurance contract under the Internal Revenue Code.

When a change from Option A to Option B is made, the Face Amount after the change is effected will be equal to the Face Amount before the change less the Policy Value on the effective date of the change. When a change from Option B to Option A is made, the Face Amount after the change will be equal to the Face Amount before the change is effected plus the Policy Value on the effective date of the change.

Changing the Face Amount

On or after the first Policy Anniversary, the Owner may request a change in the Face Amount. The request must be received in writing in Good Order at the Home Office.

Increasing the Face Amount. Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. In addition, the Insured’s current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See “Premiums Upon Increase in Face Amount.” The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy’s lapse protection is in effect, the Policy’s Minimum Monthly Premium amount will also generally be increased.

An administrative fee will be charged for the first twelve months following an increase in the Face Amount.

As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (i.e., credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See “Tax Considerations — Other Considerations.” Please consult your tax advisor.

Decreasing the Face Amount. If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See “Tax Considerations — Policies which are MECs.”

Protective Life reserves the right to decline a request to decrease the Face Amount if compliance with the Guideline Premium Limitation under current tax law resulting from such a decrease would result in the Policy failing the definition of life insurance, or if to effect the requested decrease, payments to the Owner would have to be made from Policy Value for compliance with the Guideline Premium Limitation, and the amount of such payments would exceed the Surrender Value under the Policy.

TABLE OF CONTENTS

The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.

Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. Decreasing the Face Amount also may have tax consequences. See “Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years.”

Settlement Options

The Company offers a variety of ways of receiving proceeds payable under the Policy, such as on surrender or death, other than in a lump sum. Any sales representative authorized to sell this Policy can further explain these settlement options upon request. All of these settlement options are forms of fixed-benefit annuities, which do not vary with the investment performance of a separate account. Under each of the fixed-benefit settlement options, no surrender or withdrawal may be made once payments have begun.

The following settlement options may be elected.

Option 1 — Payment for a Fixed Period. Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.

Option 2 — Life Income with Payments for a Guaranteed Period. Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.

Option 3 — Interest Income. Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.

Option 4 — Payments for a Fixed Amount. Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.

Minimum Amounts. Protective Life reserves the right to pay the total amount of the Policy in one lump sum, if less than $5,000. If monthly payments are less than $50, payments may be made quarterly, semi-annually, or annually at Protective Life’s option.

Other Requirements. Settlement options must be elected by Written Notice in Good Order received by Protective Life at the Home Office. The Owner may elect settlement options during the Insured’s lifetime; Beneficiaries may elect settlement options thereafter if Death Benefit Proceeds are payable in a lump sum. The effective date of an option applied to Death Benefit Proceeds is the date the Due Proof of Death of the Insured is received at the Home Office. The effective date of an option applied to Surrender Value is the effective date of the surrender where a settlement option has been elected. We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner’s estate.

If Protective Life has available, at the time a settlement option is elected, options or rates on a more favorable basis than those guaranteed, the higher benefits will apply.

Escheatment of Death Benefit

Every state has unclaimed property laws which generally declare life insurance policies to be abandoned after a period of inactivity of 3 to 5 years from the date the Death Benefit is due and payable. For example, if the payment of a Death Benefit has been triggered, but, if after a thorough search, Protective Life is still unable to locate the Beneficiary of the Death Benefit, or the Beneficiary does not come forward to claim the Death Benefit in a timely manner, the Death Benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. This “escheatment” is revocable, however, and the state is obligated to pay the Death Benefit (without interest) if your Beneficiary steps forward to claim the Death Benefit with the proper documentation. To prevent such escheatment, it is important that you

TABLE OF CONTENTS

update your Beneficiary designations, including addresses, if and as they change. Such updates should be communicated in writing, by telephone, or other approved electronic means to the Home Office.

OTHER BENEFITS AVAILABLE UNDER THE POLICY

In addition to the standard Death Benefits associated with your Policy, other standard and optional benefits may also be available to you. The following table summarizes information about these optional benefits. Information about the fees associated with each benefit included in the table may be found in the Fee Table.

	Name of Benefit			Purpose			Is Benefit Standard or Optional?			Brief Description of Restrictions/Limitations
	Terminal Illness Accelerated Death Benefit Endorsement			Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.			Standard			• Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to: • The lesser of 60% of the current face amount of the Policy or $1,000,000; minus • Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy. • Minimum acceleration permitted is $15,000. • The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest. • Any acceleration taken will reduce the amount available for Policy Loans and withdrawals. • Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.

TABLE OF CONTENTS

	Name of Benefit			Purpose			Is Benefit Standard or Optional?			Brief Description of Restrictions/Limitations
	Lapse Protection Endorsement			Guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule.			Standard			• Minimum monthly premium will vary by Policy benefits, Issue Age, sex and rate class of the Insured. • Protection is only effective: • 20 years for issue ages 0-49, • to attained age 70 for issue ages 50-64, • 5 years for issue ages 65-80 • If on any Monthly Anniversary Day, the total premiums paid less any Withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount, this provision will terminate. • Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount.

TABLE OF CONTENTS

Name of Benefit	Purpose	Is Benefit Standard or Optional?	Brief Description of Restrictions/Limitations
Overloan Protection Endorsement	Policy will not Lapse due to an outstanding Policy loan in certain circumstances.	Standard	• Policy must be in force at least 20 Policy Years. • Insured’s Attained Age must be at least 65. • Withdrawals in an amount equal to the total premiums paid must have been taken. • Policy Debt must exceed the Face Amount and be at least 95% of the Cash Value. • Not available if accelerated benefits have been received or if Monthly Deductions are being waived or premiums credited under any endorsement or rider attached to the Policy. • Not available if the resulting Death Benefit is not compliant with our reasonable interpretation of the Code. • Not available if the Policy is a modified endowment contract (“MEC”).
Accidental Death Benefit Rider	Provides an additional death benefit payable if Insured’s death results from certain accidental causes.	Optional	• Insured under the base Policy must be between the ages of 15 and 60 to elect this rider. Coverage expires at age 65. • The minimum amount of coverage is $1,000. • Maximum amount of coverage is $250,000 for the Company and affiliates’ policies in force and applied for.
Children’s Term Life Insurance Rider	Provides a death benefit payable on the death of a covered child.	Optional	• Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Coverage expires at age 75. • Maximum amount of coverage is $25,000 for the Company and affiliates’ policies in force and applied for. • The minimum amount of coverage is $1,000.

TABLE OF CONTENTS

Name of Benefit	Purpose	Is Benefit Standard or Optional?	Brief Description of Restrictions/Limitations
ExtendCare Chronic Illness Accelerated Death Benefit Rider	Allows Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that Insured has a qualifying chronic illness that is expected to last 90 or more days.	Optional	• Can only be added at the time of Policy issue. • There is a minimum base Policy Face Amount of $100,000 and a maximum base Policy Face Amount of $5,000,000. • Maximum monthly benefit cannot exceed 5% of the base Policy Face Amount. • Insured under the base Policy must be between the ages of 20 and 80 to elect this rider. • Death Benefit Option A must be in effect in order to receive benefit payments under the rider. • Any irrevocable Beneficiaries or assignees of record must give written consent for benefit payments to be made. • The rider is subject to a Lifetime Maximum Benefit and a Monthly Maximum Benefit. • Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.
Income Provider Option Pre-Determined Death Benefit Payout Endorsement	Converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule.	Optional	• Can only be added at the time of Policy issue. • You may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of payments. • A Beneficiary cannot change the Death Benefit Payment Schedule or elect a single lump sum after the death of the Insured.

TABLE OF CONTENTS

Name of Benefit	Purpose	Is Benefit Standard or Optional?	Brief Description of Restrictions/Limitations
Protected Insurability Benefit Rider	Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability.	Optional	• Can only be added at the time of Policy issue. • The maximum amount of coverage is $50,000 per option date, for the Company and affiliates’ policies in force and applied for. • The minimum amount of coverage is $10,000. • Insured under the base policy must be between the ages of 0 and 37. Coverage expires at age 40.
Waiver of Specified Premium Rider	Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured.	Optional	• Insured under the base Policy must be between the ages of 15 and 55 at the time the rider is issued. Coverage expires at age 65. • Insured must be disabled for at least six consecutive months, and the disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday.
Dollar-Cost Averaging	Allows for the systematic transfer of specified dollar amounts from a Sub- Account or the Fixed Account to one or more other specified Sub- Accounts.	Standard	• No transfers may be made into the Fixed Account. • Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.
Portfolio Rebalancing	Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.	Standard	• Rebalancing transfers cannot be made into Fixed Account. • Minimum Variable Account Value of $100 required.
Policy Loans	Allows Owner to borrow from the Policy’s Cash Value.	Standard	• Other than Carryover loans, not available during the first Policy Year. • Maximum loan amount is 99% of Cash Value. • Minimum loan amount is $500. • Certain policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a policy loan.

TABLE OF CONTENTS

SUPPLEMENTAL RIDERS AND ENDORSEMENTS

The following supplemental riders and endorsements may be available to be added to your Policy subject to state availability. Monthly charges, if applicable, for these riders will be deducted from your Policy Value as part of the monthly deduction. See “Monthly Deduction.” The supplemental riders and endorsements available with the Policies provide fixed benefits that do not vary with the investment experience of the Variable Account. Additional rules and limits apply to these supplemental riders. Not all such riders may be available at any time, and supplemental riders in addition to those listed below may be made available. The ExtendCare Chronic Illness Accelerated Death Benefit Rider, the Protected Insurability Benefit Rider, and the Income Provider Option Pre-Determined Death Benefit Payout Endorsement may only be purchased or added at the time the Policy is issued. The Overloan Protection Endorsement, the Lapse Protection Endorsement, and the Terminal Illness Accelerated Death Benefit Endorsement are automatically added to all Policies at the time of issue. The Children’s Term Life Insurance Rider, the Accidental Death Benefit Rider and the Waiver of Specified Premium Rider may be added at the time of Policy issue or after issue, subject to availability and additional underwriting. Please ask your Protective Life agent for further information, or contact the Home Office.

Children’s Term Life Insurance Rider. Provides a death benefit payable on the death of a covered child. More than one child can be covered. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $25,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Children are eligible to be covered between 15 days and 25 years of age as long as coverage is in place prior to age 18.

Accidental Death Benefit Rider. Provides an additional death benefit payable if the Insured’s death results from certain accidental causes. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $250,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 60 to elect this rider.

Waiver of Specified Premium Rider. Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured. After the Insured has been totally disabled (as defined in the rider) for six consecutive months, Protective Life will credit premiums to the Policy equal to the specified premium amount shown in the Policy multiplied by the number of Monthly Anniversary Days that have occurred since the onset of total disability. The disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday. Monthly Anniversary Days that occur more than one calendar year prior to the date that we receive a claim under a rider are not included for the purpose of this calculation. Subsequent to the time that the Insured has been totally disabled for six months, we will credit a premium equal to the specified premium amount on each Monthly Anniversary Day. The Owner may change the specified premium amount by Written Notice in Good Order received by Protective Life at the Home Office after the first Policy Anniversary and before the Insured becomes totally disabled. Increases are subject to evidence of insurability. The Insured under the base Policy must be between the ages of 15 and 55 to elect this rider.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Waiver of Specified Premiums Rider. At age 55, the insured has a covered total disability while the rider is in force. The Company receives proof of disability and waives the Policy monthly specified premiums for 6 months. During this time, the Policy deductions continue to be in effect.

ExtendCare Chronic Illness Accelerated Death Benefit Rider (not available in all states)

This rider allows the Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that the Insured has a qualifying chronic illness that is expected to last 90 or more days (the”Certification”). A qualifying chronic illness is an illness or condition that (1) prevents the Insured from performing at least two activities of daily living, such as eating, bathing, or dressing, without substantial assistance or (2) requires substantial supervision of the Insured to protect them from threats to their health and safety due to severe cognitive impairment. The licensed health care practitioner who provides the Certification can be a physician, registered professional nurse or licensed social worker, but cannot be the Owner or Insured or a family member of either the Owner or Insured. We reserve the right to require that the Insured be examined by a licensed health care practitioner chosen by us.

Under the ExtendCare Chronic Illness Accelerated Death Benefit Rider, Protective Life makes either 12 monthly payments or a single lump sum payment to the Owner for a 12-month period, known as a “Benefit Period.” The initial Benefit Period begins on the first Monthly Anniversary after we approve an Owner’s written request for accelerated payments and all conditions under the rider for benefit payments to be made have been met. Each subsequent Benefit Period begins on the first Monthly Anniversary following (1) the end of the most recent prior Benefit Period, (2) our receipt of the Certification for the new Benefit Period, and (3) when all other conditions under the rider for benefit

TABLE OF CONTENTS

payments to be made have been met. In addition to our receipt of the Owner’s written request for accelerated payments and the Certification, for each Benefit Period the conditions noted below must be met for the Owner to receive benefit payments under this rider.

The Insured is alive.

Both the Policy and the rider are inforce.

We received a written consent from any irrevocable Beneficiaries or assignees of record of the Policy to allow benefit payments to be made to the Owner.

90 consecutive days from the date we receive the Certification (the “Elimination Period”) has passed. For Benefit Periods after the initial Benefit Period, this requirement does not apply if less than 30 days have passed from the date of the end of the prior Benefit Period and the date we receive the Certification for the new Benefit Period.

The Insured has a qualifying chronic illness at the time a benefit payment is made.

Death Benefit Option A is in effect. If the Owner did not elect Death Benefit Option A, we will change the Death Benefit Option under the Policy to Death Benefit Option A prior to our payment of the first benefit payment under this rider. We do not allow any further changes to the Death Benefit Option during a Benefit Period.

For each Benefit Period, the Owner can elect to receive a benefit payment each month or a single lump sum payment at the beginning of the Benefit Period. The lump sum payment is equal to the present value of each monthly benefit payment payable during the Benefit Period. The rider is subject to both a Lifetime Maximum Benefit and a Monthly Maximum Benefit. The information necessary to determine these amounts is set forth in the Policy schedule and the rider.

The Owner or Insured is responsible for the cost of the Certification for the initial Benefit Period. We will cover the cost of the Certification for any subsequent Benefit Period. We begin deducting a monthly charge upon issuance of this rider based, in part, on a maximum monthly benefit amount selected by the Owner at the time of Policy issue. During a Benefit Period, all monthly deductions required to maintain the Policy will be waived. If the Insured is certified as chronically ill for three consecutive Benefit Periods, the monthly deductions will be waived for as long as the Policy is in force. It is possible that for tax purposes some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy. See “Tax Considerations.”

We must receive any written request for benefit payments, to change the amount of monthly benefit payments or to receive a single lump sum benefit payment for a Benefit Period in Good Order at our Home Office.

The minimum Policy Face Amount to elect this rider is $100,000 and the maximum is $5,000,000. The maximum monthly benefit cannot exceed 5% of the Policy Face Amount. Typically, this will force a minimum Face Amount higher than $100,000 at monthly amounts greater than $5,000 or the current IRS per diem limit. The Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the ExtendCare Rider with a benefit amount of $5,000 for a monthly cost of $4.24. In 10 years, while the insured is still alive and the rider and the Policy are still in force, the insured is diagnosed with a chronic illness that prevents them from performing at least two activities of daily living and that is expected to persist for at least 90 days. Once The Company receives written certification from a licensed health care professional and after a 90 day waiting period, the insured will receive either monthly benefits of $5,000 or a lump sum of the present value of the 12 monthly payments as an accelerated payment of part of the Policy’s Death Benefit. The payments will continue for each 12 month Benefit Period where the insured can certify that they are still chronically ill. The insured’s Death Benefit will be reduced dollar for dollar by the amount of payments they receive. So if they are chronically ill for one year and take monthly benefits, they will have received $60,000 in accelerated benefits. If the insured dies after that, the death benefit will be $40,000.

Protected Insurability Benefit Rider. Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. The minimum amount of coverage is $10,000 and the maximum is $50,000. Fees associated with this rider stop at Insured’s age 40.

Example: Assume a 25 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Protected Insurability Benefit Rider. While the rider is in force at age 31, the Insured purchases an additional $50,000 in coverage with no required underwriting or proof of insurability, but with a change to the monthly deduction specified premium. If the Insured dies after the purchase while the Policy is still in force, the death benefit would be $150,000.

TABLE OF CONTENTS

Overloan Protection Endorsement. Under the provisions of this endorsement, your Policy will not Lapse due to an outstanding Policy loan and the Death Benefit will be at least $10,000 as long as all of the terms and conditions of the endorsement are met:

The Policy has been in force at least 20 Policy Years;

The Insured’s Attained Age is at least 65;

Withdrawals in an amount equal to the total premiums paid have been taken;

The Policy Debt is at least 95% of the Cash Value;

The Policy Debt exceeds the Face Amount;

Accelerated benefits have not been received under any endorsement or rider attached to your Policy;

Monthly Deductions or premiums are not being credited or waived under any endorsement or rider attached to your Policy;

Invoking this benefit does not result in a death benefit that is not compliant with our reasonable interpretation of the Code; and

The Policy is not a modified endowment contract.

When the Policyholder chooses to exercise the benefit under the Overloan Protection Endorsement, we deduct a charge equal to the lesser of the Policy Value minus Policy Debt or 5% of the Policy Value.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount. The Overloan Protection Endorsement is automatically added. At age 70, the insured has been taking loans from his policy so that the Policy Debt is more than 99% of the policy value and the Debt exceeds the Face Amount of the Policy. The insured has taken the maximum amount of withdrawals, the amount equal to their total premiums paid. At this point, any riders on the Policy will be terminated and any Variable Account Value will be transferred to the Fixed Account. In addition, no policy transactions or withdrawals will be allowed. The policy will remain in force and if they die while the endorsement is still in force, the Death Benefit will be the policy value minus the policy debt, with a minimum value of $10,000.

Income Provider Option Pre-Determined Death Benefit Payout Endorsement. (not available in all distribution channels) The endorsement converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule that describes the amount, frequency, and duration of payment of the Death Benefit Proceeds. If the Death Benefit is adjusted under the Policy while the Insured is living, the amounts shown in the payment schedule will be adjusted pro-rata. The Owner may choose to change the payment schedule or elect a lump sum payment of the Death Benefit Proceeds prior to the Insured’s death, but the Beneficiary will not be able to change the payment schedule after the Insured’s death. The Owner may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of the payment schedule.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and adds the Income Provider Option Pre-Determined Death Benefit Payout Endorsement. When the insured dies, the beneficiary will receive a series of payments specified at the time of Policy issue.

Lapse Protection Endorsement. The endorsement guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule, if for each month that the Policy has been inforce, the total premiums paid (less any withdrawals or Policy loans) is equal to, or greater than, the Minimum Monthly Guarantee Amount multiplied by the number of completed Policy months, including the current month, since the Policy Effective Date. The Minimum Monthly Guarantee Amount is based upon the Company’s anticipated cost of providing lapse protection on a specific Policy for the stated lapse protection period. This amount varies with Policy benefits, Issue Age, sex and rate class of the Insured. Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount. The lapse protection provision is effective during the first 20 Policy Years (if the Insured’s Issue Age is 0 through 49), up to attained age 70 (if the Insured’s Issue Age is 50-64), or during the first 5 Policy Years (for Insured’s Issue Age 65 and above). If on any Monthly Anniversary Day, the total premiums paid less any withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount this provision will terminate.

Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $100,000 Face Amount. The Lapse Protection Endorsement is included on the Policy. The Policy specifies a Monthly Guarantee Premium of $42.00. The owner makes an initial premium payment of $45.00.

On the 24th monthly anniversary, assume the owner has made 24 subsequent premium payments of the same amount and taken no partial surrenders or Policy Loans. The total of the actual premiums paid for the Policy is $1,080

TABLE OF CONTENTS

(the amount of the initial premium payment plus the amount of the subsequent premium payments). Because there have been no partial surrenders and there is no Outstanding Debt, the net premiums paid is equal to $1,080.

The amount of premiums required to meet the endorsement conditions is $1,008 (the Monthly Guarantee Premium amount specified in the Policy multiplied by the number of months since the Policy date).

Because the net premiums paid exceed the amount of premiums required, the conditions have been met on this monthly anniversary day and the rider remains in effect. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $100,000.

Assume instead that on the 24th monthly anniversary, the owner missed the last two premium payments. The net premiums paid is then equal to $990. Because the net premiums paid is now less than the amount of premiums required, the owner must pay additional premiums of at least $18.00 within the 60 day grace period to keep the Policy in effect. If the endorsement terminates and the insured dies while the Cash Value of the Policy is zero, the death benefit will be $0.

Terminal Illness Accelerated Death Benefit Endorsement. The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest.

The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The insured’s Death Benefit is reduced dollar-for-dollar by the amount of payments received and accumulated interest under the accelerated death benefit.The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.

The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

•

the lesser of 60% of the current face amount of the Policy or $1,000,000; minus

•

any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.

Dollar-Cost Averaging

If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account (“Source Sub-Account”) or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.

To elect dollar-cost averaging, Policy Value in the Source Sub-Account or the Fixed Account must be at least $5,000 at the time of election. Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. At least $100 must be transferred each month or $300 each quarter. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29th, 30th, or 31st. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.

Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.

TABLE OF CONTENTS

Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.

Portfolio Rebalancing

At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts (“Portfolio Rebalancing”). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29th, 30th or 31st. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.

Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.

Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.

LOANS

You may obtain two types of loans under a Policy, a standard loan and/or a carry-over loan. A carry-over loan is a loan which is transferred from another policy that is exchanged for the Policy under Section 1035 of the Internal Revenue Code. A carry-over loan must be approved by Protective Life and can only be executed at the time of issue. After the first Policy Year while the Policy has Cash Value and the Insured is still living, you may borrow from Protective Life under a standard loan using the Policy as the security for the loan. A standard loan is any loan that is not a carry-over loan. Policy loans must be requested by Written Notice in Good Order received at the Home Office. Generally the minimum loan amount is $500 and the maximum loan amount is 99% of the Policy’s Cash Value. This maximum is reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received. Outstanding Policy Debt and any lien therefore reduces the amount available for new Policy loans. Loan proceeds generally are mailed within seven calendar days of the loan being approved.

Loan Collateral

When a Policy loan is made, an amount equal to the loan is transferred out of the Sub-Accounts and the Fixed Account and into a Loan Account established for the Policy. Like the Fixed Account, a Policy’s Loan Account is part of Protective Life’s General Account and amounts therein earn interest as credited by Protective Life from time to time. Because Loan Account values are part of Policy Value, a loan will have no immediate effect on the Policy Value. In contrast, Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is reduced immediately by the amount transferred to the Loan Account. The Owner can specify the Sub-Accounts and the Fixed Account from which collateral is transferred to the Loan Account. If no allocation is specified, collateral is transferred from each Sub-Account and from the Fixed Account in the same proportion that the value in each Sub-Account and the Fixed Account bears to the total unloaned Policy Value on the date that the loan is made.

TABLE OF CONTENTS

On each Policy Anniversary, an amount of Policy Value equal to any due and unpaid loan interest (explained below), is also transferred to the Loan Account. Such interest is transferred from each Sub-Account and the Fixed Account in the same proportion that each Sub-Account Value and the Fixed Account Value bears to the total unloaned Policy Value.

Loan Repayment

You may repay all or part of your Policy Debt (the amount borrowed plus unpaid interest) at any time while the Insured is living and the Policy is in force. Loan repayments in Good Order must be sent to the Home Office and are credited as of the Valuation Day received. The Owner may specify by Written Notice that any unscheduled premiums paid while a loan is outstanding be applied as loan repayments. (Loan repayments, unlike unscheduled premium payments, are not subject to the premium expense charge.) When a loan repayment is made, Policy Value in the Loan Account in an amount equal to the repayment is transferred from the Loan Account to the Sub-Accounts and the Fixed Account. Thus, a loan repayment will have no immediate effect on the Policy Value, but the Surrender Value (including, as applicable, Variable Account Value and Fixed Account Value) under a Policy is increased immediately by the amount transferred from the Loan Account. Unless specified otherwise by the Owner(s), amounts are transferred to the Sub-Accounts and the Fixed Account in the same proportion that Net Premiums are allocated. Protective Life’s ability to credit interest on Policy Value in the Loan Account is subject to the Company’s financial strength and claims paying ability.

Interest

Protective Life charges interest daily on any outstanding loan at the following effective annual rates:

Loan Interest Rates
	Current Standard Loan Charge		Guaranteed Standard Loan Charge		Current Carry-Over Loan Charge		Guaranteed Carry-Over Loan Charge
Policy Years 1-10		5.00%		5.00%		4.00%		5.00%
Policy Years 11 and greater		3.00%		3.25%		3.00%		3.25%

Interest will accrue daily on any outstanding loan, and is considered part of Policy Debt. Interest is due and payable at the end of each Policy Year. We will notify you of the amount due. If interest is not paid when due, the amount of the interest is added to the principal amount of the loan. If the interest payment is received prior to or on the policy anniversary date it will be applied as of the anniversary date. If the interest payment is received after the anniversary date it will be applied as of the Valuation Day it is received and credited as a partial loan repayment.

The Loan Account is credited with an effective annual interest rate of not less than 1.00% for Policies with applications signed before October 13, 2025 and for Policies with applications signed on or after October 13, 2025 no less than 3.00% (3% current). Protective Life determines the rate of interest to be credited to the Loan Account and may redetermine it at any time. Once determined, the new rate of interest to be credited is applied beginning at the next Policy Year following the date on which Protective Life determined the new rate of interest to be credited to the Loan Account. The Policy Owner will be notified in advance about any change to the interest rate credited to the Loan Account in their quarterly policy statement. On each Policy Anniversary, the interest earned on the Loan Account since the previous Policy Anniversary is transferred to the Sub-Accounts and to the Fixed Account. The interest is transferred and allocated to the Sub-Accounts and the Fixed Account in the same proportion that Net Premiums are allocated. Protective Life’s ability to credit interest on Policy Value in the Loan Account is subject to the Company’s financial strength and claims paying ability.

The difference between the rate of interest charged on borrowed money and the rate credited on the Loan Account is the net cost of the loan. The net cost of loans is set forth in the table below.

Net Cost of Loans
	Current Standard Loan		Guaranteed Standard Loan (1)		Current Carry-Over Loan		Guaranteed Carry-Over Loan (1)
Policy Years 1-10		2.00%		2.00%		1.00%		2.00%
Policy Years 11 and greater		0.00%		0.25%		0.00%		0.25%

(1)

For Policies with applications signed before October 13, 2025, the Maximum Guaranteed Charge for Standard and Carry-Over Loans was 4.00% in Policy Years 1-10, and 2.25% in Policy Years 11 and greater.

Non-Payment of Policy Loan

If the Insured dies while a loan is outstanding, the Policy Debt (which includes any accrued but unpaid interest) is deducted from the Death Benefit in calculating the Death Benefit Proceeds.

TABLE OF CONTENTS

If the Loan Account Value exceeds the Cash Value less any lien and accrued interest (i.e., the Surrender Value becomes zero) on any Valuation Day, you must pay that excess amount. The Company will send you (or any assignee of record) a notice of the amount you must pay. You must pay this amount within 31 days after the notice is sent, or the Policy will Lapse.

Effect of Policy Loans

A loan, whether or not repaid, has a permanent effect on the Death Benefit and Policy Value because the investment results of the Sub-Accounts and current interest rates credited on Fixed Account Value do not apply to Policy Value in the Loan Account. The larger the loan and longer the loan is outstanding, the greater will be the effect of Policy Value held as collateral in the Loan Account. Depending on the investment results of the Sub-Accounts or credited interest rates for the Fixed Account while the loan is outstanding, the effect could be favorable or unfavorable. Policy loans also may increase the potential for Lapse if investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan balance and will increase Policy Debt. If a Policy lapses with loans outstanding, certain amounts may be subject to income tax. In addition, if your Policy is a MEC, loans may be currently taxable and subject to a 10% additional tax. See “Tax Considerations,” for a discussion of the tax treatment of Policy loans.

TRANSFERS

Upon receipt of Written Notice in Good Order to Protective Life at the Home Office you may transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below. Transfer requests (including telephone transfer requests — described below) received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Day the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Day. Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. See “Suspension or Delay of Payments.” The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account or the Fixed Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) or the Fixed Account would be less than $100, Protective Life reserves the right to transfer the entire amount instead of the requested amount. Protective Life reserves the right to restrict the maximum amount which may be transferred from the Fixed Account in any Policy Year. The maximum is currently the greater of $2,500 or 25% of the Fixed Account Value. Due to this limitation, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Protective Life reserves the right to limit transfers to 12 per Policy Year. For each additional transfer over 12 in any Policy Year, Protective Life reserves the right to charge a transfer fee. We will give written notice thirty (30) days before we impose a transfer fee or limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.

Limitations on frequent transfers, including “market timing” transfers. Frequent transfers may involve an effort to take advantage of the possibility of a lag between a change in the value of a Fund’s portfolio securities and the reflection of that change in the Fund’s share price. This strategy, sometimes referred to as “market timing,” involves an attempt to buy shares of a Fund at a price that does not reflect the current market value of the portfolio securities of the Fund, and then to realize a profit when the Fund shares are sold the next Valuation Day or thereafter.

When you request a transfer among the Sub-Accounts, your request triggers the purchase and redemption of Fund shares. Frequent transfers cause frequent purchases and redemptions of Fund shares. Frequent purchases and redemptions of Fund shares can cause adverse effects for a Fund, Fund shareholders, the Variable Account, other Owners, beneficiaries or Owners of other variable life insurance policies we issue that invest in the Variable Account. Frequent transfers can result in the following adverse effects:

•

Increased brokerage trading and transaction costs;

•

Disruption of planned investment strategies;

•

Forced and unplanned liquidation and portfolio turnover;

•

Lost opportunity costs; and

•

Large asset swings that decrease the Fund’s ability to provide maximum investment return to all Policy Owners.

In order to try to protect our Policy Owners and the Funds from the potential adverse effects of frequent transfer activity, the Company has implemented certain market timing policies and procedures (the “Market Timing Procedures”). Our

TABLE OF CONTENTS

Market Timing Procedures are designed to detect and prevent frequent, short-term transfer activity that may adversely affect the Funds, Fund shareholders, the Variable Account, other Policy Owners’ beneficiaries and Policy Owners of other variable life policies we issue that invest in the Variable Account.

We monitor transfer activity in the Policies to identify frequent transfer activity in any Policy. Our current Market Timing Procedures are intended to detect transfer activity in which the transfers exceed a certain dollar amount and a certain number of transfers involving the same Sub-Accounts within a specific time period. We regularly review transaction reports in an attempt to identify transfers that exceed our established parameters. We do not include transfers made pursuant to the dollar-cost averaging and Portfolio Rebalancing programs when monitoring for frequent transfer activity.

When we identify transfer activity exceeding our established parameters in a Policy or group of Policies that appear to be under common control, we suspend non-written methods of requesting transfers for that Policy or group of Policies. All transfer requests for the affected Policy or group of Policies must be made by Written Notice in Good Order to the Home Office. We notify the affected Policy Owner(s) in writing of these restrictions.

In addition to our Market Timing Procedures, the Funds may have their own market timing policies and restrictions. While we reserve the right to enforce the Funds’ policies and procedures, Owners and other persons with interests under the Policies should be aware that we may not have the contractual authority or the operational capacity to apply the market timing policies and procedures of the Funds. However, under SEC rules, we are required to: (1) enter into a written agreement with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Owners, and (2) execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Owners who violate the market timing policies established by the Fund.

Some of the Funds have reserved the right to temporarily or permanently refuse payments or transfer requests from us if, in the judgment of the Fund’s investment adviser, the Fund would be unable to invest effectively in accordance with its investment objective or policies, or would otherwise potentially be adversely affected. To the extent permitted by law, we reserve the right to delay or refuse to honor a transfer request, or to reverse a transfer at any time we are unable to purchase or redeem shares of any of the Funds because of the Fund’s refusal or restriction on purchases or transfers between impacted Funds. We will notify the Policy Owner(s) of any refusal or restriction on a purchase or transfer by a Fund relating to that Policy Owner’s transfer request. Some Funds also may impose redemption fees on short-term trading (i.e., redemptions of mutual Fund shares within a certain number of business days after purchase). We also reserve the right to implement, administer, and collect any redemption fees imposed by any of the Funds. You should read the prospectus of each of the Funds for more information about its ability to refuse or restrict purchases or transfers between impacted Funds of its shares, which may be more or less restrictive than our Market Timing Procedures and those of other Funds, and to impose redemption fees.

We apply our Market Timing Procedures consistently to all Policy Owners without special arrangement, waiver or exception. We reserve the right to change our Market Timing Procedures at any time without prior notice as we deem necessary or appropriate to better detect and deter potentially harmful frequent transfer activity, to comply with state or federal regulatory requirements, or both. We may change our parameters to monitor for different dollar amounts, number of transfers, time period of the transfers, or any of these.

Policy Owners seeking to engage in frequent transfer activity may employ a variety of strategies to avoid detection. Our ability to detect and deter such transfer activity is limited by operational systems and technological limitations. Furthermore, the identification of Policy Owners determined to be engaged in transfer activity that may adversely affect others involves judgments that are inherently subjective. Accordingly, despite our best efforts, we cannot guarantee that our Market Timing Procedures will detect or deter every potential market timer. In addition, because other insurance companies, retirement plans, or both may invest in the Funds, we cannot guarantee that the Funds will not suffer harm from frequent transfer activity in contracts or policies issued by other insurance companies or by retirement plan participants.

Reservation of Rights

Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.

Telephone Transfers

Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.

TABLE OF CONTENTS

Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.

A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider’s, your agent’s, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.

SURRENDERS AND WITHDRAWALS

Surrender Privileges

At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Surrender Value. Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day. The Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option. Payment is generally made within 7 calendar days. All coverage and optional benefits will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of the Policy surrender. A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See “Tax Considerations.” in the Prospectus.)

Withdrawal Privileges

At any time after the first Policy Year, an Owner, by Written Notice in Good Order received at the Home Office, may make a withdrawal of Surrender Value of not less than $500. Protective Life will withdraw the amount requested, plus a withdrawal charge from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time.

Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day.

The Owner may specify the amount of the withdrawal to be made from any Sub-Account or the Fixed Account. If the Owner does not so specify, or if the Sub-Account Value or Fixed Account Value is insufficient to carry out the request, the withdrawal from each Sub-Account and the Fixed Account is based on the proportion that such Sub-Account(s) Value and Fixed Account Value bears to the total unloaned Policy Value on the Valuation Day immediately prior to the Withdrawal. Payment is generally made within seven calendar days.

If Death Benefit Option A is in effect, Protective Life will reduce the Face Amount by the amount withdrawn if total withdrawals in a Policy Year exceed $5,000. The Company reserves the right to increase or decrease the amount of total withdrawals that will not result in a reduction of the Face Amount, or terminate the ability to withdraw any amount that does not trigger a reduction in the Face Amount. Protective Life may reject a withdrawal request if the withdrawal would reduce the Face Amount below the minimum amount for which the Policy would be issued under Protective Life’s then-current rules, or if the withdrawal would cause the Policy to fail to qualify as a life insurance contract under applicable tax laws, as interpreted by Protective Life. If the Face Amount at the time of the withdrawal includes increases from the Initial Face Amount and the withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the Initial Face Amount. Withdrawals may have tax consequences. See “Tax Considerations” in the Prospectus.

SUSPENSION OR DELAYS IN PAYMENTS

Protective Life will ordinarily pay any Death Benefit proceeds, Policy loans, withdrawals, Advisory Fees from Policy Value, or surrenders within seven calendar days after receipt at the Home Office of all the documents required for such a payment. Other than the Death Benefit, which is determined as of the date of death of the Insured, the amount will be determined as of the Valuation Day of receipt of all required documents in Good Order at the Home Office. However, Protective Life may delay making a payment or processing a transfer request if (1) the New York Stock Exchange is closed for other than a regular holiday or weekend, trading on the Exchange is restricted by the SEC, or the SEC declares that an emergency exists as a result of which the disposal or valuation of Variable Account assets is not reasonably

TABLE OF CONTENTS

practicable; (2) the SEC by order permits postponement of payment to protect Owners; or (3) your Premium check has not cleared your bank. See “Payments from the Fixed Account.”

In certain circumstances, applicable federal law may require Protective Life to “freeze” your account and refuse your request for a transfer, withdrawal, Advisory Fee payment, surrender, loan or death proceeds until receipt of instructions from the appropriate regulator. We also may be required to provide information about you and your account to a government regulator.

If, pursuant to SEC rules, the Invesco V.I. U.S. Government Money Portfolio suspends payment of redemption proceeds in connection with a liquidation of the Fund, we will delay payment of any transfer, partial withdrawal, Advisory Fee payment, surrender, loan, or death benefit from the Invesco V.I. U.S. Government Money Portfolio Sub-Account until the Fund is liquidated.

We may delay the payment of proceeds of any partial withdrawal, surrender or loan for up to six months after our receipt of Written Notice in Good Order of your request where the proceeds would be taken from Fixed Account Value.

LAPSE AND REINSTATEMENT

Lapse

Failure to pay planned periodic premiums will not necessarily cause a Policy to Lapse (terminate without value). Paying all planned periodic premiums will not necessarily prevent a Policy from lapsing. Except when the Lapse Protection Endorsement of the Policy is in effect, a Policy will Lapse if its Policy Value less the Policy Debt is insufficient to cover the Monthly Deduction on the Monthly Anniversary Day. Absent any lapse protection, if the Surrender Value on any Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. This could happen if investment experience has been sufficiently unfavorable that it has resulted in a decrease in Surrender Value or the Surrender Value has decreased because you have not paid sufficient Net Premiums to offset prior Monthly Deductions.

You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions. Protective Life will send you, at your last known address and the last known address of any assignee of record, notice of the premium required to prevent Lapse. A Policy will remain in effect during the grace period. If the Insured should die during the grace period, the Death Benefit Proceeds payable to the Beneficiary will reflect a reduction for the Monthly Deductions due on or before the date of the Insured’s death as well as any unpaid Policy Debt or liens (including accrued interest). See “Calculation of Death Benefit Proceeds.” Unless the premium stated in the notice is paid before the grace period ends, the Policy will Lapse. A Policy Lapse may have tax consequences. See “Tax Considerations” in the Prospectus.

Age 121. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse and the Death Benefit will remain in effect, regardless of your Surrender Value.

Lapse Protection. In return for paying the Minimum Monthly Guarantee Amount specified in the Policy or an amount equivalent thereto by the Monthly Anniversary Day, Protective Life guarantees that a Policy will remain in force for a specified period (the “lapse protection period”). If, for each month that the Policy has been in force, the total premiums paid, less withdrawals and Policy Debt, is greater than or equal to the Minimum Monthly Guarantee Amount multiplied by the number of complete Policy Months (including the current Policy Month) since the Policy Effective Date, the Policy’s lapse protection will remain in effect until the end of the lapse protection period, regardless of the Policy’s Surrender Value. In addition to satisfying the Minimum Monthly Guarantee Amount payment requirement noted above, the duration of the lapse protection period is limited based on the Insured’s Issue Age. This provision remains in effect for the first 20 Policy Years (if the Insured’s Issue Age is 0 through 49), up to attained age 70 (if the Insured’s Issue Age is 50 through 64), or during the first 5 Policy Years (for Insured’s Issue Age 65 and above), regardless of Surrender Value, if, for each month that the Policy has been in force since the Policy Effective Date, the total premiums paid net of any withdrawals and Policy Debt, is greater than or equal to the Minimum Monthly Guarantee Amount (shown in the Policy) multiplied by the number of complete policy months since the Policy Effective Date, including the current policy month.

We will not notify you in the event the Policy’s lapse protection is no longer in effect.

If you increase your Policy’s Face Amount or change the Death Benefit option while the Policy’s lapse protection is in effect, Protective Life will not extend the lapse protection period. The lapse protection period is based on the Policy Effective Date. However, upon an increase in Face Amount, Protective Life will recalculate the Minimum Monthly Guarantee Amount (which will generally increase). Any other change in benefits provided under this Policy or its riders which is made after the Policy Effective Date and during the period of the Policy’s lapse protection also may result in a change to the Minimum Monthly Guarantee Amount. Protective Life will notify you of any increase in the Minimum Monthly Guarantee Amount and will amend your Policy to reflect the change.

TABLE OF CONTENTS

Payment of the Minimum Monthly Guarantee Amount may not be sufficient to keep the Policy in force beyond the lapse protection period.

Reinstatement

An Owner may reinstate a Policy within 5 years of its Lapse provided that: (1) a request for reinstatement is made by Written Notice received by Protective Life at the Home Office, (2) the Insured is still living, (3) the Owner pays Net Premiums equal to (a) all Monthly Deductions that were due but unpaid during the grace period, and (b) which are at least sufficient to keep the reinstated Policy in force for three months, (4) the Insured provides Protective Life with satisfactory evidence of insurability, (5) the Owner repays or reinstates any Policy Debt and/or lien (including accrued interest) which existed at the end of the grace period; and (6) the Policy has not been surrendered. The “Approval Date” of a reinstated Policy is the date that Protective Life approves the Owner’s request for reinstatement and requirements 1-6 above have been met.

TAX CONSIDERATIONS

The following discussion of the federal income tax treatment of the Policy is not exhaustive, does not purport to cover all situations, and is not intended as tax advice. The federal income tax treatment of the Policy is unclear in certain circumstances, and a qualified tax adviser should always be consulted with regard to the application of law to individual circumstances. This discussion is based on the Internal Revenue Code of 1986, as amended (the “Code”), Treasury Department regulations, and interpretations existing on the date of this Prospectus. These authorities, however, are subject to change by Congress, the Treasury Department, and judicial decisions.

This discussion does not address state or local tax consequences associated with the purchase of the Policy. The state and local tax consequences with respect to your Policy may be different than the federal tax consequences. In addition, PROTECTIVE LIFE MAKES NO GUARANTEE REGARDING ANY TAX TREATMENT — FEDERAL, STATE OR LOCAL — OF ANY POLICY OR OF ANY TRANSACTION INVOLVING A POLICY.

Advisory Fees

The federal income tax treatment of Advisory Fees paid from your Policy Value is uncertain. You should consult a tax adviser regarding the tax treatment of Advisory Fees paid from your Policy Value and consider whether paying such Advisory Fees from another source might be more appropriate for you.

We will not treat Advisory Fees paid from your Policy Value as withdrawals for income tax reporting and withholding purposes if certain conditions are met. To meet those conditions, you and your Financial Intermediary must provide a completed written Advisory Fee Authorization form (which we will provide to you) that sets forth the amount of the Advisory Fees and the frequency with which the Advisory Fees should be deducted from your Policy Value and paid to your Financial Intermediary. The Advisory Fees may not exceed an amount equal to an annual rate of 1.5% of the Policy Value and they may be used to compensate your Financial Intermediary only for investment advice provided to you with respect to the Policy and not for any other services. During any period for which the Advisory Fee Authorization is in effect, the Advisory Fees that are subject to such authorization must be paid solely out of the Policy Value and you, as the owner, may not pay such Advisory Fees directly to the Financial Intermediary. The Advisory Fee Authorization must be irrevocable with respect to Advisory Fees paid and Advisory Fees accrued but not yet paid. Regardless of whether we tax report Advisory Fees from your Policy, the Internal Revenue Service could determine that the fees should be treated as taxable withdrawals, in which case the amount of the fee deducted from your Policy Value could be included in your gross income and could be subject to the 10% additional tax if you are under age 59½ and the Policy is a MEC.

In 2023, Protective Life obtained a private letter ruling (PLR) from the Internal Revenue Service that supports the approach described above regarding tax reporting and withholding with respect to Advisory Fees paid from your Policy Value. It is important to understand that only Protective Life can rely on that ruling in dealing with the IRS; you cannot rely on the ruling.

We may begin tax reporting Advisory Fees as withdrawals at any time, including retroactively, and withhold tax from such amounts accordingly if we conclude that such treatment is more appropriate under federal income tax law, such as if the Internal Revenue Service provides guidance in the future requiring such treatment.

Tax Status of Protective Life

Protective Life is taxed as a life insurance company under the Code. Since the operations of the Variable Account are a part of, and are taxed with, the operations of Protective Life, the Variable Account is not separately taxed as a “regulated investment company” under the Code. Under existing federal income tax laws, Protective Life’s federal taxes are not increased from the Variable Account’s premiums, investment income, and realized capital gains. This is

TABLE OF CONTENTS

because these items generally cause Protective Life’s tax-basis policy benefit reserves to increase by a similar amount. Currently, a charge for federal income taxes is not deducted from the Sub-Accounts or the Policy’s Cash Value. However, Protective Life does deduct a premium expense charge from each premium payment in all Policy Years in part to compensate us for the federal tax treatment of deferred acquisition costs. Protective Life reserves the right in the future to make a charge against the Variable Account or the Cash Values of a Policy for any federal, state, or local income taxes that we incur and determine to be properly attributable to the Variable Account or the Policy. Protective Life will promptly notify the Owner of any such charge.

Taxation of Insurance Policies

Tax Status of the Policies. Section 7702 of the Code establishes a statutory definition of life insurance for federal tax purposes. While the requirements of this section of the Code are complex, and limited guidance has been provided from the Internal Revenue Service (“IRS”) or otherwise, Protective Life believes that the Policy will meet the current statutory definition of life insurance, which places limitations on the amount of premiums that may be paid and the Policy Values that can accumulate relative to the Death Benefit. As a result, the Death Benefit payable under the Policy will generally be excludable from the Beneficiary’s gross income, and interest and other income credited under the Policy will not be taxable unless certain withdrawals are made (or are deemed to be made) from the Policy prior to the Insured’s death, as discussed below. This tax treatment will only apply, however, if (1) the investments of the Variable Account are “adequately diversified” in accordance with Treasury Department regulations, and (2) Protective Life, rather than the Owner, is considered the owner of the assets of the Variable Account for federal income tax purposes.

Diversification Requirements. The Code and Treasury Department regulations prescribe the manner in which the investments of a segregated asset account, such as the Variable Account, are to be “adequately diversified”. If the Variable Account fails to comply with these diversification standards, the Policy will not be treated as a life insurance contract for federal income tax purposes and the Owner would generally be taxed currently on the income on the contract (as defined in the tax law). Protective Life expects that the Variable Account, through the Funds, will comply with the diversification requirements prescribed by the Code and Treasury Department regulations.

Ownership Treatment. In certain circumstances, variable life insurance contract owners may be considered the owners, for federal income tax purposes, of the assets of a segregated asset account, such as the Variable Account, used to support their contracts. In those circumstances, income and gains from the segregated asset account would be includible in the contract owners’ gross income. The IRS has stated in published rulings that a variable contract owner will be considered the owner of the assets of a segregated asset account if the owner possesses incidents of ownership in those assets, such as the ability to exercise investment control over the assets.

The ownership rights under the Policy are similar to, but differ in certain respects from, the ownership rights described by the IRS in certain rulings where it was determined that contract owners were not owners of the assets of a segregated asset account (and thus were not currently taxable on the income and gains). For example, the Owner of this Policy has the choice of more investment options to which to allocate premium payments and Variable Account Values than were addressed in such rulings. These differences could result in the Policy Owner being treated as the owner of a portion of the assets of the Variable Account and thus subject to current taxation on the income and gains from those assets. In addition, Protective Life does not know what standards will be set forth in any further regulations or rulings which the Treasury Department or IRS may issue. Protective Life therefore reserves the right to modify the Policy as necessary to attempt to prevent Owners from being considered the owners of the assets of the Variable Account. However, there is no assurance that such efforts would be successful.

The remainder of this discussion assumes that the Policy will be treated as a life insurance contract for federal tax purposes.

Tax Treatment of Life Insurance Death Benefit Proceeds. In general, the amount of the Death Benefit Proceeds payable from a Policy by reason of the death of the Insured is excludable from gross income under Section 101 of the Code. Certain transfers of the Policy for valuable consideration, however, may result in a portion of the Death Benefit Proceeds being taxable.

If the Death Benefit Proceeds are not received in a lump sum and are, instead, applied under either Settlement Options 1, 2, or 4, or the Income Provider Option Pre-Determined Death Benefit Payout Endorsement, generally payments will be prorated between amounts attributable to the Death Benefit which will be excludable from the Beneficiary’s income and amounts attributable to interest (accruing after the Insured’s death) which will be includible in the Beneficiary’s income. If the Death Benefit Proceeds are applied under Option 3 (Interest Income), the interest credited will be currently includible in the Beneficiary’s income.

Accelerated death benefits paid under this Policy upon a terminal illness generally will be excludable from income under Section 101 of the Code. Certain exceptions apply for certain business-related policies.

TABLE OF CONTENTS

Tax Deferral During Accumulation Period. Under existing provisions of the Code, except as described below, any increase in an Owner’s Policy Value is generally not taxable to the Owner unless amounts are received (or are deemed to be received) from the Policy prior to the Insured’s death. If there is a surrender of the Policy, an amount equal to the excess of the amount received over the “investment in the contract” will generally be includible in the Owner’s income. The “investment in the contract” generally is the aggregate premiums paid less the aggregate amount previously received under the Policy to the extent such amounts received were excludable from gross income. Whether withdrawals (or other amounts deemed to be distributed) from the Policy constitute income to the Owner depends, in part, upon whether the Policy is considered a MEC for federal income tax purposes.

Policies Not Owned by Individuals

In the case of Policies issued to a nonnatural taxpayer, or held for the benefit of such an entity, a portion of the taxpayer’s otherwise deductible interest expenses may not be deductible as a result of ownership of a Policy even if no loans are taken under the Policy. An exception to this rule is provided for certain life insurance policies which cover the life of an individual who is a 20 percent owner, or an officer, director, or employee, of a trade or business. Entities that are considering purchasing the Policy, or entities that will be beneficiaries under a Policy, should consult a tax advisor.

Policies That Are Not MECs

Tax Treatment of Withdrawals Generally. If the Policy is not a MEC (described below), the amount of any withdrawal from the Policy generally will be treated first as non-taxable recovery of premium and then as income from the Policy. Thus, a withdrawal from a Policy that is not a MEC generally will not be includible in income except to the extent it exceeds the investment in the contract immediately before the withdrawal. It is possible that some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy for these purposes.

Certain Distributions Required by the Tax Law in the First 15 Policy Years. As indicated above, Section 7702 of the Code places limitations on the amount of premiums that may be paid and the Policy Values that can accumulate relative to the Death Benefit. Where cash distributions are required under Section 7702 of the Code in connection with a reduction in benefits during the first 15 years after the Policy is issued (or if withdrawals are made in anticipation of a reduction in benefits, within the meaning of the tax law, during this period), some or all of such amounts may be includible in income notwithstanding the general rule described in the preceding paragraph. A reduction in benefits may result upon a decrease in the Face Amount, a change from one Death Benefit Option to the other, if withdrawals are made, and in certain other instances.

Tax Treatment of Loans. If a Policy is not classified as a MEC, a loan received under the Policy generally will be treated as indebtedness of the Owner. As a result, no part of any loan under a Policy will constitute income to the Owner so long as the Policy remains in force. However in those situations where the interest rate credited to the Loan Account is identical (or nearly identical) to the interest rate charged for the loan, it is possible that some or all of the loan proceeds may be includible in income. If a Policy lapses or is surrendered when a loan is outstanding, the amount of the loan outstanding will be treated as the proceeds of a surrender for purposes of determining whether any amounts are includable in the Owner’s income. As a result, the amount of your taxable income could increase by some or all of the outstanding loan. If a Policy with an outstanding loan does not lapse due to the operation of the Overloan Protection Endorsement, there is uncertainty regarding the tax consequences. It is possible that the amount of your taxable income could increase by some or all of the outstanding loan.

Generally, interest paid on any loans under this Policy will not be tax deductible. The non-deductibility of interest includes interest paid or accrued on indebtedness with respect to one or more life insurance policies owned by a taxpayer covering any individual who is or has been an officer or employee of, or financially interested in, any trade or business carried on by the taxpayer. A limited exception to this rule exists for certain interest paid in connection with certain “key person” insurance. In the case of interest paid in connection with a loan with respect to a Policy covering the life of any key person, interest is deductible only to the extent that the aggregate amount of loans under one or more life insurance policies does not exceed $50,000. Further, even as to such loans up to $50,000, interest would not be deductible if the Policy were deemed for federal tax purposes to be a single premium life insurance policy or, in certain circumstances, if the loans were treated as “systematic borrowing” within the meaning of the tax law. A “key person” is an individual who is either an officer or a 20 percent owner of the taxpayer. The maximum number of individuals who can be treated as key persons may not exceed the greater of (1) 5 individuals or (2) the lesser of 5 percent of the total number of officers and employees of the taxpayer or 20 individuals. Owners should consult a tax advisor regarding the deductibility of interest incurred in connection with this Policy.

Policies That Are MECs

Characterization of a Policy as a MEC. In general, a Policy will be considered a MEC for federal income tax purposes if (1) the Policy is received in exchange for a life insurance contract that was a MEC, or (2) the Policy is

TABLE OF CONTENTS

entered into on or after June 21, 1988 and premiums are paid into the Policy more rapidly than the rate defined by a “7-Pay Test”. This test generally provides that a Policy will fail this test (and thus be considered a MEC) if the accumulated amount paid under the Policy at any time during any 7- Pay period exceeds the cumulative sum of the net level premiums which would have been paid to that time if the Policy provided for paid-up future benefits after the payment of 7 level annual premiums. A material change of the Policy (as defined in the tax law) will generally result in a reapplication of the 7-Pay Test. In addition, any reduction in benefits during the 7-Pay period will affect the application of this test. Protective Life will monitor the Policies and will attempt to notify Owners on a timely basis if a Policy is in jeopardy of becoming a MEC. The Policy Owner may then request that Protective Life take whatever steps are available to avoid treating the Policy as a MEC, if that is desired.

Tax Treatment of Withdrawals, Loans, Assignments and Pledges under MECs. If the Policy is a MEC, withdrawals from the Policy will be treated first as withdrawals of income and then as a recovery of premiums paid. Thus, withdrawals will be includible in income to the extent the Policy Value exceeds the investment in the contract. It is possible that some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy for these purposes. The amount of any Policy Debt will be treated as a withdrawal for tax purposes. Distributions made within two years before a failure to meet the 7-Pay Test are treated as made under a MEC. See the discussion of interest on loans and of lapses and surrenders while loans are outstanding under the caption “Policies That Are Not MECs” also applies to Policies which are MECs.

If the Owner assigns or pledges any portion of the Policy Value (or agrees to assign or pledge any portion), such portion will be treated as a withdrawal for tax purposes. If the entire Policy Value is assigned or pledged, subsequent increases in the Policy Value are also treated as withdrawals for as long as the assignment or pledge remains in place. The Owner’s investment in the contract is increased by the amount includible in income with respect to any assignment, pledge, or loan, though it is not affected by any other aspect of the assignment, pledge, or loan (including its release or repayment). Before assigning, pledging, or requesting a loan under a Policy treated as a MEC, an Owner should consult a tax advisor.

Additional Tax. Generally, proceeds of a surrender or a withdrawal (or the amount of any deemed withdrawal such as a loan, assignment, or pledge) from a MEC are subject to an additional tax equal to 10% of the portion of the proceeds that is includible in income, unless the surrender or withdrawal is made (1) after the Owner attains age 59½, (2) because the Owner has become disabled (as defined in the tax law), or (3) as substantially equal periodic payments over the life or life expectancy of the Owner (or the joint lives or life expectancies of the Owner and his or her Beneficiary, as defined in the tax law).

Aggregation of Policies. All life insurance contracts which are treated as MECs and which are purchased by the same person from Protective Life or any of its affiliates within the same calendar year will be aggregated and treated as one contract for purposes of determining the tax on withdrawals (including deemed withdrawals). The effects of such aggregation are not always clear; however, it could affect the amount of a surrender or a withdrawal (or a deemed withdrawal) that is taxable and the amount which might be subject to the 10% additional tax described above.

Constructive Receipt Issues

The IRS could determine that an Owner is in constructive receipt of the Cash Value of the Policy if the Cash Value equals the Death Benefit, which can occur in some instances where the Insured is age 95 or older. If the Owner was determined to be in constructive receipt of the Cash Value, an amount equal to the excess of the Cash Value over the investment in the contract could be includible in the Owner’s income at that time.

Section 1035 Exchanges

Section 1035 of the Code provides that no gain or loss will be recognized on the exchange of a life insurance policy for another life insurance policy, endowment contract, annuity contract, or long-term care insurance contract, provided that certain requirements are met. If the Policy is being issued in exchange for another life insurance policy, the requirements that must be met to receive tax-free treatment under Section 1035 of the Code, include but are not limited to: (1) the policies must have the same insured, and (2) the exchange must occur through an assignment of your old policy to us or by a direct transfer of the account value of the old policy to us by the issuer of the old policy. If your old policy was a MEC the Policy will also be a MEC. You cannot exchange an endowment, annuity, or long-term care insurance contract for a life insurance policy tax-free. If any money or other property is received in the exchange (“boot”), gain (but not loss) will be recognized equal to the lesser of the gain realized on the exchange or the amount of the boot received. We accept Section 1035 exchanges of life insurance policies with outstanding loans. If the amount of the loan under the policy exchanged is greater than the amount of the loan under the policy issued in the exchange, the difference will be treated as boot and may result in the recognition of gain. Generally, the Policy will have the same investment in the contract as the exchanged policy. However, if boot is received in the exchange the investment in the contract will be adjusted. Special rules and procedures apply to Section 1035 exchanges. These rules can be complex, and if you wish to take advantage of Section 1035, you should consult a tax and/or legal adviser.

TABLE OF CONTENTS

Actions to Ensure Compliance with the Tax Law

Protective Life believes that the maximum amount of premiums it has determined for the Policies will comply with the federal tax definition of life insurance. Protective Life will monitor the amount of premiums paid, and, if the premiums paid exceed those permitted by the tax definition of life insurance, Protective Life will immediately refund the excess premiums with interest to the extent required by the Code. Protective Life also reserves the right to increase the Death Benefit (which may result in larger charges under a Policy) or to take any other action deemed necessary to ensure the compliance of the Policy with the federal tax definition of life insurance.

Other Considerations

Changing the Owner, designating an irrevocable beneficiary, exchanging the Policy, increasing the Face Amount, changing from one Death Benefit Option to another, and other changes under the Policy may have tax consequences (other than those discussed herein) depending on the circumstances of such change or withdrawal. In addition, special tax consequences may apply if you sell your Policy.

In the case of an “employer-owned life insurance contract” as defined in the tax law that is issued (or deemed to be issued) after August 17, 2006, the portion of the death benefit excludable from gross income generally will be limited to the premiums paid for the contract. However, this limitation on the death benefit exclusion will not apply if certain notice and consent requirements are satisfied and one of several exceptions is satisfied. These exceptions include circumstances in which the death benefit is payable to certain heirs of the insured or to acquire an ownership interest in a business, or where the contract covers the life of a director or an insured who is “highly compensated” within the meaning of the tax law. These rules, including the definition of an employer-owned life insurance contract, are complex, and you should consult with your advisers for guidance as to their application.

Estate, Gift and Generation-Skipping Transfer Tax Considerations

The transfer of the Policy or designation of a beneficiary may have federal, state, and/or local transfer and inheritance tax consequences, including the imposition of gift, estate, and generation-skipping transfer taxes. For example, the transfer of the Policy to, or the designation as a beneficiary of, or the payment of proceeds to, a person who is assigned to a generation which is two or more generations below the generation assignment of the owner may have generation-skipping transfer tax consequences in addition to gift and estate tax consequences under federal tax law. The individual situation of each Owner or beneficiary will determine the extent, if any, to which federal, state, and local transfer and inheritance taxes may be imposed and how ownership or receipt of Policy proceeds will be treated for purposes of federal, state and local estate, inheritance, generation-skipping and other taxes. If this Policy is used with estate and gift tax planning in mind, you should consult with your tax advisor as to the most up-to-date information as to federal estate, gift and generation skipping tax rules.

Medicare Hospital Insurance Tax

A Medicare hospital insurance tax of 3.8% will apply to some types of investment income. This tax will apply to the taxable portion of (1) any proceeds distributed from the Policy as annuity payments pursuant to a settlement option prior to the death of the Insured, or (2) the proceeds of any sale or disposition of the Policy. This tax only applies to taxpayers with “modified adjusted gross income” above $250,000 in the case of married couples filing jointly or a qualifying widow(er) with dependent child, $125,000 in the case of married couples filing separately, and $200,000 for all others. For more information regarding this tax and whether it may apply to you, please consult your tax advisor.

Federal Income Tax Withholding

In General. Protective Life will withhold and remit to the federal government a part of the taxable portion of a surrender and withdrawal made under a Policy unless the Owner notifies Protective Life in writing and such notice is received at the Home Office at or before the time of the surrender or withdrawal that he or she elects not to have any amounts withheld. Regardless of whether the Owner requests that no taxes be withheld or whether Protective Life withholds a sufficient amount of taxes, the Owner will be responsible for the payment of any taxes including any additional tax that may be due on the amounts received. The Owner may also be required to pay penalties under the estimated tax rules if the Owner’s withholding and estimated tax payments are insufficient to satisfy the Owner’s tax liability.

Nonresident Aliens and Foreign Corporations

The discussion above provides general information regarding U.S. federal withholding tax consequences to life insurance purchasers that are U.S. citizens or residents. Purchasers or beneficiaries that are not U.S. citizens or residents will generally be subject to U.S. federal withholding tax on taxable distributions (including taxable Death Benefit Proceeds) from life insurance policies at a 30% rate, unless a lower treaty rate applies. Prospective purchasers that are not U.S. citizens or residents are advised to consult with a tax advisor regarding federal tax withholding with respect to distributions from a Policy.

TABLE OF CONTENTS

FATCA Withholding

If the payee of a distribution (including the Death Benefit) from the Policy is a foreign financial institution (“FFI”) or a non-financial foreign entity (“NFFE”) within the meaning of the Code as amended by the Foreign Account Tax Compliance Act (“FATCA”), the distribution could be subject to U.S. federal withholding tax on the taxable amount of the distribution at a 30% rate irrespective of the status of any beneficial owner of the Policy or the nature of the distribution. The rules relating to FATCA are complex, and a tax advisor should be consulted if an FFI or NFFE is or may be designated as a payee with respect to the Policy.

EXCHANGE PRIVILEGE

The Company is offering, where allowed by law, to Owners of certain existing life policies (“Existing Life Policy” and/or “Existing Life Policies”) issued by it, such as interest sensitive whole life insurance, universal life insurance, and term life insurance policies, the opportunity to exchange such a life policy for this Policy. The Company reserves the right to modify, amend, terminate or suspend the Exchange Privilege at any time or from time to time. Owners of Existing Life Policies may exchange their Existing Life Policies for this Policy. Owners of Existing Life Policies may also make a partial or full surrender from their Existing Life Policies and use the proceeds to purchase this Policy. All charges and deductions described in this Prospectus are equally applicable to Policies purchased in an exchange. All charges and deductions may not be assessed under an Existing Life Policy in connection with an exchange, surrender, or partial surrender of an Existing Life Policy.

The Policy differs from the Existing Life Policies in many significant respects. Most importantly, the Policy Value under this Policy may consist, entirely or in part, of Variable Account Value which fluctuates in response to the net investment return of the Variable Account. In contrast, the policy values under the Existing Life Policies always reflect interest credited by the Company. While a minimum rate of interest (typically 1 to 4.5%) is guaranteed, the Company in the past has credited interest at higher rates. Accordingly, policy values under the Existing Life Policies reflect current interest rates and do not vary with the investment performance of a Variable Account.

The Policy also differs from the Existing Life Policies with respect to the Death Benefit. The Death Benefit payable under the Existing Life Policies is either a specified fixed dollar amount or a specified fixed dollar amount plus policy cash value, with policy cash value equal to premium payments under the Existing Life Policy credited at a specified rate(s) of interest, less charges. However, unlike the death benefit payable under an Existing Life Policy, the Death Benefit under the Policy may reflect changes in Variable Account Value as part of Policy Value. If the Guideline Premium Limitation/Cash Value Corridor Test applies to the Policy, under Death Benefit Option A, the Death Benefit will vary with the Policy Value whenever the Policy Value multiplied by the applicable specified percentage is greater than the Face Amount. If the Cash Value Accumulation Test applies to the Policy, under Death Benefit Option A, the Death Benefit will vary with the Policy Value whenever the minimum death benefit is greater than the Face Amount. If either test applies, under Death Benefit Option B, the Death Benefit will always vary with Policy Value. The death benefits under the Existing Life Policies do not reflect of the investment performance of a variable separate account of Protective Life.

There are other significant differences between the Policy and the Existing Life Policies. For example, under the Policy, there are additional fees and expenses, such as transfer fees, and mortality and expense risk charges and underlying fund expenses, none of which are assessed under the Existing Life Policies. The Lapse Protection Guarantee under the Policy may be for a shorter or longer period than the lapse protection guarantee under the particular Existing Life Policy that may be exchanged for the Policy. In addition, the sale of the Policy is subject to regulation by the U.S. Securities and Exchange Commission and the Financial Industry Regulatory Authority, but the Existing Life Policies are not. Both the Policies and the Existing Life Policies are subject to regulation by the insurance departments of the states in which they are sold.

A table which generally summarizes the different charges under the respective policies is as follows. For more complete details owners of Existing Life Policies should refer to their policy forms for a complete description. For more information on guaranteed charges for the Policy, see “Charges and Deductions.”

	Existing Life Policy	Policy
Sales Charges/Premium Expense Charge	Ranges from 0% to 12% of each premium payment in all Policy Years. The premium expense charge can vary by age under certain policies.	2% of each premium payment in all Policy Years.
Administrative Fees	Ranges from $4 to $9 per month in all Policy Years	$9 per month in all Policy Years and a fee per $1,000 of Initial Face Amount per month that varies based on the Insured’s Issue Age, sex and rate class.

TABLE OF CONTENTS

	Existing Life Policy	Policy
Mortality and Expense Charges	None	A guaranteed maximum monthly charge equal to 0.050% multiplied by the Variable Account Value, which is equivalent to annual rate of 0.6% of such amount; currently 0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.
Withdrawal Charges	$25	The lesser of $25 or 2% of the withdrawal amount requested.
Monthly Deductions	A monthly deduction consisting of: (1) cost of insurance charges (2) administrative fees (see above) (3) any charges for supplemental riders (applies to Existing Life Policies which are universal life plans).	A monthly deduction consisting of: (1) cost of insurance charges (2) administrative fees (see above) (3) monthly mortality and expense charges (see above) and (4) any charges for supplemental riders.
Surrender Charges	Surrender charges vary by policy type and are incurred during a surrender charge period which ranges from 0 Policy Years up to 19 Policy Years.	None
Guaranteed Interest Rate	Ranges from 1% to 4.5%.	Only Fixed Account: 1%

Effects of the Exchange Offer

The Policy will be issued to Existing Life Policy Owners. Evidence of insurability may be required.

If an Existing Life Policy Insured is within current issue age limits, the Owner may carry over existing riders if available with the Policy. Evidence of insurability may be required. An increase or addition of riders will require full evidence of insurability.

The Contestable and Suicide provisions in the Policy will begin again as of the effective date of the exchange, if evidence of insurability is required. If evidence of insurability is not required on the exchange, the Contestable and Suicide provisions will not begin again.

Owners of Existing Life Policies should carefully consider whether it will be advantageous to replace an Existing Life Policy with a Policy. It may not be advantageous to exchange an Existing Life Policy for a Policy (or to surrender in full or in part an Existing Life Policy and use the surrender or partial surrender proceeds to purchase a Policy). Replacement of existing insurance with the Policy may reduce or otherwise change existing Policy Benefits. Additional fees and charges also may apply.

Tax Matters. The Company believes that an exchange of an Existing Life Policy for a Policy generally should be treated as a nontaxable exchange within the meaning of Section 1035 of the Internal Revenue Code. A Policy purchased in exchange will generally be treated as a newly issued contract as of the effective date of the Policy. This could have various tax consequences. See “Tax Considerations.”

If you surrender your Existing Life Policy in whole or in part and after receipt of the proceeds you use the surrender proceeds or partial surrender proceeds to purchase a Policy, it will not be treated as a non-taxable exchange. The surrender proceeds will generally be includible in income.

Owners of Existing Life Policies should consult their tax advisers before exchanging an Existing Life Policy for this Policy, or before surrendering in whole or in part their Existing Life Policy and using the proceeds to purchase this Policy.

TABLE OF CONTENTS

USE OF THE POLICY

Life insurance, including variable life insurance, can be used to provide for many individual and business needs, in addition to providing a death benefit. Possible applications of a variable life insurance policy, such as this Policy include:(1) serving as vehicle for accumulating funds for a college education, (2) estate planning, (3) serving as an investment vehicle on various types of deferred compensation arrangements, (4) buy-sell arrangements, (5) split dollar arrangements, and (6) a supplement to other retirement plans.

As with any investment, using this Policy under these or other applications entails certain risks. For example, if investment performance of Sub-Accounts to which Policy Value is allocated is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate Cash Value or Surrender Value sufficient to adequately fund the application for which the Policy was purchased. Similarly, certain transactions under a Policy entail risks in connection with the application for which the Policy is purchased. Withdrawals, the payment of Advisory Fees from Policy Value, Policy loans and interest paid on Policy loans may significantly affect current and future Policy Value, Cash Value, Surrender Value or Death Benefit Proceeds. If, for example, a Policy loan is taken but not repaid prior to the death of the Insured, the Policy Debt is subtracted from the Death Benefit in computing the Death Benefit Proceeds paid to a Beneficiary.

Prior to utilizing this Policy for the above applications, you should consider whether the anticipated duration of the Policy is appropriate for the application for which you intend to purchase it.

In addition, you need to consider the tax implications of using the Policy with these applications. The tax implications of using this Policy with these applications can be complex and generally are not addressed in the discussion of “Tax Considerations” above. Loans and withdrawals will affect the Policy Value and Death Benefit. There may be penalties and taxes if the Policy is surrendered, Lapses, matures or if a withdrawal or a loan is made. Because of these risks, you need to carefully consider how you use this Policy. This Policy may not be suitable for all persons, under any of these applications.

STATE VARIATIONS

The Prospectus and SAI describe all material rights, benefits and obligations under the Policy. Any material state variations in the Policy are covered in this Prospectus and in a state specific policy form for use in that state. If you would like to review a copy of your Policy and its endorsements and riders, if any, contact our Home Office or your sales representative.

SALE OF THE POLICIES

We have entered into an agreement with Investment Distributors, Inc. (“IDI”) under which IDI has agreed to distribute the Policies on a “best efforts” basis. Under the agreement, IDI serves as principal underwriter (as defined under Federal securities laws and regulations) for the Policies. IDI is a Tennessee corporation and was established in 1993. IDI, a wholly owned subsidiary of PLC, is an affiliate of Protective Life, and its home office shares the same address as Protective Life. IDI is registered with the SEC under the Securities Exchange Act of 1934 as a broker-dealer and is a member firm of the Financial Industry Regulatory Authority (“FINRA”).

IDI does not sell Policies directly to purchasers. IDI, together with Protective Life, enters into distribution agreements with Financial Intermediaries of Protective Life and IDI for the sale of the Policies. Financial advisers of these Financial Intermediaries sell the Policies directly to purchasers. These financial advisers must be licensed as insurance agents by applicable state insurance authorities and appointed as agents of Protective Life in order to sell the Policies.

We pay commissions and additional asset-based compensation to Selling Broker-Dealers through IDI. IDI does not retain any commission payment or other amounts as principal underwriter for the Policies. However, we pay IDI a fee to cover some or all of IDI’s operating and other expenses.

We offer the Policies on a continuous basis. While we anticipate continuing to offer the Policies, we reserve the right to discontinue the offering at any time.

We paid the following aggregate dollar amounts to IDI in commissions and additional asset-based compensation relating to sales of our variable life policies, which IDI passed along directly to the Selling Broker-Dealers.

Fiscal Year Ended	Amount Paid to IDI
December 31, 2023		$	44,125,570
December 31, 2024		$	54,476,984
December 31, 2025		$	53,943,492

TABLE OF CONTENTS

Commissions

We do not pay Commissions to the Financial Intermediaries that sell this Policy. Financial Intermediaries receive compensation in connection with the Policy in the form of Advisory Fees pursuant to an agreement between you and the Financial Intermediary. These Financial Intermediaries may include broker-dealers or their affiliated insurance agencies. Financial Intermediaries may also be registered investment advisers, or be affiliated with or in a contractual relation with, a registered investment adviser. If you have entered into an agreement with an investment adviser, your investment adviser is paid pursuant to that investment advisory agreement. We do not set the amount, or receive any of the amount paid to your investment adviser. You should ask your Financial Intermediary about compensation they receive related to this Policy. Under certain circumstances, described below in the discussion of “Additional Payments,” your financial adviser’s Financial Intermediary may receive payments as well as other, non-cash compensation, from us so that we have access to the financial advisers in order to educate them about the Policies, as well as other products offered by Protective Life, and to encourage sales of this Policy. You may wish to speak with your financial adviser or an appropriate person at his/her associated selling Financial Intermediary about these payments, sometimes referred to as “revenue sharing arrangements”, and the potential conflict of interest that they may create for your Financial Intermediary.

We intend to recoup sales and marketing expenses through fees and charges deducted under the Policies or from our general account. In the normal course of business, we may also provide non-cash compensation in connection with the promotion of the Policies, including conferences and seminars (including travel, lodging and meals in connection therewith), and items of relatively small value, such as promotional gifts, meals, or tickets to sporting or entertainment events in accordance with all applicable federal and state rules, including FINRA’s non-cash compensation rules.

Additional Payments. Subject to FINRA, broker-dealer and other rules, we or our affiliates also may pay the following types of fees to, among other things, encourage the sale of this Policy. These additional payments could create an incentive for your Financial Intermediary to recommend products that pay them more than others, which may not necessarily be to your benefit. All or a portion of the payments we make to Financial Intermediaries may be passed on to financial advisers according to a Financial Intermediary’s internal compensation practices.

•

Access to Financial Intermediaries and/or broker-dealers for us such as one-on-one wholesaler visits or attendance at national sales meetings or similar events.

•

Gifts & Entertainment Occasional meals and entertainment, tickets to sporting events and other gifts.

•

Joint marketing campaigns and/or event advertising/participation; sponsorship of sales contests and/or promotions in which participants (including Financial Intermediaries) receive prizes such as travel awards, merchandise and recognition; client generation expenses.

•

Marketing Expense Allowances Pay Fund related parties for wholesaler support, training and marketing activities for certain Funds.

•

Sales support through such things as providing hardware and software, operational and systems integration, links to our website from a Financial Intermediary’s websites; shareholder services (including subaccounting sponsorship of broker-dealer due diligence meetings; and/or expense allowances and reimbursements).

•

We may also pay to selected Financial Intermediaries, including those listed above as well as others, additional compensation in the form of (1) payments for participation in meetings and conferences that include presentations about our products (including the Policies), and (2) payments to help defray the costs of sales conferences and educational seminars for the Financial Intermediaries’ registered representatives.

LEGAL PROCEEDINGS

Protective Life and its subsidiaries, like other insurance companies, in the ordinary course of business are involved in some class action and other lawsuits, or alternatively in arbitration. In some class action and other lawsuits involving insurance companies, substantial damages have been sought and material payments have been made. Although the outcome of any litigation or arbitration cannot be predicted, Protective Life believes that at the present time there are no pending or threatened lawsuits that are reasonably likely to have a material adverse impact on the Variable Account, the ability of IDI to perform its contract with the Variable Account, or the ability of Protective Life to meet its obligations under the Policies.

FINANCIAL STATEMENTS

The financial statements of the Company and the Variable Account are incorporated by reference in the Statement of Additional Information.

TABLE OF CONTENTS

APPENDIX: FUNDS AVAILABLE UNDER THE POLICY

The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.

The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund’s past performance is not necessarily an indication of future performance.

Asset Allocation Type	Fund - Investment Adviser; Sub-Adviser(s), as applicable	Current Expenses	Average Annual Total Returns (as of 12/31/2025)
Asset Allocation Type	Fund - Investment Adviser; Sub-Adviser(s), as applicable	Current Expenses	1 Year	5 Year	10 Year
Allocation	American Funds Insurance Series® Asset Allocation Fund - Class 1 - Capital Research and Management Company	0.29%	16.16%	9.24%	10.05%
International Equity	American Funds Insurance Series® Global Growth Fund - Class 1 - Capital Research and Management Company(1)	0.40%	21.98%	8.51%	12.46%
U.S. Equity	American Funds Insurance Series® Growth-Income Fund - Class 1 - Capital Research and Management Company	0.28%	18.37%	14.19%	14.20%
International Equity	American Funds Insurance Series® New World Fund® - Class 1 - Capital Research and Management Company(1)	0.57%	28.60%	5.59%	9.53%
Allocation	BlackRock Global Allocation V.I. Fund - Class I (1)	0.76%	19.80%	5.79%	7.59%
U.S. Equity	ClearBridge Variable Mid Cap Portfolio - Class I - Franklin Templeton Fund Adviser, LLC	0.82%	4.35%	4.50%	7.50%
U.S. Equity	ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC	0.81%	9.23%	-0.17%	9.38%
Allocation	Dimensional VA Global Moderate Allocation Portfolio - Institutional Class(1)	0.28%	14.68%	8.42%	8.65%
International Equity	Dimensional VA International Small Portfolio - Institutional Class	0.39%	36.99%	8.89%	8.68%
International Equity	Dimensional VA International Value Portfolio - Institutional Class	0.27%	45.64%	15.85%	10.46%
Taxable Bond	Dimensional VA Short-Term Fixed Portfolio - Institutional Class	0.12%	4.33%	2.65%	1.97%
U.S. Equity	Dimensional VA U.S. Large Value Portfolio - Institutional Class	0.21%	15.83%	11.97%	10.51%
U.S. Equity	Dimensional VA U.S. Targeted Value Portfolio - Institutional Class	0.29%	8.95%	13.60%	11.00%
Taxable Bond	Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class	0.11%	7.55%	1.05%	3.12%
Allocation	Fidelity® VIP Balanced Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited	0.41%	15.25%	9.52%	11.13%
U.S. Equity	Fidelity® VIP Growth Opportunities Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited	0.56%	22.02%	11.31%	19.94%
Taxable Bond	Fidelity® VIP Investment Grade Bond Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited	0.37%	7.22%	0.06%	2.71%
U.S. Equity	Fidelity® VIP Mid Cap Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited	0.55%	11.75%	10.10%	10.59%

TABLE OF CONTENTS

Asset Allocation Type	Fund - Investment Adviser; Sub-Adviser(s), as applicable	Current Expenses	Average Annual Total Returns (as of 12/31/2025)
Asset Allocation Type	Fund - Investment Adviser; Sub-Adviser(s), as applicable	Current Expenses	1 Year	5 Year	10 Year
Taxable Bond	Goldman Sachs VIT Core Fixed Income Fund - Institutional Class(1)	0.42%	7.46%	-0.57%	2.11%
U.S. Equity	Goldman Sachs VIT Mid Cap Value Fund - Institutional Class(1)	0.81%	9.39%	10.05%	10.02%
International Equity	Invesco® V.I. Global Fund - Series I	0.81%	15.32%	7.28%	11.00%
Buffer	Invesco® V.I. S&P 500 Buffer December Fund - Series I (1)(2)	0.71%	12.53%	-	-
Buffer	Invesco® V.I. S&P 500 Buffer June Fund - Series I (1)(2)	0.71%	13.65%	-	-
Buffer	Invesco® V.I. S&P 500 Buffer March Fund - Series I (1)(2)	0.71%	7.64%	-	-
Buffer	Invesco® V.I. S&P 500 Buffer September Fund - Series I (1)(2)	0.71%	12.78%	-	-
Money Market	Invesco® V.I. U.S. Government Money Portfolio - Series I	0.67%	3.64%	2.80%	1.76%
Sector Equity	Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares	0.73%	25.15%	13.71%	21.48%
Taxable Bond	Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC	0.98%	8.33%	2.10%	4.72%
Taxable Bond	PIMCO VIT Real Return Portfolio - Institutional Class - Pacific Investment Management Company LLC	1.24%	8.01%	1.36%	3.37%
Taxable Bond	PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Managaement Company LLC	0.58%	9.05%	0.16%	2.51%
U.S. Equity	Putnam VT Sustainable Leaders Fund - Class IA - Franklin Advisers, Inc.; Franklin Templeton Investment Management Limited	0.63%	10.99%	10.62%	14.98%
U.S. Equity	Schwab® S&P 500 Index Portfolio	0.03%	17.83%	14.38%	14.75%
Allocation	TOPS® Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Aggressive Growth ETF Portfolio)	0.29%	19.17%	9.69%	10.71%
Allocation	TOPS® Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC	0.31%	10.39%	4.61%	5.25%
Allocation	TOPS® Moderately Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Growth ETF Portfolio)	0.29%	18.31%	8.85%	9.80%
Allocation	TOPS® Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Moderate Growth ETF Portfolio)	0.29%	15.50%	7.20%	8.26%
Allocation	Vanguard Variable Insurance Funds - Balanced Portfolio- Wellington Management Company LLP	0.20%	16.46%	9.28%	10.02%
U.S. Equity	Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named the Vanguard Variable Insurance Funds - Capital Growth Portfolio)	0.34%	28.97%	13.97%	14.96%
Allocation	Vanguard Variable Insurance Funds - Conservative Allocation Portfolio	0.12%	12.72%	4.22%	6.14%
U.S. Equity	Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC	0.29%	16.79%	12.59%	11.51%
U.S. Equity	Vanguard Variable Insurance Funds - Equity Index Portfolio	0.14%	17.70%	14.26%	14.65%
U.S. Equity	Vanguard Variable Insurance Funds - Growth Portfolio - Wellington Management Company, LLP	0.36%	16.88%	11.36%	15.58%

TABLE OF CONTENTS

Asset Allocation Type	Fund - Investment Adviser; Sub-Adviser(s), as applicable	Current Expenses	Average Annual Total Returns (as of 12/31/2025)
Asset Allocation Type	Fund - Investment Adviser; Sub-Adviser(s), as applicable	Current Expenses	1 Year	5 Year	10 Year
International Equity	Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.	0.32%	19.96%	0.62%	10.48%
U.S. Equity	Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio	0.17%	11.54%	8.46%	10.77%
Sector Equity	Vanguard Variable Insurance Funds - Real Estate Index Portfolio	0.26%	3.11%	4.50%	5.08%
Taxable Bond	Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio	0.14%	6.93%	-0.50%	1.90%
U.S. Equity	Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio	0.13%	16.93%	12.97%	14.09%

(1)

These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.

(2)

The Sub-Account investing in this Fund is closed to Policies with applications signed on and after May 1, 2025.

TABLE OF CONTENTS

APPENDIX: RETURN OF PURCHASE PAYMENT DEATH BENEFIT CALCULATION EXAMPLES

EXAMPLES OF DEATH BENEFIT COMPUTATIONS UNDER OPTIONS A AND B

(Guideline Premium Limitation Test Example)

Option A Example. For purposes of this example, assume that the Insured’s Attained Age is between 0 and 40 and that there is no outstanding Policy Debt or liens. Under Option A, a Policy with a $100,000 Face Amount will generally pay $100,000 in Death Benefits. However, because the Death Benefit must be equal to or be greater than 250% of the Policy Value, any time that the Policy Value exceeds $40,000, the Death Benefit will exceed the $100,000 Face Amount. Each additional dollar added to Policy Value above $40,000 will increase the Death Benefit by $2.50. A Policy with a $100,000 Face Amount and a Policy Value of $50,000 will provide Death Benefit of $125,000 ($50,000 x 250%); a Policy Value of $60,000 will provide a Death Benefit of $150,000 ($60,000 x 250%); a Policy Value of $70,000 will provide a Death Benefit of $175,000 ($70,000 x 250%).

Similarly, so long as Policy Value exceeds $40,000, each dollar taken out of Policy Value will reduce the Death Benefit by $2.50. If, for example, the Policy Value is reduced from $45,000 to $40,000 because of partial surrenders, Advisory Fees, charges, or negative investment performance, the Death Benefit will be reduced from $112,500 to $100,000. If at any time, however, the Policy Value multiplied by the Face Amount Percentage is less than the Face Amount, the Death Benefit will equal the current Face Amount of the Policy.

Above Attained Age 40, the Face Amount Percentage becomes lower as the Insured’s Attained Age increases. If the Attained Age of the Insured in the example above were, for example, 50 (rather than between 0 and 40), the specified amount factor would be 185%. The Death Benefit would not exceed the $100,000 Face Amount unless the Policy Value exceeded approximately $54,055 (rather than $40,000), and each dollar then added to or taken from the Policy Value would change the life insurance proceeds by $1.85 (rather than $2.50).

Option B Example. For purposes of this example, assume that the Insured’s Attained Age is between 0 and 40 and that there is no outstanding Policy Debt or liens. Under Option B, a Policy with a Face Amount of $100,000 will generally provide a Death Benefit of $100,000 plus Policy Value. Thus, for example, a Policy with a Policy Value of $10,000 will have a Death Benefit of $110,000 ($100,000 + $10,000); a Policy Value of $20,000 will provide a Death Benefit of $120,000 ($100,000 + $20,000). The Death Benefit, however, must be at least 250% of the Policy Value. As a result, if the Policy Value exceeds $66,666, the Death Benefit will be greater than the Face Amount plus Policy Value. Each additional dollar of Policy Value above $66,666 will increase the Death Benefit by $2.50. A Policy with a Face Amount of $100,000 and a Policy Value of $70,000 will provide a Death Benefit of $175,000 ($70,000 x 250%); a Policy Value of $80,000 will provide a Death Benefit of $200,000 ($80,000 x 250%).

Similarly, any time Policy Value exceeds $66,666, each dollar taken out of Policy Value will reduce the Death Benefit by $2.50. If, for example, the Policy Value is reduced from $80,000 to $75,000 because of partial surrenders, Advisory Fees, charges, or negative investment performance, the Death Benefit will be reduced from $200,000 to $187,500. If at any time, however, Policy Value multiplied by the Face Amount percentage is less than the Face Amount plus the Policy Value, then the Death Benefit will be the current Face Amount plus Policy Value of the Policy.

The Face Amount percentage becomes lower as the Insured’s Attained Age increases. If the Attained Age of the Insured in the example above were, for example, 50 (rather than under 40), the Face Amount factor would be 185%. The amount of the Death Benefit would be the sum of the Policy Value plus $100,000 unless the Policy Value exceeded $117,647 (rather than $66,666), and each dollar then added to or taken from the Policy Value would change the Death Benefit by $1.85 (rather than $2.50).

Table of Face Amount Percentages

Attained Age	Percentage		Attained Age	Percentage		Attained Age	Percentage		Attained Age	Percentage
0-40		250%	50		185%	60		130%	70		115%
41		243%	51		178%	61		128%	71		113%
42		236%	52		171%	62		126%	72		111%
43		229%	53		164%	63		124%	73		109%
44		222%	54		157%	64		122%	74		107%
45		215%	55		150%	65		120%	75-90		105%
46		209%	56		146%	66		119%	91		104%
47		203%	57		142%	67		118%	92		103%
48		197%	58		138%	68		117%	93		102%
49		191%	59		134%	69		116%	94		101%
									95+		100%

TABLE OF CONTENTS

EXAMPLES OF DEATH BENEFIT COMPUTATIONS UNDER OPTIONS A AND B

(Cash Value Accumulation Test Example)

Option A Example. For purposes of this example, assume that the Insured is a male, standard nontobacco class and the Insured’s Attained Age is 40 in the second or later Policy Year and that there is no outstanding Policy Debt or liens. Under Option A, a Policy with a $100,000 Face Amount will generally pay $100,000 in Death Benefits. However, because the Death Benefit must be equal to or be greater than 229% of the Policy Value, any time that the Policy Value exceeds $43,668, the Death Benefit will exceed the $100,000 Face Amount. Each additional dollar added to Policy Value above $43,668 will increase the Death Benefit by $2.29. A Policy with a $100,000 Face Amount and a Policy Value of $50,000 will provide Death Benefit of $114,500 ($50,000 x 229%); a Policy Value of $60,000 will provide a Death Benefit of $137,400 ($60,000 x 229%); a Policy Value of $70,000 will provide a Death Benefit of $160,300 ($70,000 x 229%).

Similarly, so long as Policy Value exceeds $43,668, each dollar taken out of Policy Value will reduce the Death Benefit by $2.29. If, for example, the Policy Value is reduced from $50,000 to $43,668 because of partial surrenders, Advisory Fees, charges, or negative investment performance, the Death Benefit will be reduced from $114,500 to $100,000. If at any time, however, the Policy Value multiplied by the Face Amount Percentage is less than the Face Amount, the Death Benefit will equal the current Face Amount of the Policy.

The Face Amount Percentage generally becomes lower as the Insured’s Attained Age increases. If the Attained Age of the Insured in the example above were, for example, 50 (rather than 40), the specified amount factor would be 192%. The Death Benefit would not exceed the $100,000 Face Amount unless the Policy Value exceeded approximately $52,083 (rather than $43,668), and each dollar then added to or taken from the Policy Value would change the life insurance proceeds by $1.92 (rather than $2.29).

Option B Example. For purposes of this example, assume that the Insured is a male, standard nontobacco class and the Insured’s Attained Age is 40 in the second or later Policy Year and that there is no outstanding Policy Debt or liens. Under Option B, a Policy with a Face Amount of $100,000 will generally provide a Death Benefit of $100,000 plus Policy Value. Thus, for example, a Policy with a Policy Value of $10,000 will have a Death Benefit of $110,000 ($100,000 + $10,000); a Policy Value of $20,000 will provide a Death Benefit of $120,000 ($100,000 + $20,000). The Death Benefit, however, must be at least 229% of the Policy Value. As a result, if the Policy Value exceeds $77,519, the Death Benefit will be greater than the Face Amount plus Policy Value. Each additional dollar of Policy Value above $77,519 will increase the Death Benefit by $2.29. A Policy with a Face Amount of $100,000 and a Policy Value of $50,000 will provide a Death Benefit of $150,000 ($50,000 x 229%); a Policy Value of $80,000 will provide a Death Benefit of $183,200 ($80,000 x 229%).

Similarly, any time Policy Value exceeds $77,519, each dollar taken out of Policy Value will reduce the Death Benefit by $2.29. If, for example, the Policy Value is reduced from $80,000 to $75,000 because of partial surrenders, Advisory Fees, charges, or negative investment performance, the Death Benefit will be reduced from $183,200 to $175,000. If at any time, however, Policy Value multiplied by the Face Amount percentage is less than the Face Amount plus the Policy Value, then the Death Benefit will be the current Face Amount plus Policy Value of the Policy.

The Face Amount Percentage generally becomes lower as the Insured’s Attained Age increases. If the Attained Age of the Insured in the example above were, for example, 50 (rather than 40), the Face Amount factor would be 192%. The amount of the Death Benefit would be the sum of the Policy Value plus $100,000 unless the Policy Value exceeded $108,695 (rather than $77,519), and each dollar then added to or taken from the Policy Value would change the Death Benefit by $1.92 (rather than $2.29).

TABLE OF CONTENTS

APPENDIX: RIGHT TO CANCEL

RIGHT TO CANCEL (FREE LOOK) TIME PERIODS AND POLICY PROVISION VARIATIONS

States

Free-look period/Right to cancel language

AL, AK, AZ, AR, CO, CT, DE, DC, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NC, ND, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA WV, WI, WY

THE OWNER HAS THE RIGHT TO RETURN THIS POLICY. The Owner may cancel this Policy after receipt by returning the Policy to the Company’s Home Office, or to any Agent of the Company, with a written request for cancellation within thirty (30) days after receipt. Return of this Policy by mail is effective on actual receipt by the Company. The returned Policy will be treated as if it had never been issued. The Company will promptly refund an amount equal to the greater of: (a) all the premiums paid or (b) the sum of the value of the amounts allocated to the Fixed Account, including any interest credited, accumulated to the date that this Policy is returned to the Company, and the value of the amounts allocated to the Sub-Accounts, adjusted to reflect their net investment experience to the end of the valuation period in which the Policy is returned to the Company.

THE OWNER HAS THE RIGHT TO RETURN THIS POLICY. Important. You have purchased a variable life insurance contract. Carefully review it for limitations. This Policy may be returned by the Owner for cancellation by delivering it or mailing it to the Company or to the agent through whom it was purchased, within 30 days from the date you received it. Return of the Policy during the 30 day cancellation period shall entitle the Owner to a refund of Account Value and any Policy Fee paid. The Account Value and Policy Fee shall be refunded within 30 days from the date the Company is notified that the Owner has canceled the Policy.

A return of the Policy after 30 days may result in a substantial penalty, known as a Surrender Charge. Please refer to the “Surrenders and Withdrawals” section of this Policy.

(The above right to cancel period is varied for individual Policy Owners aged 60 years or over as follows)

IMPORTANT! YOU HAVE PURCHASED A VARIABLE LIFE INSURANCE POLICY, REFERRED TO BELOW AS A “POLICY”. CAREFULLY REVIEW IT FOR LIMITATIONS.

This Policy may be returned within 30 days from the date you received it. During that 30-day period, your money will be placed in a fixed account or money-market fund, unless you direct that the premium be invested in a stock or bond portfolio underlying the Policy during the 30-day period. If you do not direct that the premium be invested in a stock or bond portfolio, and if you return the Policy within the 30-day period, you will be entitled to a refund of the premium and any policy fee paid. If you direct that the premium be invested in a stock or bond portfolio during the 30-day period, and if you return the Policy during that period, you will be entitled to a refund of the Policy’s Account Value on the day the policy is received by the insurance company or agent who sold you this Policy, which could be less than the premium you paid for the Policy, plus any policy fee paid.

TABLE OF CONTENTS

APPENDIX: FINANCIAL INTERMEDIARY VARIATIONS

There may be variations in the availability of investment options, benefits, and/or other features described in this prospectus – including restrictions, limitations, and other variations – which may apply depending on the financial intermediary through which this Policy was sold. For example, a financial intermediary may not recommend certain investment options, optional benefits, or other features available under the Policy.

Currently, we are not aware of any variations in the offering of the Policy by any financial intermediary. Variations may be imposed by some financial intermediaries without our knowledge. We do not believe we can obtain information about other financial intermediary variations, restrictions and/or limitations without unreasonable effort or expense. In some cases, if a particular investment option, benefit and/or feature described in this prospectus is of interest to you, you may contact us directly to discuss availability. If we become aware of any variations we will update this appendix.

You should always discuss with your financial professional any limitations, restrictions, or other variations related to the investment options, benefits, and/or other features available to you through your financial professional.

TABLE OF CONTENTS

To learn more about the Policy, you should read the Statement of Additional Information (“SAI”) dated the same date as this Prospectus. The SAI contains more detailed information about the Policy than is contained in this Prospectus. Personalized illustrations of Death Benefits, Cash Value, and Policy Values are available without charge. For a free copy of the SAI, to receive personalized illustrations, and to request other information about the Policy please contact Brokerage Life Services at the toll-free telephone number shown on the cover. To request an SAI by mail, please tear off, complete and return this form to Protective Life’s Brokerage Life Services Division customer service at the address shown on the cover.

The SAI has been filed with the SEC and is incorporated by reference into this Prospectus. The SEC maintains an Internet website (http://www.sec.gov) that contains the SAI and other information about us and the Policy. Information about us and the Policy (including the SAI) may also be reviewed and copied at the SEC’s Public Reference Room in Washington, D.C., or may be obtained, upon payment of a duplicating fee, by writing the Public Reference Section of the SEC, 100 F Street, N.E., Washington, D.C. 20549-0102. Additional information on the operation of the Public Reference Room may be obtained by calling the SEC at (202) 942-8090.

Please send me a free copy of the SAI for the Protective Investors Benefit Advisory VUL.


	Name:

	Address:

	City, State, Zip:

	Daytime Telephone Number:

EDGAR Contract Identifier C000239749

PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT
(Registrant)

PROTECTIVE LIFE INSURANCE COMPANY
(Depositor)

2801 Highway 280 South
Birmingham, Alabama 35223
(800) 265-1545

STATEMENT OF ADDITIONAL INFORMATION
Individual Flexible Premium Variable and Fixed Life Insurance Policy

This Statement of Additional Information ("SAI") contains additional information regarding the individual flexible premium variable and fixed life insurance policy (the "Policy") offered by Protective Life Insurance Company ("Protective Life"). The Policy is issued to individuals. This SAI is not a prospectus and should be read together with the Prospectus for the Policy dated May 1, 2026, and the prospectuses for the Funds. You may obtain a copy of these prospectuses by writing or calling us at our address or phone number shown above. Capitalized terms in this SAI have the same meanings as in the Prospectus for the Policy.

May 1, 2026

TABLE OF CONTENTS

Company	3
Variable Account	3
Illustrations	3
CEFLI	3
Other Investors in the Funds	3
Assignment	3
State Regulation	4
Reports to Owners	4
Experts	4
Reinsurance	4
Additional Information	4
Financial Statements	5

Company

The Policies are issued by Protective Life Insurance Company ("Protective Life" or the "Depositor"). Protective Life is a Nebraska corporation that was founded in 1907. Following its receipt of an Order Approving Redomestication on December 20, 2024, Protective Life redomesticated from Tennessee to Nebraska, and became an insurance company domiciled in the State of Nebraska as of December 31, 2024. Protective Life markets individual life insurance, credit life and disability insurance, guaranteed investment contracts, guaranteed funding agreements, fixed and variable annuities and extended service contracts. Protective Life is currently licensed to transact life insurance business in 49 states and the District of Columbia. Protective Life is the principal operating subsidiary of Protective Life Corporation (“PLC”), a U.S. insurance holding company of Daiichi Life Group, Inc. ("Daiichi") (formerly Dai-ichi Life Holdings, Inc.). Daiichi’s stock is traded on the Tokyo Stock Exchange.

Variable Account

Illustrations

We may provide illustrations for Death Benefit, Policy Value, and Surrender Value based on hypothetical rates of return that are not guaranteed. The illustrations also assume costs of insurance for a hypothetical person. These illustrations are illustrative only and are not a representation of past or future performance. Your rates of return and insurance charges may be higher or lower than these illustrations. The actual return on your policy account value will depend on factors such as the amounts you allocate to particular Funds, the amounts deducted for the Policy's monthly charges, the Funds' expense ratios, and your policy loan and partial withdrawal history.

Before you purchase the Policy and upon request thereafter, we will provide illustrations of future benefits under the Policy based upon the proposed insured's age and underwriting class, face amount, planned premiums, and riders requested. We reserve the right to charge a reasonable fee for this service to persons who request more than one illustration during a Policy Year.

CEFLI

Protective Life is a member of the Compliance & Ethics Forum for Life Insurers ("CEFLI"), and as such may include the CEFLI logo and information about CEFLI membership in Protective advertisements. Companies that belong to CEFLI subscribe to a set of ethical standards covering the various aspects of sales and service for individually sold life insurance and annuities.

Other Investors in the Funds

Shares of the underlying Funds (a complete list of the Funds is included in the Prospectus under Appendix: Funds Available Under the Policy) are sold to separate accounts of insurance companies, which may or may not be affiliated with Protective Life or each other, a practice known as "shared funding." They may also be sold to separate accounts to serve as the underlying investment for both variable annuity contracts and variable life insurance policies, a practice known as "mixed funding." Shares of some of these Funds may also be sold to certain qualified pension and retirement plans. As a result, there is a possibility that a material conflict may arise among and between the interests of Policy Owners and other of the Fund's various investors. In the event of any such material conflicts, Protective Life will consider what action may be appropriate, including removing the Fund from the Variable Account or replacing the Fund with another Fund. The board of directors (or trustees) of each of the Funds monitors events related to their Funds to identify possible material irreconcilable conflicts among and between the interests of the Fund's various investors. There are certain risks associated with mixed and shared funding and with the sale of shares to qualified pension and retirement plans, as disclosed in each Fund's prospectus.

Assignment

The Policy may be assigned in accordance with its terms. An assignment is binding upon Protective Life only if it is in writing and filed at the Home Office. Once Protective Life has received a signed copy of the assignment, the Owner's

rights and the interest of any beneficiary (or any other person) will be subject to the assignment. Protective Life assumes no responsibility for the validity or sufficiency of any assignment. An assignment is subject to any Policy Debt and any liens. An assignment may result in certain amounts being subject to income tax and a 10% additional tax. (See "Tax Considerations" in the prospectuses.)

State Regulation

Protective Life is subject to regulation by the Nebraska Department of Insurance, which periodically examines the financial condition and operations of Protective Life. Protective Life is also subject to the insurance laws and regulations of all jurisdictions where it does business. The Policy has been filed with and, where required, approved by, insurance officials in those jurisdictions where it is sold.

Protective Life is required to submit annual statements of operations, including financial statements, to the insurance departments of the various jurisdictions where it does business to determine solvency and compliance with applicable insurance laws and regulations.

Reports to Owners

Each year you will be sent a report at your last known address showing, as of the end of the current report period: the Death Benefit; Policy Value; Fixed Account Value; Variable Account Value; Loan Account Value; Sub-Account Values; premiums paid since the last report; withdrawals since the last report; any Policy loans and accrued interest; Surrender Value; current Net Premium allocations; charges deducted since the last report; any liens and accrued interest; and any other information required by law. You will also be sent a notice that the annual and a semi-annual reports for each Fund underlying a Sub-Account to which you have allocated Policy Value, as required by the Investment Company Act of 1940, is available online. In addition, when you pay premiums or request any other financial transaction under your Policy you will receive a written confirmation of these transactions.

Experts

The financial statements of the subaccounts that comprise Protective Variable Life Separate Account as of December 31, 2025, and for each of the years or periods presented, have been incorporated by reference in this Statement of Additional Information in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

The financial statements of Protective Life Insurance Company as of December 31, 2025 and 2024, and for each of the years in the three-year period ended December 31, 2025, have been incorporated by reference in this Statement of Additional Information in reliance upon the report of KPMG LLP, independent registered public accounting firm, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing.

The audit report covering the December 31, 2025 financial statements includes explanatory language that states that the financial statements are prepared by Protective Life Insurance Company using statutory accounting practices prescribed or permitted by the Nebraska Department of Insurance, which is a basis of accounting other than U.S. generally accepted accounting principles. Accordingly, the audit report states that the financial statements are not intended to be and, therefore, are not presented fairly in accordance with U.S. generally accepted accounting principles and further states that those financial statements are presented fairly, in all material respects, in accordance with statutory accounting practices prescribed or permitted by the Nebraska Department of Insurance.

The business address for KPMG LLP is 420 20th Street North, Suite 1800, Birmingham, Alabama 35203

Reinsurance

The Company may reinsure a portion of the risks assumed under the Policies.

Additional Information

A registration statement has been filed with the SEC under the Securities Act of 1933, as amended, with respect to the Policies. Not all the information set forth in the registration statement, and the amendments and exhibits thereto, has been

included in the prospectuses and this SAI. Statements contained in this SAI concerning the content of the Policies and other legal instruments are intended to be summaries. For a complete statement of the terms of these documents, reference should be made to the instruments filed with the SEC at 100 F Street, N.E., Washington, DC 20549. The instruments may also be accessed using the SEC's website at http://www.sec.gov.

Financial Statements

The audited statements of assets and liabilities of the subaccounts that comprise Protective Variable Life Separate Account as of December 31, 2025, and the related statements of operations for the year or period then ended, and the statements of changes in net assets for each of the years or periods in the two-year period then ended as well as the Report of Independent Registered Public Accounting Firm are incorporated into the Statement of Additional Information by reference to the Variable Account’s Form N-VPFS, File No. 811-07337, filed with the SEC on April 21, 2026.

The audited statutory statements of admitted assets, liabilities, and capital and surplus of Protective Life Insurance Company as of December 31, 2025 and 2024, and the related statutory statements of operations, changes in capital and surplus, and cash flow for each of the years in the three-year period ended December 31, 2025 as well as the Independent Auditors' Report are incorporated into the Statement of Additional Information by reference to the Variable Account’s Form N-VPFS, File No. 811-07337, filed with the SEC on April 6, 2026. Protective Life's audited financial statements should be considered only as bearing on its ability to meet its obligations under the Policies. They should not be considered as bearing on the investment performance of the assets held in the Variable Account.

PART C

OTHER INFORMATION  

Item 30. Exhibits

(a) Board of Directors Resolutions

(a) (1) Resolution of the Board of Directors of Protective Life Insurance Company establishing Protective Variable Life Separate Account is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(b) Custodial Agreements - Not Applicable.

(c) (1) Underwriting Agreement among Protective Life Insurance Company, Investment Distributors, Inc. and Protective Variable Life Separate Account is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(c) (1) (i) Amendment No. 1 dated June 1, 1998 to the Underwriting Agreement (PLICO-IDI-PVLSA) is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on July 19, 2019.

(c) (1) (ii) Second Amended Distribution Agreement dated October 24, 2013 (PLICO-IDI) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-190294), filed with the Commission on April 25, 2014.

(c) (1) (iii) Revised Second Amended Distribution Agreement dated June 1, 2018 (PLICO-IDI) is incorporated herein by reference to Post-Effective Amendment No. 26 to the Form N-4 Registration Statement (File No. 333-112892), filed with the Commission on July 20, 2018.

(c) (1) (iv) Amendment No. 1 to the Second Amended Distribution Agreement (PLICO-IDI) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on July 27, 2020.

(c) (1) (v) Revised Schedule to Second Amended Distribution Agreement between IDI and PLICO is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on November 25, 2020.

(c) (2) Distribution Agreement between Investment Distributors, Inc. and broker-dealers is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(c) (2) (i) Third Amended and Restated Distribution Agreement (PLICO-IDI) is incorporated herein by reference to the Post-Effective Amendment No. 6 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on June 9, 2025.

(d) Contracts

(d) (1) Protective Investors Benefit Advisory VUL Form of Contract is incorporated by reference to the Form N-6 Registration Statement (File No. 333-267465), as filed with the Commission on September 16, 2022.

(d) (2) Children’s Term Life Insurance Rider is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

C-1

(d) (3) Protected Insurability Rider is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (4) Accidental Death Benefit Rider is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (5) Waiver of Specified Premium Rider is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (6) Chronic Illness Accelerated Death Benefit Rider is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (7) Pre-Determined Death Benefit Payout Endorsement is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (8) Overloan Protection Endorsement is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (9) Terminal Illness Accelerated Death Benefit Endorsement is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (10) Lapse Protection Endorsement is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (11) ExtendCare Rider is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(d) (11) (i) Revised ExtendCare Rider is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on August 8, 2020.

(d)(12) Policy Value Credit Endorsement is incorporated by reference to the Form N-6 Registration Statement (File No. 333-267465), as filed with the Commission on September 16, 2022.

(e) Applications

(e) (1) Form of Variable Universal Individual Life Insurance Application is incorporated herein by reference to the Form N-6 Registration Statement (File No. 333-232740), as filed with the Commission on July 19, 2019.

(f) Depositor's Certificate of Incorporation and By-Laws

(f) (1) 2011 Amended and Restated Charter of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 8 to the Form N-4 Registration Statement (File No. 333-153041), filed with the Commission on September 16, 2011.

(f) (1) (i) 2020 Amended and Restated Charter of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

(f) (1) (ii) 2024 Amended and Restated Articles of Incorporation of Protective Life Insurance Company- filed herein.

(f) (2) 2011 Amended and Restated By-laws of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 8 to the Form N-4 Registration Statement (File No. 333-153041), filed with the Commission on September 16, 2011.

C-2

(f) (2) (i) 2020 Amended and Restated By-laws of Protective Life Insurance Company is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

(f) (2) (ii) 2024 Amended and Restated Bylaws of Protective Life Insurance Company- filed herein.

(g) Reinsurance Contracts

(g) (1) Automatic and Facultative Yearly Renewable Term Agreement is incorporated herein by reference to Post-Effective Amendment No. 7 to the Form N-6 Registration Statement (File No. 333-52215), filed with the Commission on April 30, 2003.

(g) (2) Yearly Renewable Term Reinsurance Agreement is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-6 Registration Statement (333-52215) as filed with the Commission on April 27, 2009.

(g) (3) List of Reinsurers is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-6 Registration Statement (333-206951), filed with the Commission on April 25, 2019.

(h) Participation Agreements

(h) (1) Participation Agreement dated April 11, 2007 (Fidelity Variable Insurance Products) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (1) (i) Rule 22c-2 Shareholder Information Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

(h) (1) (ii) Amendment dated October 15, 2020 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (1) (iii) Amendment dated October 11, 2021 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-261426), filed with the Commission on November 30, 2021.

(h) (1) (iv) Amendment dated March 10, 2022 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on April 15, 2022.

(h) (1) (v) Amendment dated December 15, 2022 to Participation Agreement (Fidelity Variable Insurance Products) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (2) Participation Agreement dated April 30, 2002 (Lord Abbett Series Fund) is incorporated herein by reference to Post-Effective Amendment No. 3 to the Form N-4 Registration Statement (File No. 333-94047), filed with the Commission on April 25, 2002.

(h) (2) (i) Rule 22c-2 Shareholder Information Agreement (Lord Abbett Series Fund) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

(h) (2) (ii) Amendment dated April 28, 2022 (Lord Abbett Series Fund) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the N-4 Registration Statement (File No. 333-261426), filed July 5, 2022.

(h) (3) Participation Agreement dated December 19, 2003 (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-112892), filed with the Commission on February 17, 2004.

(h) (3) (i) Rule 22c-2 Shareholder Information Agreement dated April 11, 2007 (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

C-3

(h) (3) (ii) Amendment dated April 12, 2011 to Participation Agreement re Summary Prospectus (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 19 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on April 25, 2011.

(h) (3) (iii) Amendment dated December 22, 2020 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

(h) (3) (iv) Amendment dated April 12, 2021 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

(h) (3) (v) Amendment dated March 24, 2022 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on April 15, 2022.

(h) (3) (vi) Amendment dated December 15, 2022 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (3) (vii) Amendment dated April 23, 2024 to Participation Agreement (Goldman Sachs Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 7 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 23, 2025.

(h) (4) Participation Agreement dated February 1, 2015 (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 12 to the Form N-4 Registration Statement (File No. 333-190294), as filed with the Commission on April 28, 2021.

(h) (4) (i) Rule 22c-2 Shareholder Information Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 17 to the Form N-4 Registration Statement (File No. 33-70984), filed with the Commission on April 27, 2007.

(h) (4) (ii) Participation Agreement dated November 30, 2020 (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

(h) (4) (iii) Addendum dated November 30, 2020 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

(h) (4) (iv) Amendment dated March 31, 2021 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

(h) (4) (v) Amendment dated April 1, 2022 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the N-4 Registration Statement (File No. 333-261426), filed July 5, 2022.

(h) (4) (vi) Amendment dated November 1, 2022 to Participation Agreement (Franklin Templeton Variable Insurance Products Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (5) Participation Agreement dated November 1, 2009 (Legg Mason) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

C-4

(h) (5) (i) Amendment dated April 11, 2014 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (5) (ii) Amendment dated September 10, 2019 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (5) (iii) Amendment dated August 11, 2020 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (5) (iv) Amendment dated November 30, 2020 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

(h) (5) (v) Amendment dated April 7, 2021 to Participation Agreement (Legg Mason) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

(h) (5) (vi) Amendment dated October 26, 2022 to Participation Agreement (Legg Mason) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-267354), filed with the Commission on December 15, 2022.

(h) (6) Participation Agreement dated November 1, 2009 (PIMCO Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

(h) (6) (i) Novation of and Amendment dated April 25, 2011 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (6) (ii) Amendment dated April 25, 2011 to Participation Agreement re Summary Prospectuses (PIMCO Variable Insurance Trust) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (6) (iii) Amendment dated September 1, 2020 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

(h) (6) (iv) Amendment dated April 2, 2021 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

(h) (6) (v) Amendment dated August 9, 2022 to Participation Agreement (PIMCO Variable Insurance Trust) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-267354), filed with the Commission on September 9, 2022.

(h) (7) Participation Agreement dated November 1, 2009 (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

(h) (7) (i) Rule 22c-2 Information Sharing Agreement (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 15 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on October 28, 2009.

(h) (7) (ii) Amendment dated November 30, 2020 to Participation Agreement (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 9 to the Form N-4 Registration Statement (File No. 333-201919), filed with the Commission on February 11, 2021.

(h) (7) (iii) Amendment dated August 10, 2022 to Participation Agreement (Royce Capital) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

C-5

(h) (8) Participation Agreement dated February 1, 2015 (AIM-Invesco Variable Insurance Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (8) (i) Rule 22c-2 Agreement (AIM-Invesco Variable Insurance Funds) is incorporated herein by reference to Post-Effective Amendment No. 12 to the Form N-4 Registration Statement (File No. 333-179649), as filed with the Commission on August 24, 2016.

(h) (8) (ii) Amendment dated March 22, 2022 to Participation Agreement (AIM-Invesco Variable Insurance Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the N-4 Registration Statement (File No. 333-261426), filed with the Commission on July 5, 2022.

(h) (9) Participation Agreement dated June 18, 2015 (American Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (9) (i) Rule 22c-2 Shareholder Information Agreement (American Funds) is incorporated herein by reference to Post-Effective Amendment No. 11 to the Form N-4 Registration Statement (File No. 333-113070), filed with the Commission on April 30, 2008.

(h) (9) (ii) Amendment dated October 1, 2019 to Participation Agreement (American Funds) is incorporated herein by reference to Pre-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on November 25, 2020.

(h) (9) (iii) Amendment dated November 25, 2020 to Participation Agreement (American Funds) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

(h) (9) (iv) Amendment dated March 22, 2021 to Participation Agreement (American Funds) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File 333-240192), filed with the Commission on April 16, 2021.

(h) (9) (v) Amendment dated April 29, 2022 to Participation Agreement (American Funds) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-261466), filed with the Commission on July 5, 2022.

(h) (9) (vi) Amendment dated August 1, 2022 to Participation Agreement (American Funds) is incorporated herein by reference to the Form N-4 Registration Statement (File No. 333-267354), filed with the Commission on September 9, 2022.

(h) (10) Participation Agreement dated July 1, 2017 (Northern Lights Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 6 to the Form N-6 Registration Statement (File No. 333-206951), as filed with the Commission on July 12, 2017.

(h) (10) (i) Amendment dated September 1, 2020 to Participation Agreement (Northern Lights Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 6 to the Form N-6 Registration Statement (File No. 333-232740), filed with the Commission on August 6, 2021.

(h) (10) (ii) Amendment dated March 22, 2022 to Participation Agreement (Northern Lights Variable Trust) - is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (Filed No. 333-267465), filed with the Commission on April 25, 2023.

(h) (10) (iii) Amendment dated September 15, 2022 to Participation Agreement (Northern Lights Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (11) Participation Agreement dated October 15, 2017 (DFA Investment Dimensions Group Inc.) is incorporated herein by reference to Post-Effective Amendment No. 28 to the Form N-6 Registration Statement (File No. 333-52215), filed with the Commission on November 27, 2017.

(h) (11) (i) Amendment dated August 20, 2020 to Participation Agreement (DFA Investment Dimensions Group) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-237747), filed with the Commission on August 24, 2020.

C-6

(h) (12) Participation Agreement dated April 1, 2017 (Vanguard Variable Insurance Fund) is incorporated herein by reference to Post-Effective Amendment No. 27 to the Form N-6 Registration Statement (File No. 333-52215), as filed with the Commission on April 27, 2017.

(h) (12) (i) Amendment dated November 1, 2019 to Participation Agreement (Vanguard Variable Insurance Fund) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (333-232740), filed with the Commission on October 29, 2019.

(h) (12) (ii) Participation Agreement dated November 23, 2020 (Vanguard Variable Insurance Fund) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-237747), filed with the Commission on April 28, 2021.

(h) (12) (iii) Revised Schedule A dated April 30, 2021 to Participation Agreement (Vanguard Variable Insurance Fund) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-237747), filed with the Commission on April 28, 2021.

(h) (12) (iv) Revised Schedule A dated October 13, 2022 to Participation Agreement (Vanguard Variable Insurance Fund) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (13) Participation Agreement dated December 1, 2020 (BlackRock) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

(h) (13) (i) Amendment dated May 1, 2021 to Participation Agreement (BlackRock) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), filed with the Commission on April 16, 2021.

(h) (13) (ii) Amendment dated April 1, 2022 to Participation Agreement (BlackRock) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (13) (iii) Amendment dated September 16, 2022 to Participation Agreement (BlackRock) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (14) Participation Agreement dated November 9, 2020 (Putnam Variable Trust) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

(h) (14) (i) Rule 22(c)-2 Agreement dated November 9, 2020 (Putnam Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on April 25, 2022.

(h) (14) (ii) Amendment dated March 30, 2022 (Putnam Variable Trust) - is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (14) (iii) Amendment dated September 21, 2022 to Participation Agreement (Putnam Variable Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (15) Participation Agreement dated December 3, 2020 (Janus Aspen Series) is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-248236), filed with the Commission on December 16, 2020.

(h) (15) (i) Amendment dated October 11, 2021 to Participation Agreement (Janus Aspen Series) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on April 15, 2022.

(h) (15) (ii) Amendment dated March 1, 2022 to Participation Agreement (Janus Aspen Series) is incorporated herein by reference to Post-Effective Amendment No. 2 to the Form N-4 Registration Statement (File No. 333-240102), filed with the Commission on April 15, 2022.

C-7

(h) (15) (iii) Amendment dated October 1, 2022 to Participation Agreement (Janus Aspen Series) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(h) (16) Participation Agreement dated November 9, 2020 (Schwab Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-4 Registration Statement (File No. 333-240192), file with the Commission on April 16, 2021.

(h) (16) (i) Amendment dated December 15, 2022 to Participation Agreement (Schwab Variable Insurance Trust) is incorporated herein by reference to Post-Effective Amendment No. 1 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on April 25, 2023.

(i) Administrative Contracts - Not Applicable.

(j) Other Material Contracts - Not Applicable.

(k) Legal Opinion

(k) (1) Opinion and Consent of Bradley Strickling, Esq. is incorporated by reference to the Form N-6 Registration Statement (File No. 333-267465), as filed with the Commission on September 16, 2022.

(l) Actuarial Opinion- Not Applicable.

(m) Calculation- Not Applicable.

(n) Other Opinions

(n) (1) Consents of KPMG LLP - Filed herein.

(n) (2) Powers of Attorney – Filed herein.

(o) Omitted Financial Statements - Not Applicable.

(p) Initial Capital Agreements - Not Applicable.

(q) Redeemability Exemption

(q) (1) Memorandum Pursuant to Rule 6e-3(T)(b)(12)(iii) Describing Issue, Transfer and Redemption Procedures is incorporated herein by reference to Pre-Effective Amendment No. 1 to the Form N-6 Registration Statement (333-232740), filed with the Commission on October 29, 2019.

(r) Form of Initial Summary Prospectus is incorporated herein by reference to Post-Effective Amendment No. 4 to the Form N-6 Registration Statement (File No. 333-267465), filed with the Commission on October 20, 2023.

C-8

Item 31.    Directors and Officers of the Depositor

Name and Principal Business Address*		Position and Offices with Depositor
Adams, D. Scott		Executive Vice President, Chief Transformation and Strategy Officer
Bartlett, Malcolm Lee		Senior Vice President, Corporate Tax
Bern, Leigh Bynum		Senior Vice President, Chief Financial Actuary, and Appointed Actuary
Bielen, Richard J.		Chairman of the Board, Chief Executive Officerand Director
Black, Lance P.		Executive Vice President, Acquisitions and Corporate Development
Byrd, Kenneth		Senior Vice President, Operations
Cramer, Steve		Senior Vice President, and Chief Product Officer
Creutzmann, Scott E.		Senior Vice President, and Chief Compliance Officer
Cropenbaker, John		Senior Vice President, Executive Benefits Markets
Drew, Mark L.		Executive Vice President, and Chief Legal Officer
Evesque, Wendy L.		Executive Vice President, and Chief Human Resources Officer
Goldsmith, Lisa M.		Director
Hardeman, James C.		Senior Vice President, Financial Planning and Analysis
Harrison, Wade V.		Vice Chairman, Chief Operating Officer, and Director
Herring, Derry W		Senior Vice President, and Chief Auditor
Karchunas, M. Scott		Senior Vice President, and President, Asset Protection Division
Kohler, Matthew		Senior Vice President, and Chief Information Officer
Kurtz, Richard J.		Senior Vice President, and Chief Distribution Officer
Lassiter, Frank Q.		Vice President, Head of Treasury, and Treasurer
Lawrence, Mary Pat		Senior Vice President, Government Affairs
Lebel, Dominique		Senior Vice President, and Chief Risk Officer
McDonald, Laura Y.		Senior Vice President, and Chief Mortgage and Real Estate Officer
Passafiume, Philip E.		Executive Vice President, and Chief Investment Officer
Peeler, Rachelle R.		Senior Vice President, and Senior Human Resources Partner
Peevy, Melinda		Secretary
Pugh, Barbara N.		Senior Vice President, and Chief Accounting Officer
Radnoti, Francis L.		Senior Vice President, Chief Product Officer, and Designated Illustration Actuary
Ray, Webster M.		Senior Vice President, Investments
Seurkamp, Aaron C.		Senior Vice President, and President, Retirement Division
Wagner, James		Senior Vice President, and Chief Distribution Officer
Wahlheim, Cary T.		Senior Vice President, and Senior Counsel
Walker, Steven G.		Vice Chairman, Finance and Risk, and Director
Wells, Paul R.		President, Chief Financial Officer, and Director
Whitcomb, John		Senior Vice President, Retirement Operations and Strategic Planning
Williams, Doyle J.		Senior Vice President, and Chief Marketing Officer

* Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama 35223

Item 32.    Persons Controlled by or Under Common Control With the Depositor or Registrant

The registrant is a segregated asset account of the Company and is therefore owned and controlled by the Company. All of the Company’s outstanding voting common stock is owned by Protective Life Corporation, a subsidiary of Dai-ichi Life Group, Inc. Protective Life Corporation is described more fully in the prospectus included in this registration statement.

For more information regarding the company structure of Protective Life Corporation and Dai-ichi Life Group, Inc., please refer to the Organizational Chart filed herein.

Item 33.    Indemnification

Article XI of the By-laws of Protective Life provides, in substance, that any of Protective Life’s directors and officers, who is a party or is threatened to be made a party to any action, suit or proceeding, other than an action by or in the right of Protective Life, by reason of the fact that he is or was an officer or director, shall be indemnified by Protective Life against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with such claim,

C-9

action, suit or proceeding if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. If the claim, action or suit is or was by or in the right of Protective Life to procure a judgment in its favor, such person shall be indemnified by Protective Life against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection with the defense or settlement of such action or suit if he acted in good faith and in a manner he reasonably believed to be in or not opposed to the best interests of Protective Life, except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his duty to Protective Life unless and only to the extent that the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper. To the extent that a director or officer has been successful on the merits or otherwise in defense of any such action, suit or proceeding, or in defense of any claim, issue or matter therein, he shall be indemnified by Protective Life against expenses (including attorneys’ fees) actually and reasonably incurred by him in connection therewith, not withstanding that he has not been successful on any other claim issue or matter in any such action, suit or proceeding. Unless ordered by a court, indemnification shall be made by Protective Life only as authorized in the specific case upon a determination that indemnification of the officer or director is proper in the circumstances because he has met the applicable standard of conduct. Such determination shall be made (a) by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to, or who have been successful on the merits or otherwise with respect to, such claim action, suit or proceeding, or (b) if such a quorum is not obtainable, or, even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion or (c) by the shareholders.

In addition, the executive officers and directors are insured by PLC’s Directors’ and Officers’ Liability Insurance Policy including Company Reimbursement and are indemnified by a written contract with PLC which supplements such coverage.

Insofar as indemnification for liability arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Securities and Exchange Commission such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

C-10

Item 34.    Principal Underwriters

(a)  Investment Distributors, Inc. (“IDI”) is the principal underwriter of the Policies as defined in the Investment Company Act of 1940. IDI is also principal underwriter for the Protective Variable Annuity Separate Account, PLICO Variable Annuity Account S, Protective COLI VUL, Protective COLI PPVUL, Variable Annuity Separate Account A of Protective Life, PLAIC Variable Annuity Account S, Protective NY COLI VUL, and Protective NY Variable Life Separate Account. The principal underwriter, IDI, is also currently distributing units of interest in the following separate accounts: Variable Annuity-1 Series Account, Variable Annuity-1 Series Account of Great West Life & Annuity Insurance Company of New York, Variable Annuity-2 Series Account, Variable Annuity-2 Series Account [New York], Variable Annuity-3 Series Account, COLI VUL-2 Series Account, COLI VUL-2 Series Account of Great West Life & Annuity Insurance Company of New York, COLI VUL-4 Series Account of Great-West Life & Annuity Insurance Company, Maxim Series Account of Great West Life & Annuity Insurance Company, Prestige Variable Life Account, Pinnacle Series Account of Great West Life & Annuity Insurance Company, Trillium Variable Annuity Account.

(b)  The following information is furnished with respect to the officers and directors of IDI:

Name and Principal Business Address*		Position and Offices with Underwriter
Baggett, Alan		Assistant Financial Officer
Barkson, Carl		Vice President, Head of Corporate Tax
Carlson, Martha H.		Designated Responsible Licensed Producer
Coffman, Benjamin P.		Chief Financial Officer
Collazo, Kimberly		Assistant Secretary
Creutzmann, Scott E.		Director
Lane, Jamie L.		Director
Leopard, Mona		Assistant Secretary
McCreless, Kevin L.		Chief Compliance Officer
Morsch, Letitia A.		Assistant Secretary and Director
Peevy, Melinda		Secretary
Tennent, Rayburn		Assistant Financial Officer
Wagner, James		President and Director

*  Unless otherwise indicated, principal business address is 2801 Highway 280 South, Birmingham, Alabama, 35223.

(c)  The following commissions were received by each principal underwriter, directly or indirectly, from the Registrant during the Registrant’s last fiscal year:

(1) Name of Principal Underwriter		(2) Net Underwriting Discounts		(3) Compensation on Redemption		(4) Brokerage Commissions		(5) Other Compensation
Investment Distributors, Inc.		N/A		None		N/A		N/A

Item 35.    Location of Accounts and Records.

All accounts and records required to be maintained by Section 31(a) of the Investment Company Act of 1940 and the rules thereunder are maintained by Protective Life Insurance Company at 2801 Highway 280 South, Birmingham, Alabama 35223.

Item 36.    Management Services.

All management contracts are discussed in the Prospectus or Statement of Additional Information.

Item 37.    Fee Representation.

Protective Life Insurance Company represents that the fees and charges deducted under the Policy, in the aggregate, are reasonable in relation to the services rendered, the expenses expected to be incurred, and the risks assumed by Protective Life Insurance Company.

C-11

SIGNATURES

Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant of this Registration Statement certifies that it meets all of the requirements for effectiveness of this Registration Statement under Rule 485(b) under the Securities Act and has duly caused this Post-Effective Amendment to the Registration Statement on Form N-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Birmingham, State of Alabama, on April 23, 2026.

PROTECTIVE VARIABLE LIFE SEPARATE ACCOUNT

By:	*
Paul R. Wells, President
Protective Life Insurance Company

PROTECTIVE LIFE INSURANCE COMPANY

By:	*
Paul R. Wells, President
Protective Life Insurance Company

As required by the Securities Act of 1933, this Post-Effective Amendment to the Registration Statement on Form N-6 has been signed by the following persons in the capacities and on the dates indicated:

Signature		Title	Date
*		Chairman of the Board,	April 23, 2026
Richard J. Bielen		Chief Executive Officer, and Director
		(Principal Executive Officer)

*		Vice Chairman, Chief Operating Officer and Director	April 23, 2026
Wade V. Harrison

*		President, Chief Financial Officer, and Director	April 23, 2026
Paul R. Wells		(Principal Operating and Accounting Officer)

*BY:	/S/ BRANDON J. CAGE		April 23, 2026
Brandon J. Cage
Attorney-in-Fact

C-12

EXHIBIT LIST

(f) (1) (ii) 2024 Amended and Restated Articles of Incorporation of Protective Life Insurance Company

(f) (2) (ii) 2024 Amended and Restated Bylaws of Protective Life Insurance Company

(n) (1) Consents of KPMG LLP

(n) (2) Powers of Attorney

Item (32) Organizational Chart of Daiichi Life Group, Inc.

C-13

EX-99.(F)(1)(II) 2 tm263879d5_ex99-xfx1xii.htm EXHIBIT 99.(F)(1)(II)

	NE Sec of State - Robed B. Evnen
	Filing Document #: 2412235205        Pages: 7
	Company Name: PROTECTIVE LIFE INSURANCE COMPANY
	Filing Date and Time: 12/26/2024 04:44 PM

NEBRASKA DEPT OF INSURANCE

DEC 19 2024

Tentative Approval

NOT FINAL

ARTICLES OF DOMESTICATION

PROTECTIVE LIFE INSURANCE COMPANY

For the purpose of its redomestication from the State of Tennessee to the State of Nebraska, pursuant to the applicable provisions of Chapter 44 of the Nebraska Insurance Code and the Nebraska Model Business Corporation Act, the undersigned hereby executes the following Articles of Domestication ("the Articles"):

ARTICLE 1

The name of the Company immediately before the filing of the Articles is Protective Life Insurance Company.

ARTICLE 2

The Company was originally incorporated under the laws of Tennessee on July 24, 1907.

ARTICLE 3

The domestication of the Company in the State of Nebraska was duly authorized as required by the laws of the State of Tennessee.

Execution Version

Protective Life Insurance Company

Articles of Domestication

STATE OF NEBRASKA

DEPARTMENT OF INSURANCE

JAN 03 2024

APPROVED

IN WITNESS WHEREOF, Protective Life Insurance Company has caused these Articles of Domestication to be executed in duplicate in its corporate name and its corporate seal to be affixed hereto by its duly authorized officers, this 19^th day of December, 2024.

	Protective Life Insurance Company

	By:	/s/ Richard J. Bielen
	Richard J. Bielen
	President, Chief Executive Officer, and Chairman of the Board

STATE OF ALABAMA

)

COUNTY OF JEFFERSON

)

I HEREBY CERTIFY that on this day, before me, an officer duly authorized in the State and County aforesaid to take acknowledgements, Richard J. Bielen, Charmain of the Board of Protective Life Insurance Company, personally appeared before me and acknowledges the execution of the foregoing Articles of Domestication of Protective Life Insurance Company, and who having been duly sworn, stated that any representations therein contained are true.

WITNESS my hand and Notarial Seal in the County and State last aforesaid, the 19^th day of December, 2024.

	/s/ Vanessa Ricaurte
	NOTARY PUBLIC

{SEAL}

Execution Version

Protective Life Insurance Company

Articles of Domestication

NEBRASKA DEPT OF INSURANCE

DEC 19 2024

Tentative Approval

NOT FINAL

AMENDED AND RESTATED

ARTICLES OF INCORPORATION

PROTECTIVE LIFE INSURANCE COMPANY

WHEREAS, Protective Life Insurance Company ("the Company") was originally incorporated in 1907 under the laws of Tennessee; and

WHEREAS, the Company now desires to amend and restate its Amended and Restated Charter (the "Charter") in connection with the redomestication of the Company from the State of Tennessee to the State of Nebraska pursuant to the Nebraska Model Business Corporation Act and Chapter 44 of the Nebraska Insurance Code, and these Articles of Incorporation amend and restate the provisions of the Charter and all restatements thereof and amendments thereto.

WHEREAS, the Company in connection with the redomestication of the Company from the State of Tennessee to the State of Nebraska pursuant to the Nebraska Model Business Corporation Act, the Company has filed Articles of Domestication with the Nebraska Secretary or State.

NOW THEREFORE, the Company hereby adopts the following Amended and Restated Articles of Incorporation:

ARTICLE 1
NAME

The name of the Company shall be Protective Life Insurance Company.

ARTICLE 2
DURATION

The duration of the Company shall be perpetual.

ARTICLE 3

PURPQSES, OBJECTS AND POWERS

The purposes, objects and powers of the Company are:

To engage in any lawful business, act or activity for which a corporation may be organized under the Nebraska Model Business Corporation Act, it being the purpose and intent of this Article 3 to invest the Company with the broadest purposes, objects and powers lawfully permitted a corporation formed under the said Act.

STATE OF NEBRASKA

DEPARTMENT OF INSURANCE

JAN 03 2024

APPROVED

To carry on any and all aspects, ordinary or extraordinary, of any lawful business and to enter into and carry out any transaction, ordinary or extraordinary, permitted by law, having and exercising in connection therewith all powers given to corporations by the laws of the State of Nebraska.

Without limiting the scope and generality of the foregoing, the Company shall have the following specific purposes, objects and powers:

To transact the business of life, disability, health and accident insurance and to issue annuities and endowments and every other kind of insurance in such places as may be approved by the Board of Directors subject to applicable regulatory approvals, including without limitation, to transact the business of insuring the lives of individuals and the writing of every kind of insurance pertaining to life, including the granting, selling, purchasing and disposing of annuities and endowments; to accept risks and insure against accidents or sickness; to effect reinsurance; and generally to make all contracts and to do and perform all things whatsoever pertaining to the business of insuring lives and of taking risks against accidents or sickness, or the granting, selling, purchasing and disposing of annuities and endowments; all in a manner not inconsistent with the laws of the State of Nebraska or the provisions hereof.

To have and to exercise any and all of the powers specifically granted in the insurance laws of the State of Nebraska, none of which shall be deemed to be inconsistent with the nature, character or object of the Company and none of which are denied to it by these Amended and Restated Articles of Incorporation, including, without limitation, the power to accept and execute all legal trusts which may be confided to the Company.

ARTICLE 4

CAPITAL STOCK

The Company is authorized to issue five million (5,000,000) shares of stock, one dollar ($1.00) par value per share. All such shares are to be of one class and shall be designated as Common Stock. The shareholders of the Company shall not have preemptive rights.

ARTICLE 5

REGISTERED AGENT AND REGISTERED OFFICE

C T Corporation System shall serve as the registered agent. The business address of the registered agent and the registered office address is 5601 South 59^th Street, Suite C, Lincoln, Nebraska 68516.

The principal place of business of the Company shall be in Omaha, Nebraska or at such other city within the State of Nebraska as the Board of Directors may determine or at such city as the Board of Directors may determine provided such city complies with applicable law. The

Company may establish branches and agencies in any other part of the State of Nebraska, in other states or territories of the United States, or in the District of Columbia.

ARTICLE 6

BOARD OF DIRECTORS

The business and affairs of the Company shall be managed by the Board of Directors. The number of directors of the Company shall be fixed from time to time in the manner provided in the Bylaws, or, in the absence of a by-law fixing or providing a manner of determining the number of directors. The number of directors shall be determined by the shareholders. The Board of Directors shall consist of at least five (5) or more individuals, with the number specified in or fixed in accordance with the Bylaws, and no decrease in the number of directors shall have the effect of shortening the term of any incumbent director. Any director may be removed in accordance with the provisions of the Bylaws and the laws of the State of Nebraska.

To the fullest extent permitted by the Nebraska Model Business Corporation Act as in effect on the date hereof and as hereafter amended from time to time, a director of the Company shall not be liable to the Company or its shareholders for monetary damages for breach of fiduciary duty as a director. If the Nebraska Model Business Corporation Act or any successor statute is amended after adoption of this provision to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of a director of the Company shall be eliminated or limited to the fullest extent permitted by the Nebraska Model Business Corporation Act, as so amended from time to time, provided, in no event shall a director be exempt from any obligation imposed by Chapter 44, Nebraska Code Annotated. Any repeal or modification of this Article 7 by the shareholders of the Company shall not adversely affect any right or protection of a director of the Company existing at the time of such repeal or modification or with respect to events occurring prior to such time.

In addition to the powers and authorities bereinbefore or by statute expressly conferred upon them, the directors are hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the Company; subject, nevertheless, to the provisions of the Code of Nebraska, these Amended and Restated Articles of Incorporation and to any Bylaws from time to time adopted; provided, however, that no Bylaws so adopted shall invalidate any prior act of the directors which would have been valid if such Bylaw had not been adopted.

ARTICLE 8

INTERNAL AFFAIRS

The following provisions for the regulation of the business and for the conduct of the affairs of the Company, the directors and the shareholders are hereby adopted:

The power to alter, amend, or repeal the Bylaws or adopt new Bylaws shall be vested in the Board of Directors and the shareholders, or either of them, which power may be exercised in the manner and to the extent provided in the Bylaws, provided, however, that the Board of Directors may not alter, amend or repeal any Bylaw establishing what constitutes a quorum at such shareholders' meetings, or which was adopted by the shareholders and specifically provides that it cannot be altered, amended or repealed by the Board of Directors. The Bylaws may contain any provisions for the regulation of the business and for the conduct of the affairs of the Company, the directors and shareholders not inconsistent with these Amended and Restated Articles of Incorporation.

The Company reserves the right from time to time to amend, alter or repeal each and every provision contained in these Amended and Restated Articles of Incorporation, or to add one or more additional provisions, in the manner now or hereafter prescribed or permitted by the Nebraska Insurance Code or the Nebraska Model Business Corporation Act, and all rights conferred upon shareholders at any time are granted subject to this reservation.

IN WITNESS WHEREOF, Protective Life Insurance Company has caused these Amended and Restated Articles of Incorporation to be executed in the duplicate for it by its President and Chairman of the Board and by its Secretary this 19^th day of December, 2024.

	PROTECTIVE LIFE INSURANCE COMPANY

	By:	/s/ Richard J. Bielen
	Richard J. Bielen
	President, Chief Executive Officer, and Chairman of the Board

	By:	/s/ Felicia Malloch Lee
	Felicia Malloch Lee
	Secretary

STATE OF ALABAMA

)

COUNTY OF JEFFERSON

)

I HEREBY CERTIFY that on this day, before me, an officer duly authorized in the State and County aforesaid to take acknowledgements, Richard J. Bielen, Charmain of the Board of Protective Life Insurance Company, personally appeared before me and acknowledges the execution of the foregoing Amended and Restated Articles of Incorporation of Protective Life Insurance Company, and who having been duly sworn, stated that any representations therein contained are true.

WITNESS my hand and Notarial Seal in the County and State last aforesaid, the 19^th day of December, 2024.

	Vanessa Ricaurte
	NOTARY PUBLIC

{SEAL}

EX-99.(F)(2)(II) 3 tm263879d5_ex99-xfx2xii.htm EXHIBIT 99.(F)(2)(II)

	STATE OF NEBRASKA
	DEPARTMENT OF INSURANCE

	JAN 14 2025

	FILED

AMENDED AND RESTATED BYLAWS

PROTECTIVE LIFE INSURANCE COMPANY

(herein called the "Company")

ARTICLE I
OFFICES

The principal place of business and statutory home office of the Company shall be in Omaha, Nebraska. The administrative office of the Company shall be in Birmingham, Jefferson County, Alabama, or at any such other place as the Board of Directors may determine or at such place as the Board of Directors may determine provided such place complies with applicable law.

ARTICLE II

SHAREHOLDERS

Section 1.     Meetings. The annual meeting of the shareholders for the purpose of electing directors and for the transaction of such other business as may come before the meeting shall be held at such date and time during the calendar year as shall be specified by resolution of the Board of Directors. Special meetings of the shareholders may be called for any purposes by the Board of Directors, the Executive Committee or the chief executive officer.

Section 2.     Place of Meeting. The place of meeting shall be the administrative office of the Company in the State of Alabama unless some other place, either within or without the State of Nebraska, is designated by the shareholders or by the Board of Directors.

Section 3.     Notice of Meeting. Written or printed notice stating the place, day and hour of the meeting and, in case of a special meeting, the purpose or purposes for which the meeting is called, shall be delivered not less than ten, or, in the case it is proposed to increase the stock or bonded indebtedness of the Company, not less than thirty nor more than sixty days before the date of the meeting, either personally or by mail or e-mail, by or at the direction of the Board of Directors, the chief executive officer, or the Secretary to each shareholder of record entitled to vote at such meeting. If sent by email, such notice shall be deemed to be delivered when sent. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail, addressed to the shareholder at the address as it appears on the stock transfer books of the Company, with postage thereon prepaid.

Section 4.     Fixing of Record Date. For the purpose of determining shareholders entitled to notice of or to vote at any meeting of shareholders or any adjournment thereof, or shareholders entitled to receive payment of any dividend, or in order to make a determination of shareholders for any other purpose, the Board of Directors of the Company may fix in advance a date as the record date for any such determination of shareholders, such date in any case to be not more than seventy days and, in case of a meeting of shareholders, not less than ten days prior to the date on which the particular action, requiring such determination of shareholders, is to be taken. If no record date is fixed for the determination of shareholders entitled to notice of or to vote at a meeting of shareholders, or shareholders entitled to receive payment of a dividend, the date on which notice of the meeting is mailed or the date on which the resolution of the Board of Directors declaring such dividend is adopted, as the case may be, shall be the record date for such determination of shareholders.

Section 5.     Proxies. At all meetings of shareholders, a shareholder may vote by proxy executed in writing by the shareholder or by his duly authorized attorney in fact. Such proxy shall be filed with the

Secretary of the Company before or at the time of the meeting. No proxy shall be valid after eleven months from the date of its execution, unless otherwise provided in the proxy.

Section 6.     Voting of Shares. Each outstanding share entitled to vote shall be entitled to one vote upon each matter submitted to a vote at a meeting of shareholders.

Section 7.     Voting of Shares by Certain Holders. Shares held by another corporation if a majority of the shares entitled to vote for the election of directors of such other corporation is held by the Company shall not be voted at any meeting or counted in determining the total number of outstanding shares at any given time. Treasury shares and shares of stock held by the Company in a fiduciary capacity shall not be voted directly or indirectly, at any meeting, and shall not be counted in determining the total number of outstanding shares at any given time.

Section 8.     Informal Action by Shareholders. Any action required to be taken at a meeting of the shareholders, or any other action which may be taken at a meeting of the shareholders, may be taken without a meeting if a consent in writing, setting forth the action so taken, shall be signed by all of the shareholders entitled to vote with respect to the subject matter thereof.

ARTICLE III

BOARD OF DIRECTORS

Section 1.     General Powers. The business and affairs of the Company shall be managed by its Board of Directors.

Section 2.     Number, Tenure and Qualifications. The number of directors of the Company shall be fixed from time to time by resolution of the shareholders; provided that the Board shall consist of a range from at least five (5) persons to no more than twenty (20) persons, and that no decrease in the number of directors shall have the effect of shortening the term of any incumbent director. Each director shall hold office until the next annual meeting of shareholders and until his successor shall have been elected and qualified or until there is a decrease in the number of directors. Directors need not be shareholders or residents of the state of the Company's domicile except as otherwise provided by law or by the shareholders of the Company.

Section 3.     Regular Meetings. Regular meetings may be held either within or without the state of the Company's domicile, if permitted by law, without notice.

Section 4.     Special Meetings. Special meetings of the Board of Directors of any committee designated thereby may be called by or at the request of the President, the chief executive officer, or any two directors. A special meeting of the Board of Directors or of any committee designated thereby shall be held at the administrative office of the Company, provided that by resolution, or by waiver signed by all directors, it may be held at any other place, either within or without the state of the Company's domicile.

Section 5.     Notice. Notice of any special meeting shall be given at least one day previously thereto by written notice giving the date, time and place of the meeting delivered personally or mailed to each director at his business address, or by telegram or e-mail. If mailed, such notice shall be deemed to be delivered when deposited in the United States mail so addressed, with postage thereon prepaid. If notice be given by telegram or e-mail, such notice shall be deemed to be delivered when the telegram is delivered to the telegraph company, or when the e-mail is sent. If sent by facsimile transmission, electronic mail or other electronic transmission, such notice shall be deemed to be delivered when sent. Any director may waive notice of any meeting. The attendance of a director at a meeting shall constitute

a waiver of notice of such meeting, except where a director attends a meeting for the express purpose of objecting to the transaction of any business because the meeting is not lawfully called or convened.

Section 6.     Quorum. A majority of the number of directors fixed in the manner provided by Section 2 of this Article III shall constitute a quorum for the transaction of business at any meeting of the Board of Directors, but if less than such majority is present at a meeting, a majority of the directors present may adjourn the meeting from time to time without further notice. If a quorum is present when a meeting is convened, the directors present may continue to do business taking action by a vote of a majority of a quorum until adjournment, notwithstanding the withdrawal of enough directors to leave less than a quorum or the refusal of any director present to vote. Notwithstanding the foregoing provisions of this section to the contrary, in the event of an emergency caused by an enemy attack, or a natural or other disaster, or other occurrence that creates an emergency, as declared by the President, the chief executive officer or senior officer on site, at each meeting of the Board during such emergency the presence of one-third of the total number of directors, but in any event not less than two directors, shall constitute a quorum and be sufficient for the transaction of business.

Section 7.     Manner of Acting. The act of the majority of the directors present at a meeting at which a quorum is present shall be the act of the Board of Directors. Members of the Board of Directors or of any committee thereof may participate in a meeting of the Board or committee by means of a conference telephone or similar communications equipment by means of which all persons participating in the meeting can hear each other at the same time and participation by such means shall constitute presence in person at a meeting.

Section 8.     Vacancies. Any vacancy occurring in the Board of Directors may be filled by the affirmative vote of a majority of the remaining directors, though less than a quorum of the Board of Directors. A director elected to fill a vacancy shall be elected until the next annual meeting of shareholders. Any directorship to be filled by reason of an increase in the number of directors shall be filled by election at an annual meeting or at a special meeting of shareholders called for that purpose.

Section 9.     Committees. The Board of Directors may, by resolution or resolutions adopted by a majority of the full Board of Directors, designate one or more committees, each committee to consist of 1 (one) or more of the directors of the Company, which, to the extent provided in such resolution or resolutions, shall have and may during intervals between the meetings of the Board exercise the powers of the Board of Directors in the management of the business and affairs of the Company and may have power to authorize the seal of the Company to be affixed to all papers which may require it; provided, however, that no such committee shall have the authority of the Board of Directors in reference to: authorize distributions, except according to a formula or method prescribed by the Board of Directors; fill vacancies on the Board of Directors or on any of its committees; adopt, amend or repeal the bylaws of the Company; authorize or approve reacquisition of shares, except according to a formula or method prescribed by the Board of Directors; or authorize or approve the issuance or sale or contract for sale of shares or determine the designation and relative rights, preferences, and limitations of a class or series of shares, except that the Board of Director's may authorize a committee (or senior executive officer of the Company) to do so within limits specifically prescribed by the Board of Directors. Such committee or committees shall have such name or names as may be determined from time to time by resolution or resolutions adopted by the Board of Directors. The designation of any such committee or committees and the delegation thereto of authority shall not operate to relieve the Board of Directors, or any member thereof, of any responsibility imposed upon it or him/her by law.

Section 10.     Informal Action. Any action required or permitted under the Nebraska corporate or insurance laws, the Articles of Incorporation or these bylaws to be taken at any meeting of the Board of Directors or of

any committee thereof may be taken without a meeting, if a written consent setting forth the action so taken is signed by all members of the Board of Directors or of such committee, as the case may be. Such written consent shall be filed with the minutes of proceedings of the Board of Directors or committee.

Section 11.     Removal of Directors. At any meeting of shareholders, including a meeting called expressly for that purpose, one or more directors may be removed, with or without cause, by a vote of the holders of a majority of shares then entitled to vote at an election of directors and the shareholders may at such meeting elect a successor director or directors for the unexpired term of the director or directors removed.

ARTICLE IV
OFFICERS

Section 1.     Number. The officers of the Company shall be a President and a Secretary and, in the discretion of the Board of Directors which may leave one or more offices vacant from time to time, a Chairman of the Board, one or more Executive Vice Presidents, Senior Vice Presidents, Vice Presidents, Second Vice Presidents (the number thereof to be determined by the Board of Directors), a Treasurer, one or more Assistant Secretaries and Assistant Treasurers and such other officers and assistant officers as may be deemed necessary by the Board of Directors. All such officers shall be elected for a term of one year and shall by subject to removal by the Board of Directors at its pleasure. Such officers shall perform such duties and exercise such powers as are conferred by the Board of Directors or as are conferred herein. The Board of Directors may designate one of such elected officers the chief executive officer of the Company. The Board of Directors or the chief executive officer, by and with the consent and approval of the Board of Directors or of the Executive Committee if any, may appoint such other officers and agents as, in its or his discretion, are required for the proper transaction of the Company's business. The same individual may simultaneously hold more than one office in a corporation, except the offices of President and Secretary. The Board of Directors shall be and is hereby authorized to adopt and amend from time-to-time Bylaws to be effective in the event of an emergency caused by an enemy attack, dealing with or making provisions during such emergency for continuity of management, succession to the authority and duties of officers, vacancies in office, alternative offices or other matters deemed necessary or desirable to enable the Company to carry on its business and affairs.

Section 2.     Chairman of the Board. Any director may be designated as Chairman of the Board and shall preside, when present, at all meetings of the shareholders and of the Board of Directors. The Chairman of the Board shall perform such other duties as from time to time may be assigned to him/her by the Board of Directors.

Section 3.     President. Subject to the control of the Board of Directors, the President shall have general management and control of the affairs and business of the Company, and shall perform all other duties and exercise all other powers commonly incident to his office, or which are or may at any time be authorized or required by law. He/She shall keep the Board of Directors fully informed concerning the affairs and business of the Company. The Board of Directors may by resolution designate the officer of the Company who in the event of the death, unavailability or incapacity of the President shall perform the duties of the President until the Board of Directors shall designate another person to perform such duties.

Section 4.     Vice Presidents. Each Vice President shall have powers and perform such duties as shall from time to time be assigned to him/her by these bylaws or by the Board of Directors and shall have and may be assigned to him/her by the chief executive officer.

Section 5.     Other Authority of Officers. The Chairman of the Board of Directors and the President may sign and execute all authorized bonds, contracts or other obligations in the name of the Company, and with the Secretary or an Assistant Secretary, may sign all certificates of shares of the capital stock of the Company, and do and perform such other acts and things as may from time to time be assigned to each of them by the Board of Directors. The chief executive officer, the President, the Treasurer or such other officers as are authorized by the Board of Directors may enter into contracts in the name of the Company or sell and convey any real estate or securities now or hereafter belonging to the Company and execute any deeds or written instruments of transfer necessary to convey good title thereto and each of the foregoing officers, or the Secretary or the Treasurer of the Company, is authorized and empowered to satisfy and discharge of record any mortgage or deed of trust now or hereafter of record in which the Company is a grantee or of which it is the owner, and any such satisfaction and discharge heretofore or hereafter so entered by any such officer shall be valid and in all respects binding on the Company.

Section 6.     Secretary. The Secretary shall attend all meetings of the shareholders, and record all votes and the minutes of all proceedings in a book to be kept for that purpose, and shall perform like duties for the Board and its committees as required. He/She shall give or cause to be given, notice of all meetings of the shareholders and of the Board of Directors. He/She shall record all transfers of stock, and cancel and preserve all certificates of stock transferred, and shall keep a record, alphabetically arranged, of all persons who are shareholders of the Company, showing their places of residence and the number of shares of stock held by them respectively. The Secretary shall also be the transfer agent of the Company for the transfer of all certificates of stock ordered by the Board of Directors, and shall affix the seal of the Company to all certificates of stock or other instruments requiring the seal. He/She shall keep such other books and perform such other duties as may be assigned to him/her from time to time. The Board of Directors may designate a bank or trust company as transfer agent of the Company stock, in which case such transfer agent shall perform all duties above set forth relative to transfers of such stock.

Section 7.     Treasurer. The Treasurer shall have custody of all the funds and securities of the Company, and shall perform such duties as may from time to time be assigned to him/her by the Board of Directors or the chief executive officer.

Section 8.     Assistant Secretaries and Assistant Treasurers. The Assistant Secretaries may sign with the President certificates for shares of the Company the issuance of which shall have been authorized by a resolution of the Board of Directors. The Assistant Treasurers shall, respectively, if required by the Board of Directors, give bonds for the faithful discharge of their duties in such sums and with such sureties as the Board of Directors shall determine. The Assistant Secretaries and Assistant Treasurers, in general, shall perform such duties as shall be assigned to them by the Secretary or the Treasurer, respectively, or by the President or the Board of Directors.

Section 9.     Election and Term of Office. The officers of the Company to be elected by the Board of Directors shall be elected annually by the Board of Directors at the first meeting of the Board of Directors held after each annual meeting of the shareholders. If the election of officers shall not be held at such meeting, such election shall be held as soon thereafter as conveniently may be. Each officer shall hold office until his successor shall have been duly elected and shall have qualified or until his death or until he/she shall resign or shall have been removed in the manner hereinafter provided.

Section 10.     Removal. The Chief Executive Officer, Chairman of the Board, or President may be removed, with or without cause, at any time by action of the Board of Directors. Any other officer elected by the Board of Directors may be removed, with or without cause, at any time, by action of the Board of Directors or the Executive Committee, if any. Any other officer, agent or employee, including

any officer, agent or employee appointed by the Board of Directors, may be removed, with or without cause, at any time by the Board of Directors, the Chief Executive Officer, the Executive Committee, if any, or the superior officer to whom authority to so remove has been delegated by these bylaws or by the Chief Executive Officer.

Section 11.     Vacancies. A vacancy in any office elected or appointed by the Board of Directors because of death, resignation, removal, disqualification or otherwise, may be filled by the Board of Directors for the unexpired portion of the term. A vacancy in any other office for any reason shall be filled by the Board of Directors, or any committee, or superior officer to whom authority in the premises may have been delegated by these bylaws or by resolution of the Board of Directors.

ARTICLE V

CONTRACTS, LOANS, CHECKS AND DEPOSITS

Section 1.     Contracts. The Board of Directors may authorize any officer or officers, agent or agents, to enter into any contract or execute and deliver any instrument in the name of and on behalf of the Company, and such authority may be general or confined to specific instances.

Section 2.     Loans. No loans shall be contracted on behalf of the Company and no evidence of indebtedness shall be issued in its name unless authorized by a resolution of the Board of Directors. Such authority may be general or confined to specific instances. Notwithstanding anything herein to the contrary, any loans to directors who are not also employees of the Company or a subsidiary thereof, or the use of the credit of the Company to assist same, shall require authorization in the particular case by shareholders of the Company, and any loans to employees, whether or not directors, of the Company or of any subsidiary shall be made only in compliance with the applicable law of the domiciliary state.

Section 3.     Checks, Drafts, etc. All checks, drafts or other orders for the payment of money, notes or other evidences of indebtedness issued in the name of the Company shall be signed by such officer or officers, agent or agents of the Company and in such manner as shall from time to time be determined by resolution of the Board of Directors.

Section 4.     Deposits. All funds of the Company not otherwise employed shall be deposited from time to time to the credit of the Company in such banks, trust companies or other depositaries as the Board of Directors may select.

Section 5.     Proxies. Unless otherwise provided by resolution of the Board of Directors, the Chief Executive Officer may from time to time appoint an attorney or agent of the Company, in the name and on behalf of the Company, to cast the votes which the Company may be entitled to cast as the holder of stock or other securities in any other corporation any of whose stock or securities may be held by the Company, at meetings of the holders of the stock or other securities of such other corporation, or to consent in writing, in the name and on behalf of the Company as such holder, to any action by such other corporation, and may instruct the person or persons so appointed as to the manner of casting such votes or giving such consent, and may execute or cause to be executed, in the name and on behalf of the Company and under its corporate seal or otherwise, all such written proxies or other instruments as he/she may deem necessary or proper in the premises.

ARTICLE VI

CERTIFICATES FOR SHARES AND THEIR TRANSFER

Section 1.     Certificates of Shares. Certificates may be issued for whole or fractional shares. Certificates representing shares of the Company shall be in such form as shall be determined by the

Board of Directors. Such certificates shall be signed in the manner provided by the Model Business Corporation Act of the domiciliary state and any act amendatory thereof, supplementary thereto or substituted therefore. All certificates for shares shall be consecutively numbered or otherwise identified. The name and address of the person to whom the shares represented thereby are issued, with the number of shares and date of issue, shall be entered on the stock transfer books of the Company. All certificates surrendered to the Company for transfer shall be canceled and no new certificate shall be issued until the former certificate for a like number of shares shall have been surrendered and canceled, except that in case of a lost, destroyed or mutilated certificate a new one may be issued therefore upon such terms and indemnity to the Company as the Board of Directors may prescribe.

Section 2.     Transfer of Shares. Transfer of shares of the Company shall be made only on the stock transfer books of the Company by the holder of record thereof or by his legal representative, who shall furnish proper evidence of authority to transfer, or by his attorney thereunto authorized by power of attorney duly executed and filed with the Secretary of the Company, and on surrender for cancellation of the certificate for such shares. The person in whose name shares stand on the books of the Company shall be deemed by the Company to be the owner thereof for all purposes.

ARTICLE VII
FISCAL YEAR

The fiscal year of the Company shall begin on the first day of January and end on the 31st day of December in each year.

ARTICLE VIII
DIVIDENDS

The Board of Directors may from time to time declare, and the Company may pay, dividends on its outstanding shares in the manner and upon the terms and conditions provided by law and the Articles of Incorporation.

ARTICLE IX

SEAL

The corporate seal shall have inscribed thereon the name of the Company and the words "Corporate Seal," including the name of the state of domicile. The seal may be used by causing it or a facsimile thereof to be impressed or affixed or otherwise reproduced.

ARTICLE X

WAIVER OF NOTICE

Whenever any notice is required to be given to any shareholder or director of the Company under the provisions of these by-laws, the Articles of Incorporation, the provisions of the Nebraska Model Business Corporation Act of the domiciliary state or the domiciliary state Insurance Code and any act amendatory thereof, supplementary thereto or substituted therefore, or the domiciliary state Constitution, a waiver thereof in writing, signed by the person or persons entitled to such notice, whether before or after the time stated therein, shall be deemed equivalent to the giving of such notice.

ARTICLE XI

INDEMNIFICATION

In amplification and not in limitation of applicable provisions of the Insurance Code of the state of domicile and the Model Business Corporation Act of the state of domicile:

(a)            The Company shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed claim, action, suit or proceeding, whether civil, criminal, administrative or investigative, including appeals (other than an action by or in the right of the Company), by reason of the fact that he/she is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, partner, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys' fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by him/her in connection with such claim, action, suit or proceeding if he/she acted in good faith and in a manner he/she reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had no reasonable cause to believe his conduct was unlawful. The termination of any claim, action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent shall not, of itself, create a presumption that the person did not act in good faith and in a manner which he/she reasonably believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had reasonable cause to believe that his conduct was unlawful.

(b)            The Company shall indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed claim, action or suit by or in the right of the Company to procure a judgment in its favor by reason of the fact that he/she is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, partner, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against expenses (including attorneys' fees) actually and reasonably incurred by him/her in connection with the defense or settlement of such action or suit if he/she acted in good faith and in a manner he/she reasonably believed to be in or not opposed to the best interests of the Company and except that no indemnification shall be made in respect of any claim, issue or matter as to which such person shall have been adjudged to be liable for negligence or misconduct in the performance of his duty to the Company unless and only to the extent that the court in which such action or suit was brought shall determine upon application that, despite the adjudication of liability but in view of all circumstances of the case, such person is fairly and reasonably entitled to indemnity for such expenses which such court shall deem proper.

(c)            To the extent that a director, officer, employee or agent of the Company has been successful on the merits or otherwise in defense of any action, suit or proceeding referred to in subsections (a) and (b), or in defense of any claim, issue or matter therein, he/she shall be indemnified against expenses (including attorneys' fees) actually and reasonably incurred by him/her in connection therewith, notwithstanding that he/she has not been successful on any other claim, issue or matter in any such action, suit or proceeding.

(d)           Any indemnification under subsections (a) and (b) (unless ordered by a court) shall be made by the Company only as authorized in the specific case upon a determination that indemnification of the director, officer, employee or agent is proper in the circumstances because he/she has met the applicable standard of conduct set forth in subsections (a) and (b).

Such determination shall be made (1) by the Board of Directors by a majority vote of a quorum consisting of directors who were not parties to, or who have been wholly successful on the merits or otherwise with respect to, such claim, action, suit or proceeding, or (2) if such a quorum is not obtainable, or even if obtainable a quorum of disinterested directors so directs, by independent legal counsel in a written opinion, or (3) by the shareholders.

(e)            Expenses (including attorneys' fees) incurred in defending a civil or criminal claim, action, suit or proceeding may be paid by the Company in advance of the final disposition of such claim, action, suit or proceeding as authorized in the manner provided in subsection (d) upon receipt of an undertaking by or on behalf of the director, officer, employee or agent to repay such amount if and to the extent that it shall ultimately be determined that he/she is not entitled to be indemnified by the Company as authorized in this Section.

(f)            The indemnification authorized by this Section shall not be deemed exclusive of and shall be in addition to any other riots to which those indemnified may be entitled under any statute, rule of law, provision of articles of incorporation, bylaw, agreement, vote of shareholders or disinterested directors or otherwise, both as to action in his official capacity and as to action in another capacity while holding such office, and shall continue as to a person who has ceased to be a director, officer, employee or agent and shall inure to the benefit of the heirs, executors and administrators of such a person.

(g)           The Company shall have power to purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the Company, or is or was serving at the request of the Company as a director, officer, partner, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against him/her and incurred by him/her in any such capacity or arising out of his status as such, whether or not the Company would have the power to indemnify him/her against such liability under the provisions of this Section.

ARTICLE XII
AMENDMENTS

Section 1.     Power of Directors to Amend. The Board of Directors shall have power to alter, amend and repeal the bylaws of the Company or adopt new bylaws for the Company at any regular or special meeting of the Board, provided that the Board of Directors may not alter, amend or repeal any bylaw which establishes what constitutes a quorum at such shareholders' meetings, or which was adopted by the shareholders and specifically provides that it cannot be altered, amended or repealed by the Board of Directors.

Section 2.     Power of Shareholders to Amend. The shareholders may alter, amend, or repeal the bylaws of the Company or adopt new bylaws for the Company at any annual meeting or at a special meeting, and all bylaws made by the directors may be altered or repealed by the shareholders.

The foregoing are hereby certified by the undersigned officer of Protective Life Insurance Company to be a true and accurate copy of the Amended and Restated Bylaws of Protective Life Insurance Company and to be in full force and effect this date.

Given under my hand and the seal of the Company this 26 day of December, 2024.


	President

[CORPORATE SEAL]

EX-99.(N)(1) 4 tm262570d1_ex99-xnx1.htm EXHIBIT 99.(N)(1)

Exhibit (n)(1)

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated April 1, 2026, with respect to the financial statements of Protective Life Insurance Company, incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the Statement of Additional Information.

/s/ KPMG LLP

Birmingham, Alabama

April 23, 2026

Consent of Independent Registered Public Accounting Firm

We consent to the use of our report dated April 20, 2026, with respect to the financial statements of the subaccounts that comprise Protective Variable Life Separate Account, incorporated herein by reference, and to the reference to our firm under the heading “Experts” in the Statement of Additional Information.

/s/ KPMG LLP

Birmingham, Alabama

April 23, 2026

EX-99.(N)(2) 5 tm263879d5_ex99-xnx2.htm EXHIBIT 99.(N)(2)

PROTECTIVE LIFE INSURANCE COMPANY

POWER OF ATTORNEY

KNOW ALL MEN BY THESE PRESENTS, that each of the undersigned Directors of Protective Life Insurance Company, a Nebraska corporation (the “Company’), by his or her execution hereof or upon an identical counterpart hereof, does hereby constitute and appoint Richard J. Bielen, Bradford D. Rodgers, Bradley A. Strickling, Lindsay A. Thorpe, and Brandon J. Cage and each of them (with full power to each of them to act alone), as my true and lawful attorney-in-fact and agent, with full power of substitution and re-substitution, for me and in my name, place and stead, in any and all capacities to execute (either in writing or electronically) on behalf of the Company or its separate accounts relating to annuity contracts and life insurance policies registered under the Securities Act of 1933 and/or the Investment Company Act of 1940, the “Registration Statements,” as defined below, and any and all amendments thereto, together with all exhibits, instruments, and other documents necessary or appropriate in connection therewith, and to file the same with the Securities and Exchange Commission or any other federal or state regulatory authority as may be necessary or desirable, hereby ratifying and confirming all and every act and thing requisite to all intents and purposes that said attorney-in-fact and agent or his or her substitute, may lawfully do or cause to be done by virtue hereof. This Power of Attorney does not revoke any prior power of attorney. This Power of Attorney shall not be revoked by any subsequent power of attorney I may execute, unless such subsequent power of attorney specifically revokes this Power of Attorney or specifically states that the instrument is intended to revoke all prior powers of attorney.

The “Registration Statements” covered by this Power of Attorney are defined to include the registration statements listed below:

Contract Name	Registration Statement Securities Act File Number	Separate Account Name	Separate Account Investment Company Act File Number
Aspirations	333-261426	Protective Variable Annuity Separate Account	811-8108
Dimensions	333-176657	Protective Variable Annuity Separate Account	811-8108
Dimensions IV	333-233415	Protective Variable Annuity Separate Account	811-8108
Dimensions V	333-267354	Protective Variable Annuity Separate Account	811-8108
Investors Series	333-190294	Protective Variable Annuity Separate Account	811-8108
Premiere II-III	333-52215	Protective Variable Life Separate Account	811-7337
Protective DualCare VUL	333-292264	Protective Variable Life Separate Account	811-7337
Protective Executive Benefits Registered VUL	333-248236	Protective COLI VUL	811-23604
Protective Investors Benefit Advisory	333-237747	Protective Variable Annuity Separate Account	811-8108
Protective Investors Benefit Advisory VUL	333-267465	Protective Variable Life Separate Account	811-7337
Protective Variable Annuity II B Series	333-201919	Protective Variable Annuity Separate Account	811-8108
Protective Market Defender Annuity	333-278664	N/A	N/A

Protective Market Defender II Annuity	333-271426	N/A	N/A
PVA B Series, C Series, L Series	333-179649	Protective Variable Annuity Separate Account	811-8108
Schwab Genesis Variable Annuity	333-240192	PLICO Variable Annuity Account S	811-23593
Schwab Genesis Advisory Variable Annuity	333-240102	PLICO Variable Annuity Account S	811-23593
Strategic Objectives II VUL	333-232740	Protective Variable Life Separate Account	811-7337
Values	333-112892	Protective Variable Annuity Separate Account	811-8108
Values Advantage	333-113070	Protective Variable Annuity Separate Account	811-8108

IN WITNESS WHEREOF, I have hereunto set my hand this 10^th day of March, 2026.

/s/ Richard J. Bielen
Richard J. Bielen

WITNESS TO ALL SIGNATURES:


/s/ Brandon J. Cage
Brandon J. Cage
Vice President and Managing Counsel
Attorney-in-Fact
Protective Life Insurance Company

PROTECTIVE LIFE INSURANCE COMPANY

POWER OF ATTORNEY

The “Registration Statements” covered by this Power of Attorney are defined to include the registration statements listed below:

Contract Name	Registration Statement Securities Act File Number	Separate Account Name	Separate Account Investment Company Act File Number
Aspirations	333-261426	Protective Variable Annuity Separate Account	811-8108
Dimensions	333-176657	Protective Variable Annuity Separate Account	811-8108
Dimensions IV	333-233415	Protective Variable Annuity Separate Account	811-8108
Dimensions V	333-267354	Protective Variable Annuity Separate Account	811-8108
Investors Series	333-190294	Protective Variable Annuity Separate Account	811-8108
Premiere II-III	333-52215	Protective Variable Life Separate Account	811-7337
Protective DualCare VUL	333-292264	Protective Variable Life Separate Account	811-7337
Protective Executive Benefits Registered VUL	333-248236	Protective COLI VUL	811-23604
Protective Investors Benefit Advisory	333-237747	Protective Variable Annuity Separate Account	811-8108
Protective Investors Benefit Advisory VUL	333-267465	Protective Variable Life Separate Account	811-7337
Protective Variable Annuity II B Series	333-201919	Protective Variable Annuity Separate Account	811-8108
Protective Market Defender Annuity	333-278664	N/A	N/A

Protective Market Defender II Annuity	333-271426	N/A	N/A
PVA B Series, C Series, L Series	333-179649	Protective Variable Annuity Separate Account	811-8108
Schwab Genesis Variable Annuity	333-240192	PLICO Variable Annuity Account S	811-23593
Schwab Genesis Advisory Variable Annuity	333-240102	PLICO Variable Annuity Account S	811-23593
Strategic Objectives II VUL	333-232740	Protective Variable Life Separate Account	811-7337
Values	333-112892	Protective Variable Annuity Separate Account	811-8108
Values Advantage	333-113070	Protective Variable Annuity Separate Account	811-8108

IN WITNESS WHEREOF, I have hereunto set my hand this 10^th day of March, 2026.

/s/ Wade V. Harrison
Wade V. Harrison

WITNESS TO ALL SIGNATURES:


/s/ Brandon J. Cage
Brandon J. Cage
Vice President and Managing Counsel
Attorney-in-Fact
Protective Life Insurance Company

PROTECTIVE LIFE INSURANCE COMPANY

POWER OF ATTORNEY

The “Registration Statements” covered by this Power of Attorney are defined to include the registration statements listed below:

Contract Name	Registration Statement Securities Act File Number	Separate Account Name	Separate Account Investment Company Act File Number
Aspirations	333-261426	Protective Variable Annuity Separate Account	811-8108
Dimensions	333-176657	Protective Variable Annuity Separate Account	811-8108
Dimensions IV	333-233415	Protective Variable Annuity Separate Account	811-8108
Dimensions V	333-267354	Protective Variable Annuity Separate Account	811-8108
Investors Series	333-190294	Protective Variable Annuity Separate Account	811-8108
Premiere II-III	333-52215	Protective Variable Life Separate Account	811-7337
Protective DualCare VUL	333-292264	Protective Variable Life Separate Account	811-7337
Protective Executive Benefits Registered VUL	333-248236	Protective COLI VUL	811-23604
Protective Investors Benefit Advisory	333-237747	Protective Variable Annuity Separate Account	811-8108
Protective Investors Benefit Advisory VUL	333-267465	Protective Variable Life Separate Account	811-7337
Protective Variable Annuity II B Series	333-201919	Protective Variable Annuity Separate Account	811-8108
Protective Market Defender Annuity	333-278664	N/A	N/A

Protective Market Defender II Annuity	333-271426	N/A	N/A
PVA B Series, C Series, L Series	333-179649	Protective Variable Annuity Separate Account	811-8108
Schwab Genesis Variable Annuity	333-240192	PLICO Variable Annuity Account S	811-23593
Schwab Genesis Advisory Variable Annuity	333-240102	PLICO Variable Annuity Account S	811-23593
Strategic Objectives II VUL	333-232740	Protective Variable Life Separate Account	811-7337
Values	333-112892	Protective Variable Annuity Separate Account	811-8108
Values Advantage	333-113070	Protective Variable Annuity Separate Account	811-8108

IN WITNESS WHEREOF, I have hereunto set my hand this 10^th day of March, 2026.

/s/ Paul R. Wells
Paul R. Wells


WITNESS TO ALL SIGNATURES:


/s/ Brandon J. Cage
Brandon J. Cage
Vice President and Managing Counsel
Attorney-in-Fact
Protective Life Insurance Company

EX-99.32 6 tm263879d1_ex99-32.htm EXHIBIT 99.32

1 Except as otherwise indicated, chart does not reflect less than 50% ownership interests 2 Insurance company 3 Pages 6-9 contain a list of Protective Life Corporation’s subsidiaries 4 The voting rights pertaining to The Dai-ichi Life Research Institute Inc. are split among other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● DAI-ICHI SEIMEI CARD SERVICE Co., LTD. – 9.58% ● Nihon Bussan Co., Ltd. – 8.75% As such, the Dai-ichi group owns 100% of the voting rights pertaining to The Dai-ichi Life Research Institute Inc. 5 The voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Are split among the other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● Nihon Bussan Co., Ltd. – 20% As such, the Dai-ichi group owns 95% of the voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Dai-ichi Life Holdings, Inc.* (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life International Holdings LLC (Japan) TAL Life Limited2 (Australia) Asset Management One Co., Ltd. (Japan) TAL Direct Pty Ltd. (Australia) TAL Services Limited (Australia) Asset Management One USA Inc. (USA) Dai-ichi Life Vietnam Fund Management Company Limited (Vietnam) The Dai-ichi Life Insurance Company, Limited2 (Japan) 1 49% Dai-ichi Life Insurance Company of Vietnam, Limited 2 (Vietnam) 81.67% International Life Solutions Proprietary Limited (South Africa) The Neo First Life Insurance Company, Limited 2 (Japan) Dai-ichi Life International (Europe) Limited (UK) Daiichi Life Asia Pacific Pte. Ltd. (Singapore) The Dai-ichi Life Research Institute Inc.4 (Japan) Star Union Dai-ichi Life Insurance Company Limited 2 (India) 36.84% 47.42% Lifebroker Pty Limited (Australia) DLI North America Inc. (USA) QOLead, Limited (Japan) Dai-ichi Life International Limited (Japan) Effissimo Capital Management Pte Ltd. (“Effissimo”) and Effissimo’s controlling persons Takashi Kousaka, Hisaaki Sato, and Yoichiro Imai are considered by the New York State Department of Financial Services, for New York insurance regulatory purposes only, to be controlling persons of MONY Life Insurance Company and Protective Life and Annuity Insurance Company. Based on the Statement of Changes to Large-Volume Holdings available on Electronic Disclosure for Investors’ Network (EDINET) as of April 10, 2025, Effissimo, a non-affiliated asset management company, may be deemed the beneficial owner of 10.99% of the common stock of Dai-ichi Life Holdings, Inc. * 99.9988% Daiichi Life Insurance (Cambodia) PLC.2 (Cambodia) The Dai-ichi Life Techno Cross Co., Ltd. (Japan) TAL Daiichi Life Australia Pty Ltd (Australia) National Financial Solutions Pty Limited (Australia) TAL Australia Distribution Limited (Australia) Vertex Investment Solutions Co., Ltd. (Japan) TAL Life Insurance Services Limited2 (Australia) YuLife Holdings Ltd. (United Kingdom) 10.49% Partners Group Holdings Limited (New Zealand) Protective Life Corporation3 (USA) PT Panin Internasional (Indonesia) ipet Insurance Co., Ltd.2 (Japan) Topaz Capital, Inc. (Japan) 73.1670% Panin Dai-ichi Life2 (Indonesia) 95% Dai-ichi Life Reinsurance Bermuda Ltd. (Bermuda) The Dai-ichi Frontier Life Insurance Co., Ltd.2 (Japan) 49% 5% Benefit One Inc. (Japan) DL – Canyon Investments LLC (USA) 100% 0.0012% DAI-ICHI SEIMEI CARD SERVICE Co., LTD.5 (Japan) 75% Daiichi Life Insurance Myanmar Ltd.2 (Myanmar) Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) 50% Subsidiaries shown on subsequent pages. Challenger Limited (Australia) 19.9% Dai-ichi Mekong Shared Service Center Company Limited (Vietnam) Nihon Bussan Co., Ltd. (Japan) 1 Except as otherwise indicated, chart does not reflect less than 50% ownership interests 2 Insurance company 3 Pages 6-9 contain a list of Protective Life Corporation’s subsidiaries 4 The voting rights pertaining to The Dai-ichi Life Research Institute Inc. are split among other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● DAI-ICHI SEIMEI CARD SERVICE Co., LTD. – 9.58% ● Nihon Bussan Co., Ltd. – 8.75% As such, the Dai-ichi group owns 100% of the voting rights pertaining to The Dai-ichi Life Research Institute Inc. 5 The voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Are split among the other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● Nihon Bussan Co., Ltd. – 20% As such, the Dai-ichi group owns 95% of the voting rights pertaining to DAI-ICHI SEIMEI CARD SERVICE Co., LTD. Dai-ichi Life Holdings, Inc.* (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life International Holdings LLC (Japan) TAL Life Limited2 (Australia) Asset Management One Co., Ltd. (Japan) TAL Direct Pty Ltd. (Australia) TAL Services Limited (Australia) Asset Management One USA Inc. (USA) Dai-ichi Life Vietnam Fund Management Company Limited (Vietnam) The Dai-ichi Life Insurance Company, Limited2 (Japan) 1 49% Dai-ichi Life Insurance Company of Vietnam, Limited 2 (Vietnam) 81.67% International Life Solutions Proprietary Limited (South Africa) The Neo First Life Insurance Company, Limited 2 (Japan) Dai-ichi Life International (Europe) Limited (UK) Daiichi Life Asia Pacific Pte. Ltd. (Singapore) The Dai-ichi Life Research Institute Inc.4 (Japan) Star Union Dai-ichi Life Insurance Company Limited 2 (India) 36.84% 47.42% Lifebroker Pty Limited (Australia) DLI North America Inc. (USA) QOLead, Limited (Japan) Dai-ichi Life International Limited (Japan) Effissimo Capital Management Pte Ltd. (“Effissimo”) and Effissimo’s controlling persons Takashi Kousaka, Hisaaki Sato, and Yoichiro Imai are considered by the New York State Department of Financial Services, for New York insurance regulatory purposes only, to be controlling persons of MONY Life Insurance Company and Protective Life and Annuity Insurance Company. Based on the Statement of Changes to Large-Volume Holdings available on Electronic Disclosure for Investors’ Network (EDINET) as of April 10, 2025, Effissimo, a non-affiliated asset management company, may be deemed the beneficial owner of 10.99% of the common stock of Dai-ichi Life Holdings, Inc. * 99.9988% Daiichi Life Insurance (Cambodia) PLC.2 (Cambodia) The Dai-ichi Life Techno Cross Co., Ltd. (Japan) TAL Daiichi Life Australia Pty Ltd (Australia) National Financial Solutions Pty Limited (Australia) TAL Australia Distribution Limited (Australia) Vertex Investment Solutions Co., Ltd. (Japan) TAL Life Insurance Services Limited2 (Australia) YuLife Holdings Ltd. (United Kingdom) 10.49% Partners Group Holdings Limited (New Zealand) Protective Life Corporation3 (USA) PT Panin Internasional (Indonesia) ipet Insurance Co., Ltd.2 (Japan) Topaz Capital, Inc. (Japan) 73.1670% Panin Dai-ichi Life2 (Indonesia) 95% Dai-ichi Life Reinsurance Bermuda Ltd. (Bermuda) The Dai-ichi Frontier Life Insurance Co., Ltd.2 (Japan) 49% 5% Benefit One Inc. (Japan) DL – Canyon Investments LLC (USA) 100% 0.0012% DAI-ICHI SEIMEI CARD SERVICE Co., LTD.5 (Japan) 75% Daiichi Life Insurance Myanmar Ltd.2 (Myanmar) Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) 50% Subsidiaries shown on subsequent pages. Challenger Limited (Australia) 19.9% Dai-ichi Mekong Shared Service Center Company Limited (Vietnam) Nihon Bussan Co., Ltd. (Japan)

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Partners Life Limited1 (New Zealand) Dai-ichi Life International Holdings LLC (Japan) Evince Limited (New Zealand) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Partners Group Nominee Limited (New Zealand) Partners Group Holdings Limited (New Zealand) 1 insurance company Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 100%

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life Challenged Co., Ltd. (Japan) 49% 80% 1 The voting rights pertaining to Corporate-pension Business Service Co., Ltd. are split among the other affiliates of Dai-ichi Life Holdings, Inc. as follows: ● The Dai-ichi Life Techno Cross Co., Ltd. – 1% As such, the Dai-ichi group owns 50% of the voting rights pertaining to Corporate-pension Business Service Co., Ltd. The Dai-ichi Life Insurance Company, Limited (Japan) A.F. BUILDING MANAGEMENT CO., LTD. (Japan) Dai-ichi Life Business Service Co., Ltd. (Japan) 100% Alpha Consulting Co., Ltd. (Japan) 100% Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Smart Small-amount and Short-term Insurance Company, Limited (Japan) 100% 100% Corporate-pension Business Service Co., Ltd. 1 (Japan)

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Benefit One Inc. (Japan) BENEFIT ONE USA, INC. (USA) BENEFIT ONE INTERNATIONAL PTE. LTD. (Singapore) PT. BENEFIT ONE INDONESIA (Indonesia) REWARDZ BENEFITS SDN. BHD. (Malaysia) FLABULESS FZ LLC (UAE) REWARDZ PRIVATE LIMITED (Singapore) BENEFITONE ENGAGEMENT TECHNOLOGIES PRIVATE LIMITED (India) Rouken Publishing Co. Ltd. (Japan) BENEFIT ONE CONSULTING (SHANGHAI) INC. (China) 1% 61.5% 70% 99% 38.5% Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Benefit One Inc. (Japan) BENEFIT ONE USA, INC. (USA) BENEFIT ONE INTERNATIONAL PTE. LTD. (Singapore) PT. BENEFIT ONE INDONESIA (Indonesia) REWARDZ BENEFITS SDN. BHD. (Malaysia) FLABULESS FZ LLC (UAE) REWARDZ PRIVATE LIMITED (Singapore) BENEFITONE ENGAGEMENT TECHNOLOGIES PRIVATE LIMITED (India) Rouken Publishing Co. Ltd. (Japan) BENEFIT ONE CONSULTING (SHANGHAI) INC. (China) 1% 61.5% 70% 99% 38.5%

Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) THE DAI-ICHI BUILDING CO., LTD. (Japan) Marubeni Asset Management Co., Ltd. (Japan) O.M. Building Management Inc.3 (Japan) 50% SOHGO HOUSING CO., LTD.2 (Japan) Dai-Ichi Life Realty Asset Management Co., Ltd.1 (Japan) Marubeni REIT Advisors Co., Ltd. (Japan) Marubeni Real Estate Development Co., Ltd. (Japan) Marubeni Real Estate Management Co., Ltd. (Japan) 85.5% 40% 70% 1 The shares of Dai-ichi Life Realty Asset Management Co., Ltd. are held 70% by Daiichi Life Marubeni Real Estate Co., Ltd. and 30% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd., and therefore the percentage of voting rights in Dai-ichi Life Realty Asset Management Co., Ltd. held by the Dai-ichi group is 50%. 2 The shares of SOHGO HOUSING CO., Ltd. are held 85.5% by Daiichi Life Marubeni Real Estate Co., Ltd. and 14.5% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. and therefore the percentage of voting rights in SOHGO HOUSING CO., Ltd. held by the Dai-ichi group is 50%. 3 The shares of O.M. Building Management Inc. are held 40% by THE DAI-ICHI BUILDING CO., LTD. and 10% by The Dai-ichi Life Insurance Company, Limited. Since Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. the percentage of voting rights in O.M. Building Management Inc. held by the Dai-ichi group is 30%. Marubeni Real Estate Agency Co., Ltd. (Japan) Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Daiichi Life Marubeni Real Estate Co., Ltd. (Japan) THE DAI-ICHI BUILDING CO., LTD. (Japan) Marubeni Asset Management Co., Ltd. (Japan) O.M. Building Management Inc.3 (Japan) 50% SOHGO HOUSING CO., LTD.2 (Japan) Dai-Ichi Life Realty Asset Management Co., Ltd.1 (Japan) Marubeni REIT Advisors Co., Ltd. (Japan) Marubeni Real Estate Development Co., Ltd. (Japan) Marubeni Real Estate Management Co., Ltd. (Japan) 85.5% 40% 70% 1 The shares of Dai-ichi Life Realty Asset Management Co., Ltd. are held 70% by Daiichi Life Marubeni Real Estate Co., Ltd. and 30% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd., and therefore the percentage of voting rights in Dai-ichi Life Realty Asset Management Co., Ltd. held by the Dai-ichi group is 50%. 2 The shares of SOHGO HOUSING CO., Ltd. are held 85.5% by Daiichi Life Marubeni Real Estate Co., Ltd. and 14.5% by THE DAI-ICHI BUILDING CO., LTD. In other words, they are wholly owned by Daiichi Life Marubeni Real Estate Co., Ltd. and its subsidiaries. Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. and therefore the percentage of voting rights in SOHGO HOUSING CO., Ltd. held by the Dai-ichi group is 50%. 3 The shares of O.M. Building Management Inc. are held 40% by THE DAI-ICHI BUILDING CO., LTD. and 10% by The Dai-ichi Life Insurance Company, Limited. Since Dai-ichi Life Holdings, Inc. owns 50% of the shares of Daiichi Life Marubeni Real Estate Co., Ltd. the percentage of voting rights in O.M. Building Management Inc. held by the Dai-ichi group is 30%. Marubeni Real Estate Agency Co., Ltd. (Japan)

Protective Life Corporation (DE) TIN 95-2492236 Protective Life Insurance Company1 (NE) PLC owns 100% of stock TIN 63-0169720 NAIC 68136 1 insurance company 2 special purpose financial insurance company Protective Life and Annuity Insurance Company1 (AL) (commercially domiciled – NY) PLC owns 100% of non-voting preferred stock PLICO owns 100% of voting stock TIN 63-0761690 NAIC 88536 MONY Life Insurance Company1 (NY) PLICO owns 100% of stock TIN 13-1632487 NAIC 66370 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) ShelterPoint Group, Inc. (NY) PLICO owns 100% of stock TIN 11-2284016 ShelterPoint Life Insurance Company1 (NY) TIN 11-2284118 NAIC 81434 ShelterPoint Insurance Company.1 (FL) TIN 86-0367818 NAIC 89958 Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 100% 100% Protective ML Holdings 1, LLC (DE) PLICO owns 100% of membership interests TIN 33-4524758 Magnolia Re, Inc. (VT)2 PLICO owns 100% of stock TIN 39-2280797 NAIC17815

Protective Life Corporation (DE) TIN 95-2492236 Protective Life Insurance Company1 (NE) PLC owns 100% of stock TIN 63-0169720 NAIC 68136 Protective Property & Casualty Insurance Company 1 (MO) PLICO owns 100% of stock TIN 43-1139865 NAIC 35769 Protective Asset Protection, Inc. (MO) (formerly Lyndon Insurance Group, Inc.) PLICO owns 100% of stock TIN 43-1802403 Asset Protection Financial, Inc. (MO) (formerly Lyndon Financial Corporation) PPCIC owns 100% of stock TIN 43-1819865 Western General Dealer Services, Inc. (CA) PAP owns 100% of stock TIN 47-0939814 Western General Warranty Corporation2 (FL) PAP owns 100% of stock TIN 59-3126230 First Protection Company (MN) PAP owns 100% of stock TIN 41-1703034 First Protection Corporation of Florida2 (FL) FPC owns 100% of stock TIN 41-1637611 Protective Administrative Services, Inc. (MO) PAP owns 100% of stock TIN 43-1724227 1 insurance company 2 specialty insurer USWC Holding Company (USWC) (FL) PLICO owns 100% of stock TIN 20-8645816 New World Warranty Corp.2 (FL) USWC owns 100% of stock TIN 20-8639268 USWC Installment Program, Inc. (FL) USWC owns 100% of stock TIN 20-8646196 United States Warranty Corp.2 (FL) USWC owns 100% of stock TIN 59-1651866 Western Diversified Services, Inc. (IL) PLICO owns 100% of stock TIN 36-2600350 The Advantage Warranty Corporation2 (FL) WDS owns 100% of stock TIN 36-3445516 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Atlas Peak Insurance Company, Ltd.1 (Turks & Caicos) PLICO owns 100% of stock TIN 98-0137725 A.U.L. Corp. (NV) PLICO owns 100% of stock TIN 68-0300949 Wisconsin A.U.L., Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0440623 AUL Insurance Agency, Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0406407 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Life Reinsurance Bermuda Ltd. (Bermuda) PLICO owns 100% of stock TIN 98-1512479 Protective Life Corporation (DE) TIN 95-2492236 Protective Life Insurance Company1 (NE) PLC owns 100% of stock TIN 63-0169720 NAIC 68136 Protective Property & Casualty Insurance Company 1 (MO) PLICO owns 100% of stock TIN 43-1139865 NAIC 35769 Protective Asset Protection, Inc. (MO) (formerly Lyndon Insurance Group, Inc.) PLICO owns 100% of stock TIN 43-1802403 Asset Protection Financial, Inc. (MO) (formerly Lyndon Financial Corporation) PPCIC owns 100% of stock TIN 43-1819865 Western General Dealer Services, Inc. (CA) PAP owns 100% of stock TIN 47-0939814 Western General Warranty Corporation2 (FL) PAP owns 100% of stock TIN 59-3126230 First Protection Company (MN) PAP owns 100% of stock TIN 41-1703034 First Protection Corporation of Florida2 (FL) FPC owns 100% of stock TIN 41-1637611 Protective Administrative Services, Inc. (MO) PAP owns 100% of stock TIN 43-1724227 1 insurance company 2 specialty insurer USWC Holding Company (USWC) (FL) PLICO owns 100% of stock TIN 20-8645816 New World Warranty Corp.2 (FL) USWC owns 100% of stock TIN 20-8639268 USWC Installment Program, Inc. (FL) USWC owns 100% of stock TIN 20-8646196 United States Warranty Corp.2 (FL) USWC owns 100% of stock TIN 59-1651866 Western Diversified Services, Inc. (IL) PLICO owns 100% of stock TIN 36-2600350 The Advantage Warranty Corporation2 (FL) WDS owns 100% of stock TIN 36-3445516 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Atlas Peak Insurance Company, Ltd.1 (Turks & Caicos) PLICO owns 100% of stock TIN 98-0137725 A.U.L. Corp. (NV) PLICO owns 100% of stock TIN 68-0300949 Wisconsin A.U.L., Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0440623 AUL Insurance Agency, Inc. (CA) A.U.L. Corp. owns 100% of stock TIN 68-0406407 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Life Reinsurance Bermuda Ltd. (Bermuda) PLICO owns 100% of stock TIN 98-1512479

Protective Life Corporation (DE) TIN 95-2492236 1 specialty insurer 2 special purpose financial insurance company Investment Distributors, Inc. (TN) PLC owns 100% of stock TIN 63-1100710 Warranty Topco, Inc. (DE) PLC owns 100% of stock TIN 26-3854933 Empower Financial Resources, Inc. (DE) (formerly Financial Leadership Alliance, Inc.) PLC owns 100% of stock TIN 46-5331907 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 National Warranty Corp. (OR) Warranty Topco, Inc. owns 100% of stock TIN 93-1198148 Interstate National Dealer Services, Inc. (DE) Warranty Topco, Inc. owns 100% of stock TIN 11-3078398 PIPCO Reinsurance Company, Ltd. (Turks & Caicos) Warranty Topco, Inc. owns 100% of stock TIN 98-0159153 Interstate National Dealer Services of Florida, Inc.1 (FL) INDS owns 100% of stock TIN 11-3284019 Interstate Administrative Services, Inc. (DE) INDS owns 100% of stock TIN 20-1549705 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Golden Gate Captive Insurance Company2 (VT) PLC owns 100% of stock TIN 63-1191165 NAIC 60234 Concourse Distributors, Inc. (AL) PLC owns 100% of stock TIN 33-1396088 Chesterfield International Reinsurance Limited (Nevis) PLC owns 100% of stock TIN 98-0458684 Dealer Services Reinsurance, Ltd. (Bermuda) PLC owns 100% of stock TIN 98-0199455 First Protection Corporation (MN) PLC owns 100% of stock TIN 41-1368934 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Foundation, LLC (AL) PLC owns 100% of membership interests TIN 41-5073717 Protective Life Corporation (DE) TIN 95-2492236 1 specialty insurer 2 special purpose financial insurance company Investment Distributors, Inc. (TN) PLC owns 100% of stock TIN 63-1100710 Warranty Topco, Inc. (DE) PLC owns 100% of stock TIN 26-3854933 Empower Financial Resources, Inc. (DE) (formerly Financial Leadership Alliance, Inc.) PLC owns 100% of stock TIN 46-5331907 Organizational Chart of Dai-ichi Life Holdings, Inc. as of March 31, 2026 National Warranty Corp. (OR) Warranty Topco, Inc. owns 100% of stock TIN 93-1198148 Interstate National Dealer Services, Inc. (DE) Warranty Topco, Inc. owns 100% of stock TIN 11-3078398 PIPCO Reinsurance Company, Ltd. (Turks & Caicos) Warranty Topco, Inc. owns 100% of stock TIN 98-0159153 Interstate National Dealer Services of Florida, Inc.1 (FL) INDS owns 100% of stock TIN 11-3284019 Interstate Administrative Services, Inc. (DE) INDS owns 100% of stock TIN 20-1549705 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Golden Gate Captive Insurance Company2 (VT) PLC owns 100% of stock TIN 63-1191165 NAIC 60234 Concourse Distributors, Inc. (AL) PLC owns 100% of stock TIN 33-1396088 Chesterfield International Reinsurance Limited (Nevis) PLC owns 100% of stock TIN 98-0458684 Dealer Services Reinsurance, Ltd. (Bermuda) PLC owns 100% of stock TIN 98-0199455 First Protection Corporation (MN) PLC owns 100% of stock TIN 41-1368934 Dai-ichi Life International Limited (Japan) 100% 99.9988% 0.0012% 100% Protective Foundation, LLC (AL) PLC owns 100% of membership interests TIN 41-5073717

Organizational Chart of Protective Life Corporation as of March 31, 2026 Protective Life Corporation (DE)1 TIN 95-2492236 Turbo Topco, Inc. (DE) TIN 84-2855430 Turbo Buyer, Inc. (DE) TIN 84-2774149 PGM Holdings Corporation (DE) TIN - 90-0919323 Piston Acquisition Company, Inc. (DE) TIN 81-2921633 Portfolio Holding, Inc. (DE) “PHI” TIN 46-1625561 Turbo Intermediate, Inc. (DE) TIN 84-2888092 Folio Protection Company, Inc. (TX) TIN 84-2790842 Portfolio Services Limited, Inc. (TX) TIN 99-0380279 Express Systems, Inc. (CA) TIN 33-0620692 Portfolio SE, Inc. (TX)4 TIN 30-0964112 Standard Group Insurance, Ltd. (TCI) TIN 04-3160317 Express Performance RE, Ltd. (TCI) TIN 98-0596201 SGR Ltd. (TCI) TIN None Portfolio Captive Insurance Company (TX)3 TIN 81-1383985 PRO Consulting, LLC (WA) TIN 91-1914078 National Automotive Experts LLC (OH) TIN 20-4752011 Veritas Insurance Ltd. (TCI) TIN 98-0698837 ALDS Holdings, Inc. (DE) TIN 92-1647133 Finance Concepts LLC (CA) TIN 45-0980182 Sean Moore Holdings, Inc. (DE) TIN 93-3532764 New Global Administrators, LLC (MA) TIN 37-2027711 New RMG LLC (CT) TIN 35-2741013 New AIG LLC (MA) TIN 38-4206540 NWAN, Inc. (OH) TIN 46-1273738 Villa Mani Reinsurance Company, Ltd. (TCI) TIN 98-1437144 Imprise Captive Insurance Co. (OH)3 TIN 36-4812450 Automotive Platform Holdings LLC (DE) 2 TIN 86-2884016 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 1 Unless otherwise indicated, all ownership interests are 100% 2 PHI owns 50%; New AIG owns 50% 3 captive insurance company 4 specialty insurer Organizational Chart of Protective Life Corporation as of March 31, 2026 Protective Life Corporation (DE)1 TIN 95-2492236 Turbo Topco, Inc. (DE) TIN 84-2855430 Turbo Buyer, Inc. (DE) TIN 84-2774149 PGM Holdings Corporation (DE) TIN - 90-0919323 Piston Acquisition Company, Inc. (DE) TIN 81-2921633 Portfolio Holding, Inc. (DE) “PHI” TIN 46-1625561 Turbo Intermediate, Inc. (DE) TIN 84-2888092 Folio Protection Company, Inc. (TX) TIN 84-2790842 Portfolio Services Limited, Inc. (TX) TIN 99-0380279 Express Systems, Inc. (CA) TIN 33-0620692 Portfolio SE, Inc. (TX)4 TIN 30-0964112 Standard Group Insurance, Ltd. (TCI) TIN 04-3160317 Express Performance RE, Ltd. (TCI) TIN 98-0596201 SGR Ltd. (TCI) TIN None Portfolio Captive Insurance Company (TX)3 TIN 81-1383985 PRO Consulting, LLC (WA) TIN 91-1914078 National Automotive Experts LLC (OH) TIN 20-4752011 Veritas Insurance Ltd. (TCI) TIN 98-0698837 ALDS Holdings, Inc. (DE) TIN 92-1647133 Finance Concepts LLC (CA) TIN 45-0980182 Sean Moore Holdings, Inc. (DE) TIN 93-3532764 New Global Administrators, LLC (MA) TIN 37-2027711 New RMG LLC (CT) TIN 35-2741013 New AIG LLC (MA) TIN 38-4206540 NWAN, Inc. (OH) TIN 46-1273738 Villa Mani Reinsurance Company, Ltd. (TCI) TIN 98-1437144 Imprise Captive Insurance Co. (OH)3 TIN 36-4812450 Automotive Platform Holdings LLC (DE) 2 TIN 86-2884016 Dai-ichi Life Holdings, Inc. (Japan) (Ultimate Controlling Person) Dai-ichi Life International Holdings LLC (Japan) Dai-ichi Life International Limited (Japan) 99.9988% 0.0012% 1 Unless otherwise indicated, all ownership interests are 100% 2 PHI owns 50%; New AIG owns 50% 3 captive insurance company 4 specialty insurer

EX-101.SCH 8 ck0000948923-20260423.xsd XBRL TAXONOMY EXTENSION SCHEMA EX-101.DEF 9 ck0000948923-20260423_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 ck0000948923-20260423_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Accidental Death Benefit Rider [Member] Administrative Charge For Face Amount Increases [Member] Administrative Charge [Member] Advisory Fee Risk [Member] After October 13, 2025 [Member] American Funds Insurance Series® Asset Allocation Fund - Class 1 [Member] American Funds Insurance Series® Global Growth Fund - Class 1 [Member] American Funds Insurance Series® Growth-Income Fund - Class 1 [Member] American Funds Insurance Series® New World Fund® - Class 1 [Member] BlackRock Global Allocation V.I. Fund - Class I [Member] Business Disruption and Cyber Security Risks [Member] Children's Term Life Insurance Rider [Member] ClearBridge Variable Mid Cap Portfolio - Class I [Member] ClearBridge Variable Small Cap Growth Portfolio - Class I [Member] Dimensional VA Global Moderate Allocation Portfolio - Institutional Class [Member] Dimensional VA International Small Portfolio - Institutional Class [Member] Dimensional VA International Value Portfolio - Institutional Class [Member] Dimensional VA Short-Term Fixed Portfolio - Institutional Class [Member] Dimensional VA U.S. Large Value Portfolio - Institutional Class [Member] Dimensional VA U.S. Targeted Value Portfolio - Institutional Class [Member] Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class [Member] Dollar-Cost Averaging [Member] ExtendCare Chronic Illness Accelerated Death Benefit Rider [Member] ExtendCare Rider [Member] Fidelity® VIP Balanced Portfolio - Initial Class [Member] Fidelity® VIP Growth Opportunities Portfolio - Initial Class [Member] Fidelity® VIP Investment Grade Bond Portfolio - Initial Class [Member] Fidelity® VIP Mid Cap Portfolio - Initial Class [Member] First 10 Policy Years [Member] Fund Risks [Member] Goldman Sachs VIT Core Fixed Income Fund - Institutional Class [Member] Goldman Sachs VIT Mid Cap Value Fund - Institutional Class [Member] Income Provider Option Pre-Determined Death Benefit Payout Endorsement [Member] Interest Rate Before October 13 2025 [Member] Interest Rate [Member] Invesco® V.I. Global Fund - Series I [Member] Invesco® V.I. S&P 500 Buffer December Fund - Series I [Member] Invesco® V.I. S&P 500 Buffer June Fund - Series I [Member] Invesco® V.I. S&P 500 Buffer March Fund - Series I [Member] Invesco® V.I. S&P 500 Buffer September Fund - Series I [Member] Invesco® V.I. U.S. Government Money Portfolio - Series I [Member] Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares [Member] Lapse Protection Endorsement [Member] Loan Risks [Member] Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC [Member] Net Cost of Loans for Carryover Loans After the First 10 Policy Years [Member] Net Cost of Loans for Carryover Loans During the First 10 Policy Loans [Member] Net Cost Of Loans For Standard Loans After The First10 Policy Years [Member] Net Cost Of Loans For Standard Loans During The First10 Policy Years [Member] On or After February 1, 2024, But Before October 13, 2025 [Member] On or After October 13, 2025 [Member] On or Before February 1, 2024 [Member] On or Before October 13, 2025 [Member] Option 1 Death Benefit [Member] Option 2 Death Benefit [Member] Option 3 Death Benefit [Member] Option 4 Death Benefit [Member] Overloan Protection Endorsement [Member] PIMCO VIT Real Return Portfolio - Institutional Class [Member] PIMCO VIT Total Return Portfolio - Institutional Class [Member] Policies With Application Signed On Or After October Two Policy Years [Member] Policies With Application Signed On Or After October Years Thereafter [Member] Policy Illustration Fee [Member] Policy Loans [Member] Policy Years After 10 [Member] Portfolio Rebalancing [Member] Protected Insurability Benefit Rider [Member] Putnam VT Sustainable Leaders Fund - Class IA [Member] Reservation of Rights [Member] Schwab® S&P 500 Index Portfolio [Member] Specialized Uses of the Policy [Member] Standard [Member] TOPS® Aggressive ETF Portfolio - Class 1 [Member] TOPS® Conservative ETF Portfolio - Class 1 [Member] TOPS® Moderate ETF Portfolio - Class 1 [Member] TOPS® Moderately Aggressive ETF Portfolio- Class 1 [Member] Tax Risk [Member] Telephone Transfers [Member] Terminal Illness Accelerated Death Benefit Endorsement [Member] Vanguard Variable Insurance Funds - Balanced Portfolio [Member] Vanguard Variable Insurance Funds - Conservative Allocation Portfolio [Member] Vanguard Variable Insurance Funds - Equity Income Portfolio [Member] Vanguard Variable Insurance Funds - Equity Index Portfolio [Member] Vanguard Variable Insurance Funds - Growth Portfolio [Member] Vanguard Variable Insurance Funds - International Portfolio [Member] Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio [Member] Vanguard Variable Insurance Funds - PRIMECAP Portfolio [Member] Vanguard Variable Insurance Funds - Real Estate Index Portfolio [Member] Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio [Member] Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio [Member] Waiver of Specified Premium Rider [Member] Withdrawal and Surrender Risks [Member] Withdrawal Charge [Member] Fidelity VIPBalanced Portfolio Initial Class Member Invesco VISP500 Buffer September Fund Series IMember Vanguard Variable Insurance Funds Balanced Portfolio Member Overloan Protection Endorsement Member Dimensional VAShort Term Fixed Portfolio Institutional Class Member Protected Insurability Benefit Rider Member Goldman Sachs VITCore Fixed Income Fund Institutional Class Member Policy Loans Member Childrens Term Life Insurance Rider Member Dimensional VAInternational Value Portfolio Institutional Class Member Fund Risks Member Option2 Death Benefit Member Policies With Application Signed On Or After October Two Policy Years Member On Or After October132025 Member Putnam VTSustainable Leaders Fund Class IAMember Portfolio Rebalancing Member Vanguard Variable Insurance Funds Total Stock Market Index Portfolio Member Net Cost Of Loans For Standard Loans During The First10 Policy Years Member Vanguard Variable Insurance Funds Growth Portfolio Member Specialized Uses Of The Policy Member Withdrawal And Surrender Risks Member Janus Henderson Global Technology And Innovation Portfolio Institutional Shares Member Clear Bridge Variable Mid Cap Portfolio Class IMember Withdrawal Charge Member After October132025 Member Invesco VISP500 Buffer March Fund Series IMember Advisory Fee Risk Member Lord Abbett Series Fund Bond Debenture Portfolio Class VCMember Vanguard Variable Insurance Funds Conservative Allocation Portfolio Member Vanguard Variable Insurance Funds International Portfolio Member Fidelity VIPMid Cap Portfolio Initial Class Member Dollar Cost Averaging Member TOPSModerate ETFPortfolio Class1 Member Fidelity VIPGrowth Opportunities Portfolio Initial Class Member PIMCOVITTotal Return Portfolio Institutional Class Member TOPSAggressive ETFPortfolio Class1 Member Vanguard Variable Insurance Funds Mid Cap Index Portfolio Member Dimensional VAGlobal Moderate Allocation Portfolio Institutional Class Member Invesco VIUSGovernment Money Portfolio Series IMember Accidental Death Benefit Rider Member Fidelity VIPInvestment Grade Bond Portfolio Initial Class Member TOPSConservative ETFPortfolio Class1 Member Schwab SP500 Index Portfolio Member Invesco VISP500 Buffer June Fund Series IMember On Or Before October132025 Member Income Provider Option Pre Determined Death Benefit Payout Endorsement Member PIMCOVITReal Return Portfolio Institutional Class Member Option1 Death Benefit Member Vanguard Variable Insurance Funds Total Bond Market Index Portfolio Member On Or Before February12024 Member Interest Rate Before October132025 Member Goldman Sachs VITMid Cap Value Fund Institutional Class Member Standard Member Waiver Of Specified Premium Rider Member Vanguard Variable Insurance Funds Equity Index Portfolio Member Administrative Charge For Face Amount Increases Member Policy Years After10 Member Dimensional VAInternational Small Portfolio Institutional Class Member Clear Bridge Variable Small Cap Growth Portfolio Class IMember Extend Care Rider Member Net Cost Of Loans For Standard Loans After The First10 Policy Years Member Tax Risk Member Policy Illustration Fee Member Reservation Of Rights Member Terminal Illness Accelerated Death Benefit Endorsement Member Vanguard Variable Insurance Funds Real Estate Index Portfolio Member Administrative Charge Member Loan Risks Member First10 Policy Years Member Invesco VIGlobal Fund Series IMember Vanguard Variable Insurance Funds PRIMECAPPortfolio Member Interest Rate Member Telephone Transfers Member Option3 Death Benefit Member TOPSModerately Aggressive ETFPortfolio Class1 Member Vanguard Variable Insurance Funds Equity Income Portfolio Member Lapse Protection Endorsement Member American Funds Insurance Series Asset Allocation Fund Class1 Member Business Disruption And Cyber Security Risks Member Dimensional VITInflation Protected Securities Portfolio Institutional Class Member On Or After February12024 But Before October132025 Member Black Rock Global Allocation VIFund Class IMember Dimensional VAUSLarge Value Portfolio Institutional Class Member American Funds Insurance Series New World Fund Class1 Member Extend Care Chronic Illness Accelerated Death Benefit Rider Member Net Cost Of Loans For Carryover Loans After The First10 Policy Years Member American Funds Insurance Series Growth Income Fund Class1 Member Net Cost Of Loans For Carryover Loans During The First10 Policy Loans Member Policies With Application Signed On Or After October Years Thereafter Member American Funds Insurance Series Global Growth Fund Class1 Member Invesco VISP500 Buffer December Fund Series IMember Option4 Death Benefit Member Dimensional VAUSTargeted Value Portfolio Institutional Class Member EX-101.PRE 11 ck0000948923-20260423_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 12 tm263879d1_2025q4orgchrt1.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt1.jpg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�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end GRAPHIC 13 tm263879d1_2025q4orgchrt2.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt2.jpg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end GRAPHIC 14 tm263879d1_2025q4orgchrt3.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt3.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" -1!$P# 2( A$! Q$!_\0 M'0 ! 0 # ,! 0 <%!@@#! D" ?_$ &$0 $$ 0,! P8'"0P% M" @%!0 ! @,$!08'$1(($R$4(C%7E=05%A<809;2(S(W4556=M/5"3A'4F%U MDY2SM+7#)#-"<8$T-6)S=(67MD-3O--[.#=ZM/8 MK>3]TNT/H?7U>+*Z/Q6E93JJV[BN?U.=&OA(J(WGA>>>[3GPY [(V_ MW6T9NMCY;VC-5X?5-6%R-EDQ-Z.RD3E]"/Z%7I7^1>#:CY_;EZ.P&P/[H;L^ MNV>+IZ8?JK%7X,]B,/"V"M+"QCE9*Z%B(U%Y;SSPG*Q\^GDUK9[M([_VNSSK M3?W4^ML=E].8"MD:5/3#,/!$ZU9;*UD-B65C$5&L<_A6M5.48G/BJJ!])@?/ M*GNOV@]NLQV;[NI-U*&JL1N?F:?PA19@*M>2I%*UCUKQR-;YT:MD1%=PUR*U M.%X4T#>KMH;HZ.U;F]1:7W4EU1C,9J1F/?A<)HQ'Z?K5EE1O M8KD5?O7(B^ ?4PPV>UGI_2MO%UYRJY MSNI41J(U$Y-$K]HW56ZFVG9&U/J"##7LYF]:.H9"S8Q-:956.58^]AZV+W#U M1J*KHNE>?1PG@!])0?/76VO.T,_M68[:C0&]\.K+"RK?SS/B?1@K:>HJ]%:R M2;EZR2="HB-X:J\M\>5\-5[5G:VW-T-K/<*]HS=>>['I:U'$S3FF]&)>QU1J M.:U[[$X7T!]+9;M>">*"6Q%'-*CG1QO>B.>C?OE1/I MXY3G\1CM+:RP&N<6N2TWG,;J#')*Z%;>*MQV84D:O#F=;%5.I%\%3GE#Y]UT MUUK?]T;T3FHM;,QK;^@*^;\D3$QRLBINZ5FHIU._VW]3N^^^3E$X7@UW:SM+ MZ[PG9PT!I_1B8+3NK]>Z_OX"OEX,-6@JXZ)LK>J;R>)C8WR>?'GE0/ MI\#A2'?;=O97<7=':K6&LZ^O,AC]#V=68'5+<3!2G@?&QR=W-#&BQN1')RG* M+Z/'GGA-#TUVA]_L#IKL[;EZAW$H9O";@9FOA[^EH\#7@C9%(Y6I-W[4ZUD5 M&JY>GI:BJB(G'**'TG,-\<]/_&KXL?#N,^,ODWEGP-Y9'Y9W'/'>]SSU]'/A MU<<<_2?-;M)]L;<_0^K=;YO1^ZLV:J:=S+*B:?T_HQ+.%J0I(UCHKV2F8BME M7GA>[5R=7"(J<^%KP>0=E_W3S&WGL2-]K;".=6)Z&JZ=%X__ ' ["U-JK"Z* MPMG,:@R]'!XFLG5->R-EE>"-/^D]ZHB?\5,+M_O!H;=>I9LZ,U?A-4055XL. MQ-^.QW*KZ.M&JJMYX7CGCDY)[9F.J;B=LKLZ[?:N8EK0%YUV_-CK"_Z-=N1L M7NV2)Z'<<-3I7T]:I])5,5LCL9MGVEX,IIJ:CH[<:Y@96-TMAY8Z=:]5\[JE M6JQJ(YR=//*+_L(JIX<@7G2NLL!KK%KDM-YS&ZAQR2NA6YBK<=F%)&KPYG6Q M53J1?!4YY0S!\?=G-=;P;(=CRUNAI/7E/&Z:Q&L9JSM)OPT,R7VR66MD?+8> MJO;XNX1K$;PB<\\J6SM;]J+<'3FN=4Q:)W4M8]^!Q$-Z/2VD]')F'PO6+O'N MR5J9G=P,X_BN7AOBK>4\0^BQX4N0+;6JD\:VD8DBP]:=:,YX1W3Z>.45.3Y[ M:B[1F^FZNL=@=*Z$U;C='7MP-&.RV2M38N*S'!.U'.?,QKVJO/#%1&\]/G>* M'F[)^E-PZ/[H!O*S/;C)FYL71QZ9A?@:&),JU\'W%C>E?N"1*O/+$\_CQ1.0 M/H2>IE*JIS/VLMX]>8K M=7:O:+;K,5=)YS6\UF2QJ6U39;6E7@9U.2*)_F.>[Q^^_$GHYY3EWM!;F[L7 M=K^T3LQJ_7-;-Y#1F/J9;XQU\-##)EL=,K4=4FC:J,A?S)&O6SQ\UR>//('T M?T#N9I+=3#29;1VI,7J?&1S+ ^WBK3+$;)$1%5BJU5X7A47C\2H:V[M,[/MR M3\<]2+X<<<\FJ=B?0US079IT75O9*EE9K MN/@OMFI8F''(R.2%BLCU59Y76C1K7)T3\=;.E55R<+X+R!]*(Y&31MDCJ=78+0^&ER^H\UCM/XF%6MDOY2U'6@8KE1&HLCU1J*JJB)ROBJGS'V5[ M0.K]+]B';:E6W,;HNW/G[V)J6VX1^;R]ZE"_S(J5;H# M+=J#<'6G8ZWN;JZ:/464TCJ:ACZEG5>F*L%B6"29G"6J+V.B;(WCT*U515]/ M*<@?5#RN#R7RGOH_)NCO.^ZDZ.CCGJY]'''CR8[2VKL%KC#19?3F:QVH,3*Y MS8[^+M1V8'JU>'(DC%5JJBHJ+X^"H0FYVQMM/H.4-I>T7N _L^;":)T5=PNC-2[AZAR5*3.T\'59!C MX(9UZEBJL8V%9'=2>EOCPOTKR@?2/56LL!H7%IDM29S&Z>QRRMA2YE;<=:%9 M'+PUG6]43J5?0G/*F4DGCBA=,^1K(6M5[I'.1&HWCGE5_%P?.3MP::W>TCV3 M<[C-QM8877BQ:LQ:X/-5J?D=J2/K7S;<+&-C:J+QQT*O**O*E#T;N3NYMWVI M)MK= MQF7O8B;R?(U:%R.>6E+X_B<10L8Q%\/%43Q7Q7Q-*["/[X3M7_ *8L_P X#KF?6>GZ MVJ:^F9L[C8M268'6H,.^Y&VY+"BJBR-A5>MS$5%Y!B-);PZ%U[J+*X'3 M>K\)GLUBN?+J&.OQSS5N'=*];6JJIP[P7\2^'I.9-ZWO%8G"*L?6C5^E/$Y V%W)UAV9^R%-K' 9S'+ MF=9:N=ING9?IV.2;%N25ZSVG2,1TEE7(U.F%S51JIX([T ?8HPMG6VG:>JJF MF+&?Q<&I;<+K-?#27(VW)HF\]4C(5=UN:G"\N1.$X4Y5['N^6OM2[MZJT'J? M4&1W%T[6QT62Q6M+VDYL"]S^IK9:SXGQ1HJHKD5%1.51%\5]"3SM2Y[6VFOW M1O;*]M]I:KK'4S-(6FPXFY?;2CD8KYT>Y97>"<-Y7CZ0.[:VMM.W-56],5\_ MBY]2U(6V;&&CN1NN0Q.XZ9'PH[K:U>4X MOX/QMJY''9N="/I/FS9WURVP.=[9^M=.PQ29MNH,56HN MM,ZHXI)DW'BH MJ$E9[J_,L7$7FR,1>GIKM$Z%T9L1K;,;JX[/8W'*J(Y%1.'>GGT=\.U/O1MWOAJNKJC7.2VGPU/+ M-BT]';T6R_I^_1ZD1'S76HZ='.3Q7H:O"^'+?H#Z9&%RFMM.X//XO!9+/XO' MYO*]7P?C;5R.*S0[/^X>\%7-Y5/'P7T^' =L TO9ZMK MJEMYB:^Y%W#Y/6$3%9F1$.41$3GGCP)KVTMU,GM5M3 M5MX;76.V_P C?R4--F3M8Q^3LO:[E71U*K6.[V9>/!')T^GE4\%0+\#YN[0] MJ7?K/Z1W]P&(ERVN-6Z4IT[>GI=0::BQ>4GGI- MO[$O:8U3KS=Z;2>J]U;6H;4V,6>33.K=)MP>7K6F^+^Y6%%BDC1.>4<[JX\4 M:G"@=YG@O7ZV+I3W+EB*I4KQNEFL3O1D<;&IRYSG+X(B(G*JIS'VLMX]>8K= M7:O:+;K,5=)YS6\UF2QJ6U39;6E7@9U.2*)_F.>[Q^^_$GHYY3GG=37BU77PT,4F2QTD?,E2:%JHR-ZHYJ=;?%/'T@?0#;_= M/1VZV.LW]&ZHQ.J:569:\]C$W&6&12<<]+E8J\+PJ+_N/[I/=31>OSC@^T3)\/XS2V7QF!PEI^7STOD=0: M/BP739B8YR25$1J.E@Y;QU/1$7\2< ?2$\-NW!CZDUJU-'6K0,=)+-,]&,C8 MB&KPWGTJ=%8/1F_>E]*ZFMZXW/PVXNC\CI&U/8BFQ4>/O4;CH M'*B0) SHDB^CE[D7\2)QXAT]IK5&&UGA:V8T_EZ&=Q%E%6#(8VRRQ7E1%5%5 MLC%5KN%14\%]**>]C&,:BE:\MF5'2NM+S(LBJUR\-Z43EOXEY^D M^^FA=*;F;89G3&M\B_%Z9R*,BMSLO)3541Z.1O>+X(BJB)Q]/H SFCMQ=*;B M5K%C2FI\-J:"N_NYI<-D(K;8G?Q7+&YR(O\ (I[;-7X*35#]--S>.=J)E9+C M\0EN-;;8%7I258>>M&<^'5QQS])P)V<-%-VI[CE^[^8CE:K$Y\[E57[[R]F3:[*;2_NC6KL3G=79#7.?LZ'C MOY'.9)$:^>>2>/E&,3E&1M1$:UO*\(G_ ^AIJVK-U=%:"OU*.IM88#3MVY M_P FK9;)P59)_'CS&R.17>/AX&TG /;;VGVIQ^J=3_\ Y>M[F;Y[E4V8[!8& MR]EA<:C&]"6HO-1:T3..I7NQE'3_=MF^%K-R..IT.^]=WJ MN1G"\IPO/"GSR39&"YVJM@MF]S6PZOPVG-N)GOK7>9*TUSSV/I5=81*UJ-CF]W!*Q6N69O4][6 ML;PJJ]40#Z/:X<5J32NJ,-J:.J_N[#\/D(;:0N_BO6-R]*_R*?)K<[1V>V_[*.\&X&% MTY:V^T3N3J7&0XG242]P^'&HK^9',3PB[[S4Z?Q+^)4.A^QE7Q.WG:B?=HVKT]^BIRLGI54=Z.>5#Z M M $7[0W90T=VC9,+D,O:R^G=48-ZOQ>I=.6_);]3GQ5K7 M\*BMY\>%3P^A4Y4M Y]V3[%NDMGM89'6=S/ZEU_KJ]66F[4FK;_ )7:AA5. M%9$O2B-14\.5Y7CPY1%5#RXSLRX?9_LPZLVUTAC9M:U+=>]-%B]26V-\MEGY MY.FZVB\NW(9.WKO. M,N8['UXU1S:N.1.GECG(GH;SZ.55$Y.EU=)9#)+EX-. M5,M&RE1MJ]'++&QT+D%3L( 27 ]FK36GMTM::^AR.8GS6K, M5!B+\<\T2P,BBC1C71M2)%1ZHG*JKE3GT(GH-,P?83T%I_2&V.G*V7U(ZEM[ MF9,YBI)+-=99IWO5ZMG5($1S.5\$:C%_E.C0!R/IW]S@TWH_4&;S.GMX-W,# M>S5M;N1?C=0UX?*I%)@P7>4K,+4R5*)45([*=UPO5_M=*-147T)X&+3L!;;ILO!MQY=J%:= M/,RY_'9M+L<>2Q]U[NKO(961-:G'H1%:O\O*HBITL .>-!=B?2FD:FMY\KJ3 M4^L]4:PQC\/DM3Y^ZR>^RHYBL[J%>CI8B)POBU?%$YY1.#V[78QT3;V\VLT: M_*9],7MUD8,GB96V(.^GEB55:EA>YZ7-7E>48UB_RH7P 4\$?U(G\O"<6/"]FW3>$WHH; MGQY+,6-14].QZ:;%/+$M9]=CD$\/!.-3V.[&&A=B]4Y3553 M):CU?J_(5_))-0ZNR7E]UD/TQL?TM1$\$\>.?#CGCP+V .<4[".@4[/-_9OX M7U'\6+N47+R6_*:_EJ3+*DO2C^XZ.GJ:B<="KQ]/TF*UI^Y]:,UEK75.<9K# M6F H:KJQUL]A,-DVUZF15D?0Q\B=VKO1XJG/"KSX<*J+U& (1HKL=:.T-J[; M74=/+Z@M7] X27 XMMNQ LH=ES#X;M( M9+>+%ZFU!C,GEH(X6./NXW2-5G4O2G"HB.^^1%_&A:0!)-_P#L MU::[0E;!392_E]/:@P%E;>'U#I^TE>]1D5$ZNAZMR>NVM9G]5Y*['+E;*-5%8C9'1JQK6\>"="^GQY\..D !A=% MZ4J:%T?A--T))IJ.(I0T()++D=*Z.)B,:KE1$17<-3GA$3GZ$.5$_*\\(GB=B@#G;<#L.:$U9I MG;[%:?OYO;R?0;GK@LEIFTD5BNUZ(DB*Y[7]77QRKE\555\5Y5%P<7[G=MZS M0&O=(OU)K&SC]:WJN2REFUD8)K7E$#NKO&2/@5>7N\7]?5SSX=)U* ,>F%@3 M ?!'7)Y-Y-Y+U/*?'T^CBHYKLX::SN]='="Q>RK,_4P,N MGHZTOC_HE5 $[V#V.P79UVSQ^A]-V\C=Q-*6:6 M.;*R1R3JLDBO=RK&,;QRY>/-3P_&17._N=FE\GK[5>K<5NGNKH^_J:^_(Y"M MIC4,5&N^5RJOWK:_*HG*\=2N5.?2=7 "%Z/[(FF])Z_TIK.75.K=1:@T[@Y\ M!!;SN0CM/M02R/>Y\[^Z1SY$61414OV$=NH=@I-I7V\[8PB91^ M:JY.2W&W(4[CG]:2Q2,C:UJM551.6KX*O/)T8 (QL3V8<7LCG<[J&;5>IM=: MIS,<<%K-:HO)8F2&/[R-B-:UK4\$Y7A57A/'Z#,9KL]Z=SN_^G]W[%W*,U+A M,9+B:]6.6-*;XI.OJ<]BQJ]7>>O"H]$]'@4\ 2:+LSZ23>S5FYUB7(7LOJ?# M,P60QMF2-U!U9$:G#6)&C^51J(O+U3Q7P0E.G/W.706!S&%9/JK6>;T5@[_P MGBM#Y/*)+B:ECJ5R*C.A'.:U554:KOI7GGE>>KP!!2)%[MU96QHK%:JHY.I7^*)]'*+KF@.P1I?1>X&C-;9#7>NM M7:BTFV2'&S9[*1SQMKNC6-L"L[KP8U%54Z5:JJOBJIPB=.@#FKY@NWWR??$_ MX8U+\&?&[XY][Y57[[RSGGN^>XX[K_H]/5_TC9-QNS1@\YKW5>YE:M8SNK,C MI.?3;<#D++(\9:B5%J-7[U7O?W/K2VM\ M]J::+7NNL!IG5%KRS.:5Q>48W'W9.45WFOC#HXJ7(][766-6\/B@1/N2,9&UJN^;TN[YKHW.=PGHZ7-_XE0 '.\? M8=T)%L;K/:I,MJ+XO:JRLF8NV5LP>5QS/D9(K8G=ST(SF-O".8Y>%7Q/YN=V M*--Z^U!A-1XC5NJ]!:IQF)9@G9K35YD$]RDUJ(D<_+%1R^'@J(GC_N3CHD 0 MK0?8]T?MF[;MNG,UJ;&4]%^4NAHQ9%O<9.2?_6276]'W5W/BG"M1%^CCP,WV MB^S?@>TAI[#4,ME-R&I-8ZBLZVI05!EM MH^Q?A-L]QZ&NLOK?5^X>H\71=C<38U3>9.W'UW>#FQHQC>7*BJBN55]*^'/B M=#@"2;_]FK37:$K8*;*7\OI[4& LK;P^H=/VDKWJ,BHG5T/5KD5J\)RBI]'T M&J:1[$FB],Z W T];S6HM09;7D#J^?U5E;C)LI9:K5:B->K.AJ-15Z4Z%3\? M/"'0P UK;?06/VNT!I_2&*FLV,;A*,5"O+<$1/Y# MGK.?N;^UNH] 0:1O9#4DV.AU//JIL_E5?O\ RB9$22'J[CCN5X3S>GJ\$\XZ MJ '/6J>PYMYK!^ZJY&SFGLW%CJ,R43+$365%K(G;R44[7U)8UC[KH6'S48BJK>A4\557 M=1TR (AIWL?Z!P/9OEV1G^$LSHR1DK7/R,[%MHKY5EZT?&QC48UIK'766;AIM/XZUJ/(,F7&4I&*QS($2-$1W2JIU.1 M?]QTN .>9>P_H6;970NV#LMJ%,!H_*Q9BA92S!Y5+-'(^1K97=STJSF1W*-: MU>$3Q*GO!M)IS?/;O+Z*U76?9PN3C1LGPO8MTQL;K:SK*74^J=>ZK=23&5LKJS():DIU$XXABX:WI3P1/'G^3 MCE>=XH[ Z>Q_: R6[\=S)NU+?P[,)+5=+'Y&D#7HY'-9W?7U\HGBKU3^0I@ MC?9OVNU!MI#KU^>OW[+,WJ:UD\?7R.0\MEK57(U&MZT1&M15:YR,:GFMW"W'PVHLJB,D=A,Q7K1PQ(U&MBC_ -&5R,1&IYJN M7Q\3K 5] M"-]*_0JHN.UI^YT;;:SV;TAMDF:U7@],Z;L278DQ-Z!DURR_[Z>PZ2!Z/?RK ME16HU$ZEX3T<=3@#F32W8 T+@]!ZQT?F-5ZXUQA=3P0PV(]49AEI]18G*YDE M=S8F=V]'*B\KS]ZGAQRBYO8#L:Z:V'U=>@ M M "6]H'.9_%8/2U+3F=FTW=S6I*.+ER5:O!/+%#(KE?T-F8^/E4;QRYJ\ MR<)[@/DAUUZ\]7>R<)[@!602;Y(==>O/5WLG">X#Y( M==>O/5WLG">X 5D$F^2'77KSU=[)PGN ^2'77KSU=[)PGN %9!)ODAUUZ\]7 M>R<)[@/DAUUZ\]7>R<)[@!602;Y(==>O/5WLG">X#Y(==>O/5WLG">X 5D$F M^2'77KSU=[)PGN ^2'77KSU=[)PGN %9!)ODAUUZ\]7>R<)[@/DAUUZ\]7>R M<)[@!602;Y(==>O/5WLG">X#Y(==>O/5WLG">X 5D$F^2'77KSU=[)PGN ^2 M'77KSU=[)PGN %9!)ODAUUZ\]7>R<)[@/DAUUZ\]7>R<)[@!602;Y(==>O/5 MWLG">X#Y(==>O/5WLG">X 5D$F^2'77KSU=[)PGN ^2'77KSU=[)PGN %9!) MODAUUZ\]7>R<)[@/DAUUZ\]7>R<)[@!602;Y(==>O/5WLG">X#Y(==>O/5WL MG">X 5D$F^2'77KSU=[)PGN ^2'77KSU=[)PGN %9!)ODAUUZ\]7>R<)[@/D MAUUZ\]7>R<)[@!602;Y(==>O/5WLG">X#Y(==>O/5WLG">X 5D$F^2'77KSU M=[)PGN ^2'77KSU=[)PGN %9!)ODAUUZ\]7>R<)[@/DAUUZ\]7>R<)[@!602 M;Y(==>O/5WLG">X#Y(==>O/5WLG">X 5D$F^2'77KSU=[)PGN ^2'77KSU=[ M)PGN %9!)ODAUUZ\]7>R<)[@/DAUUZ\]7>R<)[@!602;Y(==>O/5WLG">X#Y M(==>O/5WLG">X 5D$F^2'77KSU=[)PGN ^2'77KSU=[)PGN %9!)ODAUUZ\] M7>R<)[@/DAUUZ\]7>R<)[@!600K7>WFX6F=#ZAS%7?'53[6/QUBW$V7$816* M^.)SFHY$HHO'*)SXE6V^S%G4.@M-96ZYK[E[&5K4SFMZ45[XFNN[& MNAE=/8=8'6Q>%XY54ZD5$7Z#L0@?:F[,V9[0-[0&4T[KQ M- YS1V3?E*=]<.S)=4JM:C?N;Y6-\%;SX]2+^(".:(S.M.S'VN(]K)-;:IW4 MTGJ'2UG.T*^JK[+61K6H.M5C;9?T)TO2-4\[I:G4G/H55][:'M[YC7F]N+VY MU)IC3F.L9NC:LUW::U3%E9\<^%CG]S;[MO0UZM:OWKEX7Z%^C9\!V';V1RFL MM1[E;HY/<'6^?T_-IN#-LQD.-CQE25JH[N*\3E:CN5\5Y\?'P\54UK9O]S]S MFVVMMO-19+<;&Y%FBZUJA5QV.TK%198@FB6/JD>R;J=-XHY9'=7/")PGBJAM M/8[W[TQ+V<<%G-6:ODPWEN1R$,$VN=3QVK1U!JBKJO"6ZF,:U,'9KM5L;.A9%2=O#E1?O/#Z -5[ M3>]N\-;LG[K3ZFTC>VMU3A%HK2S>GZ]T._2M^QH.QJ;$Y#&9[O[,L,<2HJ2/2/[E/SR[J3JZ5_C> MDSFINQ[KS=':G7^FMP=YK>>R^J_)&1V(<3W6.Q<<$C'\0TTF1.I_1YSNM/3Z M/Q[5K#LG_&O=6GK/XT^2^3Z'M:-\B^#NOJ[Y%3RGK[U...?]7T^/\9 /:[,6 MKYM7]C[2NHDM9B2Q:PD\QJ/,Y#/Y:>>ZDM_*6GV9Y$;:D:U'2/57+PB(BV$P.V MGPS\+_!>.?C_ (4\E[GO>I7KU]UUNXXZ_1U+Z/2079[L9;U;'Z=Q.F=,=I5E M32F/L.E;BET%3D5S7R+)(SO7SN>G4KG>/*\<^ $#WYWWUY7V0WM31]S4T/<; MCNP=S*7M5/DGI1*^-&QTN(FK#$]5Z.[:J]"*J]2\\%%;VS]0[%T)M!8S15?, M6M!X>&]JE^I=;));1\J+*M:K-*SJM2-8O//">CI1/1S2-1]@CXP;?[E:8^/7 M5?!'5Y'TR-?Y/T]^G><]/'7RWT_>G@WD[!=O7.Z>H=9:3UGC=-2 M:HJP5Q>47EKFKQXHO@J'SARG;?STO[GQ0PL2[H0:_2O"C]= M.K66UWN\MY5WPCWG4O+/,YY\5\T^G*[;5X-HY=!U+;H:RX9^(9_ZS^7^0#$9_M9:X=J^YH;;';V'7V5TK@:F4U%>R>82DQJRPH]L$7+'+)*YO MCRO"XF^'9\UMBLKF,-HC*:;U%DUS:6=G?@M&87*X>S0L54?+E?+XGLFE=,CT2->9'.X1CO M3QRGI @>XW:RW8W1QVQ^I8-*V]O=#ZGUS19C\GB]0N6Q=J=XYBP6X6-9PV1/ M.1.7-7I5%3T*NWT>U_;V=TGN[J6+#Y_6$E'E>41,]GNP)\-Z9UCB/CWW/QBU]%KCOO@?J\GZ'<^2\=^G5S_Z MSE/_ & /Q6[=&9T5D]UL5NEH"+3&5T3@XM11P8K*I>9;KRN:R.+K5C4;)UO8 MU5\4\5\/#Q\.E.VGN%#K[;;3>NMI:^GH]<4[63HV\?FTN*VO%769&+&D2+WW M'2BMY1/.3A?2B9K?OLJ5M0YW>#7]M]_5$&IM&,P*Z4Q59L=M5A>V5LD,[GJC MI.6(K6*Q/%$\5]!S#L!I77FZ?:%V9GMY77^:Q^CL3>K7;NH]+)@F82-U98H8 M&.\Y)K'*IS)U+STM7A.% O/9L[>^=[0.X.+QD6CM/U\)DI)V+'3U3!)E\6D? M/#K5*1L;U1W'_HNKCGZ3LTXTTMV ?XOG?R%Y[/M77E; :G77V1M9*S)J*\_$RW:L-:5N.Y:D#5 MCB541$5'\*JJY6JU5XYX0.0-%]K?4^RVFM\=392+)[@^2[J+I^AC;V5DYK02 MJJ-9 KT>C&MX\&)TM\?H*Q0[)^/G=?&/7L6N.^^!^?)^AW5Y+Q MW_G\_P#K.4_]@W'6\I]'"?1?SF7;CLT[M:5:K,P4F#P->AAF5:]=RLZ([=F M+O7-LRQIQPB\)X>DONA<-E].Z.P^,S^==J?-5*S(KF9=5;66Y*B>=*L355&< MKX]**J(!G0 :EN[^"?6O\ ,EW^P>-H_P %&B_YDI?V#!N[ M^"?6O\R7?[!XVC_!1HO^9*7]@P#;0 M M "3=H/^#7]-<;_F%9)-V@_P"#7]-<;_F 5D M !.,9N->U)OEF-(XQL*8;3>-AGR]A[%=(^W855@ MA8O/#4;&QSW>"\]XQ/#Q,'E=]5TQOIJG3.>FQN+T?@](P:CFRA&QHJ(C>>57Q7P0T2E%JW26Z_:&QVE(J4]$D"MYYX:LC57P4UO,:1W?W)S>YNO<5HM^A\]=TG3T]B,9J&Q2L2V)X[ M#YIY$1CY86IP]6QK(O"NX56H@%JT[VHMO-3OR\=?(Y.E8QF,DS4M?+X.]CY9 M:+$Y=8A98A8LS/Y6([TI^-#^Z%[4FVNXV3J4,-GI^]NU7W:4M_&6J5>]"Q.9 M'UYIHF1S(Q/ON[<[CA>?!#F+*;3;@4M0:CUGFK]35(:\CHHHUZ'(G=<\JB]2-X:9_1FE]T=W]#;,OAT52T=7T=@UR%3+7M9PB=*([T@7[1O:BVYUYJ7&X/$9:\ZUE6R M.Q=BYAKM2IDDC17/6K8EA;%/PB*OF.7E$Y3E#TM*]KK:W6F9Q&-Q>>MR29:R MZC2M38BY%3FM)UU4JZ*M;(B*U$:J=2FWZ>V)UIC^SQM#IF3!)% MG,#K.ME\E52U!]PK-O3RODZT?TN\Q[5X:JN7GCCGE +;MAN+>U#JS7.D*T[WJ?>RVH6RS3(GX^A+$;5_EY3Z"Z@ !J M6[OX)]:_S)=_L'C:/\%&B_YDI?V#!N[^"?6O\R7?[!XVC_!1HO\ F2E_8, V MT M DW:#_@U M_37&_P"85DDW:#_@U_37&_Y@%9 :EK;7K=*9?3.) M@JI=R6=N.@BB63H2.&.-TL\JKPO@UC>$3Z7.:GASR:35[0JV=KMO-8_ '3\; M;]:EY%Y9SY)WR2+U=?=^?QW?HX;SSZ4X,]N+I2]PMAS'-C[U?%L35=TMYX\>0\>ANUUBM:UH%?AY<+85F&?*M_RGR?G()R MC(IFUE;(]O*(B+THY>>58B*J9^OVN-J[<#9HM0VW0/@9<;+\"7T8M9SNGRCJ M6#CN$=YKIOO&KX.%[(]K"TZ%!FL(I*%>/!K(UV)5)9)L:J\.1W?\-; M(U516]*JU?'J7T&13LKHFC?@%-34?!__ $^KRGI[W_\ Q\_^\!MF MI>TAH?3=C*5'W[EN]1991(Z^,M/AGF@A=-)7BL)$L3YD8U56-KUNVL78RU&K>=7GQUI6T6V/"+RF1(NBNCG5/ M3E[%:6[U"W>S^"R%AL:(Q&*BJ MWE53I/,F^E'3& H3:^QUG2>>L/L-=AZD4V5>K('<26(_)XG/=7X5KN]QN!MIF"U+CJF3Q[KM2W5E'6S5E@LR,D6."NEABPI&Z- MB1_='HB<]2/YY S=G?[;'4=Z734N89EF7EBHRL;CK$]*5;,*210OG2)8>98W MITM5WG]7"(J^!@=N^U'MSD-,8F)C;>EHVTYIHL;-B+<<=*E7E?#WKW)"C(H4 M[KCJ&\\GKZ6[*=32&F4P='4,KJC,YB,Q$^>HCGHVC%7C2)RH]$57^3\ M]:(G3U_>KQX^KA>R:E;$:BQ>5U2EZCD\)8P<'DF.\GEKPR7);3'NUT MRI]ZU'=*>">* 9S,]J+3;'XMF!AGR\]JX^K8K78;&-GK-\BL6HY5BGA:]S'I M75K7<(U>55%7IX/QICM3Z7R. H9#-O3&6<@ZM%5QV-AN9*RZ66C%<6)615D5 M7M9(J^8CT5K47E%56MQ5[LQ9C4VJZ^J-3:UK9#/1=W#UT,*M6OY/'5MP,8D: MV)%1ZNNOD<]7JB]*-1K4\3S[=]ESXA9S3N1^,WE_P1;9:[OR#N^]Z<3'CNGG MO5Z>>[[SGA?3T_1U 96GO]M#HC%U6X_+Q5<;?1F267'XVU-"U;4J]$D[XXG) M$^617<)*K7.=RG'@9'=7=G-Z*UII73. P>&RMW.5[EE9\[FWXRO ROW7*=3* MTZN<[O4X3A/O5\3GO4NP&M]%0W=#:3\NR..SWP9Y=D'XF%U:98;/4]Z3+:1: MO1&B(YKHY>OA.A455XZ0W V1P>YFO=*Y_4%7'Y>A@JUV!,3D\>RU%,^?NN). M7JJ-5G=+_LKSU>E./$-8TEVL-(Y/3%?(:@>N#O\ ?6XK-6BR?)P0,KSN@DLK M/#%PVLKVKQ/(V-OIYX5%1-BO=HW0%#)9''NRMVS;H6FT9F4<-=M(ZRYB/2&- MT4+DEDZ'(_HC5SNGEW'"*IIN[/9,Q6X.I8,MBY<'AV)B6X66ED, R_!'7:][ MV.KL[V-L4B=X]/.21BHJ$3PY10VJ_VC=O,;%CY9\^[N;M9EQ)8Z%F1E>! M[U8V6RYL:I68KTS M7Y26%MAT21OO+H)F/='+ M$J_2K)&/;S]/2;(:)LAI;(:/VSQ='+1MARDTMK(6H&JBI#+9LRV7Q\IX+T+, MK>4]/2;V &I;N_@GUK_,EW^P>-H_P4:+_F2E_8,&[O MX)]:_P R7?[!XVC_ 4:+_F2E_8, VT M M TG=C;5^YV#QM.#.W-.7\;DZ^5IY&E%%*^.:%5 M5$5DK7-NG+^P,9^I'R6[C>NG+^P,9^I*R )-\ENX MWKIR_L#&?J1\ENXWKIR_L#&?J2L@"3?);N-ZZNG+^P,9^I'R6[C>NG+^P,9^I*R )-\ENXWKIR_L#&?J1\ENXWK MIR_L#&?J2L@"3?);N-ZZNG+^P,9 M^I'R6[C>NG+^P,9^I*R )-\ENXWKIR_L#&?J1\ENXWKIR_L#&?J2L@"3?);N M-ZZNG+^P,9^I'R6[C>NG+^P,9^I M*R )-\ENXWKIR_L#&?J1\ENXWKIR_L#&?J2L@"3?);N-ZZNG+^P,9^I-)TIA-T<]N5KK3LV\>295P/D'<2-P.-Z MG]_"LCNK[C]"IX'1Y)MN/P][P_\ <_\ =7 /DMW&]=.7]@8S]2/DMW&]=.7] M@8S]25D 2;Y+=QO73E_8&,_4CY+=QO73E_8&,_4E9 $F^2W<;UTY?V!C/U(^ M2W<;UTY?V!C/U)60!)ODMW&]=.7]@8S]2/DMW&]=.7]@8S]25D 2;Y+=QO73 ME_8&,_4CY+=QO73E_8&,_4E9 $F^2W<;UTY?V!C/U(^2W<;UTY?V!C/U)60! M)ODMW&]=.7]@8S]2/DMW&]=.7]@8S]25D 2;Y+=QO73E_8&,_4CY+=QO73E_ M8&,_4E9 $F^2W<;UTY?V!C/U(^2W<;UTY?V!C/U)60!)ODMW&]=.7]@8S]2/ MDMW&]=.7]@8S]25D 2;Y+=QO73E_8&,_4CY+=QO73E_8&,_4E9 $F^2W<;UT MY?V!C/U(^2W<;UTY?V!C/U)60!&,]LIK[4>#R.)N;TYE:E^M)5F1F"QJ.Z'M M5KN%[GP7A5*MIO!P:8T]B\/6?))6Q]6*I$^545[FQL1B*[A$3GA/'A#(@ M M M !)MN/P][P_\ <_\ =7%9)-MQ^'O>'_N?^ZN MK( M M &J;L2O@VLUE)&]T[>V5KV=341>E4\%3T*=*$F[0 M?\&OZ:XW_,*R M M -2W=_!/K7^9+O\ 8/-M-2W=_!/K7^9+O]@\!M'^ M"C1?\R4O[!AMIJ6T?X*-%_S)2_L&&V@ !R3VQ=#V)MQ]IKM'6NM\ FI=4U< M%D*F#U/YS7];O2G/BO;V7TUB-038^;*8JEDIL= M82W2DN5V2NJSHBHDL:N1>AZ(JIU-X7Q7Q,??VYTGE9LC+=TOAKDN2F@L77V, M?$]UJ6'CN))55OGNCX3H5W*MX3C@#F'L]]L/66[F\-3#9/!8VKIC+S96&FR" MO-#;HK3DZ$662216V.M$7J2-C>[56HO/).M[,U.[[NSJG1U[1U#'V] M.4J6IIJM3OEI+(K/)%?W#VIT7IG5>1U/B-)83%ZCR2 M*ES+4\?%%:LGF=C]N-1:I^,V6V_TMD]2=3'_#%S M#5IKG4Q$1B]\YBOY:B(B+SX<(!R1+VWM>U-?Z)PJTL/;QMVQA\1FX4QUAEBI M>I[5\#/:5[1U^MV.Z-FSA]67\[D=-96ZS-5 M(;]FG6?$^RC>_P @LBR1.^YIPJR(Y.6\*GAQTYD=E=OLQJM^I[^AM.7M1O6- MSLM9Q4$EI71JBQKWKF*[EJHG"\\IPG'H0S-316GJ&EW::JX'&5M..B? N'BI MQMJ+&_E7L[E$Z.EW4[E..%Y7GT@3)3QWY8 MTFAEKJZ5DTCG]4C%_P!KO'+SQR[E?$\7:PW;S&/U+I:'0>H*S9+6GM2V$N5[ MTTD#):]%LC5='#,UCWIXJU7HY6.X5./'GH_4FV.CM9:;J:>S^D\'G,!4Z/)\ M5DL;#8JP]#>EG1$]JM;TM\$X3P3P0QV'V.VXT]4BJXK;_2V,JQ).V."GA:T3 M&).Q(YT1K6(B=XQ$:_\ C(B(O* <)[:=K',A=T\QM;]"-X1/HX,OJ#0VF]6V()\YI_%YF>"&:O%+D*4<[HX MIF]$S&J]JJC7M\UR)X.3P7D#CR3M?[N8K ZD9=Q6C;V=;IK"ZDQ+:K9*T;&W MI>A\#VSV6I/(Q$56M;)$KUX:GBJ&=VX[9>H=0V-NJ.79A8[66SN7PN==+CK6 M.DINJU._C:L,TKNZE7EO4G7*WC[UWXNE\AM-HC*U+56[H[ 6JUJC%C)XIL9" MYLM2->8J[D5OC$Q?%K%\UOT(AKW;K77.4X];3/;CW2RF&S%.;$:<744&H\!B*MBUC;%2 M!T.21R];X$M2/16\(K55Z*K5\6-7P.MM%Z.VSR&GYYM-:8T[#B#/OF*YRM=Z6JY514Y4#F/%=KC='/9BEHECM#835C,QGZ%S4.5 MK66XE\>-;$Y.B+OT>QTB2HJ\R.1K6.7A?0?G,=M[6U?=>#"8[%Z9RF!Q\F$K M9"7'K-99D'7VM<^:G=ZV1MC;U?QRR<+PJ*=1:@V7VWU?CGX[,Z(TSEJ4] MUV4=6MXNO(R2T_[ZPK5;PLCD;XO]*HGBJGKXW;[;36N8QNJX-)8"]F,(]U"G MDI<5$EJ@L+E8L3'.8CX^A45$1../2G@H$:[3697,;_;;:#U'K#)Z'V_RF,R- MZQ#3<;VALUI[%Z6T9MGK[%ZRJ. MQ67S'QVW AGD2S#3FZ/)6*U\+I7HJJBSJYR=+>KAQUYJ_0NF]P<4F,U3I[%: MEQJ/23R/+TH[4/4GH=T2-5.4_'P8G4FS.@-8X/&87.Z)T]F,/BU1:-"[BX)8 M*G'H[ICFJC/1QPU$ XUF[>&Z6H<3;U!I_ :5Q^)I0Z;DEH9:&U)9E?E.&*U) M&2M:UK'KU([H7EO"<<^)M+.U?NG-E<%I)7Z&HZEMZTS.DK.8N4[3:")3K1SQ MS,A\H1Z.=WG2K%D7E43A4.K;.V&C;KK3K&DL%.ZTM9;"RXV%RS+7X\GZ^6^= MW7"='/WG'F\&D[B=EW0.YFHM.9'+8/'NJ8K(7,G9Q24('5-D,4G=N*T:UVJ]T)-QK-:I2TFW2[-P6Z$CAEJV777++ DD M=A9$F1GFN%:=$Y/8#;'-/QSLAMWI6^N.J^0T_*<+6D2M7^B*-', M7I9XKYJ>'BOXS+R;9Z45LBPZ:PT$[KR95LS,;"KFWD;TMM^+?]>UEG=WM56L;FZ6&P%/2^(P=H_6US2&].P43<]/AP>@];Z=S.2N:GLZVR#\EG\K<@KQRVY'*WP1C8^[8U$8B)PWE. M55%1>%2BZXVQT=N;5K5M8:3P>K*U5ZR00YS&PW&1.5.%Y>M\OI2:CFX,5H*ODZD4]V>:C)._*-KNYBCE2/GI4=U_0C. M/'J"CL7MMC,;)CJ>WVE:F/DK>1OJP86LR)T'>][W2L1G"L[SS^GCCJ\[CGQ, MK+MMI&>U+9ETMA9+,UV+)23/Q\*O?;B;TQ6%7IY65C41&O7SFIX(J K;>9O4%G!6Y+-B6Y/!=?&BK/),Y[G)]SX5RN1K$>G'BB MMW#3_;;W/RS,;IZ?'Z5J:AS&:Q>/J:@M4K,&.K16Z\L[N]JNL+*KF]UTL=WC M6R=;53CQ0Z]=LSH!S\,[XDZ>1<*R:+&(F+@1*3)>>];$B-X8C^IW4B<(O*\^ MD]*KV?ML*6E+NF*^WFEX=.79DLV<2S#UTK32IZ'OCZ.ESD^A53E/H FW8;U; MG]:;4:AR&I,RN=R3-6YBOY4VS)/"C&6%1K(7/28NI'6BZW+RYW0Q$3E?I7CE3+@ !)NT'_!K^FN-_S" MLDF[0?\ !K^FN-_S"L@ M M #4MW?P3ZU_F2[_8/-M-2W=_!/K7^9+O\ M8/ ;1_@HT7_,E+^P8;::EM'^"C1?\R4O[!AMH "1:B MQ>KL1NSG\KING3N6LGA:#*;LHLC*O-:S*MB!TK&N6)SX["*QRM406*]I'I/EV.R:3]Y;;+4>QCV,C5(^MEA MJ]ZJ\(WP.S0!R/IGL=9RCA[3^77,^IO[8-;5.N=6Z0QNU6X5C/Z5\D^%JODV.3R?RF)98/%;O"]3$5? Z".5NSS M^_J[6_\ ^D?\,D J'RZYGU-[A_T.-]^'RZYGU-[A_P!#C??BL@"3?+KF?4WN M'_0XWWX?+KF?4WN'_0XWWXK( DWRZYGU-[A_T.-]^'RZYGU-[A_T.-]^*R ) M-\NN9]3>X?\ 0XWWX?+KF?4WN'_0XWWXK( DWRZYGU-[A_T.-]^'RZYGU-[A M_P!#C??BL@"3?+KF?4WN'_0XWWX?+KF?4WN'_0XWWXK( DWRZYGU-[A_T.-] M^'RZYGU-[A_T.-]^*R )-\NN9]3>X?\ 0XWWX?+KF?4WN'_0XWWXK( DWRZY MGU-[A_T.-]^'RZYGU-[A_P!#C??BL@#GW6>J=2[IYS06/J[7ZOPL5'4U/)VL MAEVT(Z\,$22*]56.T]RKXHB(C5Y53H( M M &-U+J/&Z.TYE<]F;;*&(Q526]=M/15;#!$Q7R/5$15X1K57P3GP R M0)*WM2: >U'-DU,K53E%31V8\?\ _4/[\Z+0/\?4_P!3LQ[H!602;YT6@?X^ MI_J=F/=!\Z+0/\?4_P!3LQ[H!602;YT6@?X^I_J=F/=!\Z+0/\?4_P!3LQ[H M!602;YT6@?X^I_J=F/=!\Z+0/\?4_P!3LQ[H!602;YT6@?X^I_J=F/=#"3=M MC:2'(7*+LKJ!URF]L5F&/1V9>Z%[F-D1KT2HO2JL>QW"^/#D7T*@%T!"_GK[ M3_E#4OU*S?N8^>OM/^4-2_4K-^Y@70$+^>OM/^4-2_4K-^YCYZ^T_P"4-2_4 MK-^Y@70$+^>OM/\ E#4OU*S?N8^>OM/^4-2_4K-^Y@70$+^>OM/^4-2_4K-^ MYCYZ^T_Y0U+]2LW[F!= 0OYZ^T_Y0U+]2LW[F/GK[3_E#4OU*S?N8%T!"_GK M[3_E#4OU*S?N8^>OM/\ E#4OU*S?N8%T!"_GK[3_ )0U+]2LW[F/GK[3_E#4 MOU*S?N8%T!"_GK[3_E#4OU*S?N8^>OM/^4-2_4K-^Y@70'/]_MW[,8N2O'JR67*R!DVCLTU97(U7*C46IXJB(J^'T(JGY^?GLM^7L]]3LU[F!T$#GWY^ M>RWY>SWU.S7N8^?GLM^7L]]3LU[F!T$#GWY^>RWY>SWU.S7N8^?GLM^7L]]3 MLU[F!T$#GWY^>RWY>SWU.S7N8^?GLM^7L]]3LU[F!T$#GWY^>RWY>SWU.S7N M8^?GLM^7L]]3LU[F!T$#GWY^>RWY>SWU.S7N8^?GLM^7L]]3LU[F!T$#GWY^ M>RWY>SWU.S7N8^?GLM^7L]]3LU[F!T$#GWY^>RWY>SWU.S7N8^?GLM^7L]]3 MLU[F!T$#GWY^>RWY>SWU.S7N8^?GLM^7L]]3LU[F!T$3T) M(YNJ-E97Q\.5$3O&MZO2WE/$#O\ !"_GK[3_ )0U+]2LW[F/GK[3_E#4OU*S M?N8%T!"_GK[3_E#4OU*S?N8^>OM/^4-2_4K-^Y@70$+^>OM/^4-2_4K-^YCY MZ^T_Y0U+]2LW[F!= 0OYZ^T_Y0U+]2LW[F/GK[3_ )0U+]2LW[F!= 0OYZ^T M_P"4-2_4K-^YCYZ^T_Y0U+]2LW[F!= 0OYZ^T_Y0U+]2LW[F/GK[3_E#4OU* MS?N8%T!"_GK[3_E#4OU*S?N8^>OM/^4-2_4K-^Y@70$+^>OM/^4-2_4K-^YC MYZ^T_P"4-2_4K-^Y@70$+^>OM/\ E#4OU*S?N8^>OM/^4-2_4K-^Y@70$+^> MOM/^4-2_4K-^YCYZ^T_Y0U+]2LW[F!= 0OYZ^T_Y0U+]2LW[F/GK[3_E#4OU M*S?N8%T!"_GK[3_E#4OU*S?N8^>OM/\ E#4OU*S?N8%T!"_GK[3_ )0U+]2L MW[F/GK[3_E#4OU*S?N8%T!%L+VPMK]1UI;&,R&H+T,4KH)'0Z0S#NB1O@YCO M]$\')]*+XF0^=%H'^/J?ZG9CW0"L@DWSHM _Q]3_ %.S'N@^=%H'^/J?ZG9C MW0"L@DWSHM _Q]3_ %.S'N@^=%H'^/J?ZG9CW0"L@DWSHM _Q]3_ %.S'N@^ M=%H'^/J?ZG9CW0"L@DWSHM _Q]3_ %.S'N@^=%H'^/J?ZG9CW0"L@DWSHM _ MQ]3_ %.S'N@^=%H'^/J?ZG9CW0"L@DWSHM _Q]3_ %.S'N@^=%H'^/J?ZG9C MW0"L@DWSHM _Q]3_ %.S'N@^=%H'^/J?ZG9CW0"L@DWSHM _Q]3_ %.S'N@^ M=%H'^/J?ZG9CW0"L@DWSHM _Q]3_ %.S'N@^=%H'^/J?ZG9CW0"L@DWSHM _ MQ]3_ %.S'N@^=%H'^/J?ZG9CW0"L@U+;W=73.Z4&3ETY=L65QEE*ER&Y0L4I MH)5C9(UKHIXV/3EDC'(O'"HO@IMH M )9VK/WKN\/Z&YC^Y3%3)9VK/WKN\/Z&YC^Y3 4 MRE_R.#_JV_\ T/.>"E_R.#_JV_\ T/. )-LW^%#?C]+JG^ 8DK)) MMF_PH;\?I=4_P#$@5D !)MU/PS[*?SKDO\+LE9)-N MI^&?93^='_ +G_ +JXK))M MN/P][P_]S_W5P%9 $F[/G\)7Z:Y M/_+*R2;L^?PE?IKD_P#+*R $FVI_#)O;_/ M&._PJH5DDVU/X9-[?YXQW^%5"L@ M 'I9K-4-.8BYE,K<@QV-IQ.GL6[+T9'%&U.7.+N *"":Y MGM'[Z1]&]"VQ Z6)T;G1N3EJJUR(JY9BG8VN]CE:^*)S5XOFK45_)V$JTV7,1=JMFF5%-KXV2.B>Z%SF(DZ)*QT?, M:N\Y./2J.3K4 +FM-BG> M^XGDDTD;7,KK'Y3&Y>\5K43J7GS5*SN)V?'NNXJIAJ>3NY6]4FMY-9)'?!S% M96BBF:B\)Q+:6*&%45W^K69R(B\JO4@ C_9MU!K//:=R?QNCR*L@DKMISY;% M)C;#E6M&ZQ'W*1Q_"E_R.#_JV_\ T/. )-LW M^%#?C]+JG^ 8DK))MF_PH;\?I=4_P#$@5DQ^H,E8P^%NW:F,LYFU!$KXL?4= M&V6P[Z&-61S6(JK]+G(B?C,@ .T_%%,DMF ME0;6EL]#"[^:]UGFZ>A<17TYC]=5K>6KY7(7 M*MB?'-92="U'Q0MF9)]V\IA5$=(O0G5]_P )SLSNSK=QVCL-3PVI8:^H\'J2 MYJ3&Y*UCED@1]B:PY\$L*2M5S.[LO8JM>U>41R<>@QM#LV:ATW8QVI,#K&A! MN VUDK.1R=[#.FHW/+G1NE8E=MAKHT8L,/1]U=PD?#NKJ7@-3K]K/4F0GT7D M5QN.Q6(OU:\N0K3UY9GSO\JF@O+!.CVM8RJV%97*YCN6N3GI]);-G=R6;C82 MU:GOXU#;'8;Y.=EF.7/5ZN.E<]\O^U_K(TC[=J_K#7MP=R=H=R=#YS2V3W-TS!C\Q4DIS MRU,_3;*UCTX56*YSD1?]Z+_N U'*9>99(N'W&)N5*VZVG M\K8O7)+]S(9+/T5GL3O1K5<[NU8Q.&L8U$:U$X:GT\J!9P8#2VX&E] MI,1J!:W3W_P5?BL]UU<]/5T.7IYZ5XY]/"_B,^ &E9+>W;O#9"S0R&O=, M4;U:1T4]:SF:\A\AC,C,R"#F6W:E@; O>2.VPD:/5Z*Y554[IO'"IZ5YY^B>X M33.QN+R47E>\&)S.GJ3+K,7IN_G\>M+');1S9^[5B-D=YKWL;WCW=#7N1/Y M]2WK?=K3T4.%AU+/JW-ZDT@NH*KV8ZK'-CK$QN,UQG[N+H8J:Z^U9OX_BW=8Y[O)&6611<0=W75DTSU M;&C>\@ZNGJ5#,[93[1[<9QF6FWLQNJ;M7&MPV.?FL_CE\@HM5\/''ZBP.Q.I<7%4L;M8N&9TEYUV]#J/']_D&7%:MF*97(J=+T M9&WEB- .FVN1[4/Y4 RP "3=GS^$K]-< MG_EE9)-V?/X2OTUR?^65D 1+4V_]VMO[I30F#QL%W#6+%BGFLM+U*L-EM1]B M.M#PJ(KT:Q'/5>4:CV)QRJ\6TA5_L?Z-^473.K<38S&(EQ67LYFS39FLA)#; MGF8]'*UBV>B+SW];NEG#DY:J=*J!IV [4>KYZFELW>HZ?OX_6:92/"8'&-E; MD:LU6*66..>1TCFS*_N58]&QQ]V]S4\X\NA.U%E\K6HU<]D=/4Y'WXI+&?EA M?0H1T$@ADL*K9I5XD;/,E5JJ_A7\KQRQS39M&]E]<)NI4UCF+^G[TV/M6KM> MQB]-PX[(79IFO8U]ZQ&]4G6..1[6]+&45ZU>*&2*.JZ'O6J]J=_,]7(]JJ]_/'"< 6&&:.Q"R6)[98I&HYCV M+RUR+XHJ*GI0_9@- Z1@T!H? ::K6)+=?$48:+)YOOY$C8C4E5:G/"HO M'TH!NX)-\#;Z?GAMY]5+W[2'P-OI^>&WGU4O?M("L@DWP-OI^>&WGU4O?M(? M V^GYX;>?52]^T@*R"3? V^GYX;>?52]^TA\#;Z?GAMY]5+W[2 ;4_ADWM_G MC'?X54*R0/3NUV]&F]3ZKSE?6VA)+.HK4%JS'+I:ZK(W15HZ[49QD45$5L35 M7E5\57Z/ V/X&WT_/#;SZJ7OVD!63B_M2:1R>:W%URZ:#5U1U_3=2E@JVF,7 M/:IZ@F:^5[JU]\<;VM:UZM;PYT/W.1Z]:ISQ=_@;?3\\-O/JI>_:0^!M]/SP MV\^JE[]I 0S+8;4*4-6[?V],Y9FJ]1ZUQN=JVJF-GDQ[*J.I222^5HU8F)"E M>5G2YZ.Y1J(B]2O7' W[U4:5OX&WT_/#;SZJ7OVD/@;?3\\-O/JI>_:0&;V2S&H\WH MAUC4J77V6W[452SDZ7D5NS4;*Y()9H.AG=O M3TI8SN:T3F?Y3.6,[C:F7J8J? M(58ULC47EBJU4^JY6H]&RM1>6*K51R([CP5%] $V^ M:5LKZJM(^QX/LCYI6ROJJTC['@^R;ZS7.FY,1C,JW4&+=B\I+'!0NI=C6&W( M]51C(G]72]SE1>$:JJO'@?C46X&E](^5IG=1XG#+4J>7V$R%Z*!8:W6C.^?U M.3ICZU1O4OARO'/($TG[%6PUB9\LFTFDE>]>55,7&G*_[D0\?S)-A/5'I/V9 M'_\ 8LV.R-3+X^M>H68;M*S&V:"S7D22.6-RUR>#FJBHJ*G@O)J]?>30% MO5S]*0:XTW-JADKH'82/+UW76R)]\Q8$?UHY/I3CD#0?F2;">J/2?LR/_P"P M^9)L)ZH])^S(_P#[%N/1DSN-AS4.'?D:C,M- ZS%0=.U)Y(FJC72-CYZE:BN M:BN1.$5R?C C_P R383U1Z3]F1__ &'S)-A/5'I/V9'_ /8MP B/S)-A/5'I M/V9'_P#8_J=B381%1?DCTE_QQD:__P#"V@"(]G/2F&T-K'>O!:>QE7"X6IJN MMY/CZ,2100]>$QCW=#$\&\NE55?I+<2;9W\*6^WZ5T_\!Q160.:ML-A MMN=Q\YN9FM5:(P.H\L[6.0A6[DZ$=B;H8D36-ZG(J\(B<(GH0WSYI6ROJJTC M['@^R.SY_"5^FN3_ ,LK($F^:5LKZJM(^QX/LCYI6ROJJTC['@^R5D\<\\56 M"2::1D,,;5>^21R-:UJ)RJJJ^A$3Z0)5\TK97U5:1]CP?9'S2ME?55I'V/!] MDV_1>ZVB=R)++-):QP&J7UD19VX7*07%B1?0KDC<[IY_E,Y8SN-J9>IBI\A5 MARER.26M2DG:V>=C..MS&*O4Y&]3>51/#J3GT@33YI6ROJJTC['@^R?EO9'V M3:KE3:G2"*Y>55,/!XKQQ_%_D*;1SN-RE[(4J>0JV[F/D;%YJ/: MV1J+RQ5:J.1%XY147T'YJ:@Q>0MY&K5R5.S:QKVQW889VO?5C96HO+%5 MJHY$=QX*B^@";?-*V5]56D?8\'V1\TK97U5:1]CP?9-]9KG34EC@H74NQK#;D>JHQD3^KI>YRHO"-557CP/QJ+<#2^D?*TSNH\3AEJ5/+[" M9"]% L-;K1G?/ZG)TQ]:HWJ7PY7CGD#1?FE;*^JK2/L>#[(^:5LKZJM(^QX/ MLE1QV1J9?'UKU"S#=I68VS06:\B21RQN3EKVN3PAB=+5Z?H\YW#4Y3Q\4/>Q6X6GX.GK^LK69IH8;$4LL* MHV6-CT5T:KZ$C_B!BOB+IK\WL5_4HOLCXBZ:_-[%?U*+[)I>+[3.V^:W M31=/47?9U]J6C%_H-AM2:S&BK)!':6-('RM1%Y8UZN3A?#P4I#,C5E;(YEF% M[8W]V]6R(J-?_%7\2_R 8I=!:9>K4\43T^!MGPG3[J6 M3RN#NXN.\?WB<,Y]'*\^'I3_ .8&,^(NFOS>Q7]2B^R/B+IK\WL5_4HOLG\U M?KC Z!TM?U)J#*08S!T6=Y8N2JJM8G/'"(G*N555$1J(JJJHB(JF"VZWNT9N MIC\I(5[:T+8T[C4&01.55.5\$1/\ @5+XBZ:_-[%?U*+[)H79C_!OE_TS MU7_Y@R!60,'\1=-?F]BOZE%]D?$737YO8K^I1?9.&>T7MU-FMZ]X+-?;S4^6 MUQD:V%;HG4F,PMI8:=ID7#Y$OM:D4+6.Z5?U/3E$5.%]!_=8ZTWTU#K3'<+PT#N7XBZ:_-[ M%?U*+[(^(NFOS>Q7]2B^R$VSC;FMR;5RIJZG8NYG,Z9CH6,8YV- ML>4]RCJS46)LKNCKDB5K7.1&N?X*!V=\1=-?F]BOZE%]D_*:'TRY51,!B55O MI1*47A__ !.=.R)9W&RVKM09?<##Y*MD+&F\5$^]D<.E&2U/'-=:]'/[MG4Y M&)$Y6^AO6BHB=7CS3I;3.O=M<]K'([?:/U.FIW8G*NERMW2MFKE*5AUAKHHY MIT5]7+*_QZ'-8YS6ISRB<@?2/XBZ:_-[%?U*+[(^(NFOS>Q7]2B^R<>PY_?[ M1FJ[]B3):WU9BJF7RU".G+@ZR=_4;B_**\[7LJM17K:7NV/YZ%5$9TJO*+@= MI=4=H?7>5P6#R>8UK@G)NGM):EO\ M8ZW4TYJ!=>YK-/S>4BEB6E_^(]RMQ7,=6:^.-+,;HNEZM:KD>CGL:J>#4T;9 M_$;DX'3L6 T3BLUHW 7]7I'-G<%I:?%):IKCI7/F;CKK9DIHDS(F*]K6L>]> M43E?$.[OB+IK\WL5_4HOLCXBZ:_-[%?U*+[)P[5U_P!H;!:#E?F)-=9.YE<+ MA+,EEF"9#+B[Q(99$Z^41.KE-9QN!WLJ]ST2)J(K84CD0P4.G]+Y?3^2C9+:2/2KI,Y1MHV>)&Q MRN3&J[O%C655C>UO45T&IK-:A7T]75C'4[ M#?@R)G545RI,USO2JND:GFK](';7Q%TU^;V*_J47V1\1=-?F]BOZE%]DY);K M[?6WN@M=B:GBR,F0=$F%7 M;A&X=:'6EI+:P_P#*?*/#H6;GJ\U8^#"XG=/? MK66(Q<%.+6F(F6CIBG?NS:56!\=R2V^/*R,2:MTNZ6=*N=TK&U$1R>'BH=H? M$737YO8K^I1?9'Q%TU^;V*_J47V3DW86/=!_:3P]G7>3UG8Q\.(S.+K27\7W M5.UW.1'NUIR0*E%K%[Q.\5J)-.KD7SNE>$ [?\ B+IK\WL5_4HOLCXB MZ:_-[%?U*+[)QUJ;4.^&"MW\%D,RM7#0QV:E^%T,\3T1>6O M8Y$5J_R*@%!^(NFOS>Q7]2B^R3O8FA6QFO=]:U.O%4KLUG7Z88&(QC>IBL@223LG;)Q,<]^UFCV,:BJYSL1 B(GXU\TUK1FS79DW&?>;I32VVNIG47 M]W;;AX*5I:[O'A']WSTKX+Z?Q*4K>[160W(V?UGI;$W&X_)YC$V:5:R]51K) M'QJUO*IXHG*\+Q]"J*?8Q>8JQY;+5X;#7 M6JU:Q ]&PQ.B:Y&.>^-_4[_9]*!#[(^:5LKZJM(^QX/LG.^ M.V:W2FL8[(9V?5N"T1BF:@R53%S:I>ZW2CX@?CH+;X[#G3JCF3N1O7*UJ*C7 M.^@TO:G0V].KMJ,;F\7!K+XOY+$8&QE*-W5B27L^YLBONRTIG656LDD"L;PY M\*KQT\-XY Z\^:5LKZJM(^QX/LG@L]EC8VEW7E&V6C(.^D2*/O<57;UO7T-3 MEOBJ_B0@6 V1WFM6,/!XK__ &GZ^:5LKZJM(^QX M/LD4[,>VO: TGA]1_"^73$YB:*FSG5Z2Y:K/::Z1;5B)L>2>]$>BL1%1T+?! M/N*<*2/':4WSW(9K.[H.WJ>ME(/@'8_S2ME?55I'V/!]D\%[LL;&8RE8N7-LM&5*E>-TLUB?%5V1 MQ,:G+G.$1$1555\$X.:J.P.]F/CHZ@EIT$U&^G/5L/BK_! MT4CF9"9[T[UDSV]4\B-YXRSL9E*->[2VRT9;IV(VS0V(,57?'*QR MI]IM\(]4:=5(=1+D8*^GV4LQ7 MU&QF-QE>&NQN3KVJR3IWTLCT?P](Y$=U-7K;TF^=E?:?I< MTA S+?"V?=D6IF&VG\]+732=*I"K4YC1&*B)XJH%)^:5LKZJM(^QX/LCYI6R MOJJTC['@^R5D 0S8?16!V]W=W=PFFMR,;PB*O M2G*IZ>$+F2;;C\/>\/\ W/\ W5Q60 2;M;?O7-V_P!%-NOKR5IX M[4<^9YS%:O4URIXIXG+&D-Y-34-%:YM0:\O9; X34NFKDF8P^IKFAK53THJ@?2X'SMR>]VHM2[M:DRFG-<96_HRY/B935O:7T=K+9/8JM\L3J:IDL7 M7UAD,1J62I;@8^C,KTLSQR(]O,C/'J7QO:8U-G\_ M07 Z>PT6:SV/ED^[8N;(-5^5A1.>F;R=Z,DD1.IJL>O/AX!]/ BM@LO9UHOF->I0) M-VB?^;M _IKAO[PA623=HG_F[0/Z:X;^\(5D M )-V2?WK6T?Z*8S^ZQE"U?1GRFD\U2JL[VS8HSPQ,Y1.I[HW(B[3/TZFCL94EHVF69 MLEE;&'M9CR-(VM6-'5:LC)DC)N6%[?FC)LUA ML'=@\NOV*55]K(8:U#)32U/56RR.%DCV6'QJU..\[KI:KV-_3[<^GD MTSC. ,!GML- MRH.S%LSCGZ;NZDUII?.8K*97%MR57RA[8'O=)Q-+,V)SN%3_ -)X\F![0>T^ MYO:'M7+CM$YS 8Z? U*K<-9S]6)[;<>7BE>KEKVE8J^3H]R+U*G@B??(B% T MOVO95^3VYI:[F6?)I4BG^YLE=+#PY?-[UC.M$56\\ M 3S9+:W=[3':3S.2U#;S"Z39-D$;8L9!UFG1]3>9G1M=Y=WW3U*UO/3 MST\M]):J/:CI%B=T]3.IG**N/39OM"9'0E*".EF,9D(<%?H0K#J'N[*.?DZDD M"O62[,Z.1:[)UX2:1&(G2C_%&G6G:-W*R>T&RVIM7X>O4M9+&11/ABO,I&N:J^#E]"IX\&L;Z=H^79+5&A:EG3TV1P>9AR%O)Y&"6-'4X:M99GJ MUCGM5R\>*^GP143E51 .?-S-BM\ZE*SBM-6-36M-P:CRTM""+4+YKC():M9* M4ZROOP/6..=+*],DKNE7=2Q/3A#*8O:C?:AO'J:S))J._C\CB+==^7FS;88X MY'4VMA6FC;;F-NY\;CL+O[F-Y-=:SQU[2]C2N-Q6.P]^C M7R'=KKY'1321JU6Q1JU$X8['29>\ZQ;F9W34D<]OEEML?GHO'3*B.\7=#.>#HH "3;._A2WV_2NG_@. M**R2;9W\*6^WZ5T_\!Q160)-V?/X2OTUR?\ EE9)-V?/X2OTUR?^6>AO+N;K M'';E:.V[T)\"4<[GZEW)2974->6S6@@K=VBL;%%)&Y[W.E;_ +:(U$5>%] % MH,1J^C/E-)YJE59WMFQ1GAB9RB=3W1N1$Y7P3Q5/2>/P-O7 M>G]/895U-IZ%9H)KT]>U4G2.Y#7F1[:]A9(G)WR*UK^ARIXJB>A0ENG=C=WZ MVCM,SXS;)^C]0:1T)9T_(Y^:J1V,[:E[AJ-CDIV.IK6)'(]'/DCTI'J&_5LZ=S]7!U)\G4^,#V5UK334:JVIF,8DJR^,**K55B(J M\)^/@)IKC:C>B?5V:OY>CF=4:;LYV&S=QFC\XF(DOQIBF1-DK]5MKH8F6T5R MQNE1?0[A_'BQ/9_W/Q^Y-C6%6CF\;=M:EQ$LT?QG25DF-;BVPVUG:DK63N25 MJ-5SV=;E:CFIQXFXY3M_::P-9T>7T9J##9A_D#JV-R-G'P>41VX9YXY$F=9[ MIB)%7>JH][5ZG-:B*IX-==N>N_"T;.@--7\RV1<'+ MZ3B:69L3G<*G_I/'DP/:#VGW-[0]JY<=HG.8#'3X&I5;AK.?JQ/;;CR\4KU< MM>TK%7R='N1>I4\$3[Y$0KFZVZ>OG[NQ[>;>NTUC;]73S]1W>%[$F[ MJ."-L4L:MY5%5TBJJ-3CS5/6=VN,=A\W3Q&5P%RTVO+C*&WGTKP&D[);6[O:8[2>9R6H;>872;)L@C;%C(.LT[ ME-W0E&)C7W7JU\2-7E?)HU\']3Y.ODZV/XJ\(JG-3>U'J*EV0+>[DVG:F5SD M$L\?P;2=W$'#;SJS7+WCU7A&HBJG5RJ^CCZ Z6!SA@>UE>UGN]HO2V)TA>Q^ M$R>7R.&R&7RG7,YJ%F0OT)7V),4Q8\%Y-(MF1:SN[:Z M9BJQ58Y%56(O"KX=\ #A[$]@K4M*K0L7+^GL2N8UT;FQL5%YL !S'HC8;=?1-&70^/U#IFEH".YE+<&8C MCFDS+VVN^>R-8W,2.-TMD57(Q$Z4Y4F& ["6JGXF"AD*6C,-1B7 UKN M,Q<\TM;--HV^^L7K*.KM^[RL56HQ4=SRJ.D5#NLCW:"W$S&@,QM6S&9)F-J9 MG5M?&9)9(XW-EJN@GIO"^'I YLU+V#=:H[3B8!-*128C*9&: MD^:=5KX^M-D?*HFMK2TY6.1K/#IB6!S7(G$JM,UGNQYN7F[&=QWE>EH\.Y=5 MOH7'7K'E$[\NQ>[[V)*ZMC2-R\.X>]53Q1/H7;MX>U3JS;/>;,8K'XO"9[2\ M>$QLE%'7W0N==N7UJL?+(D3T;&UW/5PJ\(G/BKN&[YV7-TM0[BX?6:ZPN4/A MJCJW)XNO4I3,DCB@@6-$CC>C(UE:U7+Y[F]7BG4!&L#V*=4X3<2QEJ\.E*E) M^6DR;KM>:1MF=),,^DZ)S$KI][.Y9$57KRDKUX1W@[0-9]CS-;-Z6TYE(L%A M<[C:-?3L&8P&,Q]N[7RUNHMA+$MN&"L^1\2]\QR2)%(_EB=3$3Q/HH .2=M= MA\]K;L/Z?T<^!FD=1PY"7,4JN0J2Q0PR,RTMNO'+"Y$D;&YO0BM5$*U(U MSYIO"Y./"ULFW)W MTHNN9.^ZACZ/F.>DEFPV&58VJK>E/,X5RIRJ>DTO!=N/3WPUBJ6J,)9T]7O8 M2CEOA"E,N6K0NLVI*[6/FJQOC;%U,:J3*]$=WC4X:J*5K=C:=-T:V*6'5&>T MCDL7.^>MD,#/$UR];%8]DDE>&M;Z0-EN=K?;''Y/-TK.;M0IB M8[DDMQ^,LI5G6HG-MD$_=]$[XD^^;&KE3A?!>%X_FU/:CTSO'N'D]+X#&9V- ME/%095N2R.*L5(9XY7O:WI[UC53GHY:KN.M%7IYZ5XUW*=B71V9FR\-O/ZCD MPEQN46GADGKI7QYZU5S71=7>-5SO0Y&KS][RBRUL<2\11H[ESE^]16JO'4U#,9SMB;7X#.W\3 M/ELC9LT7U8IY*&%N6H4DLI&M>-LD<3FO?(DK%:UJJJ^/AX*:?JKL!:"U5DKM MMV6R]*.?(6+\%2.O0F@II8BCBL11,FJR(C'I%&J*O+F*Q%8YOCSNR]E71Z.O M=U:RM>.WG,7GUBBEB1DTWH#>/.IA M]-7[\F06I)=9'>Q-JFDD<>$YY1R^(&>?VL=MFY?4U!N5O2IIRM M-:R5V+$VGU(FQ1I+*U)DCZ'/:QR+THO*^A.513]:H[5VV^D998;V5O2VF6JE M)*U+%6K,TD]FNMB"-C(XW*Y71M5?!/#T+PII^4["VALYK/)ZAR&6S=F2_C;. M+=73R2-6Q3UTKOYG972=Z(Q.6QR2.8UW*HU/0F4TEV/=.:8S^/SEG5&IL_F* M>4IY9+62FJIWDM:G)4B:YL5=B(Q(I%Y1$155J+SZ>0]ZYVQ=L,9.W@[L;I&/L-K-?"U8N96]\YK.6(OIY]'B?M_:_P!M$Q=&XR]EYY+5 MFU67'P8&[)=KNK.:VRZ:ND2R1-C5[.ISVHGG)Z32<3^Y]: Q64R5],[J.::] M(U[^74FKPV_'>:CGMK(^5>]B1.N5SW]"JWJ\&JW9LCV0< [.39O"ZNU5I?.3 MY#(W9LEBK-=LSF7G1NL5T5\#D:SF)BMGOXX9W,2.1\?6WK:URJWG^1>-5P?:!U7K'7F2J:8VX=F MM$XK/.T[>SR9F.*TR=G"33,J.CX=#&Y>%7O4V&:QQW\B3)"EA_5PO@^5S6]3N$3D]B3LLZ<^/\VI*VH-3 MT*-C+MS]G3-/(MCQ5C((B?=WL2/O.55$U5Z2^QV5RM%U& M"]/8^$,#>K=VM-O5:BYDA3F6-BHY8T\[A47CQ,%>["FBLI')4N:AU-/AX73N MQ.+6Q72'$=_:99G2!>XZW=;XT3[JZ3I:JHWCGD_NYW8TPVIM+ZH3!Y2]'J'( M?#UNI\(6&)4;:RE=(94DZ(5?W;>EJMXY*K55L*>:Y/O\ PY7_ &>D#?- ;YZ,W/OU:6FLJ[(V+&+3 M,-8E:5G1769T**]7-3H=WC'MZ'<.\QWAX&_'-.S?9EU%M]#J[*IDJNFM0ZFU M7%F9H1,?+"Q7-?USJY$8Q$69>%\/'I8 2;9?\(^_'Z9UO\ MR_ARLDFV7_"/OQ^F=;_R_AP*R )-V5/P!Z7_P#BO[U,4;4^3EPNF\MD(6L? M-4J2V&-D15:KFL5R(O''ARA.>RI^ /2__P 5_>IBHY"C!E*%FE:9WM:Q$Z&5 MG*IU,&O'*[JQC;[ED MEEM=V].E7>5\?"G8OLT[:X3*U,C0TRRK;J3,L0.CMV$;&]M/R)JH MSO.GA*_F<<)Z6+[*>V.#RF'O8[ 6*3\76AJ0P0Y6XE>2.%'-A[^+O> MB=T:/>C72HYR<^GT 3;&?N@6C\IMOJ'6$>F\RR##7*U.6DZS169BS.I+UJKN M\Z^KE5\?$" X;]T&Q&E=(8^36S*^8S\EF\VRW 0.QO<5JSHT>^:KD)(Y8YT[ MUO\ HS5D>OBK5V;IROJG)49]-9^OIS&YF#!6]62MKMQ\5F:)LD?/W7 MO.E4>Q%=T<(KVH9MO8\VK90I5F8.^R2M//8=>9G+S;EITRL69+%A)N\G:_NX M^ILCG-7H3P\#8\OL)M[J/3>L=-7\!#Z1JQUN\ M\49TM7Q5RKPF;S_;7TII37&GM*9K YK$Y;)14Y+E>ZZK'+C76I710LDB6?KE M7K:O4L+9$:WARKPIN^I>S3MUJN2>:Y@9(;BS(]>7*OT@:MN;NUN'8W:S&B-O5TKC9-/X"+/Y"[JR.=\=GO))&QPL6 M*1G=-1(G*Z5W6C>4\U?$]F'M88B'6573]O 9%]=N1IX*_J.A)#-C*V4LPMEC MKM57MFD:J/:G>I%T\N;SQRO&W[G]GC;[>3(UK^K=/IDKE>!U5)X;EBJ^2!R] M2PRK#(SO8E7Q[N3J;Z?#Q/6E[-&W,FM*^J$T^L.2@DAF9!!=L14N^BC[J&9: MK9$A65D?FMD5G4U..%\$X"H TK1&U>-T!F[UW%V[ZU9Z-6A%2M79[+(60+(J M.ZI7O51K>>>.3=0)-MQ^'O>'_N?^ZN*R2;;C\/>\/\ W/\ W5Q6 M0 2;M;?O7-V_P!%F=AK&CX] M209&1FI\LS#U9J,+'L@E>CCPYY23:=_<\*V(JXW%V-P\D[ U\A5RUF M#&U%IVK-NO1;7CE\H25RM^Z)),OFJO+T3GS>I0K-[M;[?8_46WN(FMVD?KO% M29;"VTC9W$C&,:_NG.Z^6R.1W#6\*BJBIRB\<^I:[8V@:-?:V:RS*P-W$1C\ M8CJ[%6HQRL:U]KB14C:KY(V(J*[SG(G\I.8?W/?&RX"' 9'6EO(X7'8W)8W" M==+IMXUMBU%:KR)/WJ]3Z\D7@J-;U([CS>/'TIOW.FKFM-LQV\[V6+O7]]U3HR7I5S>.AJG>I+(K4>Q7]U&_I1RB MM5W:^#OV,;?R[8Z*4V20LZI%1'6DE5O''CW?T^CTD\U]V&LQK:++8[Y0:D.$ MSU^OF5X53W\3V*+6#W)U-J:MG-& MV69S)VL@ZQD=#,L9BJV>/H=%%D/*T;T]7//T"CV[M+V]NLKKN;0VM*.D\? M0^$%R,\-!4FC[UL:(QC+CG]2J_GAS6^"+X\\(NG;=?N<]+;W6&%S\.N)+DF, MFQTT==V+Z6)Y/3DKS(W[LO3WSWME7T\*SCSN>I/SI+]S]MZ8V^R>D$U-HQE6 M[2;3?F,;H%E3+2HVQ',BSVDN.69%6/A45$Y\%Y\.%"FZA[9>D<5IW/9[$X'4 M>K\1A,=2R]VW@H:SV,J6H9963)WL\:JC6PN1R>E%5$1%\>-KL]H#$8C9U^XN M?P&>TWCO,2+%9"O"_(3ND>UD+8XX99&N=(Y[4:G7_M>/!.\-V*,9IC"[WX;" MZCEI8GHC.E>KA>.=ZVFW@Q>[=++K M5QV3P.6PUQC'O8Y'-:BS6'R?P(V/'459"Z%8$I=\JJR1CW]:][U*JHJ*G'!E-&;):VV] MJ:GS=;6U/+:TU%7LNPB,@LR-J=S5@@B6?[BR-6QKRY[U=PJ*J=7*!F^T M3_S=H']-<-_>$*R17>=N29H[:UN:?#+F$U9@4NOK)Q$Z?OF]XK$^AO5SQ_(6 MH )-V2?WK6T?Z*8S^ZQE9)-V2?WK6T?Z*8 MS^ZQE9 $^W2V(T;O'-C;&I:%M]W'-ECJWL;DK./LQQR(B2Q][7D8Y6/1$1S% M547CT%! $DH]E3;#%9:M?H:=DQZUZL=1M.IDK4-1[(X5@C<^NV5(WR-BP6@;^,T-C[.G(;%31$L4^GV2S2N6B^-G0Q4 M.1'.5C&\KZ2=ZDT)K_)4=SM*8.GBI*^HLA;=8MY>6:#FO;J11Q30R,C>CUB< MR1CHE1%5&M\YOAS.=WNS%K>6SJK4E6'#9%B4\FR.&@W_ $R]#+1=!#$K&5.] M<]'(SE'6'M7I16M:J(@'0&0[-^V&2W 9KJUINO)J#RMEU9_*YTK26FITLG=6 M23N'S(G@DCF*Y./28VEV9MK=(MS=VIAKD"35I&21P9:\]:D'>I8DBJ,;*JUV MND1'*R!&HY>$X5/ D6K^R;J_5.'NUZ6/T;@:5];#VX.L]'UL?(^K# R6)TU" M1.IRQO>]&Q1/Y;VD]24M8W8L3-F:68CR5N_5;)+ &^X_:/26MMJLMIW)6+&JM*:HL39.7O+D[.\CGE M[]K8Y&O21C&^;T\.3CCPX3P3&M[)NVGDN/K2XS+7HJ-B6S!\(ZCR5QR++%W, MK%=-8>KHGQ^:Z)5Z'?2TV78S3U_2VTVF\;DXG5[S*[I)*[O3!WCW2)$O_L(] M&?\ NF]@2W1?9EV]V^D=+A,9D:\[IJ4[YIL[?GD>M1)$JM*K0AU9B'9!U"1TE2S7MST[%=7-Z7]$T#V2-1R>#D1W M"IZ44USL^?PE?IKD_P#+*R!+7=F';!<7+C6:4A@H2XVKB'5Z]F>)GDM>=9X8 MT1LB<=,JJY7)YSE5>I50Q#^QSM+-6%C9IV6)6Q1]] MT1-=-&UZHQ&^//XU+2 )+F.RMMGFUB=-@K->1ERW=66EEKE:21]J1)++'OCE M:KXI'HBK$Y59X)PU#ULQLGMI:R>0PM;'1U<\],AG>ISIK#*\MV!U2>=\;G+& MY'L5S4B=YJ]+NEJ<*J6,C&>Q6M\-NCJV[IG'8_(R9>GCI(_A:26"N^&%)XYX M&SL8_NI$=)'(WEKD/%#7<5V?]I-:9'&:LQN"\*JPQ1UZMNS6J M+)358H>^J->V-\D"M1WY9Y^Z>L**Q'PO:Q$:B6FS+Y^]DJU6=B ML?' ^3ABJU?%JOZ%DX7_ -8![FD=J<;HG43LCC;=]*K<5!B8:%F[/88QDK(7659&[K3J1S&HJ+Z%0M@ D6.[*6VF+U&F=KX?()DT6=[979R^YK))ZZUI MYFL6?I262)RH^5$ZW+PY5ZD1Q4L5C*^%Q=/'5$>VK4A97B265TKT8UJ-;R]Z MJYR$GBY55?2JJI[8 DV@/WP^[7_ &+!_P!G9*R2;0'[X?=K_L6#_L[)60)- MVH_P02?S]@/\8IE9)-VH_P $$G\_8#_&*960 #":LU93TA0K6+3)9GVK M<-&M7@1%DFFE>C6M;RJ)]*N557P1KE^@TCX^-P-W&8/R.W*N MK*U:6CWECODA[OON4[SB*1/0B^/ASRIE]V-+9#4-?3-[%L6:YA,W7R/<-LXO!5L7MM++9QZU:&-@KT?NM M.=5E[N*-$X=&]>7\-3AR\K^,]_3&:V(TE27):=M;?X>KAY70>5XMU*%E.2PB M(YO6SCH67NFHOBG7W:>GI$QHGLJZEP5J]IZSJ2!FEH6XB1MY,:CK=Z6H^25 MJL>L[NZ1KU8CD>Q_4G/"IRJF;T?V3K^G\W5R>3UL[,S02XJ3B2G87J\BDE>G M"S6Y>CK69?-9TL;QYK$YX L6&W(P6H<[4QV-N1WF7L>N3HWZLK):UR%K^B3N MWMTKKG3[EF\HQ6"IY61ESH2/OY[]Q)N[1B.< MJ)&UG"JO@JN:J?2B5\ DV*_?7:H_0K$_P!^R)6238K]]=JC]"L3_?LB M5D )-V8_P;Y?\ 3/5?_F#(%9)-V8_P;Y?],]5_^8,@5D 03MAP MY!NDM"9&CALOG(\3K3%9&W7P>.FOV&5XWN61Z0PM<]R(GXD^DO9J6Z.L9]#Z M1DO4XHYLC8M5L?29,BK'W]B9D,:O1%15:BO1RHBHJHB@F1L:2D@NP.=FH6V&JVS75R<0*]_2Y.GI3KXX3DT?5B[^2:1U M3B\A+J[6%*[C=2T6T9(I9%>VPK96HJ]2=TKU5O/"VPZ1JHZ5. M$XY9QXI=IBL@ &'UE/+5TAG)H9'0S1T9 MWLD8Y4/TKNUC$UQ0EP3=2V[5E+MFO#)8CBG M=9596N:G4Y.MSG)RG*;&+@99N-:QRI"QZ.5O*HG'*H MQR]*>/'"\>*<^7$9S&:GP=#)4IX[6.R-6.Y7>YJM[V%[4]6-[Q MKG-9PCW<"U/9K6ZCL=>DEL/?'%W;GS,= QK M5?\ ?>:]_'H\?251LL#6.E:^-&<^<]%3CGT>*_\ R/Y+:CA9(JNZE8U7*QB= M3N$3GP1/%5]'A_*!Y@>A@LY1U+AJ65QMAMJA^ 2;;C\/>\/\ W/\ W5Q623;N; MM_HKD_[M(5DDW:V_>N;M_HKD_P"[2 5D .2NSI'BL[H34&TVN=!:EE=< MSN9M319S2UUF+GA=>EFB7RF2)(7(Y.AS?.\5XX.D&:R;8W"FTM7K]ZZIC6Y" MY95_'==Y(YD+$;QXJ[NY55>4X1B>GJ\-+TUVD=-93!8"[E8KN(L9=6-2..E9 MM5Z[I)W00MELLB[MBO>SA.I6^E/]X'%&G>SQIO16A-A+6I]FLMD<EO0YR)X>**=;=D-<[IG:W!:4U)B<[C[[(K=^FS) MUI7)4H.MR)5K2SKRU)FQ*S[DKNI&IX^@VS$]H_0NM%:KHTSAS7( MO"K31'U[ MM?LD"L@DWQKWN]6FB/KW:_9(^->]WJTT1]>[7[) K()-\:][O5IHCZ]VOV2/ MC7O=ZM-$?7NU^R0*R"3?&O>[U::(^O=K]DCXU[W>K31'U[M?LD"L@DWQKWN] M6FB/KW:_9(^->]WJTT1]>[7[) K()-\:][O5IHCZ]VOV2/C7O=ZM-$?7NU^R M0*R"3?&O>[U::(^O=K]DCXU[W>K31'U[M?LD"L@DWQKWN]6FB/KW:_9(^->] MWJTT1]>[7[) ;._A2WV_2NG_ (#BBLDPV6TGJO"97<'.ZOHXG%9'4^K31'U[M M?LD?&O>[U::(^O=K]D@5D$F^->]WJTT1]>[7[)'QKWN]6FB/KW:_9(%9!)OC M7O=ZM-$?7NU^R1\:][O5IHCZ]VOV2!602;XU[W>K31'U[M?LD?&O>[U::(^O M=K]D@5D$F^->]WJTT1]>[7[)'QKWN]6FB/KW:_9(#0'[X?=K_L6#_L[)625; M2Z5UE5UUKC5>L<9AL+/G&4(*]##967(M8VNR5%<^22M!PKEE\$1J^CTE5 DW M:C_!!)_/V _QBF5DT?>G0-_ MQ7-?5^][Z/@S?3\X]O/ MJ_>]] K()-\&;Z?G'MY]7[WOH^#-]/SCV\^K][WT"L@DWP9OI^<>WGU?O>^C MX,WT_./;SZOWO?0*R"3?!F^GYQ[>?5^][Z/@S?3\X]O/J_>]] K()-\&;Z?G M'MY]7[WOH^#-]/SCV\^K][WT"L@DWP9OI^<>WGU?O>^CX,WT_./;SZOWO?0* MR"3?!F^GYQ[>?5^][Z/@S?3\X]O/J_>]] 8K]]=JC]"L3_?LB5DENW>WFL<= MN3G=9:RS>#R-R]B:>(@K8+'358XXX)K$JOWGU?O>^@5D$F^#-]/SCV\^K][WT?!F M^GYQ[>?5^][Z!602;X,WT_./;SZOWO?1\&;Z?G'MY]7[WOH%9!)O@S?3\X]O M/J_>]]'P9OI^<>WGU?O>^@5DUO<'1L>O-+6,4ZPM.?O8;56TC.ON+$,C98G] M/*]]'P9OI^<>WGU?O>^@>X[LY:#GGRL M\^*LR2Y-W>3<9.VUL#UL)9BUU8F35EYV, M=5GBGQC\G<]\&;Z?G'MY]7[WOH^#- M]/SCV\^K][WT#W8^S=M['>;:3"V'/8^22*-^5N.AA5]AEEZ1Q++T1HLT3'JU MB(G+?1PJH91FT^+KZRQF:K?Z/7I6;F2\C3J=WMZRU&/G5SG+QPSO&HU$1/NB MKX<&O?!F^GYQ[>?5^][Z/@S?3\X]O/J_>]] K()-\&;Z?G'MY]7[WOH^#-]/ MSCV\^K][WT"L@DWP9OI^<>WGU?O>^CX,WT_./;SZOWO?0*R"3?!F^GYQ[>?5 M^][Z/@S?3\X]O/J_>]] K()-\&;Z?G'MY]7[WOH^#-]/SCV\^K][WT"LDFV7 M_"/OQ^F=;_R_AQ\&;Z?G'MY]7[WOIE=GMO\ /Z*FUIDM3Y7&Y7-:GS;E_\ XK^]3%9.?]ML M5O/M;HZGI>KHC1>:JX^2=L-^36-JL^=CYGO:YT28Q_0O#TY3J=_O4V?XU[W> MK31'U[M?LD"L@DWQKWN]6FB/KW:_9(^->]WJTT1]>[7[) K()-\:][O5IHCZ M]VOV2/C7O=ZM-$?7NU^R0,->P&N\;G]QZNG,?C;LV8R45[KS,LU>&>G)0;7Z M8YV,>C9(Y8>5:K'KE:B6&L5%1%CYY]WJTT1]>[7[)'QKWN]6FB/KW:_9($/P M_9>ICDM:?8O+'.AJS,=9?W]&5C;#G3-1S70/7ICX[WJX M5-GVZ[+.6T4F!R^57!V=08F]BIWY2OWDECR6KCTK3Q,>L2.\]R*J,3A%1?'A M? I/QKWN]6FB/KW:_9(^->]WJTT1]>[7[) S6Q6#O8#;2A#D8)*EBS8MWTJ2 MIP^M'/9EF9$Y/H5K9&HJ?0J*AOY)OC7O=ZM-$?7NU^R1\:][O5IHCZ]VOV2! M602;XU[W>K31'U[M?LD?&O>[U::(^O=K]D@5D$F^->]WJTT1]>[7[)'QKWN] M6FB/KW:_9(#;C\/>\/\ W/\ W5Q626;0Z5UA1UCKK5&L,;A\-:S\E)(*&'RD MN09&R"%8U#QN;M_HKD_[M(5DDW:V_>N M;M_HKD_[M(!60 $RU;M+>S^N[N9QVH+VGH\A1JPS6\9*UEF*>K,^2%4:] MCXY(W-FE:]CT5%1&^"^E-3L]CC1UF?!3/RF9>_#QTVUUD\DE=UUIUG:]'OKN M?$KWJJO2)S&N^E/!"\@#G?3O9!IV-#X7&ZMU+E-DBR+ MR.2MTRQ.=TJJ3LD7S&<*G2ALF![+&D]/:;GPE:_EUIRTXZ2JZ2!JMC9=DN-Z M4;$C47O)7)X)QTHB(B*G)9 !J&WFCK.EUU'=OR1/R.ED43$ M543GB**/E>/ONKZ#;P DW:)_YNT#^FN&_O"%9)-VB?^;M _IKAO[PA60 M M M &(U?I/%Z\TIF--YRLM MS#9>G+0NUTD=&LL,C%8]O4Q4L,UE\;E:OBG4U>%*H M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M 3[;R_K&?7 MNX=34DB38BM>K_ ;XZ"UXDKO@:YS6O5565R.Y1SN>.KE$1J>!D-UM:Y7;W1M M_4&,P#=0MQ\,MJU76ZVJK(8XW/K&)T_P"MY553I:C?%?$H./W9T?EM72:8IY^I M8SC%TWH&:_GH)LI)6AQ-J"JEI]:1\=QTM=+#75U8U5E; MW:JY5;Z$:KOO>%7:=0[LZ1TK@<1FLEG:T.,R[FLQUB/JF2VYT:R-2)&(JO56 M-541$\>/ #;0:)8WUT!6DP[7ZJQRIEHHYZCV2*]CHY'=$;W.1%2-KG^:BO5J M*Y%1/%.# 6NU'M[!GL9C8\N^Q%=DNQOR4=>1*=5:K%=-WLJM1J(G"HJIRB*B M\JG %:!-'=H314U:O;IYFM/2\JDK6Y)E? ^KT59+*N=&]B.7[G&KD\$Y;XHJ M\'C3M&Z%MQ5[./S]*[26=T=J=9'1K Q*TME)$:YO+VK'"YR*G@J(JHJ\ 4\$ MYK]HC;FUB9LE#JNG)5BGCKKTMD61SY&J^/HCZ>MZ.8USDKH+4V:P.9OUL?3M8N!TZ2.FE[IK^$3GI1>>5_D\.55.0H8-2TY MNSI#5VH;6"P^?J7\K6217UXG+YR,=T2*QRIQ(C'>:[H5>E?!>%-3DWNRU_,Y M1=/Z&OZATWB,FN)O92M:C;.LS7-;,L%94ZI61.=PY>IJ^:[I1W'B%9!/KV_^ MW>,MY:M:U9CX)<4R62VKW+T,2)427AW'2]8U5$>C556\^=P,-O\ [?9_.Q8: MEJ:L_)R/;$VO+')$J2.C[QK%5[41KW,\Y&KPJHBJB+PH%!!-OG'[:K2M6TU? M1?!7DBC3UM3]I?;[2]'-329ORVSBZ M<]N2E4A>Z67N8^\DBCY1&NE:WA7,YZF^ER(B+P%2!HF(WOT5F,OC,1%G(8LO MD(HI(J4['L>CI(^\9$Y51$;*K/.2-RHY4\43@]G5N\6C-"9V##Y_4%7%Y*:% MMAL$R.\(G/5B2.5$5&,ZTZ5E>KGCQ I )I:[0VA\3/?;E=08^E%!82&&1DZS+,SN(IW2\, M:JM8ULS%5R^:B*U5:O M4G*'LM[0NW;\1)DFZIJOK,LI45K62+,LJL[Q&MBZ>MW,?GHJ-5%;YW/'B!1 M:)%OIH"?+5L=%JO'26+$+9XGLEYAC5=U*WQXX\3(:4W2 MTQKK&9"]I_*,RT5!$=.R"-Z2M16=;5Z'(CE1S?%J\<.3T*H&U@BNV7:6J:]Q M\N:N8NKA]+)1?D$S468@MQ5&,5.8KJ-X\FFX7GH57)YKDZN4X-ED[0NWD6-J MWG:F@2&S:?2BC2&59EG:SO'1K%T=:.1BH_A6IYOG>CQ HH-#O[T:7KW,#7JY M6G;=E_)YHE[[H1*\[)713E>4X\5"D@]# Y_':IPU/+8B[!D<9OJK M-ZD5RLX21K7*B->YBJB.:U55JKPY$ VX&BY+?+0>'RN6QMW4U.M;Q4,T]QLG M4C8FQ,1\J=?'2YS&JCG-:JN:B\JB&LY_M/Z0HUZD^(MPYN"5+??2ME6!M98* MKK/,B/;U(U[&HK7<<*BHY.4 L -#T;O1IS66(U3E(Y9<9C]-WIZ-^SDHU@B8 ML+4<^1'.X16<*OC_ ">/!ZCNT5MRS%_"#]3UV5_*TH]#X96S=^L2RMC[I6=? M+HT5S?-\Y/%.0*.":U.TCMG?HSW*VLUN0@;:KO:KG-6%TBQ=XY4148U)&JQ5=PC7 M>"\*!10:9C-Y-%9G6*Z5HZAJ6L_US1I3CZE5SHO]YDXX9:B12*]DB3-ZH4[Q$Z6ND3Q:URHKOH13VM4;M: M/T7G*N'S>?J8[)648YD$JKRUKW]#'/5$5(T<[S6J]41R^"V)H+( M9.K#1%;TJJ-Y7KZU\UJ??*B\HF]S[WZ$K9C(X MN34]%MW'Q336&=2JUJ1,[R5$?QTN*H@&\@U'Y6=)?$N+5BYJ) MNGIGMCANNC>U)G.=TL;&U6]3U"%U?& MUY)7O26PVNDD?F\21MD=PY[%E410K8-"EWXV_@O9.G+JJA#/C62264D MB*QR?2CD1?%/#Q V@$?SO:8TW%Z/ST8J]73X\<&6L;C4Z^E-,YUZ0)7SDM**+FPB,1;'3T]+N/.^^\/! M.?Y -O!'P\-?.09**]?\ADFK*Y>ZYAFD9*UO3S*QZP.8U8TW6R5./&5\K%:K3H_O8IEE1J]/'@GW)?'GT\IPG &X MGF+WDHY+:C3FNG55IT\RE)65YY>'1^42,8U.41>IR*].$1/%?#Z36=N^U7H[ M6F)K7,E;BTW)>N2P4JMQTG>/A;+W,ELM/7QRY#&V,C'>MV60Q)W4D3%C\Y4Y\_P#NJ:]IWM-:&RNG ML7D\EF*N#7(RV&003R]Y]SBLOK]\YS45&1N[AOG(G/(%8!$\_P!J_2&F M-%9#.9&1*]ZO->BAQ"R]G#5=PBJJ-Y53/6^T5H;!V;5; M/9VGB+,-JU D3GNEY9!+WP.09D*\, MRUYN&.C?%(B(JL>QZ(YKN'-7AR)X*B^A4 SP)ID=_M+:>U'J+%9ZS\#?!-ZO MCHYI4=)Y9-+52RC8V,:KEI#JK'S3Y>.*6GWY>EC&M1%,JXNR[55)(3O\ /\.F3NG+)YOW M)$D\Q5DZ>'>'I\ *""8Z]WVQ6@=Q\)I6] D4=S'V'CZ%0"U T&7?K;^#,6<7)JFBV]7E[B2/EW'>=XV)S&NXZ7*U[V-< MC57H5?.X/W:WST%3K3V)=446Q06+-21R.<[IFKO:R:/A$Y5S7R,;Q]*O:BB\_I_RGR/X5Q]BCY1T=?==[&YG5T\IU<=7/'*<\>E#-DR[1/: M!TYV9MLK6N-4U>*LL&*@;+,Y\CN&\(YS6HGIY57)_\U1 ,?J+8%,_2 M?!\.=PKM&3Z0Z_(^KCO.C_2/]8GH[O[SZ>?OO U_;_LI5M!;A5]0,S%.[2K7 M[.3AADQCO+$GG:Y'HMAT[F="+)(J(V%K^%1%>J<\V?2.IJ>M=*874./25M#+ M4H;]=)V=$B1RQM>SJ;]#N')RGT*1ON.S-B]=Z]S^>NY>Q#C\QAIL=+BX8D1&6I(E@= M=:]5_P!9W'W/CI]"<\_08N7LVY[)ZBQVI*S'W M:Q>4N=WCDMRKWG7PBHWAG"*BSG&]I_6VW.A:ES/8REJ-N2^$UQREW3GICX88 M^A/NB\=[W//5_L=7H=QX^CV<=$:YQ>N&7]3T9Z.)PVF*^G:+;=*"M*JLF5W" M]U9G256M:SF7[FURKYK$\3'9C6^3V(SN'6'55_45+):8M9.Y0U+4*G2J*J(BN\.51 RNO>S+8=MQC*=+)6,I=P$.4EK5ZE6.. M6U-9M,LLZ>\E1B=VZ-/-<[B3T*K.3UMJ=F=6ZDUKG->:QL?!EZW8N1UZCL8R MNZ6*:E5KI(L3;,W==*UW<-61[G(O*JWT'M/W[SE_E4X>Y?O>%UK2>_NM&?#.0OKA\IIW)Z@M8RK M+0R$D\E=R8M+35@E1B,= CF.1%X15Z^KE/O0,_)V0[K,%\%0:KQLL#%QTL3K MN#E=)'-6H,IND9+%;BEC5S8VO:L;V.:O4BND:O";-KC;#63<7M%C]/YSX0RF MF\DC[FH,U7\KZF-H6(EEFB[Z-[UJ^+N'HB\K]*L.BC5CVK'U+61%X7SO-Y\$5%#)2]B6DEVK/'J&M82:M%!E?A'$K M.Z=S;,L[Y*Z).UD/4Z>1.F1DS43IX3E%5=CS'9FR4^C].8?#:U=A+V(=ED3) M1XY7O41\G5RJ+THGAZ ,A%V-+4L.7\LUJR6?)3NL/>S'3O1K MEQMBC]]/;ED=X6$DY=(J\L5/!')TY_679635M]]E-3>2(['5\?T?!_7QW5"] M4Z_]:GI\NZ^/H[OCE>KEN)P/:*USG;]73+].8K#ZHL7YX&V\K))#4[F*JVPK MEA1SI&2*CD:C7.]"*]%5/-,'HSM":UISY7*WF83,Z=OZBLX^JM2_)8="Y,8E MMOEA$1&R-KT2<)]"JB>.K8CM+:XM7M-X*YA-/09W5%7&7,;99 M8G\DJLMQ69%;.BIU/I9$3S>.5SNJ=Y\YENS])J&L^'3N4=FX\#> MR5-R30TVID4ISVX7/;PK4;U/:KT5&\ISSPH&>V\V#NZ*U!IZQEO2R/\;NI?$_CMF=6XC(YNGIG7-? Z4S64 M?EK-=,4Z3(UI)'(^=E:SWR,8V1R*O+HGJWK=PJ^'3K^I,_>V5RCL-IK5\VJ\ MME+F+K,PNJ;4EII,1\ V-91 M,T[2GR%K$UFXC_2*\MM[W2=_-W_$S6I+*C4:R-?.17*[CQ\K]A=0ZRUYK9VRDOW-G>,7EJQ*Y>[\'(BFKV^UKJRECFOE MP>,9-CY;"YM\M2^Q]".-L#V]_52-T\+5;,JK.QL\341J\KU\-IN[&9O9O76W M&E(U>Q<_<3V70PL?%6CFXZF=:.>]5;PY4B5$5/$#7L=V6\:C&IPJI'XF/U7V1< MEK'5&0RF1U[+/!/)DW0Q34IY9(8[E:6!(TZK2Q-;'WJ*WNX8^I&\.Y5>H\5K M>/+Z!DS^F]-9ZAK=FEZ%W,WLEJ.RYDR0PR<+0;(QOW25GBCIG<\.PD4J<.8CVH[I7^5.> .?Z'9 8FL$S.2S]&]#8M09" M\R+%S0V768X&1*M>;RI4@8JQM>GF.D8O/3*G@J?S4W9SS.1UQD\1@MY9TV8M3H^U,^6.*:>SWD;T8_P>_O&)U>#?!.-]TCJ+,7]T=W,Q-3@9GZD&H*D>/NP9..F]^(=)GIG6$&LJ5J6A3RE!\*]")F<58I*KE3E%1LK6*Y/Q\?_ # C M-;LMYO"Y[*9S$:_3X9RE1^.N6\QB/+%EKOJU(7N\)X_NRNJ))WBJK?NBHK'< MQO=M::FQ-O7/W%S;C(*U?'SK3J-GHNJJD$4UN5T:_C9+%9K&U>X>U[8[$3W*O#7(J/ M;TJG"HY%4Z" '.F)[(TN"SN+MXW5<&,IU:L=:>/'XCR>:XUM=8ECEZ)T@EA5 M5ZNB:"1R<=*/1..-PV:V-N[5X?.XZ?4[[E;(QQQ5ZN,@FJ5L>C6.:KX(I;$_ M=/=U(JHQ6QHK6]+&^/-; '-F<['UC6RW'ZHU5CK5Q^+EQD>3Q.GVT;MKJ?&] MLM^7OWI:5JPM7I1L3557+PG/AL.W_9F;HS4F'SD^7Q\URED)[TT6.Q+JT,R/ MIK6:Q.N>5Z*B*KE>$1J<<7( <]5>Q_CH<-;QDNHIYJT^;6^Q?)4:^"@ MV">&&@Q>OP;&EB14?_+]Z>#/=E?/ZIKZ==E]<8W(6].1-J8R*33SF4T@2)8W M=]'';;))*Y.A>MLK&HK$XC1%O=Q>42BU MT++$2.15?7:YJ+&]KY&JQ'-7A_@Y%3DQMO9K6^8R5#4F2U]2DU;CK_E=#HPC MUQ-6-:[X'Q)56SWCE M*1[[U!['/?+:=+=D56S<(CFR.[MB-\Q6IRLB+PGXU;MKJJWNC%K32VJ,/AYE MPZ8B>IF,'+D&O:DZRH]KH[<'2O+N.%1Q30!SSENS!GYZD2S-1/*F\O;)$CF/\$1'*US7^#BM8C2.4QVC9].OS421,QT>/ MHW*E-8IZ_3 D:R.5TCVO=UHKTX:U$3AJ]7'4NV #F_1G9%OZ=UIB]1Y+6R9> MU2FH3/:M&PYTZUFV6HKI)[DST<_RE57QZ4Z/!J(OAG-N.R]5V\W%34465IVZ M4%J]%Q]-U5UZ::LL;&67>4>3S(UW#FO= V3E&\R*B+S[.?[)V4U MS)=RFH-9UW9^_1EH32TL,L,#(G49:L:)$MAR]35F>]SNM>I?!$8B(=( "5X[ M9C)XK1VO]/U-5NIIJ2U8MT[]6DL=C'/FC:U_+N]7O.'-Y142-41>.>?.-1T- MV5K.E-60YZYJQF1G9EHLJ^)E&?ASF49ZG3WD]J:1>4F1_4Y[EY:J>A4Z>@@! MSU#V4K>+LZ&R.*U?#6S.D,=#3HS6<2LT$KV+,CGRQ).U5:YD[V]*/147AW5] M!YH.RGW>$U14DU1WMS4.&GQUNU\'(UK9YKD]J2=C.\\&=4ZM2/GP1JI8L5B=3TJM#.4I<;Y1-+% ]ZM6O-WK$A.8Y7 M)X(Q')Q][QXX*#L65JUW,=&H::T;J9&2%TF(<^Y#/;@DC>Y9G6%8K&K-(Y&M MB8_A4:LBISSTR )WKW:W(:JVZQ&F<7J27!3T'U5=/1*U?!/%4Y19C@^QX_$Z>R>,DU>V9UZI8JK*W&N1(^]R*75=PZ=RKPO+/% MRJOI5>?!>D@!S_?[*2W=26\LFJEB6?(OR"1IC^5;U92"_P!//>^/'<]WSQ_M M=7'ATKK\78WS*W'W[>XB7\FVFRM#;MXVQ.YSV7:]MDDJ277<^-=&JR+NF<.\ MUK..#J KGI,Z2PYDD:=;T1K&1/ MX5.7JJM>KRX%]FY"V.%87+!/ MY4QC7.:J\*Z%_"_0I90!S;G^Q_:R^=IRP:WEAPF/LUY=U6**JE=(& M_P"E-AZ>.7=20H_E?%SD\#9I>RWAW:7P6,9FR+,]SI>F9O+V]+/N?A&BN54RNT^P_R7V;TOPY\)^4XF'%]/DG==/=V+4W7] M^[GGRKIX^CHYY\>$K( A6G-@-6X_;O Z(RVM<+?P6$EQTM-]+3DU:RODEF*9 MJ2/==D:[J2)6KPQO"NY^CI75W]B:LERK*FHJ=ECZ\=6^E[$.F=(QEF69JP?Z M0UD;E29S%[QDS5X14:BG3H T+4FT.*U;N7B-596.GD:^.Q5G&MQMVDR9KG2R MQ/[U'.5416]UQQT^/5Z4XX67UNR/:P^"R.&P^L*]''YG'SXC+,DPO>+)4?;L M6&I6XG:D#VI:DCZG)(U?-7H14X.C0!S;>[(N1@PV>QN"UM!CH<_7L4LDMS"K M:5T#[L]J-(O](9W;V^4R,5SNM')PO2U4,[/V8$FN:TG^,G"ZCQ^8H<>0?\G\ MOG2;JY[SSNCIXX\.KT\M]!=0!R%7V,UKE=85=(+7?4T3CKV9N)=R>)JSQJMN MM-&CNM;+_*&NDL.JHU5LNT^UVI]IX:V-9GZV;Q-F]+8N120V6 M1TH>X1L<5-LUJ9\;>\:CE:Y[V^<[I1G@A6 !*+&Q"6-U'ZS7-\=6;AS'D7DG M/'=XU]+N^OK^GK[SJZ?#CIX_VC ;?]G'-[:66MP>N(H4NP GVXNWFH-P-"TL/\:68C+Q6H;-B_0J MSPP648Y5=$L<=EDS&.14YZ)T7P]*HJM620=C:_2Q6)JT]<0T[E*STMA4@G9;:]O'*MXF=,QW@KF*O//3@ EF[&Q<>ZF4;Q',JJY$5&OK-Y9QYR.7Q0T;4O9,R&MK$;'&OWO4J\+)S93&5ZO M&1Q#9J[;2.B=;LNC[Q%=Y0Z"%5:US7,5G+7\\*G2H GVTVW6R&-O4WH>LCEY3A[4;TK00 M !B]3VL30T M]D;>>6LW#5H'SVWW&HZ%D3$ZG.#* M9&%N5R%EC98JU.-5E>CHN\8Z1)'1LB5K5YXD7E41 -_T_G,=J7!T,MB+45W% MW8&6*MF!>621N1%:Y/Y%14/)8Q%"WD:F0GI5YK]-'MK6I(FNE@1Z(CT8Y4Y; MU(B<\>GA.3CO5>QFZ-+3K--PXR?45;"Y*]8Q%G&RP5Z,\5EK)6,DJON12Q)% M*LK&R1SI)&G"L1_*]-'[2.W>L];:>T@[#XBYD\I1KS=_3IW8W5&V'1L1O>ME ML5Y'(CFN1L\ M4VW^E[%-E273>(EJLBG@; ^C$K$CF=U3,1O3 MQTR.1%Z:WH5%8C MEUO"*H7W#;-;?:8Q63QV)T-IK$XW)1]W?J4L17AAM,3_9E8UB(]/3 MX.13T=!8K;&+)M;HW%::KW(:K+S),-1AC5L$_+&R-?&U$Z7I K>47Q2-/H1# M'[--S";&JU[]B_)'/%9?)&Y%:DK7N5[F]'#U7^,U>5YY.>- M(]F756+THZ:+2EG":@Q6G\/1Q7=9.&/IN5[UA]B1G=3JSSF/:Y'/X56R*WA% M5S0.M,_MOI+5<5N/-Z6PN8CMRLGL,R&/AG2:1C>ACWH]J]3FM\U%7Q1/!#1F M:_V;9J)VE5=@8+\646OY-+C4CA2^L?=*U)'1I&LRL7N_!W4J+T^/H)YL!M+N M%I'=2?+:G=EEYCO-R&0EN5G5,FY\Z.@8T+KG M+Z>W"T''H?(0Q:DU3-?@U--=H^0UZKYXI.^Z6V%L=XU(U5K>Y3SNGE43Q N6 MN-":#RNEJ]?5>EL'EL!B&HZO4R.*BM05$1O0G=Q*QR-X:O2G2GH\/0?JKHK0 M^F+6)I5--87&S.>U*,=7&1L1CHHY.GI5K.&=#'RHGHX1[D3[Y47E/5FSF[V: MU;GK]+3=B@MUF6@FEK9*)K;+9)&NJJLK[KWRIPSP1T<*1\]+6\+;?=O M4K*28W4%*]9C7)^3V,96=BUILDI2QPLDYJ)(Q&]*^=TIQR@5C3N! MT/M]GEPN PV%TYE,M')>=5Q=&.LZTV-S6OD=W;4ZNE96IROCYYDJ^.T]EK6H M88\=2GFL/;6RR/J)_I*]TWI;*JM^ZHD;FIX\IPO'\AR_:[/>1U7G9+46WF3T MKAZV!RL-&EJ=3.MW0YR&W)IK7&FMEMVI\ MQ>DPN7N5H[-7(6+S?,Z,95CF?WC'.[K[K',G5X<+R[T<*!7_ )&] ?%M-/?$ M?3?Q?2?RE,5\$5_)4E_]9W71T]7_ $N.3)MT'IEE=(&Z=Q*0).MI(DHQ=*3+ M'W2R<=/'4L?F=7IZ?#T>!R!MKHQFZVN+RZ>P=NAHFCJ&E)9I29R*W#$UN*L( M[SX;$D;V]]+"JQL>[QI/KQ4W5K..ADC M6")56*)6N:J=#%55:WT-55X1#(1:7PT&GDP$>(HQX)(%K)BVUF)6[E4X6/NN M.GIX\.GC@XYU'I;5>4U_6IYS0^;R-S,,U+D:.$AS=>*2JCYJ:5IY'MLMC\Q7 M?[+W.8JJK4*K.BU#B<;?CJR7K*UFLCLGB]'(BJU$ I.G-H]#Z/I+3P>C\%B:JV8[BPT\=#$U9V?ZN7A&_ M?M_V7>EOT<'L-VRT>S+93*-TG@VY/*QNAR%U,="DUR-W@YDS^GF1J\)RCE5% M.2+6Q^^V"@QTV+EER%S%U8,S"DF8:J3Y-[&4Y:TCGO17-961TG6[S7/7E%5Q MMB=G/5&!LV;6+KY&;)UL[3BIY!F9[F1V+;C(X)U:JO5&=4J/545JN5R([I7A M% O2;'[W)TSE:^PT^-K2I M)U^S&EJ>1(U;(LJ069X4\4;]U8D;GJJJZ/E$59OB-I]= MX>33[^YJV!ZOC>G"]+E*M7C= M,/IS2&J+F,U?BJ-.29L\MV#(5H$C6>5\7D[I7.Z45_,;4:CEYY:C>.41I#XN MSO?U#@4R-O#V\1J/-9^W;F;\(-:F,I2V9IFK*V.1622L:]_3T*[IDGYY5&\I MNVU6 W,AVPU+AL]-\%99*GDF$DD2JB5G^3(WJ9Y,G2D+9?&/J^Z=*>=X@;#N M-I/:K"9&'6NL-*Z=FR_E%>"',6L+':O.FZD; V-R1NE''!X-1 M:+V=P5K&4\SIC1T%FJ]CZ->?%5ED@=/81C7QMZ%5G7.]/.1$Y>O*KR0C']GO M4F=S6EI;.B+>)PV.N8>;(4,QEH+JV;<+Y5M7V<3R)PK7-17*K9).4Y9YIMG: M(V*RNX6ZV.RM'3#\G2L4L?4LY*"W# ^NV'*PSRHY72,D\84>J+&B_>JG@JIR M'1^+P]#!UG5L;1K8^NZ62=T56%L3%D>Y7O>J-1$ZG.PQ&L:B3(U45[UZ6N6-ZLG]"*JQ<(G+N *Q M8T[@X\=DX9L9CVT;KW6+\O1D9J&+OL*R1ROC9*UZ??N3NR[;];0:BUUJO4>5QF/FMO;I6*GB'MO-B:V]Y5 M(Z3AJO:B.[IR>>Y..%5$7TH!=<_J#':6PUK+9:VRCCJK.N:Q)STL;SQRO'\J MH>6YF*./MT:MJY!7LWI'1589)$:^=Z,5ZM8B^+E1K7.7CZ$4X U1@,AN-J6U MI'$5;.8UC8^,3,IDJVH(GQWF]\C846))^N!8VN;&G>LBZ%3ABN1>2NY_L_YR MCK:";&:9LWL!C=1RVL6R+)Q-DIPS8GN7S1/ED58T2UYR\(KN>7HQWTAU<#FG M9'1&KMO=M-P:N?Q5G$U5H==*6[/&MN:1*[TE=(V"S/#SRC?NK$B=(O*NC141 M5D^#VBW"U7MYIJ_IS!YK!Z=L8[#RY;#RY:O9L9V1LS8>C(XV)Z7...?1]'')YZ\[+5>*:)W5%(U'M=PJ'4>TS9'7&$JS:A@;:Q.IFYF MR]^4DR?6VOCEQ*QM56)(J*Q+*-=T(U7=2=7'T@=<'IXG,4<]CXKV-N07Z4O5 MW=BO(CXW\.5J\.3P7A45/^!RWV2KN/SFX&HEQ6/GJXQFE\5%;Z\U%DX;%QS[ M"RRH^*:5J*].'+U*U[D5%P_A55L44;7/D5$155&M7A$Y7P/=TKJO$:WP57,X+(0Y/&6458K,#N6JJ*K7 M(J>E'(J*BM7A45%1414)WN7AL]A]T=(:ZQ>G[>K:F-Q][%V\;CY8&6HN_="] ML\23R1L=PL*M66N)FM=*]CH7/?#WR\QN9XHO+@ZS!QEF]LKVE;VA:N?TKD]4Y;-:GSMF M_C:65CCEO0]-E]95<^=D?0UCF.2-7MX_%U)P>_IC9K<_'7,0W,TF)[95E17.3CP#KX]/'9BCEUM>0W(+? MDL[JL_AR?-? EF2S>3)LE MGBRKG^8Y7/NQ,C5&M9TS,;,Y$3I1&)Z?)G.S[N DER.MIK),Q&%:]CB2S&U>[\C;,V2^MEL+N.>=.U7L1NIDZN.2*EFV8 M5(\C\&8.EE*KK&#?)9ZZRR2RV&M161\(DD3I71<*UJ.1?$.V3U)\K5K9&I1D MD5MJTU[H6=*KU(SCJ\43A..I/2O^XY2M; :VBJ6;\5;+/U!=R>=9>N5,ZR&> M:C-6F2LC'NCS7+RK6^.%\G=V&-6!Z-15ZU;&KE [1-;UQN+I[;>C4N:BR*8^"W82K7 MXADE=+*K7.Z&MC:YRKTLR:>9D;G=Z]$5>M>4553D"Z:3UAAM=82++X#(PY3'2NE8RM'X2A===7?7GNR]\V)[NN.;ET;GN M:US$XDC&N:O+7)RBGZ.47[$:^K.MY7"I9Q.JKV4U U^3DRG4D M=2>K.E+EJ2*G0DRPN1K6JK'>!<-J=(EM595Q$U['2LDE M9!,V65U?RM&2L1KUXZ> M8PV5J)C;/0WIZ,K2MR=+VM553JAB>]8UX145$ Z6])X[$[*M>6:5W3%&U7N= MPJ\(BIJ*KB-*UY*^B+]*.[DF-O(CHKU2.3N8VHY_4O?R/ M@5SD\/\ 1UZE\Y.0Z1H7HJM2-8 MW*])%?RB&V]G_:+5F!TWK3'9EF8P,&6Q\52"')6JTG19[J1LMB-L$LJ)RKF< MO<]'/5J*K&JG*A6--;W:'UAJ),'A]0U[N2>DBPL:Q[8[*1KQ)W$KFHR;I_VN M[<[CZ>#>3FS'8SR/I8KN?.X1@,MC+3,3/CK,-J_0AN,C2W6E?%WD-IR-2>!EB)KF/7A9.']"*KD#I;%9_'Y MR7(Q4;3+,F/LK3M-9S]RF1C7JQ?Y>E[%_P#>0R!%NSSIC*:"J:CJS:*R>F\? MF=26;U2K8O5;*TJWDL#6+*K+#^$<^-[6LC5_3X<\-\2T@ M M /XJ(J*BIRB_0I_0!X:E.O0@;!5@C MK0MYXCB8C6ISZ?!#S ?E6-5Z.Z4ZD3A'<>*(?H #P/I M5Y;4=E]>)]F)%:R9S$5[$7THB^E.3S@ >"*E7@L33QUXHYYN.\E:Q$<_CT=2 M^E>/Y3S@ ?Q41R*BIRB^E%#6HQJ-:B-:B<(B>A#^@ \%6E7H,4Y3GA?QGZ M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M M # __9 end GRAPHIC 15 tm263879d1_2025q4orgchrt4.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt4.jpg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end GRAPHIC 16 tm263879d1_2025q4orgchrt5.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt5.jpg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end GRAPHIC 17 tm263879d1_2025q4orgchrt6.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt6.jpg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~~L6[M(X'B MZ\^L<6OB=XE<2U'ON9@-6+I4/[37OB-.5"+X71 =;FM*7,77+43Z>K(MT<24 M*-!GON:3(R+D9TW3S4J#J6=U(J6E.5,"2B*S8<9&B6HV4.+-!?H2;A)W_22O MT#S*TDHJF%'Q;%N>P#~~
GRAPHIC 18 tm263879d1_2025q4orgchrt7.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt7.jpg M_]C_X 02D9)1@ ! 0 0 ! #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" -1!$P# 2( A$! Q$!_\0 M'0 ! 0 # ,! 0 <%!@@" P0) ?_$ &D0 & 0(" PD)"@L# M"08 #P ! @,$!08'$1(3"!@A%!47(C%7EI?4%CA!5%:5M-/5(S)1575VDY31 MT@DS-38W6&%T=[.U)$)Q)5)S@9*QLK;!-$-B,236M?"HTEQ*(B(DF:CW\A$9D'0X#C[3GIRY57ZT8_I;K?I2_I;D&1 MI_Y%L&;-N?"F.&>R6C4@MDJ,]D]BU'Q*21DG[C.2%NH^_;)"5FKB3\*=MR ;^ FM=TF-(;:6<6%JGADJ3W2B&335_ M$4I3R]R0V1R'4;%:.](R)5;8W,=A] M!F1&GB0I9&GM^G6!SGX629[C-!-8CIENQ;.WCQWD,J, MB2X:%K)7"9F1$>VQF9$0G^K?2E@X50X)=X;&Q_/Z?*+A%6F>WED. PVDSV-Q MI;AJ3(41[ERT'Q;D NP"9S^D[HY5SY$&;JS@T.;'<4R]&?R2&AQI:3V4A23< MW)1&1D9'VD8^K*ND/I;@UPS4Y%J/BE%9O(2ZB)8W,=ATT*+="C2I9&25%VD9 M]A_ H0" 9GTUM/,*Z1&+:0RK".JVN8QR7K5_-=-*22C M8MR=;,C/B(CR>BG213J75Y]9Y)64N%UF*6KM>Y-1E,2Q96TC?=YY;>Q1C_"A MP]R_" M@#2<2UNT[SZ#:3<:SO&[^)5-F]/?K;9A]$1LB,S6Z:%F2$[)4?$K8 MMB,]Q\%9TCM)[N[K:>NU-P^PM;+8H4.)>Q779)F>Q$VE*S-1F?81%Y=CV\@" MB@- S'I :8Z>7Z:/*-0\7QVY41*[@M+B/'?21ENDU(6LC21EY#/8C^ :#=]* MMNIZ76*:(LXXF8U?T:[M&1(L2)+:22^HD$R39\9&3'WW,+[[R=G:%] 0[I8= M*NEZ*^'U=A*J)>49'=RR@4F/0%<#TY_LW+BX5<*2XDD9DE1[K21)/<2_3/IN MYNG6W'M,=8]'9>FUKDS*GJ6=&LD6$=[8C,FW.!.R3[-C,E&9*-)*0DCW =@@ M.5NCC_"#8%K5064S*9V/Z963%T]41*NVR)E3LPD)09.HXTM'L9KX=B(RW+;< MS/873/=;=/=*Y,6/F6<8]BTF6GC88N+-F*XZG?;B2E:B,T[]AJ\A?A ;J T6 M[UXTTQJ#73+;4/%:R)91CFP7I=U&:1+8+RNM&I95V/5#)DER?:RVXS"#,]B(W%F22,S\G:)[F'2ATZQW1K)M2:S+*+)J M.EC.K-=9;,+0_(2@U(BDLE&1.K/A223[=U%V& K0#G+H4=**]Z5F$6^3VN+U M&-0&I"6X**Z^:L75I/BXDOMI(E,+3LG8ED1J)>Y)(MC.*5W\)1J)E4G.7<0Z M-\_+*;$+!Z#8SX&3I-:>6I1<7)[E-9[I0:MD\6WX0'? "+Z-]+73W5_0V)JD M=S$Q7'E.'%G*OI349,&2DR)3+CBE$G?M2:3W\8E)/8M]B]&HO2LQ:FT7R'/M M/[/&=24TZV$.Q(V41(3"3<=2C9V2LU(9/91J(EENK;8O*0"W@,#B>2.Y)@U/ M?NQ&HC\^N9G+B-2T2&VE+:)9H2^GQ5D1GMQEV&1;EV&)7H=TH(&H^C\_/\T8 MQ_3NNAV+L%UQ65P[*&DD\'"I4MLTMI4HU[WP;[C:=*>DI@>KE/6 M%393CTC*)-6U92<:B7+#\N(:FDK6VM)&2O$-7"HS26Q^4B\@"J@))T9-<9W2 M!T[D9-88_7XT^U8/02AUN0QKMLR02#XS?CD2",S49<'E+;?X2&N:'=*OPS:[ MZM:;^Y?O/[@I2(W?/OAS^[N):T<7*Y2>7]YOMQ*\H"_ (SJ!TA7L!U[Q/ )% M+4E27%;(L9>0SV_EV$JUHZ5G@AZ0>E.F'N M7[[>[IU;??7OAR>X>%9)WY7*5S/+_P Y("_@(#;]*OO5TQZ/0?W+\WOG2JM_ M=!WPVY>R'E?!OV:YGG3[PNEU>TMPG#7J341G-+-59)M*6_:<3 M5*);22-:&T.<>_,,R(U(W)/89[]@=1@(+I/TK:S,*S,;+-48WIY74-\JC9F/ MY?!FLRE]O":EH-),N*X3^Y+/B\OX!2,,UFP#4:WG56*9MCV2V<$C5*AU-HQ* M=93N1&:DH49D6YD6_DW[/* W(!-7^DSI!%L)\%_5/"V)D!?*E,.Y!$0MA?%P M\*R-SL/B\78_(?9Y1]>4](+3#!LD+'LBU$Q:BO?%WK;&XCL/IXB(T\2%K(T[ MD9;;[;[]FX#?P'\2HEI)23)23+WL"_ )K8])C2&H>Y,W5/#(KO=*X9H=OXB M5$\C8EMF7,[%),RW(_)N6_E&=SO5S!]+X429F&846+QIAF49VWL6HQ/[;;\O MC47'MN1GMOL1@-M 8['\BJ;AHV,^)XTJ/EELE1[JV+8C,>.":YZB:-_PC$#5+I5W^BTW"_< M^NNE6,2-=JM^>4IR(I6Y&SR$<'$AM:_OU;<.W;ON [( <:=%;^$>K>D[J]EF M((P]&,4]'72K1-_(N2=0\PR^VWQ*;-E!-D:7.,S-9DG;;M\HZ-PS7[3+46TD M5F*ZA8OD=C'0IUR)5V\>0ZE"=N)?"A9F:2W+=1=G]H#?@&@X_K_IAEMU'J*/ M47%+JUD-./LPJ^[C/NN-HWXU)2A9F9))*C,R\G"?X#'CC.OVF^=6$ZMQ7/<9 MR>VB-+> MRK-VNB8_99$RY(DDDD<+B.-+2C)2E&DB)/E29$9GV"[:L:CP-(=-LBS.TC2I ML&EAKEN1H+?,>>V\B$)_"9F1;GV%ON>Q$8#;0''W1[_A IFK6KU'I]F6E5KI MK9Y'4G4M,Z.25KXE%RFS;(T-K,C[=^$R/;LWR6)_PAN&:D=+"JT9PJ M"G)H,EB0W$1;F'5X ./-?\ ^$#G MZ6:JY-@V%Z36NI,O$ZLK;(9C%B4)F SP)69E]Q<-9$A:3,^SMW(M]CV#L,!Q MEEO\)14)PO2R=@& VN?99J"T\_!QAN4F*ZPAE:FWN-S@38$1*-!OC-_@,3(*M5O1W+TDYD:6P1&HE+, MF4$T2DI,TF9GN>Q?[R3,.M@ M M !^>O3V*PT4Z7.BFO]A43;; J-E55;.PFC=."9J>(G%%Y"W3( M,T[[;FUMN1F0_0H>+C:76U(6DEH41I4E1;D9?"1D _,[5?6NAZR2(MQC\[PZ#J'A=YC%DY)9@6\)V"^[#=-IY"'$FDU(6 M7WJBWW(_PE$#\/IN4:17&"=&&GPS'2@:BTU_'8RJ8FM4PYS3D(\1]XTD3RE MJ2:D%NK@2DR\7R#YNE?F=3EF;:[L.5F-X+=,Y I":55"_/NKA2)!\<@YSW&4 M1))(W%SL+A(]AVVX_ M=L?*=5".R*Q.''[X$WR2E\I/-X-]^'CVWVW[=M]@'X_8Y(P#%NDYT2\DS6#5 M%C=EIU 3+FS*\I#,F>EF0PRIS9"N-U"TQT$HR,T<+?:1)+:=WE+D%MT;=;'J MV-,FX]!U:3*R&/!(S4<)*7BXE;?[A+-&_P !'PG\&Y?N)-J8-D[&F5LUE,BKK M7($/=4*42$.(4A.ZS,XY;[>,I&^Y$F)Y8Z=XUCO0+Z/N:UM)"AY=/SM:9-V MRPE,MU)/2"2A3NW$:2Y+>R=]B-.Y%N9C]O*RH@4K"F*^%'@,J6;BFXS26TFH M_*HR21=I_A'U@/PTZ9>:5.3:O]("!(K,;P:WBSTLM1)%"_97.0&VO^.;DN\: M(2.6GF&IHVMT&DMG/*+KT>YJ;#II]%5Y+_='_P#"2.@W.+B[4QIB3+?^PR,O M^H?J8=5".R*Q.''[X$WR2E\I/-X-]^'CVWVW[=M]A]0#A'^$TQ+(:C)-$M8Z MNEEY%2:>7O=US"A(YCK;!NL.\TD_\W[@I)J\A&I.^Q;F-@TY_A"RZ0FOV,X; MI#B$O)$^TMRVVV47CJ41),B(U#LX 'X7T&FV+SOX M/'7#,Y-# D97$S=F+&N'8Z528[1.QO$;<,N)"3YKFY$9;[]N^Q#9.DSGE;<: MC0J:YK\=Q2>C3>L)K)KVB?O)]XMR"TI#$1I?&PRLUK4A+Q(0I*D.'S-SX1^U M@^6150IDR-+?AQWY47B-A]QI*EM;EL? HRW3N7EV ?A[HCAU%JWD?0\Q7(V$ M7%*^FW8F0G%GPJ2B=(=)M6QD9$>R3V_ ?]HZ0J\5TOT1_A7&*2PQZGH*%_'H M,;&HRZTEM=\5NOKH ME3#:B08S,.*T6S;$=LFT(+\!)+L(!S)_!HXU44G0VT^FUU5"KYMI&=D3Y$6. MAMR6Z3[J"6ZI)$:U$E))W5N>Q$7D(<7=$#IDZ;]%NPZ0,7,YDSOO8Y1)DU]; M#A./*E\"G4\/$1<"=U&1>,HA^N@ /Q0.FN-$.@1A+69X) 6UE^H#US&EY0Q* M7%IF51F6FI#T=DTFLU$VXI*%DM*D$?B+XB(3.)8P3P'I3,5U[ O(4FOII#$R MKITT\66E-E'(W&8:4I)M!&O8O%+REEMI3K1-&B%P&ZA/E+@*0DO[5[>51;_O /6^PU*8<9>;0\RXDT+;<22DJ M(^PR,C\I /R7U^R_0'-.C=TAYVAF#V-,R3E0BSR&-'+4D&A=M,-)Z>[ 82TN8ZJ&YQN/&DB-Q M:N-6ZE;F>_\ 80_5>NK(=/#;B0(C$&(WV(8C-DVA/P]B2(B(?2 X7_@=?>J6 MGYTS?\J.(KHSTH-.NC-TX.DY+U"NG:=BVN":AJ:A/2>8IMYTUD9-)5ML2D^7 M;RC]4@ ?F?ENJ&%=(_\ A$>CUD6-/(R'$K7';*(HID-:$/I2F>VZVMIU)&:3 MV41D9;&7X2')<_3AV3T4-:KC',>BFY4ZDE'L94.&GG,U*4K/DFI)$HHY/$PH MT$9)(TI5L7#N7[R#^&1&1D9;D?P& _+3^#YDP\OZ9]WD.'/X\U0L8LF-9M8+ MC\NMI%F9M\HC*2X:R?XDD9^+XW LRW\8SVG^$:P*)JATR>CABR2(M MS_"/L ?D=*Z/S^A/\($G#,!R'(KRYDZ?6DBMG9#.3(EHF.0IB6B2XE""))+2 M@R[.PS/M$0[HTRL.B'B^GE#C,A/2A1E9H<;9JGD6R72?<[3?X"/@)'+3R^+< MEEQ<);&H?O /C33P$V:K(H48K%3?*5+)I/.-'_-->V^W]FX#\;>D%CN8W&M_ M2NKH!/S\B;PNG79)A$:EO(;.K5*,B+M,N%*U'M_ND8^>DRG1G)^D#T.DZ45< M>#9P'*^-DKL:O7&XYA+9\5U:DI)YTEK M8NZJ;72B6<:6PN.Z3:S0K@6DTJV47:1[&?:7:0#\!+A>D&DMTF1LI)HSW)3:CX2\JM]Z6QXMANONM$F':5SL MZ3;=U6.(:C8NI4F 'XDUFFN+7711Z7F6V%# F MY+6YDU6Q5R+:O7/@IDE"1QI4V2%\2^-2S^],R-QM79V&7Z]#X[2H@7D0XME" MCV$4S)1L2FDNH,R\A\*B,NP!QST9.DWH1I[A&GN.X1B.58)1Y[>2HM!!MFG' MTR'TJ:2X\E:WW32RI;B4D>Y%Q)7XI=IG_?X5K+H^*='JF*9B=?DT29D$=E3] MQW2J'6JX'#3(<0PM*E[=I$D]TGN>Z5=B3[/0A+:$H0DDI26Q)(MB(AZIL*/9 M1'8LN.U*C.IX7&7D$M"R_ :3[#(!^&NE#>-W^5](Z#)OY-]C=AA"'E66 XRW M7$Z3^@7E$2!TM-.:NCBXGJ,TY5NLI MOJ*CD4]A21R861]V(0AIEQSM)*UKYYJW+9TS,M_V2CQVHC#;##:&66TDA#;: M22E*2["(B+R$0^6MHJVFY[)(B(@',W M\&CC512=#;3Z;754*OFVD9V1/D18Z&W);I/NH);JDD1K424DG=6Y[$1>0A^5 M6K<&YQ/-=8]4<>?7%LL_HT7U M5*Z6VC-A6W.//-/TTQA^+C6/JJHU>ZJ%(+N-;JTI7+>3QIXG5FLS-22XU>4? MN69$HC(RW(_*1CYJVKAT\1,6!$8@QDF9I9C-);01F>Y[)(B+M,!^/'1GZ/\ M"R/^#@U5SC%\>.;J@Z]-@L6,?C5**"7<6Q%N?&9?#L*9T5<\ MZ,5W*T1I<7P"PM=8(5$I$JVH(;L4JR2EG:2[/7S&DO)49N'Q&3VQ'MV<1$?Z MBCXH5+7UDF5(AP(T61*5QR'6&4H6\K\*S(MU'_:8#\*Z_3G&/_T8M_F9T4!6 M6)SY$=%TJ.DY:&2;;+E)=VXB1XRCX2/8S/?;7R3V(S%0 !^3.@>I..ZD?P@^&9KH^Y=Y M"[EE=)F9Q%R&.4@J/F<:ELL/J:2;:$'P)(T'PGNE)*,E&DJG;X!C>F?\*]HY M18I1P<>IV<.E+1#KV$M-\2D6'$HR+RJ/X5'N9_"8_0>!3P*I=F.6^$S4P+8I$5*B)9F9;FKAW(B5Q?H'@FC]'I]EV:Y/"=G3;S+IK 'Y)76<::Z2:U]%C67&X]G7Z%0**90LV$F&M;K#[: MYB'#=2@C,W%+?XSV^^\.4LNPS:09F6Q'XRB(MR(S47ZXV-;$MX;D2?%8FQ7.Q;$ALG$*[=^U)D M9&/>VVAEM*$))"$D24I26Q$1>0B(!^+N++Q?7;HKZZ-8Y:WF?:\7,6)DN33I M->;2'&&);2EQXI$9[H01F>VQ&KA+9)$E*2V'H%9"Q#Z3NE,#2/+SJ[JW^Y;.MH9\V*_PI5RWFXZUH5LHC(]E)(]C M(R_"-R$]Z1/O?M3OS7L_HCH"=X#H5=Y)@N.6TS6K4ONN?6QI3W+L())XUM)4 MK8NY.PMS,9[JX6?GJU.^<8/L8WO2/^BC"_R)"_R$#;0$7ZN%GYZM3OG&#[&' M5PL_/5J=\XP?8Q: 1?JX6?GJU.^<8/L8=7"S\]6IWSC!]C%H !%^KA9^>K4 M[YQ@^QAU<+/SU:G?.,'V,6@ $7ZN%GYZM3OG&#[&'5PL_/5J=\XP?8Q: 1? MJX6?GJU.^<8/L8=7"S\]6IWSC!]C%H !%^KA9^>K4[YQ@^QAU<+/SU:G?.,' MV,6@<\?PA'O,M5?R67^K4[YQ@^QCB;4;0_ M$NBII'H3K!I9&F8MFDZPI8]BW&L9#C5NW)9)3S;C3CBD]ID?8DB+M/L\FVZ= M(GIWY_I/J??MTU_A=O4TMPQ 7C5?5SYK_(4I*5KE3R)+##VYF1-D9['L7;MV MAU+U<+/SU:G?.,'V,.KA9^>K4[YQ@^QB.X?K)B>G?2KZ1E]DT6LQJHJ*VD>G M7Z$RG'WDN-$22=22UIV2:B(N6VD^WMW\HU3..E3@=QTF<,U"Q:+79=20<$O; M!N\;3*:E%W-S#6PVE2DH))FG8S4TH^WL,!T;U<+/SU:G?.,'V,.KA9^>K4[Y MQ@^QB<]'_4#I":C5F+YKDK.%3-/\JK79SL&L0]'FTZ%(-3&RUJ43^Y&1*+8M MNW8_P\M=O570GH_::7T3W-2=.;/-GJW8[QV+G=$IPE/\[C)">$R,B3 MPGY-SWWV(.Z^KA9^>K4[YQ@^QAU<+/SU:G?.,'V,:)T1;J-::U=)2.Q25]4Y M#RY#3LF&I\W)BN4K[H[S'5I)7_1DA/\ 8,!T8??R=*7_ *:G^CJ 5KJX6?GJ MU.^<8/L8]+'1\F2E.I9UQU*>4TK@<)NT@*-"OP'M$[#_ +!&-=[VU9Z9-C78 MS74D3*2TOF28>06"9*W6=GU;MFE#Q(X-B,]^#BXMO&V[!RYT<-8>-:E$GAV22=MRW[2#]$.KA9^>K M4[YQ@^QAU<+/SU:G?.,'V,8SH<:^W6OFGMO*R2)$9O*.V>JGYE:RZU#L$H(C M;DLI=\9*5I478?D,C_X%RMI=JKGFG?2,Z4Z?Q*IK-,[O[AEJ?>I6Y$KV67E+=6:$&1K7L>Q%OMV#W=*#7+,,UT#UP!VAU<+/SU:G?.,'V M,.KA9^>K4[YQ@^QCF'I":X:LZP4G22J\43C%=I]@D.12V$6S8>7/L5&PHWW& MW$J)+?"6YI(TF1[$1^7Q;EL8"2=7"S\]6IWSC!]C#JX6?GJU.^<8/L8@>L&02<3_ (0U^\A);5,K M=)K"8REXC-!K;=<6DE$1D9EN1;]I#%:9]+O6R=(T!R?+&<0KA9^>K4[YQ@^QAU<+/SU:G?.,'V,1 MW237;7[7N=+SK#86&^#R-DCU,6.V"7F[!V(RO@K4[YQ@^QBT B_5PL_/5J=\XP?8PZN%GYZM3OG&# M[&+0 "+]7"S\]6IWSC!]C#JX6?GJU.^<8/L8M (OU<+/SU:G?.,'V,.KA9^ M>K4[YQ@^QBT B_5PL_/5J=\XP?8PZN%GYZM3OG&#[&+0 "+]7"S\]6IWSC! M]C#JX6?GJU.^<8/L8M (OU<+/SU:G?.,'V,?SHO6MY)J]0:>[R&QR<\>R^; M40["VY1R3C(:86E*U-H02C(W5]O#OML7P"TB(=&/^4=9_P#$*P^CQ %O M '*+?2'&.N*:IU\FW&N<[ MPD9$E"D)(U$6ZN'=6E85TY-0,VK3O8U!CK5936=107%::'SD3)DQU;*G8SW- M)+32%DT9(6A9J(U;K3L6_3>3]'C!G0+*3&DHGMLI80^ MTZVX2FE$VDD;(-)&6^Y'N>^&JNB3I;17='9UV.NP7*=,7N>,S8RDQG5QC4<9 MU]GF<#[K9K6:7'"4K=1F9F>VP1/3'IJY&>;5&,ZJ1JW"Y?,-<];M3+CJ,G6F M288)M2W#:,GW'B4^X9-FAIM1D3[W[4[\U[/Z(Z*$)[TB?>_:G?FO9 M_1'0&5TC_HHPO\B0O\A VT:EI'_11A?Y$A?Y"!MH TS M6/2JIUOTRR#!KV1-B5-W'[FD/5RT(?0GB)6Z%+2I)'NDO*DQN8 .8<&_@_L) MQ/)L9N+G--0-0TXRM#M-69C?%,@P'$$1(6TREI!$:2(MB\A;%V=@QV6?P:B4;Z4J949GN78E9J(OP=B=NKP 3+#> MC]CF$ZI9EGL:78S;C*HT.+/8FK:7&2F,C@0;:4MI,C,NU6ZC+?R$0^7,>C1A MV=:IU>=6J9CDR!22Z JMM3:8+\622B=YB.#C-6RC(C)9%_88JX .;-,.@MBV MF6445FG,LRR&MQQ#[>/T-Q9(>H<:>8+12E0++)9[LB5,0DE+8KXJ"=?X=R,B4LS;:WV["<49=I$/EU^SZ^PG( MM)(M+.[B8O7R@-BT6T=K=$#Y?#Q:7*3AL\)GMV[=H^"PZ9%%63\J4[A>7.8[BMNY M3W>2LQ8ZH,%Q*DI-:B-\G5H+B)2E-MKX",C5L PZ.@'@,+2W%\-K;S)ZN3BU MD_;4F319K3=I"?>6:G.%Q+1(-![[&DT>0B^'M'D?0'P.7IGDN)V=YD]M-R:S MCVUUDTN:TY:37V%DILE+4T:"06VQ))'D,^W?M&SYYTJ:[!)%](5@^77&,8^M M"+?)H$6.4*+Q)2HU))U]#KR4DM)J4TVLB_"9EL/1F/2TJ\7RG*Z2#A&692K% MX<>QM9E+'C&Q'BNL\TG=W7VS5LDC\1)&L^$]D[=H# :C] _#M1,QR^Z+*LOQ MF#F+)(R&DH;)#$.R<2GA2ZM*FU'Q%Y3(CV5MVD9&9'F:OH88346U58,VE^IZ MNPM6"M)7(8-*H*B,C<5LR6[W;]\1DG_X!E7]6'8FK.GJB:8STV%.M< MADW)#A;]DD^3LI/;Y$$@_P"T<0:J]$74K++;-<.I],\HIHU[DJ;"*["RUE6) MM(-Y*ESCBJV=)TT$K[F?%MOV)W(A^JH .9]1^@M0:D6MR\[GV;T=/D#;+=[C M]79(*!/Y:2(CX'&UFWOMV\!D1_@(;MAND%IA^NKUY7SYL7!(N*1J&%2.62G8 MQ/-N$9.-Q^'9LTMH))K-2E*X_@(CWL0 )%F?1DQ?.-5Y>H,^?;M7,G&9&*K8 MCO-)CE%>-1J623;-7,+B/8^+A\GBF,- Z'6&5V,:143=G>JB:8STV%.MG>F36G4O)GVLBR"^.]LW+1;=Y-*2B$:]ON,8N% M/+9+;L1V[?A&Y@ "(=&/^4=9_P#$*P^CQ!;QR5H_ MKK4:?99K-5S<//9[O/H<2L;*/L;$9.W-894CB\4_%WWV,C\AD ZU 17 MK78[\BM3_5Y<^S!UKL=^16I_J\N?9@%J 17K78[\BM3_ %>7/LP=:['?D5J? MZO+GV8!:@$5ZUV._(K4_U>7/LP=:['?D5J?ZO+GV8!:@$5ZUV._(K4_U>7/L MP=:['?D5J?ZO+GV8!:@$5ZUV._(K4_U>7/LP=:['?D5J?ZO+GV8!:@$5ZUV. M_(K4_P!7ES[,'6NQWY%:G^KRY]F 6H!%>M=COR*U/]7ES[,'6NQWY%:G^KRY M]F 6H!%>M=COR*U/]7ES[,'6NQWY%:G^KRY]F 6H!%>M=COR*U/]7ES[,-HT MOUSQK5NTO:NG8NZ^VHTQW)]??TLJLD-(?YG)7P2&T&I*N2YL9;_>G_9N%" M M ?(XY.*UCMMQXZJU M3+JGY"I"B>0Z2F^6A+? 9*2I)NFI1K2:30@B2OC,T?6 )[TB?>_:G?FO9_1 M'10A/>D3[W[4[\U[/Z(Z RND?]%&%_D2%_D(&VC4M(_Z*,+_ ")"_P A VT M &OZ@9G#T\PNXR2>E;D:NCJ>-IO[]U7D2VG_X ME*,DE_:9#3*_6F4Y7:D+G4*(\W"HS;K[+]MX[1,M)JIZALEFJ.TVR:W2X>(SX"5PI+B, MR(R 8C6F$O&=<](<]=+_ ))C/3<=GN_!'[M0CD.*_ 1O,H;W_"X0U=K1[5_* M\XPN)FEE03\7Q#(W[^/D#,IP[&Q2:7DQF%QN2EMHT$]LI1.*W)!;%VF*IG&K M])7::0IF/P\8BQR8.+8TLYVTCS5NK-"8[:>0V\;Y*(BY:6E<1*(TF?:1!S;8 M]"O42YD5CMHO$;>\KLE8NE9A9VMA*L9[+MP'+5-A)2\Y-[VKB)I9G?%3Z&^;RSBYHV))\6^Q[CT MYOKS75.BR-1<4:CY37R7(S4$GY"X3+_.DHCDI3AM+4A)*7N9\LSV3Y %3 1" MCZ2[%?D5[1YS K*6?6LPWVUXU9/7C4HY*W$-LH2B,T\;^[2CY26E&:>TC,M] ML\YTF]-FC9)60.F:X;M@LDUDM7W#V[[=H^69TG- M-(2XA+R3G(DPV;!+\:!)?9:C.N*;0ZZXALTLHXT*29N&DDF6RM@%1 :IAN M A.FGOOM](GWOVIWY MKV?T1T4(8C,,7AYOB5WCM@IU$"W@OU\A3"B2X3;K:FU&DS(R(]E'L9D?: Q. MD?\ 11A?Y$A?Y"!MHC=1T?\ (J*IA5D'7+4)B%"81&8:[FH%<#:$DE*=SJS, M]B(BW,]Q]?@4RSS[ZA_JF/\ V4 K("3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_ M -E *R DW@4RSS[ZA_JF/_90>!3+//OJ'^J8_P#90"L@)-X%,L\^^H?ZIC_V M4'@4RSS[ZA_JF/\ V4 K("3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_ -E *R D MW@4RSS[ZA_JF/_90>!3+//OJ'^J8_P#90"L@)-X%,L\^^H?ZIC_V4'@4RSS[ MZA_JF/\ V4 K("3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_ -E ,_KAAR3):5D2D\1;]I'F_ IEGGWU#_5,?^R@\"F6 M>??4/]4Q_P"R@&MGT6%0+Y-A49,W#:3,6XF/)K3>VC+JVJ]37$3R/'X6B63G MD(SV-!^4>W$.BV6*55;#]TO=1P[NJN.9WOX./N*$U%Y>W-/;CY7'Q=O#Q;;' MMN>?\"F6>??4/]4Q_P"R@\"F6>??4/\ 5,?^R@$YS+H96.5TUA4%GW!53FK! M"H=:CN2I;TCG--HEMM\Q)/$@U.)TRVQ-:>YZ72C(V3P<>Y& MC?W:M>A_WT)PO=9R^.3.D?R;O_ .TS(DGA M_C?]WN3AW^'F;]G#L>Z>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_ -E"BS2-4=++ M_#L[5J!BZYUC<2[AR411*E$Y$-I??4/]4Q_[*'\7HOE3:34K7C4)*4EN9G%Q\B(OFH!Z-3.C-BN9XC74U%5T M>+=[K1NVCM-4[:X3KR4+;,GX[:FN8DT.*+L6E1'L9*+883$>BLWBL.\0W=5J M7;:B>J'6XF/,-1$+E#J M.ZE*V4,-IQZL-Z?S75,M'#;[R<HIWGY,A;AMI81&13F\IWC2I)MDCC(TJW(MCV#(8GT5[O"'(%G3 M9O#AWE=,=?@L=YWW*>*RZPEEUEN&N:I:"5P)7XCZ2)1=B2(S(_?!Z)35?BF4 MTS>4.+7?T3=0]*=@D9H>[IDR79'"3A$9*7*5LV6W"22\8QIB]2,51WF/K1:@ MK1:L(DLN-TM2M##:Y'(VONYM^.1I\I&/66J&)J[Z[=*#44^] MI;KVH*O_ &DNZ>Y-XO\ R)_M9=T&36\?F>,9$ NFFV*V$+.L_P EGL*B)MI4 M:'#97L2E1XK/+2Z9?!QK6Z9?_#P_A%&'(\/4O%)TZJBM]*'4)#MDVXXT;]+4 MLH:X%/I4A]2Z8BCKXHL@N!TT*,VE=G8*9C.F]_E^.UMY6Z\ZCN5UC'1*C+>K MJ)I2FUI)25&A=22D[D9'L9$?: M@"3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_V M4 K("3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_V4 K("3>!3+//OJ'^J8_]E!X% M,L\^^H?ZIC_V4 K("3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_V4 K("3>!3+// MOJ'^J8_]E!X%,L\^^H?ZIC_V4 K("3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_V M4 K("3>!3+//OJ'^J8_]E!X%,L\^^H?ZIC_V4 K(B'1C_E'6?_$*P^CQ!EO MIEGGWU#_ %3'_LH;!I-I1$TEJKF*Q=VV12[BU>N)UES#33:2 MV;3L24$ WD !"=-/??:X_D/%_\ [D+L(3II M[[[7'\AXO_\ <@%V M M !#-6_?/Z!__ M +?^A(%S$,U;]\_H'_\ M_Z$@:?I_7?;7\:X\WIGO/F+F ,SL#UR&426'&7 M$DM#B30I*BW(R,MC(Q[ ?G_ .@KJ3%GP[MN8\\ZEI:H:T$:6W>$G7$+2LU+)3*2,C'78 . )W0"S]>*UV/Q[V&UWYB=S MY/9LW+R5.<5H[.4E;2HRNZB03JB0I*HZC6:C7N@^ OC;Z ^HB4SR4C&UF9;6 M1]^Y1>Z8N^S<[9/^S_\ )/BI6G_9M_NBB/X.(?H6 #BV/T$)=OIC24MA'I*J MZ;M)KSDEF;)EJKZUQV0\S"2M24]V+);YH4\^DE$AY_A,S5VWKHT8!G.FVG*J M?/[]&0W!2S<9?1/?G$TSRFD\'.>0A:MW$NN;&6R2<)!=B2%8 M !"=-/??:X_D/%_P#[ MD+L(3II[[[7'\AXO_P#<@%V M M PMDD*%U5,#^,YMZP+_ -M&/Z*W\FZH?XA7WTD6\!(. MJI@?QG-O6!?^VAU5,#^,YMZP+_VT5\ $@ZJF!_&8MJE2P+NYQROA6 M\:3@T=;;TL&LK'Z^/0Q$OR9TN7)=80TT]S^ M6X:E((B2:4$G8S-9^0@VOJJ8'\9S;U@7_MH=53 _C.;>L"_]M$]S;I@7>.9; MI['8TWR9J)=E<)LJ"=6H;N4+AM(6DV#.0EA39\1F;G&I*DEXI[]@W'1GI)0M M:]0Y,&E4?N?=QBOR"(B1!-J2GNAQU)DXYSE),RY>W 39;&1^.K?L#(]53 _C M.;>L"_\ ;0ZJF!_&L83":62#9BN MJ2VI25+,S49)\;8R(S\A$.?:'^$ O#R:FG7U7W)@D;#6,DM9\:E^[37GUJ;: M0P1SCY*3SKGW/0\AO'\:@M' @1Y#JVB<^ZR"7PDI/:DN)7;N6^Q M[!8>JI@?QG-O6!?^VAU5,#^,YMZP+_VT3*!T\:^)99HQ>87=L][Y:)3 M7P&E=P,-/FP^/KR6O3)KV.*SB(<2VOD$A]7C)6HB/F-OP]HUPNGY79(O#4XGA=S9JML ML/%[)EQR(XN$M+/-,T*9D+:=,TF1D:7#(B2O?M(DG,MGA%DOE5.JI@?QG-O6 M!?\ MH=53 _C.;>L"_\ ;1/:#IO5;>&4\N;07F6WLF+96DR+BU8A'<5?%G/1 ME2'4/23V+[EMLE:U+,C,DEOPED9?3OP-JY.-#I2YLKF$1DE!FD]]RVV,X2W'JJ8'\9S;U@7_ +:'54P/XSFWK O_ &T: MEE/32QZHSS(L#9I+:#D\.!92*^19ML%%ENQ&%.J^YI?[H2@R+Q5K;0E9$?"H M?+J3TH;G3_HRZ6ZG/1JU,G(W:'OL@XK[K++4Q"%R#9;0OF;I)2N MUGY-R4 MW?JJ8'\9S;U@7_MH=53 _C.;>L"_]M$PQOIX4-MD^HRTQI-UCE3.IJO'8U75 MOLVEG+F-NFIDVY*FRWXFSV,R;222,S,^PQ[+/IS53.7XRGN!ZBQ]"+Y.50[N M(96=8_7QD/G5?=]25?,FN*ES29XE(:EDA39MJ2:2):5)/ M?BWVX126^FWA?NS512J')H$%%U-Q]60R8;)5Y38K:G'&^)+QN&1H0I1*)&WD M(]C["#9NJI@?QG-O6!?^VAU5,#^,YMZP+_VT:)"Z?>$.US]A/Q;,J6 6/OY1 M$DSZ]@D3J]I:$$ZUPOJ/QS66Q+))D7:KA+8SI^BFNE9KIA\S(*BILJIB,Z;/ M!8G'<2Z? 2B4V['==:<3L9=J5GL>Y'L8#%]53 _C.;>L"_\ ;0ZJF!_&JX'$-*4E6QS3(]C(CV,MA2-"K.7=Z(Z>V-A)=FSY>.UTB1)?6 M:W'7%QFU*6I1]IJ,S,S,_*9C[-7?Z)\U_(DW_(6,5T=O>_:9?FQ6?1&@%" M &F:U6,JHT;SR=!D.Q)L6@GOL2&5FA;3B8[AI4E1=I&1D1D M9?@$\Q#HQ859XE23),W-G9,B"P\ZOW?7Q<2U-I,SV*;L7:9^0;WKW_07J+^; MEC]%<&=P'^8F.?DV-_E) 3[JJ8'\9S;U@7_MH=53 _C.;>L"_P#;17P 2#JJ M8'\9S;U@7_MH=53 _C.;>L"_]M%? !(.JI@?QG-O6!?^VAU5,#^,YMZP+_VT M5\ $@ZJF!_&6I:[ CXW2EDMPB)">$E*,D^-PD7$K?J\?.W7Q69S\UN,RB8^A#;LA+9$XX MA!J-"5*\IDDUKV(_)Q'MY3 2CJJ8'\9S;U@7_MH=53 _C.;>L"_]M%? !(.J MI@?QG-O6!?\ MH=53 _C.;>L"_\ ;17P 2#JJ8'\9S;U@7_MH=53 _C.;>L" M_P#;17P 2#JJ8'\9S;U@7_MH=53 _C.;>L"_]M%? !(.JI@?QG-O6!?^VAU5 M,#^,YMZP+_VT5\ $@ZJF!_&)72?DV3_E*&H]%_P![3I+^ M:-1]#: 4T M $0Z*W\FZH?XA M7WTD6\1#HK?R;JA_B%??21;P :#K=HW5:\8"]BES8V=3$5)B67'05Q#(J*[8N,KRV\R"VEPI;^3VTN/)G%W(H MU1VB2;'(Y234HS;-HR,SW/<]MND0 0#3WH4X'I]T][Z ",4_1@JHESCEU;YAEF47E+WR-$ M^XG-.J>.YCZ-%^C#BVA=JW/H9]Q+>111[(1U[CLE2E.D:>Y.9P[J["X]^PNT8XN@AIVK%GZ!^;?2X+N,1<5W>DL\: M(\>0<7)CFZ MF+'=6ZA:3Y&Q.&IPR,S(T[;;)+RCHP '-N4=!;$,GF7DES(\@C+L+EG((Z$E M#=1 G(8Y"W&TNQUDLG&R(E(=XT]G81&-KPKHJXE@5E5V,.RN7Y4#'9&-DN7( M:43K+SW.<=7LV7W4UGV;;((NPD>06<3/6-]XKK3J,XE2ZB1D2.[$)\BU(C/N M1T'OV;&^AK;?_>)("M\C1$J<:/%XSJ)+'&#.JI,^ME1B?GP9XV%)V)QU?"I"4K21_?&?:,D?0NP!%3?54.3<0*^UD4KZXT:0UM'[V$@HR& M^)HS))DVGCXC49]NQI$YP?+M:LLRS966T]7-E5ZWK!ZG03T9"VIAR4<3M M)D%<3,2=7?%)CE'6IUJ82(KCC9 M)225J2J1Y$D1D1[%L1;!A*_H%817YG.R)&0Y*;DB39RD0^;$)II4]I;-:C3PI(NSWDZLLT3X,AI*ZV5 0M$=V M-Q-&1'LXKB)SC)6_D(8%KH,8"^AM=O8W]].<[[+L9LZ2US+-VQ92S(<>X&DD M1DA"2039()/"788Z* !S4WT$<5DP+EBYS3,\@?M*V#4.2Y\N*;C4:'()^.AO MAC)(C(TDDS,C-1;F?C'Q#89W1"Q"3'X>[+20I&3S;-ER9)96TXTX1- M$9L;+/Q2,E__ !F+H #AK0WH99W RM2LTLI]%15^+2<8@KK,G5,D-(=?0M)Q M%%&:-AI"4;$3G,6>^RC41;#HG07HV8_H!"R1%383[6;D,E$FPF3&HS'&I".! M/"U&9::1V>4R1NHS,S,Q7 ]-M814N5+S"B4 MR_%6Q&:4AU.Q$1F:BV[-NTQT "::/:#5&CLN_L6+N_RF_O7&EV%YDLQ,F6\ M3:>%I&Z$(0E*2,]B2DO+V[BE@ -0UA4:-),W4236940=$=/8T;0K+[&.SCMQ]I$?8+AJ[_ $3YK^1)O^0L8KH[>]^TR_-BL^B- -<\->H7]7W-/GF@^T0\ M->H7]7W-/GF@^T190 1KPUZA?U?:#[1#PUZA?U?:#[1%E !&O#7J M%_5]S3YYH/M$/#7J%_5]S3YYH/M$64 $:\->H7]7W-/GF@^T1_<=Z0TZ5J9C MN$91IKDN#V601YDBMD6( Z :)KW_07J+^;EC]%<&=P'^8F.?DV-_E)&"U[_H+U%_- MRQ^BN#.X#_,3'/R;&_RD@,\ AVMNI.H-+JK@N$8"O&HTF_@V4UZ5D<.1(0 MGN8F32A),O-FGBYA[F?%ML78-!QGI^43U9IRB_Q^1&MF'-KM.\XR3$\)M9$*A>^Q=M;/03 E:=%@IX\T>+DDTE#[H>X]N?S]N=Q\S;F'Q M???V>3L& E]$S2Z?/O),G'Y#R;A3BY,0[6849*W'4/.J99)TD,J6XVA2C;)) MJ,NWRGN&$Q3I.^[34+%<<9HYN/2)EK;4]G7VS#3K[+\.*U(+A=9D*0DC2\@] MR)S?D^B=HKANH.'Q&W(U]D-?3KCVJ.)3*7IA1GR^Y.<)K2?%PJ2I23V(_& M(QLBNBKIAWD>JVL==BQW&:]A+D:SEMOLE!(RB*:=)WC;6V2CV6@R4>_C&8V) M[1;#Y.%4N)OU;DBCIY;$Z&P]-?4M+[+O-;<4Z:^-Q1++B/C4?$?EW 0+(^GW M&1@=W=T.GU\Y*CU*K>N*T0TL^FMV95)&EKDDAZ&XLY,6-W1(C$TE\W"-*>)).*23:E(425GL1GNUAT M>M'$8W9T\FMBQJJNJ'JF82K9]'<<)Y],QQ*UF[NWNXA+I+,R46Q;&2>P?2?1 M6TQG2+68Y4S9C=S$D]Q&F"U/?6S$6X29!J/B-)&:4$HTDKMV,C(:SF_ M\(-653N65>.8?.N+ZC?80EHY\%;+S:YR(BU&IN0KEJ):RV;7PJ\9._"6^UWM M>C]@-W)ER)M#SGI;==OIR6XK'="91DT9O[1TI>03A0\2UMNI;02FS,T*VWVW&67T<-.%K6KW,,H M2JPBVAMMR7D-E(CQ^YV%$@EDDB2T1(X"+A/RF1GV@(U6=.ZOSF]JJC%Z8XTL M\IJJ>:=@_'EMJB3%/)YC3D5]:2<(V3(TJ,^'X2/X+#CFI]G<=(3,\#>CQ$5- M+2UUC'?0E1/KYG\&*Q7HB:5X9*@R:S'I12(+\. M1&VQD1#+9;T<<#S;.E9E90;5O(U,LQ MW)E9D%C )UMI2E-I6W'?0A9$:E??)/RGN C3/3UKJ2H>=M<5N[U^-W3)ER*2 M+'8:C146CD!"C0]*-2E<:4]B3/BXN+9);D7SZ@].J304LNQJ,0F)FUT2\*=0 M6B&2?1*KU1TJ(Y#<@VR01/DH^$EFHBV(TF6RK"?15TM.+.C^Y?[C.85&D)[X M2O';5,.:HM^;V?[09KW+8_\ =^][![;?HO:97J[1(B<-/+4I"B)1[;GM^@NOMOK)G&9UT[%Y&+5M37U$Z#'L.6ALY-6W:KB_[VG27\T:CZ&T IH M M (AT5OY-U0_Q"OOI(MXDD[HL:?3;JVM$,Y)6R MK68Y83$5&87$!AV0X>[CG)8E(;2I1]I\*2W'KZJN"?',X]860>W *^ D'55P M3XYG'K"R#VX.JK@GQS./6%D'MP"O@)!U5<$^.9QZPL@]N#JJX)\L+(/;@ZJN"?',X]860>W *^ D'55P3XYG'K"R#VX.JK@GQ MS./6%D'MP"O@)!U5<$^.9QZPL@]N#JJX)\L+( M/;@ZJN"?',X]860>W *^ D'55P3XYG'K"R#VX.JK@GQS./6%D'MP"OCYI];$ MM6"9F1FI3*7$.DAY!*(EH42D*(C^$E$1D?P&1&)3U5<$^.9QZPL@]N#JJX)\ MDR%-V=G%]WEXKNCN>*A;/C*F&I/ M"I1GXIEO\.Y .OQ\S5;$8G2)K<9IN9(2A#SZ4$2W$IWX24KRF1<2MB^#<_PB M4]57!/CF<>L+(/;@ZJN"?',X]860>W *^ D'55P3XYG'K"R#VX.JK@GQS./6 M%D'MP"O@)!U5<$^.9QZPL@]N#JJX)\L+(/;@Z MJN"?',X]860>W *^ D'55P3XYG'K"R#VX.JK@GQS./6%D'MP"O@)!U5<$^.9 MQZPL@]N#JJX)\L+(/;@ZJN"?',X]860>W *^ MD'55P3XYG'K"R#VX.JK@GQS./6%D'MP"O@)!U5<$^.9QZPL@]N#JJX)\^_Z/G]PR?Z/$'0 Y_P!7/??]'S^X M9/\ 1X@#H !HFO?]!>HOYN6/T5P9W ?YB8Y^38W^4D8+7O^@O47\W+'Z*X M,[@/\Q,<_)L;_*2 SP YDOF\LE8-JAB=7BLC(K:[MK>)+ M?8EL,KBD^TGN%U275()3)LJ0DU)49IY>Q)5V[:)JWC>KN./Y5>M-W-=0P8%D MA(C,S^],=,# M^*22TF2B(R/RD8#1]#8-G6:.89$N$N(LF:F.AY#OWZ#)LMDJ_M(MB/\ M(;R M # 9__ ##R3\FR?\I0U'HO^]ITE_-&H^AM#;L__F'DGY-D M_P"4H:CT7_>TZ2_FC4?0V@%- M M '/^L1;]+?H[_V,Y(?_ .1L%_ZC MH 0#5XM^EST>_P"R+DI__DL8O_4!?QA+/.,PQFQQWK+T:;^5FVJ=UBF*MRH5VQCMBIA$IE*K MF3$LW),ME7,7N2C:X"(W.%'WJ2,B+L#I$]:M/$PJ28>>8R42\<-JJD'<1^78 M+)1)-+"N/9TR49),D;GN9$/HB:L8382ID:+EU'*DPIS=7)98L6EK8EN*-+;" MTDHS2XI1*(D'VF:3+;L,<(7'1RU0G6^I]RC3N6_'U*AV<*MKG)D(G,>6_.;> M;=E%SN%)*2@WE['''([;YDVEMER2LONVZS*6^:3/@;V#N\!C\?.Q50UIW"64VYQFCF)C;\HG MN$N82-_]WBWV_L&0 <_P"KGOO^ MCY_<,G^CQ!T .?\ 5SWW_1\_N&3_ $>( Z :)KW_07J-^;EC]%<&1P&X@ M>X3'/]MC?R;&_P#>I_\ Q2?[1L5A7Q;>!)@SHS,V%*:4P_&D-DXVZVHC)2%I M/#]4 I/?B!\=C?I4_M#OQ ^.QOTJ?VB;=5# M1'S.8!Z+P?J@ZJ&B/FB\'ZH.JAHCYG, ]%X/U0"D]^('QV-^E3^T._$#X[&_2I_:)MU4-$?,Y@ M'HO!^J#JH:(^9S /1>#]4 I/?B!\=C?I4_M#OQ ^.QOTJ?VB;=5#1'S.8!Z+ MP?J@ZJ&B/FB\'Z MH.JAHCYG, ]%X/U0"D]^('QV-^E3^T._$#X[&_2I_:)MU4-$?,Y@'HO!^J&C M:\=NGT.U$GP-)<&A3HN.6+\>3&QN&VZRXF,XI*T*)HC2HC(C(R[2,@'07 M?B ?_P#/1OTJ?VAWX@?'8WZ5/[1S[H/T8-&[?0[3N?/TEP:;.E8Y7/R),C&X M;CKSBHS:E+6HVC-2C,S,S/M,S&\]5#1'S.8!Z+P?J@%)[\0/CL;]*G]H=^(' MQV-^E3^T3;JH:(^9S /1>#]4'50T1\SF >B\'ZH!2>_$#X[&_2I_:'?B!\=C M?I4_M$VZJ&B/F#]4'50T1\SF >B\'ZH!2>_$#X[&_2I_:'?B!\=C?I4_M$VZ MJ&B/F2?[;&_DV3_ .]3_P#BE?VC M7.B_[VG27\T:CZ&T/GZI^B/F M,K<]DD0V?JKXY\L=3/6%<^T@+, C/57QSY8ZF>L*Y]I#JKXY\L=3/6%<^T@+ M, C/57QSY8ZF>L*Y]I#JKXY\L=3/6%<^T@+, C/57QSY8ZF>L*Y]I#JKXY\L M=3/6%<^T@+, C/57QSY8ZF>L*Y]I#JKXY\L=3/6%<^T@+, C/57QSY8ZF>L* MY]I#JKXY\L=3/6%<^T@+, C/57QSY8ZF>L*Y]I#JKXY\L=3/6%<^T@+, C/5 M7QSY8ZF>L*Y]I#JKXY\L=3/6%<^T@+,(%JT6_2ZZ/_\ 9!R8_P#\GB%_ZC+] M5?'/ECJ9ZPKGVD8^9T-L(L+FNMY5_J#(M*Y+J(8?M(S+S;C+SZD+2IMQ:3(R/RCJ M !S_ *N>^_Z/G]PR?Z/$'0 Y_P!7/??]'S^X9/\ 1X@#H M !+]?=2KK3NHQ2-CC< [S)LCAX_%DVC*WHT4WN-2WEMH6VISA0TO9 M)+3NHR\8A.&NDGEECHWA5C&@TT7-=9==KH[[AV%]+<=89@OF\;\ MN4:%()1DTSQI:2I&V^RG/+L'1H#AV9TSM6L?IL>RBSPJ#+PV8A[:SCUANI\#5K3FLNXEO$NI1-H8L'X M,5Z,TF43:%K2EMXB<2G9:5)XO*E25%N1D8#?P 3WI$^]^U._->S^B.BA"> M](GWOVIWYKV?T1T Z.WO?M,OS8K/HC0H0GO1V][]IE^;%9]$:%" M M $8T^] M]/K%^1<<_P#N LXC&GWOI]8OR+CG_P!P%G 3+I,:FVFC.@N;YO2QXDJU MHZYFKCSRZPFC3Q,2 M4..N%QF2NPB41[E_:*@WT[\(E5M9(A8KG=A-LVGID.ICX\ONUZ"TE)JG$VI1 M?[.?&1)69D:CWX2/8;ED/1KQV=H3D.G-''K,8^Y[&KX?+\(U'+^BOD!W6(9'@F>LXKE-)C)8G)E3:8IT>9#V3XQ-=-:UNN<3; M>Z24A!\/WNY[D&QZA]/J%C./5$RKTYS/OE+OH%2]77-.Y%=;9D^,EY!$:B<4 MI)&2$$HC-78KA\A[1B'2VK7]3+G%XTEEWN5#Z692UN*+F M*W41&DB29EMMN6XP>5=%74S/\08BY-K#&LKZMN:RWJ'&\<2U7Q%0]]B4P3_& MM3G%NH^:1;D6Q$/9EO0C3F&(ZH5LG,U1;C,,ACY-"MXM;P+IYC3;:4J0GG;N M?>*_WD=BS+X-S#,6'3HT]8K(,NOKLGR%R<[/*-#IJHY#[D:&O@D3"22B_P!G M2HC(EF>ZMCV28S.O'2'/"^BQ;:N8*J!=-I@1I]:NY=@A]9TZK&#K-J9!R:EEU^$XS-8I*V#%H7W;2RL'> FVT.<[@XUF:E);X"W M01*XBV/?;,DZ+.IFHFGD_#\WUF@WM8XY!=B'%P]$-494>0V[N9IE*-?$EO@V M,RVWW[=MA\FI?04C:B+S^4YE:&9^0Y+!R> ;]43S$)Z,P3)-.MF[]W;6GBW[ M4&6_]G:%GTYUSQO4W!K;)ZU$^$S3NR(UG76D8X\R"^P6[K3K9F>RB+8^PS(R M,MC$2TBUGZ0.K%=BFHM;C6'2M.,AF[%0MO/-6\.O-:DIE*D+<)I:R)/$;9([ M2,B+MWVJ?1]T!9T7T_M,?GS*ZXDV\MZ9/'8Q*\D*BMN3E/J<-HUJ)1-$KM,U=O#Y"WV M55'3:T_3C%O92X.25UQ66S-&[BLNJ4FXYEL, M=9=/73JKIX$AVJRQRXE6KU&>-,4JW+9BYCDT*JBQ\@B0K1R2S3WTZK6S6V[D$29T3<]UO=_@VB6,7;O;R^^/=9&7%_&GRN#?R>/O\ V -MU@UBM]Y)N+8=4G@.5OOX M2SF^F+QI=GDO*Y M.5T]LEE%WC=LY723CI-*'6U(2]'=(C,]N)IU&Y;_ 'R5? -)TFT=U.TGHJ3& MXNH6*S\8K'#+D.X?)3,<94ZI:D<\K/@)>RC(E\HR+L/A/R#8M&\8L(E_J%E= MG%=@/9-=YD?9M M_:6X=$@(-UI;?S":M?-E?[<'6EM_,)JU\V5_MP"\@(-UI;?S":M?-E?[<'6E MM_,)JU\V5_MP"\@(-UI;?S":M?-E?[<'6EM_,)JU\V5_MP"HZBZ;4.JF/HI\ MACOO1FI+4V.]$E.Q9$:0TKB;>:>:4E;:TGY%),OA+R&9#4G^C#I\]B$/&DU] MG'JH/*7#;CWDYM45]MY3R9+2B>W1(YCBU&^7W17$9*4HNP:WUI;?S":M?-E? M[<'6EM_,)JU\V5_MP#*Q.B)I; FTDF-026.]*620PW:RR9EFR^N0RJ4WS>&2 MI#SBW"4\2CXE&9F8S.>]''3W4PLC+(J1Z9[HCA':&Q9RXQR>Y.(XVYM.HV)! MK4>R=B,]C/M+;^835KYLK_ &X.M+;^835KYLK_ &X!ORM$<0DTE34V M$.?>0*N2Y+BMWEQ,L5$ZMM;9J6N0\M3FR'%DDEFHD[[I(CV,?=IGI5B^C^/+ MH\2K55E:MXY"VW)3TE:G.!"-S<>6M9[(;0DB,]B)"2+8B$SZTMOYA-6OFRO] MN#K2V_F$U:^;*_VX!>0$&ZTMOYA-6OFRO]N#K2V_F$U:^;*_VX!>1/>D3[W[ M4[\U[/Z(Z-(ZTMOYA-6OFRO]N&K:KZ^9%G.EN8XW T'U4:G7%-,KXZY%; 2V MEQUA;:36933,D[J+Z2225<1\1&+@ #A:FU+SZEA6V5HO;BYIJS%M[ M6M4^X\M"'9EBCNYGM,^:SRFM]NTVR47E2D4O5++YM7I-I5:6-_-CU\FL)<\F M+TZJ3+D'!);2SE&M'$25DI:FS7NORDESAX3Z>'BMM#I$2TDLB,CV46_:7D < M=:>ZD9+%SG'[#(;!W*LFG-1([F(5UU,BSX2N]:77'%07'&HKB5.$O=:T\)&Z MG[H1IX2V/.]4X,S5ZCKXN0VV.YJGN2=+QFSOX\=,.,DU'W&F(T^;,N3*VX2+ M=S@)25<:-DDKJ+EHYG,X4\S;AXMNW;\&X\@'%<74W,K*%GC^43;ZB2UD-0_- M@29G>HH\1UHN*#&D\:29/?@\C/7DCOFZP[W)L1IG?[5H2XA2%I)25%L:5%N1D/X;2%&@S0DS1VIW+[WX.S\ #S M !&^E-_,G$?S\Q7_6H8L@C?2F_F3B/Y^8K_ *U#%D M M M 2_-.CQCF:9C M*RA5KE%#:O8S+?QABNJ[3?+K4STYLO MKAH'1]P7,M7M%B=)9@=ZFXZ%KW,TMI. HR27P$9G_Q%!ZO M]_Y\M2OTE3]G@/'JNTWRZU,].;+ZX.J[3?+K4STYLOKAY=7^_P#/EJ5^DJ?L M\.K_ '_GRU*_25/V> \>J[3?+K4STYLOK@ZKM-\NM3/3FR^N'EU?[_SY:E?I M*G[/#J_W_GRU*_25/V> \>J[3?+K4STYLOK@ZKM-\NM3/3FR^N'EU?[_ ,^6 MI7Z2I^SPZO\ ?^?+4K])4_9X#QZKM-\NM3/3FR^N#JNTWRZU,].;+ZX>75_O M_/EJ5^DJ?L\.K_?^?+4K])4_9X#QZKM-\NM3/3FR^N#JNTWRZU,].;+ZX>75 M_O\ SY:E?I*G[/#J_P!_Y\M2OTE3]G@/'JNTWRZU,].;+ZX.J[3?+K4STYLO MKAY=7^_\^6I7Z2I^SPZO]_Y\M2OTE3]G@/'JNTWRZU,].;+ZX.J[3?+K4STY MLOKAY=7^_P#/EJ5^DJ?L\.K_ '_GRU*_25/V> \>J[3?+K4STYLOKA(]0='C MH.D5I%B/6#)YK8FIQ49J,IDR5S=T[&XOR>7<5[J_W_GRU*_2 M5/V>,%:=$=RZRNBR6;K)J0_=T;(B*!L?$3:"[2/R=FP# M-]5VF^76IGIS9?7!U7:;Y=:F>G-E]G-E]<'5=IOEUJ9ZG-E]<'5=IOEUJ9Z'5_O\ MSY:E?I*G[/ >/5=IOEUJ9Z/5=IOEUJ9ZG-E]'5_O_/EJ5^DJ?L\!X]5VF^76IGIS9?7!U7:;Y=:F>G-E]G-E]<'5=IOEUJ9Z'<9=82HQR M&'4NLK6TMTTKX7$)41*(RW278+,(YU?[_P ^6I7Z2I^SQ]O18RZYSK0'#[O( M+!=K<2([B9$UU"$+>-#SC9*42$I3N9(+?8B+?X %6 M M M !$^A3[T_2S\AL?]QBV")]"GWI^EGY# M8_[C%L $7R;ICZ18=F]AB=UE+M?<5\MJ#,-RHG'%CO.$DVT.2B9-E.Y+3 MVFLB[?*+,2TF6Y*(RVWWW^#\(Y!9Z&L_4G5W6"PS>XR6GPJ]OH4V+255C%1" MNFFH[7C2$DA;Q$3C?#P\39F1>3X1HUIT.^I:6;9QX]MTS\G:7X2&7):3(S)1&1=A]OD'YU5W1*SN/DV'Y"QI^JLA,W5ZNI MIRFQ77L4BR8Z"@J4?-X.%M\EO&AE2^#B\4C/L&M87T0=7JW ;N&O$)4%/(J6 M[JA*QB,MY0IB7S)6QMOK):EM\1QM M4O*@Q.U3LDFF^8Z:$I(S/A3VG_Q(O*9#ZL7R6!F./P+NK6\NOG-$\PJ1&,5=3/N6U42;B-+>KVY#9=R MR5$MTFV4D[Q+-EA:R;^#[ MSFN'A6?,-U)\DS;XNPBW[ 'Z"DHC4:=RXB\I;]I#7*S47'KC.;O#H=ASLCIH M[$N?"Y+B>2T]Q<))82D2'T*_WR^#X %:N>D3@]%955?)FV1V%I;O4<.(S2 MS7'GI+)$;O"A+1F;:"41F]MR]NWBV(Q2242M]C(]CV/;X!P$?0_S7(-0JV_G M8G'AS&\LRFT;LY,N,XJ&U)CH.N>\5PS/:07$1)(U)-.YD78-MZ!V@6=Z19+; MS,GQZ1C#"Z6/ F(5(C*:M)Z'%*7+X6773<5L9_=G#0I1+V-'B[@.K,*U&Q[4 M-FX=Q^P[O;J+)^HFJ-EQKE2F3(G6_'2GBVW+QBW2?P&8V,UI2I)&HB-7D(S\ MHX(B=#[*\FU')66X:U88FYD^6V;[4B;'6TXS+9:*$M39.;JXEHW))ENDTD:B M3V&-'R/HIZNE7:226\(DV^4T>/P*]Q5C.@3(,9]F2I9I6HWFWXII09'SHKCG M&1$DT]@#],1XJ<0@C-2B21=AF9[#A>JT4U78U)JZUW"7^\M=J7998[D*;.)W M,[#DQG$-DVV;O--1*5LHC06W9MOV[:%;="W,*C0+3W'(.F4:POYSLU_*W3D1 M)6;:O$Y!M\OM MX^+L(!W,E1*+=)D?;MV&(_,Z7&E4#4'W&O9.:;E$AAUTC M-6Y$;JE)4YV&:"V'EIM@FL>DI/Z=5NGM%?8^_ELBX]VMM8,N12A/R3?6:HG$ M3_=2>(TI,B-.Y$>^Q .O>(C4:=RXB[3+X1_.-)']\7EV\OPC\[W.BWJ>[D$Y M+&&/1,N3+R"1;9^=M'-&10I3#Z(L,D\WF>5;)<+J$H;Y>Y'VC%3^@?E,;&+4 MZW VF[M.%T)05ILHY+*_9D$L2GMND: M5)D*<<(V^,TO2%FL]C(S3XI&'ZB$9'Y#W^#L&B9%J5,HM6L2PXJ%UV#>QY;Q MW2I"$MM+91QY%P_K/I))Z,U=GN<4\*OQ5-3?T5U MAD%4UM*;24F,;$^.VT2S7QN\P^(C3NLTDKM(MQV+T=M((^FND>%5MI$8EY) MC+E2I[S1*>3,D[N2E)69;IXEK41[>4B(C ;!J!K3ANEK,Y_*+E-7'@16YLMX MV7'$QV7'DLMJ7P)/AXEJV+?_ )JC\B3,O[EFL^'80U-*>Y=%;BKC,YEN4 ME)SDOG!/FK3PFR1*)#BC)/!P%ONDP'2=?KGC%A"E3%LY#5PXRV6WI%WC-C6- MIYKA-H/BDL-DHN(RW,M^$CW/8NT4 QKM%M2X=GCNH4)5A3KB1/=I<0) MY/272-IEI@HTMY25J<<1Y2(C[.WL'2%!&DPJ*MCS%\V6U&;;>7OOQ+))$H__ M *[@/O !$NA;[V3"/^BD_2GA;1$NA;[V3"/^BD_2G@%M M M !S_E72?R%O5[+=/\ !-)KG4"PQ1B"Y;RH]O K MVF52VU.LI24AU)K(T(/7\!F7]HMX U[4/(9&)8!DMY$0TY+K*R3- M90^1FVI;;2EI)1$9&9;I+?8R_P"(Y^HND;G;D&%,>C5]S6RN])*LTXS84[,= MZ5-98(T\;: MTFE2=TF1EN1F6Y&1C#9+IQC^78@SC%E$?73,G'-IJ-,?C.-FPI*V5)>:6EQ) MI4A)D9*W[ &JY=E^76FI;N&8A)IJEZ%3HMY4^Z@NS$N\QU;;32&VWFN$MVEF MI9J/;=)$GMW+(W6ITC%:7%D3:9R]R:[^Y-UF./M.-K=0R;CQH=?4TGEI)*MC M49&?86QF8]-CH%B5FQ#2\J_[HBMN,(GIR6Q*8IEPR-;*Y//YJVS,B/@4HR(^ MTB(8/*YFBJ.\V"6V48]23:5;;5=51LC*MGPU-?$6_8:DI2>Q]I;#VEI'HCD;BD-0Z*: MJ+6PR4W'LC/EPXCZEL+,DN=B$NH61K/[XT*2HU$1D,ODV(Z65F/M6U[)K*VE MDNRGVK&7;JCL+7.\9Y2'3=(MW/*G8^SRHV 9/!=5FM3]/9&2XS7E+=2IUEB& M[/C+2XZCLV-YAQU!%N9;GN9EV[IW+820^D=F4G!ZZ[8@T4>5"Q=647,=QIYQ M#Z"?4WW/&5S$FV>S;A\Q9+[>'Q.T]J]@Z,#PNQD8M07$([B69V;\%^X5,L)' M$E)<]9NN+>61I2@B49F6Q%MV;#7KS3#2A5ECF*SWHD*QCQ5,5],5VZP_+B\? M,4TMHG25(:XT<1I62T]A_!N TGP^YW/1%E5M75RXM\5B=3%8@ONRH:(:G2)5RON:M4^I+ MKR4H6YRXIN*-"U<)(,S-)_"0^2EJ-(Z/)L8L*VRI&+A^$ENE2BYW[J92E:2< M:;-TTO*X5N%S>%2ME*+B[3 8W,>DG$H&KU,''+644-<^##LG.0F'+GQ6''G( MY?=N:6Q-++B4A*3-"B)7DW\+3I!*TUTNPJ_S>O=D65XPE;ZH!1X<9A9M\S92 MY$GEHW(R2E)NF:C\GP[?/R]!+^UOKQ.48Y.6E+SUER\HXHL8WT82\1H2Z3Y&2 M'5;&:"(UI,NWLWW>3T<\ DLN-%3RHK:W77C3"MID;AYJ$H=0GEO)X6UDA'$T M6R%&DC-)GVC^O]'33V1-*2J@-))=0^W%;G2416G4&@R<;CI<)IM?W)!&I*2- M1$9&9D9D8;-I_D=>3')U:T-J<6:U$@E&?"GB49DE.R2WV(B+L M&7 ?+-JX=D;!RXC$HV'"=:-]M*^6LO(I.Y=AE^$NT?4 /6;#1OI>-M!O)2: M$N&DN(DF9&9$?X#,B[/["'L 'K>CM2"03K2'20HEI):2/A47D,M_A+$]@ M B70M][)A'_12?I3PMHXXZ*NK6H-+H%BD*LT/R3((#*)"6K.+=5#+;Y= MTNGNE#LM*R[3,O&27D =C@(CX;M4/ZNV5^D%%[:'ANU0_J[97Z047MH"W )] MHGJ^QK-C%C9II)^.3:NVETEA66*V7'8\J,YP.IXV5K0LM_\ >2HR/_\ V*" M U;57*96"Z7YADD%MIZ;3T\RQ8;D$9MJ<:86XDE$1D9I,TEOL9' MM$"68=0:XY3B-'=*U7QB.JQ@L3#9+"%J)LW&TKX=^^!;[;[;C>ND3[W[4[\ MU[/Z(Z,KI'_11A?Y$A?Y" &D>X/7#SNXSZ#+^T ]P>N'G=QGT&7]H"R C?N M#UP\[N,^@R_M /<'KAYW<9]!E_: ]W20UZ=T#H\:FL5%=:O7EPBI0=MY=G:0#:?<'KAYW<9]!E_: >X/7#SNXSZ#+^T!K\SI MOZ?=W8Y"K8]_8R[FUC5I1U4DN.ZPW(;6XS*4AQHE*96EM1I4DC(]E>0DJVS, M;IC:63*^QELW4YQ$53266RJ)?-L"=>4RTJ&CE\4E*W4J02FB46Y?@[0'O]P> MN'G=QGT&7]H![@]X/7#SNXSZ#+^T![;_I*T M$;0[+]2*&+*MVL;:?.54SFG:Z2A]HB-3#J'6^-I6RDGVH/L,C+YF7"8?'[@]=W&?09?V@,!I/TR\5SNLQ)J^8>QK(\@:CNE7MQIDB-#.2: MNY6WI2XS2&W'209I)1$2O]TU$:5*UC7[IQEH?J?S[UUD6R,YN3H@3 M9W.4LN3#BFPLWW"Y?WI++?B+R;@*-[@]=W&?09?V@/A MR3I?X)1LY!&:D2%751 DRE1IL.2Q%6^Q'*0]%[J)E:.X/7#SNXSZ#+^T!].'=*73W.(5/+K9]BVS<6**R 0:.8V6Z%-MK42_O>S8S(^P? QTP=,IDN%&A65K8ORZQ5PVB!1S9'#% M2IU',5P-'P[K96DB/8S/A(B/B(![O<'KAYW<9]!E_: >X/7#SNXSZ#+^T!C' M>FUI2Q3,V*[.WV6J:E<-%#-7*8.)P')YK26C4V3:7$*,U$1;'OOV&,ZYTI]- MV[R16]^9*VXT8I4FS;K9*J^.DX_=)(8VY+D]Y6CX/7#SNXSZ#+^T ]P>N'G=QGT&7]H#Y7.F1 MI@RFK0NPMDS;!Z3'17'13>ZV'(_+-\GV>5Q,\"74*,UD1<)\6^P^?'^FOI1D MUM75\*UMR>L'HC+#DF@G,,GW47^RK4XMDDI0Z>Z4*,R)1D>WDW 9+W!ZX>=W M&?09?V@'N#UP\[N,^@R_M ?0[TK-,F*!%RYD"T5[E6]<-K."_P 2X[MZ:N&EC&29#>5UY25-1?2*7B[T3'GN%F.P\X^ M^T3!+C$GG\)I<+_=[#/?8@V#W!ZX>=W&?09?V@'N#UP\[N,^@R_M 9[)=9(U M'GFFF/18)64;-CEFS8)?X"80S')]*N#A/CXR,B\J=O+V^0:Q==+3#\8SW-,9 MN8ES!X/7#SNXSZ#+^T!GM"-9(^N>&3,CBUCU5'9MIM8VS(-7,64=Y31.*2M"% M(-7#N:%)W3OL>^PHP"-^X/7#SNXSZ#+^T ]P>N'G=QGT&7]H"R DW1VSC)\ MPJLTA9;-K[.UQO)I=&4^MA*AMR6VVV5I6;1N.<*ONIEV*,O%+^T5D1#HQ_RC MK/\ XA6'T>(+> .8]"/?P=*;^[XE]!D#IP_@Z4W]WQ+Z#('3@ M ")]"GWI^EGY#8_P"XQ;!$^A3[T_2S\AL? M]QBV #0,@Q>SG:V8=?L1N.IKZFSC29',27+<=7%-M/" M9\1[DVOM(C(MNW;!<2EX]5N0K*MHI45N6EYR$A MI"DK>639I2M*DJV5N9+/[Y)J(]QS'I#P\)U3FX=84[J6T4I6<6U-\B9?DF3Z MDPU%P^(M2([BDJW,E;*+;;Y+DA;R#,DGPDDUD9OJW,O&VSV.=(/(=0D$UAV%Q+*=&@]\)[-C='$0TE M3[S3332RCKYCB^YUJ\8D)3NG=7:-BU7UM3I?08W(D53:;B]>Y#%?93.0AE1, MJ=<)QQI#QF:209;-H7N>WP;J()EE.A5U70B>HKIU\1JJDP#MW:]R?*<1 7W.U%L MW9+7-6AU)MO$THN,VD.DXM1F2DGQ*.F5/2JCVNI&.XJ5)&2JV9BN$;5LAZ3] MWC+?YC33:#0\PGEFA3I.EXQ]B3&3=Z05B[A61Y"QB!5Z*.V?KY:+^U;A-QV6 MVDN=T/+2APT\7&E*6TI6K=2>+A[>$,3D&,9A5UV6Y:Q@[>69Q8WB$541]Z*H MJZ"PHT1GT\UYM!\)GHH-1'99F)B(D*F6 M:6I3#TB*4E*$L\O@624*21_=4K,^+@0HDF8O (E MT+?>R81_T4GZ4\+:(ET+?>R81_T4GZ4\ MH " =#W^2=6O\3,C^EF+^(!T/ M?Y)U:_Q,R/Z68OX ">](GWOVIWYKV?T1T972/\ HHPO\B0O\A Q M72)][]J=^:]G]$=&5TC_ **,+_(D+_(0 VT !I.I>D5#JN_BZ[XGG6L?M46 M\>.@FS:?=2VXV2'4K0KB1LXH]BV/KF5( M;B]Q+<-:N%*4\25[F9;DK8B^#?M%' !SM#Z%./,2ZVQE9CE-G?5TN ]$MYCD M-3S3$-MUMF+PICDV;? ^Z2C-!K4:M^/EZ*N+4^B.3Z9%.GJK,C) M[OA8QV8<22I3I$DU(2RPAE!D24D6S6W9V[CY5]%.!9QJEC(<_P RRHJE;ZH2 MK1V 2F"=B.Q5H+DQ&]T\#IF6^Y\24GOMN1W( '/5?T(,"J\YQG)V)5BN321: M^-R)#4-Y,LX3?!&<6XJ.;J%$6W%R5MI4:4[EV#8=2.B]A.HUQEM[>OV#4R\@ M0XRY3+[;2JTXBW'&9,99H,VG4J<,^(S47879MOO9!/\ 7Z%/L=&,PCUB''92 MZ]S[FS]^XV7:XA/]IH)9%_Q 0!SHV:$7FHE\RYJ1'F9)D\60V]6%851SUO3( MI-N26S)CG\:VCXR3N;9&M2DHV5L*A'Z(N(1GVWF[2^2XW=]_DJ3):(RD=P=P M\.Y-$9(Y1<79V\?;Q;>*)K>:9YM?9[>3J"NO'J*SR6IO:MY$JK[PNL-,1"-U M])K[LXD\I?"E!;&:6^PRWW^;#=(=9)+\./DMAD?4Y' M2MXURS:PVZ^.XR\RTXR MG9EN*3"C4V\X2UJ;4M9F1FK.M8T[(7*9-Y,=N M0[(2LC)DB-9K>42N(C2I)$1I\N^I6.B6I!L6,N+/RGOBN)LV'FVH MZDR"<0ON5+S:5+)O@,]B4DCX@&5PCH4ZQ*/C4N02>TC;/?<= Z2HF.YUJ++42DP')4%H]S(TJF-Q$ M)DJ+;L/8^6@S+_>0K\ #Y='>C1C>B^'W^/UCQ([IH)KE(211 MV&D'PIW\92349F9F9[B?1_X/_"'J!BEO]60679$8BJV5SD3DFP:8Y&:T/MI4 ME3AK[-R/GZ6?D-C_ +C%L$$Z%V0U3'13TO;Z6G_&L']81^ MT!,8W1M@4C#"<;RW(\8>[C57RY,!<53DQ@WG'4DOFL+)*D*>=X5H)*B)1EN? M9MLV4:30K^IQJ-#MK.CG8XLEUEI$6V]):^XJ942C?0XESB;6HC-1&>_;OOVC M:/=+3_C6#^L(_:/$\II26E!V\ EJ(S))R4;F1>7X?[2_^H"88YT7\>Q6PK%5 MUQ[BV4LJ;-MQI3:V^%)&1+2HR41&1]A#;O=+3_ (U@_K"/ MVA[I:?\ &L']81^T!+\:Z,&-XE/JSK+6X9J(3\2:JG4XRIB3+C-$TS(<4;7, MXB2E!FE*TI,T)/A\I'8AC?=+3_C6#^L(_:'NEI_QK!_6$?M 9(!C?=+3_C6# M^L(_:'NEI_QK!_6$?M 9(!C?=+3_ (U@_K"/VA[I:?\ &L']81^T!D@&-]TM M/^-8/ZPC]H>Z6G_&L']81^T!D@&-]TM/^-8/ZPC]H>Z6G_&L']81^T!D@&-] MTM/^-8/ZPC]H>Z6G_&L']81^T!D@&-]TM/\ C6#^L(_:'NEI_P :P?UA'[0& M2$2Z%OO9,(_Z*3]*>%;]TM/^-8/ZPC]HD?0J6EWHPX,M"B6A3,@TJ2>Y&7=3 MW:0"W (I9=#?2FTO;BX53W,.=;S7;&<=;E-M":>DNJXG'.4S*0@C4?:>R2 M'IZEVE?Q/*/3>\]L%Q !#NI=I7\3RCTWO/; ZEVE?Q/*/3>\]L%Q !#NI=I7 M\3RCTWO/; ZEVE?Q/*/3>\]L%Q !#NI=I7\3RCTWO/; ZEVE?Q/*/3>\]L%Q M !ROKGT0M,Z/1/4&RB1,D3+AX]82&3=S*Y=02T1G%)XD+EFE1;D6Z5$9'Y#( MR%ZT?03>DN$H3OPIHX)%N9F?\0CX3\HQ?2)][]J=^:]G]$=&5TC_ **,+_(D M+_(0 VT T!+9&M-RUHADN9%$@'95EK-@-,FA?)4AFP5&2:BX]]S0DC/8R+?X" M+L'\QS47.,F9D99'=QR/A[%M+@JJ9,=Y,XX[#SC"G2DDZ:.::VS4EGD[&1DG MC(^T;"WT>\);1:M=R6RH=F\[(E5Z\@L%0UN./4=_3@2S?[M[Y]Q'923@=U_&.Y.9R>9OV\7!OQ>-]]V@-'Q?5K-UQ MM/RMY@U/J>4E_8D<*R)MO8U;EV%L>?S3I$5> M&6EM&7CMY90ZR2BODV4)#!L)F.,DZW')*G2<-2B4@N(D&@E.)(U%V[8B%#T. MTZSZ)#5E=+6Y%!>44&@LLI-28#KI;'W/"=?-#*E$O8N!!&1+V3L2MCV0L2TS MR;.&[UN5!GWJTIM.3'N%J9=Y6[)2E14N\I:D;&WSE(,TFDBXB-);!ILCIE86 MVS:G K;BS[W+,C;B--;O-$RESG-\3A$:.)9-;F9>.1EY"W'VV/2QH*6PAU]I MCMW5SWK%VL>9FNP64QWD+N6P]Z](=$<)Q=JV M>CTU/C\FM16-64BW6U'=B./G)0A+RG=C)3BN,E$>YEL1'P[$/MO, TDR7*U5 MLZ;#7?W!JL5U;&0/,NV"%I;(U+CMO)YS1I8;\4TJ1XAGMVGN&'=J8XR MGM2:]EV0;2ER6=W$ U-?5Z88U%I\<5=5ZG;:8W<0F+&\ M-Z5:/[I4A\E..FN1VI1MN:D^*G8O%+;R52:6:9T625,R72TM5+;0JWCVUF7 MEITC:;2OG.'RVU$E24)+9/89)+R@-3G=(.[ML_Q'%*C%YE%8S;-#=LU>-QWE ML0U1G'T+;Y,KAW632RWXE&G@7N@SX=_=J'THX&)66;44"CERLAQVLD3T-2GX MS*))MLD[NAM3Q/*;V5MS";X=TJ+BWVW^[#ZW1:GL*"QI[T,PO)+B?96=6_-D3FWFWFG;&4< M?[JSR75(8YG+;6IO=)K0DE;&?;V@-0E=*BCIH:YMOC]Y!K6UOQ#LB1'<80S^:^Z2[N-Z@8KC]MBME3/7[<49FK?=&Q>-LE6UET<]/C=>4]2/S$.MN(6Q,LY(N8>YF:C,S,_Z71VP V74.TTB6XZE:7)4NTEOR5<2V5\ M1O+=-SC)49@TKXN)'+3PF1 *0/Z/XE))21%OL1;=I[F/Z B'1C M_E'6?_$*P^CQ!;Q$.C'_ "CK/_B%8?1X@MX Y MCT(]_!TIO[OB7T&0.G!S'H1[^#I3?W?$OH,@=. M )>]T6-%I+SC MSND.!NNN*-:W%XS"-2E&>YF9FUVF9CPZJ6B?F=P'T8A?5"I@ EG52T3\SN ^ MC$+ZH.JEHGYGNG1]TMJ>F;T8*6#IKB$*FMRRCOC71Z**W'F\JO:6USFR;X7.!1FI M/$1\)F9EL8[G'*_2%]_5T2O^&7?Z8T JO52T3\SN ^C$+ZH.JEHGYG1"$)(D MI27P$1;#[@ !/>D3[W[4[\U[/Z(Z,KI'_11A?Y$A?Y"! MC>D&RY)T#U*::0IUUS&;-*$(+=2C.*X1$1%Y3$QTOZ86B%?IGB465JKBD:2Q M41&G67;1I*VUI902DJ(SW(R,C(R,!T: C/7-T)\[F(?.[/[P=]4=XE(=>:;=(C4:>)+I;&9*+B(C(YG@71_P!1<2R+ M%VW(DI4R ]6OE,6[&>IDDS!4RMV0V3B)"Y#:G%H2EOA;4DF_[5%:>N;H3YW, M0^=V?W@ZYNA/G ?1DFFEW;Y;ICD-DQ67>14ED^*)5TYW=W6O5RGI,F*:5-1EFY)0XEEEQ/&I2$K-6YI1MN M9GX8GICJQ@>5:GY#R:FZN[JB;*)8Q'.6J58)#KFZ$^=S$/G=G]X!.M1^C[D->4&APN%*./84\*KGV MJBC.));,PWU/+6XZAQMPU+<<4M"'>89[;(41*'58C/7-T)\[F(?.[/[P=V+\.?&5Q,R&^3&3Q MH5Y%)W2HMR[.PQ?P !S'H1[^#I3?W?$OH,@=.# MF/0CW\'2F_N^)?09 Z< M '*_ M2%]_5T2O^&7?Z8T.J!ROTA??U=$K_AEW^F- .J M M !S'H1[^#I3?W?$OH M,@=.#F/0CW\'2F_N^)?09 Z< M $&UGIE9ETAM*\8EW&05]'+H\AFR8M%?3:KGO,N5B6E.+ MBNMJ7PD\[L1F9%QGV#8NK/B7XZU!]8V0^W *N E'5GQ+\=:@^L;(?;@ZL^)? MCK4'UC9#[< JX"4=6?$OQUJ#ZQLA]N#JSXE^.M0?6-D/MP"K@)1U9\2_'6H/ MK&R'VX.K/B7XZU!]8V0^W *N E'5GQ+\=:@^L;(?;@ZL^)?CK4'UC9#[< JX M"4=6?$OQUJ#ZQLA]N#JSXE^.M0?6-D/MP"K@)1U9\2_'6H/K&R'VX.K/B7XZ MU!]8V0^W *N E'5GQ+\=:@^L;(?;@ZL^)?CK4'UC9#[< JX"4=6?$OQUJ#ZQ MLA]N#JSXE^.M0?6-D/MP"K@)1U9\2_'6H/K&R'VX.K/B7XZU!]8V0^W *N E M'5GQ+\=:@^L;(?;@ZL^)?CK4'UC9#[< JX"4=6?$OQUJ#ZQLA]N#JSXE^.M0 M?6-D/MP"K@)1U9\2_'6H/K&R'VX.K/B7XZU!]8V0^W *N E'5GQ+\=:@^L;( M?;@ZL^)?CK4'UC9#[< JXY7Z0OOZNB5_PR[_ $QH5'JSXE^.M0?6-D/MPPEW MT,].,@N:BXFR,U?N:+<4V-V5C"?5G]RLFWV8KCC:C2J49*V4DCV,C(_A&VXET9<:M,5IILG) MM17),B$R\ZOPA7A<2E((S/8I>Q=I@+P CG57Q/Y1ZC>L2]]K#JKXG\H]1O6) M>^U@+& CG57Q/Y1ZC>L2]]K#JKXG\H]1O6)>^U@+& CG57Q/Y1ZC>L2]]K#J MKXG\H]1O6)>^U@+& CG57Q/Y1ZC>L2]]K#JKXG\H]1O6)>^U@+& CG57Q/Y1 MZC>L2]]K#JKXG\H]1O6)>^U@+& CG57Q/Y1ZC>L2]]K#JKXG\H]1O6)>^U@+ M& CG57Q/Y1ZC>L2]]K#JKXG\H]1O6)>^U@+& CG57Q/Y1ZC>L2]]K#JKXG\H M]1O6)>^U@+& CG57Q/Y1ZC>L2]]K#JKXG\H]1O6)>^U@+& CG57Q/Y1ZC>L2 M]]K#JKXG\H]1O6)>^U@+& CG57Q/Y1ZC>L2]]K#JKXG\H]1O6)>^U@+& CG5 M7Q/Y1ZC>L2]]K$BZ0FC,# )VDZ*3+M1(J+W.8%+8)5G]TOG1'&9"EM^-*/AW M-M'C)V,MNP^TP'8 "1]6#$OQ[J'ZQ;_VT.K!B7X]U#]8M_[: K@"1]6#$OQ[ MJ'ZQ;_VT.K!B7X]U#]8M_P"V@*X D?5@Q+\>ZA^L6_\ ;0ZL&)?CW4/UBW_M MH"N )'U8,2_'NH?K%O\ VT.K!B7X]U#]8M_[: K@"1]6#$OQ[J'ZQ;_VT.K! MB7X]U#]8M_[: K@"1]6#$OQ[J'ZQ;_VT.K!B7X]U#]8M_P"V@*X D?5@Q+\> MZA^L6_\ ;0ZL&)?CW4/UBW_MH"N )'U8,2_'NH?K%O\ VT.K!B7X]U#]8M_[ M: K@"1]6#$OQ[J'ZQ;_VT.K!B7X]U#]8M_[: K@"1]6#$OQ[J'ZQ;_VT.K!B M7X]U#]8M_P"V@*X D?5@Q+\>ZA^L6_\ ;0ZL&)?CW4/UBW_MH"N )'U8,2_' MNH?K%O\ VT:?BV*)TUZ7--C]3?93+I+#!K.?(@7F36%JR_@Z4W]WQ+Z#('3@ G6I6L2 M\ RK',:K\-OLTO+R+-G,1:1R$WRF8JHZ75N+ER6$_?2VB(DF9GV]A; ** DG MAHS7S"YY\XX_]J!X:,U\PN>?../_ &H K8"2>&C-?,+GGSCC_P!J!X:,U\PN M>?../_:@"M@))X:,U\PN>?../_:@>&C-?,+GGSCC_P!J *V DGAHS7S"YY\X MX_\ :@>&C-?,+GGSCC_VH K8"2>&C-?,+GGSCC_VH'AHS7S"YY\XX_\ :@"M M@))X:,U\PN>?../_ &H'AHS7S"YY\XX_]J *V DGAHS7S"YY\XX_]J!X:,U\ MPN>?../_ &H ^+.O?:Z0_FSD_P#G5 M YCR3)M1;G7#!R3V(S+M^$3&HU]RJ]J8 M5G!T*SQ^%-81)8=[OH$\;:TDI*MCLR,MR,CV,MP%F 23PT9KYA<\^<6 Z! &#SO+X6GN$9#E-DV^[74 M==(LY+<9)*=4TRTIQ9((S(C4:4GL1F1;_"0#. (Y7Z[9=:0(TV+H1GCL:0TE MYI??"@+B0HB,CV.SW+L,O*/H\-&:^87//G''_M0!6P$D\-&:^87//G''_M0/ M#1FOF%SSYQQ_[4 5L!)/#1FOF%SSYQQ_[4#PT9KYA<\^<?../_:@G,[(=1I72(I<^3H9F15$+%9] M&XP=G0\\WGY<-Y"B+OEP\!)C+(SXM]S3L1]ID'4("2>&C-?,+GGSCC_VH'AH MS7S"YY\XX_\ :@"M@))X:,U\PN>?../_ &H'AHS7S"YY\XX_]J *V DGAHS7 MS"YY\XX_]J!X:,U\PN>?../_ &H K8"2>&C-?,+GGSCC_P!J!X:,U\PN>?.. M/_:@"M@))X:,U\PN>?../_:@>&C-?,+GGSCC_P!J *V DGAHS7S"YY\XX_\ M:@W#2O4:OU;T_IS'WU^EGYJ9-])I0%A :# MK/JJ6D.-U5L=8=KW==0*?DD_R>#NE]+/,WX5;\/%OP[%OMMN7E ;\ Y>U2Z: MKFGDK)XS6(QW"I16MC;/UM.J5<%$BRFH\1J1)D..DRLVTH-Y+9)2E9 MJ,O@&[9]T@I^EV@A:BY9A[E#-8?CL3Z279-F47F2D,*<[H0E25((EY#9Y8F),3:5%38PZNMFX_S+5RY??84\:&6&&S5N@D+( M]N+L29F9#Z.NA@J;Y]',=?QU5/!LX5I$:>??FO2I+L=$1$1+7-YI+9,MOOM] MR-)<)F OX#F;&.G3BUI'?LKN"K':-E%HZY(>.2[))N).;ADHXY1B,N-3J3-) MF2T'V<*NTRW!WI?Z9L5#4]=A;$I9-\G'7%(4;2":2 M:C\0U>0N'FK4.W9G'C[DU=8NPDV]K8N(6MI+E;0SI3+SB&4OFVVXVR:5JY*R MX>"6BJE'$;[M;)<0G)'+Y;9ND9$DE* M(]^SL,!9 $2=Z8^E\9^X8E65M#D5;T=AV/(HIJ'G>>\;+*F6S:XG4K<2:2-) M'\'P&6_OB]+W2Z54/6)WLF,RS!>GN-RJR2R\E#,DHKJ.6ILEW%NI M/9L9& LP"/Z[=(=C1B+&Y-(N^GNU-E=JBG)[FY<6&QS%J4HT*/=2U--D6W^^ M9_[NQZCJ)TP%8*W8S2C2VWOQJ=(E>*1^( MZ. Y-3NQNY)]'+0RX@E\9.-.-I<:=(]BVXDJ,C+X%(4 M6Y^4!LH (WG?OJ=(_S?R3_ ,=6+((WG?OJ=(_S?R3_ ,=6 L@ ">](GWO MVIWYKV?T1T972/\ HHPO\B0O\A Q72)][]J=^:]G]$=&5TC_ **,+_(D+_(0 M VT!QQ8=+S/V.D)>8=7U51=5-7D[-,Y50Z6P5/*$IAMQV8J:2U1D$WQGNE24 MF9%_:-OK>G#6W.,4]Q!TYR^0JVARK:)"_P!B2\NMC)0;TSQI!))!&OA2C?C4 M9=B=NT!TP Y&B?PA-,U&R"PL,6FHJDW3-50.HFPV>^*%PDRS<6MY]"&MFSXM MEF7WZ$ENKB)- Q+I;U>HUBEO#L-R3)*Q$.-)EVD=$9MF&Y(CF^RRXE;Q+W-) M$2E)2:$FI.Y^4R"\@.1=-.G6Y?LT]EEF-/4-985M=*=2PVVX4+NN:_%0^X_W M09&SNT@C+EDI/%N?8>R<[8=/_ JV7C;;U5;MLW+*9A/.KBM&S$"1;R$-*3! M9-3R3XBYNYK62$D2#W/?8C#I !S18=.B@AQ]F<'RJ;818EC,MJ]A,0G:M$!Y M+4LG35()*S2:R47+-?$1EL,<]_"*Z<)E9&4>OMIL.HBRY+4B.J*I4PXQ(-Y" M&>=S6S+C\4W4H2OA5L9[=H=4 .8:3IHR?=G?P:0 MWQJ;2]'-UU4=Y24=K2G%&1_#\!83 -?-0F\+B:A9P6&.8=:X\O((U93OJBV< M0B)"D-&J0]RGRX%EQ.;LI0K^PR =,@.3D?PC&$JI*2P5CEPA-A92:QQ3DN W M'8<8-OBVDKD$RX:B>0I"4+,U$2MB[.VD-]*O%W+0X)5UF2RN+:FYADRE'-KX MIR7E\1N$1(4@MDF>W;Y>$NT!:0'&\S^$&;OH,";B6,*D#],RLO(N+5]WB]M4Y;>-4ZV*I'(<)\I MZ'%$\THG3(VFR9=4LS,E))/DW[ '1H#G;.>E5)TZUGR'$IV//WD%GO+%JH]. MA!3'Y011Y,N I^ M(IY2R9)UA$E3FQ\!&:DI-)<:2W,]R(.C ',=1T\\8M*9<]S#LH@JD5T.QJ8S MZ8AN6J),KN5I+7"^9(,WNS[J:.SQO(/MROIOXU@604E%D^+7M!9D55?.FH2;#25J6EUU"C4GQT-F1$M._E/8.@ '*L?^$#QY]EN6K3_ "]J ML7%:L>[EE!X$PUS.XSD&DI)JV2]LGAVXC(]R+;M&R,=-+'%74Z)*Q;(*^O:? MMH46VDG$3&FR:[B.2T@S?W1XJ3-*W"0D]CW,M@'0P#EBF_A ,:R*G8D5.%Y% M;63LJ=$[WP'X#VQQ8R)+BR?*3RE(-IPC(TK/)XEDI#1EP)+A(]U$?$9GV[D1;2I[I,74;-L$YL*M1AN1 MR[-M^2M*RD16&9#<6*YQPG$D6W"9F'1P#F73CI"YSJ]=*H:EB MBQZ:]-L)#,^?">E-HK62BFP1LD^V:WUE+0:CXTI21'XIC=,&UHN+6WQ^ONXD M%MV5:V>.RW(*5DVR:H_F[-_R M5"LB3=+/WLFJ/YNS?\E0K( Y^Z6_\HZ$_XFU?T>6.@1S]TM_Y1T)_ MQ-J_H\L!T" F72@][1JW^:-O]"=%-$RZ4'O:-6_S1M_H M3H#;\!_F)CGY-C?Y21GA*';LWW$F@]/ZFL/E&3U,R+>Q6J5JM4W*.GE*.P=FIW998:)OC4X>Z= MD;<1^/V;(49!> $1E2%M)1=3Y'%4.7CBF*>8M,:&WS2<6^9-;-&E3#B# M2O97$7#MN9#,5'20Q3+<'S;(<:.98KQ6&N7+@3H4BO=47F3I='35I>L[1F78/28Y07*.:4F.N/RS?)]KE<3)-I=0 MM1K(BX3XM]AZD]+O$+?%*?(J!J?/K9]U%J".=7S(;BR?0I:'&$''4;^Z4^*1 M$1&?8:DGV +F Y:TEZ=U+G%#/N\FI/HW3DT^PS!9%[4]WY)8I@.ST5+-?*:6TEM[D*3*5R5=R; M.DIO[J1>,1D Z* 0GI.])I[H\KQMMJ@@V)7*GR.PN[?O57L&TE)DTN2;+J4N MN<6R"624GPGNHMA]]?TL\"=CG(1&7+92I@W M3;2I24DL^(BW+REN%G 1&GZ96E=U1NW#5U/C5Z:]5JT]-IYQM6BI3,]5E/A)B5,&98K;9BR.0N0^2(Y&R@E MFDE&HN$C/8E*(C,!= $4L.F-I55KORE7\EINF2Z;CYU2PZF,OE\,@ MT/+0VHFS5LI1?\12\#SFKU&QF+?5!3$0I!J2E$^$[$>2I*C2HE-.I2HNTOP; M'Y2W(!L #GWKI872OY&QD[$^GD55U:5C+,"')LER68),J?DF3+)\M)$\1F2N MPB(SXC&[4W2+P;(LW8Q:KGS;">\EK:5&K)*X2%N,D^VTN23?*0XIHR62%*(] MC+X3(@%, :QF^:IQ%5'';C=V3[BP1 C,&YP%]ZIQQ9GL?8AIMQ7D[3(B[-]Q MJVD.MR=5I:&"ICK.*B@7?$%(P+,DYK4RGU1NXIL&=(KID4E\9-/,K-*ME;%N1EPJ(]B[%$)OT+ M?>R81_T4GZ4\ MH #F/0CW\'2F_N^)?09 Z<',>A'OX.E-_=\ M2^@R!TX CV8^^OTL_-3)OI-*+"(]F/OK]+/S M4R;Z32@+" #3-7-*ZO6/"WLT>NBZ$.G-#;8%8H[ZRI&'0IL**4E]M2)92C6;JY!$V7$HE.N M&G@X$I-9]FVQ#H$ '/U#T*<*Q+3W%<7QZZR6@DXQ+E3*O(H$QE-DTN0:NYAZ\LZ/V"Y9=3,_AYM84=O<6T*Q@9!6SHBFX\IM MA4-M,?F-+;63B'%(-"R7Q&?B['L-/C=&/1E=^UBM1J!)B9I71HC;#,6YAN64 M9^+)=EIEW& MNH+\Q)R9[4M];B&V?%43S*4_>D1$:B,M]C+Z]<>B7=6LM5QIQ.)B]G6ME83I M%A;G!6@IL1J,XTTM$1\C:,F&S-"D)B3%EQHY,\YE2TJ+91<9&E:5$9*,C(:_8=#7'Y59";C9GF,*Y:1 M/8EWY3F'YM@S--)RFGC=94V1*X$[))UK' VJT,V2-HR<02BY:T$K8^(NPB+H+5?3L\LRC3V[B5;4RPH[ MUN0N4M225&C&TZEQ2>(R\JC;(R3XQ_\ A"DZ/9R2<7,\2D[X=L4LNZHO_+_ M /RJQ*W8^Z]OB-+<^[]$BNRS*]-I5%(BS<)JKZ;ER+#(F>4^9*R-*V+)*Y2%1FX392%]S.)8)Q''P,\)G]\K[X?RMTOU$9U M:K,GA4M[6XE'**Q(HK3(D2Y\IHI#Y[JD<]1DEHW$N\@W%I6GQ>(S\0@W8NC$ M<"9BS;626N0,1LG1E%S9Y),Y\Z6\RPI$=MM+;:&D()1H,R2E!$2/(9F-JR[1 MMK+<[E66,E,F9D3[W[4[\U[/Z(Z,KI'_ $48 M7^1(7^0@8KI$^]^U._->S^B.C*Z1_P!%&%_D2%_D( ?50Z>X_C$S))597]S/ MY'+.=:+YSB^Z'C;2T:]E*,D>(A);)V+LWVWW,:5=]%K36_Q?'<>?HI,>LQ^* MY KDP;67&=;BN$1.QU/-NI<<:61$2D+4HE;=I"L CUCT2M,+!29L_-N/ MU5M6=YI<>79RWR5"YJWDL)-;IFVE*W5FG@V-.Y;&6Q;9*UZ-^GUO98].+X-]NP:Y=:!8+D%3D-=,I5&Q?6B+J.<@D$B0TXEPELK232-C;-.VW]I[T( '.]ST'\ N=>D2TODZ[Q\"B6ASB)?'VGV$0^_,=!="\)BW,[*$P<1+]:L&R#-;73]5!-?JE5 MEXJ9*LHQ,+55QSE6Z(9-O13(DI;>2XA2'FU-D?BJ)232?D[1K57IQ<:,ZHUUK2XYD M&=UTBJGHGV$>17-OG-D36Y"EK0Z]'023V5L3:=BV(MM^T\5BN#9?IOGKV6R, M,G9+%D/7<=%?7R89R8I2)_=#3Q$Z\A'"Z@B2K9?$GA3N6V^P;=A>-:)='%EU M%==4^.^ZOADN.7&1*>5;*[?NW%)>5S5*X^U9;FK=)&9]@_L7H;Z.QX=PPQAZ M"CVT14)U/?"4M+,=3A.&W&(W3*,GC2E6S/ 6Y%^ :U3XKD^$SL@EN:6-6;.2 MT<2$S4T4F&4>K4VEU*H;O.<:+DF;A+-39++=3G9][Q9>YTZRVBTMTRH$HM\B M8I&&XU["QVV[WRY9)BJ0@VWU/,F:$N\)FDW$F9$1]NVQA]%;./RI#I M+-TWY]S.E.*4<540S4IUY1G]P6IO8^PBVV[2(RTZGT8T^Q#5K3O,7,RHVJ.C MIW*+#JZ3+-R0ZIU1$H^['Y"U2>$C-#:$I+@)9EN?8*'H_B=V_I*NASVO<4\\ M[)9W!SW"(NSBV["B[NBN95& U=$SB:YCTW#58 MRE$>1&)NGD=TFX3B^)PON?"I*MVN,R-E);;[ *YD>':.W6H=I>V\NG7EM4J% M96"EW2FW8?L]U)(E<9<6_9MBV>CKHSEJ:1J#'3-B16^^$ M:' OY1QI32Y:Y)..MH>X)#?="EK3S"4DCW(NPMAJM9HG=WV2L45[23(M5 L[ MNPD9$W)8(IR);G''2ULM3G&DS0:B<022-@OOB,AD=*=.]0-/\\@*;BK;QRP+ MF6!2'HSIL(+NDTM.+(^8;A*-A9X&4K6DEGP$G8]S[-S'U.Z"Z4:IW\+4%F*5V\^<22 MQ/K;N3W'(7&W*.]RVGB:<4@C4DEF1GL9EOL9D- U0TSU%RO(C%I1CJ:VWEPY,#O1VKL)-_, M1W21O\[_ &QQ3_\ M))Y%4V4.YMLJF,K05 M_P"Z!!5*V^%GEH;@J=(C6E:5&>[;7D4KF*XN$PN^J&@6!ZS/PI&749V,F(TX MPU)CS9$-WDKVXVE+8<0I;:MBW;49I/X2&.D]Ń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end GRAPHIC 19 tm263879d1_2025q4orgchrt8.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt8.jpg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end GRAPHIC 20 tm263879d1_2025q4orgchrt9.jpg GRAPHIC begin 644 tm263879d1_2025q4orgchrt9.jpg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
~~OK 2*HR#)K63E%K8:EKQF/B]ZU3> R(,1<60VE+& MZY.[9.FY(-PS3T;C9%SHV2>QDK'X_KU;9#KO9T:Y<^+A]J]+H:>3XG<0PS.C M((S>1+4UT3IN**4DDQ>27$9-Q6WEECM5;Y) ;:;;O)T!EE)3WV5-R3;+9*G6UJ;6I)?(1J09E_ 9#~~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end GRAPHIC 21 tm263879d5_bylawsimg01.jpg GRAPHIC begin 644 tm263879d5_bylawsimg01.jpg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tm263879d5_resartofincimg01.jpg GRAPHIC begin 644 tm263879d5_resartofincimg01.jpg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tm263879d5_resartofincimg02.jpg GRAPHIC begin 644 tm263879d5_resartofincimg02.jpg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end XML 26 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 27 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} ZIP 32 0001104659-26-047667-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-26-047667-xbrl.zip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end XML 35 tm262570d1_485bpos_htm.xml IDEA: XBRL DOCUMENT 0000948923 2026-04-23 2026-04-23 0000948923 ck0000948923:WithdrawalChargeMember 2026-04-23 2026-04-23 0000948923 vip:RiskOfLossMember 2026-04-23 2026-04-23 0000948923 vip:NotShortTermInvestmentRiskMember 2026-04-23 2026-04-23 0000948923 vip:InvestmentOptionsRiskMember 2026-04-23 2026-04-23 0000948923 vip:InsuranceCompanyRiskMember 2026-04-23 2026-04-23 0000948923 vip:ContractLapseRiskMember 2026-04-23 2026-04-23 0000948923 ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:OverloanProtectionEndorsementMember 2026-04-23 2026-04-23 0000948923 ck0000948923:PolicyIllustrationFeeMember 2026-04-23 2026-04-23 0000948923 ck0000948923:OnOrAfterFebruary12024ButBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:OnOrBeforeFebruary12024Member 2026-04-23 2026-04-23 0000948923 ck0000948923:First10PolicyYearsMember 2026-04-23 2026-04-23 0000948923 ck0000948923:PolicyYearsAfter10Member 2026-04-23 2026-04-23 0000948923 ck0000948923:StandardMember ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:StandardMember ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:AdministrativeChargeMember ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:AdministrativeChargeMember ck0000948923:PoliciesWithApplicationSignedOnOrAfterOctoberTwoPolicyYearsMember 2026-04-23 2026-04-23 0000948923 ck0000948923:AdministrativeChargeMember ck0000948923:PoliciesWithApplicationSignedOnOrAfterOctoberYearsThereafterMember 2026-04-23 2026-04-23 0000948923 ck0000948923:AdministrativeChargeForFaceAmountIncreasesMember ck0000948923:AfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:AdministrativeChargeForFaceAmountIncreasesMember ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:ChildrensTermLifeInsuranceRiderMember 2026-04-23 2026-04-23 0000948923 ck0000948923:AccidentalDeathBenefitRiderMember 2026-04-23 2026-04-23 0000948923 ck0000948923:WaiverOfSpecifiedPremiumRiderMember 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember 2026-04-23 2026-04-23 0000948923 ck0000948923:NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InterestRateMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InterestRateBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:ProtectedInsurabilityBenefitRiderMember 2026-04-23 2026-04-23 0000948923 ck0000948923:ExtendCareRiderMember ck0000948923:OnOrAfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:ExtendCareRiderMember ck0000948923:AfterOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:ExtendCareRiderMember ck0000948923:OnOrBeforeOctober132025Member 2026-04-23 2026-04-23 0000948923 ck0000948923:ExtendCareRiderMember 2026-04-23 2026-04-23 0000948923 ck0000948923:WithdrawalAndSurrenderRisksMember 2026-04-23 2026-04-23 0000948923 ck0000948923:AdvisoryFeeRiskMember 2026-04-23 2026-04-23 0000948923 ck0000948923:TaxRiskMember 2026-04-23 2026-04-23 0000948923 ck0000948923:LoanRisksMember 2026-04-23 2026-04-23 0000948923 ck0000948923:SpecializedUsesOfThePolicyMember 2026-04-23 2026-04-23 0000948923 ck0000948923:FundRisksMember 2026-04-23 2026-04-23 0000948923 ck0000948923:BusinessDisruptionAndCyberSecurityRisksMember 2026-04-23 2026-04-23 0000948923 ck0000948923:Option1DeathBenefitMember 2026-04-23 2026-04-23 0000948923 ck0000948923:Option2DeathBenefitMember 2026-04-23 2026-04-23 0000948923 ck0000948923:Option3DeathBenefitMember 2026-04-23 2026-04-23 0000948923 ck0000948923:Option4DeathBenefitMember 2026-04-23 2026-04-23 0000948923 ck0000948923:TerminalIllnessAcceleratedDeathBenefitEndorsementMember 2026-04-23 2026-04-23 0000948923 ck0000948923:LapseProtectionEndorsementMember 2026-04-23 2026-04-23 0000948923 ck0000948923:ExtendCareChronicIllnessAcceleratedDeathBenefitRiderMember 2026-04-23 2026-04-23 0000948923 ck0000948923:IncomeProviderOptionPreDeterminedDeathBenefitPayoutEndorsementMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DollarCostAveragingMember 2026-04-23 2026-04-23 0000948923 ck0000948923:PortfolioRebalancingMember 2026-04-23 2026-04-23 0000948923 ck0000948923:PolicyLoansMember 2026-04-23 2026-04-23 0000948923 ck0000948923:ReservationOfRightsMember 2026-04-23 2026-04-23 0000948923 ck0000948923:TelephoneTransfersMember 2026-04-23 2026-04-23 0000948923 ck0000948923:AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:AmericanFundsInsuranceSeriesNewWorldFundClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:BlackRockGlobalAllocationVIFundClassIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:ClearBridgeVariableMidCapPortfolioClassIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:ClearBridgeVariableSmallCapGrowthPortfolioClassIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DimensionalVAGlobalModerateAllocationPortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DimensionalVAInternationalSmallPortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DimensionalVAInternationalValuePortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DimensionalVAShortTermFixedPortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DimensionalVAUSLargeValuePortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DimensionalVAUSTargetedValuePortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:FidelityVIPBalancedPortfolioInitialClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:FidelityVIPInvestmentGradeBondPortfolioInitialClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:FidelityVIPMidCapPortfolioInitialClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:GoldmanSachsVITMidCapValueFundInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InvescoVIGlobalFundSeriesIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InvescoVISP500BufferDecemberFundSeriesIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InvescoVISP500BufferJuneFundSeriesIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InvescoVISP500BufferMarchFundSeriesIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InvescoVISP500BufferSeptemberFundSeriesIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:InvescoVIUSGovernmentMoneyPortfolioSeriesIMember 2026-04-23 2026-04-23 0000948923 ck0000948923:JanusHendersonGlobalTechnologyAndInnovationPortfolioInstitutionalSharesMember 2026-04-23 2026-04-23 0000948923 ck0000948923:LordAbbettSeriesFundBondDebenturePortfolioClassVCMember 2026-04-23 2026-04-23 0000948923 ck0000948923:PIMCOVITRealReturnPortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:PIMCOVITTotalReturnPortfolioInstitutionalClassMember 2026-04-23 2026-04-23 0000948923 ck0000948923:PutnamVTSustainableLeadersFundClassIAMember 2026-04-23 2026-04-23 0000948923 ck0000948923:SchwabSP500IndexPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:TOPSAggressiveETFPortfolioClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:TOPSConservativeETFPortfolioClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:TOPSModeratelyAggressiveETFPortfolioClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:TOPSModerateETFPortfolioClass1Member 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsBalancedPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsPRIMECAPPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsConservativeAllocationPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsEquityIncomePortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsEquityIndexPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsGrowthPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsInternationalPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsMidCapIndexPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsTotalBondMarketIndexPortfolioMember 2026-04-23 2026-04-23 0000948923 ck0000948923:VanguardVariableInsuranceFundsTotalStockMarketIndexPortfolioMember 2026-04-23 2026-04-23 iso4217:USD pure 2026-04-23 N-6 N-6 Protective Variable Life Separate Account <table style="width:523pt; margin-top:10pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#A5A5A5; width:8pt"></td> <td colspan="4" style="background:#A5A5A5; padding:3.5pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">FEES AND EXPENSES</div> </td> <td style="padding:0pt; background:#A5A5A5; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:8pt"></td> <td style="padding:2.583pt 0pt 2.167pt 0pt; width:120pt"> <div style="font-weight:bold">Charges for Early Withdrawals</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.583pt 0pt 2.167pt 0pt; width:379pt"> <div>If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25. The withdrawal charge applies for as long as you own the Policy.</div> <div style="margin-top:4pt">For additional information about charges for early withdrawals, see “CHARGES AND DEDUCTIONS” in the Prospectus.</div> </td> <td style="padding:0pt; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:8pt"></td> <td style="background:#E5E5E5; padding:2.833pt 0pt 2.167pt 0pt; width:120pt"> <div style="font-weight:bold">Transaction Charges</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.833pt 0pt 2.167pt 0pt; width:379pt; white-space:normal"> <div>In addition to withdrawal charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy and charges for transfers between investment options, requesting Policy illustrations, and exercising the Overloan Protection Endorsement.</div> <div style="margin-top:4pt">For additional information about transaction charges, see “CHARGES AND DEDUCTIONS” in the Prospectus.</div> </td> <td style="padding:0pt; background:#E5E5E5; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:8pt"></td> <td style="padding:2.833pt 0pt 0.5pt 0pt; width:120pt"> <div style="font-weight:bold">Ongoing Fees and Expenses (annual charges)</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.833pt 0pt 0.5pt 0pt; width:379pt"> <div>In addition to the withdrawal charge and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, administration, mortality and expense risk, loans including fees and expenses covering the cost of insurance (“COI”) under the Policy and the cost of optional Policy Loans benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy. Fees and expenses under the Policy do not reflect any Advisory Fees paid from your Policy Value or your other assets to the Financial Intermediary.</div> <div style="margin-top:4pt">You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:</div> </td> <td style="padding:0pt; width:8pt"></td> </tr> </table><table style="width:391pt; height:23.5pt; margin-left:132pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="background:#E5E5E5; border-bottom:1px solid #000000; padding:3.5pt 0pt 1.5pt 0pt; width:241pt; text-align:left"> <div style="white-space:nowrap">Annual Fee</div> </td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="background:#E5E5E5; border-bottom:1px solid #000000; padding:3.5pt 0pt 1.5pt 0pt; width:63pt"> <div style="white-space:nowrap; text-align:center">Minimum</div> </td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="background:#E5E5E5; border-bottom:1px solid #000000; padding:3.5pt 0pt 1.5pt 0pt; width:63pt"> <div style="white-space:nowrap; text-align:center">Maximum</div> </td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:right; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.25pt 0pt 1.5pt 0pt; width:241pt; text-align:left">Fund Options (Fund fees and expenses) <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.25pt 0.5pt 1.5pt 0pt; width:63pt"> <div style="text-align:right">0.03%</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.25pt 0.5pt 1.5pt 0pt; width:63pt"> <div style="text-align:right">1.24%</div> </td> <td style="padding:0pt; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="float:left; margin-left:136pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:6pt"> <span style="position:relative; bottom:3.25pt">(1)</span> <br/> </div><div style="margin-top:6.5pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:156pt; font-style:italic; font-size:6pt"> <span style="font-size:8pt">As a percentage of Fund assets.</span> </div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="margin-left:136pt; margin-top:6pt; width:387pt; line-height:12.5pt">For additional information about ongoing fees and expenses, see “CHARGES AND DEDUCTIONS” in the Prospectus.</div> <div style="font-weight:bold">Charges for Early Withdrawals</div> <div>If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25. The withdrawal charge applies for as long as you own the Policy.</div> <div style="margin-top:4pt">For additional information about charges for early withdrawals, see “CHARGES AND DEDUCTIONS” in the Prospectus.</div> 25 <div style="font-weight:bold">Transaction Charges</div> <div>In addition to withdrawal charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy and charges for transfers between investment options, requesting Policy illustrations, and exercising the Overloan Protection Endorsement.</div> <div style="margin-top:4pt">For additional information about transaction charges, see “CHARGES AND DEDUCTIONS” in the Prospectus.</div> <div style="font-weight:bold">Ongoing Fees and Expenses (annual charges)</div> <div>In addition to the withdrawal charge and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, administration, mortality and expense risk, loans including fees and expenses covering the cost of insurance (“COI”) under the Policy and the cost of optional Policy Loans benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy. Fees and expenses under the Policy do not reflect any Advisory Fees paid from your Policy Value or your other assets to the Financial Intermediary.</div> <div style="margin-top:4pt">You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:</div> <table style="width:391pt; height:23.5pt; margin-left:132pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="background:#E5E5E5; border-bottom:1px solid #000000; padding:3.5pt 0pt 1.5pt 0pt; width:241pt; text-align:left"> <div style="white-space:nowrap">Annual Fee</div> </td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="background:#E5E5E5; border-bottom:1px solid #000000; padding:3.5pt 0pt 1.5pt 0pt; width:63pt"> <div style="white-space:nowrap; text-align:center">Minimum</div> </td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> <td style="background:#E5E5E5; border-bottom:1px solid #000000; padding:3.5pt 0pt 1.5pt 0pt; width:63pt"> <div style="white-space:nowrap; text-align:center">Maximum</div> </td> <td style="padding:0pt; background:#E5E5E5; border-bottom:1px solid #000000; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:right; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.25pt 0pt 1.5pt 0pt; width:241pt; text-align:left">Fund Options (Fund fees and expenses) <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.25pt 0.5pt 1.5pt 0pt; width:63pt"> <div style="text-align:right">0.03%</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.25pt 0.5pt 1.5pt 0pt; width:63pt"> <div style="text-align:right">1.24%</div> </td> <td style="padding:0pt; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="float:left; margin-left:136pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:6pt"> <span style="position:relative; bottom:3.25pt">(1)</span> <br/> </div><div style="margin-top:6.5pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:156pt; font-style:italic; font-size:6pt"> <span style="font-size:8pt">As a percentage of Fund assets.</span> </div> 0.0003 0.0124 <div style="margin-top:6.5pt; margin-bottom:0pt; line-height:8pt; text-align:left; margin-left:156pt; font-style:italic; font-size:6pt"> <span style="font-size:8pt">As a percentage of Fund assets.</span> </div> <table style="width:523pt; min-height:224.5pt; margin-top:10pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#A5A5A5; width:8pt"></td> <td colspan="4" style="background:#A5A5A5; padding:2.75pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">RISKS</div> </td> <td style="padding:0pt; background:#A5A5A5; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:8pt"></td> <td style="padding:2.583pt 0pt 2.167pt 0pt; width:120pt"> <div style="font-weight:bold">Risk of Loss</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.583pt 0pt 2.167pt 0pt; width:379pt; white-space:normal"> <div>You can lose money by investing in this Policy, including loss of principal.</div> <div style="margin-top:4pt">For additional information about the risk of loss, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” in the Prospectus.</div> </td> <td style="padding:0pt; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:8pt"></td> <td style="background:#E5E5E5; padding:2.833pt 0pt 3pt 0pt; width:120pt"> <div style="font-weight:bold">Not a Short-Term Investment</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.833pt 0pt 3pt 0pt; width:379pt"> <div>The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered. Withdrawals are not available in the first Policy Year.</div> <div style="margin-top:4pt">If you elect to pay Advisory Fees from your Policy Value, such payments will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits.</div> <div style="margin-top:4pt">For additional information about the investment profile of the Policy, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “CHARGES AND DEDUCTIONS,” “USE OF THE POLICY,” “TAX CONSIDERATIONS--Taxation of Insurance Policies” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.</div> </td> <td style="padding:0pt; background:#E5E5E5; width:8pt"></td> </tr> </table><table style="width:523pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#A5A5A5; width:8pt"></td> <td colspan="4" style="background:#A5A5A5; padding:3.5pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">RISKS</div> </td> <td style="padding:0pt; background:#A5A5A5; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:8pt"></td> <td style="padding:2.583pt 0pt 2.167pt 0pt; width:120pt"> <div style="font-weight:bold">Risks Associated with Investment Options</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.583pt 0pt 2.167pt 0pt; width:379pt"> <div>An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision. </div> <div style="margin-top:4pt">For additional information about the risks associated with Investment Options, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “THE COMPANY AND THE FIXED ACCOUNT,” “THE VARIABLE ACCOUNT AND THE FUNDS” and “FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY” in the Prospectus.</div> </td> <td style="padding:0pt; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:8pt"></td> <td style="background:#E5E5E5; padding:2.833pt 0pt 2.167pt 0pt; width:120pt"> <div style="font-weight:bold">Insurance Company Risks</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.833pt 0pt 2.167pt 0pt; width:379pt"> <div>An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free <span style="white-space:nowrap">1-888-353-2654</span>.</div> <div style="margin-top:4pt">For additional information about Company risks, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” and “THE COMPANY AND THE FIXED ACCOUNT” in the Prospectus.</div> </td> <td style="padding:0pt; background:#E5E5E5; width:8pt"></td> </tr> <tr style="line-height:11pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:8pt"></td> <td style="padding:2.833pt 0pt 0.5pt 0pt; width:120pt"> <div style="font-weight:bold">Policy Lapse</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.833pt 0pt 0.5pt 0pt; width:379pt; white-space:normal"> <div>Your Policy could terminate if the value of your Policy becomes too low to support the Policy’s monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.</div> <div style="margin-top:4pt">For additional information about Policy Lapse, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “PREMIUMS,” “LOANS,” and “LAPSE AND REINSTATEMENT” in the Prospectus.</div> </td> <td style="padding:0pt; width:8pt"></td> </tr> </table> <div style="font-weight:bold">Risk of Loss</div> <div>You can lose money by investing in this Policy, including loss of principal.</div> <div style="margin-top:4pt">For additional information about the risk of loss, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” in the Prospectus.</div> <div style="font-weight:bold">Not a Short-Term Investment</div> <div>The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered. Withdrawals are not available in the first Policy Year.</div> <div style="margin-top:4pt">If you elect to pay Advisory Fees from your Policy Value, such payments will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits.</div> <div style="margin-top:4pt">For additional information about the investment profile of the Policy, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “CHARGES AND DEDUCTIONS,” “USE OF THE POLICY,” “TAX CONSIDERATIONS--Taxation of Insurance Policies” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.</div> <div style="font-weight:bold">Risks Associated with Investment Options</div> <div>An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision. </div> <div style="margin-top:4pt">For additional information about the risks associated with Investment Options, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “THE COMPANY AND THE FIXED ACCOUNT,” “THE VARIABLE ACCOUNT AND THE FUNDS” and “FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY” in the Prospectus.</div> <div style="font-weight:bold">Insurance Company Risks</div> <div>An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free <span style="white-space:nowrap">1-888-353-2654</span>.</div> <div style="margin-top:4pt">For additional information about Company risks, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” and “THE COMPANY AND THE FIXED ACCOUNT” in the Prospectus.</div> <div style="font-weight:bold">Policy Lapse</div> <div>Your Policy could terminate if the value of your Policy becomes too low to support the Policy’s monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.</div> <div style="margin-top:4pt">For additional information about Policy Lapse, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “PREMIUMS,” “LOANS,” and “LAPSE AND REINSTATEMENT” in the Prospectus.</div> <div style="font-weight:bold">Investments</div> <div>While you may transfer amounts in the Sub-Accounts (which invest in shares of a corresponding Fund) and the Fixed Account, certain restrictions and transfer fees apply with regard to the number and amount of such transfers. Transfers are also subject to the excessive trading and market timing policies described in the Prospectus. </div> <div style="margin-top:4pt">We reserve the right to remove or substitute Funds as investment options. </div> <div style="margin-top:4pt">For additional information about Investment Options, see “TRANSFERS” and “ADDITION, DELETION, OR SUBSTITUTION OF INVESTMENTS” in the Prospectus.</div> <div style="font-weight:bold">Optional Benefits</div> <div>Optional benefits, including Policy Loans, are subject to additional charges. Some optional benefits are available only at the time your Policy is issued and may not be available for all Owners or Insureds. The maximum loan amount we allow at any time may not exceed 99% of the Policy’s Cash Value reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received.</div> <div style="margin-top:4pt">If You elect to pay Advisory Fees from your Policy Value, these payments may reduce the death benefit and other guaranteed benefits.</div> <div style="margin-top:4pt">For additional information about the optional benefits, see “OTHER BENEFITS AVAILABLE UNDER THE POLICY,” “SUPPLEMENTAL RIDERS AND ENDORSEMENTS,” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Payment of Advisory Fees” in the Prospectus.</div> <div style="font-weight:bold">Tax Implications</div> <div>You should consult with a tax professional to determine the tax implications regarding the purchase, ownership, and use of a Policy. Withdrawals and surrenders may be subject to income tax and will be taxed at ordinary tax rates. In addition, withdrawals and surrenders may be subject to an additional tax depending on the circumstances.</div> <div style="margin-top:4pt">If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC.</div> <div style="margin-top:4pt">For additional information about tax implications, see “TAX CONSIDERATIONS” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.</div> <div style="font-weight:bold">Investment Professional Compensation</div> <div>Some investment professionals have and may receive compensation for selling the Policy to investors which may include revenue sharing, marketing allowances and other compensation. These investment professionals may have a financial incentive to offer or recommend the Policy over another investment. </div> <div style="margin-top:4pt">For additional information about compensation, see “SALE OF THE POLICIES” in the Prospectus.</div> <div style="font-weight:bold">Exchanges</div> <div>Some investment professionals may have a financial incentive to offer an investor a new policy in place of the one he or she already owns. You should only exchange your policy if you determine, after comparing the features, fees, and risks of both policies, that it is preferable for you to purchase the new policy rather than continue to own the existing policy. </div> <div style="margin-top:4pt">For additional information about exchanges, see “EXCHANGE PRIVILEGE” and “TAX CONSIDERATIONS--Section 1035 Exchanges” in the Prospectus.</div> <div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <div style="text-align:center; width:523pt; line-height:12pt; font-weight:bold">FEE TABLE</div> <div style="margin-top:4pt; width:523pt; line-height:12pt; font-weight:bold">The following tables describe the fees and expenses that you will pay when buying, owning, and surrendering or making withdrawals from the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay. Please refer to your Policy specifications page for information about the specific fees you will pay each year based on the options you have elected. On and after the Policy Anniversary when the Insured is age 121, we do not deduct any fees and charges other than the interest charged on loans (if a loan is outstanding).</div> <div style="margin-top:6pt; width:523pt; line-height:12pt; font-weight:bold">The first table describes the fees and expenses that you will pay at the time that you pay premiums, allow the Policy to Lapse, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals. These fees and expenses do not reflect any Advisory Fees paid to Financial Intermediaries from Policy Value or other assets of the Owner for the provision of investment advice. If such fees were reflected, costs would be higher.</div> <div style="-keep: true"> <table style="width:523pt; min-height:282.6pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Transaction Fees<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">Premium Expense Charge (for Policies with an application signed on or after October 13, 2025):</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:normal">Upon receipt of each premium payment </div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">5%</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">2%</div> </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">Premium Expense Charge (for Policies with an application signed before October 13, 2025):</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:normal">Upon receipt of each premium payment</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">3.5%</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">2%</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <span style="font-weight:bold">Transfer Fee:</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:normal">Upon each transfer in excess of 12 in a Policy Year </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$25 per transfer </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0 per transfer </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:bold">Withdrawal Charge:</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">At the time of each withdrawal of Policy Value </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">The lesser of 2.0% of the amount withdrawn or $25 </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">The lesser of 2.0% of the amount withdrawn or $25</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Overloan Protection Endorsement</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">When the Benefit is Exercised</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">5% of Policy Value</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">5% of Policy Value</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <span style="font-weight:bold">Policy Illustration Fee</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">Upon each illustration request in excess of 1 in a Policy Year</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$50 per illustration requested</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0 per illustration requested</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table> </div> <div style="margin-top:13.5pt; width:523pt"> <div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div> </div> <div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div> <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(2)</span> <br/> </div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:12pt; font-weight:bold">The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds’ fees and expenses.These fees and expenses do not reflect any Advisory Fees paid to Financial Intermediaries from Policy Value or other assets of the Owner for the provision of investment advice.<span style="font-weight:normal"> </span></div> <div style="-keep: true"> <table style="width:523pt; min-height:402.6pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt">Base Contract Charge<span style="font-weight:normal">:</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <div style="font-weight:normal"> <span style="font-weight:bold">Cost of Insurance (for Policies with an application signed on or after October 13, 2025):</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$83.33 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$70.46 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.18 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.04 per $1000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt">Cost of Insurance (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(1)</span><span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(2)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$83.33 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$59.39 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.18 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.04 per $1000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold"><span style="-sec-ix-hidden: hidden-fact-1">Cost of Insurance</span> (for Policies with an application signed before February 1, 2024):</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"><span style="-sec-ix-hidden: hidden-fact-0">On the Policy Effective Date and each Monthly Anniversary Day</span> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $83.33 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $81.67 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco class during the first Policy Year<span style="font-style:normal">.</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.18 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.07 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table> </div> <div style="margin-top:13.5pt; width:523pt"> <div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div> </div> <div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div> <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:7.5pt"> <span style="position:relative; bottom:4.25pt">(2)</span> <br/> </div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic; font-size:7.5pt"> <span style="font-size:10pt">See definition of Net Amount at Risk in the Special Terms.</span> </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <div style="-keep: true"> <table style="width:523pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:8pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:3.5pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Mortality and Expense Risk Charge:</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">0.050% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Standard Administrative Fee (for Policies with an application signed on or after October 13, 2025):</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$9.00</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$9.00</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Standard Administrative Fee (for Policies with an application signed before October 13, 2025):</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$8.00</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$8.00</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Administrative Charge (for Policies with an application signed on or after October 13, 2025):</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(3)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.10 – $3.75 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.10 – $3.41 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.04-$1.36 per $1,000 of Initial Face Amount thereafter</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate classwith a Face Amount of $100,000<span style="font-style:normal">.</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.89 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.81 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.33 per $1,000 of Initial Face Amount thereafter</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; min-width:4pt"></td> <td colspan="10" style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt">Administrative Charge (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(3)</span></td> <td style="padding:0pt; min-width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class with a Face Amount of $100,000<span style="font-style:normal">. </span></div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter.</td> <td style="padding:0pt; width:4pt"></td> </tr> </table> </div> <div style="margin-top:13.5pt; width:523pt"> <div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(3)</span> <br/> </div> <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <div style="-keep: true"> <table style="width:523pt; height:408.6pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt">Administrative Charge (for Policies with an application signed before February 1, 2024)<span style="font-weight:normal">: </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(3)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.31 per $1,000 of Initial Face Amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.31 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; min-width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:0pt">Administrative Charge For Face Amount Increases (for Policies with an application signed on or after October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(4)</span></td> <td style="padding:0pt; background:#E5E5E5; min-width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.75 – $4.95 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.75 – $4.95 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$3.30 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$3.30 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; min-width:4pt"></td> <td colspan="10" style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt"> <div style="font-weight:bold">Administrative Charge For Face Amount Increases (for Policies with an application signed before October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(4)</span></div> </td> <td style="padding:0pt; min-width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.39 – $1.74 per $1,000 of any increase in Face Amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.39 – $1.74 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.09 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.09 per $1,000 of any increase in Face Amount</td> <td style="padding:0pt; width:4pt"></td> </tr> </table> </div> <div style="margin-top:13.5pt; width:523pt"> <div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(3)</span> <br/> </div> <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(4)</span> <br/> </div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <div style="-keep: true"> <table style="width:523pt; min-height:426.6pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt">Optional Benefit Charges:</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Net Cost of Loans (for Policies with an application signed on or after October 13, 2025)<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(5)</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On each Policy Anniversary, as applicable <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(6)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carryover loans.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Net Cost of Loans (for Policies with an application signed before October 13, 2025)<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(5)</span></div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On each Policy Anniversary, as applicable <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(6)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">4.00% (annually) in Policy Years 1 through 10; 2.25% in Policy Years 11 and thereafter for both standard and carryover loans. </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Children’s Term Life Insurance Rider</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Accidental Death Benefit Rider</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(7)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 – $0.14 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 – $0.14 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="margin-left:10pt; font-style:italic">Charge for a 34 year old</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 per $1,000 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 per $1,000 of rider coverage amount</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Waiver of Specified Premium Rider</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(8)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.86 – $19.19 per $100 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.86 – $19.19 per $100 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 39 year old male in the nontobacco class</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$4.42 per $100 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$4.42 per $100 of rider coverage amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table> </div> <div style="margin-top:13.5pt; width:523pt"> <div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(5)</span> <br/> </div> <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(6)</span> <br/> </div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(7)</span> <br/> </div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(8)</span> <br/> </div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <div style="-keep: true"> <table style="width:523pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">ExtendCare Rider (for Policies with an application signed on or after October 13, 2025)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(9)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $18.96 per $1,000 of Net Amount at Risk </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $16.62 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 57 year old female in the nontobacco rate class with a Face Amount of $250,000 and monthly benefit of $10,800</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">ExtendCare Rider (for Policies with an application signed before October 13, 2025)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(9)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $29.77 per $1,000 of Net Amount at Risk </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $17.90 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:italic; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt">Charge for a 57 year old female in the nontobacco rate class in the First Policy Year with a Face Amount of $250,000 and monthly benefit of $10,800</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-style:normal">On the Effective Date and each Monthly Anniversary Day</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-style:normal">$0.01 per $1,000 of Net Amount at Risk</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-style:normal">$0.01 per $1,000 of Net Amount at Risk</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Protected Insurability Benefit Rider</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(10)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 – $0.13 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 – $0.13 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a child less than 6 months old</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 per $1,000 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 per $1,000 of rider coverage amount</td> <td style="padding:0pt; width:4pt"></td> </tr> </table> </div> <div style="margin-top:13.5pt; width:523pt"> <div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div> </div> <div style="-keep: true"> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div> <div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(9)</span> <br/> </div> <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. Not available in CA.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> <div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(10)</span> <br/> </div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Protected Insurability Rider varies based on the Insured’s Issue Age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="text-align:center; width:523pt; line-height:12pt; font-weight:bold">ANNUAL FUND EXPENSES</div> <div style="-keep: true"> <div style="margin-top:4pt; width:523pt; line-height:12pt; font-weight:bold">The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund’s fees and expenses is contained in the prospectus for each Fund.A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See “APPENDIX - FUNDS AVAILABLE UNDER THE POLICY”.</div> </div> <div style="margin-top:2pt; width:523pt; line-height:10pt"> </div> </div> <div style="border:1pt #000 solid; margin-top:0pt; min-height:137.5pt; padding-bottom:-8.5pt; margin-left:36pt; width:522.5pt"> <div style="margin-top:6pt; text-align:center; width:511pt; line-height:12pt; font-weight:bold">Annual Fund Expenses</div> <div style="-keep: true"> <table style="width:499pt; height:52.5pt; margin-left:12pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="border-bottom:1px solid #FFFFFF; padding:0pt 0pt 0.5pt 0pt; width:397.45pt; text-align:left"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="4" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt"> <div style="white-space:nowrap; text-align:center">Minimum<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt; border-bottom:1px solid #FFFFFF"></td> <td style="padding:0pt 0pt 0.5pt 0pt; border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; border-bottom:1px solid #FFFFFF; min-width:6pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:0pt; width:0pt; border-bottom:1px solid #FFFFFF"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="4" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt"> <div style="white-space:nowrap; text-align:center">Maximum<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:0pt"></td> </tr> <tr style="line-height:10pt; background-color:#CCEEFF; white-space:nowrap; text-align:left; vertical-align:bottom; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:397.45pt"> <div style="white-space:nowrap">Total Annual Fund Expenses </div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap">0.03<span style="position:absolute">%</span></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap"><span style="-sec-ix-hidden: hidden-fact-2">–</span></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap">1.24<span style="position:absolute">% <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span></span></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt; width:0pt"></td> </tr> <tr style="line-height:12pt; white-space:nowrap; text-align:left; vertical-align:bottom; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:397.45pt; white-space:normal"> <div style="margin-left:20pt; text-indent:-10pt">(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt; width:0pt"></td> </tr> </table> </div> <div style="margin-left:12pt; margin-top:13.5pt; width:511pt"> <div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div> </div> <div style="float:left; margin-left:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div> <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:32pt; font-style:italic">The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> <table style="width:523pt; min-height:282.6pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Transaction Fees<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">Premium Expense Charge (for Policies with an application signed on or after October 13, 2025):</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:normal">Upon receipt of each premium payment </div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">5%</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">2%</div> </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">Premium Expense Charge (for Policies with an application signed before October 13, 2025):</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:normal">Upon receipt of each premium payment</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">3.5%</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:normal">2%</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <span style="font-weight:bold">Transfer Fee:</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:normal">Upon each transfer in excess of 12 in a Policy Year </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$25 per transfer </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0 per transfer </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="font-weight:bold">Withdrawal Charge:</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">At the time of each withdrawal of Policy Value </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">The lesser of 2.0% of the amount withdrawn or $25 </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">The lesser of 2.0% of the amount withdrawn or $25</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Overloan Protection Endorsement</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">When the Benefit is Exercised</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">5% of Policy Value</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">5% of Policy Value</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <span style="font-weight:bold">Policy Illustration Fee</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">Upon each illustration request in excess of 1 in a Policy Year</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$50 per illustration requested</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0 per illustration requested</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div><div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(2)</span> <br/> </div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.</div> Premium Expense Charge Upon receipt of each premium payment 0.05 0.02 Premium Expense Charge Upon receipt of each premium payment 0.035 0.02 <span style="font-weight:bold">Transfer Fee:</span> Upon each transfer in excess of 12 in a Policy Year 25 0 Withdrawal Charge: At the time of each withdrawal of Policy Value 0.02 25 0.02 25 Overloan Protection Endorsement When the Benefit is Exercised 0.05 0.05 <span style="font-weight:bold">Policy Illustration Fee</span> Upon each illustration request in excess of 1 in a Policy Year 50 0 <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.</div> <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.</div> <table style="width:523pt; min-height:402.6pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt">Base Contract Charge<span style="font-weight:normal">:</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <div style="font-weight:normal"> <span style="font-weight:bold">Cost of Insurance (for Policies with an application signed on or after October 13, 2025):</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$83.33 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$70.46 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.18 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.04 per $1000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt">Cost of Insurance (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(1)</span><span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(2)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$83.33 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01-$59.39 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.18 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.04 per $1000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold"><span style="-sec-ix-hidden: hidden-fact-1">Cost of Insurance</span> (for Policies with an application signed before February 1, 2024):</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(1)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"><span style="-sec-ix-hidden: hidden-fact-0">On the Policy Effective Date and each Monthly Anniversary Day</span> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $83.33 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $81.67 per $1,000 of Net Amount at Risk <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(2)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco class during the first Policy Year<span style="font-style:normal">.</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.18 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.07 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div><div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:7.5pt"> <span style="position:relative; bottom:4.25pt">(2)</span> <br/> </div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic; font-size:7.5pt"> <span style="font-size:10pt">See definition of Net Amount at Risk in the Special Terms.</span> </div><table style="width:523pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:8pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:3.5pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Mortality and Expense Risk Charge:</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">0.050% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 0.833pt 0pt; width:122.75pt">0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Standard Administrative Fee (for Policies with an application signed on or after October 13, 2025):</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$9.00</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$9.00</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Standard Administrative Fee (for Policies with an application signed before October 13, 2025):</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$8.00</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap">$8.00</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Administrative Charge (for Policies with an application signed on or after October 13, 2025):</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(3)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.10 – $3.75 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.10 – $3.41 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.04-$1.36 per $1,000 of Initial Face Amount thereafter</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate classwith a Face Amount of $100,000<span style="font-style:normal">.</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.89 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.81 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.33 per $1,000 of Initial Face Amount thereafter</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; min-width:4pt"></td> <td colspan="10" style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt">Administrative Charge (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(3)</span></td> <td style="padding:0pt; min-width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class with a Face Amount of $100,000<span style="font-style:normal">. </span></div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter.</td> <td style="padding:0pt; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(3)</span> <br/> </div><div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div><table style="width:523pt; height:408.6pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 2.633pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt">Administrative Charge (for Policies with an application signed before February 1, 2024)<span style="font-weight:normal">: </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(3)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.09 – $3.66 per $1,000 of Initial Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.31 per $1,000 of Initial Face Amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.31 per $1,000 of Initial Face Amount</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; min-width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:0pt">Administrative Charge For Face Amount Increases (for Policies with an application signed on or after October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(4)</span></td> <td style="padding:0pt; background:#E5E5E5; min-width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.75 – $4.95 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.75 – $4.95 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$3.30 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$3.30 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; min-width:4pt"></td> <td colspan="10" style="padding:2.167pt 0pt 0.833pt 0pt; width:0pt"> <div style="font-weight:bold">Administrative Charge For Face Amount Increases (for Policies with an application signed before October 13, 2025):<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(4)</span></div> </td> <td style="padding:0pt; min-width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.39 – $1.74 per $1,000 of any increase in Face Amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.39 – $1.74 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.09 per $1,000 of any increase in Face Amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.09 per $1,000 of any increase in Face Amount</td> <td style="padding:0pt; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(3)</span> <br/> </div><div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(4)</span> <br/> </div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div><table style="width:523pt; min-height:426.6pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt">Optional Benefit Charges:</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Net Cost of Loans (for Policies with an application signed on or after October 13, 2025)<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(5)</span></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On each Policy Anniversary, as applicable <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(6)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carryover loans.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Net Cost of Loans (for Policies with an application signed before October 13, 2025)<span style="font-weight:normal"> </span><span style="position:relative; bottom:4.25pt; font-size:6.5pt; font-weight:normal">(5)</span></div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On each Policy Anniversary, as applicable <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(6)</span></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">4.00% (annually) in Policy Years 1 through 10; 2.25% in Policy Years 11 and thereafter for both standard and carryover loans. </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Children’s Term Life Insurance Rider</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.45 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Accidental Death Benefit Rider</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(7)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 – $0.14 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 – $0.14 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt; white-space:nowrap"> <div style="margin-left:10pt; font-style:italic">Charge for a 34 year old</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 per $1,000 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.08 per $1,000 of rider coverage amount</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Waiver of Specified Premium Rider</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(8)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.86 – $19.19 per $100 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$1.86 – $19.19 per $100 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 39 year old male in the nontobacco class</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$4.42 per $100 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$4.42 per $100 of rider coverage amount</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(5)</span> <br/> </div><div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(6)</span> <br/> </div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(7)</span> <br/> </div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div> Cost of Insurance On the Policy Effective Date and each Monthly Anniversary Day 0.01 83.33 0.01 70.46 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.</div> On the Policy Effective Date and each Monthly Anniversary Day$0.18 per $1,000 of Net Amount at Risk$0.04 per $1000 of Net Amount at Risk Cost of Insurance On the Policy Effective Date and each Monthly Anniversary Day 0.01 83.33 0.01 59.39 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.</div> On the Policy Effective Date and each Monthly Anniversary Day$0.18 per $1,000 of Net Amount at Risk$0.04 per $1000 of Net Amount at Risk 0.01 83.33 0.01 81.67 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco class during the first Policy Year<span style="font-style:normal">.</span></div> On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk$0.07 per $1,000 of Net Amount at Risk <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.</div> Mortality and Expense Risk Charge: On the Policy Effective Date and each Monthly Anniversary Day 0.006 0.00204 0.00096 Standard Administrative Fee On the Policy Effective Date and each Monthly Anniversary Day 9 9 Standard Administrative Fee On the Policy Effective Date and each Monthly Anniversary Day 8 8 Administrative Charge On the Policy Effective Date and each Monthly Anniversary Day 0.1 3.75 0.1 3.41 0.04 1.36 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate classwith a Face Amount of $100,000<span style="font-style:normal">.</span></div> On the Policy Effective Date and each Monthly Anniversary Day$0.89 per $1,000 of Initial Face Amount$0.81 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.33 per $1,000 of Initial Face Amount thereafter Administrative Charge On the Policy Effective Date and each Monthly Anniversary Day 0.09 3.66 0.09 3.66 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class with a Face Amount of $100,000<span style="font-style:normal">. </span></div> On the Policy Effective Date and each Monthly Anniversary Day $0.45 per $1,000 of Initial Face Amount$0.45 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter. <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.</div> Administrative Charge On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years 0.09 3.66 0.09 3.66 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years $0.31 per $1,000 of Initial Face Amount $0.31 per $1,000 of Initial Face Amount Administrative Charge For Face Amount Increases On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days 0.75 4.95 0.75 4.95 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $3.30 per $1,000 of any increase in Face Amount $3.30 per $1,000 of any increase in Face Amount Administrative Charge For Face Amount Increases On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days 0.39 1.74 0.39 1.74 <div style="margin-left:10pt; font-style:italic">Charge for a 49 year old male in the nontobacco rate class</div> On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $1.09 per $1,000 of any increase in Face Amount $1.09 per $1,000 of any increase in Face Amount Net Cost of Loans On each Policy Anniversary, as applicable 0.02 0.02 0.0025 0.0025 0.02 0.01 0 Net Cost of Loans On each Policy Anniversary, as applicable 0.04 0.04 0.0225 0.0225 0.02 0.01 0 Children’s Term Life Insurance Rider On the Effective Date and each Monthly Anniversary Day 0.45 0.45 <span style="font-weight:bold">Accidental Death Benefit Rider</span> On the Effective Date and each Monthly Anniversary Day 0.08 0.14 0.08 0.14 On the Effective Date and each Monthly Anniversary Day $0.08 per $1,000 of rider coverage amount $0.08 per $1,000 of rider coverage amount $0.08 per $1,000 of rider coverage amount <span style="font-weight:bold">Waiver of Specified Premium Rider</span> On the Effective Date and each Monthly Anniversary Day 1.86 19.19 1.86 19.19 On the Effective Date and each Monthly Anniversary Day $4.42 per $100 of rider coverage amount $4.42 per $100 of rider coverage amount <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).</div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.</div> 0.05 0.04 0.05 0.03 0.0325 0.03 0.03 0.01 <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(8)</span> <br/> </div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div> The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. <div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div><table style="width:523pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="10" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt; width:0pt"> <div style="white-space:nowrap; text-align:center">Periodic Charges Other Than Fund Operating Expenses<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">When Charge is Deducted<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Maximum Guaranteed Charge<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.183pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Amount Deducted — <br/>Current Charge</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.25pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">ExtendCare Rider (for Policies with an application signed on or after October 13, 2025)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(9)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $18.96 per $1,000 of Net Amount at Risk </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $16.62 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a 57 year old female in the nontobacco rate class with a Face Amount of $250,000 and monthly benefit of $10,800</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td colspan="10" style="background:#E5E5E5; padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">ExtendCare Rider (for Policies with an application signed before October 13, 2025)</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(9)</span></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $29.77 per $1,000 of Net Amount at Risk </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.01 – $17.90 per $1,000 of Net Amount at Risk</td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:italic; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt">Charge for a 57 year old female in the nontobacco rate class in the First Policy Year with a Face Amount of $250,000 and monthly benefit of $10,800</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-style:normal">On the Effective Date and each Monthly Anniversary Day</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-style:normal">$0.01 per $1,000 of Net Amount at Risk</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="font-style:normal">$0.01 per $1,000 of Net Amount at Risk</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td colspan="10" style="padding:3.5pt 0pt 1.5pt 0pt; width:0pt"> <span style="font-weight:bold">Protected Insurability Benefit Rider</span> <span style="position:relative; bottom:4.25pt; font-size:6.5pt">(10)</span></td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Minimum and Maximum Charge</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 – $0.13 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 – $0.13 per $1,000 of rider coverage amount </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:12pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt"> <div style="margin-left:10pt; font-style:italic">Charge for a child less than 6 months old</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">On the Effective Date and each Monthly Anniversary Day </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 per $1,000 of rider coverage amount </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:122.75pt">$0.03 per $1,000 of rider coverage amount</td> <td style="padding:0pt; width:4pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt">?</div><div style="float:left; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(9)</span> <br/> </div>The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. ExtendCare Rider On the Effective Date and each Monthly Anniversary Day 0.01 18.96 0.01 16.62 On the Effective Date and each Monthly Anniversary Day$0.01 per $1,000 of Net Amount at Risk$0.01 per $1,000 of Net Amount at Risk ExtendCare Rider On the Effective Date and each Monthly Anniversary Day 0.01 29.77 0.01 17.9 <div style="font-style:normal">On the Effective Date and each Monthly Anniversary Day</div> <div style="font-style:normal">$0.01 per $1,000 of Net Amount at Risk</div> <div style="font-style:normal">$0.01 per $1,000 of Net Amount at Risk</div> <span style="font-weight:bold">Protected Insurability Benefit Rider</span> On the Effective Date and each Monthly Anniversary Day 0.03 0.13 0.03 0.13 On the Effective Date and each Monthly Anniversary Day $0.03 per $1,000 of rider coverage amount $0.03 per $1,000 of rider coverage amount <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. Not available in CA.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; line-height:12pt; margin-top:2pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(10)</span> <br/> </div><div style="margin-top:2pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic">The charge for the Protected Insurability Rider varies based on the Insured’s Issue Age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.</div> <div style="text-align:center; width:523pt; line-height:12pt; font-weight:bold">ANNUAL FUND EXPENSES</div><div style="margin-top:4pt; width:523pt; line-height:12pt; font-weight:bold">The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund’s fees and expenses is contained in the prospectus for each Fund.A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See “APPENDIX - FUNDS AVAILABLE UNDER THE POLICY”.</div><div style="margin-top:6pt; text-align:center; width:511pt; line-height:12pt; font-weight:bold">Annual Fund Expenses</div><table style="width:499pt; height:52.5pt; margin-left:12pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="border-bottom:1px solid #FFFFFF; padding:0pt 0pt 0.5pt 0pt; width:397.45pt; text-align:left"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="4" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt"> <div style="white-space:nowrap; text-align:center">Minimum<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt; border-bottom:1px solid #FFFFFF"></td> <td style="padding:0pt 0pt 0.5pt 0pt; border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; border-bottom:1px solid #FFFFFF; min-width:6pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:0pt; width:0pt; border-bottom:1px solid #FFFFFF"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="4" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt"> <div style="white-space:nowrap; text-align:center">Maximum<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:0pt"></td> </tr> <tr style="line-height:10pt; background-color:#CCEEFF; white-space:nowrap; text-align:left; vertical-align:bottom; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:397.45pt"> <div style="white-space:nowrap">Total Annual Fund Expenses </div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap">0.03<span style="position:absolute">%</span></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap"><span style="-sec-ix-hidden: hidden-fact-2">–</span></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap">1.24<span style="position:absolute">% <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span></span></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt; width:0pt"></td> </tr> <tr style="line-height:12pt; white-space:nowrap; text-align:left; vertical-align:bottom; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:397.45pt; white-space:normal"> <div style="margin-left:20pt; text-indent:-10pt">(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt; width:0pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="float:left; margin-left:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div><div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:32pt; font-style:italic">The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.</div> <div style="margin-top:6pt; text-align:center; width:511pt; line-height:12pt; font-weight:bold">Annual Fund Expenses</div><table style="width:499pt; height:52.5pt; margin-left:12pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="border-bottom:1px solid #FFFFFF; padding:0pt 0pt 0.5pt 0pt; width:397.45pt; text-align:left"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="4" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt"> <div style="white-space:nowrap; text-align:center">Minimum<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt; border-bottom:1px solid #FFFFFF"></td> <td style="padding:0pt 0pt 0.5pt 0pt; border-bottom:1px solid #FFFFFF; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; border-bottom:1px solid #FFFFFF; min-width:6pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:0pt; width:0pt; border-bottom:1px solid #FFFFFF"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td colspan="4" style="border-bottom:1px solid #000000; padding:2.167pt 0pt 2.5pt 0pt"> <div style="white-space:nowrap; text-align:center">Maximum<span style="font-weight:normal; font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:0pt"></td> </tr> <tr style="line-height:10pt; background-color:#CCEEFF; white-space:nowrap; text-align:left; vertical-align:bottom; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:3.25pt 0pt 1.5pt 0pt; width:397.45pt"> <div style="white-space:nowrap">Total Annual Fund Expenses </div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap">0.03<span style="position:absolute">%</span></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap"><span style="-sec-ix-hidden: hidden-fact-2">–</span></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:3.25pt 0pt 1.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap">1.24<span style="position:absolute">% <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span></span></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt; width:0pt"></td> </tr> <tr style="line-height:12pt; white-space:nowrap; text-align:left; vertical-align:bottom; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:10pt"> <td style="padding:2.167pt 0pt 0.833pt 0pt; width:397.45pt; white-space:normal"> <div style="margin-left:20pt; text-indent:-10pt">(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:7.83pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:6pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:0pt; width:0pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:0pt; text-align:right"></td> <td style="padding:0pt 0pt 0.5pt 0pt; min-width:17.25pt; text-align:right; white-space:nowrap"></td> <td style="padding:0pt; padding-left:8.72pt; width:0pt"></td> <td style="padding:0pt; width:0pt"></td> </tr> </table><div style="margin-left:0pt; width:108pt; margin-top:0pt; font-size:1pt; line-height:0pt; border-bottom:1pt solid #000000"></div><div style="float:left; margin-left:12pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div><div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:32pt; font-style:italic">The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.</div> 0.0003 0.0124 <div style="margin-top:7pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:32pt; font-style:italic">The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.</div> <div style="margin-top:12pt; height:418pt; margin-left:36pt; width:523pt"> <div style="text-align:center; width:523pt; line-height:12pt; font-weight:bold">PRINCIPAL RISKS OF INVESTING IN THE POLICY</div> <div style="margin-top:6pt; width:523pt; line-height:12pt; font-weight:bold">Investment Risk</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. <span style="font-style:italic; font-weight:bold">You could lose everything you invest. </span>If you allocate Policy Value to the Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See “The Variable Account and The Funds.” </div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Risk of Lapse</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement of the Policy will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See “Lapse and Reinstatement--Lapse” and “Lapse Protection.”</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Withdrawal and Surrender Risks</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">The Surrender Value of the Policy is generally the Cash Value less any Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. <span style="font-weight:bold">The Policy is not suitable as a short-term investment.</span></div> <div style="margin-top:6pt; width:523pt; line-height:12pt">Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy. </div> <div style="margin-top:6pt; width:523pt; line-height:12pt">A surrender or withdrawal may have tax consequences. See “TAX CONSIDERATIONS.”</div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:12pt; font-weight:bold">Advisory Fee Risk</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Advisory Fees paid from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits. If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC. See “TAX CONSIDERATIONS--Advisory Fees” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Maximum Permitted Advisory Fee Paid from Policy Value.”</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Tax Risks</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy’s Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 59½ at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">See “Tax Considerations.” <span style="font-style:italic">You should consult a qualified tax adviser for assistance in all Policy related tax matters.</span></div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Loan Risks</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See “Policy Loans” and “Tax Considerations — Tax Treatment of Loans.” Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Specialized Uses of the Policy</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See “Tax Considerations — Other Considerations.”</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Fund Risks</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">A comprehensive discussion of the risks of each Fund may be found in each Fund’s prospectus. Please refer to the Funds’ prospectuses for more information.</div> </div><div style="width:523pt; line-height:12pt; font-weight:bold">Business Disruption and Cyber Security Risks</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure <span style="font-style:italic">(e.g.,</span> hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds’ ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt; font-weight:bold">Investment Risk</div><div style="margin-top:6pt; width:523pt; line-height:12pt">If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. <span style="font-style:italic; font-weight:bold">You could lose everything you invest. </span>If you allocate Policy Value to the Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See “The Variable Account and The Funds.” </div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Risk of Lapse</div><div style="margin-top:6pt; width:523pt; line-height:12pt">There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement of the Policy will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See “Lapse and Reinstatement--Lapse” and “Lapse Protection.”</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Withdrawal and Surrender Risks</div><div style="margin-top:6pt; width:523pt; line-height:12pt">The Surrender Value of the Policy is generally the Cash Value less any Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. <span style="font-weight:bold">The Policy is not suitable as a short-term investment.</span></div><div style="margin-top:6pt; width:523pt; line-height:12pt">Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy. </div><div style="margin-top:6pt; width:523pt; line-height:12pt">A surrender or withdrawal may have tax consequences. See “TAX CONSIDERATIONS.”</div> <div style="width:523pt; line-height:12pt; font-weight:bold">Advisory Fee Risk</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Advisory Fees paid from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits. If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC. See “TAX CONSIDERATIONS--Advisory Fees” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Maximum Permitted Advisory Fee Paid from Policy Value.”</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Tax Risks</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy’s Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 59½ at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.</div><div style="margin-top:6pt; width:523pt; line-height:12pt">See “Tax Considerations.” <span style="font-style:italic">You should consult a qualified tax adviser for assistance in all Policy related tax matters.</span></div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Loan Risks</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See “Policy Loans” and “Tax Considerations — Tax Treatment of Loans.” Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Specialized Uses of the Policy</div>Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See “Tax Considerations — Other Considerations. <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Fund Risks</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">A comprehensive discussion of the risks of each Fund may be found in each Fund’s prospectus. Please refer to the Funds’ prospectuses for more information.</div> <div style="width:523pt; line-height:12pt; font-weight:bold">Business Disruption and Cyber Security Risks</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure <span style="font-style:italic">(e.g.,</span> hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds’ ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.</div> <div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold">STANDARD DEATH BENEFITS</div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt; font-style:italic">Payment of Advisory Fees from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits under your Policy. Work with your Financial Intermediary when selecting your Death Benefit Option and the potential impact of Advisory Fee payments on the death benefit.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">As long as the Policy remains in force, Protective Life will pay the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner’s estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option. Payment of the Death Benefit Proceeds may have tax consequences. See “Tax Considerations — Tax Treatment of Life Insurance Death Benefit Proceeds” in the Prospectus.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">If an Owner has elected the Income Provider Option Pre-Determined Death Benefit Payout Endorsement, we will pay the Death Benefit Proceeds pursuant to a payment schedule established according to the terms of the endorsement. See “Supplemental Riders and Endorsements” in the Prospectus.</div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:12pt; font-weight:bold">Limits on Policy Rights</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Incontestability.</span>   Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider, after the Policy or rider has been in force during the Insured’s lifetime for two years from the Policy Effective Date or the effective date of the rider. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the evidence of insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Suicide Exclusion.</span>   If the Insured dies by suicide, while sane or insane, within two years after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Insured dies by suicide within two years after an increase in Face Amount, the Death Benefit with respect to the increase will be limited to the sum of the monthly cost of insurance charges made for that increase.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Misstatement of Age or Sex.</span>   If the Insured’s age or sex has been misstated in the application for the Policy or in any application for supplemental riders, the Death Benefit under the Policy or such supplemental riders is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders, at the correct age and sex.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt; font-weight:bold">Calculation of Death Benefit Proceeds</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured’s death, plus benefits under any supplemental riders or endorsements, minus (1) any Policy Debt on that date, (2) any liens for payments made under an accelerated death benefit rider or endorsement including accrued interest, and (3) any past due Monthly Deductions if the Insured died during the grace period.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The calculation of the Death Benefit depends on the Death Benefit option and the federal tax compliance test that you select. You must select the Death Benefit option and the tax compliance test before your Policy is issued. Once the Policy is issued, you may not change the tax compliance test.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic">Federal Tax Compliance Tests.</span> Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies one of two federal tax compliance tests: (1) the Guideline Premium Limitation/Cash Value Corridor Test, and (2) the Cash Value Accumulation Test.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Guideline Premium Limitation/Cash Value Corridor Test (“GPT”) has two components, a premium limit component and a corridor component. The premium limit restricts the amount of premium payments that can be paid into the Policy. The corridor requires that the Death Benefit be at least a certain percentage (varying each year by Attained Age of the Insured) of the Policy Value. The Cash Value Accumulation Test (“CVAT”) does not have a premium limit, but does have a requirement that the Death Benefit be at least a certain percentage (varying based on the Attained Age, duration at death, sex and rate class of the Insured) of the Policy Value.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">In applying for the Policy, you may select either federal tax compliance test. The Death Benefit will vary depending on which test is selected. There are a number of considerations involved in deciding which test to use.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">For example, if your goal is to maximize your Cash Value in early Policy Years relative to the Policy’s Death Benefit and other benefits, you may want to consider selecting the CVAT because it generally permits more premiums to be paid in early Policy years. The CVAT may require the Policy to have a higher Death Benefit relative to the Policy’s Cash Value in later Policy Years, however, which could increase the mortality charges that will apply in those later years.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Alternatively, if your goal is to maximize your Cash Value in later Policy Years relative to the Policy’s Death Benefit and other benefits, you may want to consider selecting the GPT and paying premiums up to the maximum permitted by the GPT. Funding a Policy in this manner may allow for lower mortality charges in later Policy Years in comparison with the mortality charges that would apply under a Policy tested under the CVAT.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Which federal tax compliance test is better for you will depend on not only your goals, but on a number of other considerations. These other considerations include, but are not limited to, the characteristics of the Insured, the amount and timing of premiums that will be paid, and the earnings under the Policy.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Death Benefit Option you choose will also affect the amount of your Death Benefit. If the GPT applies to the Policy, under Death Benefit Option A, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the Policy Value multiplied by the applicable specified percentage is greater than the Face Amount under the Policy. Under Death Benefit Option B, your Death Benefit will always vary with Policy Value.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Similarly, if the CVAT applies to the Policy, under Death Benefit Option A, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the minimum death benefit is greater </div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:11.5pt">than the Face Amount under the Policy. Under Death Benefit Option B, your Death Benefit will always vary with the Policy Value. See “Death Benefit Options” for detailed information about each Death Benefit Option.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt; font-weight:bold">You should consult your Financial Intermediary for more information about which federal tax compliance test and death benefit option you should choose in light of your specific goals and circumstances.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary, or Beneficiaries, in a lump sum, unless a Settlement Option has been selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured’s death and are moved to the general account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Death Benefit Options</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt; font-style:italic">Payments of Advisory Fees from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits under your Policy. Work with your Financial Intermediary when selecting your Death Benefit Option and the potential impact of Advisory Fee payments on the death benefit.</div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Death Benefit Options Under Policies Complying with the Guideline Premium Limitation/Cash Value Corridor Test.</span>   If the Policy is not issued under the Cash Value Accumulation Test, it will satisfy the Guideline Premium Limitation/Cash Value Corridor Test of federal tax law and the Death Benefit is determined as follows:</div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.76pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.76pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Under Death Benefit Option A, the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured’s death, or (2) a specified percentage of the Policy Value on the date of the Insured’s death as indicated on a table set forth in Appendix A to the Prospectus.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.76pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.76pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Under Death Benefit Option B, the Death Benefit is the greater of: (1) the Face Amount under the Policy plus the Policy Value on the date of the Insured’s death, or (2) a specified percentage of the Policy Value on the date of the Insured’s death as indicated on a table set forth in Appendix A to the Prospectus.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt">The specified percentage under both options is 250% when the Insured has reached an Attained Age of 40 or less by date of death and decreases each year thereafter to 100% when the Insured has reached an Attained Age of 95 or greater at death. A table showing these percentages for Attained Ages 0 to 95 and examples of Death Benefit calculations for both Death Benefit Options are found in Appendix A to the Prospectus.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Under Death Benefit Option A, the Death Benefit remains level at the Face Amount unless the Policy Value multiplied by the specified percentage of Policy Value exceeds that Face Amount, in which event the Death Benefit varies as the Policy Value varies. Owners who are satisfied with the amount of their insurance coverage under the Policy and who prefer to have favorable investment performance and additional premiums reflected in higher Policy Value, rather than increased Death Benefits, generally should select Option A. Under Death Benefit Option B, the Death Benefit always varies as the Policy Value varies (although it is never less than the Face Amount). Owners who prefer to have favorable investment performance and additional premiums reflected in increased Death Benefits generally should select Option B.</div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Death Benefit Options Under Policies Complying with the Cash Value Accumulation Test.</span>   If the Policy is issued under the Cash Value Accumulation Test, the Death Benefit is determined as follows:</div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.77pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.77pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Under Death Benefit Option A, the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured’s death, or (2) the minimum death benefit described below.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.78pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.78pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Under Death Benefit Option B, the Death Benefit is the greater of: (1) the Face Amount under the Policy plus the Policy Value on the date of the Insured’s death, or (2) the minimum death benefit described below.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt">The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating </div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:11.5pt">the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured attains age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Owners who are satisfied with the amount of their insurance coverage under the Policy and who prefer to have favorable investment performance and additional premiums reflected in higher Policy Value, rather than increased Death Benefits, generally should select Option A. Under Death Benefit Option B, the Death Benefit always varies as the Policy Value varies (although it is never less than the Face Amount). Owners who prefer to have favorable investment performance and additional premiums reflected in increased Death Benefits generally should select Option B.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Examples of Death Benefit calculations for both Death Benefit Options under the Cash Value Accumulation Test are found in Appendix A to the Prospectus.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Changing Death Benefit Options</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Owner must indicate a Death Benefit Option in the application for the Policy. On or after the first Policy Anniversary, the Owner may change the Death Benefit Option on the Policy subject to the following rules. The request must be received in writing in Good Order at the Home Office. After any change, the Face Amount must be at least $100,000. The effective date of the change will be the Monthly Anniversary Day that coincides with or next follows the day that Protective Life approves the request. Protective Life may require satisfactory evidence of insurability. All changes must be approved by Protective Life at the Home Office before they will be effective. Protective Life reserves the right to decline to change the Death Benefit Option if the change would cause the Policy to fail to qualify as a life insurance contract under the Internal Revenue Code.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">When a change from Option A to Option B is made, the Face Amount after the change is effected will be equal to the Face Amount before the change less the Policy Value on the effective date of the change. When a change from Option B to Option A is made, the Face Amount after the change will be equal to the Face Amount before the change is effected plus the Policy Value on the effective date of the change. </div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Changing the Face Amount<span style="font-weight:normal"> </span></div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">On or after the first Policy Anniversary, the Owner may request a change in the Face Amount. The request must be received in writing in Good Order at the Home Office.</div> <div style="margin-top:11.6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Increasing the Face Amount.</span>   Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. In addition, the Insured’s current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See “Premiums Upon Increase in Face Amount.” The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy’s lapse protection is in effect, the Policy’s Minimum Monthly Premium amount will also generally be increased.</div> <div style="margin-top:4pt; width:523pt; line-height:12pt">An administrative fee will be charged for the first twelve months following an increase in the Face Amount.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (<span style="font-style:italic">i.e.</span>, credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See “Tax Considerations — Other Considerations.” Please consult your tax advisor.</div> <div style="margin-top:11.6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Decreasing the Face Amount.</span>   If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See “Tax Considerations — Policies which are MECs.”</div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt">Protective Life reserves the right to decline a request to decrease the Face Amount if compliance with the Guideline Premium Limitation under current tax law resulting from such a decrease would result in the Policy failing the definition of life insurance, or if to effect the requested decrease, payments to the Owner would have to be made from Policy Value for compliance with the Guideline Premium Limitation, and the amount of such payments would exceed the Surrender Value under the Policy.</div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:11.5pt">The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. Decreasing the Face Amount also may have tax consequences. See “Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years.”</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Settlement Options</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Company offers a variety of ways of receiving proceeds payable under the Policy, such as on surrender or death, other than in a lump sum. Any sales representative authorized to sell this Policy can further explain these settlement options upon request. All of these settlement options are forms of fixed-benefit annuities, which do not vary with the investment performance of a separate account. Under each of the fixed-benefit settlement options, no surrender or withdrawal may be made once payments have begun.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">The following settlement options may be elected.</div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 1 — Payment for a Fixed Period.</span>   Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 2 — Life Income with Payments for a Guaranteed Period.</span>   Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 3 — Interest Income.</span>   Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 4 — Payments for a Fixed Amount.</span>   Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Minimum Amounts.</span>   Protective Life reserves the right to pay the total amount of the Policy in one lump sum, if less than $5,000. If monthly payments are less than $50, payments may be made quarterly, semi-annually, or annually at Protective Life’s option.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Other Requirements.</span>   Settlement options must be elected by Written Notice in Good Order received by Protective Life at the Home Office. The Owner may elect settlement options during the Insured’s lifetime; Beneficiaries may elect settlement options thereafter if Death Benefit Proceeds are payable in a lump sum. The effective date of an option applied to Death Benefit Proceeds is the date the Due Proof of Death of the Insured is received at the Home Office. The effective date of an option applied to Surrender Value is the effective date of the surrender where a settlement option has been elected. We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner’s estate.</div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt">If Protective Life has available, at the time a settlement option is elected, options or rates on a more favorable basis than those guaranteed, the higher benefits will apply.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Escheatment of Death Benefit</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Every state has unclaimed property laws which generally declare life insurance policies to be abandoned after a period of inactivity of 3 to 5 years from the date the Death Benefit is due and payable. For example, if the payment of a Death Benefit has been triggered, but, if after a thorough search, Protective Life is still unable to locate the Beneficiary of the Death Benefit, or the Beneficiary does not come forward to claim the Death Benefit in a timely manner, the Death Benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. This “escheatment” is revocable, however, and the state is obligated to pay the Death Benefit (without interest) if your Beneficiary steps forward to claim the Death Benefit with the proper documentation. To prevent such escheatment, it is important that you </div> </div><div style="width:523pt; line-height:12.5pt; font-size:10pt">update your Beneficiary designations, including addresses, if and as they change. Such updates should be communicated in writing, by telephone, or other approved electronic means to the Home Office.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Changing Death Benefit Options</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Owner must indicate a Death Benefit Option in the application for the Policy. On or after the first Policy Anniversary, the Owner may change the Death Benefit Option on the Policy subject to the following rules. The request must be received in writing in Good Order at the Home Office. After any change, the Face Amount must be at least $100,000. The effective date of the change will be the Monthly Anniversary Day that coincides with or next follows the day that Protective Life approves the request. Protective Life may require satisfactory evidence of insurability. All changes must be approved by Protective Life at the Home Office before they will be effective. Protective Life reserves the right to decline to change the Death Benefit Option if the change would cause the Policy to fail to qualify as a life insurance contract under the Internal Revenue Code.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">When a change from Option A to Option B is made, the Face Amount after the change is effected will be equal to the Face Amount before the change less the Policy Value on the effective date of the change. When a change from Option B to Option A is made, the Face Amount after the change will be equal to the Face Amount before the change is effected plus the Policy Value on the effective date of the change. </div><div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Changing the Face Amount<span style="font-weight:normal"> </span></div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">On or after the first Policy Anniversary, the Owner may request a change in the Face Amount. The request must be received in writing in Good Order at the Home Office.</div><div style="margin-top:11.6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Increasing the Face Amount.</span>   Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. In addition, the Insured’s current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See “Premiums Upon Increase in Face Amount.” The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy’s lapse protection is in effect, the Policy’s Minimum Monthly Premium amount will also generally be increased.</div><div style="margin-top:4pt; width:523pt; line-height:12pt">An administrative fee will be charged for the first twelve months following an increase in the Face Amount.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (<span style="font-style:italic">i.e.</span>, credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See “Tax Considerations — Other Considerations.” Please consult your tax advisor.</div><div style="margin-top:11.6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Decreasing the Face Amount.</span>   If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See “Tax Considerations — Policies which are MECs.”</div><div style="margin-top:4pt; width:523pt; line-height:11.5pt">Protective Life reserves the right to decline a request to decrease the Face Amount if compliance with the Guideline Premium Limitation under current tax law resulting from such a decrease would result in the Policy failing the definition of life insurance, or if to effect the requested decrease, payments to the Owner would have to be made from Policy Value for compliance with the Guideline Premium Limitation, and the amount of such payments would exceed the Surrender Value under the Policy.</div><div style="width:523pt; line-height:11.5pt">The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office. </div>Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. Decreasing the Face Amount also may have tax consequences. See “Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years. <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 1 — Payment for a Fixed Period.</span>   Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 2 — Life Income with Payments for a Guaranteed Period.</span>   Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 3 — Interest Income.</span>   Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Option 4 — Payments for a Fixed Amount.</span>   Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only. </div> <div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold; font-size:10pt">OTHER BENEFITS AVAILABLE UNDER THE POLICY</div> <div style="margin-top:4pt; width:523pt; line-height:12.5pt; font-size:10pt">In addition to the standard Death Benefits associated with your Policy, other standard and optional benefits may also be available to you. The following table summarizes information about these optional benefits. Information about the fees associated with each benefit included in the table may be found in the Fee Table.</div> <table style="width:523pt; margin-top:4pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Name of Benefit</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Purpose</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Is Benefit Standard <br/>or Optional?</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Brief Description of <br/>Restrictions/Limitations</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 1pt 0pt; width:122.75pt"> <div style="font-weight:bold">Terminal Illness Accelerated Death Benefit Endorsement</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 1pt 0pt; width:122.75pt">Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 1pt 0pt; width:122.75pt; white-space:nowrap">Standard</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 1pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to: </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">The lesser of 60% of the current face amount of the Policy or $1,000,000; minus</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Minimum acceleration permitted is $15,000.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; width:4pt"></td> </tr> </table><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <table style="width:523pt; min-height:382.1pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Name of Benefit</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Purpose</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Is Benefit Standard <br/>or Optional?</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Brief Description of <br/>Restrictions/Limitations</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 1pt 0pt; width:122.75pt"> <div style="font-weight:bold">Lapse Protection Endorsement</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 1pt 0pt; width:122.75pt">Guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 1pt 0pt; width:122.75pt; white-space:nowrap">Standard</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 1pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Minimum monthly premium will vary by Policy benefits, Issue Age, sex and rate class of the Insured. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Protection is only effective: </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">20 years for issue ages 0-49,</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">to attained age 70 for issue ages 50-64,</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">5 years for issue ages 65-80 </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">If on any Monthly Anniversary Day, the total premiums paid less any Withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount, this provision will terminate.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <table style="width:523pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Name of Benefit</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Purpose</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Is Benefit Standard <br/>or Optional?</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Brief Description of <br/>Restrictions/Limitations</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Overloan Protection Endorsement</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt">Policy will not Lapse due to an outstanding Policy loan in certain circumstances.</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt; white-space:nowrap">Standard</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Policy must be in force at least 20 Policy Years.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured’s Attained Age must be at least 65.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Withdrawals in an amount equal to the total premiums paid must have been taken.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Policy Debt must exceed the Face Amount and be at least 95% of the Cash Value. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Not available if accelerated benefits have been received or if Monthly Deductions are being waived or premiums credited under any endorsement or rider attached to the Policy. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Not available if the resulting Death Benefit is not compliant with our reasonable interpretation of the Code.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Not available if the Policy is a modified endowment contract (“MEC”).</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Accidental Death Benefit Rider</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt">Provides an additional death benefit payable if Insured’s death results from certain accidental causes.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt; white-space:nowrap">Optional</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 15 and 60 to elect this rider. Coverage expires at age 65.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The minimum amount of coverage is $1,000. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum amount of coverage is $250,000 for the Company and affiliates’ policies in force and applied for.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt"> <div style="font-weight:bold">Children’s Term Life Insurance Rider</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt">Provides a death benefit payable on the death of a covered child.</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt; white-space:nowrap">Optional</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Coverage expires at age 75.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum amount of coverage is $25,000 for the Company and affiliates’ policies in force and applied for.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The minimum amount of coverage is $1,000.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; width:4pt"></td> </tr> </table> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <table style="width:523pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Name of Benefit</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Purpose</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Is Benefit Standard <br/>or Optional?</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Brief Description of <br/>Restrictions/Limitations</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">ExtendCare Chronic Illness Accelerated Death Benefit Rider</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt">Allows Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that Insured has a qualifying chronic illness that is expected to last 90 or more days.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt; white-space:nowrap">Optional</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Can only be added at the time of Policy issue.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">There is a minimum base Policy Face Amount of $100,000 and a maximum base Policy Face Amount of $5,000,000. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum monthly benefit cannot exceed 5% of the base Policy Face Amount. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Death Benefit Option A must be in effect in order to receive benefit payments under the rider.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Any irrevocable Beneficiaries or assignees of record must give written consent for benefit payments to be made. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The rider is subject to a Lifetime Maximum Benefit and a Monthly Maximum Benefit.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt"> <div style="font-weight:bold">Income Provider Option Pre-Determined Death Benefit Payout Endorsement</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt">Converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule.</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt; white-space:nowrap">Optional</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 1pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Can only be added at the time of Policy issue. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">You may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of payments.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">A Beneficiary cannot change the Death Benefit Payment Schedule or elect a single lump sum after the death of the Insured.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; width:4pt"></td> </tr> </table> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <table style="width:523pt; min-height:663.1pt; margin-top:0pt; border-collapse:collapse; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:9.6pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Name of Benefit</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="white-space:nowrap; text-align:center">Purpose</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Is Benefit Standard <br/>or Optional?</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> <td style="border-bottom:1px solid #000000; padding:2.433pt 0pt 1.967pt 0pt; width:122.75pt"> <div style="text-align:center">Brief Description of <br/>Restrictions/Limitations</div> </td> <td style="padding:0pt; border-bottom:1px solid #FFFFFF; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Protected Insurability Benefit Rider</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt">Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt; white-space:nowrap">Optional</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:1.917pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Can only be added at the time of Policy issue. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The maximum amount of coverage is $50,000 per option date, for the Company and affiliates’ policies in force and applied for. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The minimum amount of coverage is $10,000.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured under the base policy must be between the ages of 0 and 37. Coverage expires at age 40.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:normal; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Waiver of Specified Premium Rider</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt">Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured.</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt; white-space:nowrap">Optional</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 15 and 55 at the time the rider is issued. Coverage expires at age 65.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured must be disabled for at least six consecutive months, and the disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Dollar-Cost Averaging</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt; white-space:normal">Allows for the systematic transfer of specified dollar amounts from a Sub- Account or the Fixed Account to one or more other specified Sub- Accounts.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt">Standard</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt; white-space:normal"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">No transfers may be made into the Fixed Account. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt"> <div style="font-weight:bold">Portfolio Rebalancing</div> </td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt; white-space:normal">Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt">Standard</td> <td style="padding:0pt; width:4pt"></td> <td style="padding:0pt; width:4pt"></td> <td style="padding:2.167pt 0pt 2.833pt 0pt; width:122.75pt; white-space:normal"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Rebalancing transfers cannot be made into Fixed Account. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Minimum Variable Account Value of $100 required.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; width:4pt"></td> </tr> <tr style="line-height:11pt; white-space:nowrap; text-align:left; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:9pt"> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 1pt 0pt; width:122.75pt"> <div style="font-weight:bold">Policy Loans</div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 1pt 0pt; width:122.75pt; white-space:normal">Allows Owner to borrow from the Policy’s Cash Value.</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 1pt 0pt; width:122.75pt">Standard</td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> <td style="background:#E5E5E5; padding:2.167pt 0pt 1pt 0pt; width:122.75pt; white-space:normal"> <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Other than Carryover loans, not available during the first Policy Year.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum loan amount is 99% of Cash Value.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Minimum loan amount is $500.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Certain policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a policy loan.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </td> <td style="padding:0pt; background:#E5E5E5; width:4pt"></td> </tr> </table> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="text-align:center; width:523pt; line-height:12pt; font-weight:bold">SUPPLEMENTAL RIDERS AND ENDORSEMENTS</div> <div style="margin-top:4pt; width:523pt; line-height:12pt">The following supplemental riders and endorsements may be available to be added to your Policy subject to state availability. Monthly charges, if applicable, for these riders will be deducted from your Policy Value as part of the monthly deduction. See “Monthly Deduction.” The supplemental riders and endorsements available with the Policies provide fixed benefits that do not vary with the investment experience of the Variable Account. Additional rules and limits apply to these supplemental riders. Not all such riders may be available at any time, and supplemental riders in addition to those listed below may be made available. The ExtendCare Chronic Illness Accelerated Death Benefit Rider, the Protected Insurability Benefit Rider, and the Income Provider Option Pre-Determined Death Benefit Payout Endorsement may only be purchased or added at the time the Policy is issued. The Overloan Protection Endorsement, the Lapse Protection Endorsement, and the Terminal Illness Accelerated Death Benefit Endorsement are automatically added to all Policies at the time of issue. The Children’s Term Life Insurance Rider, the Accidental Death Benefit Rider and the Waiver of Specified Premium Rider may be added at the time of Policy issue or after issue, subject to availability and additional underwriting. Please ask your Protective Life agent for further information, or contact the Home Office.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Children’s Term Life Insurance Rider.</span>   Provides a death benefit payable on the death of a covered child. More than one child can be covered. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $25,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Children are eligible to be covered between 15 days and 25 years of age as long as coverage is in place prior to age 18.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Accidental Death Benefit Rider.</span>   Provides an additional death benefit payable if the Insured’s death results from certain accidental causes. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $250,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 60 to elect this rider.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Waiver of Specified Premium Rider.</span>   Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured. After the Insured has been totally disabled (as defined in the rider) for six consecutive months, Protective Life will credit premiums to the Policy equal to the specified premium amount shown in the Policy multiplied by the number of Monthly Anniversary Days that have occurred since the onset of total disability. The disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday. Monthly Anniversary Days that occur more than one calendar year prior to the date that we receive a claim under a rider are not included for the purpose of this calculation. Subsequent to the time that the Insured has been totally disabled for six months, we will credit a premium equal to the specified premium amount on each Monthly Anniversary Day. The Owner may change the specified premium amount by Written Notice in Good Order received by Protective Life at the Home Office after the first Policy Anniversary and before the Insured becomes totally disabled. Increases are subject to evidence of insurability. The Insured under the base Policy must be between the ages of 15 and 55 to elect this rider.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Waiver of Specified Premiums Rider. At age 55, the insured has a covered total disability while the rider is in force. The Company receives proof of disability and waives the Policy monthly specified premiums for 6 months. During this time, the Policy deductions continue to be in effect.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">ExtendCare Chronic Illness Accelerated Death Benefit Rider (not available in all states)</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">This rider allows the Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that the Insured has a qualifying chronic illness that is expected to last 90 or more days (the”Certification”). A qualifying chronic illness is an illness or condition that (1) prevents the Insured from performing at least two activities of daily living, such as eating, bathing, or dressing, without substantial assistance or (2) requires substantial supervision of the Insured to protect them from threats to their health and safety due to severe cognitive impairment. The licensed health care practitioner who provides the Certification can be a physician, registered professional nurse or licensed social worker, but cannot be the Owner or Insured or a family member of either the Owner or Insured. We reserve the right to require that the Insured be examined by a licensed health care practitioner chosen by us.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">Under the ExtendCare Chronic Illness Accelerated Death Benefit Rider, Protective Life makes either 12 monthly payments or a single lump sum payment to the Owner for a 12-month period, known as a “Benefit Period.” The initial Benefit Period begins on the first Monthly Anniversary after we approve an Owner’s written request for accelerated payments and all conditions under the rider for benefit payments to be made have been met. Each subsequent Benefit Period begins on the first Monthly Anniversary following (1) the end of the most recent prior Benefit Period, (2) our receipt of the Certification for the new Benefit Period, and (3) when all other conditions under the rider for benefit </div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:12pt">payments to be made have been met. In addition to our receipt of the Owner’s written request for accelerated payments and the Certification, for each Benefit Period the conditions noted below must be met for the Owner to receive benefit payments under this rider.</div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.75pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">1.<br/></div> <div style="margin-top:8.75pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">The Insured is alive.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">2.<br/></div> <div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">Both the Policy and the rider are inforce.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">3.<br/></div> <div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">We received a written consent from any irrevocable Beneficiaries or assignees of record of the Policy to allow benefit payments to be made to the Owner.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">4.<br/></div> <div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">90 consecutive days from the date we receive the Certification (the “Elimination Period”) has passed. For Benefit Periods after the initial Benefit Period, this requirement does not apply if less than 30 days have passed from the date of the end of the prior Benefit Period and the date we receive the Certification for the new Benefit Period.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">5.<br/></div> <div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">The Insured has a qualifying chronic illness at the time a benefit payment is made.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">6.<br/></div> <div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">Death Benefit Option A is in effect. If the Owner did not elect Death Benefit Option A, we will change the Death Benefit Option under the Policy to Death Benefit Option A prior to our payment of the first benefit payment under this rider. We do not allow any further changes to the Death Benefit Option during a Benefit Period.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="margin-top:6pt; width:523pt; line-height:12pt">For each Benefit Period, the Owner can elect to receive a benefit payment each month or a single lump sum payment at the beginning of the Benefit Period. The lump sum payment is equal to the present value of each monthly benefit payment payable during the Benefit Period. The rider is subject to both a Lifetime Maximum Benefit and a Monthly Maximum Benefit. The information necessary to determine these amounts is set forth in the Policy schedule and the rider. </div> <div style="margin-top:6pt; width:523pt; line-height:12pt">The Owner or Insured is responsible for the cost of the Certification for the initial Benefit Period. We will cover the cost of the Certification for any subsequent Benefit Period. We begin deducting a monthly charge upon issuance of this rider based, in part, on a maximum monthly benefit amount selected by the Owner at the time of Policy issue. During a Benefit Period, all monthly deductions required to maintain the Policy will be waived. If the Insured is certified as chronically ill for three consecutive Benefit Periods, the monthly deductions will be waived for as long as the Policy is in force. It is possible that for tax purposes some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy. See “Tax Considerations.”</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">We must receive any written request for benefit payments, to change the amount of monthly benefit payments or to receive a single lump sum benefit payment for a Benefit Period in Good Order at our Home Office.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">The minimum Policy Face Amount to elect this rider is $100,000 and the maximum is $5,000,000. The maximum monthly benefit cannot exceed 5% of the Policy Face Amount. Typically, this will force a minimum Face Amount higher than $100,000 at monthly amounts greater than $5,000 or the current IRS per diem limit. The Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the ExtendCare Rider with a benefit amount of $5,000 for a monthly cost of $4.24. In 10 years, while the insured is still alive and the rider and the Policy are still in force, the insured is diagnosed with a chronic illness that prevents them from performing at least two activities of daily living and that is expected to persist for at least 90 days. Once The Company receives written certification from a licensed health care professional and after a 90 day waiting period, the insured will receive either monthly benefits of $5,000 or a lump sum of the present value of the 12 monthly payments as an accelerated payment of part of the Policy’s Death Benefit. The payments will continue for each 12 month Benefit Period where the insured can certify that they are still chronically ill. The insured’s Death Benefit will be reduced dollar for dollar by the amount of payments they receive. So if they are chronically ill for one year and take monthly benefits, they will have received $60,000 in accelerated benefits. If the insured dies after that, the death benefit will be $40,000. </div> <div style="margin-top:12pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Protected Insurability Benefit Rider.</span>   Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. The minimum amount of coverage is $10,000 and the maximum is $50,000. Fees associated with this rider stop at Insured’s age 40.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt">Example: Assume a 25 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Protected Insurability Benefit Rider. While the rider is in force at age 31, the Insured purchases an additional $50,000 in coverage with no required underwriting or proof of insurability, but with a change to the monthly deduction specified premium. If the Insured dies after the purchase while the Policy is still in force, the death benefit would be $150,000. </div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Overloan Protection Endorsement.</span>   Under the provisions of this endorsement, your Policy will not Lapse due to an outstanding Policy loan and the Death Benefit will be at least $10,000 as long as all of the terms and conditions of the endorsement are met:</div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">1.<br/></div> <div style="margin-top:8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy has been in force at least 20 Policy Years;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">2.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Insured’s Attained Age is at least 65;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">3.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Withdrawals in an amount equal to the total premiums paid have been taken;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">4.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy Debt is at least 95% of the Cash Value;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">5.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy Debt exceeds the Face Amount;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">6.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Accelerated benefits have not been received under any endorsement or rider attached to your Policy;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">7.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Monthly Deductions or premiums are not being credited or waived under any endorsement or rider attached to your Policy;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">8.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Invoking this benefit does not result in a death benefit that is not compliant with our reasonable interpretation of the Code; and</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">9.<br/></div> <div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy is not a modified endowment contract.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">When the Policyholder chooses to exercise the benefit under the Overloan Protection Endorsement, we deduct a charge equal to the lesser of the Policy Value minus Policy Debt or 5% of the Policy Value.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount. The Overloan Protection Endorsement is automatically added. At age 70, the insured has been taking loans from his policy so that the Policy Debt is more than 99% of the policy value and the Debt exceeds the Face Amount of the Policy. The insured has taken the maximum amount of withdrawals, the amount equal to their total premiums paid. At this point, any riders on the Policy will be terminated and any Variable Account Value will be transferred to the Fixed Account. In addition, no policy transactions or withdrawals will be allowed. The policy will remain in force and if they die while the endorsement is still in force, the Death Benefit will be the policy value minus the policy debt, with a minimum value of $10,000.</div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Income Provider Option Pre-Determined Death Benefit Payout Endorsement. (not available in all distribution channels)</span>   The endorsement converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule that describes the amount, frequency, and duration of payment of the Death Benefit Proceeds. If the Death Benefit is adjusted under the Policy while the Insured is living, the amounts shown in the payment schedule will be adjusted pro-rata. The Owner may choose to change the payment schedule or elect a lump sum payment of the Death Benefit Proceeds prior to the Insured’s death, but the Beneficiary will not be able to change the payment schedule after the Insured’s death. The Owner may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of the payment schedule.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and adds the Income Provider Option Pre-Determined Death Benefit Payout Endorsement. When the insured dies, the beneficiary will receive a series of payments specified at the time of Policy issue. </div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Lapse Protection Endorsement.</span>   The endorsement guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule, if for each month that the Policy has been inforce, the total premiums paid (less any withdrawals or Policy loans) is equal to, or greater than, the Minimum Monthly Guarantee Amount multiplied by the number of completed Policy months, including the current month, since the Policy Effective Date. The Minimum Monthly Guarantee Amount is based upon the Company’s anticipated cost of providing lapse protection on a specific Policy for the stated lapse protection period. This amount varies with Policy benefits, Issue Age, sex and rate class of the Insured. Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount. The lapse protection provision is effective during the first 20 Policy Years (if the Insured’s Issue Age is 0 through 49), up to attained age 70 (if the Insured’s Issue Age is 50-64), or during the first 5 Policy Years (for Insured’s Issue Age 65 and above). If on any Monthly Anniversary Day, the total premiums paid less any withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount this provision will terminate.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $100,000 Face Amount. The Lapse Protection Endorsement is included on the Policy. The Policy specifies a Monthly Guarantee Premium of $42.00. The owner makes an initial premium payment of $45.00. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">On the 24th monthly anniversary, assume the owner has made 24 subsequent premium payments of the same amount and taken no partial surrenders or Policy Loans. The total of the actual premiums paid for the Policy is $1,080 </div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:11.5pt">(the amount of the initial premium payment plus the amount of the subsequent premium payments). Because there have been no partial surrenders and there is no Outstanding Debt, the net premiums paid is equal to $1,080. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The amount of premiums required to meet the endorsement conditions is $1,008 (the Monthly Guarantee Premium amount specified in the Policy multiplied by the number of months since the Policy date). </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Because the net premiums paid exceed the amount of premiums required, the conditions have been met on this monthly anniversary day and the rider remains in effect. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $100,000. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Assume instead that on the 24th monthly anniversary, the owner missed the last two premium payments. The net premiums paid is then equal to $990. Because the net premiums paid is now less than the amount of premiums required, the owner must pay additional premiums of at least $18.00 within the 60 day grace period to keep the Policy in effect. If the endorsement terminates and the insured dies while the Cash Value of the Policy is zero, the death benefit will be $0. </div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Terminal Illness Accelerated Death Benefit Endorsement.</span>   The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The insured’s Death Benefit is reduced dollar-for-dollar by the amount of payments received and accumulated interest under the accelerated death benefit.The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:</div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.58pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.58pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">the lesser of 60% of the current face amount of the Policy or $1,000,000; minus</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.58pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.58pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.</div> <div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold">Dollar-Cost Averaging</div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt">If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account (“Source Sub-Account”) or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">To elect dollar-cost averaging, Policy Value in the Source Sub-Account or the Fixed Account must be at least $5,000 at the time of election. Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. At least $100 must be transferred each month or $300 each quarter. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span>, 30<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span>, or 31<span style="position:relative; bottom:4.25pt; font-size:7.5pt">st</span>. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.</div> </div><div style="width:523pt; line-height:11.5pt">Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.</div> <div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold">Portfolio Rebalancing</div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt">At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts (“Portfolio Rebalancing”). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span>, 30<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span> or 31<span style="position:relative; bottom:4.25pt; font-size:7.5pt">st</span>. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt; font-style:italic; font-weight:bold">Note<span style="font-weight:normal">:</span> You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.</div><div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold">TRANSFERS</div> <div style="margin-top:4pt; width:523pt; line-height:11.5pt">Upon receipt of Written Notice in Good Order to Protective Life at the Home Office you may transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below. Transfer requests (including telephone transfer requests — described below) received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Day the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Day. Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. See “Suspension or Delay of Payments.” The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account or the Fixed Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) or the Fixed Account would be less than $100, Protective Life reserves the right to transfer the entire amount instead of the requested amount. Protective Life reserves the right to restrict the maximum amount which may be transferred from the Fixed Account in any Policy Year. The maximum is currently the greater of $2,500 or 25% of the Fixed Account Value. Due to this limitation, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Protective Life reserves the right to limit transfers to 12 per Policy Year. For each additional transfer over 12 in any Policy Year, Protective Life reserves the right to charge a transfer fee. We will give written notice thirty (30) days before we impose a transfer fee or limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.</div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Limitations on frequent transfers, including “market timing” transfers.</span>   Frequent transfers may involve an effort to take advantage of the possibility of a lag between a change in the value of a Fund’s portfolio securities and the reflection of that change in the Fund’s share price. This strategy, sometimes referred to as “market timing,” involves an attempt to buy shares of a Fund at a price that does not reflect the current market value of the portfolio securities of the Fund, and then to realize a profit when the Fund shares are sold the next Valuation Day or thereafter.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">When you request a transfer among the Sub-Accounts, your request triggers the purchase and redemption of Fund shares. Frequent transfers cause frequent purchases and redemptions of Fund shares. Frequent purchases and redemptions of Fund shares can cause adverse effects for a Fund, Fund shareholders, the Variable Account, other Owners, beneficiaries or Owners of other variable life insurance policies we issue that invest in the Variable Account. Frequent transfers can result in the following adverse effects:</div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.94pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.94pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Increased brokerage trading and transaction costs;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.94pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.94pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Disruption of planned investment strategies;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.95pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.95pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Forced and unplanned liquidation and portfolio turnover;</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.94pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.94pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Lost opportunity costs; and</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.94pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:7.94pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">Large asset swings that decrease the Fund’s ability to provide maximum investment return to all Policy Owners.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="width:523pt; line-height:11.5pt">Market Timing Procedures are designed to detect and prevent frequent, short-term transfer activity that may adversely affect the Funds, Fund shareholders, the Variable Account, other Policy Owners’ beneficiaries and Policy Owners of other variable life policies we issue that invest in the Variable Account.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">We monitor transfer activity in the Policies to identify frequent transfer activity in any Policy. Our current Market Timing Procedures are intended to detect transfer activity in which the transfers exceed a certain dollar amount and a certain number of transfers involving the same Sub-Accounts within a specific time period. We regularly review transaction reports in an attempt to identify transfers that exceed our established parameters. We do not include transfers made pursuant to the dollar-cost averaging and Portfolio Rebalancing programs when monitoring for frequent transfer activity. </div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">When we identify transfer activity exceeding our established parameters in a Policy or group of Policies that appear to be under common control, we suspend non-written methods of requesting transfers for that Policy or group of Policies. All transfer requests for the affected Policy or group of Policies must be made by Written Notice in Good Order to the Home Office. We notify the affected Policy Owner(s) in writing of these restrictions.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">In addition to our Market Timing Procedures, the Funds may have their own market timing policies and restrictions. While we reserve the right to enforce the Funds’ policies and procedures, Owners and other persons with interests under the Policies should be aware that we may not have the contractual authority or the operational capacity to apply the market timing policies and procedures of the Funds. However, under SEC rules, we are required to: (1) enter into a written agreement with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Owners, and (2) execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Owners who violate the market timing policies established by the Fund.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Some of the Funds have reserved the right to temporarily or permanently refuse payments or transfer requests from us if, in the judgment of the Fund’s investment adviser, the Fund would be unable to invest effectively in accordance with its investment objective or policies, or would otherwise potentially be adversely affected. To the extent permitted by law, we reserve the right to delay or refuse to honor a transfer request, or to reverse a transfer at any time we are unable to purchase or redeem shares of any of the Funds because of the Fund’s refusal or restriction on purchases or transfers between impacted Funds. We will notify the Policy Owner(s) of any refusal or restriction on a purchase or transfer by a Fund relating to that Policy Owner’s transfer request. Some Funds also may impose redemption fees on short-term trading (<span style="font-style:italic">i.e.</span>, redemptions of mutual Fund shares within a certain number of business days after purchase). We also reserve the right to implement, administer, and collect any redemption fees imposed by any of the Funds. You should read the prospectus of each of the Funds for more information about its ability to refuse or restrict purchases or transfers between impacted Funds of its shares, which may be more or less restrictive than our Market Timing Procedures and those of other Funds, and to impose redemption fees.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">We apply our Market Timing Procedures consistently to all Policy Owners without special arrangement, waiver or exception. We reserve the right to change our Market Timing Procedures at any time without prior notice as we deem necessary or appropriate to better detect and deter potentially harmful frequent transfer activity, to comply with state or federal regulatory requirements, or both. We may change our parameters to monitor for different dollar amounts, number of transfers, time period of the transfers, or any of these.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Policy Owners seeking to engage in frequent transfer activity may employ a variety of strategies to avoid detection. Our ability to detect and deter such transfer activity is limited by operational systems and technological limitations. Furthermore, the identification of Policy Owners determined to be engaged in transfer activity that may adversely affect others involves judgments that are inherently subjective. Accordingly, despite our best efforts, we cannot guarantee that our Market Timing Procedures will detect or deter every potential market timer. In addition, because other insurance companies, retirement plans, or both may invest in the Funds, we cannot guarantee that the Funds will not suffer harm from frequent transfer activity in contracts or policies issued by other insurance companies or by retirement plan participants.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Reservation of Rights</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Telephone Transfers</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.</div> </div><div style="width:523pt; line-height:11.5pt">Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider’s, your agent’s, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.</div> <div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold">SURRENDERS AND WITHDRAWALS</div> <div style="margin-top:6pt; width:523pt; line-height:12pt; font-weight:bold">Surrender Privileges</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Surrender Value. Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day. The Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option. Payment is generally made within 7 calendar days. All coverage and optional benefits will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of the Policy surrender. A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See “Tax Considerations.” in the Prospectus.)</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Withdrawal Privileges</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">At any time after the first Policy Year, an Owner, by Written Notice in Good Order received at the Home Office, may make a withdrawal of Surrender Value of not less than $500. Protective Life will withdraw the amount requested, plus a withdrawal charge from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">The Owner may specify the amount of the withdrawal to be made from any Sub-Account or the Fixed Account. If the Owner does not so specify, or if the Sub-Account Value or Fixed Account Value is insufficient to carry out the request, the withdrawal from each Sub-Account and the Fixed Account is based on the proportion that such Sub-Account(s) Value and Fixed Account Value bears to the total unloaned Policy Value on the Valuation Day immediately prior to the Withdrawal. Payment is generally made within seven calendar days.</div> <div style="margin-top:6pt; width:523pt; line-height:11.5pt">If Death Benefit Option A is in effect, Protective Life will reduce the Face Amount by the amount withdrawn if total withdrawals in a Policy Year exceed $5,000. The Company reserves the right to increase or decrease the amount of total withdrawals that will not result in a reduction of the Face Amount, or terminate the ability to withdraw any amount that does not trigger a reduction in the Face Amount. Protective Life may reject a withdrawal request if the withdrawal would reduce the Face Amount below the minimum amount for which the Policy would be issued under Protective Life’s then-current rules, or if the withdrawal would cause the Policy to fail to qualify as a life insurance contract under applicable tax laws, as interpreted by Protective Life. If the Face Amount at the time of the withdrawal includes increases from the Initial Face Amount and the withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the Initial Face Amount. Withdrawals may have tax consequences. See “Tax Considerations” in the Prospectus.</div> Terminal Illness Accelerated Death Benefit Endorsement Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness. Standard <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to: </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">The lesser of 60% of the current face amount of the Policy or $1,000,000; minus</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Minimum acceleration permitted is $15,000.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.</div> Lapse Protection Endorsement Guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule. Standard <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Minimum monthly premium will vary by Policy benefits, Issue Age, sex and rate class of the Insured. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Protection is only effective: </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">20 years for issue ages 0-49,</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">to attained age 70 for issue ages 50-64,</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; margin-left:20pt; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:30pt">5 years for issue ages 65-80 </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">If on any Monthly Anniversary Day, the total premiums paid less any Withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount, this provision will terminate.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount.</div> Overloan Protection Endorsement Policy will not Lapse due to an outstanding Policy loan in certain circumstances. Standard <div style="line-height:11pt; text-align:left; margin-left:10pt">Policy must be in force at least 20 Policy Years.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured’s Attained Age must be at least 65.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Withdrawals in an amount equal to the total premiums paid must have been taken.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Policy Debt must exceed the Face Amount and be at least 95% of the Cash Value. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Not available if accelerated benefits have been received or if Monthly Deductions are being waived or premiums credited under any endorsement or rider attached to the Policy. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Not available if the resulting Death Benefit is not compliant with our reasonable interpretation of the Code.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Not available if the Policy is a modified endowment contract (“MEC”).</div> Accidental Death Benefit Rider Provides an additional death benefit payable if Insured’s death results from certain accidental causes. Optional <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 15 and 60 to elect this rider. Coverage expires at age 65.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The minimum amount of coverage is $1,000. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum amount of coverage is $250,000 for the Company and affiliates’ policies in force and applied for.</div> Children’s Term Life Insurance Rider Provides a death benefit payable on the death of a covered child. Optional <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Coverage expires at age 75.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum amount of coverage is $25,000 for the Company and affiliates’ policies in force and applied for.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The minimum amount of coverage is $1,000.</div> ExtendCare Chronic Illness Accelerated Death Benefit Rider Allows Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that Insured has a qualifying chronic illness that is expected to last 90 or more days. Optional <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Can only be added at the time of Policy issue.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">There is a minimum base Policy Face Amount of $100,000 and a maximum base Policy Face Amount of $5,000,000. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum monthly benefit cannot exceed 5% of the base Policy Face Amount. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Death Benefit Option A must be in effect in order to receive benefit payments under the rider.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Any irrevocable Beneficiaries or assignees of record must give written consent for benefit payments to be made. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The rider is subject to a Lifetime Maximum Benefit and a Monthly Maximum Benefit.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.</div> Income Provider Option Pre-Determined Death Benefit Payout Endorsement Converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule. Optional <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Can only be added at the time of Policy issue. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">You may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of payments.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">A Beneficiary cannot change the Death Benefit Payment Schedule or elect a single lump sum after the death of the Insured.</div> Protected Insurability Benefit Rider Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. Optional <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Can only be added at the time of Policy issue. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The maximum amount of coverage is $50,000 per option date, for the Company and affiliates’ policies in force and applied for. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">The minimum amount of coverage is $10,000.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured under the base policy must be between the ages of 0 and 37. Coverage expires at age 40.</div> Waiver of Specified Premium Rider Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured. Optional <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Insured under the base Policy must be between the ages of 15 and 55 at the time the rider is issued. Coverage expires at age 65.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Insured must be disabled for at least six consecutive months, and the disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday.</div> Dollar-Cost Averaging Allows for the systematic transfer of specified dollar amounts from a Sub- Account or the Fixed Account to one or more other specified Sub- Accounts. Standard <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">No transfers may be made into the Fixed Account. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months. Portfolio Rebalancing Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value. Standard <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Rebalancing transfers cannot be made into Fixed Account. </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Minimum Variable Account Value of $100 required.</div> Policy Loans Allows Owner to borrow from the Policy’s Cash Value. Standard <div style="float:left; line-height:11pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="line-height:11pt; text-align:left; margin-left:10pt">Other than Carryover loans, not available during the first Policy Year.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Maximum loan amount is 99% of Cash Value.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Minimum loan amount is $500.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:11pt; margin-top:10pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div> <div style="margin-top:10pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:10pt">Certain policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a policy loan.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Children’s Term Life Insurance Rider.</span>   Provides a death benefit payable on the death of a covered child. More than one child can be covered. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $25,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Children are eligible to be covered between 15 days and 25 years of age as long as coverage is in place prior to age 18.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Accidental Death Benefit Rider.</span>   Provides an additional death benefit payable if the Insured’s death results from certain accidental causes. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $250,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 60 to elect this rider.</div> <div style="margin-top:6pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Waiver of Specified Premium Rider.</span>   Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured. After the Insured has been totally disabled (as defined in the rider) for six consecutive months, Protective Life will credit premiums to the Policy equal to the specified premium amount shown in the Policy multiplied by the number of Monthly Anniversary Days that have occurred since the onset of total disability. The disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday. Monthly Anniversary Days that occur more than one calendar year prior to the date that we receive a claim under a rider are not included for the purpose of this calculation. Subsequent to the time that the Insured has been totally disabled for six months, we will credit a premium equal to the specified premium amount on each Monthly Anniversary Day. The Owner may change the specified premium amount by Written Notice in Good Order received by Protective Life at the Home Office after the first Policy Anniversary and before the Insured becomes totally disabled. Increases are subject to evidence of insurability. The Insured under the base Policy must be between the ages of 15 and 55 to elect this rider.</div><div style="margin-top:6pt; width:523pt; line-height:12pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Waiver of Specified Premiums Rider. At age 55, the insured has a covered total disability while the rider is in force. The Company receives proof of disability and waives the Policy monthly specified premiums for 6 months. During this time, the Policy deductions continue to be in effect.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">ExtendCare Chronic Illness Accelerated Death Benefit Rider (not available in all states)</div><div style="margin-top:6pt; width:523pt; line-height:12pt">This rider allows the Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that the Insured has a qualifying chronic illness that is expected to last 90 or more days (the”Certification”). A qualifying chronic illness is an illness or condition that (1) prevents the Insured from performing at least two activities of daily living, such as eating, bathing, or dressing, without substantial assistance or (2) requires substantial supervision of the Insured to protect them from threats to their health and safety due to severe cognitive impairment. The licensed health care practitioner who provides the Certification can be a physician, registered professional nurse or licensed social worker, but cannot be the Owner or Insured or a family member of either the Owner or Insured. We reserve the right to require that the Insured be examined by a licensed health care practitioner chosen by us.</div><div style="margin-top:6pt; width:523pt; line-height:12pt">Under the ExtendCare Chronic Illness Accelerated Death Benefit Rider, Protective Life makes either 12 monthly payments or a single lump sum payment to the Owner for a 12-month period, known as a “Benefit Period.” The initial Benefit Period begins on the first Monthly Anniversary after we approve an Owner’s written request for accelerated payments and all conditions under the rider for benefit payments to be made have been met. Each subsequent Benefit Period begins on the first Monthly Anniversary following (1) the end of the most recent prior Benefit Period, (2) our receipt of the Certification for the new Benefit Period, and (3) when all other conditions under the rider for benefit </div><div style="width:523pt; line-height:12pt">payments to be made have been met. In addition to our receipt of the Owner’s written request for accelerated payments and the Certification, for each Benefit Period the conditions noted below must be met for the Owner to receive benefit payments under this rider.</div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.75pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">1.<br/></div><div style="margin-top:8.75pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">The Insured is alive.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">2.<br/></div><div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">Both the Policy and the rider are inforce.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">3.<br/></div><div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">We received a written consent from any irrevocable Beneficiaries or assignees of record of the Policy to allow benefit payments to be made to the Owner.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">4.<br/></div><div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">90 consecutive days from the date we receive the Certification (the “Elimination Period”) has passed. For Benefit Periods after the initial Benefit Period, this requirement does not apply if less than 30 days have passed from the date of the end of the prior Benefit Period and the date we receive the Certification for the new Benefit Period.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">5.<br/></div><div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">The Insured has a qualifying chronic illness at the time a benefit payment is made.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:8.25pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">6.<br/></div><div style="margin-top:8.25pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:40pt">Death Benefit Option A is in effect. If the Owner did not elect Death Benefit Option A, we will change the Death Benefit Option under the Policy to Death Benefit Option A prior to our payment of the first benefit payment under this rider. We do not allow any further changes to the Death Benefit Option during a Benefit Period.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="margin-top:6pt; width:523pt; line-height:12pt">For each Benefit Period, the Owner can elect to receive a benefit payment each month or a single lump sum payment at the beginning of the Benefit Period. The lump sum payment is equal to the present value of each monthly benefit payment payable during the Benefit Period. The rider is subject to both a Lifetime Maximum Benefit and a Monthly Maximum Benefit. The information necessary to determine these amounts is set forth in the Policy schedule and the rider. </div><div style="margin-top:6pt; width:523pt; line-height:12pt">The Owner or Insured is responsible for the cost of the Certification for the initial Benefit Period. We will cover the cost of the Certification for any subsequent Benefit Period. We begin deducting a monthly charge upon issuance of this rider based, in part, on a maximum monthly benefit amount selected by the Owner at the time of Policy issue. During a Benefit Period, all monthly deductions required to maintain the Policy will be waived. If the Insured is certified as chronically ill for three consecutive Benefit Periods, the monthly deductions will be waived for as long as the Policy is in force. It is possible that for tax purposes some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy. See “Tax Considerations.”</div><div style="margin-top:6pt; width:523pt; line-height:12pt">We must receive any written request for benefit payments, to change the amount of monthly benefit payments or to receive a single lump sum benefit payment for a Benefit Period in Good Order at our Home Office.</div><div style="margin-top:6pt; width:523pt; line-height:12pt">The minimum Policy Face Amount to elect this rider is $100,000 and the maximum is $5,000,000. The maximum monthly benefit cannot exceed 5% of the Policy Face Amount. Typically, this will force a minimum Face Amount higher than $100,000 at monthly amounts greater than $5,000 or the current IRS per diem limit. The Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.</div><div style="margin-top:6pt; width:523pt; line-height:12pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the ExtendCare Rider with a benefit amount of $5,000 for a monthly cost of $4.24. In 10 years, while the insured is still alive and the rider and the Policy are still in force, the insured is diagnosed with a chronic illness that prevents them from performing at least two activities of daily living and that is expected to persist for at least 90 days. Once The Company receives written certification from a licensed health care professional and after a 90 day waiting period, the insured will receive either monthly benefits of $5,000 or a lump sum of the present value of the 12 monthly payments as an accelerated payment of part of the Policy’s Death Benefit. The payments will continue for each 12 month Benefit Period where the insured can certify that they are still chronically ill. The insured’s Death Benefit will be reduced dollar for dollar by the amount of payments they receive. So if they are chronically ill for one year and take monthly benefits, they will have received $60,000 in accelerated benefits. If the insured dies after that, the death benefit will be $40,000. </div> <div style="margin-top:12pt; width:523pt; line-height:12pt"> <span style="font-style:italic; font-weight:bold">Protected Insurability Benefit Rider.</span>   Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. The minimum amount of coverage is $10,000 and the maximum is $50,000. Fees associated with this rider stop at Insured’s age 40.</div><div style="margin-top:6pt; width:523pt; line-height:12pt">Example: Assume a 25 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Protected Insurability Benefit Rider. While the rider is in force at age 31, the Insured purchases an additional $50,000 in coverage with no required underwriting or proof of insurability, but with a change to the monthly deduction specified premium. If the Insured dies after the purchase while the Policy is still in force, the death benefit would be $150,000. </div> <div style="width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Overloan Protection Endorsement.</span>   Under the provisions of this endorsement, your Policy will not Lapse due to an outstanding Policy loan and the Death Benefit will be at least $10,000 as long as all of the terms and conditions of the endorsement are met:</div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:8pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">1.<br/></div><div style="margin-top:8pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy has been in force at least 20 Policy Years;</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">2.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Insured’s Attained Age is at least 65;</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">3.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Withdrawals in an amount equal to the total premiums paid have been taken;</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">4.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy Debt is at least 95% of the Cash Value;</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">5.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy Debt exceeds the Face Amount;</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">6.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Accelerated benefits have not been received under any endorsement or rider attached to your Policy;</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">7.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Monthly Deductions or premiums are not being credited or waived under any endorsement or rider attached to your Policy;</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">8.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">Invoking this benefit does not result in a death benefit that is not compliant with our reasonable interpretation of the Code; and</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11pt; margin-top:7.5pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap">9.<br/></div><div style="margin-top:7.5pt; margin-bottom:0pt; line-height:11pt; text-align:left; margin-left:40pt">The Policy is not a modified endowment contract.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">When the Policyholder chooses to exercise the benefit under the Overloan Protection Endorsement, we deduct a charge equal to the lesser of the Policy Value minus Policy Debt or 5% of the Policy Value.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount. The Overloan Protection Endorsement is automatically added. At age 70, the insured has been taking loans from his policy so that the Policy Debt is more than 99% of the policy value and the Debt exceeds the Face Amount of the Policy. The insured has taken the maximum amount of withdrawals, the amount equal to their total premiums paid. At this point, any riders on the Policy will be terminated and any Variable Account Value will be transferred to the Fixed Account. In addition, no policy transactions or withdrawals will be allowed. The policy will remain in force and if they die while the endorsement is still in force, the Death Benefit will be the policy value minus the policy debt, with a minimum value of $10,000.</div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Income Provider Option Pre-Determined Death Benefit Payout Endorsement. (not available in all distribution channels)</span>   The endorsement converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule that describes the amount, frequency, and duration of payment of the Death Benefit Proceeds. If the Death Benefit is adjusted under the Policy while the Insured is living, the amounts shown in the payment schedule will be adjusted pro-rata. The Owner may choose to change the payment schedule or elect a lump sum payment of the Death Benefit Proceeds prior to the Insured’s death, but the Beneficiary will not be able to change the payment schedule after the Insured’s death. The Owner may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of the payment schedule.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and adds the Income Provider Option Pre-Determined Death Benefit Payout Endorsement. When the insured dies, the beneficiary will receive a series of payments specified at the time of Policy issue. </div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Lapse Protection Endorsement.</span>   The endorsement guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule, if for each month that the Policy has been inforce, the total premiums paid (less any withdrawals or Policy loans) is equal to, or greater than, the Minimum Monthly Guarantee Amount multiplied by the number of completed Policy months, including the current month, since the Policy Effective Date. The Minimum Monthly Guarantee Amount is based upon the Company’s anticipated cost of providing lapse protection on a specific Policy for the stated lapse protection period. This amount varies with Policy benefits, Issue Age, sex and rate class of the Insured. Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount. The lapse protection provision is effective during the first 20 Policy Years (if the Insured’s Issue Age is 0 through 49), up to attained age 70 (if the Insured’s Issue Age is 50-64), or during the first 5 Policy Years (for Insured’s Issue Age 65 and above). If on any Monthly Anniversary Day, the total premiums paid less any withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount this provision will terminate.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $100,000 Face Amount. The Lapse Protection Endorsement is included on the Policy. The Policy specifies a Monthly Guarantee Premium of $42.00. The owner makes an initial premium payment of $45.00. </div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">On the 24th monthly anniversary, assume the owner has made 24 subsequent premium payments of the same amount and taken no partial surrenders or Policy Loans. The total of the actual premiums paid for the Policy is $1,080 </div><div style="width:523pt; line-height:11.5pt">(the amount of the initial premium payment plus the amount of the subsequent premium payments). Because there have been no partial surrenders and there is no Outstanding Debt, the net premiums paid is equal to $1,080. </div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">The amount of premiums required to meet the endorsement conditions is $1,008 (the Monthly Guarantee Premium amount specified in the Policy multiplied by the number of months since the Policy date). </div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Because the net premiums paid exceed the amount of premiums required, the conditions have been met on this monthly anniversary day and the rider remains in effect. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $100,000. </div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Assume instead that on the 24th monthly anniversary, the owner missed the last two premium payments. The net premiums paid is then equal to $990. Because the net premiums paid is now less than the amount of premiums required, the owner must pay additional premiums of at least $18.00 within the 60 day grace period to keep the Policy in effect. If the endorsement terminates and the insured dies while the Cash Value of the Policy is zero, the death benefit will be $0. </div> <div style="margin-top:12pt; width:523pt; line-height:11.5pt"> <span style="font-style:italic; font-weight:bold">Terminal Illness Accelerated Death Benefit Endorsement.</span>   The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The insured’s Death Benefit is reduced dollar-for-dollar by the amount of payments received and accumulated interest under the accelerated death benefit.The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:</div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.58pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div><div style="margin-top:7.58pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">the lesser of 60% of the current face amount of the Policy or $1,000,000; minus</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; margin-left:20pt; line-height:11.5pt; margin-top:7.58pt; margin-bottom:0pt; text-align:left; width:10pt; white-space:nowrap">•<br/></div><div style="margin-top:7.58pt; margin-bottom:0pt; line-height:11.5pt; text-align:left; margin-left:30pt">any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.</div><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.</div> <div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold">Dollar-Cost Averaging</div><div style="margin-top:4pt; width:523pt; line-height:11.5pt">If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account (“Source Sub-Account”) or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">To elect dollar-cost averaging, Policy Value in the Source Sub-Account or the Fixed Account must be at least $5,000 at the time of election. Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. At least $100 must be transferred each month or $300 each quarter. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span>, 30<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span>, or 31<span style="position:relative; bottom:4.25pt; font-size:7.5pt">st</span>. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.</div><div style="width:523pt; line-height:11.5pt">Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.</div> <div style="margin-top:12pt; text-align:center; width:523pt; line-height:12pt; font-weight:bold">Portfolio Rebalancing</div><div style="margin-top:4pt; width:523pt; line-height:11.5pt">At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts (“Portfolio Rebalancing”). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span>, 30<span style="position:relative; bottom:4.25pt; font-size:7.5pt">th</span> or 31<span style="position:relative; bottom:4.25pt; font-size:7.5pt">st</span>. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt; font-style:italic; font-weight:bold">Note<span style="font-weight:normal">:</span> You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Reservation of Rights</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.</div> <div style="margin-top:12pt; width:523pt; line-height:12pt; font-weight:bold">Telephone Transfers</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.</div><div style="width:523pt; line-height:11.5pt">Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.</div><div style="margin-top:6pt; width:523pt; line-height:11.5pt">A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider’s, your agent’s, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.</div> <div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="text-align:center; width:523pt; line-height:12pt; font-weight:bold; font-size:10pt">APPENDIX: FUNDS AVAILABLE UNDER THE POLICY</div> <div style="-keep: true"> <div style="margin-top:6pt; width:523pt; line-height:12.5pt; font-size:10pt">The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling <span style="white-space:nowrap">1-800-265-1545</span> or by sending an email request to prospectus@protective.com.</div> </div> <div style="margin-top:6pt; width:523pt; line-height:12.5pt; font-size:10pt">The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund’s past performance is not necessarily an indication of future performance.</div> <div style="-keep: true"> <table style="width:523pt; margin-top:4pt; border-collapse:collapse; border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; height:19.68pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td rowspan="2" style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Asset<br/>Allocation <br/>Type</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:192.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Fund - Investment Adviser; <br/><span style="font-style:italic">Sub-Adviser(s), as applicable</span></div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Current <br/>Expenses</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td colspan="9" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:0pt"> <div style="text-align:center; font-style:italic"> <span style="font-style:normal">Average Annual Total Returns </span> <br/>(as of 12/31/2025)</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:8pt; height:13.36pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.68pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">1 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.68pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">5 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.68pt 0pt 2.43pt 0pt; width:54.75pt"> <div style="white-space:nowrap; text-align:center">10 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Asset Allocation Fund - Class 1 - Capital Research and Management Company</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">16.16%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">9.24%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">10.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Global Growth Fund - Class 1 - Capital Research and Management Company<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.40%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">21.98%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">8.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">12.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Growth-Income Fund - Class 1 - Capital Research and Management Company</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">18.37%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">14.19%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">14.20%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> New World Fund<span style="position:relative; bottom:3.25pt; font-size:5pt">® </span>- Class 1 - Capital Research and Management Company<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.57%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">28.60%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">5.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">9.53%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:192.5pt; text-align:left">BlackRock Global Allocation V.I. Fund - Class I <span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">0.76%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">19.80%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">5.79%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.75pt"> <div style="text-align:center">7.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">ClearBridge Variable Mid Cap Portfolio - Class I - Franklin Templeton Fund Adviser, LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.82%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">4.35%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">4.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">7.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.81%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">9.23%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">-0.17%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">9.38%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA Global Moderate Allocation Portfolio - Institutional Class<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">14.68%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">8.42%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">8.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA International Small Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">0.39%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">36.99%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">8.89%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.75pt"> <div style="text-align:center">8.68%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA International Value Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">0.27%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">45.64%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">15.85%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.75pt"> <div style="text-align:center">10.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA Short-Term Fixed Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">0.12%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">4.33%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">2.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.75pt"> <div style="text-align:center">1.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA U.S. Large Value Portfolio - Institutional Class</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.21%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">15.83%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">11.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">10.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA U.S. Targeted Value Portfolio - Institutional Class</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">8.95%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">13.60%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">11.00%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">0.11%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">7.55%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">1.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.75pt"> <div style="text-align:center">3.12%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Balanced Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.41%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">15.25%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">9.52%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">11.13%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Growth Opportunities Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited<span style="font-style:normal">; </span>Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.56%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">22.02%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">11.31%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">19.94%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Investment Grade Bond Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited<span style="font-style:normal">; </span>Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.37%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">7.22%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.06%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">2.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Mid Cap Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.55%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">11.75%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">10.10%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">10.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> </table> </div> </div><div style="margin-top:28pt; margin-left:36pt; width:523pt"> <div style="-keep: true"> <table style="width:523pt; margin-top:0pt; border-collapse:collapse; border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; height:19.77pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td rowspan="2" style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Asset<br/>Allocation <br/>Type</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:192.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Fund - Investment Adviser; <br/><span style="font-style:italic">Sub-Adviser(s), as applicable</span></div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Current <br/>Expenses</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td colspan="9" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:0pt"> <div style="text-align:center; font-style:italic"> <span style="font-style:normal">Average Annual Total Returns </span> <br/>(as of 12/31/2025)</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:8pt; height:13.53pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.76pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">1 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.76pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">5 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.76pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="white-space:nowrap; text-align:center">10 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Goldman Sachs VIT Core Fixed Income Fund - Institutional Class<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.42%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">7.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">-0.57%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">2.11%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Goldman Sachs VIT Mid Cap Value Fund - Institutional Class<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.81%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">9.39%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">10.02%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; text-align:left">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. Global Fund - Series I<span style="font-size:10pt"> </span></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.81%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">15.32%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">7.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">11.00%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. S&P 500 Buffer December Fund - Series I <span style="position:relative; bottom:3.25pt; font-size:5pt">(1)(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.53%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-3">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-4">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-size:6pt"> <span style="font-size:8pt">Invesco</span><span style="position:relative; bottom:3.25pt; font-size:5pt">®</span><span style="font-size:8pt"> V.I. S&P 500 Buffer June Fund - Series I</span> (1)<span style="position:relative; bottom:3.25pt; font-size:5pt">(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">13.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-5">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-6">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-size:6pt"> <span style="font-size:8pt">Invesco</span><span style="position:relative; bottom:3.25pt; font-size:5pt">®</span><span style="font-size:8pt"> V.I. S&P 500 Buffer March Fund - Series I</span> (1)<span style="position:relative; bottom:3.25pt; font-size:5pt">(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">7.64%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-7">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-8">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. S&P 500 Buffer September Fund - Series I <span style="position:relative; bottom:3.25pt; font-size:5pt">(1)(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.78%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-9">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-10">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:72.75pt"> <div style="text-align:center">Money Market</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. U.S. Government Money Portfolio - Series I<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">0.67%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">3.64%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">2.80%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="text-align:center">1.76%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Sector Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.73%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">25.15%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">13.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">21.48%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.98%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">8.33%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">2.10%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">4.72%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">PIMCO VIT Real Return Portfolio - Institutional Class - Pacific Investment Management Company LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">1.24%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">8.01%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">1.36%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">3.37%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Managaement Company LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.58%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">9.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.16%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">2.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Putnam VT Sustainable Leaders Fund - Class IA - </span>Franklin Advisers, Inc.; Franklin Templeton Investment Management Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.63%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.99%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.62%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">14.98%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:192.5pt; text-align:left">Schwab<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> S&P 500 Index Portfolio</td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">0.03%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">17.83%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">14.38%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="text-align:center">14.75%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC </span>(formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Aggressive Growth ETF Portfolio)<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">19.17%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">9.69%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="text-align:center">10.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.31%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.39%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">4.61%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">5.25%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderately Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC</span> (formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Growth ETF Portfolio)</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">18.31%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">8.85%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">9.80%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC</span> (formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderate Growth ETF Portfolio)</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">15.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">7.20%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">8.26%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Balanced Portfolio- Wellington Management Company LLP</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.20%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">16.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">9.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">10.02%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named the Vanguard Variable Insurance Funds - Capital Growth Portfolio)</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.34%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">28.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">13.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">14.96%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Conservative Allocation Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.12%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.72%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">4.22%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">6.14%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">16.79%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">11.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Equity Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.14%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">17.70%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">14.26%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">14.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Growth Portfolio - Wellington Management Company, LLP</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.36%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">16.88%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">11.36%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">15.58%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> </table> </div> </div><div style="margin-top:28pt; height:702pt; margin-left:36pt; width:523pt"> <div style="-keep: true"> <table style="width:523pt; margin-top:0pt; border-collapse:collapse; border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; height:19.5pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td rowspan="2" style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Asset<br/>Allocation <br/>Type</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:192.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Fund - Investment Adviser; <br/><span style="font-style:italic">Sub-Adviser(s), as applicable</span></div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Current <br/>Expenses</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td colspan="9" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:0pt"> <div style="text-align:center; font-style:italic"> <span style="font-style:normal">Average Annual Total Returns </span> <br/>(as of 12/31/2025)</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:8pt; height:13pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.5pt 0pt 2.25pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">1 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.5pt 0pt 2.25pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">5 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.5pt 0pt 2.25pt 0pt; width:54.75pt"> <div style="white-space:nowrap; text-align:center">10 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.32%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">19.96%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.62%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">10.48%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.17%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">11.54%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">8.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">10.77%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">Sector Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Real Estate Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.26%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">3.11%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">4.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">5.08%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.14%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">6.93%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">-0.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">1.90%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.13%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">16.93%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">12.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">14.09%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> </table> </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:12pt; margin-top:3.75pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:10pt"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div> <div style="margin-top:3.75pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic; font-size:10pt">These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.</div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> <div style="float:left; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:7.5pt"> <span style="position:relative; bottom:4.25pt">(2)</span> <br/> </div> <div style="margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic; font-size:7.5pt"> <span style="font-size:10pt">The Sub-Account investing in this Fund is closed to Policies with applications signed on and after May 1, 2025.</span> </div> <div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div> </div> <div style="margin-top:6pt; width:523pt; line-height:12.5pt; font-size:10pt">The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling <span style="white-space:nowrap">1-800-265-1545</span> or by sending an email request to prospectus@protective.com.</div><div style="margin-top:6pt; width:523pt; line-height:12.5pt; font-size:10pt">The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund’s past performance is not necessarily an indication of future performance.</div> <table style="width:523pt; margin-top:4pt; border-collapse:collapse; border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; height:19.68pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td rowspan="2" style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Asset<br/>Allocation <br/>Type</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:192.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Fund - Investment Adviser; <br/><span style="font-style:italic">Sub-Adviser(s), as applicable</span></div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Current <br/>Expenses</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td colspan="9" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.763pt 0pt; width:0pt"> <div style="text-align:center; font-style:italic"> <span style="font-style:normal">Average Annual Total Returns </span> <br/>(as of 12/31/2025)</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:8pt; height:13.36pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.68pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">1 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.68pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">5 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.68pt 0pt 2.43pt 0pt; width:54.75pt"> <div style="white-space:nowrap; text-align:center">10 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Asset Allocation Fund - Class 1 - Capital Research and Management Company</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">16.16%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">9.24%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">10.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Global Growth Fund - Class 1 - Capital Research and Management Company<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.40%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">21.98%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">8.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">12.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Growth-Income Fund - Class 1 - Capital Research and Management Company</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">18.37%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">14.19%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">14.20%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> New World Fund<span style="position:relative; bottom:3.25pt; font-size:5pt">® </span>- Class 1 - Capital Research and Management Company<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.57%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">28.60%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">5.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">9.53%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:192.5pt; text-align:left">BlackRock Global Allocation V.I. Fund - Class I <span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">0.76%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">19.80%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">5.79%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 2.43pt 0pt; width:54.75pt"> <div style="text-align:center">7.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">ClearBridge Variable Mid Cap Portfolio - Class I - Franklin Templeton Fund Adviser, LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.82%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">4.35%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">4.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">7.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.81%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">9.23%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">-0.17%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">9.38%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA Global Moderate Allocation Portfolio - Institutional Class<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">0.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">14.68%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.5pt"> <div style="text-align:center">8.42%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.763pt 0pt; width:54.75pt"> <div style="text-align:center">8.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA International Small Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">0.39%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">36.99%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.5pt"> <div style="text-align:center">8.89%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.43pt 0pt; width:54.75pt"> <div style="text-align:center">8.68%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA International Value Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">0.27%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">45.64%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">15.85%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 2.44pt 0pt; width:54.75pt"> <div style="text-align:center">10.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA Short-Term Fixed Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">0.12%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">4.33%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">2.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.397pt 0pt 2.44pt 0pt; width:54.75pt"> <div style="text-align:center">1.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA U.S. Large Value Portfolio - Institutional Class</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.21%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">15.83%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">11.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">10.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VA U.S. Targeted Value Portfolio - Institutional Class</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">8.95%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">13.60%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.387pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">11.00%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">0.11%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">7.55%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.5pt"> <div style="text-align:center">1.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 2.44pt 0pt; width:54.75pt"> <div style="text-align:center">3.12%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Balanced Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.41%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">15.25%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">9.52%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.377pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">11.13%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Growth Opportunities Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited<span style="font-style:normal">; </span>Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.56%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">22.02%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">11.31%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">19.94%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Investment Grade Bond Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited<span style="font-style:normal">; </span>Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.37%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">7.22%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.06%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.367pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">2.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span><span style="font-style:normal"> VIP Mid Cap Portfolio - Initial Class - </span>FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">0.55%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">11.75%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.5pt"> <div style="text-align:center">10.10%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.357pt 0pt 1.773pt 0pt; width:54.75pt"> <div style="text-align:center">10.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> </table><table style="width:523pt; margin-top:0pt; border-collapse:collapse; border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; height:19.77pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td rowspan="2" style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Asset<br/>Allocation <br/>Type</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:192.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Fund - Investment Adviser; <br/><span style="font-style:italic">Sub-Adviser(s), as applicable</span></div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Current <br/>Expenses</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td colspan="9" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.853pt 0pt; width:0pt"> <div style="text-align:center; font-style:italic"> <span style="font-style:normal">Average Annual Total Returns </span> <br/>(as of 12/31/2025)</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:8pt; height:13.53pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.76pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">1 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.76pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">5 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.76pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="white-space:nowrap; text-align:center">10 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Goldman Sachs VIT Core Fixed Income Fund - Institutional Class<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.42%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">7.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">-0.57%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">2.11%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Goldman Sachs VIT Mid Cap Value Fund - Institutional Class<span style="position:relative; bottom:3.25pt; font-size:5pt">(1)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.81%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">9.39%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">10.02%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; text-align:left">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. Global Fund - Series I<span style="font-size:10pt"> </span></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.81%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">15.32%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">7.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">11.00%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. S&P 500 Buffer December Fund - Series I <span style="position:relative; bottom:3.25pt; font-size:5pt">(1)(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.53%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-3">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-4">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-size:6pt"> <span style="font-size:8pt">Invesco</span><span style="position:relative; bottom:3.25pt; font-size:5pt">®</span><span style="font-size:8pt"> V.I. S&P 500 Buffer June Fund - Series I</span> (1)<span style="position:relative; bottom:3.25pt; font-size:5pt">(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">13.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-5">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.187pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-6">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-size:6pt"> <span style="font-size:8pt">Invesco</span><span style="position:relative; bottom:3.25pt; font-size:5pt">®</span><span style="font-size:8pt"> V.I. S&P 500 Buffer March Fund - Series I</span> (1)<span style="position:relative; bottom:3.25pt; font-size:5pt">(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center">7.64%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-7">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.187pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-8">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Buffer</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. S&P 500 Buffer September Fund - Series I <span style="position:relative; bottom:3.25pt; font-size:5pt">(1)(2)</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.78%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-9">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center"><span style="-sec-ix-hidden: hidden-fact-10">-</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:72.75pt"> <div style="text-align:center">Money Market</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. U.S. Government Money Portfolio - Series I<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">0.67%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">3.64%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">2.80%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="text-align:center">1.76%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Sector Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.73%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">25.15%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">13.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">21.48%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.98%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">8.33%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">2.10%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">4.72%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">PIMCO VIT Real Return Portfolio - Institutional Class - Pacific Investment Management Company LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">1.24%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">8.01%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">1.36%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">3.37%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Managaement Company LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.58%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">9.05%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.16%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">2.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt; font-style:italic"> <span style="font-style:normal">Putnam VT Sustainable Leaders Fund - Class IA - </span>Franklin Advisers, Inc.; Franklin Templeton Investment Management Limited</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.63%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.99%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.62%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">14.98%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:192.5pt; text-align:left">Schwab<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> S&P 500 Index Portfolio</td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">0.03%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">17.83%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">14.38%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.477pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="text-align:center">14.75%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC </span>(formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Aggressive Growth ETF Portfolio)<span style="font-size:10pt"> </span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">19.17%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.5pt"> <div style="text-align:center">9.69%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 2.52pt 0pt; width:54.75pt"> <div style="text-align:center">10.71%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC</span></div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.31%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">10.39%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">4.61%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.467pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">5.25%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderately Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC</span> (formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Growth ETF Portfolio)</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">18.31%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">8.85%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">9.80%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - <span style="font-style:italic">Milliman Financial Risk Management, LLC</span> (formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderate Growth ETF Portfolio)</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">15.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">7.20%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.457pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">8.26%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Balanced Portfolio- Wellington Management Company LLP</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.20%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">16.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">9.28%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">10.02%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named the Vanguard Variable Insurance Funds - Capital Growth Portfolio)</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.34%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">28.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">13.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.447pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">14.96%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">Allocation</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Conservative Allocation Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.12%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.72%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">4.22%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">6.14%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.29%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">16.79%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">12.59%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.437pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">11.51%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Equity Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.14%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">17.70%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">14.26%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">14.65%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Growth Portfolio - Wellington Management Company, LLP</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">0.36%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">16.88%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.5pt"> <div style="text-align:center">11.36%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.427pt 0pt 1.853pt 0pt; width:54.75pt"> <div style="text-align:center">15.58%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> </table><table style="width:523pt; margin-top:0pt; border-collapse:collapse; border-top:0.75pt solid #000000; border-left:0.75pt solid #000000; border-right:0.75pt solid #000000; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <tr style="line-height:10pt; height:19.5pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td rowspan="2" style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Asset<br/>Allocation <br/>Type</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:192.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Fund - Investment Adviser; <br/><span style="font-style:italic">Sub-Adviser(s), as applicable</span></div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center; line-height:10pt; padding-bottom:0pt">Current <br/>Expenses</div> </td> <td rowspan="2" style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td rowspan="2" style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td colspan="9" style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.167pt 0pt 1.583pt 0pt; width:0pt"> <div style="text-align:center; font-style:italic"> <span style="font-style:normal">Average Annual Total Returns </span> <br/>(as of 12/31/2025)</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:8pt; height:13pt; white-space:nowrap; text-align:center; vertical-align:bottom; font-style:normal; font-weight:bold; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.5pt 0pt 2.25pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">1 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.5pt 0pt 2.25pt 0pt; width:54.5pt"> <div style="white-space:nowrap; text-align:center">5 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="background:#A5A5A5; border-bottom:1px solid #000000; padding:2.5pt 0pt 2.25pt 0pt; width:54.75pt"> <div style="white-space:nowrap; text-align:center">10 Year</div> </td> <td style="padding:0pt; background:#A5A5A5; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt; background-color:#A5A5A5"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">International <br/>Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.32%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">19.96%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.62%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">10.48%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.17%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">11.54%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">8.46%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">10.77%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">Sector Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Real Estate Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.26%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">3.11%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">4.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">5.08%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">Taxable Bond</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.14%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">6.93%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">-0.50%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">1.90%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> <tr style="line-height:10pt; white-space:nowrap; text-align:center; vertical-align:top; font-style:normal; font-weight:normal; font-variant:normal; text-transform:none; color:#000000; font-family:Arial, Helvetica, sans-serif; font-size:8pt"> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:72.75pt"> <div style="text-align:center">U.S. Equity</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:192.5pt; white-space:normal; text-align:left"> <div style="margin-left:10pt; text-indent:-10pt">Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">0.13%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">16.93%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.5pt"> <div style="text-align:center">12.97%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="width:0.25pt; padding:0pt; font-size:0pt; line-height:0pt; padding-left:0.75pt; background-color:#000000; border-bottom:1px solid #000000"></td> <td style="padding:0pt; border-bottom:1px solid #000000; width:3.65pt"></td> <td style="border-bottom:1px solid #000000; padding:1.167pt 0pt 1.583pt 0pt; width:54.75pt"> <div style="text-align:center">14.09%</div> </td> <td style="padding:0pt; border-bottom:1px solid #000000; width:0pt"></td> <td style="width:0pt; padding:0pt; font-size:0pt; line-height:0pt"></td> </tr> </table><div style="clear:both; padding:0pt; margin:0pt; font-size:0pt; line-height:0pt"></div><div style="float:left; line-height:12pt; margin-top:3.75pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:10pt"> <span style="position:relative; bottom:4.25pt; font-size:7.5pt">(1)</span> <br/> </div><div style="margin-top:3.75pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic; font-size:10pt">These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.</div><div style="float:left; line-height:12pt; margin-top:0pt; margin-bottom:0pt; text-align:left; width:20pt; white-space:nowrap; font-style:italic; font-size:7.5pt"> <span style="position:relative; bottom:4.25pt">(2)</span> <br/> </div><div style="margin-top:0pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic; font-size:7.5pt"> <span style="font-size:10pt">The Sub-Account investing in this Fund is closed to Policies with applications signed on and after May 1, 2025.</span> </div> American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Asset Allocation Fund - Class 1 Capital Research and Management Company 0.0029 0.1616 0.0924 0.1005 American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Global Growth Fund - Class 1 Capital Research and Management Company 0.004 0.2198 0.0851 0.1246 American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Growth-Income Fund - Class 1 Capital Research and Management Company 0.0028 0.1837 0.1419 0.142 American Funds Insurance Series<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> New World Fund<span style="position:relative; bottom:3.25pt; font-size:5pt">® </span>- Class 1 Capital Research and Management Company 0.0057 0.286 0.0559 0.0953 BlackRock Global Allocation V.I. Fund - Class I 0.0076 0.198 0.0579 0.0759 ClearBridge Variable Mid Cap Portfolio - Class I Franklin Templeton Fund Adviser, LLC 0.0082 0.0435 0.045 0.075 ClearBridge Variable Small Cap Growth Portfolio - Class I Franklin Templeton Fund Adviser, LLC 0.0081 0.0923 -0.0017 0.0938 Dimensional VA Global Moderate Allocation Portfolio - Institutional Class 0.0028 0.1468 0.0842 0.0865 Dimensional VA International Small Portfolio - Institutional Class 0.0039 0.3699 0.0889 0.0868 Dimensional VA International Value Portfolio - Institutional Class 0.0027 0.4564 0.1585 0.1046 Dimensional VA Short-Term Fixed Portfolio - Institutional Class 0.0012 0.0433 0.0265 0.0197 Dimensional VA U.S. Large Value Portfolio - Institutional Class 0.0021 0.1583 0.1197 0.1051 Dimensional VA U.S. Targeted Value Portfolio - Institutional Class 0.0029 0.0895 0.136 0.11 Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class 0.0011 0.0755 0.0105 0.0312 <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span> VIP Balanced Portfolio - Initial Class FMR Investment Management (UK) Limited Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited 0.0041 0.1525 0.0952 0.1113 <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span> VIP Growth Opportunities Portfolio - Initial Class FMR Investment Management (UK) Limited Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited 0.0056 0.2202 0.1131 0.1994 <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span> VIP Investment Grade Bond Portfolio - Initial Class FMR Investment Management (UK) Limited Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited 0.0037 0.0722 0.0006 0.0271 <span style="font-style:normal">Fidelity</span><span style="position:relative; bottom:3.25pt; font-size:5pt; font-style:normal">®</span> VIP Mid Cap Portfolio - Initial Class FMR Investment Management (UK) Limited Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited 0.0055 0.1175 0.101 0.1059 Goldman Sachs VIT Core Fixed Income Fund - Institutional Class 0.0042 0.0746 -0.0057 0.0211 Goldman Sachs VIT Mid Cap Value Fund - Institutional Class 0.0081 0.0939 0.1005 0.1002 Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. Global Fund - Series I 0.0081 0.1532 0.0728 0.11 Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. S&P 500 Buffer December Fund - Series I 0.0071 0.1253 <span style="font-size:8pt">Invesco</span><span style="position:relative; bottom:3.25pt; font-size:5pt">®</span><span style="font-size:8pt"> V.I. S&P 500 Buffer June Fund - Series I</span> 0.0071 0.1365 <span style="font-size:8pt">Invesco</span><span style="position:relative; bottom:3.25pt; font-size:5pt">®</span><span style="font-size:8pt"> V.I. S&P 500 Buffer March Fund - Series I</span> 0.0071 0.0764 Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. S&P 500 Buffer September Fund - Series I 0.0071 0.1278 Invesco<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> V.I. U.S. Government Money Portfolio - Series I 0.0067 0.0364 0.028 0.0176 Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares 0.0073 0.2515 0.1371 0.2148 Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC 0.0098 0.0833 0.021 0.0472 PIMCO VIT Real Return Portfolio - Institutional Class Pacific Investment Management Company LLC 0.0124 0.0801 0.0136 0.0337 PIMCO VIT Total Return Portfolio - Institutional Class Pacific Investment Managaement Company LLC 0.0058 0.0905 0.0016 0.0251 Putnam VT Sustainable Leaders Fund - Class IA Franklin Advisers, Inc. Franklin Templeton Investment Management Limited 0.0063 0.1099 0.1062 0.1498 Schwab<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> S&P 500 Index Portfolio 0.0003 0.1783 0.1438 0.1475 TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Aggressive ETF Portfolio- Class 1 Valmark Advisers, Inc. <span style="font-style:italic">Milliman Financial Risk Management, LLC </span>(formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Aggressive Growth ETF Portfolio) 0.0029 0.1917 0.0969 0.1071 TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Conservative ETF Portfolio - Class 1 Valmark Advisers, Inc. <span style="font-style:italic">Milliman Financial Risk Management, LLC</span> 0.0031 0.1039 0.0461 0.0525 TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderately Aggressive ETF Portfolio- Class 1 Valmark Advisers, Inc. <span style="font-style:italic">Milliman Financial Risk Management, LLC</span> (formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Growth ETF Portfolio) 0.0029 0.1831 0.0885 0.098 TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderate ETF Portfolio - Class 1 Valmark Advisers, Inc. <span style="font-style:italic">Milliman Financial Risk Management, LLC</span> (formerly, TOPS<span style="position:relative; bottom:3.25pt; font-size:5pt">®</span> Moderate Growth ETF Portfolio) 0.0029 0.155 0.072 0.0826 Vanguard Variable Insurance Funds - Balanced Portfolio- Wellington Management Company LLP 0.002 0.1646 0.0928 0.1002 Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named the Vanguard Variable Insurance Funds - Capital Growth Portfolio) 0.0034 0.2897 0.1397 0.1496 Vanguard Variable Insurance Funds - Conservative Allocation Portfolio 0.0012 0.1272 0.0422 0.0614 Vanguard Variable Insurance Funds - Equity Income Portfolio Wellington Management Company, LLP and Vanguard Portfolio Management, LLC 0.0029 0.1679 0.1259 0.1151 Vanguard Variable Insurance Funds - Equity Index Portfolio 0.0014 0.177 0.1426 0.1465 Vanguard Variable Insurance Funds - Growth Portfolio Wellington Management Company, LLP 0.0036 0.1688 0.1136 0.1558 Vanguard Variable Insurance Funds - International Portfolio Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc. 0.0032 0.1996 0.0062 0.1048 Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio 0.0017 0.1154 0.0846 0.1077 Vanguard Variable Insurance Funds - Real Estate Index Portfolio 0.0026 0.0311 0.045 0.0508 Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio 0.0014 0.0693 -0.005 0.019 Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio 0.0013 0.1693 0.1297 0.1409 <div style="margin-top:3.75pt; margin-bottom:0pt; line-height:12pt; text-align:left; margin-left:20pt; font-style:italic; font-size:10pt">These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.</div> 0000948923 false As a percentage of Fund assets. Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus. Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year. Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”. See definition of Net Amount at Risk in the Special Terms. The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office. The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025). As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death. The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.?(8)The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.Periodic Charges Other Than Fund Operating Expenses Charge When Charge is Deducted Amount Deducted — Maximum Guaranteed Charge Amount Deducted — Current ChargeExtendCare Rider (for Policies with an application signed on or after October 13, 2025) (9)Minimum and Maximum ChargeOn the Effective Date and each Monthly Anniversary Day$0.01 – $18.96 per $1,000 of Net Amount at Risk $0.01 – $16.62 per $1,000 of Net Amount at RiskCharge for a 57 year old female in the nontobacco rate class with a Face Amount of $250,000 and monthly benefit of $10,800On the Effective Date and each Monthly Anniversary Day$0.01 per $1,000 of Net Amount at Risk$0.01 per $1,000 of Net Amount at RiskExtendCare Rider (for Policies with an application signed before October 13, 2025) (9)Minimum and Maximum ChargeOn the Effective Date and each Monthly Anniversary Day$0.01 – $29.77 per $1,000 of Net Amount at Risk $0.01 – $17.90 per $1,000 of Net Amount at RiskCharge for a 57 year old female in the nontobacco rate class in the First Policy Year with a Face Amount of $250,000 and monthly benefit of $10,800On the Effective Date and each Monthly Anniversary Day$0.01 per $1,000 of Net Amount at Risk$0.01 per $1,000 of Net Amount at RiskProtected Insurability Benefit Rider (10)Minimum and Maximum ChargeOn the Effective Date and each Monthly Anniversary Day $0.03 – $0.13 per $1,000 of rider coverage amount $0.03 – $0.13 per $1,000 of rider coverage amount Charge for a child less than 6 months oldOn the Effective Date and each Monthly Anniversary Day $0.03 per $1,000 of rider coverage amount $0.03 per $1,000 of rider coverage amount?(9)The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. Not available in CA.(10)The charge for the Protected Insurability Rider varies based on the Insured’s Issue Age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses. These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year. The Sub-Account investing in this Fund is closed to Policies with applications signed on and after May 1, 2025. XML 36 R1.htm IDEA: XBRL DOCUMENT v3.26.1

N-6

Apr. 23, 2026

USD ($)

Prospectus:

Document Type N-6

Entity Registrant Name Protective Variable Life Separate Account

Entity Central Index Key 0000948923

Entity Investment Company Type N-6

Document Period End Date Apr. 23, 2026

Amendment Flag false

Item 2. Key Information [Line Items]

Fees and Expenses [Text Block]

FEES AND EXPENSES

Charges for Early Withdrawals

If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25. The withdrawal charge applies for as long as you own the Policy.

For additional information about charges for early withdrawals, see “CHARGES AND DEDUCTIONS” in the Prospectus.

Transaction Charges

In addition to withdrawal charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy and charges for transfers between investment options, requesting Policy illustrations, and exercising the Overloan Protection Endorsement.

For additional information about transaction charges, see “CHARGES AND DEDUCTIONS” in the Prospectus.

Ongoing Fees and Expenses (annual charges)

In addition to the withdrawal charge and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, administration, mortality and expense risk, loans including fees and expenses covering the cost of insurance (“COI”) under the Policy and the cost of optional Policy Loans benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy. Fees and expenses under the Policy do not reflect any Advisory Fees paid from your Policy Value or your other assets to the Financial Intermediary.

You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:

Annual Fee

Minimum

Maximum

Fund Options (Fund fees and expenses) (1)
0.03%

1.24%

(1)

As a percentage of Fund assets.

For additional information about ongoing fees and expenses, see “CHARGES AND DEDUCTIONS” in the Prospectus.

Charges for Early Withdrawals [Text Block]
Charges for Early Withdrawals

If you withdraw money from your Policy after the first year, a withdrawal charge equal to the lesser of 2% of the amount withdrawn or $25 will be deducted from the Policy Value. For example, if you were to withdraw $100,000 from your Policy, you would be assessed a withdrawal charge of $25. The withdrawal charge applies for as long as you own the Policy.

For additional information about charges for early withdrawals, see “CHARGES AND DEDUCTIONS” in the Prospectus.

Transaction Charges [Text Block]
Transaction Charges

In addition to withdrawal charges, you may be subject to other transaction charges, including charges on each premium paid under the Policy and charges for transfers between investment options, requesting Policy illustrations, and exercising the Overloan Protection Endorsement.

For additional information about transaction charges, see “CHARGES AND DEDUCTIONS” in the Prospectus.

Ongoing Fees and Expenses [Table Text Block]
Ongoing Fees and Expenses (annual charges)

In addition to the withdrawal charge and transaction charges, you are also subject to certain ongoing fees and expenses under the Policy, administration, mortality and expense risk, loans including fees and expenses covering the cost of insurance (“COI”) under the Policy and the cost of optional Policy Loans benefits available under the Policy. Such fees and expenses may be set based on characteristics of the Insured (e.g., age, sex, and rating classification). You should review the Policy specifications page of your Policy for rates applicable to your Policy. Fees and expenses under the Policy do not reflect any Advisory Fees paid from your Policy Value or your other assets to the Financial Intermediary.

You will also bear expenses associated with the Funds available under the Policy, as shown in the following table:

Annual Fee

Minimum

Maximum

Fund Options (Fund fees and expenses) (1)
0.03%

1.24%

(1)

As a percentage of Fund assets.

Investment Options (of Average Annual Net Assets) Minimum [Percent] 0.03% ^[1]

Investment Options (of Average Annual Net Assets) Maximum [Percent] 1.24% ^[1]

Investment Options Footnotes [Text Block]
As a percentage of Fund assets.

Risks [Table Text Block]

RISKS

Risk of Loss

You can lose money by investing in this Policy, including loss of principal.

For additional information about the risk of loss, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” in the Prospectus.

Not a Short-Term Investment

The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered. Withdrawals are not available in the first Policy Year.

If you elect to pay Advisory Fees from your Policy Value, such payments will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits.

For additional information about the investment profile of the Policy, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “CHARGES AND DEDUCTIONS,” “USE OF THE POLICY,” “TAX CONSIDERATIONS--Taxation of Insurance Policies” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.

RISKS

Risks Associated with Investment Options

An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.

For additional information about the risks associated with Investment Options, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “THE COMPANY AND THE FIXED ACCOUNT,” “THE VARIABLE ACCOUNT AND THE FUNDS” and “FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY” in the Prospectus.

Insurance Company Risks

An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-888-353-2654.

For additional information about Company risks, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” and “THE COMPANY AND THE FIXED ACCOUNT” in the Prospectus.

Policy Lapse

Your Policy could terminate if the value of your Policy becomes too low to support the Policy’s monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.

For additional information about Policy Lapse, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “PREMIUMS,” “LOANS,” and “LAPSE AND REINSTATEMENT” in the Prospectus.

Investment Restrictions [Text Block]
Investments

While you may transfer amounts in the Sub-Accounts (which invest in shares of a corresponding Fund) and the Fixed Account, certain restrictions and transfer fees apply with regard to the number and amount of such transfers. Transfers are also subject to the excessive trading and market timing policies described in the Prospectus.

We reserve the right to remove or substitute Funds as investment options.

For additional information about Investment Options, see “TRANSFERS” and “ADDITION, DELETION, OR SUBSTITUTION OF INVESTMENTS” in the Prospectus.

Optional Benefit Restrictions [Text Block]
Optional Benefits

Optional benefits, including Policy Loans, are subject to additional charges. Some optional benefits are available only at the time your Policy is issued and may not be available for all Owners or Insureds. The maximum loan amount we allow at any time may not exceed 99% of the Policy’s Cash Value reduced by any Policy Debt or any lien outstanding (including accrued interest) on the Valuation Day your loan request is received.

If You elect to pay Advisory Fees from your Policy Value, these payments may reduce the death benefit and other guaranteed benefits.

For additional information about the optional benefits, see “OTHER BENEFITS AVAILABLE UNDER THE POLICY,” “SUPPLEMENTAL RIDERS AND ENDORSEMENTS,” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Payment of Advisory Fees” in the Prospectus.

Tax Implications [Text Block]
Tax Implications

You should consult with a tax professional to determine the tax implications regarding the purchase, ownership, and use of a Policy. Withdrawals and surrenders may be subject to income tax and will be taxed at ordinary tax rates. In addition, withdrawals and surrenders may be subject to an additional tax depending on the circumstances.

If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC.

For additional information about tax implications, see “TAX CONSIDERATIONS” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.

Investment Professional Compensation [Text Block]
Investment Professional Compensation

Some investment professionals have and may receive compensation for selling the Policy to investors which may include revenue sharing, marketing allowances and other compensation. These investment professionals may have a financial incentive to offer or recommend the Policy over another investment.

For additional information about compensation, see “SALE OF THE POLICIES” in the Prospectus.

Exchanges [Text Block]
Exchanges

Some investment professionals may have a financial incentive to offer an investor a new policy in place of the one he or she already owns. You should only exchange your policy if you determine, after comparing the features, fees, and risks of both policies, that it is preferable for you to purchase the new policy rather than continue to own the existing policy.

For additional information about exchanges, see “EXCHANGE PRIVILEGE” and “TAX CONSIDERATIONS--Section 1035 Exchanges” in the Prospectus.

Item 4. Fee Table [Text Block]

FEE TABLE

The following tables describe the fees and expenses that you will pay when buying, owning, and surrendering or making withdrawals from the Policy. If the amount of a charge depends on the personal characteristics of the Insured, then the fee table lists the minimum and maximum charges we assess under the Policy, and the fees and charges of a representative Insured with the characteristics set forth in the table. These charges may not be typical of the charges you will pay. Please refer to your Policy specifications page for information about the specific fees you will pay each year based on the options you have elected. On and after the Policy Anniversary when the Insured is age 121, we do not deduct any fees and charges other than the interest charged on loans (if a loan is outstanding).

The first table describes the fees and expenses that you will pay at the time that you pay premiums, allow the Policy to Lapse, transfer Policy Value among the Sub-Accounts and to and from the Fixed Account, and make withdrawals. These fees and expenses do not reflect any Advisory Fees paid to Financial Intermediaries from Policy Value or other assets of the Owner for the provision of investment advice. If such fees were reflected, costs would be higher.

Transaction Fees

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Premium Expense Charge (for Policies with an application signed on or after October 13, 2025):
Upon receipt of each premium payment

5%

2%

Premium Expense Charge (for Policies with an application signed before October 13, 2025):
Upon receipt of each premium payment

3.5%

2%

Transfer Fee: (1) Upon each transfer in excess of 12 in a Policy Year $25 per transfer $0 per transfer

Withdrawal Charge:
At the time of each withdrawal of Policy Value The lesser of 2.0% of the amount withdrawn or $25 The lesser of 2.0% of the amount withdrawn or $25

Overloan Protection Endorsement
When the Benefit is Exercised 5% of Policy Value 5% of Policy Value

Policy Illustration Fee (2) Upon each illustration request in excess of 1 in a Policy Year $50 per illustration requested $0 per illustration requested

(1)

Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.

(2)

Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.

The next table describes the fees and expenses that you will pay periodically during the time that you own the Policy, not including the Funds’ fees and expenses.These fees and expenses do not reflect any Advisory Fees paid to Financial Intermediaries from Policy Value or other assets of the Owner for the provision of investment advice.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Base Contract Charge:

Cost of Insurance (for Policies with an application signed on or after October 13, 2025): (1) (2)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.01-$83.33 per $1,000 of Net Amount at Risk (2) $0.01-$70.46 per $1,000 of Net Amount at Risk (2)

Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk $0.04 per $1000 of Net Amount at Risk

Cost of Insurance (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025): (1) (2)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.01-$83.33 per $1,000 of Net Amount at Risk (2) $0.01-$59.39 per $1,000 of Net Amount at Risk (2)

Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk $0.04 per $1000 of Net Amount at Risk

Cost of Insurance (for Policies with an application signed before February 1, 2024): (1) (2)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.01 – $83.33 per $1,000 of Net Amount at Risk (2) $0.01 – $81.67 per $1,000 of Net Amount at Risk (2)

Charge for a 49 year old male in the nontobacco class during the first Policy Year.
On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk $0.07 per $1,000 of Net Amount at Risk

(1)

Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.

(2)

See definition of Net Amount at Risk in the Special Terms.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Mortality and Expense Risk Charge:
On the Policy Effective Date and each Monthly Anniversary Day 0.050% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount 0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.

Standard Administrative Fee (for Policies with an application signed on or after October 13, 2025):
On the Policy Effective Date and each Monthly Anniversary Day $9.00 $9.00

Standard Administrative Fee (for Policies with an application signed before October 13, 2025):
On the Policy Effective Date and each Monthly Anniversary Day $8.00 $8.00

Administrative Charge (for Policies with an application signed on or after October 13, 2025): (3)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.10 – $3.75 per $1,000 of Initial Face Amount $0.10 – $3.41 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.04-$1.36 per $1,000 of Initial Face Amount thereafter

Charge for a 49 year old male in the nontobacco rate classwith a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.89 per $1,000 of Initial Face Amount $0.81 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.33 per $1,000 of Initial Face Amount thereafter

Administrative Charge (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025): (3)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.09 – $3.66 per $1,000 of Initial Face Amount $0.09 – $3.66 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter

Charge for a 49 year old male in the nontobacco rate class with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.45 per $1,000 of Initial Face Amount $0.45 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter.

?

(3)

We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Administrative Charge (for Policies with an application signed before February 1, 2024): (3)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years $0.09 – $3.66 per $1,000 of Initial Face Amount $0.09 – $3.66 per $1,000 of Initial Face Amount

Charge for a 49 year old male in the nontobacco rate class
On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years $0.31 per $1,000 of Initial Face Amount $0.31 per $1,000 of Initial Face Amount

Administrative Charge For Face Amount Increases (for Policies with an application signed on or after October 13, 2025): (4)

Minimum and Maximum Charge
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $0.75 – $4.95 per $1,000 of any increase in Face Amount $0.75 – $4.95 per $1,000 of any increase in Face Amount

Charge for a 49 year old male in the nontobacco rate class
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $3.30 per $1,000 of any increase in Face Amount $3.30 per $1,000 of any increase in Face Amount

Administrative Charge For Face Amount Increases (for Policies with an application signed before October 13, 2025): (4)

Minimum and Maximum Charge
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $0.39 – $1.74 per $1,000 of any increase in Face Amount $0.39 – $1.74 per $1,000 of any increase in Face Amount

Charge for a 49 year old male in the nontobacco rate class
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $1.09 per $1,000 of any increase in Face Amount $1.09 per $1,000 of any increase in Face Amount

?

(3)

We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

?

(4)

The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Optional Benefit Charges:

Net Cost of Loans (for Policies with an application signed on or after October 13, 2025) (5)
On each Policy Anniversary, as applicable (6) 2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carryover loans. 2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter

Net Cost of Loans (for Policies with an application signed before October 13, 2025) (5)
On each Policy Anniversary, as applicable (6) 4.00% (annually) in Policy Years 1 through 10; 2.25% in Policy Years 11 and thereafter for both standard and carryover loans. 2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter

Children’s Term Life Insurance Rider
On the Effective Date and each Monthly Anniversary Day $0.45 per $1,000 of rider coverage amount $0.45 per $1,000 of rider coverage amount

Accidental Death Benefit Rider (7)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.08 – $0.14 per $1,000 of rider coverage amount $0.08 – $0.14 per $1,000 of rider coverage amount

Charge for a 34 year old
On the Effective Date and each Monthly Anniversary Day $0.08 per $1,000 of rider coverage amount $0.08 per $1,000 of rider coverage amount

Waiver of Specified Premium Rider (8)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $1.86 – $19.19 per $100 of rider coverage amount $1.86 – $19.19 per $100 of rider coverage amount

Charge for a 39 year old male in the nontobacco class
On the Effective Date and each Monthly Anniversary Day $4.42 per $100 of rider coverage amount $4.42 per $100 of rider coverage amount

?

(5)

The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).

?

(6)

As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.

?

(7)

The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

?

(8)

The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

ExtendCare Rider (for Policies with an application signed on or after October 13, 2025) (9)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.01 – $18.96 per $1,000 of Net Amount at Risk $0.01 – $16.62 per $1,000 of Net Amount at Risk

Charge for a 57 year old female in the nontobacco rate class with a Face Amount of $250,000 and monthly benefit of $10,800
On the Effective Date and each Monthly Anniversary Day $0.01 per $1,000 of Net Amount at Risk $0.01 per $1,000 of Net Amount at Risk

ExtendCare Rider (for Policies with an application signed before October 13, 2025) (9)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.01 – $29.77 per $1,000 of Net Amount at Risk $0.01 – $17.90 per $1,000 of Net Amount at Risk

Charge for a 57 year old female in the nontobacco rate class in the First Policy Year with a Face Amount of $250,000 and monthly benefit of $10,800

On the Effective Date and each Monthly Anniversary Day

$0.01 per $1,000 of Net Amount at Risk

$0.01 per $1,000 of Net Amount at Risk

Protected Insurability Benefit Rider (10)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.03 – $0.13 per $1,000 of rider coverage amount $0.03 – $0.13 per $1,000 of rider coverage amount

Charge for a child less than 6 months old
On the Effective Date and each Monthly Anniversary Day $0.03 per $1,000 of rider coverage amount $0.03 per $1,000 of rider coverage amount

?

(9)

The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. Not available in CA.

(10)

The charge for the Protected Insurability Rider varies based on the Insured’s Issue Age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

ANNUAL FUND EXPENSES

The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund’s fees and expenses is contained in the prospectus for each Fund.A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See “APPENDIX - FUNDS AVAILABLE UNDER THE POLICY”.

Annual Fund Expenses

Minimum

Maximum

Total Annual Fund Expenses
0.03% – 1.24% (1)

(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)

(1)

The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.

Transaction Expenses [Table Text Block]

Transaction Fees

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Premium Expense Charge (for Policies with an application signed on or after October 13, 2025):
Upon receipt of each premium payment

5%

2%

Premium Expense Charge (for Policies with an application signed before October 13, 2025):
Upon receipt of each premium payment

3.5%

2%

Transfer Fee: (1) Upon each transfer in excess of 12 in a Policy Year $25 per transfer $0 per transfer

Withdrawal Charge:
At the time of each withdrawal of Policy Value The lesser of 2.0% of the amount withdrawn or $25 The lesser of 2.0% of the amount withdrawn or $25

Overloan Protection Endorsement
When the Benefit is Exercised 5% of Policy Value 5% of Policy Value

Policy Illustration Fee (2) Upon each illustration request in excess of 1 in a Policy Year $50 per illustration requested $0 per illustration requested

(1)

Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.

(2)

Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.

Transfer Fees, Description [Text Block] Transfer Fee: ^[2]

Transfer Fees, When Deducted [Text Block] Upon each transfer in excess of 12 in a Policy Year ^[2]

Transfer Fee, Maximum [Dollars] $ 25 ^[2]

Transfer Fee, Current [Dollars] $ 0 ^[2]

Transfer Fee, Footnotes [Text Block]
Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.

Periodic Charges [Table Text Block]

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Base Contract Charge:

Cost of Insurance (for Policies with an application signed on or after October 13, 2025): (1) (2)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.01-$83.33 per $1,000 of Net Amount at Risk (2) $0.01-$70.46 per $1,000 of Net Amount at Risk (2)

Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk $0.04 per $1000 of Net Amount at Risk

Cost of Insurance (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025): (1) (2)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.01-$83.33 per $1,000 of Net Amount at Risk (2) $0.01-$59.39 per $1,000 of Net Amount at Risk (2)

Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk $0.04 per $1000 of Net Amount at Risk

Cost of Insurance (for Policies with an application signed before February 1, 2024): (1) (2)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.01 – $83.33 per $1,000 of Net Amount at Risk (2) $0.01 – $81.67 per $1,000 of Net Amount at Risk (2)

Charge for a 49 year old male in the nontobacco class during the first Policy Year.
On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk $0.07 per $1,000 of Net Amount at Risk

(1)

Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.

(2)

See definition of Net Amount at Risk in the Special Terms.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Mortality and Expense Risk Charge:
On the Policy Effective Date and each Monthly Anniversary Day 0.050% multiplied by the Variable Account Value, which is equivalent to an annual rate of 0.60% of such amount 0.017% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.204% for 10 Policy Years; 0.008% multiplied by the Variable Account Value, which is equivalent to an annual amount of 0.096% for each Policy Year thereafter.

Standard Administrative Fee (for Policies with an application signed on or after October 13, 2025):
On the Policy Effective Date and each Monthly Anniversary Day $9.00 $9.00

Standard Administrative Fee (for Policies with an application signed before October 13, 2025):
On the Policy Effective Date and each Monthly Anniversary Day $8.00 $8.00

Administrative Charge (for Policies with an application signed on or after October 13, 2025): (3)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.10 – $3.75 per $1,000 of Initial Face Amount $0.10 – $3.41 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.04-$1.36 per $1,000 of Initial Face Amount thereafter

Charge for a 49 year old male in the nontobacco rate classwith a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.89 per $1,000 of Initial Face Amount $0.81 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.33 per $1,000 of Initial Face Amount thereafter

Administrative Charge (for Policies with an application signed on or after February 1, 2024, but before October 13, 2025): (3)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day $0.09 – $3.66 per $1,000 of Initial Face Amount $0.09 – $3.66 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter

Charge for a 49 year old male in the nontobacco rate class with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.45 per $1,000 of Initial Face Amount $0.45 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter.

?
(3)

We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Administrative Charge (for Policies with an application signed before February 1, 2024): (3)

Minimum and Maximum Charge
On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years $0.09 – $3.66 per $1,000 of Initial Face Amount $0.09 – $3.66 per $1,000 of Initial Face Amount

Charge for a 49 year old male in the nontobacco rate class
On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years $0.31 per $1,000 of Initial Face Amount $0.31 per $1,000 of Initial Face Amount

Administrative Charge For Face Amount Increases (for Policies with an application signed on or after October 13, 2025): (4)

Minimum and Maximum Charge
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $0.75 – $4.95 per $1,000 of any increase in Face Amount $0.75 – $4.95 per $1,000 of any increase in Face Amount

Charge for a 49 year old male in the nontobacco rate class
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $3.30 per $1,000 of any increase in Face Amount $3.30 per $1,000 of any increase in Face Amount

Administrative Charge For Face Amount Increases (for Policies with an application signed before October 13, 2025): (4)

Minimum and Maximum Charge
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $0.39 – $1.74 per $1,000 of any increase in Face Amount $0.39 – $1.74 per $1,000 of any increase in Face Amount

Charge for a 49 year old male in the nontobacco rate class
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $1.09 per $1,000 of any increase in Face Amount $1.09 per $1,000 of any increase in Face Amount

?
(3)

We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

?
(4)

The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

Optional Benefit Charges:

Net Cost of Loans (for Policies with an application signed on or after October 13, 2025) (5)
On each Policy Anniversary, as applicable (6) 2.00% (annually) in Policy Years 1 through 10; 0.25% in Policy Years 11 and thereafter for both standard and carryover loans. 2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter

Net Cost of Loans (for Policies with an application signed before October 13, 2025) (5)
On each Policy Anniversary, as applicable (6) 4.00% (annually) in Policy Years 1 through 10; 2.25% in Policy Years 11 and thereafter for both standard and carryover loans. 2.00% (annually) for standard loans, 1.00% for carryover loans in Policy Years 1 through 10; 0% for all loans in Policy Years 11 and thereafter

Children’s Term Life Insurance Rider
On the Effective Date and each Monthly Anniversary Day $0.45 per $1,000 of rider coverage amount $0.45 per $1,000 of rider coverage amount

Accidental Death Benefit Rider (7)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.08 – $0.14 per $1,000 of rider coverage amount $0.08 – $0.14 per $1,000 of rider coverage amount

Charge for a 34 year old
On the Effective Date and each Monthly Anniversary Day $0.08 per $1,000 of rider coverage amount $0.08 per $1,000 of rider coverage amount

Waiver of Specified Premium Rider (8)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $1.86 – $19.19 per $100 of rider coverage amount $1.86 – $19.19 per $100 of rider coverage amount

Charge for a 39 year old male in the nontobacco class
On the Effective Date and each Monthly Anniversary Day $4.42 per $100 of rider coverage amount $4.42 per $100 of rider coverage amount

?
(5)

The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).

?
(6)

As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.

?
(7)

The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

Insurance Cost, Footnotes [Text Block]
Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.

Mortality and Expense Risk Fees, Description [Text Block] Mortality and Expense Risk Charge:

Mortality and Expense Risk Fees, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day

Mortality And Expense Risk Fees (of Face Amount), Maximum [Percent] 0.60%

Administrative Expenses, Representative Investor [Text Block] $0.08 per $1,000 of rider coverage amount

Administrative Expense (of Average Account Value), Current [Percent]

Administrative Expense, Footnotes [Text Block]
We call this the administrative charge in the Prospectus. The administrative charge varies based on the Insured’s Issue Age, sex and rate class and the Face Amount (for Policies with an application signed on or after February 1, 2024). For Policies with an application signed on or after October 13, 2025, the administrative charge will have a higher charge in the first 2 Policy Years compared to later Policy Years. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.
The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

Optional Benefit Expense, Footnotes [Text Block]
The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).
As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.

Annual Portfolio Company Expenses [Table Text Block]
Annual Fund Expenses

Minimum

Maximum

Total Annual Fund Expenses
0.03% – 1.24% (1)

(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)

(1)

The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.

Portfolio Company Expenses [Text Block]
ANNUAL FUND EXPENSES
The next item shows the minimum and maximum total operating expenses charged by the Funds (before waiver or reimbursement) during the time you own the Policy. Expenses of the Funds may be higher or lower in the future. More detail concerning each Fund’s fees and expenses is contained in the prospectus for each Fund.A complete list of Funds available under the Policy, including their annual expenses, may be found at the back of this document. See “APPENDIX - FUNDS AVAILABLE UNDER THE POLICY”.
Annual Fund Expenses

Minimum

Maximum

Total Annual Fund Expenses
0.03% – 1.24% (1)

(expenses that are deducted from Fund assets, including management fees, distribution and/or service 12b-1 fees, and other expenses)

(1)

The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.

Portfolio Company Expenses Before Waivers and Reimbursement Minimum [Percent] 0.03% ^[3]

Portfolio Company Expenses Before Waivers and Reimbursement Maximum [Percent] 1.24% ^[3]

Portfolio Company Expenses, Footnotes [Text Block]
The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.

Item 5. Principal Risks [Table Text Block]

PRINCIPAL RISKS OF INVESTING IN THE POLICY

Investment Risk

If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. You could lose everything you invest. If you allocate Policy Value to the Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See “The Variable Account and The Funds.”

Risk of Lapse

There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement of the Policy will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See “Lapse and Reinstatement--Lapse” and “Lapse Protection.”

Withdrawal and Surrender Risks

The Surrender Value of the Policy is generally the Cash Value less any Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. The Policy is not suitable as a short-term investment.

Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.

A surrender or withdrawal may have tax consequences. See “TAX CONSIDERATIONS.”

Advisory Fee Risk

Advisory Fees paid from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits. If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC. See “TAX CONSIDERATIONS--Advisory Fees” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Maximum Permitted Advisory Fee Paid from Policy Value.”

Tax Risks

Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy’s Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.

Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 59½ at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.

If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.

See “Tax Considerations.” You should consult a qualified tax adviser for assistance in all Policy related tax matters.

Loan Risks

A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.

Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See “Policy Loans” and “Tax Considerations — Tax Treatment of Loans.” Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.

If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.

Specialized Uses of the Policy

Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See “Tax Considerations — Other Considerations.”

Fund Risks

A comprehensive discussion of the risks of each Fund may be found in each Fund’s prospectus. Please refer to the Funds’ prospectuses for more information.

Business Disruption and Cyber Security Risks

We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure (e.g., hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds’ ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.

We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.

Item 10. Standard Death Benefits (N-6) [Table Text Block]
STANDARD DEATH BENEFITS

Payment of Advisory Fees from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits under your Policy. Work with your Financial Intermediary when selecting your Death Benefit Option and the potential impact of Advisory Fee payments on the death benefit.

As long as the Policy remains in force, Protective Life will pay the Death Benefit Proceeds upon receipt at the Home Office of Due Proof of Death of the Insured. Protective Life may require return of the Policy. The Death Benefit Proceeds are paid to the primary Beneficiary or a contingent Beneficiary. The Owner may name one or more primary or contingent Beneficiaries. Unless designated irrevocably, the Owner may change the Beneficiary by Written Notice prior to the death of any Owner. If no Beneficiary survives the Insured, the Death Benefit Proceeds are paid to the Owner or the Owner’s estate. Death Benefit Proceeds are paid in a lump sum or under a settlement option. Payment of the Death Benefit Proceeds may have tax consequences. See “Tax Considerations — Tax Treatment of Life Insurance Death Benefit Proceeds” in the Prospectus.

Please note that any Death Benefit payment we make in excess of the Variable Account Value, including payments under any rider, is subject to our financial strength and claims-paying ability.

If an Owner has elected the Income Provider Option Pre-Determined Death Benefit Payout Endorsement, we will pay the Death Benefit Proceeds pursuant to a payment schedule established according to the terms of the endorsement. See “Supplemental Riders and Endorsements” in the Prospectus.

Limits on Policy Rights

Incontestability.   Unless fraud is involved, Protective Life will not contest the Policy, or any supplemental rider, after the Policy or rider has been in force during the Insured’s lifetime for two years from the Policy Effective Date or the effective date of the rider. Likewise, unless fraud is involved, Protective Life will not contest an increase in the Face Amount with respect to statements made in the evidence of insurability for that increase after the increase has been in force during the life of the Insured for two years after the effective date of the increase.

Suicide Exclusion.   If the Insured dies by suicide, while sane or insane, within two years after the Policy Effective Date, the Death Benefit will be limited to the premium payments made before death, less any Policy Debt, liens (including accrued interest) and any withdrawals. If the Insured dies by suicide within two years after an increase in Face Amount, the Death Benefit with respect to the increase will be limited to the sum of the monthly cost of insurance charges made for that increase.

Misstatement of Age or Sex.   If the Insured’s age or sex has been misstated in the application for the Policy or in any application for supplemental riders, the Death Benefit under the Policy or such supplemental riders is the amount which would have been provided by the most recent cost of insurance charge, and the cost of such supplemental riders, at the correct age and sex.

Calculation of Death Benefit Proceeds

The Death Benefit Proceeds are equal to the Death Benefit calculated as of the date of the Insured’s death, plus benefits under any supplemental riders or endorsements, minus (1) any Policy Debt on that date, (2) any liens for payments made under an accelerated death benefit rider or endorsement including accrued interest, and (3) any past due Monthly Deductions if the Insured died during the grace period.

The calculation of the Death Benefit depends on the Death Benefit option and the federal tax compliance test that you select. You must select the Death Benefit option and the tax compliance test before your Policy is issued. Once the Policy is issued, you may not change the tax compliance test.

Federal Tax Compliance Tests. Under Section 7702 of the Internal Revenue Code, a Policy will generally be treated as life insurance for federal tax purposes if, at all times, it satisfies one of two federal tax compliance tests: (1) the Guideline Premium Limitation/Cash Value Corridor Test, and (2) the Cash Value Accumulation Test.

The Guideline Premium Limitation/Cash Value Corridor Test (“GPT”) has two components, a premium limit component and a corridor component. The premium limit restricts the amount of premium payments that can be paid into the Policy. The corridor requires that the Death Benefit be at least a certain percentage (varying each year by Attained Age of the Insured) of the Policy Value. The Cash Value Accumulation Test (“CVAT”) does not have a premium limit, but does have a requirement that the Death Benefit be at least a certain percentage (varying based on the Attained Age, duration at death, sex and rate class of the Insured) of the Policy Value.

In applying for the Policy, you may select either federal tax compliance test. The Death Benefit will vary depending on which test is selected. There are a number of considerations involved in deciding which test to use.

For example, if your goal is to maximize your Cash Value in early Policy Years relative to the Policy’s Death Benefit and other benefits, you may want to consider selecting the CVAT because it generally permits more premiums to be paid in early Policy years. The CVAT may require the Policy to have a higher Death Benefit relative to the Policy’s Cash Value in later Policy Years, however, which could increase the mortality charges that will apply in those later years.

Alternatively, if your goal is to maximize your Cash Value in later Policy Years relative to the Policy’s Death Benefit and other benefits, you may want to consider selecting the GPT and paying premiums up to the maximum permitted by the GPT. Funding a Policy in this manner may allow for lower mortality charges in later Policy Years in comparison with the mortality charges that would apply under a Policy tested under the CVAT.

Which federal tax compliance test is better for you will depend on not only your goals, but on a number of other considerations. These other considerations include, but are not limited to, the characteristics of the Insured, the amount and timing of premiums that will be paid, and the earnings under the Policy.

The Death Benefit Option you choose will also affect the amount of your Death Benefit. If the GPT applies to the Policy, under Death Benefit Option A, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the Policy Value multiplied by the applicable specified percentage is greater than the Face Amount under the Policy. Under Death Benefit Option B, your Death Benefit will always vary with Policy Value.

Similarly, if the CVAT applies to the Policy, under Death Benefit Option A, your Death Benefit will generally be the Face Amount. However, the Death Benefit may vary based on the Policy Value if the minimum death benefit is greater

than the Face Amount under the Policy. Under Death Benefit Option B, your Death Benefit will always vary with the Policy Value. See “Death Benefit Options” for detailed information about each Death Benefit Option.

You should consult your Financial Intermediary for more information about which federal tax compliance test and death benefit option you should choose in light of your specific goals and circumstances.

The Death Benefit Proceeds are payable when Protective Life receives a properly completed claim form and Due Proof of Death of the Insured while the Policy is in force. The Death Benefit Proceeds will be paid to the Beneficiary, or Beneficiaries, in a lump sum, unless a Settlement Option has been selected. If there is more than one Beneficiary, each Beneficiary must submit instructions in Good Order specifying the manner in which they wish to receive their portion of the Death Benefit Proceeds. The Death Benefit Proceeds are determined as of the date of the Insured’s death and are moved to the general account until payment is made. Protective Life will pay interest on the Death Benefit Proceeds payable to each Beneficiary determined in accordance with applicable state law to the date of payment.

Death Benefit Options

Payments of Advisory Fees from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits under your Policy. Work with your Financial Intermediary when selecting your Death Benefit Option and the potential impact of Advisory Fee payments on the death benefit.

Death Benefit Options Under Policies Complying with the Guideline Premium Limitation/Cash Value Corridor Test.   If the Policy is not issued under the Cash Value Accumulation Test, it will satisfy the Guideline Premium Limitation/Cash Value Corridor Test of federal tax law and the Death Benefit is determined as follows:

•

Under Death Benefit Option A, the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured’s death, or (2) a specified percentage of the Policy Value on the date of the Insured’s death as indicated on a table set forth in Appendix A to the Prospectus.

•

Under Death Benefit Option B, the Death Benefit is the greater of: (1) the Face Amount under the Policy plus the Policy Value on the date of the Insured’s death, or (2) a specified percentage of the Policy Value on the date of the Insured’s death as indicated on a table set forth in Appendix A to the Prospectus.

The specified percentage under both options is 250% when the Insured has reached an Attained Age of 40 or less by date of death and decreases each year thereafter to 100% when the Insured has reached an Attained Age of 95 or greater at death. A table showing these percentages for Attained Ages 0 to 95 and examples of Death Benefit calculations for both Death Benefit Options are found in Appendix A to the Prospectus.

Under Death Benefit Option A, the Death Benefit remains level at the Face Amount unless the Policy Value multiplied by the specified percentage of Policy Value exceeds that Face Amount, in which event the Death Benefit varies as the Policy Value varies. Owners who are satisfied with the amount of their insurance coverage under the Policy and who prefer to have favorable investment performance and additional premiums reflected in higher Policy Value, rather than increased Death Benefits, generally should select Option A. Under Death Benefit Option B, the Death Benefit always varies as the Policy Value varies (although it is never less than the Face Amount). Owners who prefer to have favorable investment performance and additional premiums reflected in increased Death Benefits generally should select Option B.

Death Benefit Options Under Policies Complying with the Cash Value Accumulation Test.   If the Policy is issued under the Cash Value Accumulation Test, the Death Benefit is determined as follows:

•

Under Death Benefit Option A, the Death Benefit is the greater of: (1) the Face Amount under the Policy on the date of the Insured’s death, or (2) the minimum death benefit described below.

•

Under Death Benefit Option B, the Death Benefit is the greater of: (1) the Face Amount under the Policy plus the Policy Value on the date of the Insured’s death, or (2) the minimum death benefit described below.

The minimum death benefit at any time is the amount of level death benefit that the Policy Value would purchase if paid as a net single premium at such time. Such net single premium is determined according to the Cash Value Accumulation Test prescribed under Section 7702 of the Internal Revenue Code, as amended or its successor, if such amendment or successor is applicable to the Policy.

For purposes of determining this net single premium, the mortality charges taken into account generally are the maximum mortality charges guaranteed under the Policy. Such charges do not, however, exceed the maximum charges permitted to be taken into account under the Cash Value Accumulation Test of Section 7702. In determining the net single premium, the interest rate taken into account is the greater of an annual effective interest rate specified in the Code or the annual effective credited interest rate or rates guaranteed on issuance of the Policy. For purposes of calculating

the Cash Value Accumulation Test, the Policy is deemed to mature on the date the Insured attains age 100, and the Policy Value deemed to exist on such date shall not exceed the least amount payable as a death benefit at any time under the Policy.

Owners who are satisfied with the amount of their insurance coverage under the Policy and who prefer to have favorable investment performance and additional premiums reflected in higher Policy Value, rather than increased Death Benefits, generally should select Option A. Under Death Benefit Option B, the Death Benefit always varies as the Policy Value varies (although it is never less than the Face Amount). Owners who prefer to have favorable investment performance and additional premiums reflected in increased Death Benefits generally should select Option B.

Examples of Death Benefit calculations for both Death Benefit Options under the Cash Value Accumulation Test are found in Appendix A to the Prospectus.

Changing Death Benefit Options

The Owner must indicate a Death Benefit Option in the application for the Policy. On or after the first Policy Anniversary, the Owner may change the Death Benefit Option on the Policy subject to the following rules. The request must be received in writing in Good Order at the Home Office. After any change, the Face Amount must be at least $100,000. The effective date of the change will be the Monthly Anniversary Day that coincides with or next follows the day that Protective Life approves the request. Protective Life may require satisfactory evidence of insurability. All changes must be approved by Protective Life at the Home Office before they will be effective. Protective Life reserves the right to decline to change the Death Benefit Option if the change would cause the Policy to fail to qualify as a life insurance contract under the Internal Revenue Code.

When a change from Option A to Option B is made, the Face Amount after the change is effected will be equal to the Face Amount before the change less the Policy Value on the effective date of the change. When a change from Option B to Option A is made, the Face Amount after the change will be equal to the Face Amount before the change is effected plus the Policy Value on the effective date of the change.

Changing the Face Amount

On or after the first Policy Anniversary, the Owner may request a change in the Face Amount. The request must be received in writing in Good Order at the Home Office.

Increasing the Face Amount.   Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. In addition, the Insured’s current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See “Premiums Upon Increase in Face Amount.” The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy’s lapse protection is in effect, the Policy’s Minimum Monthly Premium amount will also generally be increased.

An administrative fee will be charged for the first twelve months following an increase in the Face Amount.

As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (i.e., credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See “Tax Considerations — Other Considerations.” Please consult your tax advisor.

Decreasing the Face Amount.   If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See “Tax Considerations — Policies which are MECs.”

Protective Life reserves the right to decline a request to decrease the Face Amount if compliance with the Guideline Premium Limitation under current tax law resulting from such a decrease would result in the Policy failing the definition of life insurance, or if to effect the requested decrease, payments to the Owner would have to be made from Policy Value for compliance with the Guideline Premium Limitation, and the amount of such payments would exceed the Surrender Value under the Policy.

The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.

Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. Decreasing the Face Amount also may have tax consequences. See “Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years.”

Settlement Options

The Company offers a variety of ways of receiving proceeds payable under the Policy, such as on surrender or death, other than in a lump sum. Any sales representative authorized to sell this Policy can further explain these settlement options upon request. All of these settlement options are forms of fixed-benefit annuities, which do not vary with the investment performance of a separate account. Under each of the fixed-benefit settlement options, no surrender or withdrawal may be made once payments have begun.

The following settlement options may be elected.

Option 1 — Payment for a Fixed Period.   Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.

Option 2 — Life Income with Payments for a Guaranteed Period.   Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.

Option 3 — Interest Income.   Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.

Option 4 — Payments for a Fixed Amount.   Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.

Minimum Amounts.   Protective Life reserves the right to pay the total amount of the Policy in one lump sum, if less than $5,000. If monthly payments are less than $50, payments may be made quarterly, semi-annually, or annually at Protective Life’s option.

Other Requirements.   Settlement options must be elected by Written Notice in Good Order received by Protective Life at the Home Office. The Owner may elect settlement options during the Insured’s lifetime; Beneficiaries may elect settlement options thereafter if Death Benefit Proceeds are payable in a lump sum. The effective date of an option applied to Death Benefit Proceeds is the date the Due Proof of Death of the Insured is received at the Home Office. The effective date of an option applied to Surrender Value is the effective date of the surrender where a settlement option has been elected. We will pay the Death Benefit Proceeds to the Beneficiary in a lump sum, unless a Settlement Option has been selected. If the Primary or Contingent Beneficiary is not living, or if no Beneficiary has been designated, We will pay the Owner or Owner’s estate.

If Protective Life has available, at the time a settlement option is elected, options or rates on a more favorable basis than those guaranteed, the higher benefits will apply.

Escheatment of Death Benefit

Every state has unclaimed property laws which generally declare life insurance policies to be abandoned after a period of inactivity of 3 to 5 years from the date the Death Benefit is due and payable. For example, if the payment of a Death Benefit has been triggered, but, if after a thorough search, Protective Life is still unable to locate the Beneficiary of the Death Benefit, or the Beneficiary does not come forward to claim the Death Benefit in a timely manner, the Death Benefit will be paid to the abandoned property division or unclaimed property office of the state in which the Beneficiary or the Owner last resided, as shown on our books and records, or to our state of domicile. This “escheatment” is revocable, however, and the state is obligated to pay the Death Benefit (without interest) if your Beneficiary steps forward to claim the Death Benefit with the proper documentation. To prevent such escheatment, it is important that you

update your Beneficiary designations, including addresses, if and as they change. Such updates should be communicated in writing, by telephone, or other approved electronic means to the Home Office.

Additional Information about Standard Death Benefits, Note (N-6) [Text Block]
Changing Death Benefit Options
The Owner must indicate a Death Benefit Option in the application for the Policy. On or after the first Policy Anniversary, the Owner may change the Death Benefit Option on the Policy subject to the following rules. The request must be received in writing in Good Order at the Home Office. After any change, the Face Amount must be at least $100,000. The effective date of the change will be the Monthly Anniversary Day that coincides with or next follows the day that Protective Life approves the request. Protective Life may require satisfactory evidence of insurability. All changes must be approved by Protective Life at the Home Office before they will be effective. Protective Life reserves the right to decline to change the Death Benefit Option if the change would cause the Policy to fail to qualify as a life insurance contract under the Internal Revenue Code.
When a change from Option A to Option B is made, the Face Amount after the change is effected will be equal to the Face Amount before the change less the Policy Value on the effective date of the change. When a change from Option B to Option A is made, the Face Amount after the change will be equal to the Face Amount before the change is effected plus the Policy Value on the effective date of the change.
Changing the Face Amount
On or after the first Policy Anniversary, the Owner may request a change in the Face Amount. The request must be received in writing in Good Order at the Home Office.
Increasing the Face Amount.   Any increase in the Face Amount must be at least $10,000 and an application must be submitted in Good Order. Protective Life reserves the right to require satisfactory evidence of insurability. In addition, the Insured’s current Attained Age must be less than the maximum Issue Age for the Policies, as determined by Protective Life from time to time. A change in planned periodic premiums may be advisable. See “Premiums Upon Increase in Face Amount.” The increase in Face Amount will become effective as of the date shown on the supplemental Policy Specifications Page (which will be sent to you), and the Policy Value will be adjusted to the extent necessary to reflect a Monthly Deduction as of the effective date based on the increase in Face Amount. When the Policy’s lapse protection is in effect, the Policy’s Minimum Monthly Premium amount will also generally be increased.
An administrative fee will be charged for the first twelve months following an increase in the Face Amount.
As with the Policy itself, a Face Amount increase is subject to a cancellation privilege. Therefore, the Owner may exercise the privilege by canceling any increase in Face Amount within the prescribed Cancellation Period. In such an event, unless the Owner requests otherwise, an amount will be refunded (i.e., credited back to the Policy Value) above except that if no additional premiums were required in connection with the Face Amount increase, then the amount refunded is limited to that portion of the first Monthly Deduction following the increase that is attributable to cost of insurance charges for the increase and the monthly administrative fee for the increase. Increasing the Face Amount of the Policy may increase the Death Benefit and may have the effect of increasing monthly cost of insurance charges. Increasing the Face Amount may also have tax consequences. See “Tax Considerations — Other Considerations.” Please consult your tax advisor.
Decreasing the Face Amount.   If a decrease in the Face Amount would result in total premiums paid exceeding the premium limitation prescribed under current tax law to qualify your Policy as a life insurance contract, Protective Life will immediately return to you the amount of such excess above the premium limitation. Although Protective Life will attempt to notify an Owner if a decrease in the Face Amount will cause a Policy to be considered a modified endowment contract, we will not automatically return premium. See “Tax Considerations — Policies which are MECs.”
Protective Life reserves the right to decline a request to decrease the Face Amount if compliance with the Guideline Premium Limitation under current tax law resulting from such a decrease would result in the Policy failing the definition of life insurance, or if to effect the requested decrease, payments to the Owner would have to be made from Policy Value for compliance with the Guideline Premium Limitation, and the amount of such payments would exceed the Surrender Value under the Policy.
The Face Amount after any decrease must be at least $100,000. Protective Life prohibits any elected decrease in Face Amount (1) for the first 3 Policy Years; (2) for 3 years following an increase in Face Amount; and (3) for one Policy Year following the last decrease in Face Amount. If the Initial Face Amount of the Policy has been increased prior to the requested decrease, then the decrease will first be applied against any previous increases in Face Amount in the reverse order in which they occurred. The decrease will then be applied to the Initial Face Amount. A decrease in Face Amount will become effective on the Monthly Anniversary Day that coincides with or next follows receipt and acceptance of a request at the Home Office.
Decreasing the Face Amount of the Policy may reduce the Death Benefit and may have the effect of decreasing monthly cost of insurance charges. Decreasing the Face Amount also may have tax consequences. See “Tax Considerations — Certain Distributions Required by the Tax Law in the First 15 Years.

Item 11. Other Benefits Available (N-6) [Text Block]
OTHER BENEFITS AVAILABLE UNDER THE POLICY

In addition to the standard Death Benefits associated with your Policy, other standard and optional benefits may also be available to you. The following table summarizes information about these optional benefits. Information about the fees associated with each benefit included in the table may be found in the Fee Table.

Name of Benefit

Purpose

Is Benefit Standard
or Optional?

Brief Description of
Restrictions/Limitations

Terminal Illness Accelerated Death Benefit Endorsement
Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness. Standard
•

Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

•

The lesser of 60% of the current face amount of the Policy or $1,000,000; minus

•

Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

•

Minimum acceleration permitted is $15,000.

•

The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.

•

Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.

•

Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.

Name of Benefit

Purpose

Is Benefit Standard
or Optional?

Brief Description of
Restrictions/Limitations

Lapse Protection Endorsement
Guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule. Standard
•

Minimum monthly premium will vary by Policy benefits, Issue Age, sex and rate class of the Insured.

•

Protection is only effective:

•

20 years for issue ages 0-49,

•

to attained age 70 for issue ages 50-64,

•

5 years for issue ages 65-80

•

If on any Monthly Anniversary Day, the total premiums paid less any Withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount, this provision will terminate.

•

Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount.

Name of Benefit

Purpose

Is Benefit Standard
or Optional?

Brief Description of
Restrictions/Limitations

Overloan Protection Endorsement
Policy will not Lapse due to an outstanding Policy loan in certain circumstances. Standard
•

Policy must be in force at least 20 Policy Years.

•

Insured’s Attained Age must be at least 65.

•

Withdrawals in an amount equal to the total premiums paid must have been taken.

•

Policy Debt must exceed the Face Amount and be at least 95% of the Cash Value.

•

Not available if accelerated benefits have been received or if Monthly Deductions are being waived or premiums credited under any endorsement or rider attached to the Policy.

•

Not available if the resulting Death Benefit is not compliant with our reasonable interpretation of the Code.

•

Not available if the Policy is a modified endowment contract (“MEC”).

Accidental Death Benefit Rider
Provides an additional death benefit payable if Insured’s death results from certain accidental causes. Optional
•

Insured under the base Policy must be between the ages of 15 and 60 to elect this rider. Coverage expires at age 65.

•

The minimum amount of coverage is $1,000.

•

Maximum amount of coverage is $250,000 for the Company and affiliates’ policies in force and applied for.

Children’s Term Life Insurance Rider
Provides a death benefit payable on the death of a covered child. Optional
•

Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Coverage expires at age 75.

•

Maximum amount of coverage is $25,000 for the Company and affiliates’ policies in force and applied for.

•

The minimum amount of coverage is $1,000.

Name of Benefit

Purpose

Is Benefit Standard
or Optional?

Brief Description of
Restrictions/Limitations

ExtendCare Chronic Illness Accelerated Death Benefit Rider
Allows Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that Insured has a qualifying chronic illness that is expected to last 90 or more days. Optional
•

Can only be added at the time of Policy issue.

•

There is a minimum base Policy Face Amount of $100,000 and a maximum base Policy Face Amount of $5,000,000.

•

Maximum monthly benefit cannot exceed 5% of the base Policy Face Amount.

•

Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.

•

Death Benefit Option A must be in effect in order to receive benefit payments under the rider.

•

Any irrevocable Beneficiaries or assignees of record must give written consent for benefit payments to be made.

•

The rider is subject to a Lifetime Maximum Benefit and a Monthly Maximum Benefit.

•

Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.

Income Provider Option Pre-Determined Death Benefit Payout Endorsement
Converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule. Optional
•

Can only be added at the time of Policy issue.

•

You may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of payments.

•

A Beneficiary cannot change the Death Benefit Payment Schedule or elect a single lump sum after the death of the Insured.

Name of Benefit

Purpose

Is Benefit Standard
or Optional?

Brief Description of
Restrictions/Limitations

Protected Insurability Benefit Rider
Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. Optional
•

Can only be added at the time of Policy issue.

•

The maximum amount of coverage is $50,000 per option date, for the Company and affiliates’ policies in force and applied for.

•

The minimum amount of coverage is $10,000.

•

Insured under the base policy must be between the ages of 0 and 37. Coverage expires at age 40.

Waiver of Specified Premium Rider
Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured. Optional
•

Insured under the base Policy must be between the ages of 15 and 55 at the time the rider is issued. Coverage expires at age 65.

•

Insured must be disabled for at least six consecutive months, and the disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday.

Dollar-Cost Averaging
Allows for the systematic transfer of specified dollar amounts from a Sub- Account or the Fixed Account to one or more other specified Sub- Accounts. Standard
•

No transfers may be made into the Fixed Account.

•

Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.

Portfolio Rebalancing
Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value. Standard
•

Rebalancing transfers cannot be made into Fixed Account.

•

Minimum Variable Account Value of $100 required.

Policy Loans
Allows Owner to borrow from the Policy’s Cash Value. Standard
•

Other than Carryover loans, not available during the first Policy Year.

•

Maximum loan amount is 99% of Cash Value.

•

Minimum loan amount is $500.

•

Certain policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a policy loan.

SUPPLEMENTAL RIDERS AND ENDORSEMENTS

The following supplemental riders and endorsements may be available to be added to your Policy subject to state availability. Monthly charges, if applicable, for these riders will be deducted from your Policy Value as part of the monthly deduction. See “Monthly Deduction.” The supplemental riders and endorsements available with the Policies provide fixed benefits that do not vary with the investment experience of the Variable Account. Additional rules and limits apply to these supplemental riders. Not all such riders may be available at any time, and supplemental riders in addition to those listed below may be made available. The ExtendCare Chronic Illness Accelerated Death Benefit Rider, the Protected Insurability Benefit Rider, and the Income Provider Option Pre-Determined Death Benefit Payout Endorsement may only be purchased or added at the time the Policy is issued. The Overloan Protection Endorsement, the Lapse Protection Endorsement, and the Terminal Illness Accelerated Death Benefit Endorsement are automatically added to all Policies at the time of issue. The Children’s Term Life Insurance Rider, the Accidental Death Benefit Rider and the Waiver of Specified Premium Rider may be added at the time of Policy issue or after issue, subject to availability and additional underwriting. Please ask your Protective Life agent for further information, or contact the Home Office.

Children’s Term Life Insurance Rider.   Provides a death benefit payable on the death of a covered child. More than one child can be covered. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $25,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Children are eligible to be covered between 15 days and 25 years of age as long as coverage is in place prior to age 18.

Accidental Death Benefit Rider.   Provides an additional death benefit payable if the Insured’s death results from certain accidental causes. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $250,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 60 to elect this rider.

Waiver of Specified Premium Rider.   Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured. After the Insured has been totally disabled (as defined in the rider) for six consecutive months, Protective Life will credit premiums to the Policy equal to the specified premium amount shown in the Policy multiplied by the number of Monthly Anniversary Days that have occurred since the onset of total disability. The disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday. Monthly Anniversary Days that occur more than one calendar year prior to the date that we receive a claim under a rider are not included for the purpose of this calculation. Subsequent to the time that the Insured has been totally disabled for six months, we will credit a premium equal to the specified premium amount on each Monthly Anniversary Day. The Owner may change the specified premium amount by Written Notice in Good Order received by Protective Life at the Home Office after the first Policy Anniversary and before the Insured becomes totally disabled. Increases are subject to evidence of insurability. The Insured under the base Policy must be between the ages of 15 and 55 to elect this rider.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Waiver of Specified Premiums Rider. At age 55, the insured has a covered total disability while the rider is in force. The Company receives proof of disability and waives the Policy monthly specified premiums for 6 months. During this time, the Policy deductions continue to be in effect.

ExtendCare Chronic Illness Accelerated Death Benefit Rider (not available in all states)

This rider allows the Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that the Insured has a qualifying chronic illness that is expected to last 90 or more days (the”Certification”). A qualifying chronic illness is an illness or condition that (1) prevents the Insured from performing at least two activities of daily living, such as eating, bathing, or dressing, without substantial assistance or (2) requires substantial supervision of the Insured to protect them from threats to their health and safety due to severe cognitive impairment. The licensed health care practitioner who provides the Certification can be a physician, registered professional nurse or licensed social worker, but cannot be the Owner or Insured or a family member of either the Owner or Insured. We reserve the right to require that the Insured be examined by a licensed health care practitioner chosen by us.

Under the ExtendCare Chronic Illness Accelerated Death Benefit Rider, Protective Life makes either 12 monthly payments or a single lump sum payment to the Owner for a 12-month period, known as a “Benefit Period.” The initial Benefit Period begins on the first Monthly Anniversary after we approve an Owner’s written request for accelerated payments and all conditions under the rider for benefit payments to be made have been met. Each subsequent Benefit Period begins on the first Monthly Anniversary following (1) the end of the most recent prior Benefit Period, (2) our receipt of the Certification for the new Benefit Period, and (3) when all other conditions under the rider for benefit

payments to be made have been met. In addition to our receipt of the Owner’s written request for accelerated payments and the Certification, for each Benefit Period the conditions noted below must be met for the Owner to receive benefit payments under this rider.

1.

The Insured is alive.

2.

Both the Policy and the rider are inforce.

3.

We received a written consent from any irrevocable Beneficiaries or assignees of record of the Policy to allow benefit payments to be made to the Owner.

4.

90 consecutive days from the date we receive the Certification (the “Elimination Period”) has passed. For Benefit Periods after the initial Benefit Period, this requirement does not apply if less than 30 days have passed from the date of the end of the prior Benefit Period and the date we receive the Certification for the new Benefit Period.

5.

The Insured has a qualifying chronic illness at the time a benefit payment is made.

6.

Death Benefit Option A is in effect. If the Owner did not elect Death Benefit Option A, we will change the Death Benefit Option under the Policy to Death Benefit Option A prior to our payment of the first benefit payment under this rider. We do not allow any further changes to the Death Benefit Option during a Benefit Period.

For each Benefit Period, the Owner can elect to receive a benefit payment each month or a single lump sum payment at the beginning of the Benefit Period. The lump sum payment is equal to the present value of each monthly benefit payment payable during the Benefit Period. The rider is subject to both a Lifetime Maximum Benefit and a Monthly Maximum Benefit. The information necessary to determine these amounts is set forth in the Policy schedule and the rider.

The Owner or Insured is responsible for the cost of the Certification for the initial Benefit Period. We will cover the cost of the Certification for any subsequent Benefit Period. We begin deducting a monthly charge upon issuance of this rider based, in part, on a maximum monthly benefit amount selected by the Owner at the time of Policy issue. During a Benefit Period, all monthly deductions required to maintain the Policy will be waived. If the Insured is certified as chronically ill for three consecutive Benefit Periods, the monthly deductions will be waived for as long as the Policy is in force. It is possible that for tax purposes some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy. See “Tax Considerations.”

We must receive any written request for benefit payments, to change the amount of monthly benefit payments or to receive a single lump sum benefit payment for a Benefit Period in Good Order at our Home Office.

The minimum Policy Face Amount to elect this rider is $100,000 and the maximum is $5,000,000. The maximum monthly benefit cannot exceed 5% of the Policy Face Amount. Typically, this will force a minimum Face Amount higher than $100,000 at monthly amounts greater than $5,000 or the current IRS per diem limit. The Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the ExtendCare Rider with a benefit amount of $5,000 for a monthly cost of $4.24. In 10 years, while the insured is still alive and the rider and the Policy are still in force, the insured is diagnosed with a chronic illness that prevents them from performing at least two activities of daily living and that is expected to persist for at least 90 days. Once The Company receives written certification from a licensed health care professional and after a 90 day waiting period, the insured will receive either monthly benefits of $5,000 or a lump sum of the present value of the 12 monthly payments as an accelerated payment of part of the Policy’s Death Benefit. The payments will continue for each 12 month Benefit Period where the insured can certify that they are still chronically ill. The insured’s Death Benefit will be reduced dollar for dollar by the amount of payments they receive. So if they are chronically ill for one year and take monthly benefits, they will have received $60,000 in accelerated benefits. If the insured dies after that, the death benefit will be $40,000.

Protected Insurability Benefit Rider.   Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. The minimum amount of coverage is $10,000 and the maximum is $50,000. Fees associated with this rider stop at Insured’s age 40.

Example: Assume a 25 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Protected Insurability Benefit Rider. While the rider is in force at age 31, the Insured purchases an additional $50,000 in coverage with no required underwriting or proof of insurability, but with a change to the monthly deduction specified premium. If the Insured dies after the purchase while the Policy is still in force, the death benefit would be $150,000.

Overloan Protection Endorsement.   Under the provisions of this endorsement, your Policy will not Lapse due to an outstanding Policy loan and the Death Benefit will be at least $10,000 as long as all of the terms and conditions of the endorsement are met:

1.

The Policy has been in force at least 20 Policy Years;

2.

The Insured’s Attained Age is at least 65;

3.

Withdrawals in an amount equal to the total premiums paid have been taken;

4.

The Policy Debt is at least 95% of the Cash Value;

5.

The Policy Debt exceeds the Face Amount;

6.

Accelerated benefits have not been received under any endorsement or rider attached to your Policy;

7.

Monthly Deductions or premiums are not being credited or waived under any endorsement or rider attached to your Policy;

8.

Invoking this benefit does not result in a death benefit that is not compliant with our reasonable interpretation of the Code; and

9.

The Policy is not a modified endowment contract.

When the Policyholder chooses to exercise the benefit under the Overloan Protection Endorsement, we deduct a charge equal to the lesser of the Policy Value minus Policy Debt or 5% of the Policy Value.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount. The Overloan Protection Endorsement is automatically added. At age 70, the insured has been taking loans from his policy so that the Policy Debt is more than 99% of the policy value and the Debt exceeds the Face Amount of the Policy. The insured has taken the maximum amount of withdrawals, the amount equal to their total premiums paid. At this point, any riders on the Policy will be terminated and any Variable Account Value will be transferred to the Fixed Account. In addition, no policy transactions or withdrawals will be allowed. The policy will remain in force and if they die while the endorsement is still in force, the Death Benefit will be the policy value minus the policy debt, with a minimum value of $10,000.

Income Provider Option Pre-Determined Death Benefit Payout Endorsement. (not available in all distribution channels)   The endorsement converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule that describes the amount, frequency, and duration of payment of the Death Benefit Proceeds. If the Death Benefit is adjusted under the Policy while the Insured is living, the amounts shown in the payment schedule will be adjusted pro-rata. The Owner may choose to change the payment schedule or elect a lump sum payment of the Death Benefit Proceeds prior to the Insured’s death, but the Beneficiary will not be able to change the payment schedule after the Insured’s death. The Owner may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of the payment schedule.

Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and adds the Income Provider Option Pre-Determined Death Benefit Payout Endorsement. When the insured dies, the beneficiary will receive a series of payments specified at the time of Policy issue.

Lapse Protection Endorsement.   The endorsement guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule, if for each month that the Policy has been inforce, the total premiums paid (less any withdrawals or Policy loans) is equal to, or greater than, the Minimum Monthly Guarantee Amount multiplied by the number of completed Policy months, including the current month, since the Policy Effective Date. The Minimum Monthly Guarantee Amount is based upon the Company’s anticipated cost of providing lapse protection on a specific Policy for the stated lapse protection period. This amount varies with Policy benefits, Issue Age, sex and rate class of the Insured. Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount. The lapse protection provision is effective during the first 20 Policy Years (if the Insured’s Issue Age is 0 through 49), up to attained age 70 (if the Insured’s Issue Age is 50-64), or during the first 5 Policy Years (for Insured’s Issue Age 65 and above). If on any Monthly Anniversary Day, the total premiums paid less any withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount this provision will terminate.

Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $100,000 Face Amount. The Lapse Protection Endorsement is included on the Policy. The Policy specifies a Monthly Guarantee Premium of $42.00. The owner makes an initial premium payment of $45.00.

On the 24th monthly anniversary, assume the owner has made 24 subsequent premium payments of the same amount and taken no partial surrenders or Policy Loans. The total of the actual premiums paid for the Policy is $1,080

(the amount of the initial premium payment plus the amount of the subsequent premium payments). Because there have been no partial surrenders and there is no Outstanding Debt, the net premiums paid is equal to $1,080.

The amount of premiums required to meet the endorsement conditions is $1,008 (the Monthly Guarantee Premium amount specified in the Policy multiplied by the number of months since the Policy date).

Because the net premiums paid exceed the amount of premiums required, the conditions have been met on this monthly anniversary day and the rider remains in effect. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $100,000.

Assume instead that on the 24th monthly anniversary, the owner missed the last two premium payments. The net premiums paid is then equal to $990. Because the net premiums paid is now less than the amount of premiums required, the owner must pay additional premiums of at least $18.00 within the 60 day grace period to keep the Policy in effect. If the endorsement terminates and the insured dies while the Cash Value of the Policy is zero, the death benefit will be $0.

Terminal Illness Accelerated Death Benefit Endorsement.   The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest.

The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The insured’s Death Benefit is reduced dollar-for-dollar by the amount of payments received and accumulated interest under the accelerated death benefit.The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.

The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

•

the lesser of 60% of the current face amount of the Policy or $1,000,000; minus

•

any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.

Dollar-Cost Averaging

If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account (“Source Sub-Account”) or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.

To elect dollar-cost averaging, Policy Value in the Source Sub-Account or the Fixed Account must be at least $5,000 at the time of election. Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. At least $100 must be transferred each month or $300 each quarter. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29th, 30th, or 31st. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.

Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.

Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.

Portfolio Rebalancing

At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts (“Portfolio Rebalancing”). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29th, 30th or 31st. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.

Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.

Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.
TRANSFERS

Upon receipt of Written Notice in Good Order to Protective Life at the Home Office you may transfer the Fixed Account Value or any Policy Value in a Sub-Account to other Sub-Accounts or the Fixed Account, subject to certain restrictions described below. Transfer requests (including telephone transfer requests — described below) received at the Home Office before 3:00 P.M. Central Time are processed as of the Valuation Day the request is received. Requests received in Good Order at or after 3:00 P.M. Central Time are processed as of the next Valuation Day. Protective Life may, however defer transfers under the same conditions that payment of Death Benefit Proceeds, withdrawals and surrenders may be delayed. See “Suspension or Delay of Payments.” The minimum amount that may be transferred is the lesser of $100 or the entire amount in any Sub-Account or the Fixed Account from which the transfer is made. If, after the transfer, the amount remaining in a Sub-Account(s) or the Fixed Account would be less than $100, Protective Life reserves the right to transfer the entire amount instead of the requested amount. Protective Life reserves the right to restrict the maximum amount which may be transferred from the Fixed Account in any Policy Year. The maximum is currently the greater of $2,500 or 25% of the Fixed Account Value. Due to this limitation, if you want to transfer all of your Policy Value from the Fixed Account to the Variable Account, it may take several years to do so. Protective Life reserves the right to limit transfers to 12 per Policy Year. For each additional transfer over 12 in any Policy Year, Protective Life reserves the right to charge a transfer fee. We will give written notice thirty (30) days before we impose a transfer fee or limit the number of transfers. The transfer fee, if any, is deducted from the amount being transferred. Protective Life reserves the right to terminate, suspend or modify transfer privileges at any time.

Limitations on frequent transfers, including “market timing” transfers.   Frequent transfers may involve an effort to take advantage of the possibility of a lag between a change in the value of a Fund’s portfolio securities and the reflection of that change in the Fund’s share price. This strategy, sometimes referred to as “market timing,” involves an attempt to buy shares of a Fund at a price that does not reflect the current market value of the portfolio securities of the Fund, and then to realize a profit when the Fund shares are sold the next Valuation Day or thereafter.

When you request a transfer among the Sub-Accounts, your request triggers the purchase and redemption of Fund shares. Frequent transfers cause frequent purchases and redemptions of Fund shares. Frequent purchases and redemptions of Fund shares can cause adverse effects for a Fund, Fund shareholders, the Variable Account, other Owners, beneficiaries or Owners of other variable life insurance policies we issue that invest in the Variable Account. Frequent transfers can result in the following adverse effects:

•

Increased brokerage trading and transaction costs;

•

Disruption of planned investment strategies;

•

Forced and unplanned liquidation and portfolio turnover;

•

Lost opportunity costs; and

•

Large asset swings that decrease the Fund’s ability to provide maximum investment return to all Policy Owners.

Market Timing Procedures are designed to detect and prevent frequent, short-term transfer activity that may adversely affect the Funds, Fund shareholders, the Variable Account, other Policy Owners’ beneficiaries and Policy Owners of other variable life policies we issue that invest in the Variable Account.

We monitor transfer activity in the Policies to identify frequent transfer activity in any Policy. Our current Market Timing Procedures are intended to detect transfer activity in which the transfers exceed a certain dollar amount and a certain number of transfers involving the same Sub-Accounts within a specific time period. We regularly review transaction reports in an attempt to identify transfers that exceed our established parameters. We do not include transfers made pursuant to the dollar-cost averaging and Portfolio Rebalancing programs when monitoring for frequent transfer activity.

When we identify transfer activity exceeding our established parameters in a Policy or group of Policies that appear to be under common control, we suspend non-written methods of requesting transfers for that Policy or group of Policies. All transfer requests for the affected Policy or group of Policies must be made by Written Notice in Good Order to the Home Office. We notify the affected Policy Owner(s) in writing of these restrictions.

In addition to our Market Timing Procedures, the Funds may have their own market timing policies and restrictions. While we reserve the right to enforce the Funds’ policies and procedures, Owners and other persons with interests under the Policies should be aware that we may not have the contractual authority or the operational capacity to apply the market timing policies and procedures of the Funds. However, under SEC rules, we are required to: (1) enter into a written agreement with each Fund or its principal underwriter that obligates us to provide to the Fund promptly upon request certain information about the trading activity of individual Owners, and (2) execute instructions from the Fund to restrict or prohibit further purchases or transfers by specific Owners who violate the market timing policies established by the Fund.

Some of the Funds have reserved the right to temporarily or permanently refuse payments or transfer requests from us if, in the judgment of the Fund’s investment adviser, the Fund would be unable to invest effectively in accordance with its investment objective or policies, or would otherwise potentially be adversely affected. To the extent permitted by law, we reserve the right to delay or refuse to honor a transfer request, or to reverse a transfer at any time we are unable to purchase or redeem shares of any of the Funds because of the Fund’s refusal or restriction on purchases or transfers between impacted Funds. We will notify the Policy Owner(s) of any refusal or restriction on a purchase or transfer by a Fund relating to that Policy Owner’s transfer request. Some Funds also may impose redemption fees on short-term trading (i.e., redemptions of mutual Fund shares within a certain number of business days after purchase). We also reserve the right to implement, administer, and collect any redemption fees imposed by any of the Funds. You should read the prospectus of each of the Funds for more information about its ability to refuse or restrict purchases or transfers between impacted Funds of its shares, which may be more or less restrictive than our Market Timing Procedures and those of other Funds, and to impose redemption fees.

We apply our Market Timing Procedures consistently to all Policy Owners without special arrangement, waiver or exception. We reserve the right to change our Market Timing Procedures at any time without prior notice as we deem necessary or appropriate to better detect and deter potentially harmful frequent transfer activity, to comply with state or federal regulatory requirements, or both. We may change our parameters to monitor for different dollar amounts, number of transfers, time period of the transfers, or any of these.

Policy Owners seeking to engage in frequent transfer activity may employ a variety of strategies to avoid detection. Our ability to detect and deter such transfer activity is limited by operational systems and technological limitations. Furthermore, the identification of Policy Owners determined to be engaged in transfer activity that may adversely affect others involves judgments that are inherently subjective. Accordingly, despite our best efforts, we cannot guarantee that our Market Timing Procedures will detect or deter every potential market timer. In addition, because other insurance companies, retirement plans, or both may invest in the Funds, we cannot guarantee that the Funds will not suffer harm from frequent transfer activity in contracts or policies issued by other insurance companies or by retirement plan participants.

Reservation of Rights

Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.

Telephone Transfers

Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.

Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.

A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider’s, your agent’s, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.

SURRENDERS AND WITHDRAWALS

Surrender Privileges

At any time while the Policy is still in force and while the Insured is still living, you may surrender your Policy for its Surrender Value. Surrender Value is determined as of the end of the Valuation Period during which the Written Notice in Good Order requesting the surrender, the Policy and any other required documents are received by Protective Life at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time. Protective Life will process any surrender request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day. The Surrender Value is paid in a lump sum unless the Owner requests payment under a settlement option. Payment is generally made within 7 calendar days. All coverage and optional benefits will end on the effective date of surrender of the Policy. No Death Benefits will be paid after the effective date of the Policy surrender. A Policy which terminates upon surrender cannot later be reinstated. Surrenders may have tax consequences. See “Tax Considerations.” in the Prospectus.)

Withdrawal Privileges

At any time after the first Policy Year, an Owner, by Written Notice in Good Order received at the Home Office, may make a withdrawal of Surrender Value of not less than $500. Protective Life will withdraw the amount requested, plus a withdrawal charge from unloaned Policy Value as of the end of the Valuation Period during which the Written Notice in Good Order is received at the Home Office. Valuation Periods end at the close of regular trading on the New York Stock Exchange, which is generally at 3:00 p.m. Central Time.

Protective Life will process any withdrawal request in Good Order received at the Home Office at or after the end of the Valuation Period on the next Valuation Day.

The Owner may specify the amount of the withdrawal to be made from any Sub-Account or the Fixed Account. If the Owner does not so specify, or if the Sub-Account Value or Fixed Account Value is insufficient to carry out the request, the withdrawal from each Sub-Account and the Fixed Account is based on the proportion that such Sub-Account(s) Value and Fixed Account Value bears to the total unloaned Policy Value on the Valuation Day immediately prior to the Withdrawal. Payment is generally made within seven calendar days.

If Death Benefit Option A is in effect, Protective Life will reduce the Face Amount by the amount withdrawn if total withdrawals in a Policy Year exceed $5,000. The Company reserves the right to increase or decrease the amount of total withdrawals that will not result in a reduction of the Face Amount, or terminate the ability to withdraw any amount that does not trigger a reduction in the Face Amount. Protective Life may reject a withdrawal request if the withdrawal would reduce the Face Amount below the minimum amount for which the Policy would be issued under Protective Life’s then-current rules, or if the withdrawal would cause the Policy to fail to qualify as a life insurance contract under applicable tax laws, as interpreted by Protective Life. If the Face Amount at the time of the withdrawal includes increases from the Initial Face Amount and the withdrawal requires a decrease of Face Amount, the reduction is made first from the most recent increase, then from prior increases, if any, in reverse order of their being made and finally from the Initial Face Amount. Withdrawals may have tax consequences. See “Tax Considerations” in the Prospectus.

Item 18. Portfolio Companies (N-6) [Text Block]

APPENDIX: FUNDS AVAILABLE UNDER THE POLICY

The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.

The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund’s past performance is not necessarily an indication of future performance.

Asset
Allocation
Type

Fund - Investment Adviser;
Sub-Adviser(s), as applicable

Current
Expenses

Average Annual Total Returns
(as of 12/31/2025)

1 Year

5 Year

10 Year

Allocation

American Funds Insurance Series® Asset Allocation Fund - Class 1 - Capital Research and Management Company

0.29%

16.16%

9.24%

10.05%

International
Equity

American Funds Insurance Series® Global Growth Fund - Class 1 - Capital Research and Management Company(1)

0.40%

21.98%

8.51%

12.46%

U.S. Equity

American Funds Insurance Series® Growth-Income Fund - Class 1 - Capital Research and Management Company

0.28%

18.37%

14.19%

14.20%

International
Equity

American Funds Insurance Series® New World Fund® - Class 1 - Capital Research and Management Company(1)

0.57%

28.60%

5.59%

9.53%

Allocation
BlackRock Global Allocation V.I. Fund - Class I (1)
0.76%

19.80%

5.79%

7.59%

U.S. Equity

ClearBridge Variable Mid Cap Portfolio - Class I - Franklin Templeton Fund Adviser, LLC

0.82%

4.35%

4.50%

7.50%

U.S. Equity

ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC

0.81%

9.23%

-0.17%

9.38%

Allocation

Dimensional VA Global Moderate Allocation Portfolio - Institutional Class(1)

0.28%

14.68%

8.42%

8.65%

International
Equity

Dimensional VA International Small Portfolio - Institutional Class

0.39%

36.99%

8.89%

8.68%

International
Equity

Dimensional VA International Value Portfolio - Institutional Class

0.27%

45.64%

15.85%

10.46%

Taxable Bond

Dimensional VA Short-Term Fixed Portfolio - Institutional Class

0.12%

4.33%

2.65%

1.97%

U.S. Equity

Dimensional VA U.S. Large Value Portfolio - Institutional Class

0.21%

15.83%

11.97%

10.51%

U.S. Equity

Dimensional VA U.S. Targeted Value Portfolio - Institutional Class

0.29%

8.95%

13.60%

11.00%

Taxable Bond

Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class

0.11%

7.55%

1.05%

3.12%

Allocation

Fidelity® VIP Balanced Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.41%

15.25%

9.52%

11.13%

U.S. Equity

Fidelity® VIP Growth Opportunities Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.56%

22.02%

11.31%

19.94%

Taxable Bond

Fidelity® VIP Investment Grade Bond Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.37%

7.22%

0.06%

2.71%

U.S. Equity

Fidelity® VIP Mid Cap Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.55%

11.75%

10.10%

10.59%

Asset
Allocation
Type

Fund - Investment Adviser;
Sub-Adviser(s), as applicable

Current
Expenses

Average Annual Total Returns
(as of 12/31/2025)

1 Year

5 Year

10 Year

Taxable Bond

Goldman Sachs VIT Core Fixed Income Fund - Institutional Class(1)

0.42%

7.46%

-0.57%

2.11%

U.S. Equity

Goldman Sachs VIT Mid Cap Value Fund - Institutional Class(1)

0.81%

9.39%

10.05%

10.02%

International
Equity
Invesco® V.I. Global Fund - Series I
0.81%

15.32%

7.28%

11.00%

Buffer

Invesco® V.I. S&P 500 Buffer December Fund - Series I (1)(2)

0.71%

12.53%

-

-

Buffer

Invesco® V.I. S&P 500 Buffer June Fund - Series I (1)(2)

0.71%

13.65%

-

-

Buffer

Invesco® V.I. S&P 500 Buffer March Fund - Series I (1)(2)

0.71%

7.64%

-

-

Buffer

Invesco® V.I. S&P 500 Buffer September Fund - Series I (1)(2)

0.71%

12.78%

-

-

Money Market

Invesco® V.I. U.S. Government Money Portfolio - Series I

0.67%

3.64%

2.80%

1.76%

Sector Equity

Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares

0.73%

25.15%

13.71%

21.48%

Taxable Bond

Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC

0.98%

8.33%

2.10%

4.72%

Taxable Bond

PIMCO VIT Real Return Portfolio - Institutional Class - Pacific Investment Management Company LLC

1.24%

8.01%

1.36%

3.37%

Taxable Bond

PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Managaement Company LLC

0.58%

9.05%

0.16%

2.51%

U.S. Equity

Putnam VT Sustainable Leaders Fund - Class IA - Franklin Advisers, Inc.; Franklin Templeton Investment Management Limited

0.63%

10.99%

10.62%

14.98%

U.S. Equity
Schwab® S&P 500 Index Portfolio
0.03%

17.83%

14.38%

14.75%

Allocation

TOPS® Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Aggressive Growth ETF Portfolio)

0.29%

19.17%

9.69%

10.71%

Allocation

TOPS® Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC

0.31%

10.39%

4.61%

5.25%

Allocation

TOPS® Moderately Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Growth ETF Portfolio)

0.29%

18.31%

8.85%

9.80%

Allocation

TOPS® Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Moderate Growth ETF Portfolio)

0.29%

15.50%

7.20%

8.26%

Allocation

Vanguard Variable Insurance Funds - Balanced Portfolio- Wellington Management Company LLP

0.20%

16.46%

9.28%

10.02%

U.S. Equity

Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named the Vanguard Variable Insurance Funds - Capital Growth Portfolio)

0.34%

28.97%

13.97%

14.96%

Allocation

Vanguard Variable Insurance Funds - Conservative Allocation Portfolio

0.12%

12.72%

4.22%

6.14%

U.S. Equity

Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC

0.29%

16.79%

12.59%

11.51%

U.S. Equity

Vanguard Variable Insurance Funds - Equity Index Portfolio

0.14%

17.70%

14.26%

14.65%

U.S. Equity

Vanguard Variable Insurance Funds - Growth Portfolio - Wellington Management Company, LLP

0.36%

16.88%

11.36%

15.58%

Asset
Allocation
Type

Fund - Investment Adviser;
Sub-Adviser(s), as applicable

Current
Expenses

Average Annual Total Returns
(as of 12/31/2025)

1 Year

5 Year

10 Year

International
Equity

Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.

0.32%

19.96%

0.62%

10.48%

U.S. Equity

Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio

0.17%

11.54%

8.46%

10.77%

Sector Equity

Vanguard Variable Insurance Funds - Real Estate Index Portfolio

0.26%

3.11%

4.50%

5.08%

Taxable Bond

Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio

0.14%

6.93%

-0.50%

1.90%

U.S. Equity

Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio

0.13%

16.93%

12.97%

14.09%

(1)

These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.

(2)

The Sub-Account investing in this Fund is closed to Policies with applications signed on and after May 1, 2025.

Prospectuses Available [Text Block]
The following is a list of Funds available under the Policy. More information about the Funds is available in the prospectuses for the Funds, which may be amended from time to time and can be found online at www.protective.com/eprospectus. You can also request this information at no cost by calling 1-800-265-1545 or by sending an email request to prospectus@protective.com.
The current expenses and performance information below reflects fees and expenses of the Funds, but do not reflect the other fees and expenses that your Policy may charge. Expenses would be higher and performance would be lower if these other charges were included. Each Fund’s past performance is not necessarily an indication of future performance.

Portfolio Companies [Table Text Block]

Asset
Allocation
Type

Fund - Investment Adviser;
Sub-Adviser(s), as applicable

Current
Expenses

Average Annual Total Returns
(as of 12/31/2025)

1 Year

5 Year

10 Year

Allocation

American Funds Insurance Series® Asset Allocation Fund - Class 1 - Capital Research and Management Company

0.29%

16.16%

9.24%

10.05%

International
Equity

American Funds Insurance Series® Global Growth Fund - Class 1 - Capital Research and Management Company(1)

0.40%

21.98%

8.51%

12.46%

U.S. Equity

American Funds Insurance Series® Growth-Income Fund - Class 1 - Capital Research and Management Company

0.28%

18.37%

14.19%

14.20%

International
Equity

American Funds Insurance Series® New World Fund® - Class 1 - Capital Research and Management Company(1)

0.57%

28.60%

5.59%

9.53%

Allocation
BlackRock Global Allocation V.I. Fund - Class I (1)
0.76%

19.80%

5.79%

7.59%

U.S. Equity

ClearBridge Variable Mid Cap Portfolio - Class I - Franklin Templeton Fund Adviser, LLC

0.82%

4.35%

4.50%

7.50%

U.S. Equity

ClearBridge Variable Small Cap Growth Portfolio - Class I - Franklin Templeton Fund Adviser, LLC

0.81%

9.23%

-0.17%

9.38%

Allocation

Dimensional VA Global Moderate Allocation Portfolio - Institutional Class(1)

0.28%

14.68%

8.42%

8.65%

International
Equity

Dimensional VA International Small Portfolio - Institutional Class

0.39%

36.99%

8.89%

8.68%

International
Equity

Dimensional VA International Value Portfolio - Institutional Class

0.27%

45.64%

15.85%

10.46%

Taxable Bond

Dimensional VA Short-Term Fixed Portfolio - Institutional Class

0.12%

4.33%

2.65%

1.97%

U.S. Equity

Dimensional VA U.S. Large Value Portfolio - Institutional Class

0.21%

15.83%

11.97%

10.51%

U.S. Equity

Dimensional VA U.S. Targeted Value Portfolio - Institutional Class

0.29%

8.95%

13.60%

11.00%

Taxable Bond

Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class

0.11%

7.55%

1.05%

3.12%

Allocation

Fidelity® VIP Balanced Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.41%

15.25%

9.52%

11.13%

U.S. Equity

Fidelity® VIP Growth Opportunities Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.56%

22.02%

11.31%

19.94%

Taxable Bond

Fidelity® VIP Investment Grade Bond Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.37%

7.22%

0.06%

2.71%

U.S. Equity

Fidelity® VIP Mid Cap Portfolio - Initial Class - FMR Investment Management (UK) Limited; Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

0.55%

11.75%

10.10%

10.59%

Asset
Allocation
Type

Fund - Investment Adviser;
Sub-Adviser(s), as applicable

Current
Expenses

Average Annual Total Returns
(as of 12/31/2025)

1 Year

5 Year

10 Year

Taxable Bond

Goldman Sachs VIT Core Fixed Income Fund - Institutional Class(1)

0.42%

7.46%

-0.57%

2.11%

U.S. Equity

Goldman Sachs VIT Mid Cap Value Fund - Institutional Class(1)

0.81%

9.39%

10.05%

10.02%

International
Equity
Invesco® V.I. Global Fund - Series I
0.81%

15.32%

7.28%

11.00%

Buffer

Invesco® V.I. S&P 500 Buffer December Fund - Series I (1)(2)

0.71%

12.53%

-

-

Buffer

Invesco® V.I. S&P 500 Buffer June Fund - Series I (1)(2)

0.71%

13.65%

-

-

Buffer

Invesco® V.I. S&P 500 Buffer March Fund - Series I (1)(2)

0.71%

7.64%

-

-

Buffer

Invesco® V.I. S&P 500 Buffer September Fund - Series I (1)(2)

0.71%

12.78%

-

-

Money Market

Invesco® V.I. U.S. Government Money Portfolio - Series I

0.67%

3.64%

2.80%

1.76%

Sector Equity

Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares

0.73%

25.15%

13.71%

21.48%

Taxable Bond

Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC

0.98%

8.33%

2.10%

4.72%

Taxable Bond

PIMCO VIT Real Return Portfolio - Institutional Class - Pacific Investment Management Company LLC

1.24%

8.01%

1.36%

3.37%

Taxable Bond

PIMCO VIT Total Return Portfolio - Institutional Class - Pacific Investment Managaement Company LLC

0.58%

9.05%

0.16%

2.51%

U.S. Equity

Putnam VT Sustainable Leaders Fund - Class IA - Franklin Advisers, Inc.; Franklin Templeton Investment Management Limited

0.63%

10.99%

10.62%

14.98%

U.S. Equity
Schwab® S&P 500 Index Portfolio
0.03%

17.83%

14.38%

14.75%

Allocation

TOPS® Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Aggressive Growth ETF Portfolio)

0.29%

19.17%

9.69%

10.71%

Allocation

TOPS® Conservative ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC

0.31%

10.39%

4.61%

5.25%

Allocation

TOPS® Moderately Aggressive ETF Portfolio- Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Growth ETF Portfolio)

0.29%

18.31%

8.85%

9.80%

Allocation

TOPS® Moderate ETF Portfolio - Class 1 - Valmark Advisers, Inc. - Milliman Financial Risk Management, LLC (formerly, TOPS® Moderate Growth ETF Portfolio)

0.29%

15.50%

7.20%

8.26%

Allocation

Vanguard Variable Insurance Funds - Balanced Portfolio- Wellington Management Company LLP

0.20%

16.46%

9.28%

10.02%

U.S. Equity

Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named the Vanguard Variable Insurance Funds - Capital Growth Portfolio)

0.34%

28.97%

13.97%

14.96%

Allocation

Vanguard Variable Insurance Funds - Conservative Allocation Portfolio

0.12%

12.72%

4.22%

6.14%

U.S. Equity

Vanguard Variable Insurance Funds - Equity Income Portfolio - Wellington Management Company, LLP and Vanguard Portfolio Management, LLC

0.29%

16.79%

12.59%

11.51%

U.S. Equity

Vanguard Variable Insurance Funds - Equity Index Portfolio

0.14%

17.70%

14.26%

14.65%

U.S. Equity

Vanguard Variable Insurance Funds - Growth Portfolio - Wellington Management Company, LLP

0.36%

16.88%

11.36%

15.58%

Asset
Allocation
Type

Fund - Investment Adviser;
Sub-Adviser(s), as applicable

Current
Expenses

Average Annual Total Returns
(as of 12/31/2025)

1 Year

5 Year

10 Year

International
Equity

Vanguard Variable Insurance Funds - International Portfolio - Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.

0.32%

19.96%

0.62%

10.48%

U.S. Equity

Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio

0.17%

11.54%

8.46%

10.77%

Sector Equity

Vanguard Variable Insurance Funds - Real Estate Index Portfolio

0.26%

3.11%

4.50%

5.08%

Taxable Bond

Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio

0.14%

6.93%

-0.50%

1.90%

U.S. Equity

Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio

0.13%

16.93%

12.97%

14.09%

(1)

These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.
(2)

The Sub-Account investing in this Fund is closed to Policies with applications signed on and after May 1, 2025.

Temporary Fee Reductions, Current Expenses [Text Block]
These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.

Advisory Fee Risk [Member]

Item 2. Key Information [Line Items]

Principal Risk [Text Block]
Advisory Fee Risk
Advisory Fees paid from your Policy Value will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits. If you elect to have Advisory Fees paid out of your Policy Value, such payments may not exceed an amount equal to an annual rate of 1.5% of the Policy Value. Advisory Fee payments in excess of this amount, may be subject to federal and state income taxes and a 10% additional tax if you are younger than age 59½ and the Policy is a MEC. See “TAX CONSIDERATIONS--Advisory Fees” and “ADVISORY FEES PAID FROM YOUR POLICY VALUE--Maximum Permitted Advisory Fee Paid from Policy Value.”

Business Disruption and Cyber Security Risks [Member]

Item 2. Key Information [Line Items]

Principal Risk [Text Block]
Business Disruption and Cyber Security Risks
We rely heavily on interconnected computer systems and digital data to conduct our variable product policy business activities. Because our variable product policy business is highly dependent upon the effective operation of our computer systems and those of our business partners, our business is vulnerable to disruptions from utility outages, and susceptible to operational and information security risks resulting from information systems failure (e.g., hardware and software malfunctions), and cyber-attacks. These risks include, among other things, the theft, misuse, corruption and destruction of data maintained online or digitally, interference with or denial of service, attacks on websites and other operational disruption and unauthorized release of confidential Policy Owner information. Such systems failures and cyber-attacks affecting us, the Funds, intermediaries and other affiliated or third-party service providers may adversely affect us and your Policy Value. For instance, systems failures and cyber-attacks may interfere with our processing of Policy transactions, including the processing of orders from our website or with the Funds, impact our ability to calculate Policy Value or the Funds’ ability to calculate share values, cause the release and possible destruction of confidential customer or business information, impede order processing, subject us and/or our service providers and intermediaries to litigation, regulatory fines and financial losses and/or cause reputational damage. Cyber security risks may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. In addition, the risk of cyber-attacks may be higher during periods of geopolitical turmoil. Due to increasing sophistication of cyber-attacks, a cybersecurity breach could occur and persist for an extended period of time without detection. There can be no assurance that we or the Funds or our service providers will avoid losses affecting your Policy due to cyber-attacks or information security breaches in the future.
We are also exposed to risks related to natural and man-made disasters and catastrophes, such as storms, fires, floods, earthquakes, epidemics, pandemics, malicious acts, and terrorist acts, which could adversely affect our ability to conduct business. A natural or man-made disaster or catastrophe, including a pandemic (such as COVID-19), could affect the ability, or willingness, of our workforce and employees of service providers and third party administrators to perform their job responsibilities. Catastrophic events may negatively affect the computer and other systems on which we rely and may interfere with our processing of Policy-related transactions, including processing of orders from Owners and orders with the Funds, impact our ability to calculate Policy Value, or have other possible negative impacts. These events may also impact the issuers of securities in which the Funds invest, which may cause the Funds underlying your Policy to lose value. There can be no assurance that we, the Funds or our service providers will avoid losses affecting your Policy due to a natural disaster or catastrophe.

Fund Risks [Member]

Item 2. Key Information [Line Items]

Principal Risk [Text Block]
Fund Risks
A comprehensive discussion of the risks of each Fund may be found in each Fund’s prospectus. Please refer to the Funds’ prospectuses for more information.

Loan Risks [Member]

Item 2. Key Information [Line Items]

Principal Risk [Text Block]
Loan Risks
A policy loan, whether or not repaid, has a permanent effect on the Policy Value, and potentially the Death Benefit, because the investment results of the Sub-Accounts and current interest rates credited on the Fixed Account Value do not apply to Policy Value in the Loan Account. Since interest credited on the Loan Account is transferred to the Sub-Accounts, even if the interest rate charged on the Policy Debt is equal to the rate credited on Policy Value in the Loan Account, unpaid interest will be added to the outstanding loan and will increase the loan balance. The larger the loan and the longer the loan is outstanding, the greater will be the effect on Policy Value held as collateral in the Loan Account.
Your Policy may Lapse if your outstanding loan amounts reduce the Surrender Value to zero. If a Policy lapses with loans outstanding, some or all of the loan amounts may be subject to income tax. See “Policy Loans” and “Tax Considerations — Tax Treatment of Loans.” Policy loans also may increase the potential for Lapse if the investment results of the Sub-Accounts to which Surrender Value is allocated is unfavorable.
If the Insured dies while a loan is outstanding, the loan balance, which includes any unpaid interest, will be deducted from the Death Benefit.

Specialized Uses of the Policy [Member]

Item 2. Key Information [Line Items]

Principal Risk [Text Block]
Specialized Uses of the Policy
Because your Policy provides for an accumulation of Policy Values as well as Death Benefit, you may wish to use it for various individual and business planning purposes. Purchasing the Policy in part for such purposes may involve certain risks. For example, if the investment performance of the Sub-Accounts is poorer than expected or if sufficient premiums are not paid, the Policy may Lapse or may not accumulate sufficient Policy Value to fund the purpose for which you purchased the Policy. Withdrawals and Policy loans may significantly affect current and future Policy Value, Surrender Value or Death Benefit proceeds. The Policy is designed to provide benefits on a long-term basis. In addition, using a Policy for a specialized purpose may have tax consequences. See “Tax Considerations — Other Considerations.

Tax Risk [Member]

Item 2. Key Information [Line Items]

Principal Risk [Text Block]
Tax Risks
Although the federal income tax requirements applicable to the Policy are complex and there is limited guidance regarding these requirements, we anticipate that the Policy will be treated as a life insurance contract for federal income tax purposes. Assuming that a Policy qualifies as a life insurance contract for federal income tax purposes, you generally should not be considered to be in receipt of any portion of your Policy’s Cash Value until there is an actual distribution from the Policy. Moreover, Death Benefits payable under the Policy should be excludable from the gross income of the Beneficiary. Although the Beneficiary generally should not have to pay federal income tax on the Death Benefit, other taxes, such as estate taxes, may apply.
Your Policy may become a modified endowment contract as a result of: (1) the payment of excess premiums or unnecessary premiums, (2) a material change in the Policy, or (3) a reduction in your Death Benefit. If your Policy becomes a modified endowment contract, transactions such as withdrawals and loans will be treated first as a distribution of the earnings in the Policy and will be taxable as ordinary income in the year received. In addition, if the Policy Owner is under age 59½ at the time of a surrender, withdrawal or loan, the amount that is included in income is generally subject to a 10% additional tax.
If the Policy is not a modified endowment contract, distributions generally are treated first as a return of basis or investment in the contract and then as taxable income. Moreover, loans are generally not treated as distributions. Finally, neither distributions nor loans from a Policy that is not a modified endowment contract are subject to the 10% additional tax.
See “Tax Considerations.” You should consult a qualified tax adviser for assistance in all Policy related tax matters.

Withdrawal and Surrender Risks [Member]

Item 2. Key Information [Line Items]

Principal Risk [Text Block]
Withdrawal and Surrender Risks
The Surrender Value of the Policy is generally the Cash Value less any Policy Debt and any liens (including accrued interest). It is possible that your Policy will have no Surrender Value during the first few Policy Years. You should purchase the Policy only if you have the financial ability to keep it in force for a substantial period of time. You should not purchase the Policy if you intend to surrender all or part of the Policy Value in the near future. We designed the Policy to meet long-term financial goals. The Policy is not suitable as a short-term investment.
Withdrawals are not permitted during the first Policy Year. After the first Policy Year, withdrawals are permitted, subject to certain limitations, for a fee. Withdrawals may reduce the Face Amount of the Policy.
A surrender or withdrawal may have tax consequences. See “TAX CONSIDERATIONS.”

Risk of Loss [Member]

Item 2. Key Information [Line Items]

Risk [Text Block]
Risk of Loss

You can lose money by investing in this Policy, including loss of principal.

For additional information about the risk of loss, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” in the Prospectus.

Not Short Term Investment Risk [Member]

Item 2. Key Information [Line Items]

Risk [Text Block]
Not a Short-Term Investment

The Policy is not a short-term investment and is not appropriate for an investor who needs ready access to cash. The Policy is designed to provide benefits on a long-term basis. Although you are permitted to take withdrawals or surrender the Policy, federal and state income taxes may apply. Consequently, you should not use the Policy as a short-term investment or savings vehicle. Because of the long-term nature of the Policy, you should consider whether purchasing the Policy is consistent with the purpose for which it is being considered. Withdrawals are not available in the first Policy Year.

If you elect to pay Advisory Fees from your Policy Value, such payments will reduce your Policy Value and may reduce the death benefit and other guaranteed benefits.

For additional information about the investment profile of the Policy, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “CHARGES AND DEDUCTIONS,” “USE OF THE POLICY,” “TAX CONSIDERATIONS--Taxation of Insurance Policies” and “TAX CONSIDERATIONS--Advisory Fees” in the Prospectus.

Investment Options Risk [Member]

Item 2. Key Information [Line Items]

Risk [Text Block]
Risks Associated with Investment Options

An investment in the Policy is subject to the risk of poor investment performance and can vary depending on the performance of the investment options, or Funds, available under the Policy. Each investment option (including the Fixed Account investment option) will have its own unique risks, and investors should review these investment options before making an investment decision.

For additional information about the risks associated with Investment Options, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “THE COMPANY AND THE FIXED ACCOUNT,” “THE VARIABLE ACCOUNT AND THE FUNDS” and “FUND APPENDIX: FUNDS AVAILABLE UNDER THE POLICY” in the Prospectus.

Principal Risk [Text Block]
Investment Risk
If you invest your Policy Value in one or more Sub-Accounts, then you will be subject to the risk that investment performance may be unfavorable causing the Policy Value to decrease and the Monthly Deduction to increase (which, in turn, further decreases future Policy Value). This is because poor investment performance diminishes Policy Value thereby increasing the Net Amount at Risk under the Policy and, correspondingly, increasing the cost of insurance which is part of the Monthly Deduction. You could lose everything you invest. If you allocate Policy Value to the Fixed Account, then we credit your Policy Value (in the Fixed Account) with a declared rate of interest, but you assume the risk that the rate may decrease, although it will never be lower than the guaranteed minimum annual effective rate of 1%. See “The Variable Account and The Funds.”

Insurance Company Risk [Member]

Item 2. Key Information [Line Items]

Risk [Text Block]
Insurance Company Risks

An investment in the Policy is subject to the risks related to Protective Life, including that any obligations (including under the Fixed Account investment options), guarantees, or benefits are subject to the claims-paying ability of the Company. More information about the Company, including its financial strength ratings, is available upon request by calling toll-free 1-888-353-2654.

For additional information about Company risks, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY” and “THE COMPANY AND THE FIXED ACCOUNT” in the Prospectus.

Contract Lapse Risk [Member]

Item 2. Key Information [Line Items]

Risk [Text Block]
Policy Lapse

Your Policy could terminate if the value of your Policy becomes too low to support the Policy’s monthly charges. Your Policy may also Lapse due to insufficient premium payments, poor investment performance, withdrawals, unpaid loans, or loan interest. There is a cost associated with reinstating a Lapsed Policy. Death Benefits will not be paid if the Policy has Lapsed.

For additional information about Policy Lapse, see “PRINCIPAL RISKS OF INVESTING IN THE POLICY,” “PREMIUMS,” “LOANS,” and “LAPSE AND REINSTATEMENT” in the Prospectus.

Principal Risk [Text Block]
Risk of Lapse
There is a risk that your Policy will Lapse and no death benefit will be paid. Unless the lapse protection period is in effect, if your Policy Value minus the Policy Debt and any liens on a Monthly Anniversary Day is less than the amount of the Monthly Deduction due on that date, the Policy will be in default and a grace period will begin. On and after the Policy Anniversary when the Insured is age 121, the Policy will not enter the grace period or Lapse regardless of your Surrender Value. We will send you notice of the premium required to prevent Lapse. You have a 61-day grace period to make a payment of Net Premium at least sufficient to cover the current and past-due Monthly Deductions or the Policy will Lapse. You may reinstate a Lapsed Policy, subject to certain conditions. Payment of the Minimum Monthly Premium required under the Lapse Protection Endorsement of the Policy will not guarantee that the Policy will remain in force after the termination of the lapse protection period. See “Lapse and Reinstatement--Lapse” and “Lapse Protection.”

American Funds Insurance Series® Asset Allocation Fund - Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] American Funds Insurance Series® Asset Allocation Fund - Class 1

Portfolio Company Adviser [Text Block] Capital Research and Management Company

Current Expenses [Percent] 0.29%

Average Annual Total Returns, 1 Year [Percent] 16.16%

Average Annual Total Returns, 5 Years [Percent] 9.24%

Average Annual Total Returns, 10 Years [Percent] 10.05%

American Funds Insurance Series® Global Growth Fund - Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] American Funds Insurance Series® Global Growth Fund - Class 1 ^[4]

Portfolio Company Adviser [Text Block] Capital Research and Management Company ^[4]

Current Expenses [Percent] 0.40% ^[4]

Average Annual Total Returns, 1 Year [Percent] 21.98% ^[4]

Average Annual Total Returns, 5 Years [Percent] 8.51% ^[4]

Average Annual Total Returns, 10 Years [Percent] 12.46% ^[4]

American Funds Insurance Series® Growth-Income Fund - Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] American Funds Insurance Series® Growth-Income Fund - Class 1

Portfolio Company Adviser [Text Block] Capital Research and Management Company

Current Expenses [Percent] 0.28%

Average Annual Total Returns, 1 Year [Percent] 18.37%

Average Annual Total Returns, 5 Years [Percent] 14.19%

Average Annual Total Returns, 10 Years [Percent] 14.20%

American Funds Insurance Series® New World Fund® - Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] American Funds Insurance Series® New World Fund® - Class 1 ^[4]

Portfolio Company Adviser [Text Block] Capital Research and Management Company ^[4]

Current Expenses [Percent] 0.57% ^[4]

Average Annual Total Returns, 1 Year [Percent] 28.60% ^[4]

Average Annual Total Returns, 5 Years [Percent] 5.59% ^[4]

Average Annual Total Returns, 10 Years [Percent] 9.53% ^[4]

BlackRock Global Allocation V.I. Fund - Class I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] BlackRock Global Allocation V.I. Fund - Class I ^[4]

Current Expenses [Percent] 0.76% ^[4]

Average Annual Total Returns, 1 Year [Percent] 19.80% ^[4]

Average Annual Total Returns, 5 Years [Percent] 5.79% ^[4]

Average Annual Total Returns, 10 Years [Percent] 7.59% ^[4]

ClearBridge Variable Mid Cap Portfolio - Class I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] ClearBridge Variable Mid Cap Portfolio - Class I

Portfolio Company Adviser [Text Block] Franklin Templeton Fund Adviser, LLC

Current Expenses [Percent] 0.82%

Average Annual Total Returns, 1 Year [Percent] 4.35%

Average Annual Total Returns, 5 Years [Percent] 4.50%

Average Annual Total Returns, 10 Years [Percent] 7.50%

ClearBridge Variable Small Cap Growth Portfolio - Class I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] ClearBridge Variable Small Cap Growth Portfolio - Class I

Portfolio Company Adviser [Text Block] Franklin Templeton Fund Adviser, LLC

Current Expenses [Percent] 0.81%

Average Annual Total Returns, 1 Year [Percent] 9.23%

Average Annual Total Returns, 5 Years [Percent] (0.17%)

Average Annual Total Returns, 10 Years [Percent] 9.38%

Dimensional VA Global Moderate Allocation Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Dimensional VA Global Moderate Allocation Portfolio - Institutional Class ^[4]

Current Expenses [Percent] 0.28% ^[4]

Average Annual Total Returns, 1 Year [Percent] 14.68% ^[4]

Average Annual Total Returns, 5 Years [Percent] 8.42% ^[4]

Average Annual Total Returns, 10 Years [Percent] 8.65% ^[4]

Dimensional VA International Small Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Dimensional VA International Small Portfolio - Institutional Class

Current Expenses [Percent] 0.39%

Average Annual Total Returns, 1 Year [Percent] 36.99%

Average Annual Total Returns, 5 Years [Percent] 8.89%

Average Annual Total Returns, 10 Years [Percent] 8.68%

Dimensional VA International Value Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Dimensional VA International Value Portfolio - Institutional Class

Current Expenses [Percent] 0.27%

Average Annual Total Returns, 1 Year [Percent] 45.64%

Average Annual Total Returns, 5 Years [Percent] 15.85%

Average Annual Total Returns, 10 Years [Percent] 10.46%

Dimensional VA Short-Term Fixed Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Dimensional VA Short-Term Fixed Portfolio - Institutional Class

Current Expenses [Percent] 0.12%

Average Annual Total Returns, 1 Year [Percent] 4.33%

Average Annual Total Returns, 5 Years [Percent] 2.65%

Average Annual Total Returns, 10 Years [Percent] 1.97%

Dimensional VA U.S. Large Value Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Dimensional VA U.S. Large Value Portfolio - Institutional Class

Current Expenses [Percent] 0.21%

Average Annual Total Returns, 1 Year [Percent] 15.83%

Average Annual Total Returns, 5 Years [Percent] 11.97%

Average Annual Total Returns, 10 Years [Percent] 10.51%

Dimensional VA U.S. Targeted Value Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Dimensional VA U.S. Targeted Value Portfolio - Institutional Class

Current Expenses [Percent] 0.29%

Average Annual Total Returns, 1 Year [Percent] 8.95%

Average Annual Total Returns, 5 Years [Percent] 13.60%

Average Annual Total Returns, 10 Years [Percent] 11.00%

Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class

Current Expenses [Percent] 0.11%

Average Annual Total Returns, 1 Year [Percent] 7.55%

Average Annual Total Returns, 5 Years [Percent] 1.05%

Average Annual Total Returns, 10 Years [Percent] 3.12%

Fidelity® VIP Balanced Portfolio - Initial Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Fidelity® VIP Balanced Portfolio - Initial Class

Portfolio Company Adviser [Text Block] FMR Investment Management (UK) Limited

Portfolio Company Subadviser [Text Block] Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

Current Expenses [Percent] 0.41%

Average Annual Total Returns, 1 Year [Percent] 15.25%

Average Annual Total Returns, 5 Years [Percent] 9.52%

Average Annual Total Returns, 10 Years [Percent] 11.13%

Fidelity® VIP Growth Opportunities Portfolio - Initial Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Fidelity® VIP Growth Opportunities Portfolio - Initial Class

Portfolio Company Adviser [Text Block] FMR Investment Management (UK) Limited

Portfolio Company Subadviser [Text Block] Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

Current Expenses [Percent] 0.56%

Average Annual Total Returns, 1 Year [Percent] 22.02%

Average Annual Total Returns, 5 Years [Percent] 11.31%

Average Annual Total Returns, 10 Years [Percent] 19.94%

Fidelity® VIP Investment Grade Bond Portfolio - Initial Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Fidelity® VIP Investment Grade Bond Portfolio - Initial Class

Portfolio Company Adviser [Text Block] FMR Investment Management (UK) Limited

Portfolio Company Subadviser [Text Block] Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

Current Expenses [Percent] 0.37%

Average Annual Total Returns, 1 Year [Percent] 7.22%

Average Annual Total Returns, 5 Years [Percent] 0.06%

Average Annual Total Returns, 10 Years [Percent] 2.71%

Fidelity® VIP Mid Cap Portfolio - Initial Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Fidelity® VIP Mid Cap Portfolio - Initial Class

Portfolio Company Adviser [Text Block] FMR Investment Management (UK) Limited

Portfolio Company Subadviser [Text Block] Fidelity Management & Research (Japan) Limited; Fidelity Management & Research (Hong Kong) Limited

Current Expenses [Percent] 0.55%

Average Annual Total Returns, 1 Year [Percent] 11.75%

Average Annual Total Returns, 5 Years [Percent] 10.10%

Average Annual Total Returns, 10 Years [Percent] 10.59%

Goldman Sachs VIT Core Fixed Income Fund - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Goldman Sachs VIT Core Fixed Income Fund - Institutional Class ^[4]

Current Expenses [Percent] 0.42% ^[4]

Average Annual Total Returns, 1 Year [Percent] 7.46% ^[4]

Average Annual Total Returns, 5 Years [Percent] (0.57%) ^[4]

Average Annual Total Returns, 10 Years [Percent] 2.11% ^[4]

Goldman Sachs VIT Mid Cap Value Fund - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Goldman Sachs VIT Mid Cap Value Fund - Institutional Class ^[4]

Current Expenses [Percent] 0.81% ^[4]

Average Annual Total Returns, 1 Year [Percent] 9.39% ^[4]

Average Annual Total Returns, 5 Years [Percent] 10.05% ^[4]

Average Annual Total Returns, 10 Years [Percent] 10.02% ^[4]

Invesco® V.I. Global Fund - Series I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Invesco® V.I. Global Fund - Series I

Current Expenses [Percent] 0.81%

Average Annual Total Returns, 1 Year [Percent] 15.32%

Average Annual Total Returns, 5 Years [Percent] 7.28%

Average Annual Total Returns, 10 Years [Percent] 11.00%

Invesco® V.I. S&P 500 Buffer December Fund - Series I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Invesco® V.I. S&P 500 Buffer December Fund - Series I ^[4],[5]

Current Expenses [Percent] 0.71% ^[4],[5]

Average Annual Total Returns, 1 Year [Percent] 12.53% ^[4],[5]

Average Annual Total Returns, 5 Years [Percent] ^[4],[5]

Average Annual Total Returns, 10 Years [Percent] ^[4],[5]

Invesco® V.I. S&P 500 Buffer June Fund - Series I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Invesco® V.I. S&P 500 Buffer June Fund - Series I ^[4],[5]

Current Expenses [Percent] 0.71% ^[4],[5]

Average Annual Total Returns, 1 Year [Percent] 13.65% ^[4],[5]

Average Annual Total Returns, 5 Years [Percent] ^[4],[5]

Average Annual Total Returns, 10 Years [Percent] ^[4],[5]

Invesco® V.I. S&P 500 Buffer March Fund - Series I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Invesco® V.I. S&P 500 Buffer March Fund - Series I ^[4],[5]

Current Expenses [Percent] 0.71% ^[4],[5]

Average Annual Total Returns, 1 Year [Percent] 7.64% ^[4],[5]

Average Annual Total Returns, 5 Years [Percent] ^[4],[5]

Average Annual Total Returns, 10 Years [Percent] ^[4],[5]

Invesco® V.I. S&P 500 Buffer September Fund - Series I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Invesco® V.I. S&P 500 Buffer September Fund - Series I ^[4],[5]

Current Expenses [Percent] 0.71% ^[4],[5]

Average Annual Total Returns, 1 Year [Percent] 12.78% ^[4],[5]

Average Annual Total Returns, 5 Years [Percent] ^[4],[5]

Average Annual Total Returns, 10 Years [Percent] ^[4],[5]

Invesco® V.I. U.S. Government Money Portfolio - Series I [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Invesco® V.I. U.S. Government Money Portfolio - Series I

Current Expenses [Percent] 0.67%

Average Annual Total Returns, 1 Year [Percent] 3.64%

Average Annual Total Returns, 5 Years [Percent] 2.80%

Average Annual Total Returns, 10 Years [Percent] 1.76%

Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares

Current Expenses [Percent] 0.73%

Average Annual Total Returns, 1 Year [Percent] 25.15%

Average Annual Total Returns, 5 Years [Percent] 13.71%

Average Annual Total Returns, 10 Years [Percent] 21.48%

Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC

Current Expenses [Percent] 0.98%

Average Annual Total Returns, 1 Year [Percent] 8.33%

Average Annual Total Returns, 5 Years [Percent] 2.10%

Average Annual Total Returns, 10 Years [Percent] 4.72%

PIMCO VIT Real Return Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] PIMCO VIT Real Return Portfolio - Institutional Class

Portfolio Company Adviser [Text Block] Pacific Investment Management Company LLC

Current Expenses [Percent] 1.24%

Average Annual Total Returns, 1 Year [Percent] 8.01%

Average Annual Total Returns, 5 Years [Percent] 1.36%

Average Annual Total Returns, 10 Years [Percent] 3.37%

PIMCO VIT Total Return Portfolio - Institutional Class [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] PIMCO VIT Total Return Portfolio - Institutional Class

Portfolio Company Adviser [Text Block] Pacific Investment Managaement Company LLC

Current Expenses [Percent] 0.58%

Average Annual Total Returns, 1 Year [Percent] 9.05%

Average Annual Total Returns, 5 Years [Percent] 0.16%

Average Annual Total Returns, 10 Years [Percent] 2.51%

Putnam VT Sustainable Leaders Fund - Class IA [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Putnam VT Sustainable Leaders Fund - Class IA

Portfolio Company Adviser [Text Block] Franklin Advisers, Inc.

Portfolio Company Subadviser [Text Block] Franklin Templeton Investment Management Limited

Current Expenses [Percent] 0.63%

Average Annual Total Returns, 1 Year [Percent] 10.99%

Average Annual Total Returns, 5 Years [Percent] 10.62%

Average Annual Total Returns, 10 Years [Percent] 14.98%

Schwab® S&P 500 Index Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Schwab® S&P 500 Index Portfolio

Current Expenses [Percent] 0.03%

Average Annual Total Returns, 1 Year [Percent] 17.83%

Average Annual Total Returns, 5 Years [Percent] 14.38%

Average Annual Total Returns, 10 Years [Percent] 14.75%

TOPS® Aggressive ETF Portfolio - Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] TOPS® Aggressive ETF Portfolio- Class 1

Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.

Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management, LLC (formerly, TOPS® Aggressive Growth ETF Portfolio)

Current Expenses [Percent] 0.29%

Average Annual Total Returns, 1 Year [Percent] 19.17%

Average Annual Total Returns, 5 Years [Percent] 9.69%

Average Annual Total Returns, 10 Years [Percent] 10.71%

TOPS® Conservative ETF Portfolio - Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] TOPS® Conservative ETF Portfolio - Class 1

Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.

Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management, LLC

Current Expenses [Percent] 0.31%

Average Annual Total Returns, 1 Year [Percent] 10.39%

Average Annual Total Returns, 5 Years [Percent] 4.61%

Average Annual Total Returns, 10 Years [Percent] 5.25%

TOPS® Moderate ETF Portfolio - Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] TOPS® Moderate ETF Portfolio - Class 1

Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.

Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management, LLC (formerly, TOPS® Moderate Growth ETF Portfolio)

Current Expenses [Percent] 0.29%

Average Annual Total Returns, 1 Year [Percent] 15.50%

Average Annual Total Returns, 5 Years [Percent] 7.20%

Average Annual Total Returns, 10 Years [Percent] 8.26%

TOPS® Moderately Aggressive ETF Portfolio- Class 1 [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] TOPS® Moderately Aggressive ETF Portfolio- Class 1

Portfolio Company Adviser [Text Block] Valmark Advisers, Inc.

Portfolio Company Subadviser [Text Block] Milliman Financial Risk Management, LLC (formerly, TOPS® Growth ETF Portfolio)

Current Expenses [Percent] 0.29%

Average Annual Total Returns, 1 Year [Percent] 18.31%

Average Annual Total Returns, 5 Years [Percent] 8.85%

Average Annual Total Returns, 10 Years [Percent] 9.80%

Vanguard Variable Insurance Funds - Balanced Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Balanced Portfolio-

Portfolio Company Adviser [Text Block] Wellington Management Company LLP

Current Expenses [Percent] 0.20%

Average Annual Total Returns, 1 Year [Percent] 16.46%

Average Annual Total Returns, 5 Years [Percent] 9.28%

Average Annual Total Returns, 10 Years [Percent] 10.02%

Vanguard Variable Insurance Funds - Conservative Allocation Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Conservative Allocation Portfolio

Current Expenses [Percent] 0.12%

Average Annual Total Returns, 1 Year [Percent] 12.72%

Average Annual Total Returns, 5 Years [Percent] 4.22%

Average Annual Total Returns, 10 Years [Percent] 6.14%

Vanguard Variable Insurance Funds - Equity Income Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Equity Income Portfolio

Portfolio Company Adviser [Text Block] Wellington Management Company, LLP and Vanguard Portfolio Management, LLC

Current Expenses [Percent] 0.29%

Average Annual Total Returns, 1 Year [Percent] 16.79%

Average Annual Total Returns, 5 Years [Percent] 12.59%

Average Annual Total Returns, 10 Years [Percent] 11.51%

Vanguard Variable Insurance Funds - Equity Index Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Equity Index Portfolio

Current Expenses [Percent] 0.14%

Average Annual Total Returns, 1 Year [Percent] 17.70%

Average Annual Total Returns, 5 Years [Percent] 14.26%

Average Annual Total Returns, 10 Years [Percent] 14.65%

Vanguard Variable Insurance Funds - Growth Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Growth Portfolio

Portfolio Company Adviser [Text Block] Wellington Management Company, LLP

Current Expenses [Percent] 0.36%

Average Annual Total Returns, 1 Year [Percent] 16.88%

Average Annual Total Returns, 5 Years [Percent] 11.36%

Average Annual Total Returns, 10 Years [Percent] 15.58%

Vanguard Variable Insurance Funds - International Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - International Portfolio

Portfolio Company Adviser [Text Block] Baillie Gifford Overseas Limited and Schroder Investment Management North America Inc.

Current Expenses [Percent] 0.32%

Average Annual Total Returns, 1 Year [Percent] 19.96%

Average Annual Total Returns, 5 Years [Percent] 0.62%

Average Annual Total Returns, 10 Years [Percent] 10.48%

Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio

Current Expenses [Percent] 0.17%

Average Annual Total Returns, 1 Year [Percent] 11.54%

Average Annual Total Returns, 5 Years [Percent] 8.46%

Average Annual Total Returns, 10 Years [Percent] 10.77%

Vanguard Variable Insurance Funds - PRIMECAP Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - PRIMECAP Portfolio (Note: Prior to May 12, 2026, this fund was named the Vanguard Variable Insurance Funds - Capital Growth Portfolio)

Current Expenses [Percent] 0.34%

Average Annual Total Returns, 1 Year [Percent] 28.97%

Average Annual Total Returns, 5 Years [Percent] 13.97%

Average Annual Total Returns, 10 Years [Percent] 14.96%

Vanguard Variable Insurance Funds - Real Estate Index Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Real Estate Index Portfolio

Current Expenses [Percent] 0.26%

Average Annual Total Returns, 1 Year [Percent] 3.11%

Average Annual Total Returns, 5 Years [Percent] 4.50%

Average Annual Total Returns, 10 Years [Percent] 5.08%

Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio

Current Expenses [Percent] 0.14%

Average Annual Total Returns, 1 Year [Percent] 6.93%

Average Annual Total Returns, 5 Years [Percent] (0.50%)

Average Annual Total Returns, 10 Years [Percent] 1.90%

Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio [Member]

Item 2. Key Information [Line Items]

Portfolio Company Name [Text Block] Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio

Current Expenses [Percent] 0.13%

Average Annual Total Returns, 1 Year [Percent] 16.93%

Average Annual Total Returns, 5 Years [Percent] 12.97%

Average Annual Total Returns, 10 Years [Percent] 14.09%

First 10 Policy Years [Member]

Item 2. Key Information [Line Items]

Mortality And Expense Risk Fees (of Face Amount), Current [Percent] 0.204%

On or After February 1, 2024, But Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Insurance Cost, Description [Text Block] Cost of Insurance ^[6],[7]

Insurance Cost, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day ^[6],[7]

Insurance Cost, Maximum [Dollars] $ 83.33 ^[6],[7]

Insurance Cost, Current [Dollars] 59.39 ^[6],[7]

Insurance Cost, Minimum [Dollars] $ 0.01 ^[6],[7]

Expense Risk Fees, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day$0.18 per $1,000 of Net Amount at Risk$0.04 per $1000 of Net Amount at Risk ^[6],[7]

Administrative Expenses, Description [Text Block] Administrative Charge

Administrative Expenses, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day

Administrative Expenses, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco rate class with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day $0.45 per $1,000 of Initial Face Amount$0.45 per $1,000 of Initial Face Amount during the first 10 Policy Years and is discontinued thereafter.

Administrative Expense, Maximum [Dollars] $ 3.66

Administrative Expense, Current [Dollars] 3.66

Administrative Expense, Minimum [Dollars] $ 0.09

On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Premium Taxes, Description [Text Block] Premium Expense Charge

Premium Taxes, When Deducted [Text Block] Upon receipt of each premium payment

Premium Taxes (of Premium Payments), Maximum [Percent] 5.00%

Premium Taxes (of Premium Payments), Current [Percent] 2.00%

Insurance Cost, Description [Text Block] Cost of Insurance ^[6],[7]

Insurance Cost, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day ^[6],[7]

Insurance Cost, Maximum [Dollars] $ 83.33 ^[6],[7]

Insurance Cost, Current [Dollars] 70.46 ^[6],[7]

Insurance Cost, Minimum [Dollars] $ 0.01 ^[6],[7]

Expense Risk Fees, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco rate class during the first Policy Year with a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day$0.18 per $1,000 of Net Amount at Risk$0.04 per $1000 of Net Amount at Risk ^[6],[7]

Optional Benefit Charge, Description [Text Block] Net Cost of Loans ^[8]

Optional Benefit Charge, When Deducted [Text Block] On each Policy Anniversary, as applicable ^[8],[9]

On or Before February 1, 2024 [Member]

Item 2. Key Information [Line Items]

Insurance Cost, Maximum [Dollars] $ 83.33 ^[6],[7]

Insurance Cost, Current [Dollars] 81.67 ^[6],[7]

Insurance Cost, Minimum [Dollars] $ 0.01 ^[6],[7]

Expense Risk Fees, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco class during the first Policy Year.
On the Policy Effective Date and each Monthly Anniversary Day $0.18 per $1,000 of Net Amount at Risk$0.07 per $1,000 of Net Amount at Risk ^[6],[7]

Administrative Expenses, Description [Text Block] Administrative Charge

Administrative Expenses, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years

Administrative Expenses, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco rate class
On the Policy Effective Date and each Monthly Anniversary Day during first 10 Policy Years $0.31 per $1,000 of Initial Face Amount $0.31 per $1,000 of Initial Face Amount

Administrative Expense, Maximum [Dollars] $ 3.66

Administrative Expense, Current [Dollars] 3.66

Administrative Expense, Minimum [Dollars] $ 0.09

Administrative Expense (of Average Account Value), Current [Percent] ^[6],[7]

On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Premium Taxes, Description [Text Block] Premium Expense Charge

Premium Taxes, When Deducted [Text Block] Upon receipt of each premium payment

Premium Taxes (of Premium Payments), Maximum [Percent] 3.50%

Premium Taxes (of Premium Payments), Current [Percent] 2.00%

Optional Benefit Charge, Description [Text Block] Net Cost of Loans ^[8]

Optional Benefit Charge, When Deducted [Text Block] On each Policy Anniversary, as applicable ^[8],[9]

Policy Years After 10 [Member]

Item 2. Key Information [Line Items]

Administrative Expense (of Average Account Value), Current [Percent] 0.096%

Accidental Death Benefit Rider [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Description [Text Block] Accidental Death Benefit Rider ^[10]

Other Transaction Fee, When Deducted [Text Block] On the Effective Date and each Monthly Anniversary Day ^[10]

Other Transaction Fee, Maximum [Dollars] $ 0.14 ^[10]

Other Transaction Fee, Minimum [Dollars] $ 0.08 ^[10]

Other Transaction Fee, Footnotes [Text Block]
The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

?
(8)

The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

Administrative Expenses, Representative Investor [Text Block] On the Effective Date and each Monthly Anniversary Day $0.08 per $1,000 of rider coverage amount $0.08 per $1,000 of rider coverage amount

Name of Benefit [Text Block] Accidental Death Benefit Rider

Purpose of Benefit [Text Block] Provides an additional death benefit payable if Insured’s death results from certain accidental causes.

Brief Restrictions / Limitations [Text Block]
•

Insured under the base Policy must be between the ages of 15 and 60 to elect this rider. Coverage expires at age 65.

•

The minimum amount of coverage is $1,000.

•

Maximum amount of coverage is $250,000 for the Company and affiliates’ policies in force and applied for.

Name of Benefit [Text Block] Accidental Death Benefit Rider

Benefit Standard or Optional [Text Block] Optional

Operation of Benefit [Text Block]
Accidental Death Benefit Rider.   Provides an additional death benefit payable if the Insured’s death results from certain accidental causes. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $250,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 60 to elect this rider.

Administrative Charge For Face Amount Increases [Member] | After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Administrative Expenses, Description [Text Block] Administrative Charge For Face Amount Increases ^[11]

Administrative Expenses, When Deducted [Text Block] On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days ^[11]

Administrative Expenses, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco rate class
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $3.30 per $1,000 of any increase in Face Amount $3.30 per $1,000 of any increase in Face Amount ^[11]

Administrative Expense, Maximum [Dollars] $ 4.95 ^[11]

Administrative Expense, Current [Dollars] 4.95 ^[11]

Administrative Expense, Minimum [Dollars] $ 0.75 ^[11]

Administrative Charge For Face Amount Increases [Member] | On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Administrative Expenses, Description [Text Block] Administrative Charge For Face Amount Increases ^[11]

Administrative Expenses, When Deducted [Text Block] On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days ^[11]

Administrative Expenses, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco rate class
On the Effective Date of the increase and the subsequent 11 Monthly Anniversary Days $1.09 per $1,000 of any increase in Face Amount $1.09 per $1,000 of any increase in Face Amount ^[11]

Administrative Expense, Maximum [Dollars] $ 1.74

Administrative Expense, Current [Dollars] 1.74

Administrative Expense, Minimum [Dollars] $ 0.39

Administrative Charge [Member] | On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Administrative Expenses, Description [Text Block] Administrative Charge

Administrative Expenses, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day

Administrative Expenses, Representative Investor [Text Block]
Charge for a 49 year old male in the nontobacco rate classwith a Face Amount of $100,000.
On the Policy Effective Date and each Monthly Anniversary Day$0.89 per $1,000 of Initial Face Amount$0.81 per $1,000 of Initial Face Amount during the first 2 Policy Years and $0.33 per $1,000 of Initial Face Amount thereafter

Administrative Expense, Maximum [Dollars] $ 3.75

Administrative Expense, Minimum [Dollars] 0.1

Administrative Charge [Member] | Policies With Application Signed On Or After October Two Policy Years [Member]

Item 2. Key Information [Line Items]

Administrative Expense, Current [Dollars] 3.41

Administrative Expense, Minimum [Dollars] 0.1

Administrative Charge [Member] | Policies With Application Signed On Or After October Years Thereafter [Member]

Item 2. Key Information [Line Items]

Administrative Expense, Current [Dollars] 1.36

Administrative Expense, Minimum [Dollars] $ 0.04

Children's Term Life Insurance Rider [Member]

Item 2. Key Information [Line Items]

Optional Benefit Charge, Description [Text Block] Children’s Term Life Insurance Rider

Optional Benefit Charge, When Deducted [Text Block] On the Effective Date and each Monthly Anniversary Day

Optional Benefit Expense, Maximum [Dollars] $ 0.45

Optional Benefit Expense, Current [Dollars] $ 0.45

Name of Benefit [Text Block] Children’s Term Life Insurance Rider

Purpose of Benefit [Text Block] Provides a death benefit payable on the death of a covered child.

Brief Restrictions / Limitations [Text Block]
•

Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Coverage expires at age 75.

•

Maximum amount of coverage is $25,000 for the Company and affiliates’ policies in force and applied for.

•

The minimum amount of coverage is $1,000.

Name of Benefit [Text Block] Children’s Term Life Insurance Rider

Benefit Standard or Optional [Text Block] Optional

Operation of Benefit [Text Block]
Children’s Term Life Insurance Rider.   Provides a death benefit payable on the death of a covered child. More than one child can be covered. There is no cash value under this rider. The minimum amount of coverage is $1,000 and the maximum is $25,000 for the Company and affiliates’ policies in force and applied for. The Insured under the base Policy must be between the ages of 15 and 64 to elect this rider. Children are eligible to be covered between 15 days and 25 years of age as long as coverage is in place prior to age 18.

Dollar-Cost Averaging [Member]

Item 2. Key Information [Line Items]

Name of Benefit [Text Block] Dollar-Cost Averaging

Purpose of Benefit [Text Block] Allows for the systematic transfer of specified dollar amounts from a Sub- Account or the Fixed Account to one or more other specified Sub- Accounts.

Brief Restrictions / Limitations [Text Block]
•

No transfers may be made into the Fixed Account.

•
Dollar-cost averaging may be elected for periods of at least 6 months and no longer than 48 months.

Name of Benefit [Text Block] Dollar-Cost Averaging

Benefit Standard or Optional [Text Block] Standard

Operation of Benefit [Text Block]
Dollar-Cost Averaging
If you elect at the time of application or at any time thereafter by Written Notice in Good Order to Protective Life at the Home Office, you may systematically and automatically transfer, on a monthly or quarterly basis, specified dollar amounts from a Sub-Account (“Source Sub-Account”) or the Fixed Account to one or more other specified Sub-Accounts, subject to the following restriction: no transfers may be made into the Fixed Account. This is known as the dollar-cost averaging method of investment. By transferring on a regularly scheduled basis as opposed to allocating the total amount at one particular time, you may be less susceptible to the impact of market fluctuations in Sub-Account unit values. Protective Life, however, makes no guarantee that the dollar-cost averaging method will result in a profit or protect against loss.
To elect dollar-cost averaging, Policy Value in the Source Sub-Account or the Fixed Account must be at least $5,000 at the time of election. Automatic transfers for dollar-cost averaging are subject to all transfer restrictions other than the maximum transfer amount from the Fixed Account restriction and limits on frequent transfer activity. You may elect dollar cost averaging for periods of at least 6 months but no longer than 48 months. At least $100 must be transferred each month or $300 each quarter. Dollar-cost averaging transfers may commence on any day of the month that you request except the 29th, 30th, or 31st. If no day is selected, transfers will occur on the Monthly Anniversary Day. We have the right to restrict these transfers until 6 days after the end of the Cancellation Period.
Once elected, Protective Life will continue to process dollar-cost averaging transfers until the earlier of the following: (1) the number of designated transfers has been completed, (2) the Policy Value in the appropriate source Sub-Account or the Fixed Account is depleted, (3) the Owner, by Written Notice received by Protective Life at the Home Office, instructs Protective Life to cease the automatic transfers, (4) a grace period begins under the Policy, or (5) the maximum amount of Policy Value has been transferred under a dollar-cost averaging election.
Automatic transfers made to facilitate dollar-cost averaging will not count toward the 12 transfers permitted each Policy Year if Protective Life elects to limit the number of transfers or impose the transfer fee. Protective Life reserves the right to discontinue offering automatic dollar-cost averaging transfers upon 30 days written notice.

ExtendCare Chronic Illness Accelerated Death Benefit Rider [Member]

Item 2. Key Information [Line Items]

Name of Benefit [Text Block] ExtendCare Chronic Illness Accelerated Death Benefit Rider

Purpose of Benefit [Text Block] Allows Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that Insured has a qualifying chronic illness that is expected to last 90 or more days.

Brief Restrictions / Limitations [Text Block]
•

Can only be added at the time of Policy issue.

•

There is a minimum base Policy Face Amount of $100,000 and a maximum base Policy Face Amount of $5,000,000.

•

Maximum monthly benefit cannot exceed 5% of the base Policy Face Amount.

•

Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.

•

Death Benefit Option A must be in effect in order to receive benefit payments under the rider.

•

Any irrevocable Beneficiaries or assignees of record must give written consent for benefit payments to be made.

•

The rider is subject to a Lifetime Maximum Benefit and a Monthly Maximum Benefit.

•

Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.

Name of Benefit [Text Block] ExtendCare Chronic Illness Accelerated Death Benefit Rider

Benefit Standard or Optional [Text Block] Optional

Operation of Benefit [Text Block]
ExtendCare Chronic Illness Accelerated Death Benefit Rider (not available in all states)
This rider allows the Owner to request a monthly or annual accelerated payment of part of the Policy’s Death Benefit when we receive a written certification from a licensed health care practitioner that the Insured has a qualifying chronic illness that is expected to last 90 or more days (the”Certification”). A qualifying chronic illness is an illness or condition that (1) prevents the Insured from performing at least two activities of daily living, such as eating, bathing, or dressing, without substantial assistance or (2) requires substantial supervision of the Insured to protect them from threats to their health and safety due to severe cognitive impairment. The licensed health care practitioner who provides the Certification can be a physician, registered professional nurse or licensed social worker, but cannot be the Owner or Insured or a family member of either the Owner or Insured. We reserve the right to require that the Insured be examined by a licensed health care practitioner chosen by us.
Under the ExtendCare Chronic Illness Accelerated Death Benefit Rider, Protective Life makes either 12 monthly payments or a single lump sum payment to the Owner for a 12-month period, known as a “Benefit Period.” The initial Benefit Period begins on the first Monthly Anniversary after we approve an Owner’s written request for accelerated payments and all conditions under the rider for benefit payments to be made have been met. Each subsequent Benefit Period begins on the first Monthly Anniversary following (1) the end of the most recent prior Benefit Period, (2) our receipt of the Certification for the new Benefit Period, and (3) when all other conditions under the rider for benefit
payments to be made have been met. In addition to our receipt of the Owner’s written request for accelerated payments and the Certification, for each Benefit Period the conditions noted below must be met for the Owner to receive benefit payments under this rider.
1.
The Insured is alive.

2.
Both the Policy and the rider are inforce.

3.
We received a written consent from any irrevocable Beneficiaries or assignees of record of the Policy to allow benefit payments to be made to the Owner.

4.
90 consecutive days from the date we receive the Certification (the “Elimination Period”) has passed. For Benefit Periods after the initial Benefit Period, this requirement does not apply if less than 30 days have passed from the date of the end of the prior Benefit Period and the date we receive the Certification for the new Benefit Period.

5.
The Insured has a qualifying chronic illness at the time a benefit payment is made.

6.
Death Benefit Option A is in effect. If the Owner did not elect Death Benefit Option A, we will change the Death Benefit Option under the Policy to Death Benefit Option A prior to our payment of the first benefit payment under this rider. We do not allow any further changes to the Death Benefit Option during a Benefit Period.

For each Benefit Period, the Owner can elect to receive a benefit payment each month or a single lump sum payment at the beginning of the Benefit Period. The lump sum payment is equal to the present value of each monthly benefit payment payable during the Benefit Period. The rider is subject to both a Lifetime Maximum Benefit and a Monthly Maximum Benefit. The information necessary to determine these amounts is set forth in the Policy schedule and the rider.
The Owner or Insured is responsible for the cost of the Certification for the initial Benefit Period. We will cover the cost of the Certification for any subsequent Benefit Period. We begin deducting a monthly charge upon issuance of this rider based, in part, on a maximum monthly benefit amount selected by the Owner at the time of Policy issue. During a Benefit Period, all monthly deductions required to maintain the Policy will be waived. If the Insured is certified as chronically ill for three consecutive Benefit Periods, the monthly deductions will be waived for as long as the Policy is in force. It is possible that for tax purposes some or all of the charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider could be treated as a withdrawal from the Policy. See “Tax Considerations.”
We must receive any written request for benefit payments, to change the amount of monthly benefit payments or to receive a single lump sum benefit payment for a Benefit Period in Good Order at our Home Office.
The minimum Policy Face Amount to elect this rider is $100,000 and the maximum is $5,000,000. The maximum monthly benefit cannot exceed 5% of the Policy Face Amount. Typically, this will force a minimum Face Amount higher than $100,000 at monthly amounts greater than $5,000 or the current IRS per diem limit. The Insured under the base Policy must be between the ages of 20 and 80 to elect this rider.
Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the ExtendCare Rider with a benefit amount of $5,000 for a monthly cost of $4.24. In 10 years, while the insured is still alive and the rider and the Policy are still in force, the insured is diagnosed with a chronic illness that prevents them from performing at least two activities of daily living and that is expected to persist for at least 90 days. Once The Company receives written certification from a licensed health care professional and after a 90 day waiting period, the insured will receive either monthly benefits of $5,000 or a lump sum of the present value of the 12 monthly payments as an accelerated payment of part of the Policy’s Death Benefit. The payments will continue for each 12 month Benefit Period where the insured can certify that they are still chronically ill. The insured’s Death Benefit will be reduced dollar for dollar by the amount of payments they receive. So if they are chronically ill for one year and take monthly benefits, they will have received $60,000 in accelerated benefits. If the insured dies after that, the death benefit will be $40,000.

ExtendCare Rider [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Footnotes [Text Block]
The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. Not available in CA.

(10)

The charge for the Protected Insurability Rider varies based on the Insured’s Issue Age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

ExtendCare Rider [Member] | After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Administrative Expenses, Representative Investor [Text Block] On the Effective Date and each Monthly Anniversary Day$0.01 per $1,000 of Net Amount at Risk$0.01 per $1,000 of Net Amount at Risk

ExtendCare Rider [Member] | On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Description [Text Block] ExtendCare Rider ^[12]

Other Transaction Fee, When Deducted [Text Block] On the Effective Date and each Monthly Anniversary Day ^[12]

Other Transaction Fee, Maximum [Dollars] $ 18.96 ^[12]

Other Transaction Fee, Current [Dollars] 16.62 ^[12]

Other Transaction Fee, Minimum [Dollars] $ 0.01 ^[12]

ExtendCare Rider [Member] | On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Description [Text Block] ExtendCare Rider ^[12]

Other Transaction Fee, When Deducted [Text Block] On the Effective Date and each Monthly Anniversary Day ^[12]

Other Transaction Fee, Maximum [Dollars] $ 29.77 ^[12]

Other Transaction Fee, Current [Dollars] 17.9 ^[12]

Other Transaction Fee, Minimum [Dollars] $ 0.01 ^[12]

Administrative Expenses, Representative Investor [Text Block]
On the Effective Date and each Monthly Anniversary Day

$0.01 per $1,000 of Net Amount at Risk

$0.01 per $1,000 of Net Amount at Risk

Income Provider Option Pre-Determined Death Benefit Payout Endorsement [Member]

Item 2. Key Information [Line Items]

Name of Benefit [Text Block] Income Provider Option Pre-Determined Death Benefit Payout Endorsement

Purpose of Benefit [Text Block] Converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule.

Brief Restrictions / Limitations [Text Block]
•

Can only be added at the time of Policy issue.

•

You may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of payments.

•

A Beneficiary cannot change the Death Benefit Payment Schedule or elect a single lump sum after the death of the Insured.

Name of Benefit [Text Block] Income Provider Option Pre-Determined Death Benefit Payout Endorsement

Benefit Standard or Optional [Text Block] Optional

Operation of Benefit [Text Block]
Income Provider Option Pre-Determined Death Benefit Payout Endorsement. (not available in all distribution channels)   The endorsement converts the payment of Death Benefit Proceeds to the Beneficiary from a single lump sum to a series of payments pursuant to a specified payment schedule that describes the amount, frequency, and duration of payment of the Death Benefit Proceeds. If the Death Benefit is adjusted under the Policy while the Insured is living, the amounts shown in the payment schedule will be adjusted pro-rata. The Owner may choose to change the payment schedule or elect a lump sum payment of the Death Benefit Proceeds prior to the Insured’s death, but the Beneficiary will not be able to change the payment schedule after the Insured’s death. The Owner may not make a change to the Death Benefit Payment Schedule that lengthens the overall duration of the payment schedule.
Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and adds the Income Provider Option Pre-Determined Death Benefit Payout Endorsement. When the insured dies, the beneficiary will receive a series of payments specified at the time of Policy issue.

Interest Rate Before October 13 2025 [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee (of Other Amount), Maximum [Percent] 1.00%

Interest Rate [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Current [Percent] 3.00%

Other Transaction Fee (of Other Amount), Maximum [Percent] 3.00%

Lapse Protection Endorsement [Member]

Item 2. Key Information [Line Items]

Name of Benefit [Text Block] Lapse Protection Endorsement

Purpose of Benefit [Text Block] Guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule.

Brief Restrictions / Limitations [Text Block]
•

Minimum monthly premium will vary by Policy benefits, Issue Age, sex and rate class of the Insured.

•

Protection is only effective:

•

20 years for issue ages 0-49,

•

to attained age 70 for issue ages 50-64,

•

5 years for issue ages 65-80

•

If on any Monthly Anniversary Day, the total premiums paid less any Withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount, this provision will terminate.

•

Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount.

Name of Benefit [Text Block] Lapse Protection Endorsement

Benefit Standard or Optional [Text Block] Standard

Operation of Benefit [Text Block]
Lapse Protection Endorsement.   The endorsement guarantees that your Policy will not Lapse during the lapse protection period set forth in your Policy Schedule, if for each month that the Policy has been inforce, the total premiums paid (less any withdrawals or Policy loans) is equal to, or greater than, the Minimum Monthly Guarantee Amount multiplied by the number of completed Policy months, including the current month, since the Policy Effective Date. The Minimum Monthly Guarantee Amount is based upon the Company’s anticipated cost of providing lapse protection on a specific Policy for the stated lapse protection period. This amount varies with Policy benefits, Issue Age, sex and rate class of the Insured. Any change in the benefits provided by this Policy, made subsequent to the Policy Effective Date and during the lapse protection period, may result in a change to the Minimum Monthly Guarantee Amount. The lapse protection provision is effective during the first 20 Policy Years (if the Insured’s Issue Age is 0 through 49), up to attained age 70 (if the Insured’s Issue Age is 50-64), or during the first 5 Policy Years (for Insured’s Issue Age 65 and above). If on any Monthly Anniversary Day, the total premiums paid less any withdrawals and Policy Debt, does not equal or exceed the Accumulated Minimum Monthly Guarantee Amount this provision will terminate.
Example: Assume a 45 year old male preferred non-smoker purchases a Policy with a $100,000 Face Amount. The Lapse Protection Endorsement is included on the Policy. The Policy specifies a Monthly Guarantee Premium of $42.00. The owner makes an initial premium payment of $45.00.
On the 24th monthly anniversary, assume the owner has made 24 subsequent premium payments of the same amount and taken no partial surrenders or Policy Loans. The total of the actual premiums paid for the Policy is $1,080
(the amount of the initial premium payment plus the amount of the subsequent premium payments). Because there have been no partial surrenders and there is no Outstanding Debt, the net premiums paid is equal to $1,080.
The amount of premiums required to meet the endorsement conditions is $1,008 (the Monthly Guarantee Premium amount specified in the Policy multiplied by the number of months since the Policy date).
Because the net premiums paid exceed the amount of premiums required, the conditions have been met on this monthly anniversary day and the rider remains in effect. If the Cash Value of the Policy is reduced to zero at this time and the insured dies, the death benefit will still be the Face Amount of $100,000.
Assume instead that on the 24th monthly anniversary, the owner missed the last two premium payments. The net premiums paid is then equal to $990. Because the net premiums paid is now less than the amount of premiums required, the owner must pay additional premiums of at least $18.00 within the 60 day grace period to keep the Policy in effect. If the endorsement terminates and the insured dies while the Cash Value of the Policy is zero, the death benefit will be $0.

Net Cost of Loans for Carryover Loans After the First 10 Policy Years [Member] | On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 0.25% ^[8]

Net Cost of Loans for Carryover Loans After the First 10 Policy Years [Member] | On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 2.25% ^[8]

Net Cost of Loans for Carryover Loans During the First 10 Policy Loans [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Current [Percent] 4.00%

Other Transaction Fee (of Other Amount), Maximum [Percent] 5.00%

Net Cost of Loans for Carryover Loans During the First 10 Policy Loans [Member] | On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 2.00% ^[8]

Optional Benefit Expense (of Benefit Base), Current [Percent] 1.00% ^[8]

Net Cost of Loans for Carryover Loans During the First 10 Policy Loans [Member] | On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 4.00% ^[8]

Optional Benefit Expense (of Benefit Base), Current [Percent] 1.00% ^[8]

Net Cost Of Loans For Standard Loans After The First10 Policy Years [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Current [Percent] 3.00%

Other Transaction Fee (of Other Amount), Maximum [Percent] 3.25%

Net Cost Of Loans For Standard Loans After The First10 Policy Years [Member] | On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 0.25% ^[8]

Optional Benefit Expense (of Benefit Base), Current [Percent] 0.00% ^[8]

Net Cost Of Loans For Standard Loans After The First10 Policy Years [Member] | On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 2.25% ^[8]

Optional Benefit Expense (of Benefit Base), Current [Percent] 0.00% ^[8]

Net Cost Of Loans For Standard Loans During The First10 Policy Years [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee (of Other Amount), Maximum [Percent] 5.00%

Net Cost Of Loans For Standard Loans During The First10 Policy Years [Member] | On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 2.00% ^[8]

Optional Benefit Expense (of Benefit Base), Current [Percent] 2.00% ^[8]

Net Cost Of Loans For Standard Loans During The First10 Policy Years [Member] | On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Optional Benefit Expense (of Benefit Base), Maximum [Percent] 4.00% ^[8]

Optional Benefit Expense (of Benefit Base), Current [Percent] 2.00% ^[8]

Option 1 Death Benefit [Member]

Item 2. Key Information [Line Items]

Standard Death Benefit [Text Block]
Option 1 — Payment for a Fixed Period.   Equal monthly payments will be made for any period of up to 30 years. The amount of each payment depends on the total amount applied, the period selected and the monthly payment rates Protective Life is using when the first payment is due.

Option 2 Death Benefit [Member]

Item 2. Key Information [Line Items]

Standard Death Benefit [Text Block]
Option 2 — Life Income with Payments for a Guaranteed Period.   Equal monthly payments are based on the life of the named annuitant. Payments will continue for the lifetime of the annuitant with payments guaranteed for 10 or 20 years. Payments stop at the end of the selected guaranteed period or when the named person dies, whichever is later.

Option 3 Death Benefit [Member]

Item 2. Key Information [Line Items]

Standard Death Benefit [Text Block]
Option 3 — Interest Income.   Protective Life will hold any amount applied under this option. Interest on the unpaid balance will be paid each month at a rate determined by Protective Life. This rate will not be less than the equivalent of 1% per year.

Option 4 Death Benefit [Member]

Item 2. Key Information [Line Items]

Standard Death Benefit [Text Block]
Option 4 — Payments for a Fixed Amount.   Equal monthly payments will be made of an agreed fixed amount. The amount of each payment may not be less than $10 for each $1,000 applied. Interest will be credited each month on the unpaid balance and added to it. This interest will be at a rate set by us, but not less than an effective rate of 1% per year. Payments continue until the amount Protective Life holds runs out. The last payment will be for the balance only.

Overloan Protection Endorsement [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Description [Text Block] Overloan Protection Endorsement

Other Transaction Fee, When Deducted [Text Block] When the Benefit is Exercised

Other Transaction Fee, Current [Percent] 5.00%

Other Transaction Fee (of Other Amount), Maximum [Percent] 5.00%

Name of Benefit [Text Block] Overloan Protection Endorsement

Purpose of Benefit [Text Block] Policy will not Lapse due to an outstanding Policy loan in certain circumstances.

Brief Restrictions / Limitations [Text Block]
Policy must be in force at least 20 Policy Years.

•

Insured’s Attained Age must be at least 65.

•

Withdrawals in an amount equal to the total premiums paid must have been taken.

•

Policy Debt must exceed the Face Amount and be at least 95% of the Cash Value.

•

Not available if accelerated benefits have been received or if Monthly Deductions are being waived or premiums credited under any endorsement or rider attached to the Policy.

•

Not available if the resulting Death Benefit is not compliant with our reasonable interpretation of the Code.

•

Not available if the Policy is a modified endowment contract (“MEC”).

Name of Benefit [Text Block] Overloan Protection Endorsement

Benefit Standard or Optional [Text Block] Standard

Operation of Benefit [Text Block]
Overloan Protection Endorsement.   Under the provisions of this endorsement, your Policy will not Lapse due to an outstanding Policy loan and the Death Benefit will be at least $10,000 as long as all of the terms and conditions of the endorsement are met:
1.
The Policy has been in force at least 20 Policy Years;

2.
The Insured’s Attained Age is at least 65;

3.
Withdrawals in an amount equal to the total premiums paid have been taken;

4.
The Policy Debt is at least 95% of the Cash Value;

5.
The Policy Debt exceeds the Face Amount;

6.
Accelerated benefits have not been received under any endorsement or rider attached to your Policy;

7.
Monthly Deductions or premiums are not being credited or waived under any endorsement or rider attached to your Policy;

8.
Invoking this benefit does not result in a death benefit that is not compliant with our reasonable interpretation of the Code; and

9.
The Policy is not a modified endowment contract.

When the Policyholder chooses to exercise the benefit under the Overloan Protection Endorsement, we deduct a charge equal to the lesser of the Policy Value minus Policy Debt or 5% of the Policy Value.
Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount. The Overloan Protection Endorsement is automatically added. At age 70, the insured has been taking loans from his policy so that the Policy Debt is more than 99% of the policy value and the Debt exceeds the Face Amount of the Policy. The insured has taken the maximum amount of withdrawals, the amount equal to their total premiums paid. At this point, any riders on the Policy will be terminated and any Variable Account Value will be transferred to the Fixed Account. In addition, no policy transactions or withdrawals will be allowed. The policy will remain in force and if they die while the endorsement is still in force, the Death Benefit will be the policy value minus the policy debt, with a minimum value of $10,000.

Policy Illustration Fee [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Description [Text Block] Policy Illustration Fee ^[13]

Other Transaction Fee, When Deducted [Text Block] Upon each illustration request in excess of 1 in a Policy Year ^[13]

Other Transaction Fee, Maximum [Dollars] $ 50 ^[13]

Other Transaction Fee, Current [Dollars] $ 0 ^[13]

Other Transaction Fee, Footnotes [Text Block]
Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.

Policy Loans [Member]

Item 2. Key Information [Line Items]

Name of Benefit [Text Block] Policy Loans

Purpose of Benefit [Text Block] Allows Owner to borrow from the Policy’s Cash Value.

Brief Restrictions / Limitations [Text Block]
•

Other than Carryover loans, not available during the first Policy Year.

•

Maximum loan amount is 99% of Cash Value.

•

Minimum loan amount is $500.

•

Certain policy loans may be taxable. You should consult a tax adviser as to the tax consequences of taking a policy loan.

Name of Benefit [Text Block] Policy Loans

Benefit Standard or Optional [Text Block] Standard

Portfolio Rebalancing [Member]

Item 2. Key Information [Line Items]

Name of Benefit [Text Block] Portfolio Rebalancing

Purpose of Benefit [Text Block] Allows for the automatic transfer, on a regular basis, of Variable Account Value among specified Sub-Accounts to maintain a specified percentage allocation of Variable Account Value.

Brief Restrictions / Limitations [Text Block]
•

Rebalancing transfers cannot be made into Fixed Account.

•

Minimum Variable Account Value of $100 required.

Name of Benefit [Text Block] Portfolio Rebalancing

Benefit Standard or Optional [Text Block] Standard

Operation of Benefit [Text Block]
Portfolio Rebalancing
At the time of application or at any time thereafter by Written Notice in Good Order to Protective Life, you may instruct Protective Life to automatically transfer, on a quarterly, semi-annual or annual basis, your Variable Account Value among specified Sub-Accounts to achieve a particular percentage allocation of Variable Account Value among such Sub-Accounts (“Portfolio Rebalancing”). Such percentage allocations must be in whole numbers and must allocate amounts only among the Sub-Accounts. No amounts will be transferred to the Fixed Account as part of Portfolio Rebalancing. A minimum Variable Account Value of $100 is required for Portfolio Rebalancing. Unless you instruct otherwise when electing rebalancing, the percentage allocation of your Variable Account Value for Portfolio Rebalancing will be based on your premium allocation instructions in effect at the time of rebalancing. Any allocation instructions, including Portfolio Rebalancing allocation instructions, that you give us that differ from your then current Net Premium allocation instructions will be deemed to be a request to change your Net Premium allocation. Portfolio Rebalancing may commence on any day of the month that you request except the 29th, 30th or 31st. If no day is selected, rebalancing will occur on each applicable Monthly Anniversary Day. We have the right to restrict Portfolio Rebalancing until six days after the end of the Cancellation Period.
Once elected, Portfolio Rebalancing begins on the first quarterly, semi-annual or annual anniversary following election. You may change or terminate Portfolio Rebalancing by Written Notice in Good Order received by Protective Life at the Home Office, or by telephone if you have previously authorized us to take telephone instructions. If Protective Life elects to limit the number of transfers or impose the transfer fee Portfolio Rebalancing transfers will not count as one of the 12 free transfers available during any Policy Year. Protective Life reserves the right to discontinue Portfolio Rebalancing upon 30 days written notice.
Note: You may elect Portfolio Rebalancing while at the same time you transfer from a Source Sub-Account specified dollar amounts to other specified Sub-Accounts under the Dollar-Cost Averaging program. If you select as your Source Sub-Account a Sub-Account rather than the Fixed Account, however, the Portfolio Rebalancing program may reallocate amounts transferred from the Source Sub-Account back to that Source Sub-Account based on your Portfolio Rebalancing allocation instructions, and thereby undermine to some degree your selection of the Source Sub-Account as a Sub-Account from which transfers under the Dollar-Cost Averaging program would be made. Conversely, transfers under the Dollar-Cost Averaging program may cause your allocation of Variable Account Value among the Sub-Accounts to differ from the percentage allocations you specify in your Portfolio Rebalancing allocation instructions. Accordingly, we recommend that you consult with your financial professional before electing Portfolio Rebalancing while at the same time engaging in Dollar-Cost Averaging.

Protected Insurability Benefit Rider [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Description [Text Block] Protected Insurability Benefit Rider ^[14]

Other Transaction Fee, When Deducted [Text Block] On the Effective Date and each Monthly Anniversary Day ^[14]

Other Transaction Fee, Maximum [Dollars] $ 0.13 ^[14]

Other Transaction Fee, Current [Dollars] 0.13 ^[14]

Other Transaction Fee, Minimum [Dollars] $ 0.03 ^[14]

Other Transaction Fee, Footnotes [Text Block] The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

Administrative Expenses, Representative Investor [Text Block] On the Effective Date and each Monthly Anniversary Day $0.03 per $1,000 of rider coverage amount $0.03 per $1,000 of rider coverage amount

Name of Benefit [Text Block] Protected Insurability Benefit Rider

Purpose of Benefit [Text Block] Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability.

Brief Restrictions / Limitations [Text Block]
•

Can only be added at the time of Policy issue.

•

The maximum amount of coverage is $50,000 per option date, for the Company and affiliates’ policies in force and applied for.

•

The minimum amount of coverage is $10,000.

•

Insured under the base policy must be between the ages of 0 and 37. Coverage expires at age 40.

Name of Benefit [Text Block] Protected Insurability Benefit Rider

Benefit Standard or Optional [Text Block] Optional

Operation of Benefit [Text Block]
Protected Insurability Benefit Rider.   Provides the right to increase the Face Amount of your Policy at designated option dates at Insured’s age 25, 28, 31, 34, 37 and 40 without evidence of insurability. The minimum amount of coverage is $10,000 and the maximum is $50,000. Fees associated with this rider stop at Insured’s age 40.
Example: Assume a 25 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Protected Insurability Benefit Rider. While the rider is in force at age 31, the Insured purchases an additional $50,000 in coverage with no required underwriting or proof of insurability, but with a change to the monthly deduction specified premium. If the Insured dies after the purchase while the Policy is still in force, the death benefit would be $150,000.

Reservation of Rights [Member]

Item 2. Key Information [Line Items]

Operation of Benefit [Text Block]
Reservation of Rights
Protective Life reserves the right without prior notice to modify, restrict, suspend or eliminate the transfer privileges (including telephone transfers) at any time, for any class of Policies, for any reason. In particular, we reserve the right not to honor transfer requests by a third party holding a power of attorney from an Owner where that third party requests simultaneous transfers on behalf of the Owners of two or more Policies. In the event Protective Life chooses to exercise these rights, we will notify the affected Owners in writing or through a supplement to this Prospectus.

Standard [Member] | On or After October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Administrative Expenses, Description [Text Block] Standard Administrative Fee

Administrative Expenses, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day

Administrative Expense, Maximum [Dollars] $ 9

Administrative Expense, Current [Dollars] $ 9

Standard [Member] | On or Before October 13, 2025 [Member]

Item 2. Key Information [Line Items]

Administrative Expenses, Description [Text Block] Standard Administrative Fee

Administrative Expenses, When Deducted [Text Block] On the Policy Effective Date and each Monthly Anniversary Day

Administrative Expense, Maximum [Dollars] $ 8

Administrative Expense, Current [Dollars] $ 8

Telephone Transfers [Member]

Item 2. Key Information [Line Items]

Operation of Benefit [Text Block]
Telephone Transfers
Transfers may be made upon instructions given by telephone, provided the appropriate election has been made on the application or written authorization is provided.
Protective Life will confirm all transfer instructions communicated by telephone. For telephone transfers we require a form of personal identification prior to acting on instructions received by telephone. We also make a tape-recording of the instructions given by telephone. If we follow these procedures we are not liable for any losses due to unauthorized or fraudulent instructions. Protective Life reserves the right to suspend telephone transfer privileges at any time for any class of Policies.
A number of telephonic or electronic services may be available or become available in the future. Telephone and online transfers, and transfers via facsimile, may not always be available. Telephone and computer systems, whether yours, your service provider’s, your agent’s, or ours, can experience outages or slowdowns for a variety of reasons. These outages or slowdowns may prevent or delay our receipt of your request. If you are experiencing problems, you should make your transfer request in writing to the Home Office.

Terminal Illness Accelerated Death Benefit Endorsement [Member]

Item 2. Key Information [Line Items]

Name of Benefit [Text Block] Terminal Illness Accelerated Death Benefit Endorsement

Purpose of Benefit [Text Block] Provides for an accelerated death benefit payment (with certain exclusions), to the Owner if the Insured has a qualifying terminal illness.

Brief Restrictions / Limitations [Text Block]
•

Maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:

•

The lesser of 60% of the current face amount of the Policy or $1,000,000; minus

•

Any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

•

Minimum acceleration permitted is $15,000.

•

The Death Benefit will be reduced by the amount of any acceleration taken, plus accumulated interest.

•

Any acceleration taken will reduce the amount available for Policy Loans and withdrawals.

•

Ongoing Advisory Fee payments will reduce the Policy Value and may reduce the Death Benefit.

Name of Benefit [Text Block] Terminal Illness Accelerated Death Benefit Endorsement

Benefit Standard or Optional [Text Block] Standard

Operation of Benefit [Text Block]
Terminal Illness Accelerated Death Benefit Endorsement.   The endorsement provides for an accelerated death benefit payment to the Owner if the Insured has a qualifying terminal illness and all of the terms and conditions of the endorsement are met. The accelerated death benefit is based on a portion of the current Face Amount and is subject to a maximum accelerated death benefit. The minimum acceleration permitted is $15,000. There is no cost or charge for the endorsement. However, a lien equal to the accelerated death benefit payment is established against the Policy and accumulates interest.
The primary impact of the lien and any accumulated interest is a reduction in the amount of the Death Benefit by the amount of the lien plus accumulated interest. The insured’s Death Benefit is reduced dollar-for-dollar by the amount of payments received and accumulated interest under the accelerated death benefit.The lien also reduces the amount available for loans and withdrawals. Consult your sales representative and review the endorsement for limitations, terms and conditions.
The maximum aggregate amount of payments that will be paid under this rider for all policies issued by the Company or an affiliate company on the life of the same insured person is equal to:
•
the lesser of 60% of the current face amount of the Policy or $1,000,000; minus

•
any outstanding lien amount against the Policy resulting from any other accelerated death benefit rider or endorsement attached to the Policy.

Example: Assume a 45 year old male non-smoker purchases a policy with a $200,000 Face Amount. The Terminal Illness Death Benefit Endorsement is automatically added. If at age 75 the insured is diagnosed with a terminal illness (by the definition in the rider) and the rider is in force, then the insured can access up to $120,000 of the death benefit.

Waiver of Specified Premium Rider [Member]

Item 2. Key Information [Line Items]

Other Transaction Fee, Description [Text Block] Waiver of Specified Premium Rider ^[15]

Other Transaction Fee, When Deducted [Text Block] On the Effective Date and each Monthly Anniversary Day ^[15]

Other Transaction Fee, Maximum [Dollars] $ 19.19 ^[15]

Other Transaction Fee, Minimum [Dollars] $ 1.86 ^[15]

Other Transaction Fee, Footnotes [Text Block]
The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

ExtendCare Rider (for Policies with an application signed on or after October 13, 2025) (9)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.01 – $18.96 per $1,000 of Net Amount at Risk $0.01 – $16.62 per $1,000 of Net Amount at Risk

Charge for a 57 year old female in the nontobacco rate class with a Face Amount of $250,000 and monthly benefit of $10,800
On the Effective Date and each Monthly Anniversary Day $0.01 per $1,000 of Net Amount at Risk $0.01 per $1,000 of Net Amount at Risk

ExtendCare Rider (for Policies with an application signed before October 13, 2025) (9)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.01 – $29.77 per $1,000 of Net Amount at Risk $0.01 – $17.90 per $1,000 of Net Amount at Risk

Charge for a 57 year old female in the nontobacco rate class in the First Policy Year with a Face Amount of $250,000 and monthly benefit of $10,800

On the Effective Date and each Monthly Anniversary Day

$0.01 per $1,000 of Net Amount at Risk

$0.01 per $1,000 of Net Amount at Risk

Protected Insurability Benefit Rider (10)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.03 – $0.13 per $1,000 of rider coverage amount $0.03 – $0.13 per $1,000 of rider coverage amount

Charge for a child less than 6 months old
On the Effective Date and each Monthly Anniversary Day $0.03 per $1,000 of rider coverage amount $0.03 per $1,000 of rider coverage amount

?
(9)

The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

Administrative Expenses, Representative Investor [Text Block] On the Effective Date and each Monthly Anniversary Day $4.42 per $100 of rider coverage amount $4.42 per $100 of rider coverage amount

Name of Benefit [Text Block] Waiver of Specified Premium Rider

Purpose of Benefit [Text Block] Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured.

Brief Restrictions / Limitations [Text Block]
•

Insured under the base Policy must be between the ages of 15 and 55 at the time the rider is issued. Coverage expires at age 65.

•

Insured must be disabled for at least six consecutive months, and the disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday.

Name of Benefit [Text Block] Waiver of Specified Premium Rider

Benefit Standard or Optional [Text Block] Optional

Operation of Benefit [Text Block]
Waiver of Specified Premium Rider.   Provides for the crediting of a specified premium to a Policy on each Monthly Anniversary during the total disability of the Insured. After the Insured has been totally disabled (as defined in the rider) for six consecutive months, Protective Life will credit premiums to the Policy equal to the specified premium amount shown in the Policy multiplied by the number of Monthly Anniversary Days that have occurred since the onset of total disability. The disability must have begun prior to the Policy Anniversary nearest the Insured’s 65th birthday. Monthly Anniversary Days that occur more than one calendar year prior to the date that we receive a claim under a rider are not included for the purpose of this calculation. Subsequent to the time that the Insured has been totally disabled for six months, we will credit a premium equal to the specified premium amount on each Monthly Anniversary Day. The Owner may change the specified premium amount by Written Notice in Good Order received by Protective Life at the Home Office after the first Policy Anniversary and before the Insured becomes totally disabled. Increases are subject to evidence of insurability. The Insured under the base Policy must be between the ages of 15 and 55 to elect this rider.
Example: Assume a 45 year old male non-smoker purchases a Policy with a $100,000 Face Amount and purchases the Waiver of Specified Premiums Rider. At age 55, the insured has a covered total disability while the rider is in force. The Company receives proof of disability and waives the Policy monthly specified premiums for 6 months. During this time, the Policy deductions continue to be in effect.

Withdrawal Charge [Member]

Item 2. Key Information [Line Items]

Other Surrender Fees, Current [Dollars] $ 25

Other Transaction Fee, Description [Text Block] Withdrawal Charge:

Other Transaction Fee, When Deducted [Text Block] At the time of each withdrawal of Policy Value

Other Transaction Fee, Maximum [Dollars] $ 25

Other Transaction Fee, Current [Dollars] $ 25

Other Transaction Fee (of Other Amount), Maximum [Percent] 2.00%

[1]
As a percentage of Fund assets.

[2]
Protective Life currently does not assess the transfer fee, but reserves the right to do so in the future for each transfer after the first 12 transfers in any Policy Year. We will give written notice at least thirty (30) days before we impose a transfer fee. See “CHARGES AND DEDUCTIONS, Transfer Fee” in the Prospectus.

[3]
The range of Annual Fund Expenses shown here does not take into account contractual and voluntary arrangements under which the Funds’ advisers currently reimburse Fund expenses or waive fees. Please see the prospectus for each Fund for more information about that Fund’s expenses.

[4]
These Funds and their investment advisers have entered into contractual fee waivers or expense reimbursement arrangements. These temporary fee reductions are reflected in their annual expenses. Those contractual arrangements are designed to reduce total annual Fund operating expenses for Policy Owners and will continue past the current year.

[5]
The Sub-Account investing in this Fund is closed to Policies with applications signed on and after May 1, 2025.

[6]
See definition of Net Amount at Risk in the Special Terms.

[7]
Cost of insurance charges vary based on individual characteristics such as the Insured’s Issue Age, sex and rate (i.e., underwriting) class and the number of years that the Policy has been in force, Face Amount (for Policies with an application signed on or after February 1, 2024), and the Net Amount at Risk on either the Policy Effective Date or the applicable Monthly Anniversary Date. The charge generally increases with Issue Age. In determining current cost of insurance charges, we may consider a variety of factors, including those unrelated to mortality experience. The cost of insurance charges shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the guaranteed cost of insurance charges applicable to your Policy, and more detailed information concerning your cost of insurance charges is available on request from our Home Office. Also, before you purchase the Policy, you may request personalized illustrations of hypothetical future benefits under the Policy based upon the Issue Age, sex and rate classification of the Insured, and the Face Amount, planned premiums, and riders requested. The cost of insurance charge shown in the above table has been rounded to the nearest hundredth. See “Charges and Deductions-Monthly Deduction”.

[8]
The Net Cost of Loans is the difference between the rate of interest we charge you for a loan and the rate of interest we credit based upon the amount in your Loan Account. We charge interest daily on any outstanding loan at the following effective annual rates: (a) 5.00% for standard loans in Policy Years 1-10; (b) 4.00% current (5.00% guaranteed) for carry-over loans in Policy Years 1-10; and (c) 3.00% current (3.25% guaranteed) for all loans in Policy Years 11 and greater. We credit interest annually to the Loan Account on any outstanding loan at an effective annual interest rate of not less than 3.00% currently (3.00% guaranteed, 1.00% guaranteed for Policies with applications signed before October 13, 2025).

[9]
As long as a loan is outstanding, loan interest must be paid in arrears on each Policy Anniversary or, if earlier, on the date of loan repayment, Lapse, surrender, termination, or the Insured’s death.

[10]
The charge for the Accidental Death Benefit Rider varies based on the Insured’s attained age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

?
(8)

The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

[11]
The administrative charge for Face Amount increases varies based on the Insured’s Issue Age, sex, and rate class. The administrative charge shown in the table may not be typical of the charges you will pay. Your Policy’s specification page will indicate the charges applicable to your Policy, and more detailed information concerning these charges is available on request from our Home Office.

[12]
The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office. Not available in CA.

(10)

The charge for the Protected Insurability Rider varies based on the Insured’s Issue Age. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

[13]
Protective Life currently does not assess the Policy illustration fee, but reserves the right to do so in the future for each illustration requested after the first illustration in any Policy Year.

[14] The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

[15]
The charge for the Waiver of Specified Premium Rider varies based on the Issue Age, underwriting class and sex of the Insured. The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

Periodic Charges Other Than Fund Operating Expenses

Charge

When Charge is Deducted

Amount Deducted —
Maximum Guaranteed Charge

Amount Deducted —
Current Charge

ExtendCare Rider (for Policies with an application signed on or after October 13, 2025) (9)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.01 – $18.96 per $1,000 of Net Amount at Risk $0.01 – $16.62 per $1,000 of Net Amount at Risk

Charge for a 57 year old female in the nontobacco rate class with a Face Amount of $250,000 and monthly benefit of $10,800
On the Effective Date and each Monthly Anniversary Day $0.01 per $1,000 of Net Amount at Risk $0.01 per $1,000 of Net Amount at Risk

ExtendCare Rider (for Policies with an application signed before October 13, 2025) (9)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.01 – $29.77 per $1,000 of Net Amount at Risk $0.01 – $17.90 per $1,000 of Net Amount at Risk

Charge for a 57 year old female in the nontobacco rate class in the First Policy Year with a Face Amount of $250,000 and monthly benefit of $10,800

On the Effective Date and each Monthly Anniversary Day

$0.01 per $1,000 of Net Amount at Risk

$0.01 per $1,000 of Net Amount at Risk

Protected Insurability Benefit Rider (10)

Minimum and Maximum Charge
On the Effective Date and each Monthly Anniversary Day $0.03 – $0.13 per $1,000 of rider coverage amount $0.03 – $0.13 per $1,000 of rider coverage amount

Charge for a child less than 6 months old
On the Effective Date and each Monthly Anniversary Day $0.03 per $1,000 of rider coverage amount $0.03 per $1,000 of rider coverage amount

?
(9)

The charge for the ExtendCare Chronic Illness Accelerated Death Benefit Rider varies based on the Issue Age, underwriting class and sex of the Insured, the number of years that the Policy has been in force, and the Policy’s Face Amount and monthly benefit (maximum monthly benefit chosen at the issuance of the Policy). The rider charge shown in the table may not be typical of the charges you will pay. Your Policy’s specifications page will indicate the rider charge applicable to your Policy, and more detailed information concerning this charge is available on request from our Home Office.

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product).
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Regulation S-T
-Number 232
-Section 313
+ Details

Name: dei_EntityInvCompanyType

Namespace Prefix: dei_

Data Type: dei:invCompanyType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 10
-Subsection b
+ Details

Name: vip_AdditionalInformationStandardDeathBenefitsNoteN6TextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseCurrentDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseDescriptionTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseFootnotesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseMaximumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseMinimumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseOfAverageAccountValueCurrentPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseRepresentativeInvestorTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph e
+ Details

Name: vip_AdministrativeExpenseWhenDeductedTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 4
+ Details

Name: vip_AnnualPortfolioCompanyExpensesTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
+ Details

Name: vip_AverageAnnualTotalReturns10YearsPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
+ Details

Name: vip_AverageAnnualTotalReturns1YearPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
+ Details

Name: vip_AverageAnnualTotalReturns5YearsPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 11
-Subsection Instructions
-Paragraph 4
+ Details

Name: vip_BenefitStandardOrOptionalTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 11
-Subsection Instructions
-Paragraph 5
+ Details

Name: vip_BriefRestrictionsLimitationsTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 2
-Subparagraph a
+ Details

Name: vip_ChargesForEarlyWithdrawalsTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
-Subsection Instructions
-Paragraph 4
+ Details

Name: vip_CurrentExpensesPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph d
+ Details

Name: vip_ExpenseRiskFeesRepresentativeInvestorTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
+ Details

Name: vip_FeeTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph b
+ Details

Name: vip_InsuranceCostCurrentDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph b
+ Details

Name: vip_InsuranceCostDescriptionTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph b
+ Details

Name: vip_InsuranceCostFootnotesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph b
+ Details

Name: vip_InsuranceCostMaximumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph b
+ Details

Name: vip_InsuranceCostMinimumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph b
+ Details

Name: vip_InsuranceCostWhenDeductedTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 2
-Subparagraph c
-Sentence ii
+ Details

Name: vip_InvestmentOptionsFootnotesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 2
-Subparagraph c
-Sentence ii
+ Details

Name: vip_InvestmentOptionsOfAverageAnnualNetAssetsMaximumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 2
-Subparagraph c
-Sentence ii
+ Details

Name: vip_InvestmentOptionsOfAverageAnnualNetAssetsMinimumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
+ Details

Name: vip_Item2KeyInformationLineItems

Namespace Prefix: vip_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 6
-Subparagraph b
+ Details

Name: vip_KeyExchangesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 2
+ Details

Name: vip_KeyFeesExpensesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 6
-Subparagraph a
+ Details

Name: vip_KeyInvestmentProfessionalCompensationTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 4
-Subparagraph a
+ Details

Name: vip_KeyInvestmentRestrictionsTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 4
-Subparagraph b
+ Details

Name: vip_KeyOptionalBenefitRestrictionsTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 5
+ Details

Name: vip_KeyTaxImplicationsTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph d
+ Details

Name: vip_MortalityAndExpenseRiskFeesDescriptionTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph d
+ Details

Name: vip_MortalityAndExpenseRiskFeesOfFaceAmountCurrentPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph d
+ Details

Name: vip_MortalityAndExpenseRiskFeesOfFaceAmountMaximumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph d
+ Details

Name: vip_MortalityAndExpenseRiskFeesWhenDeductedTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 11
-Subsection Instructions
-Paragraph 2
+ Details

Name: vip_NameOfBenefitTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OngoingFeesAndExpensesTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 11
-Paragraph b
-Subparagraph 2
+ Details

Name: vip_OperationOfBenefitTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph f
+ Details

Name: vip_OptionalBenefitChargeDescriptionTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph f
+ Details

Name: vip_OptionalBenefitChargeWhenDeductedTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph f
+ Details

Name: vip_OptionalBenefitExpenseCurrentDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph f
+ Details

Name: vip_OptionalBenefitExpenseFootnotesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph f
+ Details

Name: vip_OptionalBenefitExpenseMaximumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph f
+ Details

Name: vip_OptionalBenefitExpenseOfBenefitBaseCurrentPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
-Subparagraph f
+ Details

Name: vip_OptionalBenefitExpenseOfBenefitBaseMaximumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 11
+ Details

Name: vip_OtherBenefitsAvailableN6TextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 1
-Subparagraph e
+ Details

Name: vip_OtherSurrenderFeesCurrentDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeCurrentDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeDescriptionTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeFootnotesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeMaximumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeMinimumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeOfOtherAmountCurrentPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeOfOtherAmountMaximumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph c
+ Details

Name: vip_OtherTransactionFeeWhenDeductedTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 3
+ Details

Name: vip_PeriodicChargesTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
+ Details

Name: vip_PortfolioCompaniesN6TextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
+ Details

Name: vip_PortfolioCompaniesTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
-Subsection Instructions
-Paragraph 3
+ Details

Name: vip_PortfolioCompanyAdviserTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 4
-Subparagraph a
+ Details

Name: vip_PortfolioCompanyExpensesBeforeWaiversAndReimbursementMaximumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 4
-Subparagraph a
+ Details

Name: vip_PortfolioCompanyExpensesBeforeWaiversAndReimbursementMinimumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 4
-Subparagraph b
+ Details

Name: vip_PortfolioCompanyExpensesFootnotesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 4
-Subparagraph a
+ Details

Name: vip_PortfolioCompanyExpensesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
-Subsection Instructions
-Paragraph 3
+ Details

Name: vip_PortfolioCompanyNameTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
-Subsection Instructions
-Paragraph 3
+ Details

Name: vip_PortfolioCompanySubadviserTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 1
-Subparagraph b
+ Details

Name: vip_PremiumTaxesDescriptionTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
+ Details

Name: vip_PremiumTaxesOfPremiumPaymentsCurrentPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
+ Details

Name: vip_PremiumTaxesOfPremiumPaymentsMaximumPercent

Namespace Prefix: vip_

Data Type: dtr-types:percentItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 1
-Subparagraph e
+ Details

Name: vip_PremiumTaxesWhenDeductedTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 5
+ Details

Name: vip_PrincipalRiskTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 5
+ Details

Name: vip_PrincipalRisksTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
No definition available.
+ Details

Name: vip_ProspectusTable

Namespace Prefix: vip_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
-Subsection Instructions
-Paragraph 1
-Subparagraph b
+ Details

Name: vip_ProspectusesAvailableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 11
-Subsection Instructions
-Paragraph 1
+ Details

Name: vip_PurposeOfBenefitTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 3
+ Details

Name: vip_RiskTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 3
+ Details

Name: vip_RisksTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 10
+ Details

Name: vip_StandardDeathBenefitTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 10
-Subsection a
+ Details

Name: vip_StandardDeathBenefitsN6TableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 18
-Subsection Instructions
-Paragraph 4
+ Details

Name: vip_TemporaryFeeReductionsCurrentExpensesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 2
-Subsection Instructions
-Paragraph 2
-Subparagraph b
+ Details

Name: vip_TransactionChargesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
+ Details

Name: vip_TransactionExpensesTableTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph b
+ Details

Name: vip_TransferFeeCurrentDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph b
+ Details

Name: vip_TransferFeeFootnotesTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 2
-Subparagraph b
+ Details

Name: vip_TransferFeeMaximumDollars

Namespace Prefix: vip_

Data Type: dtr-types:nonNegativeMonetaryItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
+ Details

Name: vip_TransferFeesDescriptionTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Form N-6
-Section 4
-Subsection Instructions
-Paragraph 1
-Subparagraph e
+ Details

Name: vip_TransferFeesWhenDeductedTextBlock

Namespace Prefix: vip_

Data Type: dtr-types:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: vip_RiskAxis=ck0000948923_AdvisoryFeeRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=ck0000948923_BusinessDisruptionAndCyberSecurityRisksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=ck0000948923_FundRisksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=ck0000948923_LoanRisksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=ck0000948923_SpecializedUsesOfThePolicyMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=ck0000948923_TaxRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=ck0000948923_WithdrawalAndSurrenderRisksMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=vip_RiskOfLossMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=vip_NotShortTermInvestmentRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=vip_InvestmentOptionsRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=vip_InsuranceCompanyRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_RiskAxis=vip_ContractLapseRiskMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_AmericanFundsInsuranceSeriesNewWorldFundClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_BlackRockGlobalAllocationVIFundClassIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_ClearBridgeVariableMidCapPortfolioClassIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_ClearBridgeVariableSmallCapGrowthPortfolioClassIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_DimensionalVAGlobalModerateAllocationPortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_DimensionalVAInternationalSmallPortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_DimensionalVAInternationalValuePortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_DimensionalVAShortTermFixedPortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_DimensionalVAUSLargeValuePortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_DimensionalVAUSTargetedValuePortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_FidelityVIPBalancedPortfolioInitialClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_FidelityVIPInvestmentGradeBondPortfolioInitialClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_FidelityVIPMidCapPortfolioInitialClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_GoldmanSachsVITMidCapValueFundInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_InvescoVIGlobalFundSeriesIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_InvescoVISP500BufferDecemberFundSeriesIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_InvescoVISP500BufferJuneFundSeriesIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_InvescoVISP500BufferMarchFundSeriesIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_InvescoVISP500BufferSeptemberFundSeriesIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_InvescoVIUSGovernmentMoneyPortfolioSeriesIMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_JanusHendersonGlobalTechnologyAndInnovationPortfolioInstitutionalSharesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_LordAbbettSeriesFundBondDebenturePortfolioClassVCMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_PIMCOVITRealReturnPortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_PIMCOVITTotalReturnPortfolioInstitutionalClassMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_PutnamVTSustainableLeadersFundClassIAMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_SchwabSP500IndexPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_TOPSAggressiveETFPortfolioClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_TOPSConservativeETFPortfolioClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_TOPSModerateETFPortfolioClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_TOPSModeratelyAggressiveETFPortfolioClass1Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsBalancedPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsConservativeAllocationPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsEquityIncomePortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsEquityIndexPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsGrowthPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsInternationalPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsMidCapIndexPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsPRIMECAPPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsTotalBondMarketIndexPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_PortfolioCompanyAxis=ck0000948923_VanguardVariableInsuranceFundsTotalStockMarketIndexPortfolioMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_First10PolicyYearsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_OnOrAfterFebruary12024ButBeforeOctober132025Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_OnOrAfterOctober132025Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_OnOrBeforeFebruary12024Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_OnOrBeforeOctober132025Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_PolicyYearsAfter10Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_AccidentalDeathBenefitRiderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_AdministrativeChargeForFaceAmountIncreasesMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_AfterOctober132025Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_AdministrativeChargeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_PoliciesWithApplicationSignedOnOrAfterOctoberTwoPolicyYearsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_GenerationAxis=ck0000948923_PoliciesWithApplicationSignedOnOrAfterOctoberYearsThereafterMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_ChildrensTermLifeInsuranceRiderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_DollarCostAveragingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_ExtendCareChronicIllnessAcceleratedDeathBenefitRiderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_ExtendCareRiderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_IncomeProviderOptionPreDeterminedDeathBenefitPayoutEndorsementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_InterestRateBeforeOctober132025Member

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_InterestRateMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_LapseProtectionEndorsementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_Option1DeathBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_Option2DeathBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_Option3DeathBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_Option4DeathBenefitMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_OverloanProtectionEndorsementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_PolicyIllustrationFeeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_PolicyLoansMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_PortfolioRebalancingMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_ProtectedInsurabilityBenefitRiderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_ReservationOfRightsMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_StandardMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_TelephoneTransfersMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_TerminalIllnessAcceleratedDeathBenefitEndorsementMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_WaiverOfSpecifiedPremiumRiderMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

X

- Details

Name: vip_BenefitAxis=ck0000948923_WithdrawalChargeMember

Namespace Prefix:

Data Type: na

Balance Type:

Period Type:

XML 37 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 110 94 1 true 98 0 false 2 false false R1.htm 010006 - Disclosure - N-6 Sheet http://xbrl.sec.gov/vip/role/N6 N-6 Cover 1 false false All Reports Book All Reports ck0000948923-20260423.xsd ck0000948923-20260423_def.xml ck0000948923-20260423_lab.xml ck0000948923-20260423_pre.xml tm262570d1_485bpos.htm http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/vip/2026 true false JSON 39 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm262570d1_485bpos.htm": { "nsprefix": "ck0000948923", "nsuri": "http://protectivelife.com/20260423", "dts": { "schema": { "local": [ "ck0000948923-20260423.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.sec.gov/dei/2026/dei-2026.xsd", "https://xbrl.sec.gov/vip/2026/vip-2026.xsd", "https://xbrl.sec.gov/vip/2026/vip-n6-2026.xsd" ] }, "definitionLink": { "local": [ "ck0000948923-20260423_def.xml" ] }, "labelLink": { "local": [ "ck0000948923-20260423_lab.xml" ] }, "presentationLink": { "local": [ "ck0000948923-20260423_pre.xml" ] }, "inline": { "local": [ "tm262570d1_485bpos.htm" ] } }, "keyStandard": 94, "keyCustom": 0, "axisStandard": 4, "axisCustom": 0, "memberStandard": 5, "memberCustom": 93, "hidden": { "total": 13, "http://xbrl.sec.gov/vip/2026": 11, "http://xbrl.sec.gov/dei/2026": 2 }, "contextCount": 110, "entityCount": 1, "segmentCount": 98, "elementCount": 394, "unitCount": 2, "baseTaxonomies": { "http://xbrl.sec.gov/vip/2026": 547, "http://xbrl.sec.gov/dei/2026": 6 }, "report": { "R1": { "role": "http://xbrl.sec.gov/vip/role/N6", "longName": "010006 - Disclosure - N-6", "shortName": "N-6", "isDefault": "true", "groupType": "Prospectus", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "dei:EntityInvCompanyType", "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm262570d1_485bpos.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c0", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "dei:EntityInvCompanyType", "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "tm262570d1_485bpos.htm", "first": true, "unique": true } } }, "tag": { "ck0000948923_AccidentalDeathBenefitRiderMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AccidentalDeathBenefitRiderMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Accidental Death Benefit Rider [Member]", "label": "Accidental Death Benefit Rider Member" } } }, "auth_ref": [] }, "vip_AdditionalInformationStandardDeathBenefitsNoteN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdditionalInformationStandardDeathBenefitsNoteN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Additional Information about Standard Death Benefits, Note (N-6) [Text Block]" } } }, "auth_ref": [ "r3" ] }, "ck0000948923_AdministrativeChargeForFaceAmountIncreasesMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AdministrativeChargeForFaceAmountIncreasesMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative Charge For Face Amount Increases [Member]", "label": "Administrative Charge For Face Amount Increases Member" } } }, "auth_ref": [] }, "ck0000948923_AdministrativeChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AdministrativeChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Administrative Charge [Member]", "label": "Administrative Charge Member" } } }, "auth_ref": [] }, "vip_AdministrativeExpenseCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Current [Dollars]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expenses, Description [Text Block]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Footnotes [Text Block]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Maximum [Dollars]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense, Minimum [Dollars]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfAverageAccountValueCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfAverageAccountValueCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Average Account Value), Current [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfAverageAccountValueMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfAverageAccountValueMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Average Account Value), Maximum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfAverageAccountValueMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfAverageAccountValueMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Average Account Value), Minimum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expense (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expenses, Representative Investor [Text Block]" } } }, "auth_ref": [ "r53" ] }, "vip_AdministrativeExpenseWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AdministrativeExpenseWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Administrative Expenses, When Deducted [Text Block]" } } }, "auth_ref": [ "r53" ] }, "ck0000948923_AdvisoryFeeRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AdvisoryFeeRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Advisory Fee Risk [Member]", "label": "Advisory Fee Risk Member" } } }, "auth_ref": [] }, "ck0000948923_AfterOctober132025Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AfterOctober132025Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "After October 13, 2025 [Member]", "label": "After October132025 Member" } } }, "auth_ref": [] }, "vip_AllBenefitsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllBenefitsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Benefits:" } } }, "auth_ref": [ "r5" ] }, "vip_AllClassesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllClassesMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Classes:" } } }, "auth_ref": [ "r41" ] }, "vip_AllContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllContractsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Contracts:" } } }, "auth_ref": [ "r41" ] }, "vip_AllPortfolioCompaniesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllPortfolioCompaniesMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Portfolio Companies:" } } }, "auth_ref": [ "r16" ] }, "vip_AllRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AllRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "All Risks:" } } }, "auth_ref": [ "r31" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AmendmentDescription", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AmendmentFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AmericanFundsInsuranceSeriesAssetAllocationFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae Asset Allocation Fund - Class 1 [Member]", "label": "American Funds Insurance Series Asset Allocation Fund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AmericanFundsInsuranceSeriesGlobalGrowthFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae Global Growth Fund - Class 1 [Member]", "label": "American Funds Insurance Series Global Growth Fund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AmericanFundsInsuranceSeriesGrowthIncomeFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae Growth-Income Fund - Class 1 [Member]", "label": "American Funds Insurance Series Growth Income Fund Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_AmericanFundsInsuranceSeriesNewWorldFundClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "AmericanFundsInsuranceSeriesNewWorldFundClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "American Funds Insurance Series\u00ae New World Fund\u00ae - Class 1 [Member]", "label": "American Funds Insurance Series New World Fund Class1 Member" } } }, "auth_ref": [] }, "vip_AnnualMaintenanceFeeCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Current [Dollars]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Description [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Footnotes [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Maximum [Dollars]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Minimum [Dollars]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfPolicyValueCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfPolicyValueCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Policy Value), Current [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfPolicyValueMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfPolicyValueMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Policy Value), Maximum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeOfPolicyValueMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeOfPolicyValueMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee (of Policy Value), Minimum [Percent]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, Representative Investor [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualMaintenanceFeeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualMaintenanceFeeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Maintenance Fee, When Deducted [Text Block]" } } }, "auth_ref": [ "r51" ] }, "vip_AnnualPortfolioCompanyExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AnnualPortfolioCompanyExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Annual Portfolio Company Expenses [Table Text Block]" } } }, "auth_ref": [ "r56" ] }, "vip_AverageAnnualTotalReturns10YearsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AverageAnnualTotalReturns10YearsPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Average Annual Total Returns, 10 Years [Percent]" } } }, "auth_ref": [ "r16" ] }, "vip_AverageAnnualTotalReturns1YearPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AverageAnnualTotalReturns1YearPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Average Annual Total Returns, 1 Year [Percent]" } } }, "auth_ref": [ "r16" ] }, "vip_AverageAnnualTotalReturns5YearsPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "AverageAnnualTotalReturns5YearsPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Average Annual Total Returns, 5 Years [Percent]" } } }, "auth_ref": [ "r16" ] }, "vip_BenefitAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefit [Axis]" } } }, "auth_ref": [ "r5" ] }, "vip_BenefitNotAvailablePortfolioCompanyFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitNotAvailablePortfolioCompanyFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefit Not Available for Portfolio Company [Flag]" } } }, "auth_ref": [ "r18" ] }, "vip_BenefitStandardOrOptionalTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitStandardOrOptionalTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefit Standard or Optional [Text Block]" } } }, "auth_ref": [ "r13" ] }, "vip_BenefitsAvailablePortfolioCompaniesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsAvailablePortfolioCompaniesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Available for Portfolio Companies [Table Text Block]" } } }, "auth_ref": [ "r19" ] }, "vip_BenefitsAvailableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsAvailableTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Available [Table Text Block]" } } }, "auth_ref": [ "r5" ] }, "vip_BenefitsDescriptionTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsDescriptionTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Description [Table Text Block]" } } }, "auth_ref": [ "r15" ] }, "vip_BenefitsLimitationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BenefitsLimitationTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Benefits Limitation [Table Text Block]" } } }, "auth_ref": [ "r9" ] }, "ck0000948923_BlackRockGlobalAllocationVIFundClassIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "BlackRockGlobalAllocationVIFundClassIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "BlackRock Global Allocation V.I. Fund - Class I [Member]", "label": "Black Rock Global Allocation VIFund Class IMember" } } }, "auth_ref": [] }, "vip_BriefRestrictionsLimitationsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "BriefRestrictionsLimitationsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Brief Restrictions / Limitations [Text Block]" } } }, "auth_ref": [ "r14" ] }, "ck0000948923_BusinessDisruptionAndCyberSecurityRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "BusinessDisruptionAndCyberSecurityRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Business Disruption and Cyber Security Risks [Member]", "label": "Business Disruption And Cyber Security Risks Member" } } }, "auth_ref": [] }, "vip_CalculationMethodOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CalculationMethodOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Calculation Method of Benefit [Text Block]" } } }, "auth_ref": [ "r8" ] }, "vip_ChargesContractValuesNoteN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ChargesContractValuesNoteN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Charges and Contract Values, Note (N-6) [Text Block]" } } }, "auth_ref": [ "r4" ] }, "vip_ChargesForEarlyWithdrawalsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ChargesForEarlyWithdrawalsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Charges for Early Withdrawals [Text Block]" } } }, "auth_ref": [ "r26" ] }, "ck0000948923_ChildrensTermLifeInsuranceRiderMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "ChildrensTermLifeInsuranceRiderMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Children's Term Life Insurance Rider [Member]", "label": "Childrens Term Life Insurance Rider Member" } } }, "auth_ref": [] }, "vip_ClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ClassAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Class [Axis]" } } }, "auth_ref": [ "r41" ] }, "ck0000948923_ClearBridgeVariableMidCapPortfolioClassIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "ClearBridgeVariableMidCapPortfolioClassIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "ClearBridge Variable Mid Cap Portfolio - Class I [Member]", "label": "Clear Bridge Variable Mid Cap Portfolio Class IMember" } } }, "auth_ref": [] }, "ck0000948923_ClearBridgeVariableSmallCapGrowthPortfolioClassIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "ClearBridgeVariableSmallCapGrowthPortfolioClassIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "ClearBridge Variable Small Cap Growth Portfolio - Class I [Member]", "label": "Clear Bridge Variable Small Cap Growth Portfolio Class IMember" } } }, "auth_ref": [] }, "vip_ContractAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ContractAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Contract [Axis]" } } }, "auth_ref": [ "r41" ] }, "vip_ContractLapseRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ContractLapseRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Contract Lapse Risk [Member]" } } }, "auth_ref": [ "r35" ] }, "vip_CurrentExpensesPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CurrentExpensesPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Current Expenses [Percent]" } } }, "auth_ref": [ "r21" ] }, "vip_CurrentExpensesPlatformChargePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CurrentExpensesPlatformChargePercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Current Expenses + Platform Charge [Percent]" } } }, "auth_ref": [ "r23" ] }, "vip_CurrentGenerationMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "CurrentGenerationMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Current Generation:" } } }, "auth_ref": [ "r5" ] }, "vip_DeferredSalesChargeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesChargeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Charge, Description [Text Block]" } } }, "auth_ref": [ "r43" ] }, "vip_DeferredSalesChargeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesChargeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Charge, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_DeferredSalesLoadCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Current [Dollars]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Footnotes [Text Block]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Maximum [Dollars]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load, Minimum [Dollars]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfAmountSurrenderedCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfAmountSurrenderedCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Amount Surrendered), Current [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfAmountSurrenderedMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfAmountSurrenderedMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Amount Surrendered), Maximum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfAmountSurrenderedMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfAmountSurrenderedMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Amount Surrendered), Minimum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfPurchasePaymentsCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfPurchasePaymentsCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Purchase Payments), Current [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfPurchasePaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfPurchasePaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Purchase Payments), Maximum [Percent]" } } }, "auth_ref": [ "r46" ] }, "vip_DeferredSalesLoadOfPurchasePaymentsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "DeferredSalesLoadOfPurchasePaymentsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Deferred Sales Load (of Purchase Payments), Minimum [Percent]" } } }, "auth_ref": [ "r46" ] }, "ck0000948923_DimensionalVAGlobalModerateAllocationPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DimensionalVAGlobalModerateAllocationPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA Global Moderate Allocation Portfolio - Institutional Class [Member]", "label": "Dimensional VAGlobal Moderate Allocation Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVAInternationalSmallPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DimensionalVAInternationalSmallPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA International Small Portfolio - Institutional Class [Member]", "label": "Dimensional VAInternational Small Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVAInternationalValuePortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DimensionalVAInternationalValuePortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA International Value Portfolio - Institutional Class [Member]", "label": "Dimensional VAInternational Value Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVAShortTermFixedPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DimensionalVAShortTermFixedPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA Short-Term Fixed Portfolio - Institutional Class [Member]", "label": "Dimensional VAShort Term Fixed Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVAUSLargeValuePortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DimensionalVAUSLargeValuePortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA U.S. Large Value Portfolio - Institutional Class [Member]", "label": "Dimensional VAUSLarge Value Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVAUSTargetedValuePortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DimensionalVAUSTargetedValuePortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VA U.S. Targeted Value Portfolio - Institutional Class [Member]", "label": "Dimensional VAUSTargeted Value Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DimensionalVITInflationProtectedSecuritiesPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dimensional VIT Inflation-Protected Securities Portfolio - Institutional Class [Member]", "label": "Dimensional VITInflation Protected Securities Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentPeriodEndDate", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentType", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ck0000948923_DollarCostAveragingMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "DollarCostAveragingMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Dollar-Cost Averaging [Member]", "label": "Dollar Cost Averaging Member" } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCentralIndexKey", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r0" ] }, "dei_EntityInvCompanyType": { "xbrltype": "invCompanyType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityInvCompanyType", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Entity Investment Company Type", "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)." } } }, "auth_ref": [ "r60" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityRegistrantName", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r0" ] }, "vip_ExpenseRiskFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Current [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Description [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, Representative Investor [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_ExpenseRiskFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ExpenseRiskFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Expense Risk Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r52" ] }, "ck0000948923_ExtendCareChronicIllnessAcceleratedDeathBenefitRiderMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "ExtendCareChronicIllnessAcceleratedDeathBenefitRiderMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "ExtendCare Chronic Illness Accelerated Death Benefit Rider [Member]", "label": "Extend Care Chronic Illness Accelerated Death Benefit Rider Member" } } }, "auth_ref": [] }, "ck0000948923_ExtendCareRiderMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "ExtendCareRiderMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "ExtendCare Rider [Member]", "label": "Extend Care Rider Member" } } }, "auth_ref": [] }, "vip_FeeTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "FeeTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 4. Fee Table [Text Block]" } } }, "auth_ref": [ "r42" ] }, "vip_FeesCostsBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "FeesCostsBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Fees and Costs of Benefit [Text Block]" } } }, "auth_ref": [ "r7" ] }, "ck0000948923_FidelityVIPBalancedPortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "FidelityVIPBalancedPortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Balanced Portfolio - Initial Class [Member]", "label": "Fidelity VIPBalanced Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "FidelityVIPGrowthOpportunitiesPortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Growth Opportunities Portfolio - Initial Class [Member]", "label": "Fidelity VIPGrowth Opportunities Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_FidelityVIPInvestmentGradeBondPortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "FidelityVIPInvestmentGradeBondPortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Investment Grade Bond Portfolio - Initial Class [Member]", "label": "Fidelity VIPInvestment Grade Bond Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_FidelityVIPMidCapPortfolioInitialClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "FidelityVIPMidCapPortfolioInitialClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fidelity\u00ae VIP Mid Cap Portfolio - Initial Class [Member]", "label": "Fidelity VIPMid Cap Portfolio Initial Class Member" } } }, "auth_ref": [] }, "ck0000948923_First10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "First10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "First 10 Policy Years [Member]", "label": "First10 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_FundRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "FundRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Fund Risks [Member]", "label": "Fund Risks Member" } } }, "auth_ref": [] }, "vip_GenerationAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GenerationAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Generation [Axis]" } } }, "auth_ref": [ "r5" ] }, "ck0000948923_GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "GoldmanSachsVITCoreFixedIncomeFundInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Goldman Sachs VIT Core Fixed Income Fund - Institutional Class [Member]", "label": "Goldman Sachs VITCore Fixed Income Fund Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_GoldmanSachsVITMidCapValueFundInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "GoldmanSachsVITMidCapValueFundInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Goldman Sachs VIT Mid Cap Value Fund - Institutional Class [Member]", "label": "Goldman Sachs VITMid Cap Value Fund Institutional Class Member" } } }, "auth_ref": [] }, "vip_GuaranteedMinimumAccumulationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumAccumulationTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Accumulation [Text Block]" } } }, "auth_ref": [ "r11" ] }, "vip_GuaranteedMinimumDeathBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumDeathBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Death Benefit [Text Block]" } } }, "auth_ref": [ "r11" ] }, "vip_GuaranteedMinimumIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Income [Text Block]" } } }, "auth_ref": [ "r11" ] }, "vip_GuaranteedMinimumWithdrawalTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "GuaranteedMinimumWithdrawalTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Guaranteed Minimum Withdrawal [Text Block]" } } }, "auth_ref": [ "r11" ] }, "ck0000948923_IncomeProviderOptionPreDeterminedDeathBenefitPayoutEndorsementMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "IncomeProviderOptionPreDeterminedDeathBenefitPayoutEndorsementMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Income Provider Option Pre-Determined Death Benefit Payout Endorsement [Member]", "label": "Income Provider Option Pre Determined Death Benefit Payout Endorsement Member" } } }, "auth_ref": [] }, "vip_InsuranceCompanyRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCompanyRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Company Risk [Member]" } } }, "auth_ref": [ "r34" ] }, "vip_InsuranceCostCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Current [Dollars]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Description [Text Block]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Footnotes [Text Block]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Maximum [Dollars]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Minimum [Dollars]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, Representative Investor [Text Block]" } } }, "auth_ref": [ "r50" ] }, "vip_InsuranceCostWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InsuranceCostWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Insurance Cost, When Deducted [Text Block]" } } }, "auth_ref": [ "r50" ] }, "ck0000948923_InterestRateBeforeOctober132025Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InterestRateBeforeOctober132025Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Before October 13 2025 [Member]", "label": "Interest Rate Before October132025 Member" } } }, "auth_ref": [] }, "ck0000948923_InterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InterestRateMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate [Member]", "label": "Interest Rate Member" } } }, "auth_ref": [] }, "ck0000948923_InvescoVIGlobalFundSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InvescoVIGlobalFundSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. Global Fund - Series I [Member]", "label": "Invesco VIGlobal Fund Series IMember" } } }, "auth_ref": [] }, "ck0000948923_InvescoVISP500BufferDecemberFundSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InvescoVISP500BufferDecemberFundSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. S&P 500 Buffer December Fund - Series\u00a0I [Member]", "label": "Invesco VISP500 Buffer December Fund Series IMember" } } }, "auth_ref": [] }, "ck0000948923_InvescoVISP500BufferJuneFundSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InvescoVISP500BufferJuneFundSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. S&P 500 Buffer June Fund - Series I [Member]", "label": "Invesco VISP500 Buffer June Fund Series IMember" } } }, "auth_ref": [] }, "ck0000948923_InvescoVISP500BufferMarchFundSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InvescoVISP500BufferMarchFundSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. S&P 500 Buffer March Fund - Series I [Member]", "label": "Invesco VISP500 Buffer March Fund Series IMember" } } }, "auth_ref": [] }, "ck0000948923_InvescoVISP500BufferSeptemberFundSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InvescoVISP500BufferSeptemberFundSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. S&P 500 Buffer September Fund - Series I [Member]", "label": "Invesco VISP500 Buffer September Fund Series IMember" } } }, "auth_ref": [] }, "ck0000948923_InvescoVIUSGovernmentMoneyPortfolioSeriesIMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "InvescoVIUSGovernmentMoneyPortfolioSeriesIMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Invesco\u00ae V.I. U.S. Government Money Portfolio - Series I [Member]", "label": "Invesco VIUSGovernment Money Portfolio Series IMember" } } }, "auth_ref": [] }, "vip_InvestmentOptionsFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options Footnotes [Text Block]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfAverageAnnualNetAssetsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfAverageAnnualNetAssetsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Average Annual Net Assets) Maximum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfAverageAnnualNetAssetsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfAverageAnnualNetAssetsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Average Annual Net Assets) Minimum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Other Amount) Maximum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options (of Other Amount) Minimum [Percent]" } } }, "auth_ref": [ "r29" ] }, "vip_InvestmentOptionsRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "InvestmentOptionsRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Options Risk [Member]" } } }, "auth_ref": [ "r33" ] }, "vip_Item2KeyInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "Item2KeyInformationLineItems", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 2. Key Information [Line Items]" } } }, "auth_ref": [ "r24" ] }, "ck0000948923_JanusHendersonGlobalTechnologyAndInnovationPortfolioInstitutionalSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "JanusHendersonGlobalTechnologyAndInnovationPortfolioInstitutionalSharesMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Janus Henderson Global Technology and Innovation Portfolio - Institutional Shares [Member]", "label": "Janus Henderson Global Technology And Innovation Portfolio Institutional Shares Member" } } }, "auth_ref": [] }, "vip_KeyExchangesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyExchangesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Exchanges [Text Block]" } } }, "auth_ref": [ "r40" ] }, "vip_KeyFeesExpensesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyFeesExpensesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Fees and Expenses [Text Block]" } } }, "auth_ref": [ "r25" ] }, "vip_KeyInvestmentProfessionalCompensationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyInvestmentProfessionalCompensationTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Professional Compensation [Text Block]" } } }, "auth_ref": [ "r39" ] }, "vip_KeyInvestmentRestrictionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyInvestmentRestrictionsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Investment Restrictions [Text Block]" } } }, "auth_ref": [ "r36" ] }, "vip_KeyOptionalBenefitRestrictionsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyOptionalBenefitRestrictionsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Restrictions [Text Block]" } } }, "auth_ref": [ "r37" ] }, "vip_KeyTaxImplicationsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "KeyTaxImplicationsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Tax Implications [Text Block]" } } }, "auth_ref": [ "r38" ] }, "ck0000948923_LapseProtectionEndorsementMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "LapseProtectionEndorsementMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Lapse Protection Endorsement [Member]", "label": "Lapse Protection Endorsement Member" } } }, "auth_ref": [] }, "vip_LimitationsRestrictionsRisksTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "LimitationsRestrictionsRisksTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Limitations, Restrictions, and Risks of Benefit [Text Block]" } } }, "auth_ref": [ "r9" ] }, "ck0000948923_LoanRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "LoanRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Loan Risks [Member]", "label": "Loan Risks Member" } } }, "auth_ref": [] }, "ck0000948923_LordAbbettSeriesFundBondDebenturePortfolioClassVCMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "LordAbbettSeriesFundBondDebenturePortfolioClassVCMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Lord Abbett Series Fund - Bond Debenture Portfolio - Class VC [Member]", "label": "Lord Abbett Series Fund Bond Debenture Portfolio Class VCMember" } } }, "auth_ref": [] }, "vip_MortalityAndExpenseRiskFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Current [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality and Expense Risk Fees, Description [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality And Expense Risk Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality and Expense Risk Fees, Representative Investor [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityAndExpenseRiskFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityAndExpenseRiskFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality and Expense Risk Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Current [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Description [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, Representative Investor [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_MortalityRiskFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "MortalityRiskFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Mortality Risk Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r52" ] }, "vip_NameOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "NameOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Name of Benefit [Text Block]" } } }, "auth_ref": [ "r12" ] }, "ck0000948923_NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "NetCostOfLoansForCarryoverLoansAfterTheFirst10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost of Loans for Carryover Loans After the First 10 Policy Years [Member]", "label": "Net Cost Of Loans For Carryover Loans After The First10 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "NetCostOfLoansForCarryoverLoansDuringTheFirst10PolicyLoansMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost of Loans for Carryover Loans During the First 10 Policy Loans [Member]", "label": "Net Cost Of Loans For Carryover Loans During The First10 Policy Loans Member" } } }, "auth_ref": [] }, "ck0000948923_NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "NetCostOfLoansForStandardLoansAfterTheFirst10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost Of Loans For Standard Loans After The First10 Policy Years [Member]", "label": "Net Cost Of Loans For Standard Loans After The First10 Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "NetCostOfLoansForStandardLoansDuringTheFirst10PolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Net Cost Of Loans For Standard Loans During The First10 Policy Years [Member]", "label": "Net Cost Of Loans For Standard Loans During The First10 Policy Years Member" } } }, "auth_ref": [] }, "vip_NotShortTermInvestmentRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "NotShortTermInvestmentRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Not Short Term Investment Risk [Member]" } } }, "auth_ref": [ "r32" ] }, "vip_OfferedEndingDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OfferedEndingDate", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Offered Ending [Date]" } } }, "auth_ref": [ "r42" ] }, "vip_OfferedStartingDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OfferedStartingDate", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Offered Starting [Date]" } } }, "auth_ref": [ "r42" ] }, "ck0000948923_OnOrAfterFebruary12024ButBeforeOctober132025Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "OnOrAfterFebruary12024ButBeforeOctober132025Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "On or After February 1, 2024, But Before October 13, 2025 [Member]", "label": "On Or After February12024 But Before October132025 Member" } } }, "auth_ref": [] }, "ck0000948923_OnOrAfterOctober132025Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "OnOrAfterOctober132025Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "On or After October 13, 2025 [Member]", "label": "On Or After October132025 Member" } } }, "auth_ref": [] }, "ck0000948923_OnOrBeforeFebruary12024Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "OnOrBeforeFebruary12024Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "On or Before February 1, 2024 [Member]", "label": "On Or Before February12024 Member" } } }, "auth_ref": [] }, "ck0000948923_OnOrBeforeOctober132025Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "OnOrBeforeOctober132025Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "On or Before October 13, 2025 [Member]", "label": "On Or Before October132025 Member" } } }, "auth_ref": [] }, "vip_OngoingFeesAndExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OngoingFeesAndExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Ongoing Fees and Expenses [Table Text Block]" } } }, "auth_ref": [ "r28" ] }, "vip_OperationOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OperationOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Operation of Benefit [Text Block]" } } }, "auth_ref": [ "r6" ] }, "ck0000948923_Option1DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "Option1DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 1 Death Benefit [Member]", "label": "Option1 Death Benefit Member" } } }, "auth_ref": [] }, "ck0000948923_Option2DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "Option2DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 2 Death Benefit [Member]", "label": "Option2 Death Benefit Member" } } }, "auth_ref": [] }, "ck0000948923_Option3DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "Option3DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 3 Death Benefit [Member]", "label": "Option3 Death Benefit Member" } } }, "auth_ref": [] }, "ck0000948923_Option4DeathBenefitMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "Option4DeathBenefitMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Option 4 Death Benefit [Member]", "label": "Option4 Death Benefit Member" } } }, "auth_ref": [] }, "vip_OptionalBenefitChargeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitChargeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Charge, Description [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitChargeRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitChargeRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Charge, Representative [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitChargeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitChargeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Charge, When Deducted [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Current [Dollars]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Footnotes [Text Block]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Maximum [Dollars]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense, Minimum [Dollars]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfBenefitBaseCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfBenefitBaseCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Benefit Base), Current [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfBenefitBaseMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfBenefitBaseMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Benefit Base), Maximum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfBenefitBaseMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfBenefitBaseMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Benefit Base), Minimum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitExpenseOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitExpenseOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit Expense (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r54" ] }, "vip_OptionalBenefitFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OptionalBenefitFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Optional Benefit [Flag]" } } }, "auth_ref": [ "r13" ] }, "vip_OtherAnnualExpenseCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Current [Dollars]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Description [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Footnotes [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Maximum [Dollars]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Minimum [Dollars]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfAverageAccountValueCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfAverageAccountValueCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Average Account Value), Current [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfAverageAccountValueMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfAverageAccountValueMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Average Account Value), Maximum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfAverageAccountValueMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfAverageAccountValueMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Average Account Value), Minimum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfFaceAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfFaceAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Face Amount), Current [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfFaceAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfFaceAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Face Amount), Maximum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfFaceAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfFaceAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Face Amount), Minimum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseRepresentativeInvestorTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseRepresentativeInvestorTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, Representative [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherAnnualExpenseWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherAnnualExpenseWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Annual Expense, When Deducted [Text Block]" } } }, "auth_ref": [ "r55" ] }, "vip_OtherBenefitsAvailableN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherBenefitsAvailableN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 11. Other Benefits Available (N-6) [Text Block]" } } }, "auth_ref": [ "r5" ] }, "vip_OtherSurrenderFeesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Current [Dollars]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Description [Text Block]" } } }, "auth_ref": [ "r46" ] }, "vip_OtherSurrenderFeesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Footnotes [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Maximum [Dollars]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, Minimum [Dollars]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherSurrenderFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherSurrenderFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Surrender Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_OtherTransactionFee1CurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1CurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1MaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1MaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1MinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1MinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1OfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1OfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1 (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1OfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1OfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1 (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee1OfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee1OfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 1 (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2CurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2CurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2MaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2MaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2MinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2MinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2OfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2OfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2 (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2OfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2OfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2 (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee2OfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee2OfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 2 (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3CurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3CurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3MaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3MaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3MinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3MinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3OfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3OfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3 (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3OfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3OfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3 (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFee3OfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFee3OfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee 3 (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Current [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Description [Text Block]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Footnotes [Text Block]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Maximum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Minimum [Dollars]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, Current [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r48" ] }, "vip_OtherTransactionFeeWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "OtherTransactionFeeWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Other Transaction Fee, When Deducted [Text Block]" } } }, "auth_ref": [ "r48" ] }, "ck0000948923_OverloanProtectionEndorsementMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "OverloanProtectionEndorsementMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Overloan Protection Endorsement [Member]", "label": "Overloan Protection Endorsement Member" } } }, "auth_ref": [] }, "ck0000948923_PIMCOVITRealReturnPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PIMCOVITRealReturnPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "PIMCO VIT Real Return Portfolio - Institutional Class [Member]", "label": "PIMCOVITReal Return Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "ck0000948923_PIMCOVITTotalReturnPortfolioInstitutionalClassMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PIMCOVITTotalReturnPortfolioInstitutionalClassMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "PIMCO VIT Total Return Portfolio - Institutional Class [Member]", "label": "PIMCOVITTotal Return Portfolio Institutional Class Member" } } }, "auth_ref": [] }, "vip_PeriodicChargesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PeriodicChargesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Periodic Charges [Table Text Block]" } } }, "auth_ref": [ "r49" ] }, "vip_PlatformChargePercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PlatformChargePercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Platform Charge [Percent]" } } }, "auth_ref": [ "r22" ] }, "vip_PlatformChargeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PlatformChargeTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Platform Charge [Text Block]" } } }, "auth_ref": [ "r22" ] }, "ck0000948923_PoliciesWithApplicationSignedOnOrAfterOctoberTwoPolicyYearsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PoliciesWithApplicationSignedOnOrAfterOctoberTwoPolicyYearsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Policies With Application Signed On Or After October Two Policy Years [Member]", "label": "Policies With Application Signed On Or After October Two Policy Years Member" } } }, "auth_ref": [] }, "ck0000948923_PoliciesWithApplicationSignedOnOrAfterOctoberYearsThereafterMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PoliciesWithApplicationSignedOnOrAfterOctoberYearsThereafterMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Policies With Application Signed On Or After October Years Thereafter [Member]", "label": "Policies With Application Signed On Or After October Years Thereafter Member" } } }, "auth_ref": [] }, "ck0000948923_PolicyIllustrationFeeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PolicyIllustrationFeeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Policy Illustration Fee [Member]", "label": "Policy Illustration Fee Member" } } }, "auth_ref": [] }, "ck0000948923_PolicyLoansMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PolicyLoansMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Policy Loans [Member]", "label": "Policy Loans Member" } } }, "auth_ref": [] }, "ck0000948923_PolicyYearsAfter10Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PolicyYearsAfter10Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Policy Years After 10 [Member]", "label": "Policy Years After10 Member" } } }, "auth_ref": [] }, "vip_PortfolioCompaniesN6TextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompaniesN6TextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 18. Portfolio Companies (N-6) [Text Block]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompaniesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompaniesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Companies [Table Text Block]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompanyAdviserTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyAdviserTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Adviser [Text Block]" } } }, "auth_ref": [ "r20" ] }, "vip_PortfolioCompanyAvailableWithBenefitFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyAvailableWithBenefitFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Available with Benefit [Flag]" } } }, "auth_ref": [ "r18" ] }, "vip_PortfolioCompanyAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company [Axis]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompanyExpensesAfterWaiversAndReimbursementMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesAfterWaiversAndReimbursementMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses After Waivers and Reimbursement Maximum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesAfterWaiversAndReimbursementMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesAfterWaiversAndReimbursementMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses After Waivers and Reimbursement Minimum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesBeforeWaiversAndReimbursementMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesBeforeWaiversAndReimbursementMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Before Waivers and Reimbursement Maximum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesBeforeWaiversAndReimbursementMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesBeforeWaiversAndReimbursementMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Before Waivers and Reimbursement Minimum [Percent]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses, Footnotes [Text Block]" } } }, "auth_ref": [ "r58" ] }, "vip_PortfolioCompanyExpensesMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Maximum [Percent] (Deprecated 2026-01-31)" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses Minimum [Percent] (Deprecated 2026-01-31)" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyExpensesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyExpensesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Expenses [Text Block]" } } }, "auth_ref": [ "r57" ] }, "vip_PortfolioCompanyNameTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyNameTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Name [Text Block]" } } }, "auth_ref": [ "r20" ] }, "vip_PortfolioCompanyObjectiveTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanyObjectiveTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Objective [Text Block]" } } }, "auth_ref": [ "r16" ] }, "vip_PortfolioCompanySubadviserTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PortfolioCompanySubadviserTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Portfolio Company Subadviser [Text Block]" } } }, "auth_ref": [ "r20" ] }, "ck0000948923_PortfolioRebalancingMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PortfolioRebalancingMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Portfolio Rebalancing [Member]", "label": "Portfolio Rebalancing Member" } } }, "auth_ref": [] }, "vip_PremiumTaxesCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Current [Dollars]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Description [Text Block]" } } }, "auth_ref": [ "r43" ] }, "vip_PremiumTaxesFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Footnotes [Text Block]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Maximum [Dollars]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, Minimum [Dollars]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfPremiumPaymentsCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfPremiumPaymentsCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Premium Payments), Current [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfPremiumPaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfPremiumPaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Premium Payments), Maximum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesOfPremiumPaymentsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesOfPremiumPaymentsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes (of Premium Payments), Minimum [Percent]" } } }, "auth_ref": [ "r42" ] }, "vip_PremiumTaxesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PremiumTaxesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Premium Taxes, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "vip_PreviouslyOfferedMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PreviouslyOfferedMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Previously Offered [Member]" } } }, "auth_ref": [ "r5" ] }, "vip_PrincipalRiskTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PrincipalRiskTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Principal Risk [Text Block]" } } }, "auth_ref": [ "r59" ] }, "vip_PrincipalRisksTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PrincipalRisksTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 5. Principal Risks [Table Text Block]" } } }, "auth_ref": [ "r59" ] }, "vip_ProspectusLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ProspectusLineItems", "lang": { "en-us": { "role": { "label": "Prospectus [Line Items]" } } }, "auth_ref": [] }, "vip_ProspectusTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ProspectusTable", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Prospectus:" } } }, "auth_ref": [] }, "vip_ProspectusesAvailableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "ProspectusesAvailableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Prospectuses Available [Text Block]" } } }, "auth_ref": [ "r17" ] }, "ck0000948923_ProtectedInsurabilityBenefitRiderMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "ProtectedInsurabilityBenefitRiderMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Protected Insurability Benefit Rider [Member]", "label": "Protected Insurability Benefit Rider Member" } } }, "auth_ref": [] }, "vip_PurposeOfBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "PurposeOfBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Purpose of Benefit [Text Block]" } } }, "auth_ref": [ "r10" ] }, "ck0000948923_PutnamVTSustainableLeadersFundClassIAMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "PutnamVTSustainableLeadersFundClassIAMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Putnam VT Sustainable Leaders Fund - Class IA [Member]", "label": "Putnam VTSustainable Leaders Fund Class IAMember" } } }, "auth_ref": [] }, "ck0000948923_ReservationOfRightsMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "ReservationOfRightsMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Reservation of Rights [Member]", "label": "Reservation Of Rights Member" } } }, "auth_ref": [] }, "vip_RiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RiskAxis", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risk [Axis]" } } }, "auth_ref": [ "r31" ] }, "vip_RiskOfLossMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RiskOfLossMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risk of Loss [Member]" } } }, "auth_ref": [ "r31" ] }, "vip_RiskTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RiskTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risk [Text Block]" } } }, "auth_ref": [ "r30" ] }, "vip_RisksTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "RisksTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Risks [Table Text Block]" } } }, "auth_ref": [ "r30" ] }, "vip_SalesLoadDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load, Description [Text Block]" } } }, "auth_ref": [ "r43" ] }, "vip_SalesLoadFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load, Footnotes [Text Block]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfPremiumPaymentsCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfPremiumPaymentsCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Premium Payments), Current [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfPremiumPaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfPremiumPaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Premium Payments), Maximum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadOfPremiumPaymentsMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadOfPremiumPaymentsMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load (of Premium Payments), Minimum [Percent]" } } }, "auth_ref": [ "r45" ] }, "vip_SalesLoadWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SalesLoadWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Sales Load, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "ck0000948923_SchwabSP500IndexPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "SchwabSP500IndexPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Schwab\u00ae S&P 500 Index Portfolio [Member]", "label": "Schwab SP500 Index Portfolio Member" } } }, "auth_ref": [] }, "vip_SomePortfolioCompaniesNotAvailableForAllBenefitsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SomePortfolioCompaniesNotAvailableForAllBenefitsTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Some Portfolio Companies not Available for All Benefits [Text Block]" } } }, "auth_ref": [ "r18" ] }, "ck0000948923_SpecializedUsesOfThePolicyMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "SpecializedUsesOfThePolicyMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Specialized Uses of the Policy [Member]", "label": "Specialized Uses Of The Policy Member" } } }, "auth_ref": [] }, "vip_StandardBenefitFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "StandardBenefitFlag", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Standard Benefit [Flag]" } } }, "auth_ref": [ "r13" ] }, "vip_StandardDeathBenefitTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "StandardDeathBenefitTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Standard Death Benefit [Text Block]" } } }, "auth_ref": [ "r1" ] }, "vip_StandardDeathBenefitsN6TableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "StandardDeathBenefitsN6TableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Item 10. Standard Death Benefits (N-6) [Table Text Block]" } } }, "auth_ref": [ "r2" ] }, "ck0000948923_StandardMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "StandardMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Standard [Member]", "label": "Standard Member" } } }, "auth_ref": [] }, "vip_SurrenderChargeExampleMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeExampleMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge Example Maximum [Dollars]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge Footnotes [Text Block]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeOfAmountSurrenderedMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeOfAmountSurrenderedMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge (of Amount Surrendered) Maximum [Percent]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge (of Other Amount) Maximum [Percent]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargeOfPurchasePaymentsMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargeOfPurchasePaymentsMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge (of Purchase Payments) Maximum [Percent]" } } }, "auth_ref": [ "r26" ] }, "vip_SurrenderChargePeriodYears": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "SurrenderChargePeriodYears", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Surrender Charge Phaseout Period, Years" } } }, "auth_ref": [ "r26" ] }, "ck0000948923_TOPSAggressiveETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "TOPSAggressiveETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae Aggressive ETF Portfolio - Class 1 [Member]", "label": "TOPSAggressive ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TOPSConservativeETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "TOPSConservativeETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae Conservative ETF Portfolio - Class 1 [Member]", "label": "TOPSConservative ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TOPSModerateETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "TOPSModerateETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae Moderate ETF Portfolio - Class 1 [Member]", "label": "TOPSModerate ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TOPSModeratelyAggressiveETFPortfolioClass1Member": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "TOPSModeratelyAggressiveETFPortfolioClass1Member", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "TOPS\u00ae Moderately Aggressive ETF Portfolio- Class 1 [Member]", "label": "TOPSModerately Aggressive ETFPortfolio Class1 Member" } } }, "auth_ref": [] }, "ck0000948923_TaxRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "TaxRiskMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Tax Risk [Member]", "label": "Tax Risk Member" } } }, "auth_ref": [] }, "ck0000948923_TelephoneTransfersMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "TelephoneTransfersMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Telephone Transfers [Member]", "label": "Telephone Transfers Member" } } }, "auth_ref": [] }, "vip_TemporaryFeeReductionsCurrentExpensesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TemporaryFeeReductionsCurrentExpensesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Temporary Fee Reductions, Current Expenses [Text Block]" } } }, "auth_ref": [ "r21" ] }, "ck0000948923_TerminalIllnessAcceleratedDeathBenefitEndorsementMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "TerminalIllnessAcceleratedDeathBenefitEndorsementMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Terminal Illness Accelerated Death Benefit Endorsement [Member]", "label": "Terminal Illness Accelerated Death Benefit Endorsement Member" } } }, "auth_ref": [] }, "vip_TransactionChargesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransactionChargesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transaction Charges [Text Block]" } } }, "auth_ref": [ "r27" ] }, "vip_TransactionExpensesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransactionExpensesTableTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transaction Expenses [Table Text Block]" } } }, "auth_ref": [ "r45" ] }, "vip_TransferFeeCurrentDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeCurrentDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Current [Dollars]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeFootnotesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeFootnotesTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Footnotes [Text Block]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeMaximumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeMaximumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Maximum [Dollars]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeMinimumDollars": { "xbrltype": "nonNegativeMonetaryItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeMinimumDollars", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee, Minimum [Dollars]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfAmountTransferredCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfAmountTransferredCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Amount Transferred), Current [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfAmountTransferredMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfAmountTransferredMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Amount Transferred), Maximum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfAmountTransferredMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfAmountTransferredMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Amount Transferred), Minimum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfOtherAmountCurrentPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfOtherAmountCurrentPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Other Amount), Current [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfOtherAmountMaximumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfOtherAmountMaximumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Other Amount), Maximum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeeOfOtherAmountMinimumPercent": { "xbrltype": "percentItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeeOfOtherAmountMinimumPercent", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fee (of Other Amount), Minimum [Percent]" } } }, "auth_ref": [ "r47" ] }, "vip_TransferFeesDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeesDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fees, Description [Text Block]" } } }, "auth_ref": [ "r42" ] }, "vip_TransferFeesWhenDeductedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/vip/2026", "localname": "TransferFeesWhenDeductedTextBlock", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "label": "Transfer Fees, When Deducted [Text Block]" } } }, "auth_ref": [ "r44" ] }, "ck0000948923_VanguardVariableInsuranceFundsBalancedPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsBalancedPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Balanced Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Balanced Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsConservativeAllocationPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsConservativeAllocationPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Conservative Allocation Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Conservative Allocation Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsEquityIncomePortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsEquityIncomePortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Equity Income Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Equity Income Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsEquityIndexPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsEquityIndexPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Equity Index Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Equity Index Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsGrowthPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsGrowthPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Growth Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Growth Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsInternationalPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsInternationalPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - International Portfolio [Member]", "label": "Vanguard Variable Insurance Funds International Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsMidCapIndexPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsMidCapIndexPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Mid-Cap Index Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Mid Cap Index Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsPRIMECAPPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsPRIMECAPPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - PRIMECAP Portfolio [Member]", "label": "Vanguard Variable Insurance Funds PRIMECAPPortfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsRealEstateIndexPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Real Estate Index Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Real Estate Index Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsTotalBondMarketIndexPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsTotalBondMarketIndexPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Total Bond Market Index Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Total Bond Market Index Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_VanguardVariableInsuranceFundsTotalStockMarketIndexPortfolioMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "VanguardVariableInsuranceFundsTotalStockMarketIndexPortfolioMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Vanguard Variable Insurance Funds - Total Stock Market Index Portfolio [Member]", "label": "Vanguard Variable Insurance Funds Total Stock Market Index Portfolio Member" } } }, "auth_ref": [] }, "ck0000948923_WaiverOfSpecifiedPremiumRiderMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "WaiverOfSpecifiedPremiumRiderMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Waiver of Specified Premium Rider [Member]", "label": "Waiver Of Specified Premium Rider Member" } } }, "auth_ref": [] }, "ck0000948923_WithdrawalAndSurrenderRisksMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "WithdrawalAndSurrenderRisksMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Withdrawal and Surrender Risks [Member]", "label": "Withdrawal And Surrender Risks Member" } } }, "auth_ref": [] }, "ck0000948923_WithdrawalChargeMember": { "xbrltype": "domainItemType", "nsuri": "http://protectivelife.com/20260423", "localname": "WithdrawalChargeMember", "presentation": [ "http://xbrl.sec.gov/vip/role/N6" ], "lang": { "en-us": { "role": { "terseLabel": "Withdrawal Charge [Member]", "label": "Withdrawal Charge Member" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10", "Subsection": "a" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10", "Subsection": "b" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "10", "Subsection": "c" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "b", "Subparagraph": "2" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "b", "Subparagraph": "3" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "b", "Subparagraph": "4" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Paragraph": "c" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "1" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "b" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "2" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "4" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "Instructions", "Paragraph": "5" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "11", "Subsection": "b" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "b" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "f" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "f", "Sentence": "2" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "3" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "4" }, "r22": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "5" }, "r23": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "18", "Subsection": "Instructions", "Paragraph": "6" }, "r24": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2" }, "r25": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2" }, "r26": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "a" }, "r27": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "b" }, "r28": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "c" }, "r29": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "c", "Sentence": "ii" }, "r30": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3" }, "r31": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "a" }, "r32": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "b" }, "r33": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "c" }, "r34": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "d" }, "r35": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "e" }, "r36": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "a" }, "r37": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "b" }, "r38": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "5" }, "r39": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "6", "Subparagraph": "a" }, "r40": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "2", "Subsection": "Instructions", "Paragraph": "6", "Subparagraph": "b" }, "r41": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "3" }, "r42": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4" }, "r43": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "b" }, "r44": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "1", "Subparagraph": "e" }, "r45": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2" }, "r46": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "a" }, "r47": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "b" }, "r48": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "2", "Subparagraph": "c" }, "r49": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3" }, "r50": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "b" }, "r51": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "c" }, "r52": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "d" }, "r53": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "e" }, "r54": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "f" }, "r55": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "3", "Subparagraph": "h" }, "r56": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "4" }, "r57": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "a" }, "r58": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "4", "Subsection": "Instructions", "Paragraph": "4", "Subparagraph": "b" }, "r59": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form N-6", "Section": "5" }, "r60": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "313" } } }